Compounds > triazoles
Page last updated: 2024-09-23

triazoles

Description

Triazoles: Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

triazoles : An azole in which the five-membered heterocyclic aromatic skeleton contains three N atoms and two C atoms. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID67516
CHEMBL ID2148102
CHEBI ID35565
CHEBI ID35566
MeSH IDM0021911

Synonyms (62)

Synonym
EN300-27201
1,2,3-triazole
v-triazole
1h-1,2,3-triazole
CHEBI:35565 ,
288-35-7
288-36-8
osotriazole
CHEBI:35566
1,2,3-1h-triazole
inchi=1/c2h3n3/c1-2-4-5-3-1/h1-2h,(h,3,4,5
2h-1,2,3-triazole
1h-1,2,3-triazole, 97%
triazoles
triazol
2h-triazole
T1880
A25412
1h-[1,2,3]triazole
[1,2,3]triazole
unii-em7554254w
em7554254w ,
CHEMBL2148102
1,2,3-triazol
A818904
27070-49-1
AKOS005207098
FT-0601191
AM20090377
AB01140
SY005819
mfcd00014490
triazacyclopentadiene
1h-1,2,3-triazol
1h-(1,2,3)-triazole
1-h-1,2,3-triazole
1h-[1,2,3]-triazole
2h-1, 2, 3-triazole
2h-(1,2,3)-triazole
1,2,3 triazole
2h-[1,2,3]triazole
1h-1,2,3 triazole
racemic triazole
1h1,2,3-triazole
1-h-1, 2, 3-triazole
STR09959
F1905-7135
PS-9378
J-509548
D70752
CS-B1285
BBL103173
2,3-diazapyrrole
STL556983
BCP18903
DTXSID30870495
Q161297
HUH ,
1~{h}-1,2,3-triazole
mfcd00962232
FT-0774760
Z237528494

Research Excerpts

Overview

ExcerptReference
"Triazoles are a major group of azole fungicides commonly used in agriculture, and veterinary and human medicine. "( Bhattacharya, B; Bondesson, M; Flores, S; Gustafsson, JÅ; Mesmar, F; Muhsen, M; Mukhopadhyay, S; Thrikawala, S; Upadhyay, S; Vergara, L; Williams, C, 2023)
"Triazoles are a class of aza-heterocycles with broad spectrum of biological importance. "( Darkwa, J; Makhubela, BCE; Meyer, D; Rono, CK, 2019)

Effects

ExcerptReference
"The triazoles presence has substantially affected the bioavailability of Fe, Cu and Zn in soil."( Ćavar Zeljković, S; Jakl, M; Jaklová Dytrtová, J; Kovač, I, 2021)
"Triazoles have been shown to be the most effective fungicide for managing Fusarium spp., but little is known about their specific activity on F."( Hellin, P; Legrève, A; Munaut, F; Scauflaire, J; Van Hese, V, 2017)
"The triazoles have been studied for over a century as an important class of heterocyclic compounds and still attract considerable attention due to their broad range of biological activities. "( Boechat, NA; da Rocha, DR; da Silva, FC; Ferreira, PG; Ferreira, VF; Magalhães, JL, 2013)

Drug Classes (1)

ClassDescription
1,2,3-triazole
1,2,3-triazole
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID701844Dissociation constant, pKa of the compound2012Journal of medicinal chemistry, Jul-12, Volume: 55, Issue:13
Mitigating heterocycle metabolism in drug discovery.
AID687184Dissociation constant, pKa of the compound at pH 2 to 3 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
AID687185Dissociation constant, pKa of the compound at pH 11 to 12 by spectrophotometric analysis2012Journal of medicinal chemistry, Jun-14, Volume: 55, Issue:11
Rational design of 4-aryl-1,2,3-triazoles for indoleamine 2,3-dioxygenase 1 inhibition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (24,888)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901657 (6.66)18.7374
1990's2146 (8.62)18.2507
2000's6407 (25.74)29.6817
2010's11834 (47.55)24.3611
2020's2844 (11.43)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2,252 (8.73%)5.53%
Reviews2,179 (8.44%)6.00%
Case Studies1,989 (7.71%)4.05%
Observational81 (0.31%)0.25%
Other19,307 (74.81%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceDescriptionRelationhip StrengthStudiesTrialsClassesRoles
imidazole[no description available]medium460imidazole
pyrazole[no description available]medium270pyrazole
pyridine[no description available]medium410azaarene;
mancude organic heteromonocyclic parent;
monocyclic heteroarene;
pyridines		environmental contaminant;
NMR chemical shift reference compound
piperazine[no description available]medium170azacycloalkane;
piperazines;
saturated organic heteromonocyclic parent		anthelminthic drug
pyrroles[no description available]medium1390pyrrole;
secondary amine
pyrroles[no description available]medium1399pyrrole;
secondary amine
piperidine[no description available]medium80azacycloalkane;
piperidines;
saturated organic heteromonocyclic parent;
secondary amine		base;
catalyst;
human metabolite;
non-polar solvent;
plant metabolite;
protic solvent;
reagent
morpholine[no description available]medium80morpholines;
saturated organic heteromonocyclic parent		NMR chemical shift reference compound
hexahydroazepine[no description available]medium10azacycloalkane;
azepanes;
saturated organic heteromonocyclic parent
isoxazoles[no description available]medium880isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
isoxazoles[no description available]medium885isoxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
oxazoles[no description available]medium7901,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
oxazoles[no description available]medium7931,3-oxazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
thiazoles[no description available]medium35001,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
thiazoles[no description available]medium35091,3-thiazoles;
mancude organic heteromonocyclic parent;
monocyclic heteroarene
1,2,4-triazole[no description available]medium47901,2,4-triazole
1,2,4-triazole[no description available]medium47911,2,4-triazole
pyridazine[no description available]medium50diazine;
pyridazines
pyrimidine[no description available]medium440diazine;
pyrimidines		Daphnia magna metabolite
pyrazines[no description available]medium9030diazine;
pyrazines		Daphnia magna metabolite
pyrazines[no description available]medium903223diazine;
pyrazines		Daphnia magna metabolite
azetidine[no description available]medium30azacycloalkane;
azetidines;
saturated organic heteromonocyclic parent
pyrrolidine[no description available]medium100azacycloalkane;
pyrrolidines;
saturated organic heteromonocyclic parent
1h-tetrazole[no description available]medium110one-carbon compound;
tetrazole
bms 665053[no description available]medium10
phenol[no description available]medium80phenolsantiseptic drug;
disinfectant;
human xenobiotic metabolite;
mouse metabolite
benzotriazole[no description available]medium4550benzotriazolesenvironmental contaminant;
xenobiotic
5-tolyltriazole[no description available]medium120benzotriazolesenvironmental contaminant;
xenobiotic
4,4'-bipyridyl[no description available]medium20bipyridine
4-phenylpyridine[no description available]medium10phenylpyridine
4-phenylpyrimidine[no description available]medium10biaryl;
pyrimidines
4(5)-phenylimidazole[no description available]medium10
posaconazole[no description available]medium1,474102aromatic ether;
conazole antifungal drug;
N-arylpiperazine;
organofluorine compound;
oxolanes;
triazole antifungal drug;
triazoles		trypanocidal drug
2-(2-(acetylamino)-4-(n-(2-cyanoethyl)ethylamino)-5-methoxyphenyl)-5-amino-7-bromo-4-chloro-2h-benzotriazole[no description available]medium110
itraconazole[no description available]medium65815aromatic ether;
conazole antifungal drug;
cyclic ketal;
dichlorobenzene;
dioxolane;
N-arylpiperazine;
triazole antifungal drug;
triazoles		EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
Hedgehog signaling pathway inhibitor;
P450 inhibitor
selenium[no description available]medium120chalcogen;
nonmetal atom		micronutrient
voriconazole[no description available]medium2,548139conazole antifungal drug;
difluorobenzene;
pyrimidines;
tertiary alcohol;
triazole antifungal drug		P450 inhibitor
amphotericin b[no description available]medium1,05022antibiotic antifungal drug;
macrolide antibiotic;
polyene antibiotic		antiamoebic agent;
antiprotozoal drug;
bacterial metabolite
triadimefon[no description available]medium2150aromatic ether;
hemiaminal ether;
ketone;
monochlorobenzenes;
triazoles
suvorexant[no description available]medium191411,3-benzoxazoles;
aromatic amide;
diazepine;
organochlorine compound;
triazoles		central nervous system depressant;
orexin receptor antagonist
norfloxacin[no description available]medium20fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug;
DNA synthesis inhibitor;
environmental contaminant;
xenobiotic
pravastatin[no description available]medium613-hydroxy carboxylic acid;
carbobicyclic compound;
carboxylic ester;
hydroxy monocarboxylic acid;
secondary alcohol;
statin (semi-synthetic)		anticholesteremic drug;
environmental contaminant;
metabolite;
xenobiotic
atorvastatin[no description available]medium146aromatic amide;
dihydroxy monocarboxylic acid;
monofluorobenzenes;
pyrroles;
statin (synthetic)		environmental contaminant;
xenobiotic
glpg0634[no description available]medium9930
pyrene[no description available]medium80ortho- and peri-fused polycyclic arenefluorescent probe;
persistent organic pollutant
ketorolac[no description available]medium50amino acid;
aromatic ketone;
monocarboxylic acid;
pyrrolizines;
racemate		analgesic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
efinaconazole[no description available]medium13024conazole antifungal drug;
olefinic compound;
organofluorine compound;
piperidines;
tertiary alcohol;
tertiary amino compound;
triazole antifungal drug		EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
lead[no description available]medium111carbon group element atom;
elemental lead;
metal atom		neurotoxin
quinoxalines[no description available]medium922mancude organic heterobicyclic parent;
naphthyridine;
ortho-fused heteroarene
hydrazine[no description available]medium28243azane;
hydrazines		EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor
selinexor[no description available]medium19843
zolpidem[no description available]medium459imidazopyridinecentral nervous system depressant;
GABA agonist;
sedative
clonazepam[no description available]medium901,4-benzodiazepinone;
monochlorobenzenes		anticonvulsant;
anxiolytic drug;
GABA modulator
rufinamide[no description available]medium15222aromatic amide;
heteroarene
clobazam[no description available]medium701,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
GABA modulator
ucb 34714[no description available]medium30gamma-lactam;
non-proteinogenic amino acid derivative		anticonvulsant
phenobarbital[no description available]medium570barbituratesanticonvulsant;
drug allergen;
excitatory amino acid antagonist;
sedative
diazepam[no description available]medium5861,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
environmental contaminant;
sedative;
xenobiotic
cannabidiol[no description available]medium90olefinic compound;
phytocannabinoid;
resorcinols		antimicrobial agent;
plant metabolite
valproic acid[no description available]medium292branched-chain fatty acid;
branched-chain saturated fatty acid		anticonvulsant;
antimanic drug;
EC 3.5.1.98 (histone deacetylase) inhibitor;
GABA agent;
neuroprotective agent;
psychotropic drug;
teratogenic agent
stiripentol[no description available]medium60
lesinurad[no description available]medium7616aryl sulfide;
cyclopropanes;
monocarboxylic acid;
naphthalenes;
organobromine compound;
triazoles		uricosuric drug
rizatriptan[no description available]medium32499tryptaminesanti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
metconazole[no description available]medium150conazole fungicide;
cyclopentanols;
monochlorobenzenes;
tertiary alcohol;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
isavuconazole[no description available]medium349371,3-thiazoles;
conazole antifungal drug;
difluorobenzene;
nitrile;
tertiary alcohol;
triazole antifungal drug		EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
ergosterol biosynthesis inhibitor;
orphan drug
floxacillin[no description available]medium40penicillin allergen;
penicillin		antibacterial drug
prothioconazole[no description available]medium700cyclopropanes;
monochlorobenzenes;
tertiary alcohol;
thiocarbonyl compound;
triazoles
tadalafil[no description available]medium20benzodioxoles;
pyrazinopyridoindole		EC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
goniothalamin[no description available]medium10
piplartine[no description available]medium10cinnamamides;
dicarboximide
2-piperidone[no description available]medium61delta-lactam;
piperidones		EC 1.2.1.88 (L-glutamate gamma-semialdehyde dehydrogenase) inhibitor
gold[no description available]medium531copper group element atom;
elemental gold
triazophos[no description available]medium1350organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
difenoconazole[no description available]medium1361aromatic ether;
conazole fungicide;
cyclic ketal;
dioxolane;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
iodine[no description available]medium210halide anion;
monoatomic iodine		human metabolite
azides[no description available]medium4600pseudohalide anionmitochondrial respiratory-chain inhibitor
bay 85-3934[no description available]medium3010
zineb[no description available]medium140dithiocarbamate salt;
macromolecule;
zinc coordination entity		antifungal agrochemical
hexaconazole[no description available]medium800dichlorobenzene;
tertiary alcohol;
triazoles		chelator
abscisic acid[no description available]medium5202-trans-abscisic acid
5-nitro-1,2,4-triazol-3-one[no description available]medium680
anthraquinone-2,6-disulfonate[no description available]medium10anthraquinone;
arenesulfonic acid
chitosan[no description available]medium301
terconazole[no description available]medium211191-(4-{[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)-4-isopropylpiperazine
doravirine[no description available]medium9330
sincalide[no description available]medium40oligopeptide
cholecystokinin[no description available]medium40
olanzapine[no description available]medium41benzodiazepine;
N-arylpiperazine;
N-methylpiperazine		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
serotonin uptake inhibitor
carboplatin[no description available]medium142
paclitaxel[no description available]medium517taxane diterpenoid;
tetracyclic diterpenoid		antineoplastic agent;
human metabolite;
metabolite;
microtubule-stabilising agent
cobalt[no description available]medium410cobalt group element atom;
metal allergen		micronutrient
sirolimus[no description available]medium6010antibiotic antifungal drug;
cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
organic heterotricyclic compound;
secondary alcohol		antibacterial drug;
anticoronaviral agent;
antineoplastic agent;
bacterial metabolite;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-n-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6s)-[no description available]medium130organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
maraviroc[no description available]medium59998tropane alkaloid
bis(diazo)benzidine[no description available]medium10
methionine[no description available]medium191aspartate family amino acid;
L-alpha-amino acid;
methionine zwitterion;
methionine;
proteinogenic amino acid		antidote to paracetamol poisoning;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical
cysteine[no description available]medium431cysteiniumfundamental metabolite
olaparib[no description available]medium120cyclopropanes;
monofluorobenzenes;
N-acylpiperazine;
phthalazines		antineoplastic agent;
apoptosis inducer;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
kpt-185[no description available]medium211
mrs 1220[no description available]medium311quinazolines
inosinic acid[no description available]medium20inosine phosphate;
purine ribonucleoside 5'-monophosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
inosine[no description available]medium130inosines;
purines D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
quinazolines[no description available]medium32921azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinazolines
ravuconazole[no description available]medium10561,3-thiazoles;
fluorobenzenes;
nitrile;
tertiary alcohol;
triazoles		antifungal drug;
antileishmanial agent;
EC 1.14.14.154 (sterol 14alpha-demethylase) inhibitor;
ergosterol biosynthesis inhibitor
tebuconazole[no description available]medium3840monochlorobenzenes;
tertiary alcohol;
triazoles
piperidines[no description available]medium26219
liquid crystal polymer[no description available]medium80conazole fungicide;
dichlorobenzene;
organobromine compound;
oxolanes;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
hydrochlorothiazide[no description available]medium30benzothiadiazine;
organochlorine compound;
sulfonamide		antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
isocryptolepine[no description available]medium10
ketoconazole[no description available]medium22511dichlorobenzene;
dioxolane;
ether;
imidazoles;
N-acylpiperazine;
N-arylpiperazine
4-aminobenzoic acid[no description available]medium30aminobenzoic acid;
aromatic amino-acid zwitterion		allergen;
Escherichia coli metabolite;
plant metabolite
acetylcellulose[no description available]medium10
epoxiconazole[no description available]medium1140epoxide;
monochlorobenzenes;
monofluorobenzenes;
triazoles
cellulose[no description available]medium310glycoside
oleic acid[no description available]medium90octadec-9-enoic acidantioxidant;
Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite;
solvent
metribuzin[no description available]medium401,2,4-triazines;
cyclic ketone;
organic sulfide		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
arsenic[no description available]medium120metalloid atom;
pnictogen		micronutrient
fluconazole[no description available]medium77638conazole antifungal drug;
difluorobenzene;
tertiary alcohol;
triazole antifungal drug		environmental contaminant;
P450 inhibitor;
xenobiotic
MK-8353[no description available]medium31aromatic ether;
dihydropyridine;
indazoles;
methyl sulfide;
N-alkylpyrrolidine;
pyridines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide;
triazoles		antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
sch772984[no description available]medium10biaryl;
indazoles;
N-acylpiperazine;
N-alkylpyrrolidine;
N-arylpiperazine;
pyridines;
pyrimidines;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary amino compound;
tertiary carboxamide		analgesic;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
indazoles[no description available]medium473indazole
moxifloxacin[no description available]medium189aromatic ether;
cyclopropanes;
fluoroquinolone antibiotic;
pyrrolidinopiperidine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone		antibacterial drug
isatin[no description available]medium330indoledioneEC 1.4.3.4 (monoamine oxidase) inhibitor;
plant metabolite
maltodextrin[no description available]medium10
betadex[no description available]medium422cyclodextrin
deferasirox[no description available]medium658116benzoic acids;
monocarboxylic acid;
phenols;
triazoles		iron chelator
rolipram[no description available]medium60pyrrolidin-2-onesantidepressant;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
pulmicort[no description available]medium4011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic acetal;
glucocorticoid;
primary alpha-hydroxy ketone		anti-inflammatory drug;
bronchodilator agent;
drug allergen
roflumilast[no description available]medium10aromatic ether;
benzamides;
chloropyridine;
cyclopropanes;
organofluorine compound		anti-asthmatic drug;
phosphodiesterase IV inhibitor
cilomilast[no description available]medium20methoxybenzenes
alpha-aminopyridine[no description available]medium395
ceefourin 1[no description available]medium50
daunorubicin[no description available]medium111aminoglycoside antibiotic;
anthracycline;
p-quinones;
tetracenequinones		antineoplastic agent;
bacterial metabolite
acridines[no description available]medium510acridines;
mancude organic heterotricyclic parent;
polycyclic heteroarene		genotoxin
urea[no description available]medium890isourea;
monocarboxylic acid amide;
one-carbon compound		Daphnia magna metabolite;
Escherichia coli metabolite;
fertilizer;
flour treatment agent;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
methampicillin[no description available]medium540monochlorobenzenes;
tertiary alcohol;
triazoles		brassinosteroid biosynthesis inhibitor
prostratin[no description available]medium50
bryostatin 1[no description available]medium70
propiconazole[no description available]medium2730conazole fungicide;
cyclic ketal;
dichlorobenzene;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
uridine[no description available]medium210uridinesdrug metabolite;
fundamental metabolite;
human metabolite
granite[no description available]medium10triazolopyrimidines
nitrates[no description available]medium220monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species
dactolisib[no description available]medium80imidazoquinoline;
nitrile;
quinolines;
ring assembly;
ureas		antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
kojic acid[no description available]medium604-pyranones;
enol;
primary alcohol		Aspergillus metabolite;
EC 1.10.3.1 (catechol oxidase) inhibitor;
EC 1.10.3.2 (laccase) inhibitor;
EC 1.13.11.24 (quercetin 2,3-dioxygenase) inhibitor;
EC 1.14.18.1 (tyrosinase) inhibitor;
EC 1.4.3.3 (D-amino-acid oxidase) inhibitor;
NF-kappaB inhibitor;
skin lightening agent
adenosine monophosphate[no description available]medium170adenosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		adenosine A1 receptor agonist;
cofactor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.11 (fructose-bisphosphatase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
calixarenes[no description available]medium300
Prothioconazole-desthio[no description available]medium110organochlorine compound
devrinol[no description available]medium10aromatic ether;
monocarboxylic acid amide;
naphthalenes
alanine[no description available]medium581alanine zwitterion;
alanine;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid		EC 4.3.1.15 (diaminopropionate ammonia-lyase) inhibitor;
fundamental metabolite
metalaxyl[no description available]medium180alanine derivative;
aromatic amide;
carboxamide;
ether;
methyl ester
triticonazole[no description available]medium200
cyclopentane[no description available]medium360cycloalkane;
cyclopentanes;
volatile organic compound		non-polar solvent
TAK-580[no description available]medium101,3-thiazolecarboxamide;
aminopyrimidine;
chloropyridine;
organofluorine compound;
pyrimidinecarboxamide;
secondary carboxamide		antineoplastic agent;
apoptosis inducer;
B-Raf inhibitor
paclobutrazol[no description available]medium2120
pymetrozine[no description available]medium101,2,4-triazines;
pyridines		antifeedant;
environmental contaminant;
TRPV channel modulator;
xenobiotic
ribavirin[no description available]medium3921-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide		anticoronaviral agent;
antiinfective agent;
antimetabolite;
antiviral agent;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
acetaminophen[no description available]medium343acetamides;
phenols		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
cyclooxygenase 3 inhibitor;
environmental contaminant;
ferroptosis inducer;
geroprotector;
hepatotoxic agent;
human blood serum metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
troglitazone[no description available]medium40chromanes;
thiazolidinone		anticoagulant;
anticonvulsant;
antineoplastic agent;
antioxidant;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
hypoglycemic agent;
platelet aggregation inhibitor;
vasodilator agent
nefazodone[no description available]medium490150aromatic ether;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazoles		alpha-adrenergic antagonist;
analgesic;
antidepressant;
serotonergic antagonist;
serotonin uptake inhibitor
amiodarone[no description available]medium1001-benzofurans;
aromatic ketone;
organoiodine compound;
tertiary amino compound		cardiovascular drug
nicotine[no description available]medium1713-(1-methylpyrrolidin-2-yl)pyridineanxiolytic drug;
biomarker;
immunomodulator;
mitogen;
neurotoxin;
nicotinic acetylcholine receptor agonist;
peripheral nervous system drug;
phytogenic insecticide;
plant metabolite;
psychotropic drug;
teratogenic agent;
xenobiotic
amphetamine[no description available]medium151primary amine
cocaine[no description available]medium240benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
morphine[no description available]medium200morphinane alkaloid;
organic heteropentacyclic compound;
tertiary amino compound		anaesthetic;
drug allergen;
environmental contaminant;
geroprotector;
mu-opioid receptor agonist;
opioid analgesic;
plant metabolite;
vasodilator agent;
xenobiotic
dicyclohexylcarbodiimide[no description available]medium80carbodiimideATP synthase inhibitor;
cross-linking reagent;
peptide coupling reagent
ferulic acid[no description available]medium10ferulic acidsanti-inflammatory agent;
antioxidant;
apoptosis inhibitor;
cardioprotective agent;
MALDI matrix material;
plant metabolite
tannins[no description available]medium40
adamantane[no description available]medium14510adamantanes;
polycyclic alkane
niacinamide[no description available]medium322pyridine alkaloid;
pyridinecarboxamide;
vitamin B3		anti-inflammatory agent;
antioxidant;
cofactor;
EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Escherichia coli metabolite;
geroprotector;
human urinary metabolite;
metabolite;
mouse metabolite;
neuroprotective agent;
Saccharomyces cerevisiae metabolite;
Sir2 inhibitor
tofacitinib[no description available]medium251N-acylpiperidine;
nitrile;
pyrrolopyrimidine;
tertiary amino compound		antirheumatic drug;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
zidovudine[no description available]medium234azide;
pyrimidine 2',3'-dideoxyribonucleoside		antimetabolite;
antiviral drug;
HIV-1 reverse transcriptase inhibitor
1,1-diphenyl-2-picrylhydrazyl[no description available]medium230
curcumin[no description available]medium170aromatic ether;
beta-diketone;
diarylheptanoid;
enone;
polyphenol		anti-inflammatory agent;
antifungal agent;
antineoplastic agent;
biological pigment;
contraceptive drug;
dye;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
EC 1.8.1.9 (thioredoxin reductase) inhibitor;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
EC 3.5.1.98 (histone deacetylase) inhibitor;
flavouring agent;
food colouring;
geroprotector;
hepatoprotective agent;
immunomodulator;
iron chelator;
ligand;
lipoxygenase inhibitor;
metabolite;
neuroprotective agent;
nutraceutical;
radical scavenger
pyrrolopyrimidine[no description available]medium30
dalteparin[no description available]medium11
gilteritinib[no description available]medium40aromatic amine;
monomethoxybenzene;
N-methylpiperazine;
oxanes;
piperidines;
primary carboxamide;
pyrazines;
secondary amino compound		antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
penconazole[no description available]medium700dichlorobenzene;
triazoles
mometasone furoate[no description available]medium1011beta-hydroxy steroid;
2-furoate ester;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
organochlorine compound;
steroid ester		anti-allergic agent;
anti-inflammatory drug
prednisolone[no description available]medium21511beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
drug metabolite;
environmental contaminant;
immunosuppressive agent;
xenobiotic
trinitrotoluene[no description available]medium110trinitrotolueneexplosive
cyclonite[no description available]medium1001,3,5-triazinanes;
N-nitro compound		explosive
octogen[no description available]medium30N-nitro compound;
tetrazocane		explosive
durapatite[no description available]medium20
ethane[no description available]medium10alkane;
gas molecular entity		plant metabolite;
refrigerant
tacrine[no description available]medium110acridines;
aromatic amine		EC 3.1.1.7 (acetylcholinesterase) inhibitor
carfilzomib[no description available]medium112epoxide;
morpholines;
tetrapeptide		antineoplastic agent;
proteasome inhibitor
uniconazole[no description available]medium750monochlorobenzenes;
secondary alcohol;
triazoles
phosphorus[no description available]medium131monoatomic phosphorus;
nonmetal atom;
pnictogen		macronutrient
haloperidol[no description available]medium273aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
nsc 23766[no description available]medium10hydrochlorideantiviral agent;
apoptosis inducer;
EC 3.6.5.2 (small monomeric GTPase) inhibitor;
muscarinic antagonist
biotin[no description available]medium80biotins;
vitamin B7		coenzyme;
cofactor;
Escherichia coli metabolite;
fundamental metabolite;
human metabolite;
mouse metabolite;
nutraceutical;
prosthetic group;
Saccharomyces cerevisiae metabolite
carfentrazone-ethyl[no description available]medium150ethyl esterproherbicide
malondialdehyde[no description available]medium461dialdehydebiomarker
carbostyril[no description available]medium544monohydroxyquinoline;
quinolone		bacterial xenobiotic metabolite
menthol[no description available]medium30p-menthane monoterpenoid;
secondary alcohol		volatile oil component
3-hydroxybutyric acid[no description available]medium20(omega-1)-hydroxy fatty acid;
3-hydroxy monocarboxylic acid;
hydroxybutyric acid		human metabolite
1,3-dipropyl-8-cyclopentylxanthine[no description available]medium1560oxopurineadenosine A1 receptor antagonist;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor
4-phenyl-1,2,4-triazoline-3,5-dione[no description available]medium230
formazans[no description available]medium40
nnd 502[no description available]medium200dichlorobenzene
terbinafine[no description available]medium1254acetylenic compound;
allylamine antifungal drug;
enyne;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
P450 inhibitor;
sterol biosynthesis inhibitor
sorafenib[no description available]medium142(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
phenylureas;
pyridinecarboxamide		angiogenesis inhibitor;
anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
ferroptosis inducer;
tyrosine kinase inhibitor
erlotinib hydrochloride[no description available]medium121hydrochloride;
terminal acetylenic compound		antineoplastic agent;
protein kinase inhibitor
tenofovir[no description available]medium4216nucleoside analogue;
phosphonic acids		antiviral drug;
drug metabolite;
HIV-1 reverse transcriptase inhibitor
monobutyl phthalate[no description available]medium20phthalic acid monoester
miconazole[no description available]medium595dichlorobenzene;
ether;
imidazoles
2-ethylhexanoic acid[no description available]medium10branched-chain fatty acid
flusilazole[no description available]medium450conazole fungicide;
monofluorobenzenes;
organosilicon compound;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
n-butoxyacetic acid[no description available]medium10carboxylic acid
ramelteon[no description available]medium173indanes
bortezomib[no description available]medium253amino acid amide;
L-phenylalanine derivative;
pyrazines		antineoplastic agent;
antiprotozoal drug;
protease inhibitor;
proteasome inhibitor
enclomiphene[no description available]medium15364
letrozole[no description available]medium1,823440nitrile;
triazoles		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
thiophenes[no description available]medium11512mancude organic heteromonocyclic parent;
monocyclic heteroarene;
thiophenes;
volatile organic compound		non-polar solvent
pyrimidinones[no description available]medium701
gsk2194069[no description available]medium20
azd3965[no description available]medium10
methotrexate[no description available]medium4315dicarboxylic acid;
monocarboxylic acid amide;
pteridines		abortifacient;
antimetabolite;
antineoplastic agent;
antirheumatic drug;
dermatologic drug;
DNA synthesis inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
immunosuppressive agent
entinostat[no description available]medium50benzamides;
carbamate ester;
primary amino compound;
pyridines;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
diniconazole[no description available]medium340dichlorobenzene;
olefinic compound;
secondary alcohol;
triazoles
pentylenetetrazole[no description available]medium380organic heterobicyclic compound;
organonitrogen heterocyclic compound
indocyanine green[no description available]medium201,1-diunsubstituted alkanesulfonate;
benzoindole;
cyanine dye
acetophenone[no description available]medium10acetophenonesanimal metabolite;
photosensitizing agent;
xenobiotic
benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone[no description available]medium20
sm 164[no description available]medium190benzenes;
organic heterobicyclic compound;
secondary carboxamide;
triazoles		antineoplastic agent;
apoptosis inducer;
radiosensitizing agent
arabinogalactan[no description available]medium20
silver[no description available]medium531copper group element atom;
elemental silver		Escherichia coli metabolite
glycolipids[no description available]medium120
lignans[no description available]medium171
celecoxib[no description available]medium183organofluorine compound;
pyrazoles;
sulfonamide;
toluenes		cyclooxygenase 2 inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
bromide[no description available]medium140halide anion;
monoatomic bromine
dolutegravir[no description available]medium83difluorobenzene;
monocarboxylic acid amide;
organic heterotricyclic compound;
secondary carboxamide		HIV-1 integrase inhibitor
chiniofon[no description available]medium40
dinoprostone[no description available]medium541prostaglandins Ehuman metabolite;
mouse metabolite;
oxytocic
warfarin[no description available]medium1116benzenes;
hydroxycoumarin;
methyl ketone
chloroacetamide[no description available]medium10
dasatinib[no description available]medium1101,3-thiazoles;
aminopyrimidine;
monocarboxylic acid amide;
N-(2-hydroxyethyl)piperazine;
N-arylpiperazine;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
crizotinib[no description available]medium1023-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
pyrachlostrobin[no description available]medium270aromatic ether;
carbamate ester;
carbanilate fungicide;
methoxycarbanilate strobilurin antifungal agent;
monochlorobenzenes;
pyrazoles		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
kresoxim-methyl[no description available]medium100aromatic ether;
methoxyiminoacetate strobilurin antifungal agent;
methyl ester;
oxime O-ether		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
xenobiotic
systhane[no description available]medium870monochlorobenzenes;
nitrile;
triazoles
chalcone[no description available]medium320chalconeEC 3.2.1.1 (alpha-amylase) inhibitor
deferoxamine[no description available]medium19922acyclic desferrioxaminebacterial metabolite;
ferroptosis inhibitor;
iron chelator;
siderophore
(5-(2,4-bis((3s)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol[no description available]medium10benzyl alcohols;
morpholines;
pyridopyrimidine;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
mTOR inhibitor
azoxystrobin[no description available]medium540aryloxypyrimidine;
enoate ester;
enol ether;
methoxyacrylate strobilurin antifungal agent;
methyl ester;
nitrile		antifungal agrochemical;
environmental contaminant;
mitochondrial cytochrome-bc1 complex inhibitor;
quinone outside inhibitor;
xenobiotic
cyproconazole[no description available]medium460cyclopropanes;
monochlorobenzenes;
tertiary alcohol;
triazoles
cyclin d1[no description available]medium254
1-hydroxybenzotriazole[no description available]medium1030benzotriazoles
triphenylphosphine[no description available]medium10benzenes;
tertiary phosphine		NMR chemical shift reference compound;
reducing agent
temozolomide[no description available]medium90imidazotetrazine;
monocarboxylic acid amide;
triazene derivative		alkylating agent;
antineoplastic agent;
prodrug
gsk525762a[no description available]medium310benzodiazepine
pelabresib[no description available]medium10monochlorobenzenes;
organic heterotricyclic compound;
primary carboxamide		antineoplastic agent;
bromodomain-containing protein 4 inhibitor
potassium oxonate[no description available]medium10organic molecular entity
allopurinol[no description available]medium685nucleobase analogue;
organic heterobicyclic compound		antimetabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
gout suppressant;
radical scavenger
oxonic acid[no description available]medium501,3,5-triazines;
monocarboxylic acid
uric acid[no description available]medium4211uric acidEscherichia coli metabolite;
human metabolite;
mouse metabolite
imidazole-4-carboxamide[no description available]medium10
aminoimidazole carboxamide[no description available]medium270aminoimidazole;
monocarboxylic acid amide		mouse metabolite
1,2,4-triazole-3-carboxamide[no description available]medium90aromatic amide;
monocarboxylic acid amide;
primary carboxamide;
triazoles		drug metabolite;
human urinary metabolite
tretinoin[no description available]medium431retinoic acid;
vitamin A		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
AP-1 antagonist;
human metabolite;
keratolytic drug;
retinoic acid receptor agonist;
retinoid X receptor agonist;
signalling molecule
micafungin[no description available]medium1146antibiotic antifungal drug;
echinocandin		antiinfective agent
thymidine[no description available]medium390pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite
acetamide[no description available]medium70acetamides;
carboximidic acid;
monocarboxylic acid amide;
N-acylammonia
fenbendazole[no description available]medium10aryl sulfide;
benzimidazoles;
carbamate ester		antinematodal drug
gibberellins[no description available]medium1420
sodium azide[no description available]medium160inorganic sodium saltantibacterial agent;
explosive;
mitochondrial respiratory-chain inhibitor;
mutagen
hydrazoic acid[no description available]medium20nitrogen hydride
carvone[no description available]medium41botanical anti-fungal agent;
carvones		allergen
favipiravir[no description available]medium20hydroxypyrazine;
organofluorine compound;
primary carboxamide		anticoronaviral agent;
antiviral drug;
EC 2.7.7.48 (RNA-directed RNA polymerase) inhibitor
s 8932[no description available]medium30aromatic amine;
C-nucleoside;
carboxylic ester;
nitrile;
phosphoramidate ester;
pyrrolotriazine		anticoronaviral agent;
antiviral drug;
prodrug
oxadiazoles[no description available]medium1431
benzofurans[no description available]medium400
maneb[no description available]medium140
nabam[no description available]medium110dithiocarbamic acids
2-oxindole[no description available]medium60gamma-lactam;
indolinone
adenosine[no description available]medium3802adenosines;
purines D-ribonucleoside		analgesic;
anti-arrhythmia drug;
fundamental metabolite;
human metabolite;
vasodilator agent
alpha-synuclein[no description available]medium40
lysine[no description available]medium200aspartate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
lysine;
organic molecular entity;
proteinogenic amino acid		algal metabolite;
anticonvulsant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
rhodium[no description available]medium640cobalt group element atom
thiosemicarbazide[no description available]medium180hydrazines;
thiocarboxamide;
thioureas
naproxen[no description available]medium170methoxynaphthalene;
monocarboxylic acid		antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
deferiprone[no description available]medium13744-pyridonesiron chelator;
protective agent
mirtazapine[no description available]medium280benzazepine;
tetracyclic antidepressant		alpha-adrenergic antagonist;
anxiolytic drug;
H1-receptor antagonist;
histamine antagonist;
oneirogen;
serotonergic antagonist
mln 8237[no description available]medium30benzazepine
losartan potassium[no description available]medium314
4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile[no description available]medium180monochlorobenzenes;
nitrile;
triazoles
ozone[no description available]medium220elemental molecule;
gas molecular entity;
reactive oxygen species;
triatomic oxygen		antiseptic drug;
disinfectant;
electrophilic reagent;
greenhouse gas;
mutagen;
oxidising agent;
tracer
pheophytin a[no description available]medium80
4-hydroxyphenylethanol[no description available]medium20phenolsanti-arrhythmia drug;
antioxidant;
cardiovascular drug;
fungal metabolite;
geroprotector;
plant metabolite;
protective agent
phenylethyl alcohol[no description available]medium20benzenes;
primary alcohol		Aspergillus metabolite;
fragrance;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite
cem 101[no description available]medium7913
mk-7655[no description available]medium20
fluxapyroxad[no description available]medium30anilide fungicide;
aromatic amide;
biphenyls;
pyrazoles;
trifluorobenzene		antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
ew-7197[no description available]medium211
pectins[no description available]medium31D-galactopyranuronic acid
acetamidine[no description available]medium20carboxamidine
thioacetamide[no description available]medium70thiocarboxamidehepatotoxic agent
lapatinib[no description available]medium4110furans;
organochlorine compound;
organofluorine compound;
quinazolines		antineoplastic agent;
tyrosine kinase inhibitor
glyceollin[no description available]medium20organic heteropentacyclic compound
ether[no description available]medium40ether;
volatile organic compound		inhalation anaesthetic;
non-polar solvent;
refrigerant
ergosterol[no description available]medium6503beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
ergostanoid;
phytosterols		fungal metabolite;
Saccharomyces cerevisiae metabolite
methane[no description available]medium832alkane;
gas molecular entity;
mononuclear parent hydride;
one-carbon compound		bacterial metabolite;
fossil fuel;
greenhouse gas
carbene[no description available]medium630carbene;
methanediyl
beta-lactams[no description available]medium150beta-lactam antibiotic allergen;
beta-lactam
chlorpyrifos-methyl[no description available]medium10chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
chlorpyrifos[no description available]medium360chloropyridine;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
pyrethrins[no description available]medium510
cyhalothrin[no description available]medium100aromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organochlorine compound;
organofluorine compound		agrochemical;
pyrethroid ester acaricide;
pyrethroid ester insecticide
phenylalanine[no description available]medium290amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
phenylalanine;
proteinogenic amino acid		algal metabolite;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
Escherichia coli metabolite;
human xenobiotic metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
d-alpha tocopherol[no description available]medium191alpha-tocopherolalgal metabolite;
antiatherogenic agent;
anticoagulant;
antioxidant;
antiviral agent;
EC 2.7.11.13 (protein kinase C) inhibitor;
immunomodulator;
micronutrient;
nutraceutical;
plant metabolite
tryptophan[no description available]medium321erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
tryptophan zwitterion;
tryptophan		antidepressant;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
arachidonic acid[no description available]medium470icosa-5,8,11,14-tetraenoic acid;
long-chain fatty acid;
omega-6 fatty acid		Daphnia galeata metabolite;
EC 3.1.1.1 (carboxylesterase) inhibitor;
human metabolite;
mouse metabolite
indole-3-carbaldehyde[no description available]medium10heteroarenecarbaldehyde;
indole alkaloid;
indoles		bacterial metabolite;
human xenobiotic metabolite;
marine metabolite;
plant metabolite
palladium[no description available]medium741metal allergen;
nickel group element atom;
platinum group metal atom
melatonin[no description available]medium171acetamides;
tryptamines		anticonvulsant;
central nervous system depressant;
geroprotector;
hormone;
human metabolite;
immunological adjuvant;
mouse metabolite;
radical scavenger
sitagliptin phosphate[no description available]medium777221
sulfanilamide[no description available]medium60substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
drug allergen;
EC 4.2.1.1 (carbonic anhydrase) inhibitor
titanium[no description available]medium181titanium group element atom
titanium dioxide[no description available]medium131titanium oxidesfood colouring
nitrofurantoin[no description available]medium10imidazolidine-2,4-dione;
nitrofuran antibiotic;
organonitrogen heterocyclic antibiotic;
organooxygen heterocyclic antibiotic		antibacterial drug;
antiinfective agent;
hepatotoxic agent
transforming growth factor beta[no description available]medium301
azamulin[no description available]medium70
latoconazole[no description available]medium60conazole antifungal drug;
imidazole antifungal drug
ruthenium[no description available]medium530iron group element atom;
platinum group metal atom
guanosine monophosphate[no description available]medium30guanosine 5'-phosphate;
purine ribonucleoside 5'-monophosphate		biomarker;
Escherichia coli metabolite;
metabolite;
mouse metabolite
pyruvic acid[no description available]medium702-oxo monocarboxylic acidcofactor;
fundamental metabolite
carbohydrazide[no description available]medium50carbohydrazide;
one-carbon compound
diphenyl sulfoxide[no description available]medium10sulfoxide
platinum[no description available]medium220elemental platinum;
nickel group element atom;
platinum group metal atom
thiophane[no description available]medium10saturated organic heteromonocyclic parent;
tetrahydrothiophenes
sta 9090[no description available]medium11213ring assembly;
triazoles
boranes[no description available]medium70boranes;
mononuclear parent hydride
cyanamide[no description available]medium10nitrile;
one-carbon compound		EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor
ametoctradin[no description available]medium50aromatic amine;
triazolopyrimidines		antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
shikimic acid[no description available]medium21alpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
shikimic acid[no description available]medium20alpha,beta-unsaturated monocarboxylic acid;
cyclohexenecarboxylic acid;
hydroxy monocarboxylic acid		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
1,3,4-oxadiazole[no description available]medium140
mannose[no description available]medium110D-aldohexose;
D-mannose;
mannopyranose		metabolite
2-methyl-4-chlorophenoxyacetic acid[no description available]medium40chlorophenoxyacetic acid;
monochlorobenzenes		environmental contaminant;
phenoxy herbicide;
synthetic auxin
metolachlor[no description available]medium70aromatic amide;
benzenes;
ether;
organochlorine compound
cefepime[no description available]medium101cephalosporin;
oxime O-ether		antibacterial drug
cephalosporin c[no description available]medium370cephalosporinfungal metabolite
nevirapine[no description available]medium70cyclopropanes;
dipyridodiazepine		antiviral drug;
HIV-1 reverse transcriptase inhibitor
bromphenol blue[no description available]medium102,1-benzoxathiole;
arenesulfonate ester;
organobromine compound;
phenols;
sultone		acid-base indicator;
dye;
two-colour indicator
emtricitabine[no description available]medium137monothioacetal;
nucleoside analogue;
organofluorine compound;
pyrimidone		antiviral drug;
HIV-1 reverse transcriptase inhibitor
lamivudine[no description available]medium2713monothioacetal;
nucleoside analogue;
oxacycle;
primary alcohol		allergen;
anti-HBV agent;
antiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor;
prodrug
fumarates[no description available]medium101butenedioate;
C4-dicarboxylate		human metabolite;
metabolite;
Saccharomyces cerevisiae metabolite
iridium[no description available]medium181cobalt group element atom;
platinum group metal atom
oxycodone[no description available]medium71organic heteropentacyclic compound;
semisynthetic derivative		antitussive;
mu-opioid receptor agonist;
opioid analgesic
trk 820[no description available]medium20phenanthrenes
morphinans[no description available]medium50isoquinoline alkaloid fundamental parent;
morphinane alkaloid
lactoferrin[no description available]medium60
meglumine antimoniate[no description available]medium20
hydrogen[no description available]medium381elemental hydrogen;
elemental molecule;
gas molecular entity		antioxidant;
electron donor;
food packaging gas;
fuel;
human metabolite
ciprofloxacin[no description available]medium250aminoquinoline;
cyclopropanes;
fluoroquinolone antibiotic;
N-arylpiperazine;
quinolinemonocarboxylic acid;
quinolone antibiotic;
quinolone;
zwitterion		antibacterial drug;
antiinfective agent;
antimicrobial agent;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
environmental contaminant;
topoisomerase IV inhibitor;
xenobiotic
urazole[no description available]medium180
colistin[no description available]medium40
azacitidine[no description available]medium232N-glycosyl-1,3,5-triazine;
nucleoside analogue		antineoplastic agent
molnupiravir[no description available]medium10isopropyl ester;
ketoxime;
nucleoside analogue		anticoronaviral agent;
antiviral drug;
prodrug
nirmatrelvir[no description available]medium10azabicyclohexane;
nitrile;
organofluorine compound;
pyrrolidin-2-ones;
pyrrolidinecarboxamide;
secondary carboxamide;
tertiary carboxamide		anticoronaviral agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor
cytidine[no description available]medium70cytidinesEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
proline[no description available]medium311amino acid zwitterion;
glutamine family amino acid;
L-alpha-amino acid;
proline;
proteinogenic amino acid		algal metabolite;
compatible osmolytes;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
leucine[no description available]medium180amino acid zwitterion;
L-alpha-amino acid;
leucine;
proteinogenic amino acid;
pyruvate family amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
eszopiclone[no description available]medium60zopiclonecentral nervous system depressant;
sedative
estriol[no description available]medium3016alpha-hydroxy steroid;
17beta-hydroxy steroid;
3-hydroxy steroid		estrogen;
human metabolite;
human xenobiotic metabolite;
mouse metabolite
dehydroepiandrosterone[no description available]medium15117-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
androstanoid		androgen;
human metabolite;
mouse metabolite
estrone[no description available]medium562017-oxo steroid;
3-hydroxy steroid;
phenolic steroid;
phenols		antineoplastic agent;
bone density conservation agent;
estrogen;
human metabolite;
mouse metabolite
azd2014[no description available]medium30
anastrozole[no description available]medium1,320302nitrile;
triazoles		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
tris(2-pyridylmethyl)amine[no description available]medium10
perampanel[no description available]medium20bipyridines;
nitrile;
pyridone		AMPA receptor antagonist;
anticonvulsant
rifampin[no description available]medium275cyclic ketal;
hydrazone;
N-iminopiperazine;
N-methylpiperazine;
rifamycins;
semisynthetic derivative;
zwitterion		angiogenesis inhibitor;
antiamoebic agent;
antineoplastic agent;
antitubercular agent;
DNA synthesis inhibitor;
EC 2.7.7.6 (RNA polymerase) inhibitor;
Escherichia coli metabolite;
geroprotector;
leprostatic drug;
neuroprotective agent;
pregnane X receptor agonist;
protein synthesis inhibitor
carbamazepine[no description available]medium300dibenzoazepine;
ureas		analgesic;
anticonvulsant;
antimanic drug;
drug allergen;
EC 3.5.1.98 (histone deacetylase) inhibitor;
environmental contaminant;
glutamate transporter activator;
mitogen;
non-narcotic analgesic;
sodium channel blocker;
xenobiotic
beryllium[no description available]medium10alkaline earth metal atom;
elemental beryllium;
metal allergen		adjuvant;
carcinogenic agent;
epitope
glycosides[no description available]medium651
adenine[no description available]medium7846-aminopurines;
purine nucleobase		Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
pci 32765[no description available]medium101acrylamides;
aromatic amine;
aromatic ether;
N-acylpiperidine;
pyrazolopyrimidine;
tertiary carboxamide		antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
abt-199[no description available]medium162aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
N-sulfonylcarboxamide;
oxanes;
pyrrolopyridine		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
aspirin[no description available]medium352benzoic acids;
phenyl acetates;
salicylates		anticoagulant;
antipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
EC 1.1.1.188 (prostaglandin-F synthase) inhibitor;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
plant activator;
platelet aggregation inhibitor;
prostaglandin antagonist;
teratogenic agent
riamilovir[no description available]medium180
tamoxifen[no description available]medium854222stilbenoid;
tertiary amino compound		angiogenesis inhibitor;
antineoplastic agent;
bone density conservation agent;
EC 1.2.3.1 (aldehyde oxidase) inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
estrogen antagonist;
estrogen receptor antagonist;
estrogen receptor modulator
fulvestrant[no description available]medium1402717beta-hydroxy steroid;
3-hydroxy steroid;
organofluorine compound;
sulfoxide		antineoplastic agent;
estrogen antagonist;
estrogen receptor antagonist
vt-464[no description available]medium91
deoxynivalenol[no description available]medium150cyclic ketone;
enone;
primary alcohol;
secondary alpha-hydroxy ketone;
trichothecene;
triol		mycotoxin
pyruvaldehyde[no description available]medium202-oxo aldehyde;
propanals		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
lansoprazole[no description available]medium51benzimidazoles;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
glucuronic acid[no description available]medium20D-glucuronic acidalgal metabolite
activins[no description available]medium10
aspartic acid[no description available]medium210aspartate family amino acid;
aspartic acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
mouse metabolite;
neurotransmitter
taurine[no description available]medium30amino sulfonic acid;
zwitterion		antioxidant;
Escherichia coli metabolite;
glycine receptor agonist;
human metabolite;
mouse metabolite;
nutrient;
radical scavenger;
Saccharomyces cerevisiae metabolite
kiss1 protein, human[no description available]medium50
sulthiame[no description available]medium10organic molecular entity
lacosamide[no description available]medium80N-acyl-amino acid
zonisamide[no description available]medium401,2-benzoxazoles;
sulfonamide		anticonvulsant;
antioxidant;
central nervous system drug;
protective agent;
T-type calcium channel blocker
1,2,4,5-tetrazine[no description available]medium10tetrazine
acetylglucosamine[no description available]medium70N-acetyl-D-glucosamineepitope
phenyl acetate[no description available]medium993benzenes;
phenyl acetates
trifloxystrobin[no description available]medium280
buprenorphine[no description available]medium32morphinane alkaloiddelta-opioid receptor antagonist;
kappa-opioid receptor antagonist;
mu-opioid receptor agonist;
opioid analgesic
naloxone[no description available]medium111morphinane alkaloid;
organic heteropentacyclic compound;
tertiary alcohol		antidote to opioid poisoning;
central nervous system depressant;
mu-opioid receptor antagonist
cc-115[no description available]medium81
n-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1h-pyrazole-4-carboxamide[no description available]medium20aromatic amide;
cyclopropanes;
organofluorine compound;
pyrazoles;
ring assembly
arginine[no description available]medium271arginine;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		biomarker;
Escherichia coli metabolite;
micronutrient;
mouse metabolite;
nutraceutical
s-adenosylmethionine[no description available]medium70organic cation;
sulfonium compound		coenzyme;
cofactor;
human metabolite;
micronutrient;
Mycoplasma genitalium metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
heme[no description available]medium360
melphalan[no description available]medium61L-phenylalanine derivative;
nitrogen mustard;
non-proteinogenic L-alpha-amino acid;
organochlorine compound		alkylating agent;
antineoplastic agent;
carcinogenic agent;
drug allergen;
immunosuppressive agent
benzeneboronic acid[no description available]medium10boronic acids
histidine[no description available]medium510amino acid zwitterion;
histidine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
benzoxazoles[no description available]medium6911,3-benzoxazoles;
mancude organic heterobicyclic parent
pyrophosphate[no description available]medium60diphosphate ion
mustard gas[no description available]medium20ethyl sulfide;
organochlorine compound		alkylating agent;
carcinogenic agent;
vesicant
clarithromycin[no description available]medium70macrolide antibioticantibacterial drug;
environmental contaminant;
protein synthesis inhibitor;
xenobiotic
zithromax[no description available]medium182macrolide antibioticantibacterial drug;
environmental contaminant;
xenobiotic
alkenes[no description available]medium480
organophosphonates[no description available]medium463divalent inorganic anion;
phosphite ion
fullerene c60[no description available]medium40fullerenegeroprotector
chlorophyll a[no description available]medium290chlorophyll;
methyl ester		cofactor
rilpivirine[no description available]medium140aminopyrimidine;
nitrile		EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor;
HIV-1 reverse transcriptase inhibitor
cytarabine[no description available]medium296beta-D-arabinoside;
monosaccharide derivative;
pyrimidine nucleoside		antimetabolite;
antineoplastic agent;
antiviral agent;
immunosuppressive agent
carbonates[no description available]medium70carbon oxoanion
dimazine[no description available]medium20hydrazinescarcinogenic agent;
fuel;
teratogenic agent
dimethylhydrazines[no description available]medium20
l 743,872[no description available]medium3668
paeonol[no description available]medium10methoxybenzenes;
phenols		metabolite
flavin mononucleotide[no description available]medium20
chloroform[no description available]medium90chloromethanes;
one-carbon compound		carcinogenic agent;
central nervous system drug;
inhalation anaesthetic;
non-polar solvent;
refrigerant
acetone[no description available]medium130ketone body;
methyl ketone;
propanones;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
human metabolite;
polar aprotic solvent
ovalbumin[no description available]medium551
benzene[no description available]medium140aromatic annulene;
benzenes;
volatile organic compound		carcinogenic agent;
environmental contaminant;
non-polar solvent
1,3,4-thiadiazole[no description available]medium260thiadiazole
oleanane[no description available]medium10terpenoid fundamental parent;
triterpene
oleanolic acid[no description available]medium140hydroxy monocarboxylic acid;
pentacyclic triterpenoid		plant metabolite
fluorescein-5-isothiocyanate[no description available]medium40fluorescein isothiocyanate
acetylcysteine[no description available]medium220acetylcysteine;
L-cysteine derivative;
N-acetyl-L-amino acid		antidote to paracetamol poisoning;
antiinfective agent;
antioxidant;
antiviral drug;
ferroptosis inhibitor;
geroprotector;
human metabolite;
mucolytic;
radical scavenger;
vulnerary
bismuth[no description available]medium50metal atom;
pnictogen
antimony[no description available]medium20metalloid atom;
pnictogen
chlorine[no description available]medium550halide anion;
monoatomic chlorine		cofactor;
Escherichia coli metabolite;
human metabolite
epoxyfarnesyl diazoacetate[no description available]medium42
acrylonitrile[no description available]medium80aliphatic nitrile;
volatile organic compound		antifungal agent;
carcinogenic agent;
fungal metabolite;
mutagen;
polar aprotic solvent
colchicine[no description available]medium181alkaloid;
colchicine		anti-inflammatory agent;
gout suppressant;
mutagen
prednisone[no description available]medium22111-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antineoplastic agent;
immunosuppressive agent;
prodrug
chromium[no description available]medium91chromium group element atom;
metal allergen		micronutrient
picolinic acid[no description available]medium21pyridinemonocarboxylic acidhuman metabolite;
MALDI matrix material
meropenem[no description available]medium40alpha,beta-unsaturated monocarboxylic acid;
carbapenemcarboxylic acid;
organic sulfide;
pyrrolidinecarboxamide		antibacterial agent;
antibacterial drug;
drug allergen
ro13-9904[no description available]medium81
carbapenems[no description available]medium50
bictegravir[no description available]medium30monocarboxylic acid amide;
organic heterotetracyclic compound;
secondary carboxamide;
trifluorobenzene		HIV-1 integrase inhibitor
raltegravir potassium[no description available]medium6915
cyclosporine[no description available]medium566
salicylic acid[no description available]medium210monohydroxybenzoic acidalgal metabolite;
antifungal agent;
antiinfective agent;
EC 1.11.1.11 (L-ascorbate peroxidase) inhibitor;
keratolytic drug;
plant hormone;
plant metabolite
glutamic acid[no description available]medium701glutamic acid;
glutamine family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
ferroptosis inducer;
micronutrient;
mouse metabolite;
neurotransmitter;
nutraceutical
silicon[no description available]medium60carbon group element atom;
metalloid atom;
nonmetal atom
spiroxamine[no description available]medium80dioxolane;
spiroketal;
tertiary amino compound		antifungal agrochemical;
environmental contaminant;
sterol biosynthesis inhibitor;
xenobiotic
sodium hydroxide[no description available]medium80alkali metal hydroxide
1-deoxynojirimycin[no description available]medium1472-(hydroxymethyl)piperidine-3,4,5-triol;
piperidine alkaloid		anti-HIV agent;
anti-obesity agent;
bacterial metabolite;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
plant metabolite
vitamin k 3[no description available]medium501,4-naphthoquinones;
vitamin K		angiogenesis inhibitor;
antineoplastic agent;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
human urinary metabolite;
nutraceutical
phosphine[no description available]medium40mononuclear parent hydride;
phosphanes;
phosphine		carcinogenic agent;
fumigant insecticide
oxalic acid[no description available]medium20alpha,omega-dicarboxylic acidalgal metabolite;
human metabolite;
plant metabolite
benzofurazan[no description available]medium10benzoxadiazole
fluorine[no description available]medium220diatomic fluorine;
gas molecular entity		NMR chemical shift reference compound
fluorides[no description available]medium150halide anion;
monoatomic fluorine
fluorouracil[no description available]medium503nucleobase analogue;
organofluorine compound		antimetabolite;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
radiosensitizing agent;
xenobiotic
stilbenes[no description available]medium310stilbene
cytochrome c-t[no description available]medium150
carbon tetrachloride[no description available]medium161chlorocarbon;
chloromethanes		hepatotoxic agent;
refrigerant
caffeine[no description available]medium992purine alkaloid;
trimethylxanthine		adenosine A2A receptor antagonist;
adenosine receptor antagonist;
adjuvant;
central nervous system stimulant;
diuretic;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
environmental contaminant;
food additive;
fungal metabolite;
geroprotector;
human blood serum metabolite;
mouse metabolite;
mutagen;
plant metabolite;
psychotropic drug;
ryanodine receptor agonist;
xenobiotic
trimethoprim[no description available]medium30aminopyrimidine;
methoxybenzenes		antibacterial drug;
diuretic;
drug allergen;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
environmental contaminant;
xenobiotic
sulfadiazine[no description available]medium81pyrimidines;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
antimicrobial agent;
antiprotozoal drug;
coccidiostat;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
xenobiotic
pyrimethamine[no description available]medium40aminopyrimidine;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
argon[no description available]medium40monoatomic argon;
noble gas atom;
p-block element atom		food packaging gas;
neuroprotective agent
amitrole[no description available]medium1460aromatic amine;
triazoles		carotenoid biosynthesis inhibitor;
EC 1.11.1.6 (catalase) inhibitor;
herbicide
febuxostat[no description available]medium2441,3-thiazolemonocarboxylic acid;
aromatic ether;
nitrile		EC 1.17.3.2 (xanthine oxidase) inhibitor
topiroxostat[no description available]medium20
allyl alcohol[no description available]medium10primary allylic alcohol;
propenol		antibacterial agent;
fungicide;
herbicide;
insecticide;
plant metabolite
2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol[no description available]medium30(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
tertiary alcohol;
triazoles
agar[no description available]medium190
spermine[no description available]medium70polyazaalkane;
tetramine		antioxidant;
fundamental metabolite;
immunosuppressive agent
1,10-phenanthroline[no description available]medium20phenanthrolineEC 2.7.1.1 (hexokinase) inhibitor;
EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor
1,7-phenanthroline[no description available]medium80phenanthroline
3-nitrobenzaldehyde[no description available]medium10
2-nitrobenzaldehyde[no description available]medium10benzaldehydes;
C-nitro compound
nickel[no description available]medium371metal allergen;
nickel group element atom		epitope;
micronutrient
tyrosine[no description available]medium431amino acid zwitterion;
erythrose 4-phosphate/phosphoenolpyruvate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
tyrosine		EC 1.3.1.43 (arogenate dehydrogenase) inhibitor;
fundamental metabolite;
micronutrient;
nutraceutical
1,3-butadiene[no description available]medium30butadienecarcinogenic agent;
mutagen
imidazolidines[no description available]medium50azacycloalkane;
imidazolidines;
saturated organic heteromonocyclic parent
adenylyl imidodiphosphate[no description available]medium20adenosine 5'-phosphate
verapamil[no description available]medium170aromatic ether;
nitrile;
polyether;
tertiary amino compound
loreclezole[no description available]medium650
oxyquinoline[no description available]medium91monohydroxyquinolineantibacterial agent;
antifungal agrochemical;
antiseptic drug;
iron chelator
n-heptane[no description available]medium20alkane;
volatile organic compound		non-polar solvent;
plant metabolite
diosgenin[no description available]medium503beta-sterol;
hexacyclic triterpenoid;
sapogenin;
spiroketal		antineoplastic agent;
antiviral agent;
apoptosis inducer;
metabolite
ibuprofen[no description available]medium283monocarboxylic acidantipyretic;
cyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
drug allergen;
environmental contaminant;
geroprotector;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
radical scavenger;
xenobiotic
trypanothione[no description available]medium10organic disulfide
2-(3',5'-di-tert-butyl-2'-hydroxyphenyl)-5-chlorobenzotriazole[no description available]medium50triazoles
panobinostat[no description available]medium101cinnamamides;
hydroxamic acid;
methylindole;
secondary amino compound		angiogenesis modulating agent;
antineoplastic agent;
EC 3.5.1.98 (histone deacetylase) inhibitor
tacrolimus[no description available]medium647macrolide lactambacterial metabolite;
immunosuppressive agent
thiazolidines[no description available]medium220thiazolidine
betulinic acid[no description available]medium100hydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-HIV agent;
anti-inflammatory agent;
antimalarial;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
plant metabolite
thiamethoxam[no description available]medium1001,3-thiazoles;
2-nitroguanidine derivative;
organochlorine compound;
oxadiazane		antifeedant;
carcinogenic agent;
environmental contaminant;
neonicotinoid insectide;
xenobiotic
calix(4)arene[no description available]medium140
tranexamic acid[no description available]medium10amino acid
aminocaproic acid[no description available]medium20amino acid zwitterion;
epsilon-amino acid;
omega-amino fatty acid		antifibrinolytic drug;
hematologic agent;
metabolite
acefylline[no description available]medium10oxopurine
nitroguanidine[no description available]medium110nitroguanidine;
one-carbon compound
ethinyl estradiol[no description available]medium10417-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound		xenoestrogen
ethinyl estradiol[no description available]medium10317-hydroxy steroid;
3-hydroxy steroid;
terminal acetylenic compound		xenoestrogen
chloroquine[no description available]medium190aminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
miltefosine[no description available]medium140phosphocholines;
phospholipid		anti-inflammatory agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antiprotozoal drug;
apoptosis inducer;
immunomodulator;
protein kinase inhibitor
aminopenicillanic acid[no description available]medium10amino acid zwitterion;
penicillanic acids		allergen
mebendazole[no description available]medium10aromatic ketone;
benzimidazoles;
carbamate ester		antinematodal drug;
microtubule-destabilising agent;
tubulin modulator
griseofulvin[no description available]medium1601-benzofurans;
antibiotic antifungal drug;
benzofuran antifungal drug;
organochlorine compound;
oxaspiro compound		antibacterial agent;
Penicillium metabolite
phthalylsulfathiazole[no description available]medium101,3-thiazoles;
dicarboxylic acid monoamide;
sulfonamide antibiotic;
sulfonamide
quinuclidines[no description available]medium100quinuclidines;
saturated organic heterobicyclic parent
dihydrotestosterone[no description available]medium22317beta-hydroxy steroid;
17beta-hydroxyandrostan-3-one;
3-oxo-5alpha-steroid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
aminoglutethimide[no description available]medium364dicarboximide;
piperidones;
substituted aniline		adrenergic agent;
anticonvulsant;
antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
ethisterone[no description available]medium3017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol		drug metabolite;
progestin
glucagon-like peptide 1[no description available]medium22451
vanillin[no description available]medium50benzaldehydes;
monomethoxybenzene;
phenols		anti-inflammatory agent;
anticonvulsant;
antioxidant;
flavouring agent;
plant metabolite
glycerol[no description available]medium131alditol;
triol		algal metabolite;
detergent;
Escherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
solvent
resveratrol[no description available]medium100resveratrolantioxidant;
phytoalexin;
plant metabolite;
quorum sensing inhibitor;
radical scavenger
tetrahydropyrimidinone[no description available]medium10
pteridines[no description available]medium70azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
pteridines
n-(2,4-dichloro-5-(4-(difluoromethyl)-4,5-dihydro-3-methyl-5-oxo-1h-1,2,4-triazol-1-yl)phenyl)methanesulfonamide[no description available]medium290dichlorobenzene;
organofluorine compound;
sulfonamide;
triazoles		agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
xenon[no description available]medium80monoatomic xenon;
noble gas atom;
p-block element atom
lupinine[no description available]medium20quinolizidine alkaloid
alprostadil[no description available]medium120prostaglandins Eanticoagulant;
human metabolite;
platelet aggregation inhibitor;
vasodilator agent
naphthoquinones[no description available]medium330
midazolam[no description available]medium2412imidazobenzodiazepine;
monofluorobenzenes;
organochlorine compound		anticonvulsant;
antineoplastic agent;
anxiolytic drug;
apoptosis inducer;
central nervous system depressant;
GABAA receptor agonist;
general anaesthetic;
muscle relaxant;
sedative
fumaric acid[no description available]medium11butenedioic acidfood acidity regulator;
fundamental metabolite;
geroprotector
cypermethrin[no description available]medium220aromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organochlorine compound		agrochemical;
molluscicide;
pyrethroid ester acaricide;
pyrethroid ester insecticide
cyfluthrin[no description available]medium20aromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organochlorine compound;
organofluorine compound		agrochemical;
pyrethroid ester insecticide
geldanamycin[no description available]medium50
thiourea[no description available]medium410one-carbon compound;
thioureas;
ureas		antioxidant;
chromophore
ebselen[no description available]medium20benzoselenazoleanti-inflammatory drug;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 2.5.1.7 (UDP-N-acetylglucosamine 1-carboxyvinyltransferase) inhibitor;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
EC 3.1.3.25 (inositol-phosphate phosphatase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 3.5.4.1 (cytosine deaminase) inhibitor;
EC 5.1.3.2 (UDP-glucose 4-epimerase) inhibitor;
enzyme mimic;
ferroptosis inhibitor;
genotoxin;
hepatoprotective agent;
neuroprotective agent;
radical scavenger
dimethyl sulfoxide[no description available]medium321sulfoxide;
volatile organic compound		alkylating agent;
antidote;
Escherichia coli metabolite;
geroprotector;
MRI contrast agent;
non-narcotic analgesic;
polar aprotic solvent;
radical scavenger
nitramine[no description available]medium10nitramineexplosive
glycine[no description available]medium1022alpha-amino acid;
amino acid zwitterion;
proteinogenic amino acid;
serine family amino acid		EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor;
fundamental metabolite;
hepatoprotective agent;
micronutrient;
neurotransmitter;
NMDA receptor agonist;
nutraceutical
trimeprazine[no description available]medium10phenothiazines
rilmazafone[no description available]medium361benzophenones
luminol[no description available]medium72
hydroxyl radical[no description available]medium221oxygen hydride;
oxygen radical;
reactive oxygen species
chlorquinaldol[no description available]medium11monohydroxyquinoline;
organochlorine compound		antibacterial drug;
antiprotozoal drug;
antiseptic drug
europium[no description available]medium61f-block element atom;
lanthanoid atom
indigo carmine[no description available]medium21
n-methyladenosine[no description available]medium21methyladenosine
nitrogen dioxide[no description available]medium31nitrogen oxide
sodium metabisulfite[no description available]medium11inorganic sodium saltfood antioxidant
zinc oxide[no description available]medium11zinc molecular entity
dithiothreitol[no description available]medium511,4-dimercaptobutane-2,3-diol;
butanediols;
dithiol;
glycol;
thiol		chelator;
human metabolite;
reducing agent
mocetinostat[no description available]medium381aminopyrimidine;
benzamides;
pyridines;
secondary amino compound;
secondary carboxamide;
substituted aniline		antineoplastic agent;
apoptosis inducer;
autophagy inducer;
cardioprotective agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
hepatotoxic agent
esmolol[no description available]medium11aromatic ether;
ethanolamines;
methyl ester;
secondary alcohol;
secondary amino compound
hydrogen sulfide[no description available]medium41gas molecular entity;
hydracid;
mononuclear parent hydride;
sulfur hydride		Escherichia coli metabolite;
genotoxin;
metabolite;
signalling molecule;
toxin;
vasodilator agent
carmine[no description available]medium11
triclosan[no description available]medium61aromatic ether;
dichlorobenzene;
monochlorobenzenes;
phenols		antibacterial agent;
antimalarial;
drug allergen;
EC 1.3.1.9 [enoyl-[acyl-carrier-protein] reductase (NADH)] inhibitor;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
fungicide;
persistent organic pollutant;
xenobiotic
protocatechuic acid[no description available]medium11catechols;
dihydroxybenzoic acid		antineoplastic agent;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
human xenobiotic metabolite;
plant metabolite
histamine[no description available]medium792aralkylamino compound;
imidazoles		human metabolite;
mouse metabolite;
neurotransmitter
galactose[no description available]medium666D-galactose;
galactopyranose		Escherichia coli metabolite;
mouse metabolite
ethylene glycol[no description available]medium21ethanediol;
glycol		metabolite;
mouse metabolite;
solvent;
toxin
uracil[no description available]medium465pyrimidine nucleobase;
pyrimidone		allergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
acebutolol[no description available]medium21alpha-D-glucosyl-(1->4)-D-mannopyranose
mitomycin[no description available]medium71mitomycinalkylating agent;
antineoplastic agent
mevalonic acid[no description available]medium513,5-dihydroxy-3-methylpentanoic acid
trifluridine[no description available]medium11nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
EC 2.1.1.45 (thymidylate synthase) inhibitor
zeolites[no description available]medium41
ma-1[no description available]medium11carboxamidine;
organochlorine compound;
pyrimidone;
pyrrolidines		antineoplastic agent;
EC 2.4.2.4 (thymidine phosphorylase) inhibitor
regorafenib[no description available]medium21(trifluoromethyl)benzenes;
aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
phenylureas;
pyridinecarboxamide		antineoplastic agent;
hepatotoxic agent;
tyrosine kinase inhibitor
sulfites[no description available]medium61divalent inorganic anion;
sulfur oxide;
sulfur oxoanion
erythrosine[no description available]medium141
2,4-dichlorophenoxyacetic acid[no description available]medium110chlorophenoxyacetic acid;
dichlorobenzene		agrochemical;
defoliant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
environmental contaminant;
phenoxy herbicide;
synthetic auxin
adenosine diphosphate ribose[no description available]medium40ADP-sugarEscherichia coli metabolite;
mouse metabolite
tetracycline[no description available]medium40
vindesine[no description available]medium20methyl ester;
organic heteropentacyclic compound;
organic heterotetracyclic compound;
primary carboxamide;
tertiary alcohol;
tertiary amino compound;
vinca alkaloid		antineoplastic agent
penthiopyrad[no description available]medium30aromatic amide;
organofluorine compound;
pyrazoles;
thiophenes
1-vinyl-1,2,4-triazole[no description available]medium60
clopidogrel[no description available]medium50methyl ester;
monochlorobenzenes;
thienopyridine		anticoagulant;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
thiamine pyrophosphate[no description available]medium60organic chloride salt;
vitamin B1
benzoin[no description available]medium60benzoins;
secondary alpha-hydroxy ketone		EC 3.1.1.1 (carboxylesterase) inhibitor
ethambutol[no description available]medium40ethanolamines;
ethylenediamine derivative		antitubercular agent;
environmental contaminant;
xenobiotic
acetonitrile[no description available]medium270aliphatic nitrile;
volatile organic compound		EC 3.5.1.4 (amidase) inhibitor;
NMR chemical shift reference compound;
polar aprotic solvent
clotrimazole[no description available]medium528conazole antifungal drug;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes		antiinfective agent;
environmental contaminant;
xenobiotic
manganese[no description available]medium180elemental manganese;
manganese group element atom		Escherichia coli metabolite;
micronutrient
carvacrol[no description available]medium40botanical anti-fungal agent;
p-menthane monoterpenoid;
phenols		agrochemical;
antimicrobial agent;
flavouring agent;
TRPA1 channel agonist;
volatile oil component
thymol[no description available]medium30monoterpenoid;
phenols		volatile oil component
pterostilbene[no description available]medium10diether;
methoxybenzenes;
stilbenol		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
hypoglycemic agent;
neuroprotective agent;
neurotransmitter;
plant metabolite;
radical scavenger
methanol[no description available]medium610alkyl alcohol;
one-carbon compound;
primary alcohol;
volatile organic compound		amphiprotic solvent;
Escherichia coli metabolite;
fuel;
human metabolite;
mouse metabolite;
Mycoplasma genitalium metabolite
hydroxyitraconazole[no description available]medium91
dinitrobenzenes[no description available]medium50
terbutryne[no description available]medium20diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
deoxycytidine[no description available]medium291pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
gemcitabine[no description available]medium110organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
environmental contaminant;
immunosuppressive agent;
photosensitizing agent;
prodrug;
radiosensitizing agent;
xenobiotic
quinoline[no description available]medium260azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
quinolines
oxcarbazepine[no description available]medium50cyclic ketone;
dibenzoazepine		anticonvulsant;
drug allergen
gs-458967[no description available]medium320
indoline[no description available]medium40indoles
coumarin[no description available]medium310coumarinsfluorescent dye;
human metabolite;
plant metabolite
thiophanate[no description available]medium90benzimidazole precursor fungicide;
carbamate ester;
carbamate fungicide;
thioureas		antifungal drug
carbendazim[no description available]medium230benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		antifungal agrochemical;
antinematodal drug;
metabolite;
microtubule-destabilising agent
blasticidin s[no description available]medium10
imidacloprid[no description available]medium270imidacloprid;
imidazolidines;
monochloropyridine		environmental contaminant;
genotoxin;
neonicotinoid insectide;
nicotinic acetylcholine receptor agonist;
xenobiotic
prizes[no description available]medium50carboxamidine;
monochloropyridine;
nitrile		environmental contaminant;
neonicotinoid insectide;
xenobiotic
carbamates[no description available]medium974amino-acid anion
navitoclax[no description available]medium50aryl sulfide;
monochlorobenzenes;
morpholines;
N-sulfonylcarboxamide;
organofluorine compound;
piperazines;
secondary amino compound;
sulfone;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor
mercaptopurine[no description available]medium50aryl thiol;
purines;
thiocarbonyl compound		anticoronaviral agent;
antimetabolite;
antineoplastic agent
arsenic trioxide[no description available]medium30
diethyl phosphate[no description available]medium20dialkyl phosphatehuman xenobiotic metabolite;
mouse metabolite
zm 241385[no description available]medium3513diamino-1,3,5-triazine
suramin[no description available]medium120naphthalenesulfonic acid;
phenylureas;
secondary carboxamide		angiogenesis inhibitor;
antinematodal drug;
antineoplastic agent;
apoptosis inhibitor;
EC 2.7.11.13 (protein kinase C) inhibitor;
GABA antagonist;
GABA-gated chloride channel antagonist;
purinergic receptor P2 antagonist;
ryanodine receptor agonist;
trypanocidal drug
flutriafol[no description available]medium210monofluorobenzenes;
tertiary alcohol;
triazoles
diflubenzuron[no description available]medium20benzoylurea insecticide;
monochlorobenzenes		insect sterilant
boron[no description available]medium80boron group element atom;
metalloid atom;
nonmetal atom		micronutrient
4,4-difluoro-4-bora-3a,4a-diaza-s-indacene[no description available]medium100BODIPY compound
mannich bases[no description available]medium310
tetrahydrofuran[no description available]medium60cyclic ether;
oxolanes;
saturated organic heteromonocyclic parent;
volatile organic compound		polar aprotic solvent
thalidomide[no description available]medium190phthalimides;
piperidones
bromochloroacetic acid[no description available]medium1002-bromocarboxylic acid;
monocarboxylic acid;
organochlorine compound
oligonucleotides[no description available]medium590
propargyl bromide[no description available]medium10
propargylamine[no description available]medium20
pargyline[no description available]medium50aromatic amine
mibefradil[no description available]medium20tetralinsT-type calcium channel blocker
6',7'-dihydroxybergamottin[no description available]medium10psoralens
quercetin[no description available]medium1107-hydroxyflavonol;
pentahydroxyflavone		antibacterial agent;
antineoplastic agent;
antioxidant;
Aurora kinase inhibitor;
chelator;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
geroprotector;
phytoestrogen;
plant metabolite;
protein kinase inhibitor;
radical scavenger
ketoprofen[no description available]medium90benzophenones;
oxo monocarboxylic acid		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
diphenhydramine[no description available]medium121ether;
tertiary amino compound		anti-allergic agent;
antidyskinesia agent;
antiemetic;
antiparkinson drug;
antipruritic drug;
antitussive;
H1-receptor antagonist;
local anaesthetic;
muscarinic antagonist;
oneirogen;
sedative
mercury[no description available]medium270elemental mercury;
zinc group element atom		neurotoxin
argininamide[no description available]medium10amino acid amide;
guanidines;
L-arginine derivative
fluorodeoxyglucose f18[no description available]medium1632-deoxy-2-((18)F)fluoro-D-glucose;
2-deoxy-2-fluoro-aldehydo-D-glucose
phosphorylcholine[no description available]medium180phosphocholinesallergen;
epitope;
hapten;
human metabolite;
mouse metabolite
pilsicainide[no description available]medium10organic heterobicyclic compound;
secondary carboxamide		anti-arrhythmia drug;
sodium channel blocker
tetrodotoxin[no description available]medium130azatetracycloalkane;
oxatetracycloalkane;
quinazoline alkaloid		animal metabolite;
bacterial metabolite;
marine metabolite;
neurotoxin;
voltage-gated sodium channel blocker
lidocaine[no description available]medium60benzenes;
monocarboxylic acid amide;
tertiary amino compound		anti-arrhythmia drug;
drug allergen;
environmental contaminant;
local anaesthetic;
xenobiotic
c.i. 42510[no description available]medium60
laccase[no description available]medium540
violuric acid[no description available]medium60
congo red[no description available]medium10bis(azo) compound
alizarin[no description available]medium21dihydroxyanthraquinonechromophore;
dye;
plant metabolite
acetosyringone[no description available]medium20acetophenones;
dimethoxybenzene;
phenols		anti-asthmatic drug;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite
fosbretabulin[no description available]medium60
econazole[no description available]medium130dichlorobenzene;
ether;
imidazoles;
monochlorobenzenes
oxytocin[no description available]medium180heterodetic cyclic peptide;
peptide hormone		oxytocic;
vasodilator agent
tetrachloroisophthalonitrile[no description available]medium130aromatic fungicide;
dinitrile;
tetrachlorobenzene		antifungal agrochemical
4-aminobenzoic acid[no description available]medium40aminobenzoate;
aromatic amino-acid anion		Escherichia coli metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
g007-lk[no description available]medium130
propargyl alcohol[no description available]medium80propynol;
terminal acetylenic compound;
volatile organic compound		antifungal agent;
Saccharomyces cerevisiae metabolite
indole[no description available]medium120indole;
polycyclic heteroarene		Escherichia coli metabolite
ascorbic acid[no description available]medium411ascorbic acid;
vitamin C		coenzyme;
cofactor;
flour treatment agent;
food antioxidant;
food colour retention agent;
geroprotector;
plant metabolite;
skin lightening agent
dora-22[no description available]medium90
mavoglurant[no description available]medium20
azd2066[no description available]medium63
fipronil[no description available]medium90(trifluoromethyl)benzenes;
dichlorobenzene;
nitrile;
primary amino compound;
pyrazoles;
sulfoxide
androstenedione[no description available]medium861517-oxo steroid;
3-oxo-Delta(4) steroid;
androstanoid		androgen;
Daphnia magna metabolite;
human metabolite;
mouse metabolite
oxypurinol[no description available]medium20pyrazolopyrimidinedrug metabolite;
EC 1.17.3.2 (xanthine oxidase) inhibitor
tigecycline[no description available]medium30
vlx600[no description available]medium81
wzb117[no description available]medium10
beta-alanine[no description available]medium20amino acid zwitterion;
beta-amino acid		agonist;
fundamental metabolite;
human metabolite;
inhibitor;
neurotransmitter
atazanavir sulfate[no description available]medium94organic sulfate salt
2-aminopyrimidine[no description available]medium30aminopyrimidine
tryptoline[no description available]medium50beta-carbolines
methylcellulose[no description available]medium60
hydroxypropylmethylcellulose acetate succinate[no description available]medium20
catechin[no description available]medium51catechinantioxidant;
plant metabolite
deoxycholic acid[no description available]medium362bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human blood serum metabolite
acetovanillone[no description available]medium50acetophenones;
aromatic ketone;
methyl ketone		antirheumatic drug;
EC 1.6.3.1. [NAD(P)H oxidase (H2O2-forming)] inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug;
plant metabolite
2-(4-(2-carboxyethyl)phenethylamino)-5'-n-ethylcarboxamidoadenosine[no description available]medium1721adenosines;
dicarboxylic acid monoamide;
monocarboxylic acid		adenosine A2A receptor agonist;
anti-inflammatory agent
benzothiazole[no description available]medium170benzothiazolesenvironmental contaminant;
plant metabolite;
xenobiotic
galactomannan[no description available]medium525oligosaccharide
mannans[no description available]medium545
oz 439[no description available]medium31
fentanyl[no description available]medium42anilide;
monocarboxylic acid amide;
piperidines		adjuvant;
anaesthesia adjuvant;
anaesthetic;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic
25-hydroxyvitamin d 2[no description available]medium20hydroxycalciol;
seco-ergostane;
vitamin D		bone density conservation agent;
human xenobiotic metabolite;
nutraceutical
everolimus[no description available]medium409cyclic acetal;
cyclic ketone;
ether;
macrolide lactam;
primary alcohol;
secondary alcohol		anticoronaviral agent;
antineoplastic agent;
geroprotector;
immunosuppressive agent;
mTOR inhibitor
diclosulam[no description available]medium70sulfonamide
5-(4-ethylbenzylidene)-2-thioxothiazolidin-4-one[no description available]medium20
sea 0400[no description available]medium10
flunarizine[no description available]medium31diarylmethane
darunavir[no description available]medium336carbamate ester;
furofuran;
sulfonamide		antiviral drug;
HIV protease inhibitor
ritonavir[no description available]medium40171,3-thiazoles;
carbamate ester;
carboxamide;
L-valine derivative;
ureas		antiviral drug;
environmental contaminant;
HIV protease inhibitor;
xenobiotic
rhodamine b[no description available]medium30organic chloride salt;
xanthene dye		fluorescent probe;
fluorochrome;
histological dye
dehydroabietic acid[no description available]medium40abietane diterpenoid;
carbotricyclic compound;
monocarboxylic acid		allergen;
metabolite
cladribine[no description available]medium11organochlorine compound;
purine 2'-deoxyribonucleoside		antineoplastic agent;
immunosuppressive agent
4,5,6,7-tetrabromo-2-azabenzimidazole[no description available]medium780
dichlororibofuranosylbenzimidazole[no description available]medium40
lysophosphatidylcholines[no description available]medium901-O-acyl-sn-glycero-3-phosphocholine
casein kinase ii[no description available]medium890
vorozole[no description available]medium11610benzotriazoles
gsk343[no description available]medium20aminopyridine;
indazoles;
N-alkylpiperazine;
N-arylpiperazine;
pyridone;
secondary carboxamide		antineoplastic agent;
apoptosis inducer;
EC 2.1.1.43 (enhancer of zeste homolog 2) inhibitor
bay h 4502[no description available]medium90biphenyls;
imidazoles
loceryl[no description available]medium140morpholine antifungal drug;
tertiary amino compound		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
EC 1.3.1.70 (Delta(14)-sterol reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
sulfur[no description available]medium300chalcogen;
nonmetal atom		macronutrient
phosphotyrosine[no description available]medium100L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid;
O(4)-phosphotyrosine		Escherichia coli metabolite;
immunogen
penicillin g[no description available]medium60penicillin allergen;
penicillin		antibacterial drug;
drug allergen;
epitope
reversan[no description available]medium10
etravirine[no description available]medium345aminopyrimidine;
aromatic ether;
dinitrile;
organobromine compound		antiviral agent;
HIV-1 reverse transcriptase inhibitor
uniconazole-p[no description available]medium90(1E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol;
conazole fungicide;
triazole fungicide		antifungal agrochemical;
EC 1.14.13.78 (ent-kaurene oxidase) inhibitor;
plant growth retardant
1,2,4-trioxane[no description available]medium20
kynurenine[no description available]medium71aromatic ketone;
non-proteinogenic alpha-amino acid;
substituted aniline		human metabolite
muramidase[no description available]medium60
4-cyano-4'-pentylbiphenyl[no description available]medium10
prochloraz[no description available]medium220amide fungicide;
aromatic ether;
conazole fungicide;
imidazole fungicide;
imidazoles;
trichlorobenzene;
ureas		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor;
environmental contaminant;
xenobiotic
baricitinib[no description available]medium140azetidines;
nitrile;
pyrazoles;
pyrrolopyrimidine;
sulfonamide		anti-inflammatory agent;
antirheumatic drug;
antiviral agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
immunosuppressive agent
asparagine[no description available]medium20amino acid zwitterion;
asparagine;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid		Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
cystobactamid 919-2[no description available]medium10
benzimidazole[no description available]medium290benzimidazole;
polycyclic heteroarene
pyrazinamide[no description available]medium40monocarboxylic acid amide;
N-acylammonia;
pyrazines		antitubercular agent;
prodrug
essramycin[no description available]medium50triazolopyrimidinesmetabolite
profenofos[no description available]medium40monochlorobenzenes;
organic thiophosphate;
organochlorine insecticide;
organophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
usnic acid[no description available]medium20benzofurans
naphthalimides[no description available]medium70
gibberellic acid[no description available]medium400C19-gibberellin;
gibberellin monocarboxylic acid;
lactone;
organic heteropentacyclic compound		mouse metabolite;
plant metabolite
brotizolam[no description available]medium123organic molecular entity
medetomidine[no description available]medium10imidazoles
atipamezole[no description available]medium10
butorphanol[no description available]medium10morphinane alkaloidantitussive;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
isoflurane[no description available]medium40organofluorine compoundinhalation anaesthetic
chlorpromazine[no description available]medium160organochlorine compound;
phenothiazines;
tertiary amine		anticoronaviral agent;
antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
phenothiazine antipsychotic drug
bifenthrin[no description available]medium20carboxylic ester;
cyclopropanecarboxylate ester;
cyclopropanes;
organochlorine compound;
organofluorine compound		pyrethroid ester acaricide;
pyrethroid ester insecticide
tetraconazole[no description available]medium620dichlorobenzene;
ether;
organofluorine compound;
triazoles
acephate[no description available]medium20mixed diacylamine;
organic thiophosphate;
organothiophosphate insecticide;
phosphoramide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
gingerol[no description available]medium10beta-hydroxy ketone;
guaiacols		antineoplastic agent;
plant metabolite
indoleacetic acid[no description available]medium170indole-3-acetic acids;
monocarboxylic acid		auxin;
human metabolite;
mouse metabolite;
plant hormone;
plant metabolite
r-7050[no description available]medium20
2'-hydroxychalcone[no description available]medium10chalcones;
phenols		anti-inflammatory agent
gaboxadol[no description available]medium31oxazole
acetochlor[no description available]medium10aromatic amide;
monocarboxylic acid amide;
organochlorine compound		environmental contaminant;
herbicide;
xenobiotic
saccharin[no description available]medium701,2-benzisothiazole;
N-sulfonylcarboxamide		environmental contaminant;
sweetening agent;
xenobiotic
plx4032[no description available]medium90aromatic ketone;
difluorobenzene;
monochlorobenzenes;
pyrrolopyridine;
sulfonamide		antineoplastic agent;
B-Raf inhibitor
bafilomycin a1[no description available]medium20cyclic hemiketal;
macrolide antibiotic;
oxanes		apoptosis inducer;
autophagy inhibitor;
bacterial metabolite;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
ferroptosis inhibitor;
fungicide;
potassium ionophore;
toxin
benzothiazide[no description available]medium10benzothiadiazine;
sulfonamide		antihypertensive agent;
diuretic
embelin[no description available]medium20dihydroxy-1,4-benzoquinonesantimicrobial agent;
antineoplastic agent;
hepatitis C protease inhibitor;
plant metabolite
methylene chloride[no description available]medium40chloromethanes;
volatile organic compound		carcinogenic agent;
polar aprotic solvent;
refrigerant
imatinib mesylate[no description available]medium231methanesulfonate saltanticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
tyrosine kinase inhibitor
aldosterone[no description available]medium16811beta-hydroxy steroid;
18-oxo steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid hormone;
mineralocorticoid;
primary alpha-hydroxy ketone;
steroid aldehyde		human metabolite;
mouse metabolite
ixazomib[no description available]medium21benzamides;
boronic acids;
dichlorobenzene;
glycine derivative		antineoplastic agent;
apoptosis inducer;
drug metabolite;
orphan drug;
proteasome inhibitor
fluquinconazole[no description available]medium70conazole fungicide;
dichlorobenzene;
organofluorine compound;
quinazolines;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
vorinostat[no description available]medium110dicarboxylic acid diamide;
hydroxamic acid		antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
glycogen[no description available]medium70
fludioxonil[no description available]medium110benzodioxoles;
nitrile;
organofluorine compound;
pyrroles		androgen antagonist;
antifungal agrochemical;
estrogen receptor agonist
cyanuric chloride[no description available]medium20chloro-1,3,5-triazine;
organochlorine compound		cross-linking reagent
4-amino-1,2,4-triazole[no description available]medium90
4-hydroxybenzaldehyde[no description available]medium10hydroxybenzaldehydeEC 1.14.17.1 (dopamine beta-monooxygenase) inhibitor;
mouse metabolite;
plant metabolite
vancomycin[no description available]medium170glycopeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
benzonidazole[no description available]medium415C-nitro compound;
imidazoles;
monocarboxylic acid amide		antiprotozoal drug
azomycin[no description available]medium699C-nitro compound;
imidazoles		antitubercular agent
fluorobenzenes[no description available]medium380monofluorobenzenesNMR chemical shift reference compound
l 838,417[no description available]medium330
iodine[no description available]medium120diatomic iodinenutrient
levoleucovorin[no description available]medium315-formyltetrahydrofolic acidantineoplastic agent;
metabolite
irinotecan[no description available]medium100carbamate ester;
delta-lactone;
N-acylpiperidine;
pyranoindolizinoquinoline;
ring assembly;
tertiary alcohol;
tertiary amino compound		antineoplastic agent;
apoptosis inducer;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
prodrug
ciclopirox[no description available]medium182cyclic hydroxamic acid;
hydroxypyridone antifungal drug;
pyridone		antibacterial agent;
antiseborrheic
tavaborole[no description available]medium192benzoxaborole;
organofluorine compound		antifungal agent;
EC 6.1.1.4 (leucine--tRNA ligase) inhibitor;
protein synthesis inhibitor
tioconazole[no description available]medium80dichlorobenzene;
ether;
imidazoles;
thiophenes
sertaconazole[no description available]medium101-benzothiophenes;
dichlorobenzene;
ether;
imidazoles
molybdenum[no description available]medium30chromium group element atommicronutrient
dexmedetomidine[no description available]medium30medetomidinealpha-adrenergic agonist;
analgesic;
non-narcotic analgesic;
sedative
imipenem, anhydrous[no description available]medium20beta-lactam antibiotic allergen;
carbapenems;
zwitterion		antibacterial drug
tazobactam[no description available]medium80penicillanic acids;
triazoles		antiinfective agent;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
avibactam[no description available]medium10azabicycloalkane;
hydroxylamine O-sulfonic acid;
monocarboxylic acid amide;
ureas		antibacterial drug;
antimicrobial agent;
EC 3.5.2.6 (beta-lactamase) inhibitor
longifolene[no description available]medium10longifolene
sesquiterpenes[no description available]medium150
vindoline[no description available]medium10
tariquidar[no description available]medium10benzamides
cinchonidine[no description available]medium10(8xi)-cinchonan-9-ol;
cinchona alkaloid		metabolite
atrazine[no description available]medium210chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
malathion[no description available]medium130diester;
ethyl ester;
organic thiophosphate
mdv 3100[no description available]medium82(trifluoromethyl)benzenes;
benzamides;
imidazolidinone;
monofluorobenzenes;
nitrile;
thiocarbonyl compound		androgen antagonist;
antineoplastic agent
maleic acid[no description available]medium10butenedioic acidalgal metabolite;
mouse metabolite;
plant metabolite
styrene[no description available]medium50styrenes;
vinylarene;
volatile organic compound		mouse metabolite;
mutagen;
plant metabolite
gsk1265744[no description available]medium30difluorobenzene;
monocarboxylic acid amide;
organic heterotricyclic compound;
secondary carboxamide		HIV-1 integrase inhibitor
incb-018424[no description available]medium30nitrile;
pyrazoles;
pyrrolopyrimidine		antineoplastic agent;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor
nadp[no description available]medium490
dextrothyroxine[no description available]medium190
docetaxel anhydrous[no description available]medium303secondary alpha-hydroxy ketone;
tetracyclic diterpenoid		antimalarial;
antineoplastic agent;
photosensitizing agent
2-mercaptobenzimidazole[no description available]medium30
diazinon[no description available]medium60organic thiophosphate;
pyrimidines		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
nematicide;
xenobiotic
sodium acetate, anhydrous[no description available]medium20organic sodium saltNMR chemical shift reference compound
rokitamycin[no description available]medium10organic molecular entity
ru 66647[no description available]medium80
erythromycin[no description available]medium123cyclic ketone;
erythromycin
cyfluthrin[no description available]medium20
clindamycin[no description available]medium21
streptogramin b[no description available]medium10cyclodepsipeptideantibacterial drug;
antimicrobial agent;
bacterial metabolite
miocamycin[no description available]medium10
phencyclidine[no description available]medium130benzenes;
piperidines		anaesthetic;
neurotoxin;
NMDA receptor antagonist;
psychotropic drug
orteronel[no description available]medium20
gsk1210151a[no description available]medium201imidazoquinoline
dazomet[no description available]medium20dithiocarbamic ester;
thiadiazinane		antibacterial agent;
antifungal agrochemical;
herbicide;
nematicide
targocil[no description available]medium40
azaguanine[no description available]medium60nucleobase analogue;
triazolopyrimidines		antimetabolite;
antineoplastic agent;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor
n-vinyl-2-pyrrolidinone[no description available]medium90pyrrolidin-2-ones
bms-663068[no description available]medium93
dextroamphetamine[no description available]medium711-phenylpropan-2-amineadrenergic agent;
adrenergic uptake inhibitor;
dopamine uptake inhibitor;
dopaminergic agent;
neurotoxin;
sympathomimetic agent
methyl-3-methoxy-4-hydroxystyryl ketone[no description available]medium10hydroxycinnamic acid
anidulafungin[no description available]medium805antibiotic antifungal drug;
azamacrocycle;
echinocandin;
heterodetic cyclic peptide;
semisynthetic derivative
tert-butyl isocyanide[no description available]medium10
trifluoromethanesulfonic acid[no description available]medium70one-carbon compound;
perfluoroalkanesulfonic acid
aluminum[no description available]medium120boron group element atom;
elemental aluminium;
metal atom
epigallocatechin gallate[no description available]medium11flavans;
gallate ester;
polyphenol		antineoplastic agent;
antioxidant;
apoptosis inducer;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent;
plant metabolite
amylopectin[no description available]medium21
sulfamethoxazole[no description available]medium81isoxazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial agent;
antiinfective agent;
antimicrobial agent;
drug allergen;
EC 1.1.1.153 [sepiapterin reductase (L-erythro-7,8-dihydrobiopterin forming)] inhibitor;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
epitope;
P450 inhibitor;
xenobiotic
levofloxacin[no description available]medium729-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
fluoroquinolone antibiotic;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
topoisomerase IV inhibitor
diallyl disulfide[no description available]medium11organic disulfideantifungal agent;
antineoplastic agent;
plant metabolite
sodium glutamate[no description available]medium11monosodium glutamateflavouring agent
bedaquiline[no description available]medium10aromatic ether;
naphthalenes;
organobromine compound;
quinolines;
tertiary alcohol;
tertiary amino compound		antitubercular agent;
ATP synthase inhibitor
ro5126766[no description available]medium20aryloxypyrimidine;
coumarins;
organofluorine compound;
pyridines;
sulfamides		antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
lutetium[no description available]medium70d-block element atom;
lanthanoid atom
gastrins[no description available]medium275
piperaquine[no description available]medium10aminoquinoline;
N-arylpiperazine;
organochlorine compound		antimalarial
primaquine[no description available]medium30aminoquinoline;
aromatic ether;
N-substituted diamine		antimalarial
ferroquine[no description available]medium10
nitd 609[no description available]medium10
sj733[no description available]medium10
chlorpheniramine[no description available]medium70monochlorobenzenes;
pyridines;
tertiary amino compound		anti-allergic agent;
antidepressant;
antipruritic drug;
H1-receptor antagonist;
histamine antagonist;
serotonin uptake inhibitor
propadiene[no description available]medium30allenes
2-propanol[no description available]medium80secondary alcohol;
secondary fatty alcohol		protic solvent
2-propanol[no description available]medium81secondary alcohol;
secondary fatty alcohol		protic solvent
phosphatidylcholines[no description available]medium1811,2-diacyl-sn-glycero-3-phosphocholine
1,2-diphytanoylphosphatidylcholine[no description available]medium10
phenanthrenes[no description available]medium110
famotidine[no description available]medium511,3-thiazoles;
guanidines;
sulfonamide		anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
sulfometuron methyl[no description available]medium10benzoate ester;
N-sulfonylurea;
pyrimidines		EC 2.2.1.6 (acetolactate synthase) inhibitor;
herbicide
1,2-benzisothiazoline-3-one[no description available]medium70organic heterobicyclic compound;
organonitrogen heterocyclic compound		disinfectant;
drug allergen;
environmental contaminant;
platelet aggregation inhibitor;
sensitiser;
xenobiotic
hydroxychloroquine[no description available]medium30aminoquinoline;
organochlorine compound;
primary alcohol;
secondary amino compound;
tertiary amino compound		anticoronaviral agent;
antimalarial;
antirheumatic drug;
dermatologic drug
cepharanthine[no description available]medium10bisbenzylisoquinoline alkaloid;
isoquinolines
finrozole[no description available]medium135
nickel ferrite[no description available]medium10
vx-770[no description available]medium20aromatic amide;
monocarboxylic acid amide;
phenols;
quinolone		CFTR potentiator;
orphan drug
lumacaftor[no description available]medium20aromatic amide;
benzodioxoles;
benzoic acids;
cyclopropanes;
organofluorine compound;
pyridines		CFTR potentiator;
orphan drug
acetohydroxamic acid[no description available]medium10acetohydroxamic acids;
carbohydroximic acid		algal metabolite;
EC 3.5.1.5 (urease) inhibitor
2,4-dinitroanisole[no description available]medium200dinitroanisolesexplosive
palbociclib[no description available]medium357aminopyridine;
aromatic ketone;
cyclopentanes;
piperidines;
pyridopyrimidine;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
bitertanol[no description available]medium160aromatic ether;
biphenyls;
secondary alcohol;
triazoles
iodoquinol[no description available]medium10monohydroxyquinoline;
organoiodine compound		antiamoebic agent;
antibacterial agent;
antiprotozoal drug;
antiseptic drug
nifedipine[no description available]medium70C-nitro compound;
dihydropyridine;
methyl ester		calcium channel blocker;
human metabolite;
tocolytic agent;
vasodilator agent
rifapentine[no description available]medium11N-alkylpiperazine;
N-iminopiperazine;
rifamycins		antitubercular agent;
leprostatic drug
isoniazid[no description available]medium191carbohydrazideantitubercular agent;
drug allergen
fenfluramine[no description available]medium31(trifluoromethyl)benzenes;
secondary amino compound		appetite depressant;
serotonergic agonist;
serotonin uptake inhibitor
amlodipine[no description available]medium20dihydropyridine;
ethyl ester;
methyl ester;
monochlorobenzenes;
primary amino compound		antihypertensive agent;
calcium channel blocker;
vasodilator agent
cx 4945[no description available]medium30
parathion[no description available]medium50C-nitro compound;
organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
mouse metabolite
birinapant[no description available]medium20dipeptide
ferrostatin-1[no description available]medium10ethyl ester;
primary arylamine;
substituted aniline		antifungal agent;
antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radiation protective agent;
radical scavenger
methyl-thiohydantoin-tryptophan[no description available]medium20organonitrogen compound;
organooxygen compound
zoxamide[no description available]medium10alpha-chloroketone;
benzamides;
dichlorobenzene
idelalisib[no description available]medium21aromatic amine;
organofluorine compound;
purines;
quinazolines;
secondary amino compound		antineoplastic agent;
apoptosis inducer;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
fludarabine[no description available]medium51purine nucleoside
vidarabine[no description available]medium82beta-D-arabinoside;
purine nucleoside		antineoplastic agent;
bacterial metabolite;
nucleoside antibiotic
valacyclovir[no description available]medium10L-valyl esterantiviral drug
piperacillin, tazobactam drug combination[no description available]medium40
rhenium[no description available]medium130manganese group element atom
desosamine[no description available]medium10amino sugar
epiglucan[no description available]medium210
flucytosine[no description available]medium1160aminopyrimidine;
nucleoside analogue;
organofluorine compound;
pyrimidine antifungal drug;
pyrimidone		prodrug
cellobiose[no description available]medium20cellobioseepitope
cellobial[no description available]medium10
isocoumarins[no description available]medium20isocoumarins
c 1311[no description available]medium70
miv 150[no description available]medium20
glycidyl methacrylate[no description available]medium30enoate ester;
epoxide
divinyl benzene[no description available]medium10styrenes
r 115866[no description available]medium263aromatic amine;
benzothiazoles;
secondary amino compound;
triazoles
midostaurin[no description available]medium60benzamides;
gamma-lactam;
indolocarbazole;
organic heterooctacyclic compound		antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
staurosporine[no description available]medium180ammonium ion derivative
idarubicin[no description available]medium92anthracycline antibiotic;
deoxy hexoside;
monosaccharide derivative
buprofezin[no description available]medium20thiadiazinane;
ureas
1,6-anhydro-3,4-dideoxy-beta-d-glycero-hex-3-enopyran-2-ulose[no description available]medium10anhydrohexose;
deoxyketohexose
alpha-naphthylphthalamic acid[no description available]medium30carboxylic acid;
dicarboxylic acid monoamide;
N-(1-naphthyl)carboxamide		herbicide
5-(4-chlorophenyl)-4h-1,2,4-triazole-3-thiol[no description available]medium60triazoles
pyrazolanthrone[no description available]medium10anthrapyrazole;
aromatic ketone;
cyclic ketone		antineoplastic agent;
c-Jun N-terminal kinase inhibitor;
geroprotector
thyroxine[no description available]medium2502-halophenol;
iodophenol;
L-phenylalanine derivative;
non-proteinogenic L-alpha-amino acid;
thyroxine zwitterion;
thyroxine		antithyroid drug;
human metabolite;
mouse metabolite;
thyroid hormone
laquinimod[no description available]medium10aromatic amide
3-(1-(3-(biphenyl-4-ylamino)-3-oxopropyl)-1h-1,2,3-triazol-4-yl)-6-hydroxy-1-methyl-2-phenyl-1h-indole-5-carboxylic acid[no description available]medium40
trametinib[no description available]medium51acetamides;
aromatic amine;
cyclopropanes;
organofluorine compound;
organoiodine compound;
pyridopyrimidine;
ring assembly		anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
chlordiazepoxide[no description available]medium131benzodiazepine
guanfacine[no description available]medium10acetamides
ketamine[no description available]medium20cyclohexanones;
monochlorobenzenes;
secondary amino compound		analgesic;
environmental contaminant;
intravenous anaesthetic;
neurotoxin;
NMDA receptor antagonist;
xenobiotic
propofol[no description available]medium40phenolsanticonvulsant;
antiemetic;
intravenous anaesthetic;
radical scavenger;
sedative
hydromorphone[no description available]medium10morphinane alkaloid;
organic heteropentacyclic compound		mu-opioid receptor agonist;
opioid analgesic
thiobarbituric acid[no description available]medium20barbituratesallergen;
reagent
thienopyrimidine[no description available]medium60
hexamethylene bisacetamide[no description available]medium30acetamides
drometrizole[no description available]medium200triazoles
phthalazine[no description available]medium20azaarene;
mancude organic heterobicyclic parent;
ortho-fused heteroarene;
phthalazines
fenpropathrin, (+-)-isomer[no description available]medium20aromatic ether;
cyclopropanecarboxylate ester		agrochemical;
pyrethroid ester acaricide;
pyrethroid ester insecticide
isoquinoline[no description available]medium60azaarene;
isoquinolines;
mancude organic heterobicyclic parent;
ortho-fused heteroarene
ursane[no description available]medium10terpenoid fundamental parent;
triterpene
lupane[no description available]medium10
ganciclovir[no description available]medium502-aminopurines;
oxopurine		antiinfective agent;
antiviral drug
triptolide[no description available]medium20diterpenoid;
epoxide;
gamma-lactam;
organic heteroheptacyclic compound		antispermatogenic agent;
plant metabolite
lithium chloride[no description available]medium70inorganic chloride;
lithium salt		antimanic drug;
geroprotector
okadaic acid[no description available]medium50ketal
nad[no description available]medium240organophosphate oxoanioncofactor;
human metabolite;
hydrogen acceptor;
Saccharomyces cerevisiae metabolite
resazurin[no description available]medium50phenoxazine
xanthenes[no description available]medium110xanthene
isothiocyanic acid[no description available]medium30hydracid;
one-carbon compound
2-chloro-n(6)cyclopentyladenosine[no description available]medium180
digoxin[no description available]medium115cardenolide glycoside;
steroid saponin		anti-arrhythmia drug;
cardiotonic drug;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
epitope
clay[no description available]medium130
climbazole[no description available]medium10aromatic ether;
hemiaminal ether;
imidazoles;
ketone;
monochlorobenzenes
glutathione disulfide[no description available]medium30glutathione derivative;
organic disulfide		Escherichia coli metabolite;
mouse metabolite
volasertib[no description available]medium20
laminaran[no description available]medium60
enfumafungin[no description available]medium10lactol;
monosaccharide derivative;
triterpenoid saponin		antifungal agent
deet[no description available]medium30benzamides;
monocarboxylic acid amide		environmental contaminant;
insect repellent;
xenobiotic
n-(4-ethylphenyl)-2-((4-ethyl-5-(3-pyridinyl)-4h-1,2,4-triazol-3-yl)thio)acetamide[no description available]medium150
lapachol[no description available]medium10
isosteviol[no description available]medium40diterpenoid
bms-626529[no description available]medium143
sar405[no description available]medium10
acetylthiocholine iodide[no description available]medium10
acetylthiocholine[no description available]medium10
nifurtimox[no description available]medium110nitrofuran antibiotic
arginyl-glycyl-aspartic acid[no description available]medium120oligopeptide
icg 001[no description available]medium10
zeatin[no description available]medium40zeatinplant metabolite
fg-4592[no description available]medium40aromatic ether;
isoquinolines;
N-acylglycine		EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor;
EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor
sc 26196[no description available]medium10
vx-970[no description available]medium20sulfonamide
trazodone[no description available]medium262monochlorobenzenes;
N-alkylpiperazine;
N-arylpiperazine;
triazolopyridine		adrenergic antagonist;
antidepressant;
anxiolytic drug;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
pitolisant[no description available]medium10organochlorine compound
oxyfluorofen[no description available]medium10aromatic etherEC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
ticagrelor[no description available]medium20aryl sulfide;
hydroxyether;
organofluorine compound;
secondary amino compound;
triazolopyrimidines		P2Y12 receptor antagonist;
platelet aggregation inhibitor
cevipabulin[no description available]medium81
efavirenz[no description available]medium3814acetylenic compound;
benzoxazine;
cyclopropanes;
organochlorine compound;
organofluorine compound		antiviral drug;
HIV-1 reverse transcriptase inhibitor
etanidazole[no description available]medium30C-nitro compound;
imidazoles;
monocarboxylic acid amide		alkylating agent;
antineoplastic agent;
prodrug;
radiosensitizing agent
pr-104[no description available]medium10
2-(2-nitro-1h-imidazol-1-yl)-n-(2,2,3,3,3-pentafluoropropyl)acetamide[no description available]medium30
ranolazine[no description available]medium100aromatic amide;
monocarboxylic acid amide;
monomethoxybenzene;
N-alkylpiperazine;
secondary alcohol
epz-6438[no description available]medium10
mepanipyrim[no description available]medium20acetylenic compound;
aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
hepatotoxic agent
methylparaben[no description available]medium30parabenantifungal agent;
antimicrobial food preservative;
neuroprotective agent;
plant metabolite
chlorine[no description available]medium110diatomic chlorine;
gas molecular entity		bleaching agent
ethyl-p-hydroxybenzoate[no description available]medium10ethyl ester;
paraben		antifungal agent;
antimicrobial food preservative;
phytoestrogen;
plant metabolite
triclocarban[no description available]medium30dichlorobenzene;
monochlorobenzenes;
phenylureas		antimicrobial agent;
antiseptic drug;
disinfectant;
environmental contaminant;
xenobiotic
propylparaben[no description available]medium90benzoate ester;
paraben;
phenols		antifungal agent;
antimicrobial agent
amphotericin b, deoxycholate drug combination[no description available]medium312
bardoxolone methyl[no description available]medium20cyclohexenones
camptothecin[no description available]medium160delta-lactone;
pyranoindolizinoquinoline;
quinoline alkaloid;
tertiary alcohol		antineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
genotoxin;
plant metabolite
levonorgestrel[no description available]medium8517beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound		contraceptive drug;
female contraceptive drug;
progestin;
synthetic oral contraceptive
ethinyl estradiol-norgestrel combination[no description available]medium11
cerium[no description available]medium70f-block element atom;
lanthanoid atom
acetosulfame[no description available]medium30organic heteromonocyclic compound;
organonitrogen heterocyclic compound;
oxacycle;
sulfamate ester		environmental contaminant;
sweetening agent;
xenobiotic
defactinib[no description available]medium10
dipyrromethene[no description available]medium10dipyrrins
porphobilinogen[no description available]medium10aralkylamino compound;
dicarboxylic acid;
pyrroles		Escherichia coli metabolite;
metabolite;
mouse metabolite
probenecid[no description available]medium70benzoic acids;
sulfonamide		uricosuric drug
su 11248[no description available]medium50monocarboxylic acid amide;
pyrroles		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
immunomodulator;
neuroprotective agent;
vascular endothelial growth factor receptor antagonist
phenacyl bromide[no description available]medium10acetophenones;
alpha-bromoketone		metabolite
thiocyanate[no description available]medium20pseudohalide anion;
sulfur molecular entity		human metabolite
oxazolidin-2-one[no description available]medium898carbamate ester;
oxazolidinone		metabolite
linezolid[no description available]medium90acetamides;
morpholines;
organofluorine compound;
oxazolidinone		antibacterial drug;
protein synthesis inhibitor
sulfamerazine[no description available]medium10pyrimidines;
sulfonamide antibiotic;
sulfonamide		antiinfective agent;
drug allergen
sulfamic acid[no description available]medium50sulfamic acids
sulfenamide[no description available]medium10
coronene[no description available]medium10ortho- and peri-fused polycyclic arene
carbofuran[no description available]medium701-benzofurans;
carbamate ester		acaricide;
agrochemical;
avicide;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nematicide
methamidophos[no description available]medium20organic thiophosphate;
organothiophosphate insecticide;
phosphoramide		acaricide;
agrochemical;
avicide
hevein[no description available]medium10
web 2086[no description available]medium5767organonitrogen heterocyclic compound;
organosulfur heterocyclic compound
1-hexadecyl-2-acetyl-glycero-3-phosphocholine[no description available]medium752102-acetyl-1-alkyl-sn-glycero-3-phosphocholineantihypertensive agent;
beta-adrenergic antagonist;
bronchoconstrictor agent;
hematologic agent;
vasodilator agent
glutaminase[no description available]medium20
ifosfamide[no description available]medium31ifosfamidesalkylating agent;
antineoplastic agent;
environmental contaminant;
immunosuppressive agent;
xenobiotic
etoposide[no description available]medium101beta-D-glucoside;
furonaphthodioxole;
organic heterotetracyclic compound		antineoplastic agent;
DNA synthesis inhibitor
deoxyglucose[no description available]medium173
alvocidib[no description available]medium40dihydroxyflavone;
hydroxypiperidine;
monochlorobenzenes;
tertiary amino compound		antineoplastic agent;
antirheumatic drug;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
kasugamycin[no description available]medium10
cgs 15943[no description available]medium880aromatic amine;
biaryl;
furans;
organochlorine compound;
primary amino compound;
quinazolines;
triazoloquinazoline		adenosine A1 receptor antagonist;
adenosine A2A receptor antagonist;
antineoplastic agent;
central nervous system stimulant
mycophenolic acid[no description available]medium512-benzofurans;
gamma-lactone;
monocarboxylic acid;
phenols		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
environmental contaminant;
immunosuppressive agent;
mycotoxin;
Penicillium metabolite;
xenobiotic
cyanides[no description available]medium500pseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor
aconitine[no description available]medium40
octane[no description available]medium10alkanexenobiotic
lenvatinib[no description available]medium10aromatic amide;
aromatic ether;
cyclopropanes;
monocarboxylic acid amide;
monochlorobenzenes;
phenylureas;
quinolines		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist;
orphan drug;
vascular endothelial growth factor receptor antagonist
lenalidomide[no description available]medium130aromatic amine;
dicarboximide;
isoindoles;
piperidones		angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
phenytoin[no description available]medium222imidazolidine-2,4-dioneanticonvulsant;
drug allergen;
sodium channel blocker;
teratogenic agent
corticosterone[no description available]medium14011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
paroxetine[no description available]medium3112aromatic ether;
benzodioxoles;
organofluorine compound;
piperidines		antidepressant;
anxiolytic drug;
hepatotoxic agent;
P450 inhibitor;
serotonin uptake inhibitor
cadmium[no description available]medium260cadmium molecular entity;
zinc group element atom
u 18666a[no description available]medium30hydrochlorideantiviral agent;
EC 1.3.1.72 (Delta(24)-sterol reductase) inhibitor;
Hedgehog signaling pathway inhibitor;
nicotinic antagonist;
sterol biosynthesis inhibitor
1-aminobenzotriazole[no description available]medium1980
divinyl sulfone[no description available]medium50sulfonecross-linking reagent
thiamorpholine[no description available]medium30saturated organic heteromonocyclic parent;
thiomorpholines
chenodeoxycholic acid[no description available]medium20bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
obeticholic acid[no description available]medium203alpha-hydroxy steroid;
7alpha-hydroxy steroid;
dihydroxy-5beta-cholanic acid		farnesoid X receptor agonist;
hepatoprotective agent
phthalocyanine[no description available]medium70phthalocyanines;
tetrapyrrole fundamental parent
3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester[no description available]medium10
ly335979[no description available]medium20carbopolycyclic compound
tanespimycin[no description available]medium1601,4-benzoquinones;
ansamycin;
carbamate ester;
organic heterobicyclic compound;
secondary amino compound		antineoplastic agent;
apoptosis inducer;
Hsp90 inhibitor
carbon monoxide[no description available]medium200carbon oxide;
gas molecular entity;
one-carbon compound		biomarker;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
human metabolite;
ligand;
metabolite;
mitochondrial respiratory-chain inhibitor;
mouse metabolite;
neurotoxin;
neurotransmitter;
P450 inhibitor;
probe;
signalling molecule;
vasodilator agent
quetiapine fumarate[no description available]medium70fumarate salt
gramine[no description available]medium10aminoalkylindole;
indole alkaloid;
tertiary amino compound		antibacterial agent;
antiviral agent;
plant metabolite;
serotonergic antagonist
glyceryl 2-arachidonate[no description available]medium302-acylglycerol 20:4;
endocannabinoid		human metabolite
gamma-aminobutyric acid[no description available]medium762amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid		human metabolite;
neurotransmitter;
Saccharomyces cerevisiae metabolite;
signalling molecule
anandamide[no description available]medium20endocannabinoid;
N-acylethanolamine 20:4		human blood serum metabolite;
neurotransmitter;
vasodilator agent
olsalazine[no description available]medium10azobenzenes;
dicarboxylic acid		non-steroidal anti-inflammatory drug;
prodrug
aprepitant[no description available]medium40(trifluoromethyl)benzenes;
cyclic acetal;
morpholines;
triazoles		antidepressant;
antiemetic;
neurokinin-1 receptor antagonist;
peripheral nervous system drug;
substance P receptor antagonist
furosemide[no description available]medium120chlorobenzoic acid;
furans;
sulfonamide		environmental contaminant;
loop diuretic;
xenobiotic
azd 6244[no description available]medium60benzimidazoles;
bromobenzenes;
hydroxamic acid ester;
monochlorobenzenes;
organofluorine compound;
secondary amino compound		anticoronaviral agent;
antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
17-(dimethylaminoethylamino)-17-demethoxygeldanamycin[no description available]medium601,4-benzoquinones;
ansamycin;
carbamate ester;
secondary amino compound;
tertiary amino compound		Hsp90 inhibitor
lignin[no description available]medium220
myricetin[no description available]medium207-hydroxyflavonol;
hexahydroxyflavone		antineoplastic agent;
antioxidant;
cyclooxygenase 1 inhibitor;
food component;
geroprotector;
hypoglycemic agent;
plant metabolite
benzbromarone[no description available]medium611-benzofurans;
aromatic ketone		uricosuric drug
arhalofenate[no description available]medium50
cardiovascular agents[no description available]medium90
teriflunomide[no description available]medium30(trifluoromethyl)benzenes;
aromatic amide;
enamide;
enol;
nitrile;
secondary carboxamide		drug metabolite;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
hepatotoxic agent;
non-steroidal anti-inflammatory drug;
tyrosine kinase inhibitor
brequinar[no description available]medium10biphenyls;
monocarboxylic acid;
monofluorobenzenes;
quinolinemonocarboxylic acid		anticoronaviral agent;
antimetabolite;
antineoplastic agent;
antiviral agent;
EC 1.3.5.2 [dihydroorotate dehydrogenase (quinone)] inhibitor;
immunosuppressive agent;
pyrimidine synthesis inhibitor
leflunomide[no description available]medium40(trifluoromethyl)benzenes;
isoxazoles;
monocarboxylic acid amide		antineoplastic agent;
antiparasitic agent;
EC 1.3.98.1 [dihydroorotate oxidase (fumarate)] inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
hepatotoxic agent;
immunosuppressive agent;
non-steroidal anti-inflammatory drug;
prodrug;
pyrimidine synthesis inhibitor;
tyrosine kinase inhibitor
vidofludimus[no description available]medium10
cobicistat[no description available]medium201,3-thiazoles;
carbamate ester;
monocarboxylic acid amide;
morpholines;
ureas		P450 inhibitor
bmn 673[no description available]medium10
hesperidin[no description available]medium503'-hydroxyflavanones;
4'-methoxyflavanones;
dihydroxyflavanone;
disaccharide derivative;
flavanone glycoside;
monomethoxyflavanone;
rutinoside		mutagen
hesperetin[no description available]medium503'-hydroxyflavanones;
4'-methoxyflavanones;
monomethoxyflavanone;
trihydroxyflavanone		antineoplastic agent;
antioxidant;
plant metabolite
3,4-dimethoxytoluene[no description available]medium10
toluene[no description available]medium60methylbenzene;
toluenes;
volatile organic compound		cholinergic antagonist;
fuel additive;
neurotoxin;
non-polar solvent
choline salicylate[no description available]medium10hydroxybenzoic acid
choline[no description available]medium20cholinesallergen;
Daphnia magna metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter;
nutrient;
plant metabolite;
Saccharomyces cerevisiae metabolite
salicylates[no description available]medium130monohydroxybenzoateplant metabolite
salsolinol[no description available]medium101-methyl-1,2,3,4-tetrahydroisoquinoline-6,7-diolhuman urinary metabolite
acetic acid[no description available]medium190monocarboxylic acidantimicrobial food preservative;
Daphnia magna metabolite;
food acidity regulator;
protic solvent
salinomycin[no description available]medium40polyketide;
spiroketal		animal growth promotant;
potassium ionophore
3-hydroxybutanal[no description available]medium30
gentamicin[no description available]medium90
ampicillin[no description available]medium120beta-lactam antibiotic;
penicillin allergen;
penicillin		antibacterial drug
ethylene oxide[no description available]medium10gas molecular entity;
oxacycle;
saturated organic heteromonocyclic parent		allergen;
mouse metabolite;
mutagen
fluoxastrobin[no description available]medium20aromatic ether;
dioxazine;
monochlorobenzenes;
organofluorine compound;
oxime O-ether;
pyrimidines;
strobilurin antifungal agent		antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
chlormequat[no description available]medium80quaternary ammonium ionplant growth retardant
ly-2157299[no description available]medium10aromatic amide;
methylpyridines;
monocarboxylic acid amide;
pyrrolopyrazole;
quinolines		antineoplastic agent;
TGFbeta receptor antagonist
paraoxon[no description available]medium20aryl dialkyl phosphate;
organophosphate insecticide		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
mouse metabolite
ssya10-001[no description available]medium30
nitrites[no description available]medium200monovalent inorganic anion;
nitrogen oxoanion;
reactive nitrogen species		human metabolite
n-methylaspartate[no description available]medium210amino dicarboxylic acid;
D-alpha-amino acid;
D-aspartic acid derivative;
secondary amino compound		neurotransmitter agent
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid[no description available]medium80non-proteinogenic alpha-amino acid
trovafloxacin[no description available]medium20
4-aminoquinoline[no description available]medium30
wrenchnolol[no description available]medium10
triethyl phosphine gold[no description available]medium10
calcium gluconate[no description available]medium10calcium saltnutraceutical
azidotrimethylsilane[no description available]medium20
fibrinogen[no description available]medium80iditolfungal metabolite
bay 80-6946[no description available]medium10
lovastatin[no description available]medium70delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
polyketide;
statin (naturally occurring)		anticholesteremic drug;
antineoplastic agent;
Aspergillus metabolite;
prodrug
folic acid[no description available]medium60folic acids;
N-acyl-amino acid		human metabolite;
mouse metabolite;
nutrient
alpha-aminobutyric acid[no description available]medium10alpha-aminobutyric acid;
D-alpha-amino acid
homopropargylglycine[no description available]medium20
acyclovir[no description available]medium802-aminopurines;
oxopurine		antimetabolite;
antiviral drug
thiometon[no description available]medium10organic thiophosphate;
organosulfur compound;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
phosalone[no description available]medium101,3-benzoxazoles;
carbamate ester;
organochlorine insecticide;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
chrysin[no description available]medium207-hydroxyflavonol;
dihydroxyflavone		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
EC 2.7.11.18 (myosin-light-chain kinase) inhibitor;
hepatoprotective agent;
plant metabolite
retinol[no description available]medium80retinol;
vitamin A		human metabolite;
mouse metabolite;
plant metabolite
eletriptan[no description available]medium325indoles;
N-alkylpyrrolidine;
sulfone		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
zolmitriptan[no description available]medium587oxazolidinone;
tryptamines		anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
naratriptan[no description available]medium393heteroarylpiperidine;
sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
almotriptan[no description available]medium274indoles;
sulfonamide;
tertiary amine		non-steroidal anti-inflammatory drug;
serotonergic agonist;
vasoconstrictor agent
1,3-cyclohexanedione[no description available]medium10beta-diketone;
cyclohexanedione
tiletamine hydrochloride[no description available]medium50
hymecromone[no description available]medium10hydroxycoumarinantineoplastic agent;
hyaluronic acid synthesis inhibitor
combretastatin[no description available]medium90
diflunisal[no description available]medium20monohydroxybenzoic acid;
organofluorine compound		non-narcotic analgesic;
non-steroidal anti-inflammatory drug
pyrimethanil[no description available]medium100aminopyrimidine;
anilinopyrimidine fungicide;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
phthalimide[no description available]medium20phthalimides
2-naphthoxyacetic acid[no description available]medium10naphthyloxyacetic acid
indole-3-acetonitrile[no description available]medium10indoles;
nitrile		auxin;
human xenobiotic metabolite;
plant hormone;
plant metabolite
indole-3-acetaldehyde[no description available]medium10indoleacetaldehydebacterial metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
indoleacetamide[no description available]medium10indoles;
monocarboxylic acid amide;
N-acylammonia		bacterial metabolite;
fungal metabolite;
plant metabolite
propylene glycol[no description available]medium30glycol;
propane-1,2-diols		allergen;
human xenobiotic metabolite;
mouse metabolite;
protic solvent
lamotrigine[no description available]medium1111,2,4-triazines;
dichlorobenzene;
primary arylamine		anticonvulsant;
antidepressant;
antimanic drug;
calcium channel blocker;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
excitatory amino acid antagonist;
geroprotector;
non-narcotic analgesic;
xenobiotic
cinromide[no description available]medium10cinnamamides;
secondary carboxamide
topiramate[no description available]medium151cyclic ketal;
ketohexose derivative;
sulfamate ester		anticonvulsant;
sodium channel blocker
felbamate[no description available]medium30carbamate esteranticonvulsant;
neuroprotective agent
incb039110[no description available]medium20
cep 33779[no description available]medium110
arq 197[no description available]medium10indoles
5-(4-amino-1-propan-2-yl-3-pyrazolo[3,4-d]pyrimidinyl)-1,3-benzoxazol-2-amine[no description available]medium31benzoxazole
4-butyrolactone[no description available]medium90butan-4-olidemetabolite;
neurotoxin
butenolide[no description available]medium10butenolide
flupyradifurone[no description available]medium20butenolide;
enamine;
monochloropyridine;
organofluorine insecticide;
tertiary amino compound		insecticide;
nicotinic acetylcholine receptor agonist
topotecan[no description available]medium51pyranoindolizinoquinolineantineoplastic agent;
EC 5.99.1.2 (DNA topoisomerase) inhibitor
ceric oxide[no description available]medium30cerium molecular entity;
metal oxide
16-(2'-o-glucopyranosylglucopyranosyloxy)hexadecanoic acid 1',4''-lactone 6',6''-diacetate[no description available]medium10
purine[no description available]medium90purine
at 13387[no description available]medium40benzamides;
isoindoles;
N-alkylpiperazine;
resorcinols;
tertiary carboxamide		antineoplastic agent;
Hsp90 inhibitor
quizartinib[no description available]medium20benzoimidazothiazole;
isoxazoles;
morpholines;
phenylureas		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
necroptosis inhibitor
grazoprevir[no description available]medium30aromatic ether;
azamacrocycle;
carbamate ester;
cyclopropanes;
lactam;
N-sulfonylcarboxamide;
quinoxaline derivative		antiviral drug;
hepatitis C protease inhibitor;
hepatoprotective agent
apixaban[no description available]medium20aromatic ether;
lactam;
piperidones;
pyrazolopyridine		anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor
azobenzene[no description available]medium60azobenzenes
4'-demethylepipodophyllotoxin[no description available]medium10furonaphthodioxole;
organic heterotetracyclic compound;
phenols		antineoplastic agent
podophyllotoxin[no description available]medium130furonaphthodioxole;
lignan;
organic heterotetracyclic compound		antimitotic;
antineoplastic agent;
keratolytic drug;
microtubule-destabilising agent;
plant metabolite;
tubulin modulator
nor-beta-lapachone[no description available]medium10
rubimaillin[no description available]medium10benzochromene;
methyl ester;
phenols		acyl-CoA:cholesterol acyltransferase 2 inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
neuroprotective agent;
NF-kappaB inhibitor;
plant metabolite
zaleplon[no description available]medium21nitrile;
pyrazolopyrimidine		anticonvulsant;
anxiolytic drug;
central nervous system depressant;
sedative
amplex red[no description available]medium10
toxin ii (anemonia sulcata)[no description available]medium20
e 4031[no description available]medium20sulfonamide
ammonium hydroxide[no description available]medium100azane;
gas molecular entity;
mononuclear parent hydride		EC 3.5.1.4 (amidase) inhibitor;
metabolite;
mouse metabolite;
neurotoxin;
NMR chemical shift reference compound;
nucleophilic reagent;
refrigerant
s 1033[no description available]medium30(trifluoromethyl)benzenes;
imidazoles;
pyridines;
pyrimidines;
secondary amino compound;
secondary carboxamide		anticoronaviral agent;
antineoplastic agent;
tyrosine kinase inhibitor
sb 225002[no description available]medium10nitrophenol
interleukin-8[no description available]medium361
glycine amide[no description available]medium20amino acid amide;
glycine derivative
glycolamide[no description available]medium10acetamides
betaine[no description available]medium50amino-acid betaine;
glycine derivative		fundamental metabolite
levodopa[no description available]medium322amino acid zwitterion;
dopa;
L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		allelochemical;
antidyskinesia agent;
antiparkinson drug;
dopaminergic agent;
hapten;
human metabolite;
mouse metabolite;
neurotoxin;
plant growth retardant;
plant metabolite;
prodrug
oxidopamine[no description available]medium250benzenetriol;
catecholamine;
primary amino compound		drug metabolite;
human metabolite;
neurotoxin
eltoprazine[no description available]medium20
diclofenac[no description available]medium191amino acid;
aromatic amine;
dichlorobenzene;
monocarboxylic acid;
secondary amino compound		antipyretic;
drug allergen;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
harmicine[no description available]medium10
2-naphthoic acid[no description available]medium10naphthoic acidmouse metabolite;
xenobiotic metabolite
benzoic acid[no description available]medium40benzoic acidsalgal metabolite;
antimicrobial food preservative;
drug allergen;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor;
human xenobiotic metabolite;
plant metabolite
benzofuran[no description available]medium401-benzofurans;
benzofuran
1h-benzotriazole-5-carboxylic acid[no description available]medium40
totarol[no description available]medium10diterpenoidmetabolite
decitabine[no description available]medium602'-deoxyribonucleoside
theasinensin a[no description available]medium10biflavonoid;
gallate ester;
proanthocyanidin		anti-inflammatory agent;
anticoronaviral agent;
apoptosis inducer;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
hepatoprotective agent;
hypoglycemic agent;
melanin synthesis inhibitor;
plant metabolite
gsk-2816126[no description available]medium10piperazines;
pyridines
spirodiclofen[no description available]medium30dichlorobenzene;
gamma-lactone;
organochlorine acaricide;
oxaspiro compound
n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide[no description available]medium30anilide fungicide;
aromatic amide;
dichlorobenzene;
monocarboxylic acid amide;
phenols		antifungal agrochemical;
EC 1.14.13.72 (methylsterol monooxygenase) inhibitor;
sterol biosynthesis inhibitor
lanosterol[no description available]medium14014alpha-methyl steroid;
3beta-sterol;
tetracyclic triterpenoid		bacterial metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
cloransulam-methyl[no description available]medium10methyl ester;
monochlorobenzenes;
organofluorine compound;
sulfonamide;
triazolopyrimidines		agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
herbicide
lormetazepam[no description available]medium111,4-benzodiazepinone;
organochlorine compound		sedative
lorazepam[no description available]medium85benzodiazepine
dactinomycin[no description available]medium150actinomycinmutagen
nu 7441[no description available]medium10dibenzothiophenes
pyrroline[no description available]medium20pyrroline
nitenpyram[no description available]medium10chloropyridyl insecticide;
nitenpyram
3,4-dihydroxyphenylglycol[no description available]medium21catechols;
tetrol		metabolite;
mouse metabolite
methoxyhydroxyphenylglycol[no description available]medium31methoxybenzenes;
phenols
secinh3[no description available]medium250triazoles
succinic acid[no description available]medium30alpha,omega-dicarboxylic acid;
C4-dicarboxylic acid		anti-ulcer drug;
fundamental metabolite;
micronutrient;
nutraceutical;
radiation protective agent
js399-19[no description available]medium20
ethacrynic acid[no description available]medium10aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid		EC 2.5.1.18 (glutathione transferase) inhibitor;
ion transport inhibitor;
loop diuretic
u-50488[no description available]medium30dichlorobenzene;
monocarboxylic acid amide;
N-alkylpyrrolidine		analgesic;
antitussive;
calcium channel blocker;
diuretic;
kappa-opioid receptor agonist
1-octanol[no description available]medium20octanol;
primary alcohol		antifungal agent;
bacterial metabolite;
fuel additive;
kairomone;
plant metabolite
dapsone[no description available]medium20substituted aniline;
sulfone		anti-inflammatory drug;
antiinfective agent;
antimalarial;
leprostatic drug
methylazoxymethanol acetate[no description available]medium10azoxy compound
methylazoxymethanol[no description available]medium10azoxy compound
ephedrine, phenobarbital, theophylline drug combination[no description available]medium10
ceftobiprole[no description available]medium10cephalosporin;
thiadiazoles		antimicrobial agent
penicillanic acid[no description available]medium110penicillanic acids
theophylline[no description available]medium741dimethylxanthineadenosine receptor antagonist;
anti-asthmatic drug;
anti-inflammatory agent;
bronchodilator agent;
drug metabolite;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
fungal metabolite;
human blood serum metabolite;
immunomodulator;
muscle relaxant;
vasodilator agent
ephedrine[no description available]medium10phenethylamine alkaloid;
phenylethanolamines		bacterial metabolite;
environmental contaminant;
nasal decongestant;
plant metabolite;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic
tedizolid phosphate[no description available]medium10carbamate ester;
organofluorine compound;
oxazolidinone;
phosphate monoester;
pyridines;
tetrazoles		antimicrobial agent;
prodrug;
protein synthesis inhibitor
tozadenant[no description available]medium30benzothiazoles
aica ribonucleotide[no description available]medium301-(phosphoribosyl)imidazolecarboxamide;
aminoimidazole		cardiovascular drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
polyethylene glycol 300[no description available]medium10poly(ethylene glycol)
n-acetyl-4-benzoquinoneimine[no description available]medium10ketoimine;
quinone imine
l-161982[no description available]medium230biphenyls
n-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)urea[no description available]medium20
aromasil[no description available]medium2674417-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor;
environmental contaminant;
xenobiotic
raloxifene hydrochloride[no description available]medium211hydrochloridebone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
anthracene[no description available]medium40acene;
anthracenes;
ortho-fused tricyclic hydrocarbon
alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc[no description available]medium10amino tetrasaccharide;
glucosamine oligosaccharide		epitope
lewis y antigen[no description available]medium10
plerixafor[no description available]medium81azacycloalkane;
azamacrocycle;
benzenes;
crown amine;
secondary amino compound;
tertiary amino compound		anti-HIV agent;
antineoplastic agent;
C-X-C chemokine receptor type 4 antagonist;
immunological adjuvant
n-iodosuccinimide[no description available]medium20dicarboximide;
pyrrolidinone
megestrol acetate[no description available]medium35820-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester		antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
sumatriptan[no description available]medium9414sulfonamide;
tryptamines		serotonergic agonist;
vasoconstrictor agent
phenylephrine[no description available]medium306phenols;
phenylethanolamines;
secondary amino compound		alpha-adrenergic agonist;
cardiotonic drug;
mydriatic agent;
nasal decongestant;
protective agent;
sympathomimetic agent;
vasoconstrictor agent
bisphenol a-glycidyl methacrylate[no description available]medium20diarylmethane
nobiletin[no description available]medium20methoxyflavoneantineoplastic agent;
plant metabolite
lopinavir[no description available]medium93amphetamines;
dicarboxylic acid diamide		anticoronaviral agent;
antiviral drug;
HIV protease inhibitor
emtricitabine, tenofovir disoproxil fumarate drug combination[no description available]medium22
benzyl bromide[no description available]medium10benzyl bromideslachrymator
sofosbuvir[no description available]medium30isopropyl ester;
L-alanyl ester;
nucleotide conjugate;
organofluorine compound;
phosphoramidate ester		antiviral drug;
hepatitis C protease inhibitor;
prodrug
ledipasvir[no description available]medium20azaspiro compound;
benzimidazole;
bridged compound;
carbamate ester;
carboxamide;
fluorenes;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organofluorine compound		antiviral drug;
hepatitis C protease inhibitor
pyrazolone[no description available]medium20
lactic acid[no description available]medium2202-hydroxy monocarboxylic acidalgal metabolite;
Daphnia magna metabolite
phenformin[no description available]medium10biguanidesantineoplastic agent;
geroprotector;
hypoglycemic agent
amoxicillin[no description available]medium60penicillin allergen;
penicillin		antibacterial drug
opromazine[no description available]medium10phenothiazines
dapi[no description available]medium50indolesfluorochrome
bisphenol a[no description available]medium100bisphenolendocrine disruptor;
environmental contaminant;
xenobiotic;
xenoestrogen
caffeic acid[no description available]medium50caffeic acidgeroprotector;
mouse metabolite
artepillin c[no description available]medium10
clothianidin[no description available]medium501,3-thiazoles;
2-nitroguanidine derivative;
clothianidin;
organochlorine compound		environmental contaminant;
neonicotinoid insectide;
nicotinic acetylcholine receptor agonist;
xenobiotic
mp470[no description available]medium10N-arylpiperazine
1,2-bis(2-aminophenoxy)ethane n,n,n',n'-tetraacetic acid acetoxymethyl ester[no description available]medium20
egtazic acid[no description available]medium100diether;
tertiary amino compound;
tetracarboxylic acid		chelator
tolvaptan[no description available]medium20benzazepine;
benzenedicarboxamide		aquaretic;
vasopressin receptor antagonist
ingenol[no description available]medium10cyclic terpene ketone;
tetracyclic diterpenoid
brassinolide[no description available]medium26022-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
brassinosteroid		plant growth stimulator;
plant hormone
ecdysterone[no description available]medium1014alpha-hydroxy steroid;
20-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
ecdysteroid;
phytoecdysteroid		animal metabolite;
plant metabolite
mk-3118[no description available]medium20
2,2'-dipyridyl[no description available]medium80bipyridinechelator;
ferroptosis inhibitor
sucrose[no description available]medium240glycosyl glycosidealgal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
osmolyte;
Saccharomyces cerevisiae metabolite;
sweetening agent
D-fructopyranose[no description available]medium211cyclic hemiketal;
D-fructose;
fructopyranose		sweetening agent
pimavanserin[no description available]medium10aromatic ether;
monofluorobenzenes;
piperidines;
tertiary amino compound;
ureas		5-hydroxytryptamine 2A receptor inverse agonist;
antipsychotic agent;
serotonergic antagonist
sar 1118[no description available]medium201-benzofurans;
isoquinolines;
L-phenylalanine derivative;
N-acyl-L-alpha-amino acid;
sulfone		anti-inflammatory drug;
lymphocyte function-associated antigen-1 antagonist
insulin degludec[no description available]medium21
h 89[no description available]medium60N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide
sb 216763[no description available]medium20indoles;
maleimides
carbachol[no description available]medium110ammonium salt;
carbamate ester		cardiotonic drug;
miotic;
muscarinic agonist;
nicotinic acetylcholine receptor agonist;
non-narcotic analgesic
angiotensin ii[no description available]medium360amino acid zwitterion;
angiotensin II		human metabolite
testosterone undecanoate[no description available]medium31steroid ester
mirabegron[no description available]medium101,3-thiazoles;
aromatic amide;
ethanolamines;
monocarboxylic acid amide		beta-adrenergic agonist
rasagiline[no description available]medium11indanes;
secondary amine;
terminal acetylenic compound		EC 1.4.3.4 (monoamine oxidase) inhibitor;
neuroprotective agent
carboxyamido-triazole[no description available]medium9115
ethionamide[no description available]medium20pyridines;
thiocarboxamide		antilipemic drug;
antitubercular agent;
fatty acid synthesis inhibitor;
leprostatic drug;
prodrug
metronidazole[no description available]medium180C-nitro compound;
imidazoles;
primary alcohol		antiamoebic agent;
antibacterial drug;
antimicrobial agent;
antiparasitic agent;
antitrichomonal drug;
environmental contaminant;
prodrug;
radiosensitizing agent;
xenobiotic
cortisone[no description available]medium11011-oxo steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
C21-steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
1-anilino-8-naphthalenesulfonate[no description available]medium190aminonaphthalene;
naphthalenesulfonic acid		fluorescent probe
lhrh, ala(6)-gly(10)-ethylamide-[no description available]medium30
fingolimod hydrochloride[no description available]medium20hydrochlorideimmunosuppressive agent;
prodrug;
sphingosine-1-phosphate receptor agonist
sildenafil citrate[no description available]medium70citrate saltEC 3.1.4.35 (3',5'-cyclic-GMP phosphodiesterase) inhibitor;
vasodilator agent
5-methylcytosine[no description available]medium20methylcytosine;
pyrimidines		human metabolite
decanoic acid[no description available]medium20medium-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
anti-inflammatory agent;
antibacterial agent;
human metabolite;
plant metabolite;
volatile oil component
guanine[no description available]medium1302-aminopurines;
oxopurine;
purine nucleobase		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
gs-5816[no description available]medium10carbamate ester;
ether;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heteropentacyclic compound;
ring assembly		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor
mk-8742[no description available]medium20carbamate ester;
imidazoles;
L-valine derivative;
N-acylpyrrolidine;
organic heterotetracyclic compound;
ring assembly		antiviral drug;
hepatitis C virus nonstructural protein 5A inhibitor;
hepatoprotective agent
pf-4989216[no description available]medium20
menotropins[no description available]medium138
2,3,4,6-tetrachlorophenol[no description available]medium140tetrachlorophenolxenobiotic metabolite
2-chlorophenol[no description available]medium102-halophenol;
monochlorophenol
enilconazole[no description available]medium90dichlorobenzene;
ether;
imidazoles
indole-3-carbinol[no description available]medium10indolyl alcoholantineoplastic agent;
plant metabolite
linagliptin[no description available]medium200aminopiperidine;
quinazolines		EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
tetrabutyltin[no description available]medium10
vinclozolin[no description available]medium110dicarboximide;
dichlorobenzene;
olefinic compound;
oxazolidinone
serine[no description available]medium250L-alpha-amino acid;
proteinogenic amino acid;
serine family amino acid;
serine zwitterion;
serine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
threonine[no description available]medium70amino acid zwitterion;
aspartate family amino acid;
L-alpha-amino acid;
proteinogenic amino acid;
threonine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
Saccharomyces cerevisiae metabolite
5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1h-1,2,4-triazole[no description available]medium70
transferrin[no description available]medium143
captan[no description available]medium50isoindoles;
organochlorine compound;
organosulfur compound;
phthalimide fungicide		antifungal agrochemical
tetrahydrophthalimide[no description available]medium10
biphenyl-indanone a[no description available]medium10biphenyls
vt-1161[no description available]medium30organic molecular entity
abemaciclib[no description available]medium41
ribociclib[no description available]medium73
colforsin[no description available]medium180acetate ester;
cyclic ketone;
labdane diterpenoid;
organic heterotricyclic compound;
tertiary alpha-hydroxy ketone;
triol		adenylate cyclase agonist;
anti-HIV agent;
antihypertensive agent;
plant metabolite;
platelet aggregation inhibitor;
protein kinase A agonist
montanine[no description available]medium10
nvp-bsk805[no description available]medium10
minocycline[no description available]medium30
omega-n-methylarginine[no description available]medium80amino acid zwitterion;
arginine derivative;
guanidines;
L-arginine derivative;
non-proteinogenic L-alpha-amino acid
calcimycin[no description available]medium180benzoxazole
n-formylmethionine leucyl-phenylalanine[no description available]medium390tripeptide
paraquat[no description available]medium50organic cationgeroprotector;
herbicide
albuterol[no description available]medium151phenols;
phenylethanolamines;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
environmental contaminant;
xenobiotic
carvedilol[no description available]medium30carbazoles;
secondary alcohol;
secondary amino compound		alpha-adrenergic antagonist;
antihypertensive agent;
beta-adrenergic antagonist;
cardiovascular drug;
vasodilator agent
bisoprolol[no description available]medium10secondary alcohol;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
sympatholytic agent
sb 334867-a[no description available]medium20naphthyridine derivative
1,4,7-triazacyclononane[no description available]medium10azacycloalkane;
crown amine;
saturated organic heteromonocyclic parent
captax[no description available]medium20aryl thiol;
benzothiazoles		carcinogenic agent;
metabolite
bupivacaine[no description available]medium20aromatic amide;
piperidinecarboxamide;
tertiary amino compound
diphenylamine[no description available]medium80aromatic amine;
bridged diphenyl fungicide;
secondary amino compound		antifungal agrochemical;
antioxidant;
carotogenesis inhibitor;
EC 1.3.99.29 [phytoene desaturase (zeta-carotene-forming)] inhibitor;
ferroptosis inhibitor;
radical scavenger
carbazole[no description available]medium20carbazole
phthalic acid[no description available]medium20benzenedicarboxylic acidhuman xenobiotic metabolite
cholecalciferol[no description available]medium114D3 vitamins;
hydroxy seco-steroid;
seco-cholestane;
secondary alcohol;
steroid hormone		geroprotector;
human metabolite
n-desmethylclobazam[no description available]medium10benzodiazepine
nonoxynol[no description available]medium11
aripiprazole[no description available]medium70aromatic ether;
delta-lactam;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
quinolone		drug metabolite;
H1-receptor antagonist;
second generation antipsychotic;
serotonergic agonist
gsk2586184[no description available]medium43
propiolic acid[no description available]medium40acetylenic fatty acid;
alpha,beta-unsaturated monocarboxylic acid;
monounsaturated fatty acid;
short-chain fatty acid;
terminal acetylenic compound		xenobiotic metabolite
er-086526[no description available]medium10cyclic ketal;
cyclic ketone;
macrocycle;
polycyclic ether;
polyether;
primary amino compound		antineoplastic agent;
microtubule-destabilising agent
diquat[no description available]medium40organic cationdefoliant;
herbicide
ursodeoxycholic acid[no description available]medium11bile acid;
C24-steroid;
dihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
brefeldin a[no description available]medium50macrolide antibioticPenicillium metabolite
guanosine 5'-o-(3-thiotriphosphate)[no description available]medium140nucleoside triphosphate analogue
15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid[no description available]medium90
sq 29548[no description available]medium40
perimidine[no description available]medium10perimidine
bms 806[no description available]medium30
cefuroxime[no description available]medium20carbamate ester;
cephalosporin
methylene blue[no description available]medium110organic chloride saltacid-base indicator;
antidepressant;
antimalarial;
antimicrobial agent;
antioxidant;
cardioprotective agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 4.6.1.2 (guanylate cyclase) inhibitor;
fluorochrome;
histological dye;
neuroprotective agent;
physical tracer
ged0301[no description available]medium10
pyrogallol[no description available]medium20benzenetriol;
phenolic donor		plant metabolite
diphenyleneiodonium[no description available]medium30organic cation
pyrogallol sulfonphthalein[no description available]medium10
pep005[no description available]medium20
ku 55933[no description available]medium10
triflumuron[no description available]medium10aromatic ether;
benzoylurea insecticide;
monochlorobenzenes;
organofluorine compound
2-naphthol[no description available]medium60naphtholantinematodal drug;
genotoxin;
human urinary metabolite;
human xenobiotic metabolite;
mouse metabolite;
radical scavenger
1,3,7,9-tetramethyluric acid[no description available]medium10oxopurine;
purine alkaloid		analgesic;
anti-inflammatory agent;
human xenobiotic metabolite;
plant metabolite
pentobarbital[no description available]medium250barbituratesGABAA receptor agonist
xav939[no description available]medium40(trifluoromethyl)benzenes;
thiopyranopyrimidine		tankyrase inhibitor
abacavir[no description available]medium502,6-diaminopurinesantiviral drug;
drug allergen;
HIV-1 reverse transcriptase inhibitor
desloratadine[no description available]medium20benzocycloheptapyridineanti-allergic agent;
cholinergic antagonist;
drug metabolite;
H1-receptor antagonist
loratadine[no description available]medium61benzocycloheptapyridine;
ethyl ester;
N-acylpiperidine;
organochlorine compound;
tertiary carboxamide		anti-allergic agent;
cholinergic antagonist;
geroprotector;
H1-receptor antagonist
amitriptyline[no description available]medium124carbotricyclic compound;
tertiary amine		adrenergic uptake inhibitor;
antidepressant;
environmental contaminant;
tropomyosin-related kinase B receptor agonist;
xenobiotic
imipramine[no description available]medium2813dibenzoazepineadrenergic uptake inhibitor;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
amikacin[no description available]medium30alpha-D-glucoside;
amino cyclitol glycoside;
aminoglycoside;
carboxamide		antibacterial drug;
antimicrobial agent;
nephrotoxin
pf 00868554[no description available]medium163triazolopyrimidines
isoleucine[no description available]medium20aspartate family amino acid;
isoleucine;
L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid		algal metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
alamethicin[no description available]medium10
emerimicins[no description available]medium20
tartaric acid[no description available]medium20tartaric acidEscherichia coli metabolite
glucosamine[no description available]medium70D-glucosamineEscherichia coli metabolite;
geroprotector;
mouse metabolite
praziquantel[no description available]medium10isoquinolines
methoxsalen[no description available]medium30aromatic ether;
psoralens		antineoplastic agent;
cross-linking reagent;
dermatologic drug;
photosensitizing agent;
plant metabolite
piribedil[no description available]medium20N-arylpiperazine
imidazo(1,2-a)pyridine[no description available]medium20
lipid a[no description available]medium41dodecanoate ester;
lipid A;
tetradecanoate ester		Escherichia coli metabolite
lactose[no description available]medium61lactose
jnj-7706621[no description available]medium140sulfonamide
benzamil[no description available]medium10guanidines;
pyrazines
amiloride[no description available]medium70aromatic amine;
guanidines;
organochlorine compound;
pyrazines		diuretic;
sodium channel blocker
mepyramine maleate[no description available]medium10
hederagenin[no description available]medium20dihydroxy monocarboxylic acid;
pentacyclic triterpenoid;
sapogenin		plant metabolite
hexarelin[no description available]medium30
kaurenoic acid[no description available]medium30
metaperiodate[no description available]medium30iodine oxoacid
metaperiodate[no description available]medium10iodine oxoanion;
monovalent inorganic anion
cpi203[no description available]medium10
epirubicin[no description available]medium131aminoglycoside;
anthracycline antibiotic;
anthracycline;
deoxy hexoside;
monosaccharide derivative;
p-quinones;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		antimicrobial agent;
antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
metformin[no description available]medium21090guanidinesenvironmental contaminant;
geroprotector;
hypoglycemic agent;
xenobiotic
fluridone[no description available]medium50phenylpyridinecarotenoid biosynthesis inhibitor
betulin[no description available]medium50diol;
pentacyclic triterpenoid		analgesic;
anti-inflammatory agent;
antineoplastic agent;
antiviral agent;
metabolite
glyoxal[no description available]medium20dialdehydeagrochemical;
allergen;
pesticide;
plant growth regulator
beta-naphthoflavone[no description available]medium150extended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound		aryl hydrocarbon receptor agonist
sphingosine kinase[no description available]medium40
dimethylformamide[no description available]medium130formamides;
volatile organic compound		geroprotector;
hepatotoxic agent;
polar aprotic solvent
chlorantranilipole[no description available]medium30monochlorobenzenes;
organobromine compound;
pyrazole insecticide;
pyrazoles;
pyridines;
secondary carboxamide		ryanodine receptor agonist
misoprostol[no description available]medium107
caprolactone[no description available]medium20epsilon-lactone
bis(p-chlorophenyl)acetic acid[no description available]medium10monocarboxylic acid;
monochlorobenzenes
ddt[no description available]medium40benzenoid aromatic compound;
chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide		bridged diphenyl acaricide;
carcinogenic agent;
endocrine disruptor;
persistent organic pollutant
spermidine[no description available]medium30polyazaalkane;
triamine		autophagy inducer;
fundamental metabolite;
geroprotector
famoxadone[no description available]medium10aromatic ether;
carbohydrazide;
oxazolidinone
trelstar[no description available]medium126
testolactone[no description available]medium213-oxo-Delta(1),Delta(4)-steroid;
seco-androstane
leuprolide[no description available]medium208oligopeptideanti-estrogen;
antineoplastic agent;
gonadotropin releasing hormone agonist
spironolactone[no description available]medium213-oxo-Delta(4) steroid;
oxaspiro compound;
steroid lactone;
thioester		aldosterone antagonist;
antihypertensive agent;
diuretic;
environmental contaminant;
xenobiotic
deslorelin[no description available]medium11oligopeptide
copper sulfate[no description available]medium50metal sulfateemetic;
fertilizer;
sensitiser
tantalum[no description available]medium10vanadium group element atom
niobium[no description available]medium20vanadium group element atom
glycidol[no description available]medium20epoxide;
primary alcohol
meglumine[no description available]medium30hexosamine;
secondary amino compound
tiotropium bromide[no description available]medium20
aniline[no description available]medium190anilines;
primary arylamine
7-methylguanosine-5'-monophosphate[no description available]medium10organophosphate oxoanion
galloflavin[no description available]medium10
4-(3-3,4-p-menthadien-(1,8)-yl)olivetol[no description available]medium10
phytic acid[no description available]medium10inositol phosphate
leupeptins[no description available]medium30
benzyloxycarbonylleucyl-leucyl-leucine aldehyde[no description available]medium30amino aldehyde;
carbamate ester;
tripeptide		proteasome inhibitor
fenitrothion[no description available]medium40C-nitro compound;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
4-aminopyridine[no description available]medium70aminopyridine;
aromatic amine		avicide;
orphan drug;
potassium channel blocker
ethylene[no description available]medium150alkene;
gas molecular entity		plant hormone;
refrigerant
octocrylene[no description available]medium20diarylmethane
formaldehyde[no description available]medium200aldehyde;
one-carbon compound		allergen;
carcinogenic agent;
disinfectant;
EC 3.5.1.4 (amidase) inhibitor;
environmental contaminant;
Escherichia coli metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
7-hydroxycoumarin[no description available]medium30hydroxycoumarinfluorescent probe;
food component;
plant metabolite
hydantoins[no description available]medium130imidazolidine-2,4-dione
zoledronic acid[no description available]medium51251,1-bis(phosphonic acid);
imidazoles		bone density conservation agent
siponimod[no description available]medium10
pemetrexed[no description available]medium10N-acyl-L-glutamic acid;
pyrrolopyrimidine		antimetabolite;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
EC 2.1.1.45 (thymidylate synthase) inhibitor;
EC 2.1.2.2 (phosphoribosylglycinamide formyltransferase) inhibitor
dihydropyridines[no description available]medium300
artenimol[no description available]medium20
atovaquone[no description available]medium10hydroxy-1,2-naphthoquinone
proguanil[no description available]medium10biguanides;
monochlorobenzenes		antimalarial;
antiprotozoal drug;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor
methyl carbamate[no description available]medium10carbamate ester
hydroxyproline[no description available]medium504-hydroxyproline;
L-alpha-amino acid zwitterion		human metabolite;
mouse metabolite;
plant metabolite
adrenomedullin[no description available]medium20
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole[no description available]medium30aromatic primary alcohol;
furans;
indazoles		antineoplastic agent;
apoptosis inducer;
platelet aggregation inhibitor;
soluble guanylate cyclase activator;
vasodilator agent
rg7388[no description available]medium20
tert-butyl beta-carboline-3-carboxylate[no description available]medium20
cl 218872[no description available]medium30pyridazines;
ring assembly
e 5842[no description available]medium150
neostigmine[no description available]medium20quaternary ammonium ionantidote to curare poisoning;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
nicardipine[no description available]medium20benzenes;
C-nitro compound;
diester;
dihydropyridine;
methyl ester;
tertiary amino compound
tolonium chloride[no description available]medium10
tegafur[no description available]medium71organohalogen compound;
pyrimidines
s 1 (combination)[no description available]medium40
cremophor el[no description available]medium10
ethyl levulinate[no description available]medium10oxo carboxylic acid
tanshinone[no description available]medium10abietane diterpenoidanticoronaviral agent
dehydroacetic acid[no description available]medium10ketone;
pyran-2,4-dione		antibacterial agent;
fungicide;
plasticiser
metsulfuron methyl[no description available]medium201,3,5-triazines;
benzoate ester;
N-sulfonylurea		environmental contaminant;
herbicide;
xenobiotic
isophthalate[no description available]medium40dicarboxylic acid dianion
oxytetracycline, anhydrous[no description available]medium10
ceritinib[no description available]medium20aminopyrimidine;
aromatic ether;
organochlorine compound;
piperidines;
secondary amino compound;
sulfone		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
flutamide[no description available]medium150(trifluoromethyl)benzenes;
monocarboxylic acid amide		androgen antagonist;
antineoplastic agent
iduronate[no description available]medium10idopyranuronic acid;
L-iduronic acid
methacrylic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid
abiraterone[no description available]medium413beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
pyridines		antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor
pha 848125[no description available]medium10
pentamidine[no description available]medium70aromatic ether;
carboxamidine;
diether		anti-inflammatory agent;
antifungal agent;
calmodulin antagonist;
chemokine receptor 5 antagonist;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
NMDA receptor antagonist;
S100 calcium-binding protein B inhibitor;
trypanocidal drug;
xenobiotic
s-allylmercaptocysteine[no description available]medium10
orcinol[no description available]medium105-alkylresorcinol;
dihydroxytoluene		Aspergillus metabolite
bromopyruvate[no description available]medium102-oxo monocarboxylic acid anion
gefitinib[no description available]medium207aromatic ether;
monochlorobenzenes;
monofluorobenzenes;
morpholines;
quinazolines;
secondary amino compound;
tertiary amino compound		antineoplastic agent;
epidermal growth factor receptor antagonist
mk 2206[no description available]medium31organic heterotricyclic compoundEC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
genistein[no description available]medium907-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
biochanin a[no description available]medium104'-methoxyisoflavones;
7-hydroxyisoflavones		antineoplastic agent;
EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
pyrazolopyridine[no description available]medium10
androst-5-en-3-ol[no description available]medium10
letermovir[no description available]medium11
isoprene[no description available]medium60alkadiene;
hemiterpene;
volatile organic compound		plant metabolite
1-hydroxy-7-azabenzotriazole[no description available]medium140
uk 68798[no description available]medium20aromatic ether;
sulfonamide;
tertiary amino compound		anti-arrhythmia drug;
potassium channel blocker
endothelin-1[no description available]medium130
monocrotaline[no description available]medium50pyrrolizidine alkaloid
glycidyl nitrate[no description available]medium20
dipyrone[no description available]medium10organic sodium saltanti-inflammatory agent;
antipyretic;
antirheumatic drug;
cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug;
prodrug
mobic[no description available]medium411,3-thiazoles;
benzothiazine;
monocarboxylic acid amide		analgesic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
sb 203580[no description available]medium20imidazoles;
monofluorobenzenes;
pyridines;
sulfoxide		EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector;
Hsp90 inhibitor;
neuroprotective agent
pipemidic acid[no description available]medium10amino acid;
monocarboxylic acid;
N-arylpiperazine;
pyridopyrimidine;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor
zn(ii)-phthalocyanine[no description available]medium10metallophthalocyanine;
zinc tetrapyrrole		fluorochrome
cyclic adp-ribose[no description available]medium20cyclic purine nucleotide;
nucleotide-sugar		metabolite;
ryanodine receptor agonist
adenosine-5'-(n-ethylcarboxamide)[no description available]medium671adenosines;
monocarboxylic acid amide		adenosine A1 receptor agonist;
adenosine A2A receptor agonist;
antineoplastic agent;
EC 3.1.4.* (phosphoric diester hydrolase) inhibitor;
vasodilator agent
4-hydroxyquinazoline[no description available]medium10quinazolines
fenvalerate[no description available]medium20aromatic ether;
carboxylic ester;
monochlorobenzenes		pyrethroid ester acaricide;
pyrethroid ester insecticide
potassium chloride[no description available]medium70inorganic chloride;
inorganic potassium salt;
potassium salt		fertilizer
ferrihydrite[no description available]medium20
acy-1215[no description available]medium10pyrimidinecarboxylic acid
daptomycin[no description available]medium10
iohexol[no description available]medium20benzenedicarboxamide;
organoiodine compound		environmental contaminant;
radioopaque medium;
xenobiotic
harmine[no description available]medium20harmala alkaloidanti-HIV agent;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
metabolite
piperonyl butoxide[no description available]medium60benzodioxolespesticide synergist
acetylacetone[no description available]medium20beta-diketone
diuron[no description available]medium703-(3,4-substituted-phenyl)-1,1-dimethylurea;
dichlorobenzene		environmental contaminant;
mitochondrial respiratory-chain inhibitor;
photosystem-II inhibitor;
urea herbicide;
xenobiotic
t-2307[no description available]medium10
albaconazole[no description available]medium261
lurasidone hydrochloride[no description available]medium21hydrochlorideadrenergic antagonist;
dopaminergic antagonist;
second generation antipsychotic;
serotonergic antagonist
1,3-propane sultone[no description available]medium10sultone
decamethrin[no description available]medium120aromatic ether;
cyclopropanecarboxylate ester;
nitrile;
organobromine compound		agrochemical;
antifeedant;
calcium channel agonist;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
pyrethroid ester insecticide
2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid[no description available]medium80
phenoxy radical[no description available]medium20organic radical
tempo[no description available]medium40aminoxyls;
piperidines		catalyst;
ferroptosis inhibitor;
radical scavenger
n-hydroxyphthalimide[no description available]medium10
acetylgalactosamine[no description available]medium10N-acetyl-D-hexosamine;
N-acetylgalactosamine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
fomesafen[no description available]medium200aromatic ether;
C-nitro compound;
monochlorobenzenes;
N-sulfonylcarboxamide;
organofluorine compound;
phenols		agrochemical;
EC 1.3.3.4 (protoporphyrinogen oxidase) inhibitor;
herbicide
triazolam[no description available]medium133triazolobenzodiazepinesedative
2,4-dinitroaniline[no description available]medium10nitroaniline
cafenstrole[no description available]medium60benzenes;
sulfone;
triazoles		agrochemical;
antimitotic;
herbicide
sanguinarine[no description available]medium10alkaloid antibiotic;
benzophenanthridine alkaloid;
botanical anti-fungal agent
kainic acid[no description available]medium120dicarboxylic acid;
L-proline derivative;
non-proteinogenic L-alpha-amino acid;
pyrrolidinecarboxylic acid		antinematodal drug;
excitatory amino acid agonist
beta-escin[no description available]medium30
acetaldehyde[no description available]medium90aldehydecarcinogenic agent;
EC 3.5.1.4 (amidase) inhibitor;
electron acceptor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
mutagen;
oxidising agent;
Saccharomyces cerevisiae metabolite;
teratogenic agent
thiram[no description available]medium30organic disulfideantibacterial drug;
antifungal agrochemical;
antiseptic drug
isoproturon[no description available]medium503-(3,4-substituted-phenyl)-1,1-dimethylureaagrochemical;
environmental contaminant;
herbicide;
xenobiotic
metaldehyde[no description available]medium10tetroxocanefuel;
molluscicide
plx 4720[no description available]medium20aromatic ketone;
difluorobenzene;
organochlorine compound;
pyrrolopyridine;
sulfonamide		antineoplastic agent;
B-Raf inhibitor
diethyl aminoethyl hexanoate[no description available]medium10
2-norbornene[no description available]medium10
maslinic acid[no description available]medium20dihydroxy monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
plant metabolite
trifluoroethanol[no description available]medium10fluoroalcohol
nutlin-3a[no description available]medium20stilbenoid
singlet oxygen[no description available]medium40chalcogen;
monoatomic oxygen;
nonmetal atom		macronutrient
3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea[no description available]medium20aminopyrimidine;
dichlorobenzene;
N-alkylpiperazine;
N-arylpiperazine;
phenylureas		antineoplastic agent;
fibroblast growth factor receptor antagonist
3-methylpyrazole[no description available]medium20
dicyandiamido[no description available]medium40guanidines;
nitrile		curing agent;
explosive;
fertilizer;
flame retardant;
nitrification inhibitor
nitrous oxide[no description available]medium40gas molecular entity;
nitrogen oxide		analgesic;
bacterial metabolite;
food packaging gas;
food propellant;
general anaesthetic;
greenhouse gas;
inhalation anaesthetic;
NMDA receptor antagonist;
raising agent;
refrigerant;
vasodilator agent
3,4-dimethylpyrazole phosphate[no description available]medium10phosphate saltnitrification inhibitor
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine[no description available]medium60methylpyridines;
phenylpyridine;
tetrahydropyridine		neurotoxin
rosiglitazone[no description available]medium154aminopyridine;
thiazolidinediones		EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
insulin-sensitizing drug
gw9662[no description available]medium20benzamides
thiabendazole[no description available]medium601,3-thiazoles;
benzimidazole fungicide;
benzimidazoles		antifungal agrochemical;
antinematodal drug
1,2,3,4,5,6,7,8-octahydroacridine[no description available]medium10
triethylamine[no description available]medium70tertiary amine
thymine[no description available]medium70pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite
aminoethoxyvinylglycine[no description available]medium20
2-amino-4-methoxy-3-butenoic acid[no description available]medium10
fusidic acid[no description available]medium1011alpha-hydroxy steroid;
3alpha-hydroxy steroid;
alpha,beta-unsaturated monocarboxylic acid;
steroid acid;
steroid antibiotic;
sterol ester		EC 2.7.1.33 (pantothenate kinase) inhibitor;
Escherichia coli metabolite;
protein synthesis inhibitor
rifamycin sv[no description available]medium10acetate ester;
cyclic ketal;
lactam;
macrocycle;
organic heterotetracyclic compound;
polyphenol;
rifamycins		antimicrobial agent;
antitubercular agent;
bacterial metabolite
rifamycins[no description available]medium10
2-methyltetrahydrofuran[no description available]medium10
neodymium[no description available]medium30f-block element atom;
lanthanoid atom
milrinone[no description available]medium50bipyridines;
nitrile;
pyridone		cardiotonic drug;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
tobramycin[no description available]medium60amino cyclitol glycosideantibacterial agent;
antimicrobial agent;
toxin
oridonin[no description available]medium20
3-iodo-2-propynylbutylcarbamate[no description available]medium40acetylenic compound;
carbamate ester;
carbamate fungicide;
organoiodine compound		antifungal agrochemical;
environmental contaminant;
xenobiotic
oxazolone[no description available]medium20
pilocarpine[no description available]medium131pilocarpineantiglaucoma drug
streptomycin[no description available]medium60antibiotic antifungal drug;
antibiotic fungicide;
streptomycins		antibacterial drug;
antifungal agrochemical;
antimicrobial agent;
antimicrobial drug;
bacterial metabolite;
protein synthesis inhibitor
mk-6096[no description available]medium40
isoprothiolane[no description available]medium10dithiolanes;
isopropyl ester;
malonate ester		antifungal agrochemical;
environmental contaminant;
insecticide;
phospholipid biosynthesis inhibitor
phenylpropiolic acid[no description available]medium20acetylenic compound;
alpha,beta-unsaturated monocarboxylic acid;
benzenes
istradefylline[no description available]medium221oxopurine
sphingosine[no description available]medium100sphing-4-eninehuman metabolite;
mouse metabolite
bezafibrate[no description available]medium30aromatic ether;
monocarboxylic acid amide;
monocarboxylic acid;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
fenofibrate[no description available]medium61aromatic ether;
chlorobenzophenone;
isopropyl ester;
monochlorobenzenes		antilipemic drug;
environmental contaminant;
geroprotector;
xenobiotic
int-777[no description available]medium10
methamphetamine[no description available]medium30amphetamines;
secondary amine		central nervous system stimulant;
environmental contaminant;
neurotoxin;
psychotropic drug;
xenobiotic
jtk-303[no description available]medium102aromatic ether;
monochlorobenzenes;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone		HIV-1 integrase inhibitor
buparlisib[no description available]medium31aminopyridine;
aminopyrimidine;
morpholines;
organofluorine compound		antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor
cyprodinil[no description available]medium100aminopyrimidine;
anilinopyrimidine fungicide;
cyclopropanes;
secondary amino compound		antifungal agrochemical;
aryl hydrocarbon receptor agonist;
environmental contaminant;
xenobiotic
fluazinam[no description available]medium30(trifluoromethyl)benzenes;
aminopyridine;
C-nitro compound;
chloropyridine;
monochlorobenzenes;
secondary amino compound		allergen;
antifungal agrochemical;
apoptosis inducer;
environmental contaminant;
xenobiotic
benzo(b)fluoranthene[no description available]medium10ortho- and peri-fused polycyclic arenemutagen
lorcaserin[no description available]medium20benzazepine;
organochlorine compound		anti-obesity agent;
appetite depressant
4-tert-butylbenzoic acid[no description available]medium10alkylbenzene
flurbiprofen[no description available]medium60fluorobiphenyl;
monocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
urushiol[no description available]medium10
naphthalene[no description available]medium40naphthalenes;
ortho-fused bicyclic arene		apoptosis inhibitor;
carcinogenic agent;
environmental contaminant;
mouse metabolite;
plant metabolite;
volatile oil component
salophen[no description available]medium10carbonyl compound
pci 34051[no description available]medium10indolecarboxamide
osmium[no description available]medium70iron group element atom;
platinum group metal atom
azd0914[no description available]medium31
flavin-adenine dinucleotide[no description available]medium20flavin adenine dinucleotide;
vitamin B2		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
prosthetic group
3-methylxanthine[no description available]medium103-methylxanthinemetabolite
methadone[no description available]medium94benzenes;
diarylmethane;
ketone;
tertiary amino compound
pantothenic acid[no description available]medium20pantothenic acid;
vitamin B5		antidote to curare poisoning;
geroprotector;
human blood serum metabolite
3-fluoro-2-(4-((2-nitro-1h-imidazol-1-yl)methyl)-1h-1,2,3-triazol-1-yl)propan-1-ol[no description available]medium84
propoxycarbazone[no description available]medium70
pd 161570[no description available]medium10
saracatinib[no description available]medium20aromatic ether;
benzodioxoles;
diether;
N-methylpiperazine;
organochlorine compound;
oxanes;
quinazolines;
secondary amino compound		anticoronaviral agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.10.2 (non-specific protein-tyrosine kinase) inhibitor;
radiosensitizing agent
linuron[no description available]medium20dichlorobenzene;
phenylureas		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
cgp 57380[no description available]medium10pyrazolopyrimidine
glipizide[no description available]medium125aromatic amide;
monocarboxylic acid amide;
N-sulfonylurea;
pyrazines		EC 2.7.1.33 (pantothenate kinase) inhibitor;
hypoglycemic agent;
insulin secretagogue
deoxyuridine[no description available]medium120pyrimidine 2'-deoxyribonucleosideEscherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
3-(3-(4-((pyridin-2-yloxy)methyl)benzyl)isoxazol-5-yl)pyridin-2-amine[no description available]medium40
tabun[no description available]medium10
trinexapac-ethyl[no description available]medium30
clodinafop-propargyl[no description available]medium10aromatic ether;
carboxylic ester;
organochlorine compound;
organofluorine compound;
propyzamide;
pyridines		agrochemical;
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
herbicide
procyanidin C1[no description available]medium10hydroxyflavan;
polyphenol;
proanthocyanidin		anti-inflammatory agent;
antioxidant;
EC 1.17.3.2 (xanthine oxidase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
lipoxygenase inhibitor;
metabolite
lithocholic acid[no description available]medium10bile acid;
C24-steroid;
monohydroxy-5beta-cholanic acid		geroprotector;
human metabolite;
mouse metabolite
1,4-naphthoquinone[no description available]medium401,4-naphthoquinones
arsenic trisulfide[no description available]medium20
niclosamide[no description available]medium10benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide		anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)-1h-benzotriazole-5-carboxylic acid[no description available]medium30
dimethyl 2,3,5,6-tetrachloroterephthalate[no description available]medium10diester;
methyl ester
calcium phosphate, dibasic, anhydrous[no description available]medium10calcium phosphate
tricalcium phosphate[no description available]medium10calcium phosphate
sch 23390[no description available]medium20benzazepine
molybdenum trioxide[no description available]medium10molybdenum oxide
psammaplin a[no description available]medium10
emamectin benzoate[no description available]medium40emamectins
1,2-bis(2-aminophenoxy)ethane-n,n,n',n'-tetraacetic acid[no description available]medium70polyamino carboxylic acid;
tetracarboxylic acid		chelator
2-amino-5-phosphonovalerate[no description available]medium40non-proteinogenic alpha-amino acidNMDA receptor antagonist
pyridoxal phosphate[no description available]medium100methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6 phosphate		coenzyme;
cofactor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
mrs2159[no description available]medium10
sulforaphane[no description available]medium20isothiocyanate;
sulfoxide		antineoplastic agent;
antioxidant;
EC 3.5.1.98 (histone deacetylase) inhibitor;
plant metabolite
guaiacol[no description available]medium30guaiacolsdisinfectant;
EC 1.1.1.25 (shikimate dehydrogenase) inhibitor;
expectorant;
plant metabolite
triphenyltin hydroxide[no description available]medium20
nivalenol[no description available]medium30trichothecene
propranolol[no description available]medium333naphthalenes;
propanolamine;
secondary amine		anti-arrhythmia drug;
antihypertensive agent;
anxiolytic drug;
beta-adrenergic antagonist;
environmental contaminant;
human blood serum metabolite;
vasodilator agent;
xenobiotic
snx 2112[no description available]medium20
procaine[no description available]medium20benzoate ester;
substituted aniline;
tertiary amino compound		central nervous system depressant;
drug allergen;
local anaesthetic;
peripheral nervous system drug
epidermal growth factor[no description available]medium30
aluminum oxide[no description available]medium30
sphingosine 1-phosphate[no description available]medium40sphingoid 1-phosphatemouse metabolite;
signalling molecule;
sphingosine-1-phosphate receptor agonist;
T-cell proliferation inhibitor;
vasodilator agent
eravacycline[no description available]medium10tetracyclines
sisomicin[no description available]medium10amino cyclitol glycoside;
aminoglycoside antibiotic;
beta-L-arabinoside;
monosaccharide derivative
achn 490[no description available]medium10
rutin[no description available]medium20disaccharide derivative;
quercetin O-glucoside;
rutinoside;
tetrahydroxyflavone		antioxidant;
metabolite
bromine[no description available]medium90diatomic bromine
omeprazole[no description available]medium213aromatic ether;
benzimidazoles;
pyridines;
sulfoxide
delavirdine[no description available]medium10aminopyridine;
indolecarboxamide;
N-acylpiperazine;
sulfonamide		antiviral drug;
HIV-1 reverse transcriptase inhibitor
iprodione[no description available]medium90benzenes;
dichlorophenyl dicarboximide fungicide;
imidazole fungicide;
imidazolidine-2,4-dione;
ureas		antifungal agrochemical;
nematicide
c.i. fluorescent brightening agent 28[no description available]medium20
thiacloprid[no description available]medium40monochloropyridine;
nitrile;
thiazolidines		environmental contaminant;
neonicotinoid insectide;
xenobiotic
valine[no description available]medium90L-alpha-amino acid zwitterion;
L-alpha-amino acid;
proteinogenic amino acid;
pyruvate family amino acid;
valine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
diltiazem[no description available]medium715-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetateantihypertensive agent;
calcium channel blocker;
vasodilator agent
simethicone[no description available]medium11
pantoprazole[no description available]medium21aromatic ether;
benzimidazoles;
organofluorine compound;
pyridines;
sulfoxide		anti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
environmental contaminant;
xenobiotic
nystatin a1[no description available]medium200nystatins
phenothiazine[no description available]medium20phenothiazineferroptosis inhibitor;
plant metabolite;
radical scavenger
atrial natriuretic factor[no description available]medium41polypeptide
lithospermate b[no description available]medium20
natriuretic peptide, brain[no description available]medium82polypeptide
fucose[no description available]medium20fucopyranose;
L-fucose		Escherichia coli metabolite;
mouse metabolite
epoetin alfa[no description available]medium31
sulbactam[no description available]medium50penicillanic acids
clioquinol[no description available]medium10monohydroxyquinoline;
organochlorine compound;
organoiodine compound		antibacterial agent;
antifungal agent;
antimicrobial agent;
antineoplastic agent;
antiprotozoal drug;
chelator;
copper chelator
cgs 12066b[no description available]medium10maleate saltprodrug;
serotonergic agonist
bw 723c86[no description available]medium10
vanadates[no description available]medium90trivalent inorganic anion;
vanadium oxoanion		EC 3.1.3.1 (alkaline phosphatase) inhibitor;
EC 3.1.3.16 (phosphoprotein phosphatase) inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor
methyl parathion[no description available]medium100C-nitro compound;
organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
genotoxin
baicalein[no description available]medium10trihydroxyflavoneangiogenesis inhibitor;
anti-inflammatory agent;
antibacterial agent;
anticoronaviral agent;
antifungal agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 1.13.11.31 (arachidonate 12-lipoxygenase) inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
EC 3.4.22.69 (SARS coronavirus main proteinase) inhibitor;
EC 4.1.1.17 (ornithine decarboxylase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hormone antagonist;
plant metabolite;
prostaglandin antagonist;
radical scavenger
thiophenol[no description available]medium10aryl thiol
shikonin[no description available]medium10hydroxy-1,4-naphthoquinone
phosphoramidic acid[no description available]medium40phosphoric acid derivative
2-dodecenoic acid[no description available]medium102-dodecenoic acid
bifenazate[no description available]medium10carboxylic esteracaricide
alpha-farnesene[no description available]medium10alpha-farnesene
beta-elemene[no description available]medium10beta-elemeneantineoplastic agent
phosphoserine[no description available]medium60non-proteinogenic alpha-amino acid;
O-phosphoamino acid;
serine derivative		human metabolite
phosphothreonine[no description available]medium30L-threonine derivative;
non-proteinogenic L-alpha-amino acid;
O-phosphoamino acid		Escherichia coli metabolite
quinine[no description available]medium70cinchona alkaloidantimalarial;
muscle relaxant;
non-narcotic analgesic
fluoxetine[no description available]medium386(trifluoromethyl)benzenes;
aromatic ether;
secondary amino compound
merocyanine dye[no description available]medium20
verlukast[no description available]medium100
phenacetin[no description available]medium60acetamides;
aromatic ether		cyclooxygenase 3 inhibitor;
non-narcotic analgesic;
peripheral nervous system drug
pitstop 2[no description available]medium10
maleimide[no description available]medium40dicarboximide;
maleimides		EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
azidohomoalanine[no description available]medium20
a-1331852[no description available]medium10
jasmonic acid[no description available]medium70oxo monocarboxylic acidjasmonates;
plant metabolite
sk&f 81297[no description available]medium10benzazepine
macimorelin[no description available]medium30
yil 781[no description available]medium10
4-nitroquinoline-1-oxide[no description available]medium30C-nitro compound;
quinoline N-oxide		carcinogenic agent
floxuridine[no description available]medium60nucleoside analogue;
organofluorine compound;
pyrimidine 2'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
antiviral drug;
radiosensitizing agent
galaxolide[no description available]medium10isochromenes;
organic heterotricyclic compound		fragrance
peucedanin[no description available]medium10aromatic ether;
furanocoumarin;
lactone		plant metabolite
bosentan anhydrous[no description available]medium10primary alcohol;
pyrimidines;
sulfonamide		antihypertensive agent;
endothelin receptor antagonist
mk-1775[no description available]medium10piperazines
perfluoro-n-heptanoic acid[no description available]medium10fluoroalkanoic acidenvironmental contaminant;
xenobiotic
perfluoropropionic acid[no description available]medium10
perfluoropentanoic acid[no description available]medium10fluoroalkanoic acidenvironmental contaminant;
xenobiotic
trifluoroacetic acid[no description available]medium70fluoroalkanoic acidhuman xenobiotic metabolite;
NMR chemical shift reference compound;
reagent
perfluorobutyric acid[no description available]medium10fluoroalkanoic acidchromatographic reagent;
environmental contaminant;
xenobiotic
perfluorooctane sulfonic acid[no description available]medium10perfluoroalkanesulfonic acidantilipemic drug;
persistent organic pollutant
perfluorohexanoic acid[no description available]medium10fluoroalkanoic acidenvironmental contaminant;
xenobiotic
1,2,3,4-tetrahydroisoquinoline[no description available]medium10isoquinolines
adenosine 5'-methylenediphosphate[no description available]medium40nucleoside diphosphate analogue
adenosine diphosphate[no description available]medium300adenosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		fundamental metabolite;
human metabolite
1-benzylpiperazine[no description available]medium10N-alkylpiperazineenvironmental contaminant;
psychotropic drug;
serotonergic agonist;
xenobiotic
vitamin b 12[no description available]medium50
apyrase[no description available]medium80
dimethoate[no description available]medium60monocarboxylic acid amide;
organic thiophosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
concanavalin a[no description available]medium120
zd 6474[no description available]medium10aromatic ether;
organobromine compound;
organofluorine compound;
piperidines;
quinazolines;
secondary amine		antineoplastic agent;
tyrosine kinase inhibitor
glucose, (beta-d)-isomer[no description available]medium5817D-glucopyranoseepitope;
mouse metabolite
triphosphoric acid[no description available]medium30acyclic phosphorus acid anhydride;
phosphorus oxoacid
enasidenib[no description available]medium101,3,5-triazines;
aminopyridine;
aromatic amine;
organofluorine compound;
secondary amino compound;
tertiary alcohol		antineoplastic agent;
EC 1.1.1.42 (isocitrate dehydrogenase) inhibitor
mitoxantrone[no description available]medium41dihydroxyanthraquinoneanalgesic;
antineoplastic agent
citric acid, anhydrous[no description available]medium30tricarboxylic acidantimicrobial agent;
chelator;
food acidity regulator;
fundamental metabolite
3-aminophenol[no description available]medium10aminophenol
pentaerythritol tetranitrate[no description available]medium20pentaerythritol nitrateexplosive;
vasodilator agent
1-naphthylamine[no description available]medium61naphthylaminehuman xenobiotic metabolite
uranium[no description available]medium10actinoid atom;
f-block element atom;
monoatomic uranium
mesalamine[no description available]medium20amino acid;
aromatic amine;
monocarboxylic acid;
monohydroxybenzoic acid;
phenols		non-steroidal anti-inflammatory drug
bms 754807[no description available]medium20pyrazoles;
pyridines;
pyrrolidines;
pyrrolotriazine		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
avermectin[no description available]medium10
medigoxin[no description available]medium10
3,3',5,5'-tetramethylbenzidine[no description available]medium10
bergenin[no description available]medium20trihydroxybenzoic acidmetabolite
fr 109615[no description available]medium10
cycloleucine[no description available]medium10non-proteinogenic alpha-amino acidEC 2.5.1.6 (methionine adenosyltransferase) inhibitor
pioglitazone[no description available]medium5020aromatic ether;
pyridines;
thiazolidinediones		antidepressant;
cardioprotective agent;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor;
ferroptosis inhibitor;
geroprotector;
hypoglycemic agent;
insulin-sensitizing drug;
PPARgamma agonist;
xenobiotic
glyburide[no description available]medium204monochlorobenzenes;
N-sulfonylurea		anti-arrhythmia drug;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor;
hypoglycemic agent
ferric chloride[no description available]medium60iron coordination entityastringent;
Lewis acid
4-amino-5-benzoyl-2-(4-methoxyphenylamino)thiazole[no description available]medium60
exenatide[no description available]medium12412
trichlorosucrose[no description available]medium20disaccharide derivative;
organochlorine compound		environmental contaminant;
sweetening agent;
xenobiotic
goserelin[no description available]medium4719organic molecular entity
incretins[no description available]medium8312
4-chloronitrobenzene[no description available]medium10C-nitro compound
patulin[no description available]medium20furopyran;
gamma-lactone;
lactol		antimicrobial agent;
Aspergillus metabolite;
carcinogenic agent;
mutagen;
mycotoxin;
Penicillium metabolite
vildagliptin[no description available]medium907amino acid amide
glucagon-like peptide 1 (7-36)amide[no description available]medium31
glutamine[no description available]medium41amino acid zwitterion;
glutamine family amino acid;
glutamine;
L-alpha-amino acid;
polar amino acid zwitterion;
proteinogenic amino acid		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
Saccharomyces cerevisiae metabolite
trimethoprim, sulfamethoxazole drug combination[no description available]medium51
vicriviroc[no description available]medium290(trifluoromethyl)benzenes
ethylene dibromide[no description available]medium20bromoalkane;
bromohydrocarbon		algal metabolite;
carcinogenic agent;
fumigant;
marine metabolite;
mouse metabolite;
mutagen
beta carotene[no description available]medium30carotenoid beta-end derivative;
cyclic carotene		antioxidant;
biological pigment;
cofactor;
ferroptosis inhibitor;
human metabolite;
mouse metabolite;
plant metabolite;
provitamin A
imidazolone[no description available]medium30organonitrogen heterocyclic compound
cyanates[no description available]medium110
c-peptide[no description available]medium2014
glimepiride[no description available]medium2416sulfonamide
mecoprop[no description available]medium20aromatic ether;
monocarboxylic acid;
monochlorobenzenes
diprotin a[no description available]medium40peptide
alogliptin[no description available]medium223nitrile;
piperidines;
primary amino compound;
pyrimidines		EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
hypoglycemic agent
dutasteride[no description available]medium43(trifluoromethyl)benzenes;
aza-steroid;
delta-lactam		antihyperplasia drug;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
ofloxacin[no description available]medium513-oxo monocarboxylic acid;
N-arylpiperazine;
N-methylpiperazine;
organofluorine compound;
oxazinoquinoline
fk 881[no description available]medium40
apomorphine[no description available]medium130aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug
liraglutide[no description available]medium617lipopeptide;
polypeptide		glucagon-like peptide-1 receptor agonist;
neuroprotective agent
gea 3162[no description available]medium360
ao 128[no description available]medium76organic molecular entity
inositol[no description available]medium196cyclitol;
hexol
alpha-lapachone[no description available]medium10organic heterotricyclic compound;
organooxygen compound
pd 98059[no description available]medium60aromatic amine;
monomethoxyflavone		EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
geroprotector
semaxinib[no description available]medium10olefinic compound;
oxindoles;
pyrroles		angiogenesis modulating agent;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide[no description available]medium20aromatic ether;
C-nitro compound;
sulfonamide		antineoplastic agent;
cyclooxygenase 2 inhibitor
ah 6809[no description available]medium60xanthones
gamma-linolenic acid[no description available]medium10linolenic acid;
omega-6 fatty acid		human metabolite;
mouse metabolite;
plant metabolite
pasireotide[no description available]medium10homodetic cyclic peptide;
peptide hormone		antineoplastic agent
benzophenone[no description available]medium30benzophenonesphotosensitizing agent;
plant metabolite
2,4-thiazolidinedione[no description available]medium60thiazolidenedione
latrunculin a[no description available]medium10cyclic hemiketal;
macrolide;
oxabicycloalkane;
thiazolidinone		actin polymerisation inhibitor;
metabolite;
toxin
cyclosporin h[no description available]medium20
cytochalasin b[no description available]medium20cytochalasin;
lactam;
lactone;
organic heterotricyclic compound		actin polymerisation inhibitor;
metabolite;
mycotoxin;
platelet aggregation inhibitor
calyculin a[no description available]medium40
deuterium[no description available]medium111dihydrogen
pyrrolidonecarboxylic acid[no description available]medium205-oxoproline;
L-proline derivative;
non-proteinogenic L-alpha-amino acid		algal metabolite
carbodiimides[no description available]medium120carbodiimide
ak 2123[no description available]medium476
canagliflozin[no description available]medium1310C-glycosyl compound;
organofluorine compound;
thiophenes		hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
sr141716[no description available]medium90amidopiperidine;
carbohydrazide;
dichlorobenzene;
monochlorobenzenes;
pyrazoles		anti-obesity agent;
appetite depressant;
CB1 receptor antagonist
miglitol[no description available]medium87piperidines
trichodermin[no description available]medium10
benzenesulfonic acid[no description available]medium10benzenesulfonic acids
vanadium[no description available]medium30elemental vanadium;
vanadium group element atom		micronutrient
oxovanadium iv[no description available]medium60vanadium oxide
dacarbazine[no description available]medium60dacarbazine
ammonium chloride[no description available]medium20ammonium salt;
inorganic chloride		ferroptosis inhibitor
mk-0916[no description available]medium21
calpain[no description available]medium10
nocodazole[no description available]medium20aromatic ketone;
benzimidazoles;
carbamate ester;
thiophenes		antimitotic;
antineoplastic agent;
microtubule-destabilising agent;
tubulin modulator
4-dimethylaminopyridine[no description available]medium20dialkylarylamine;
tertiary amino compound
methanesulfonyl chloride[no description available]medium10
oligomycin a[no description available]medium20antibiotic antifungal agent;
diketone;
oligomycin;
pentol		antineoplastic agent;
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitor;
nematicide
oligomycins[no description available]medium20
palmitic acid[no description available]medium30long-chain fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
EC 1.1.1.189 (prostaglandin-E2 9-reductase) inhibitor;
plant metabolite
exendin (9-39)[no description available]medium20
indomethacin[no description available]medium760aromatic ether;
indole-3-acetic acids;
monochlorobenzenes;
N-acylindole		analgesic;
drug metabolite;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
gout suppressant;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite;
xenobiotic
1,2-dimethylhydrazine[no description available]medium20hydrazinesalkylating agent;
carcinogenic agent
18f-fluoroethyl-l-tyrosine[no description available]medium10
bradykinin[no description available]medium241oligopeptidehuman blood serum metabolite;
vasodilator agent
20-hydroxy-5,8,11,14-eicosatetraenoic acid[no description available]medium200HETE;
hydroxy monocarboxylic acid		human metabolite;
mouse metabolite
n-hydroxy-n'-(4-butyl-2-methylphenyl)formamidine[no description available]medium100toluenes
triphenyltin[no description available]medium30
methyltestosterone[no description available]medium7017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
enone		anabolic agent;
androgen;
antineoplastic agent
fenarimol[no description available]medium50monochlorobenzenes;
pyrimidines;
tertiary alcohol
finasteride[no description available]medium1103-oxo steroid;
aza-steroid;
delta-lactam		androgen antagonist;
antihyperplasia drug;
EC 1.3.1.22 [3-oxo-5alpha-steroid 4-dehydrogenase (NADP(+))] inhibitor
perfluorooctanoic acid[no description available]medium20fluoroalkanoic acidcarcinogenic agent;
endocrine disruptor;
environmental contaminant;
surfactant;
xenobiotic
caprylates[no description available]medium50fatty acid anion 8:0;
straight-chain saturated fatty acid anion		human metabolite;
Saccharomyces cerevisiae metabolite
triiodothyronine[no description available]medium1702-halophenol;
amino acid zwitterion;
iodophenol;
iodothyronine		human metabolite;
mouse metabolite;
thyroid hormone
chlorhexidine[no description available]medium60biguanides;
monochlorobenzenes		antibacterial agent;
antiinfective agent
glucagon[no description available]medium349peptide hormone
nitracrine[no description available]medium20acridines
9-(2'-hydroxyethylamino)-4-methyl-1-nitroacridine[no description available]medium20
insulin glargine[no description available]medium206
frovatriptan[no description available]medium184carbazoles
benzohydroxamic acid[no description available]medium10
antimycin a[no description available]medium30amidobenzoic acid
zopiclone[no description available]medium72monochloropyridine;
pyrrolopyrazine		central nervous system depressant;
sedative
doxepin[no description available]medium30dibenzooxepine;
tertiary amino compound		antidepressant
gliclazide[no description available]medium30N-sulfonylureahypoglycemic agent;
insulin secretagogue;
radical scavenger
mifepristone[no description available]medium1413-oxo-Delta(4) steroid;
acetylenic compound;
tertiary amino compound		abortifacient;
contraceptive drug;
hormone antagonist;
synthetic oral contraceptive
almorexant[no description available]medium30isoquinolines
sb 649868[no description available]medium20
ac 55649[no description available]medium10biphenyls;
carboxybiphenyl
y 27632[no description available]medium40aromatic amide
penicillamine[no description available]medium160non-proteinogenic alpha-amino acid;
penicillamine		antirheumatic drug;
chelator;
copper chelator;
drug allergen
clomazone[no description available]medium30isoxazolidinone;
monochlorobenzenes		agrochemical;
carotenoid biosynthesis inhibitor;
environmental contaminant;
herbicide;
xenobiotic
methylprednisolone[no description available]medium1516-methylprednisolone;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		adrenergic agent;
anti-inflammatory drug;
antiemetic;
environmental contaminant;
neuroprotective agent;
xenobiotic
methylprednisolone acetate[no description available]medium4011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
acetate ester;
glucocorticoid;
steroid ester;
tertiary alpha-hydroxy ketone		anti-inflammatory drug
pwz-029[no description available]medium10
ry 024[no description available]medium10
florisil[no description available]medium10
cyclohexane[no description available]medium10cycloalkane;
volatile organic compound		non-polar solvent
hydralazine[no description available]medium140azaarene;
hydrazines;
ortho-fused heteroarene;
phthalazines		antihypertensive agent;
vasodilator agent
gadolinium[no description available]medium60f-block element atom;
lanthanoid atom
naltrexone[no description available]medium123cyclopropanes;
morphinane-like compound;
organic heteropentacyclic compound		antidote to opioid poisoning;
central nervous system depressant;
environmental contaminant;
mu-opioid receptor antagonist;
xenobiotic
4-o-methyl-12-o-tetradecanoylphorbol 13-acetate[no description available]medium20
tetradecanoylphorbol acetate[no description available]medium281acetate ester;
diester;
phorbol ester;
tertiary alpha-hydroxy ketone;
tetradecanoate ester		antineoplastic agent;
apoptosis inducer;
carcinogenic agent;
mitogen;
plant metabolite;
protein kinase C agonist;
reactive oxygen species generator
sesone[no description available]medium10
piperine[no description available]medium10benzodioxoles;
N-acylpiperidine;
piperidine alkaloid;
tertiary carboxamide		food component;
human blood serum metabolite;
NF-kappaB inhibitor;
plant metabolite
guanidine[no description available]medium30carboxamidine;
guanidines;
one-carbon compound
simvastatin[no description available]medium153delta-lactone;
fatty acid ester;
hexahydronaphthalenes;
statin (semi-synthetic)		EC 1.1.1.34/EC 1.1.1.88 (hydroxymethylglutaryl-CoA reductase) inhibitor;
EC 3.4.24.83 (anthrax lethal factor endopeptidase) inhibitor;
ferroptosis inducer;
geroprotector;
prodrug
miglustat[no description available]medium10piperidines;
tertiary amino compound		anti-HIV agent;
EC 2.4.1.80 (ceramide glucosyltransferase) inhibitor
didanosine[no description available]medium20purine 2',3'-dideoxyribonucleosideantimetabolite;
antiviral drug;
EC 2.4.2.1 (purine-nucleoside phosphorylase) inhibitor;
geroprotector;
HIV-1 reverse transcriptase inhibitor
elastin[no description available]medium30oligopeptide
uridine monophosphate[no description available]medium10pyrimidine ribonucleoside 5'-monophosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
human metabolite;
mouse metabolite
maytansine[no description available]medium30alpha-amino acid ester;
carbamate ester;
epoxide;
maytansinoid;
organic heterotetracyclic compound;
organochlorine compound		antimicrobial agent;
antimitotic;
antineoplastic agent;
plant metabolite;
tubulin modulator
dimethyl fumarate[no description available]medium10diester;
enoate ester;
methyl ester		antipsoriatic;
immunomodulator
vorapaxar[no description available]medium10carbamate ester;
lactone;
naphthofuran;
organofluorine compound;
pyridines		cardiovascular drug;
platelet aggregation inhibitor;
protease-activated receptor-1 antagonist
odanacatib[no description available]medium10
enfuvirtide[no description available]medium201
androstane-3,17-diol[no description available]medium4017-hydroxy steroid;
3-hydroxy steroid;
androstanoid
pentostatin[no description available]medium10coformycinsantimetabolite;
antineoplastic agent;
Aspergillus metabolite;
bacterial metabolite;
EC 3.5.4.4 (adenosine deaminase) inhibitor
procymidone[no description available]medium80
endosulfan[no description available]medium50cyclic sulfite ester;
cyclodiene organochlorine insecticide		acaricide;
agrochemical;
GABA-gated chloride channel antagonist;
persistent organic pollutant
substance p[no description available]medium143peptideneurokinin-1 receptor agonist;
neurotransmitter;
vasodilator agent
inositol 1,4,5-trisphosphate[no description available]medium110myo-inositol trisphosphatemouse metabolite
propylene oxide[no description available]medium10epoxide
dilactide[no description available]medium20dioxanes
buthionine sulfoximine[no description available]medium50diastereoisomeric mixture;
homocysteines;
non-proteinogenic alpha-amino acid;
sulfoximide		EC 6.3.2.2 (glutamate--cysteine ligase) inhibitor;
ferroptosis inducer
cysteinylglycine[no description available]medium10dipeptide zwitterion;
dipeptide		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
dizocilpine maleate[no description available]medium150maleate salt;
tetracyclic antidepressant		anaesthetic;
anticonvulsant;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist
angiogenin[no description available]medium10
hydroxyurea[no description available]medium153one-carbon compound;
ureas		antimetabolite;
antimitotic;
antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor;
genotoxin;
immunomodulator;
radical scavenger;
teratogenic agent
biuret[no description available]medium10condensed ureas
cyanuric acid[no description available]medium101,3,5-triazinanes;
1,3,5-triazines;
heteroaryl hydroxy compound		xenobiotic
thrombin aptamer[no description available]medium20
echinocandin b[no description available]medium100
pf 04929113[no description available]medium10
cadmium carbonate[no description available]medium10
zinc carbonate[no description available]medium10organooxygen compound
xylose[no description available]medium61D-xylose
repaglinide[no description available]medium52piperidines
iodosulfuron[no description available]medium10
carbonyl cyanide m-chlorophenyl hydrazone[no description available]medium10hydrazone;
monochlorobenzenes;
nitrile		antibacterial agent;
geroprotector;
ionophore
1,5-anhydroglucitol[no description available]medium43anhydro sugarhuman metabolite
fenton's reagent[no description available]medium50
ziprasidone[no description available]medium301,2-benzisothiazole;
indolones;
organochlorine compound;
piperazines		antipsychotic agent;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
psychotropic drug;
serotonergic antagonist
maropitant[no description available]medium10
quinpirole[no description available]medium90pyrazoloquinolinedopamine agonist
4-thioxothiazolidin-2-one[no description available]medium10
indium[no description available]medium20boron group element atom
a 82846a[no description available]medium10
dapivirine[no description available]medium103
fluticasone[no description available]medium2011beta-hydroxy steroid;
17alpha-hydroxy steroid;
3-oxo-Delta(4) steroid;
corticosteroid;
fluorinated steroid;
thioester		anti-allergic agent;
anti-asthmatic drug
enkephalin, leucine[no description available]medium120pentapeptide;
peptide zwitterion		analgesic;
delta-opioid receptor agonist;
human metabolite;
mu-opioid receptor agonist;
neurotransmitter;
rat metabolite
bithionol[no description available]medium10aryl sulfide;
bridged diphenyl antifungal drug;
bridged diphenyl fungicide;
dichlorobenzene;
organochlorine pesticide;
polyphenol		antifungal agrochemical;
antiplatyhelmintic drug
8-phenyltheophylline[no description available]medium80
pyridoxal phosphate-6-azophenyl-2',4'-disulfonic acid[no description available]medium70arenesulfonic acid;
azobenzenes;
methylpyridines;
monohydroxypyridine;
organic phosphate;
pyridinecarbaldehyde		purinergic receptor P2X antagonist
benzylaminopurine[no description available]medium206-aminopurinescytokinin;
plant metabolite
mercuric chloride[no description available]medium50mercury coordination entitysensitiser
sodium hypochlorite[no description available]medium10inorganic sodium saltbleaching agent;
disinfectant
kinetin[no description available]medium106-aminopurines;
furans		cytokinin;
geroprotector
indolebutyric acid[no description available]medium20indol-3-yl carboxylic acidauxin;
plant hormone;
plant metabolite
4-anisic acid[no description available]medium10methoxybenzoic acidplant metabolite
1,2-dipalmitoylphosphatidylcholine[no description available]medium10
elafin[no description available]medium20
rhodamine 6g[no description available]medium40
fosamprenavir[no description available]medium52sulfonamideprodrug
pyridine n-oxide[no description available]medium20pyridine N-oxidesdrug metabolite
piracetam[no description available]medium100organonitrogen compound;
organooxygen compound
levetiracetam[no description available]medium90pyrrolidin-2-onesanticonvulsant;
environmental contaminant;
xenobiotic
thallium[no description available]medium40boron group element atom
asbestos, crocidolite[no description available]medium10
2-methylimidazole[no description available]medium10
piperacillin[no description available]medium50penicillin allergen;
penicillin		antibacterial drug
cefoperazone[no description available]medium20cephalosporinantibacterial drug
o-phthalaldehyde[no description available]medium20benzaldehydes;
dialdehyde		epitope
dichlorodicyanobenzoquinone[no description available]medium10
phosmet[no description available]medium20organic thiophosphate;
organothiophosphate insecticide;
phthalimides		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
3-amino-5-mercapto-1,2,4-triazole[no description available]medium150
phosphonic acid[no description available]medium10
methylnitrosourea[no description available]medium100N-nitrosoureasalkylating agent;
carcinogenic agent;
mutagen;
teratogenic agent
bexarotene[no description available]medium30benzoic acids;
naphthalenes;
retinoid		antineoplastic agent
hexamidine[no description available]medium30aromatic ether;
guanidines;
polyether		antimicrobial agent;
antiseptic drug
vantocil[no description available]medium80
biguanides[no description available]medium170guanidines
maleic hydrazide[no description available]medium20pyridazinone
mepiquat[no description available]medium10quaternary ammonium ionagrochemical;
Maillard reaction product;
plant growth retardant
mitiglinide[no description available]medium55benzenes;
monocarboxylic acid
oseltamivir[no description available]medium90acetamides;
amino acid ester;
cyclohexenecarboxylate ester;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
environmental contaminant;
prodrug;
xenobiotic
1,4-diphenyl-1,2,3-triazole[no description available]medium20
fenoxycarb[no description available]medium20aromatic ether;
carbamate ester		environmental contaminant;
insecticide;
juvenile hormone mimic;
xenobiotic
dapagliflozin[no description available]medium33aromatic ether;
C-glycosyl compound;
monochlorobenzenes		hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
pramipexole[no description available]medium10benzothiazoles;
diamine		antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
radical scavenger
phosphoramidite[no description available]medium60
capecitabine[no description available]medium160carbamate ester;
cytidines;
organofluorine compound		antimetabolite;
antineoplastic agent;
prodrug
benzamide[no description available]medium40benzamides
dorsomorphin[no description available]medium30aromatic ether;
piperidines;
pyrazolopyrimidine;
pyridines		bone morphogenetic protein receptor antagonist;
EC 2.7.11.31 {[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase} inhibitor
medroxyprogesterone[no description available]medium4017alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone		contraceptive drug;
progestin;
synthetic oral contraceptive
benzyl alcohol[no description available]medium20benzyl alcoholsantioxidant;
fragrance;
metabolite;
solvent
dipicolinic acid[no description available]medium20pyridinedicarboxylic acidbacterial metabolite
benzonitrile[no description available]medium50benzenes;
nitrile
empagliflozin[no description available]medium53aromatic ether;
C-glycosyl compound;
monochlorobenzenes;
tetrahydrofuryl ether		hypoglycemic agent;
sodium-glucose transport protein subtype 2 inhibitor
(3-mercaptopropyl)trimethoxysilane[no description available]medium10
terbium[no description available]medium40f-block element atom;
lanthanoid atom
nimesulide[no description available]medium40aromatic ether;
C-nitro compound;
sulfonamide		cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
phenyl biguanide[no description available]medium10guanidinescentral nervous system drug
deoxyguanosine[no description available]medium61purine 2'-deoxyribonucleoside;
purines 2'-deoxy-D-ribonucleoside		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
8-hydroxy-2'-deoxyguanosine[no description available]medium41guanosinesbiomarker
8-bromo cyclic adenosine monophosphate[no description available]medium803',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
organobromine compound		antidepressant;
protein kinase agonist
tram 34[no description available]medium10organochlorine compound
metoprolol[no description available]medium41aromatic ether;
propanolamine;
secondary alcohol;
secondary amino compound		antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
geroprotector;
xenobiotic
lithium[no description available]medium121alkali metal atom
ethylenediamine[no description available]medium50alkane-alpha,omega-diamineGABA agonist
ng-nitroarginine methyl ester[no description available]medium440alpha-amino acid ester;
L-arginine derivative;
methyl ester;
N-nitro compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor
phorbolol myristate acetate[no description available]medium10
pirenzepine[no description available]medium20pyridobenzodiazepineanti-ulcer drug;
antispasmodic drug;
muscarinic antagonist
atropine[no description available]medium100
methoctramine[no description available]medium10hydrochloridemuscarinic antagonist
ferric oxide, saccharated[no description available]medium10
glucaric acid[no description available]medium10glucaric acidantineoplastic agent
7-dehydrocholesterol[no description available]medium203beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
cholestanoid;
Delta(5),Delta(7)-sterol		human metabolite;
mouse metabolite
ouabain[no description available]medium8011alpha-hydroxy steroid;
14beta-hydroxy steroid;
5beta-hydroxy steroid;
alpha-L-rhamnoside;
cardenolide glycoside;
steroid hormone		anti-arrhythmia drug;
cardiotonic drug;
EC 2.3.3.1 [citrate (Si)-synthase] inhibitor;
EC 3.1.3.41 (4-nitrophenylphosphatase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
EC 3.6.3.9 (Na(+)/K(+)-transporting ATPase) inhibitor;
ion transport inhibitor;
plant metabolite
dibenzofuran[no description available]medium30dibenzofurans;
mancude organic heterotricyclic parent;
polycyclic heteroarene		xenobiotic
sitagliptin phosphate, metformin hydrochloride drug combination[no description available]medium41
indol-3-yl pyruvic acid[no description available]medium102-oxo monocarboxylic acid;
indol-3-yl carboxylic acid		plant metabolite;
Saccharomyces cerevisiae metabolite
estradiol 3-benzoate[no description available]medium5017beta-hydroxy steroid;
benzoate ester		estrogen receptor agonist;
xenoestrogen
silver chloride[no description available]medium10inorganic chloride;
silver salt
dinoprost[no description available]medium60monocarboxylic acid;
prostaglandins Falpha		human metabolite;
mouse metabolite
lead chloride[no description available]medium10inorganic chloride;
lead coordination entity
cl 64855[no description available]medium20
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid[no description available]medium20azamacrocyclechelator;
copper chelator
technetium[no description available]medium70manganese group element atom
ribothymidine[no description available]medium10methyluridineantigen;
Escherichia coli metabolite;
human metabolite
bay36-7620[no description available]medium20
agn 194310[no description available]medium10
telaprevir[no description available]medium11cyclopentapyrrole;
cyclopropanes;
oligopeptide;
pyrazines		antiviral drug;
hepatitis C protease inhibitor;
peptidomimetic
dibutylaminosulfenylcarbofuran[no description available]medium301-benzofurans;
carbamate ester		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
bpmc[no description available]medium20carbamate esteragrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
herbicide;
insecticide
amelubant[no description available]medium10
leukotriene b4[no description available]medium350dihydroxy monocarboxylic acid;
hydroxy polyunsaturated fatty acid;
leukotriene;
long-chain fatty acid		human metabolite;
mouse metabolite;
plant metabolite;
vasoconstrictor agent
telcagepant[no description available]medium31
norethindrone acetate[no description available]medium973-oxo-Delta(4) steroid;
acetate ester;
terminal acetylenic compound		progestin;
synthetic oral contraceptive
norethindrone[no description available]medium14917beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
terminal acetylenic compound;
tertiary alcohol		progestin;
synthetic oral contraceptive
tak 733[no description available]medium10
dinitrofluorobenzene[no description available]medium20C-nitro compound;
organofluorine compound		agrochemical;
allergen;
chromatographic reagent;
EC 2.7.3.2 (creatine kinase) inhibitor;
protein-sequencing agent;
spectrophotometric reagent
2,4-dinitrofluorobenzene sulfonic acid[no description available]medium10
ubiquinone[no description available]medium50
ubiquinone q2[no description available]medium20ubiquinones
technetium tc 99m medronate[no description available]medium10
2-aminophenol[no description available]medium10aminophenolbacterial metabolite
fenofibric acid[no description available]medium20aromatic ketone;
chlorobenzophenone;
monocarboxylic acid		drug metabolite;
marine xenobiotic metabolite
gw 501516[no description available]medium301,3-thiazoles;
aromatic ether;
aryl sulfide;
monocarboxylic acid;
organofluorine compound		carcinogenic agent;
PPARbeta/delta agonist
int 131[no description available]medium10
nintedanib[no description available]medium10
dabrafenib[no description available]medium201,3-thiazoles;
aminopyrimidine;
organofluorine compound;
sulfonamide		anticoronaviral agent;
antineoplastic agent;
B-Raf inhibitor
2-deoxystreptamine[no description available]medium10
estrone sulfate[no description available]medium14617-oxo steroid;
steroid sulfate		human metabolite;
mouse metabolite
krn 7000[no description available]medium50glycophytoceramide;
N-acyl-beta-D-galactosylphytosphingosine		allergen;
antigen;
antineoplastic agent;
epitope;
immunological adjuvant
naadp[no description available]medium10nicotinic acid dinucleotidecalcium channel agonist;
metabolite;
signalling molecule
maleic anhydride[no description available]medium10cyclic dicarboxylic anhydride;
furans		allergen
ethanolamine[no description available]medium20ethanolamines;
primary alcohol;
primary amine		Escherichia coli metabolite;
human metabolite;
mouse metabolite
ludartin[no description available]medium10
cobaltous chloride[no description available]medium60cobalt salt;
inorganic chloride		allergen;
calcium channel blocker;
sensitiser;
two-colour indicator
hydrogen sulfite[no description available]medium10sulfur oxoanionhuman metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
toremifene[no description available]medium194aromatic ether;
organochlorine compound;
tertiary amine		antineoplastic agent;
bone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
24-hydroxycholesterol[no description available]medium2024-hydroxy steroid;
3beta-hydroxy-Delta(5)-steroid;
oxysterol
meglitinide[no description available]medium20
bepafant[no description available]medium1710
malic acid[no description available]medium102-hydroxydicarboxylic acid;
C4-dicarboxylic acid		food acidity regulator;
fundamental metabolite
enalaprilat anhydrous[no description available]medium21dicarboxylic acid;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
luzindole[no description available]medium10acetamides;
indoles		melatonin receptor antagonist
pregabalin[no description available]medium40gamma-amino acidanticonvulsant;
calcium channel blocker
rhodamine 123[no description available]medium50organic cation;
xanthene dye		fluorochrome
3,4-dihydroxyphenylacetic acid[no description available]medium110catechols;
dihydroxyphenylacetic acid		human metabolite
3-methoxytyramine[no description available]medium10monomethoxybenzene;
phenols;
phenylethylamine;
primary amino compound		biomarker;
human blood serum metabolite;
human urinary metabolite
homovanillic acid[no description available]medium70guaiacols;
monocarboxylic acid		human metabolite;
mouse metabolite
orlistat[no description available]medium20beta-lactone;
carboxylic ester;
formamides;
L-leucine derivative		anti-obesity agent;
bacterial metabolite;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
EC 3.1.1.3 (triacylglycerol lipase) inhibitor
octanoic acid[no description available]medium10medium-chain fatty acid;
straight-chain saturated fatty acid		antibacterial agent;
Escherichia coli metabolite;
human metabolite
rhamnose[no description available]medium30L-rhamnose
isoborneol[no description available]medium10borneol
calcitriol[no description available]medium70D3 vitamins;
hydroxycalciol;
triol		antineoplastic agent;
antipsoriatic;
bone density conservation agent;
calcium channel agonist;
calcium channel modulator;
hormone;
human metabolite;
immunomodulator;
metabolite;
mouse metabolite;
nutraceutical
1,25-dihydroxyergocalciferol[no description available]medium10hydroxycalciol;
seco-ergostane;
vitamin D		bone density conservation agent;
human xenobiotic metabolite;
nutraceutical
vitamin d 2[no description available]medium21hydroxy seco-steroid;
seco-ergostane;
vitamin D		bone density conservation agent;
nutraceutical;
plant metabolite;
rodenticide
rupestonic acid[no description available]medium10
hydroxyethylcellulose[no description available]medium10
chlorogenic acid[no description available]medium20cinnamate ester;
tannin		food component;
plant metabolite
9-(tetrahydro-2-furyl)-adenine[no description available]medium30
medroxyprogesterone acetate[no description available]medium10120-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
corticosteroid;
steroid ester		adjuvant;
androgen;
antineoplastic agent;
antioxidant;
female contraceptive drug;
inhibitor;
progestin;
synthetic oral contraceptive
1,8-diazabicyclo(5.4.0)undec-7-ene[no description available]medium20
deoxypyridinoline[no description available]medium21
quinidine[no description available]medium60cinchona alkaloidalpha-adrenergic antagonist;
anti-arrhythmia drug;
antimalarial;
drug allergen;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 3.6.3.44 (xenobiotic-transporting ATPase) inhibitor;
muscarinic antagonist;
P450 inhibitor;
potassium channel blocker;
sodium channel blocker
dafachronic acid[no description available]medium103-oxo-5alpha-steroid;
cholestanoid;
dafachronic acids
sq-23377[no description available]medium40cyclic ether;
enol;
polyunsaturated fatty acid;
very long-chain fatty acid		calcium ionophore;
metabolite
disulfiram[no description available]medium80organic disulfide;
organosulfur acaricide		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitor;
EC 3.1.1.1 (carboxylesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
ferroptosis inducer;
fungicide;
NF-kappaB inhibitor
w 7[no description available]medium10
s,s'-(2-(dimethylamino)-1,3-propanediyl)thiosulfuric acid ester[no description available]medium10nereistoxin analogue insecticide
24,25-dihydroxyvitamin d 3[no description available]medium30
4-(2-(6,7-dimethoxy-4-methyl-3-oxo-3,4-dihydroquinoxalinyl)ethyl)-1,2,4-triazoline-3,5-dione[no description available]medium90
bosutinib[no description available]medium21aminoquinoline;
aromatic ether;
dichlorobenzene;
N-methylpiperazine;
nitrile;
tertiary amino compound		antineoplastic agent;
tyrosine kinase inhibitor
ym 511[no description available]medium80
guanosine[no description available]medium110guanosines;
purines D-ribonucleoside		fundamental metabolite
brimonidine tartrate[no description available]medium41
apremilast[no description available]medium10aromatic ether;
N-acetylarylamine;
phthalimides;
sulfone		non-steroidal anti-inflammatory drug;
phosphodiesterase IV inhibitor
peptide yy[no description available]medium62
(1-(3-isopropyl-1,2,4-oxadiazol-5-yl)piperidin-4-yl)methyl methanesulfonate[no description available]medium11
methyl iodide[no description available]medium20iodomethanes;
methyl halides		fumigant insecticide
celastrol[no description available]medium10monocarboxylic acid;
pentacyclic triterpenoid		anti-inflammatory drug;
antineoplastic agent;
antioxidant;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Hsp90 inhibitor;
metabolite
heptakis(2,6-o-dimethyl)beta-cyclodextrin[no description available]medium30
tofisopam[no description available]medium10organic molecular entity
ulodesine[no description available]medium20
glucosaminic acid[no description available]medium10amino acid zwitterion;
gluconic acid derivative		bacterial metabolite
hydroxylamine[no description available]medium30hydroxylaminesalgal metabolite;
bacterial xenobiotic metabolite;
EC 1.1.3.13 (alcohol oxidase) inhibitor;
EC 4.2.1.22 (cystathionine beta-synthase) inhibitor;
EC 4.3.1.10 (serine-sulfate ammonia-lyase) inhibitor;
nitric oxide donor;
nucleophilic reagent
allylamine[no description available]medium120alkylamine
naftifine[no description available]medium40allylamine antifungal drug;
naphthalenes;
tertiary amine		EC 1.14.13.132 (squalene monooxygenase) inhibitor;
sterol biosynthesis inhibitor
atenolol[no description available]medium30ethanolamines;
monocarboxylic acid amide;
propanolamine		anti-arrhythmia drug;
antihypertensive agent;
beta-adrenergic antagonist;
environmental contaminant;
sympatholytic agent;
xenobiotic
enalapril[no description available]medium91dicarboxylic acid monoester;
dipeptide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
geroprotector;
prodrug
imeglimin[no description available]medium11
2-methylpentane[no description available]medium80alkane
n-hexane[no description available]medium40alkane;
volatile organic compound		neurotoxin;
non-polar solvent
malachite green[no description available]medium30organic chloride saltantibacterial agent;
antifungal drug;
carcinogenic agent;
environmental contaminant;
fluorochrome;
histological dye;
teratogenic agent
oxyntomodulin[no description available]medium82
gw 409544[no description available]medium10monocarboxylic acid
gw 7647[no description available]medium20aryl sulfide;
monocarboxylic acid;
ureas		PPARalpha agonist
ly 518674[no description available]medium103
anagliptin[no description available]medium10amino acid amide
lc15-0444[no description available]medium21organonitrogen compound;
organooxygen compound
wk-x-34[no description available]medium10
cobaltiprotoporphyrin[no description available]medium10
2-aminoimidazole[no description available]medium70
trenbolone acetate[no description available]medium20steroid ester
loperamide[no description available]medium30monocarboxylic acid amide;
monochlorobenzenes;
piperidines;
tertiary alcohol		anticoronaviral agent;
antidiarrhoeal drug;
mu-opioid receptor agonist
td-5108[no description available]medium10
gvs 111[no description available]medium20
phosphohistidine[no description available]medium40
cabozantinib[no description available]medium10aromatic ether;
dicarboxylic acid diamide;
organofluorine compound;
quinolines		antineoplastic agent;
tyrosine kinase inhibitor
gsk 1363089[no description available]medium10aromatic ether
androstane[no description available]medium10steroid fundamental parent
chondroitin sulfates[no description available]medium30
benzamidine[no description available]medium10benzenes;
carboxamidine		serine protease inhibitor
carbaryl[no description available]medium60carbamate ester;
naphthalenes		acaricide;
agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant growth retardant
rvx 208[no description available]medium10
isopentenyladenosine[no description available]medium10N-ribosyl-N(6)-isopentenyladenine;
nucleoside analogue		antineoplastic agent;
plant growth regulator;
plant metabolite
zeatin riboside[no description available]medium109-ribosylzeatin;
nucleoside analogue		cytokinin;
plant metabolite
clopenthixol[no description available]medium10N-alkylpiperazine;
primary alcohol;
thioxanthenes		alpha-adrenergic antagonist;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
pachastrissamine[no description available]medium10
2-mercaptobenzoxazole[no description available]medium10benzoxazole
hydroxyphenytoin[no description available]medium10imidazolidine-2,4-dione;
phenols		metabolite
epichlorohydrin[no description available]medium10epoxide;
organochlorine compound
dapiprazole[no description available]medium6921N-alkylpiperazine;
N-arylpiperazine;
pyridines		alpha-adrenergic antagonist;
antipsychotic agent;
miotic;
ophthalmology drug
sr 95531[no description available]medium10methoxybenzenes
lisinopril[no description available]medium30dipeptideEC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
7,8-dihydroxy-4-methylcoumarin[no description available]medium10hydroxycoumarin
dronabinol[no description available]medium30benzochromene;
diterpenoid;
phytocannabinoid;
polyketide		cannabinoid receptor agonist;
epitope;
hallucinogen;
metabolite;
non-narcotic analgesic
azd9272[no description available]medium10
4-(1h-imidazol-4-ylmethyl)piperidine[no description available]medium10piperidines
clobenpropit[no description available]medium10imidazoles;
imidothiocarbamic ester;
organochlorine compound		H3-receptor antagonist;
H4-receptor agonist
dehydroepiandrosterone sulfate[no description available]medium11317-oxo steroid;
steroid sulfate		EC 2.7.1.33 (pantothenate kinase) inhibitor;
human metabolite;
mouse metabolite
formal glycol[no description available]medium30cyclic acetal;
dioxolane
rtki cpd[no description available]medium10
4-nitrophenol[no description available]medium304-nitrophenolshuman xenobiotic metabolite;
mouse metabolite
nitrophenols[no description available]medium140
dibenzo-24-crown-8[no description available]medium20
n-hydroxysuccinimide[no description available]medium20
coronopilin[no description available]medium10sesquiterpene lactone
gabapentin[no description available]medium91gamma-amino acidanticonvulsant;
calcium channel blocker;
environmental contaminant;
xenobiotic
theobromine[no description available]medium130dimethylxanthineadenosine receptor antagonist;
bronchodilator agent;
food component;
human blood serum metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
3,7-dimethyl-1-propargylxanthine[no description available]medium120
enkephalin, ala(2)-mephe(4)-gly(5)-[no description available]medium30
cysteic acid[no description available]medium10alanine derivative;
amino sulfonic acid;
carboxyalkanesulfonic acid;
cysteine derivative;
non-proteinogenic alpha-amino acid		animal metabolite
2-methoxyestradiol[no description available]medium3017beta-hydroxy steroid;
3-hydroxy steroid		angiogenesis modulating agent;
antimitotic;
antineoplastic agent;
human metabolite;
metabolite;
mouse metabolite
orange g[no description available]medium10
flavone[no description available]medium20flavonesmetabolite;
nematicide
savirin[no description available]medium10quinazolines
gallium[no description available]medium10boron group element atom
diethyl chlorophosphate[no description available]medium10
insulin glulisine[no description available]medium11
alectinib[no description available]medium21aromatic ketone;
morpholines;
nitrile;
organic heterotetracyclic compound;
piperidines		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
transforming growth factor alpha[no description available]medium20
skatole[no description available]medium50methylindolehuman metabolite;
mammalian metabolite
sinigrin[no description available]medium10alkenylglucosinolic acid
gramicidin a[no description available]medium40
glucagon-like peptide 2[no description available]medium41
1-methylindole[no description available]medium10
helium[no description available]medium10monoatomic helium;
noble gas atom;
s-block element atom		food packaging gas
aliskiren[no description available]medium30monocarboxylic acid amide;
monomethoxybenzene		antihypertensive agent
nalmefene[no description available]medium10morphinane alkaloid
triasulfuron[no description available]medium201,3,5-triazines;
aromatic ether;
N-sulfonylurea;
organochlorine compound		agrochemical;
herbicide
halosulfuron methyl[no description available]medium10pyrazoles
salicylaldehyde isonicotinoyl hydrazone[no description available]medium10
kb r7943[no description available]medium20
ketene[no description available]medium40ketene
ticlopidine[no description available]medium80monochlorobenzenes;
thienopyridine		anticoagulant;
fibrin modulating drug;
hematologic agent;
P2Y12 receptor antagonist;
platelet aggregation inhibitor
lipoxin a4[no description available]medium30hydroxy polyunsaturated fatty acid;
lipoxin;
long-chain fatty acid		human metabolite;
metabolite
sc 58125[no description available]medium10organofluorine compound;
pyrazoles;
sulfone		antineoplastic agent;
cyclooxygenase 2 inhibitor
6-ketoprostaglandin f1 alpha[no description available]medium140prostaglandins Falphahuman metabolite;
mouse metabolite
sc 560[no description available]medium20aromatic ether;
monochlorobenzenes;
organofluorine compound;
pyrazoles		angiogenesis modulating agent;
antineoplastic agent;
apoptosis inducer;
cyclooxygenase 1 inhibitor;
non-steroidal anti-inflammatory drug
diphosphoric acid[no description available]medium10acyclic phosphorus acid anhydride;
phosphorus oxoacid		Escherichia coli metabolite
gliclazide[no description available]medium30
triflumizol[no description available]medium30
dibenzyldimethylammonium[no description available]medium10
2,4-dinitrotoluene[no description available]medium10dinitrotoluene
kaolinite[no description available]medium10aluminosilicate mineral;
mixture		antidiarrhoeal drug;
excipient
clemastine[no description available]medium60monochlorobenzenes;
N-alkylpyrrolidine		anti-allergic agent;
antipruritic drug;
H1-receptor antagonist;
muscarinic antagonist
alpha-aminooxy-beta-phenylpropionic acid[no description available]medium10
benzyl chloride[no description available]medium10benzyl chlorides
2-hydroxybutyric acid[no description available]medium112-hydroxy monocarboxylic acid;
hydroxybutyric acid		algal metabolite;
human metabolite
epothilone a[no description available]medium40epothilone;
epoxide		antineoplastic agent;
metabolite;
microtubule-stabilising agent;
tubulin modulator
dantrolene[no description available]medium10hydrazone;
imidazolidine-2,4-dione		muscle relaxant;
neuroprotective agent;
ryanodine receptor antagonist
ponatinib[no description available]medium40(trifluoromethyl)benzenes;
acetylenic compound;
benzamides;
imidazopyridazine;
N-methylpiperazine		antineoplastic agent;
tyrosine kinase inhibitor
oritavancin[no description available]medium10disaccharide derivative;
glycopeptide;
semisynthetic derivative		antibacterial drug;
antimicrobial agent
aluminum chloride[no description available]medium20aluminium coordination entityLewis acid
ethyldimethylaminopropyl carbodiimide[no description available]medium40
hydrochloric acid[no description available]medium80chlorine molecular entity;
gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
calcitonin[no description available]medium11
peroxynitrous acid[no description available]medium50nitrogen oxoacid
2,3-diaminonaphthalene[no description available]medium50
2-naphthylamine[no description available]medium60naphthylaminecarcinogenic agent
neolamellarin a[no description available]medium10
propylthiouracil[no description available]medium40pyrimidinethioneantidote to paracetamol poisoning;
antimetabolite;
antioxidant;
antithyroid drug;
carcinogenic agent;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
hormone antagonist
mannitol[no description available]medium40mannitolallergen;
antiglaucoma drug;
compatible osmolytes;
Escherichia coli metabolite;
food anticaking agent;
food bulking agent;
food humectant;
food stabiliser;
food thickening agent;
hapten;
metabolite;
osmotic diuretic;
sweetening agent
framycetin[no description available]medium70aminoglycosideallergen;
antibacterial drug;
Escherichia coli metabolite
captopril[no description available]medium20alkanethiol;
L-proline derivative;
N-acylpyrrolidine;
pyrrolidinemonocarboxylic acid		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
carbenoxolone sodium[no description available]medium10triterpenoid
8-(4-sulfophenyl)theophylline[no description available]medium140
indoxacarb[no description available]medium10methyl ester;
organochlorine insecticide		voltage-gated sodium channel blocker
luteolin[no description available]medium103'-hydroxyflavonoid;
tetrahydroxyflavone		angiogenesis inhibitor;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
c-Jun N-terminal kinase inhibitor;
EC 2.3.1.85 (fatty acid synthase) inhibitor;
immunomodulator;
nephroprotective agent;
plant metabolite;
radical scavenger;
vascular endothelial growth factor receptor antagonist
acetogenins[no description available]medium20
chamuvarinin[no description available]medium20
dicyanmethane[no description available]medium10aliphatic nitrile;
dinitrile
diazomethane[no description available]medium10diazo compoundalkylating agent;
antineoplastic agent;
carcinogenic agent;
poison
picrotoxin[no description available]medium90
validamycin a[no description available]medium10antibiotic fungicide;
polyol;
secondary amino compound;
validamycins		antifungal agrochemical;
EC 2.4.1.231 [alpha,alpha-trehalose phosphorylase (configuration-retaining)] inhibitor;
EC 2.4.1.64 (alpha,alpha-trehalose phosphorylase) inhibitor;
EC 3.2.1.28 (alpha,alpha-trehalase) inhibitor
nsc 74859[no description available]medium10amidobenzoic acid;
monohydroxybenzoic acid;
tosylate ester		STAT3 inhibitor
dideoxyadenosine[no description available]medium20adenosines;
purine 2',3'-dideoxyribonucleoside		EC 3.5.4.4 (adenosine deaminase) inhibitor;
EC 4.6.1.1 (adenylate cyclase) inhibitor
2',5'-dideoxyadenosine[no description available]medium20deoxyribonucleoside
sch 442416[no description available]medium50triazolopyrimidines
8-bromoadenosine-3',5'-cyclic monophosphorothioate[no description available]medium20
4-amino-3-phenyl-1h-1,2,4-triazole-5(4h)-thione[no description available]medium10
metoclopramide[no description available]medium31benzamides;
monochlorobenzenes;
substituted aniline;
tertiary amino compound		antiemetic;
dopaminergic antagonist;
environmental contaminant;
gastrointestinal drug;
xenobiotic
sym-trinitrobenzene[no description available]medium10trinitrobenzeneexplosive
axitinib[no description available]medium10aryl sulfide;
benzamides;
indazoles;
pyridines		antineoplastic agent;
tyrosine kinase inhibitor;
vascular endothelial growth factor receptor antagonist
propylene[no description available]medium50alkene;
gas molecular entity		refrigerant;
xenobiotic
riluzole[no description available]medium10benzothiazoles
clozapine[no description available]medium122benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound		adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic
ly 379268[no description available]medium10amino dicarboxylic acid;
bridged compound;
organic heterobicyclic compound		antipsychotic agent;
anxiolytic drug;
metabotropic glutamate receptor agonist;
neuroprotective agent
furfuryl alcohol[no description available]medium10furans;
primary alcohol		Maillard reaction product
pironetin[no description available]medium10aliphatic alcohol
lomibuvir[no description available]medium20thiophenecarboxylic acid
cyclohexanol[no description available]medium484cyclohexanols;
secondary alcohol		solvent
tegobuvir[no description available]medium10
hcv 796[no description available]medium10
phytoestrogens[no description available]medium30
danazol[no description available]medium2017beta-hydroxy steroid;
terminal acetylenic compound		anti-estrogen;
estrogen antagonist;
geroprotector
tetcyclacis[no description available]medium90
malonic acid[no description available]medium40alpha,omega-dicarboxylic acidhuman metabolite
bi 2536[no description available]medium10
dinaciclib[no description available]medium10pyrazolopyrimidine
fedratinib[no description available]medium10sulfonamide
1,4-dihydropyridine[no description available]medium10
bicalutamide[no description available]medium174(trifluoromethyl)benzenes;
monocarboxylic acid amide;
monofluorobenzenes;
nitrile;
sulfone;
tertiary alcohol
dichlorophenyl-bis-triazolylpropanol[no description available]medium50amine
palmitoyl coenzyme a[no description available]medium1011,12-saturated fatty acyl-CoA;
3-substituted propionyl-CoA;
long-chain fatty acyl-CoA;
palmitoyl bioconjugate		Escherichia coli metabolite;
mouse metabolite
dicarbine[no description available]medium10
cyclic gmp[no description available]medium3703',5'-cyclic purine nucleotide;
guanyl ribonucleotide		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
4-toluenesulfonic acid[no description available]medium20arenesulfonic acid;
toluenes
metallothionein[no description available]medium30
degrasyn[no description available]medium10
ferrocenium[no description available]medium10
kpt-276[no description available]medium61
kpt-251[no description available]medium40
n-phenyl-1h-1,2,4-triazole-3,5-diamine[no description available]medium10
ondansetron[no description available]medium40carbazoles
varenicline[no description available]medium40
pd 173074[no description available]medium10aromatic amine;
biaryl;
dimethoxybenzene;
pyridopyrimidine;
tertiary amino compound;
ureas		antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
fibroblast growth factor receptor antagonist
azd4547[no description available]medium10benzamides;
N-arylpiperazine;
pyrazoles		fibroblast growth factor receptor antagonist
4-nitrophenylgalactoside[no description available]medium10beta-D-galactoside;
monosaccharide derivative		affinity label
nitrophenylgalactosides[no description available]medium10beta-D-galactoside;
C-nitro compound		chromogenic compound
krypton[no description available]medium20monoatomic krypton;
noble gas atom;
p-block element atom
dibenzo(1,4)dioxin[no description available]medium20dibenzodioxine;
heteranthrene;
mancude organic heterotricyclic parent;
oxacycle;
polycyclic heteroarene
isopropyl 4,4'-dibromobenzilate[no description available]medium20
propargite[no description available]medium10sulfite ester;
terminal acetylenic compound		sulfite ester acaricide
cytarabine[no description available]medium10GDP-fucose
propargyl ether[no description available]medium10
edetic acid[no description available]medium100ethylenediamine derivative;
polyamino carboxylic acid;
tetracarboxylic acid		anticoagulant;
antidote;
chelator;
copper chelator;
geroprotector
etidronate[no description available]medium1041,1-bis(phosphonic acid)antineoplastic agent;
bone density conservation agent;
chelator
kt 5720[no description available]medium40carboxylic ester;
gamma-lactam;
hemiaminal;
indolocarbazole;
organic heterooctacyclic compound;
semisynthetic derivative;
tertiary alcohol		EC 2.7.11.11 (cAMP-dependent protein kinase) inhibitor
4,5,6,7-tetrabromobenzimidazole[no description available]medium50
antipyrine[no description available]medium170pyrazoloneantipyretic;
cyclooxygenase 3 inhibitor;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
terfenadine[no description available]medium71diarylmethane
fexofenadine[no description available]medium20piperidines;
tertiary amine		anti-allergic agent;
H1-receptor antagonist
mefloquine[no description available]medium40
arginine vasopressin[no description available]medium30vasopressincardiovascular drug;
hematologic agent;
mitogen
risedronic acid[no description available]medium84pyridines
unithiol[no description available]medium20
succimer[no description available]medium10dicarboxylic acid;
dithiol;
sulfur-containing carboxylic acid		chelator
trientine[no description available]medium10polyazaalkane;
tetramine		copper chelator
butaprost[no description available]medium30
pf-04418948[no description available]medium10
5-hydroxytryptophan[no description available]medium30hydroxytryptophanhuman metabolite;
neurotransmitter
fluoromisonidazole[no description available]medium50
misonidazole[no description available]medium60
18f-faza[no description available]medium20
dirhodium tetraacetate[no description available]medium10
cardanol[no description available]medium10phenols
cay 10580[no description available]medium10hydroxy monocarboxylic acid;
pyrrolidin-2-ones;
secondary alcohol		prostaglandin receptor agonist
pd 174494[no description available]medium10piperidines
quinoxyfen[no description available]medium10aromatic ether;
monofluorobenzenes;
organochlorine compound;
quinolines		antifungal agrochemical
4-azidophenylalanine[no description available]medium10
3,4-dihydro-2(1h)-quinolinone[no description available]medium10quinolines
pentoxifylline[no description available]medium70oxopurine
samarium[no description available]medium40f-block element atom;
lanthanoid atom
squalene[no description available]medium60triterpenehuman metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
sq 109[no description available]medium10
metribolone[no description available]medium2017beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid		androgen
3,4,6-tri-o-acetylglucal[no description available]medium30
piperic acid[no description available]medium10alpha,beta-unsaturated monocarboxylic acid;
benzodioxoles		plant metabolite
dithianone[no description available]medium10dinitrile;
naphthodithiin;
p-quinones		antifungal agrochemical
cupric hydroxide[no description available]medium10organic molecular entity
phenylacetaldehyde[no description available]medium10alpha-CH2-containing aldehyde;
phenylacetaldehydes		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
diethylurea[no description available]medium10
acridone[no description available]medium10acridines;
cyclic ketone
1,4-dihydroquinoline[no description available]medium20
diethylnitrosamine[no description available]medium30nitrosaminecarcinogenic agent;
hepatotoxic agent;
mutagen
etodolac[no description available]medium20monocarboxylic acid;
organic heterotricyclic compound		antipyretic;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
trilostane[no description available]medium1017beta-hydroxy steroid;
3-hydroxy steroid;
androstanoid;
epoxy steroid;
nitrile		abortifacient;
antineoplastic agent;
EC 1.1.1.210 [3beta(or 20alpha)-hydroxysteroid dehydrogenase] inhibitor
monocrotophos[no description available]medium20alkenyl phosphate;
dialkyl phosphate;
monocarboxylic acid amide;
organophosphate insecticide		acaricide;
agrochemical;
avicide;
EC 1.4.3.4 (monoamine oxidase) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
nickel sulfate[no description available]medium10metal sulfateallergen
benzyl isothiocyanate[no description available]medium10benzenes;
isothiocyanate		antibacterial drug
1-o-hexadecyl-2-n-methylcarbamol -sn-glycerol-3-phosphocholine[no description available]medium40
guanosine triphosphate[no description available]medium120guanosine 5'-phosphate;
purine ribonucleoside 5'-triphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
gamma2-msh[no description available]medium20
benzaldehyde[no description available]medium50benzaldehydesEC 3.1.1.3 (triacylglycerol lipase) inhibitor;
EC 3.5.5.1 (nitrilase) inhibitor;
flavouring agent;
fragrance;
odorant receptor agonist;
plant metabolite
hexylglutathione[no description available]medium10S-substituted glutathione
leukotriene c4[no description available]medium20leukotrienebronchoconstrictor agent;
human metabolite;
mouse metabolite
montelukast[no description available]medium30aliphatic sulfide;
monocarboxylic acid;
quinolines		anti-arrhythmia drug;
anti-asthmatic drug;
leukotriene antagonist
leukotriene d4[no description available]medium40dipeptide;
leukotriene;
organic sulfide		bronchoconstrictor agent;
human metabolite;
mouse metabolite
n-acetylneuraminic acid[no description available]medium60N-acetylneuraminic acidsantioxidant;
bacterial metabolite;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
human metabolite;
mouse metabolite
homoserine lactone[no description available]medium10ammonium ion derivative;
organic cation
sb 242084[no description available]medium10
2,3-bis(4-hydroxyphenyl)-propionitrile[no description available]medium40nitrile;
phenols		estrogen receptor agonist
mdl 100907[no description available]medium40
phosgene[no description available]medium10acyl chloride
bis(trichloromethyl) carbonate[no description available]medium10
vuf 2274[no description available]medium10
2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one[no description available]medium50chromones;
morpholines;
organochlorine compound		autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector
tryptamine[no description available]medium30aminoalkylindole;
aralkylamino compound;
indole alkaloid;
tryptamines		human metabolite;
mouse metabolite;
plant metabolite
4-amino-5-(pyridin-4-yl)-4h-1,2,4-triazole-3-thiol[no description available]medium10
ferrous sulfate[no description available]medium40iron molecular entity;
metal sulfate		reducing agent
zidovudine triphosphate[no description available]medium10
th 302[no description available]medium10
leptin[no description available]medium82
beta-thujone[no description available]medium10beta-thujone
terephthalic acid[no description available]medium10benzenedicarboxylic acid
picric acid[no description available]medium10C-nitro compoundantiseptic drug;
explosive;
fixative
benzosuberone[no description available]medium20
porphyrin a[no description available]medium10
ziconotide[no description available]medium30
5-(3-chloro-4-fluorophenyl)-3-methyl-3-(pyrimidin-5-ylmethyl)-1-(1h-1,2,4-triazol-3-yl)-1,3-dihydro-2h-indol-2-one[no description available]medium50
arl-67156[no description available]medium40
diethylzinc[no description available]medium10
tropicamide[no description available]medium1911acetamides
adenophostin a[no description available]medium10disaccharide phosphate
dihydrokainate[no description available]medium20dicarboxylic acid
hexafluoroisopropanol[no description available]medium10organofluorine compound;
secondary alcohol		drug metabolite
ethyl acetate[no description available]medium50acetate ester;
ethyl ester;
volatile organic compound		EC 3.4.19.3 (pyroglutamyl-peptidase I) inhibitor;
metabolite;
polar aprotic solvent;
Saccharomyces cerevisiae metabolite
fluvoxamine[no description available]medium133(trifluoromethyl)benzenes;
5-methoxyvalerophenone O-(2-aminoethyl)oxime		antidepressant;
anxiolytic drug;
serotonin uptake inhibitor
prazosin[no description available]medium40aromatic ether;
furans;
monocarboxylic acid amide;
piperazines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor
gadolinium chloride[no description available]medium30gadolinium coordination entityTRP channel blocker
modafinil[no description available]medium20monocarboxylic acid amide;
sulfoxide
carboxin[no description available]medium10anilide fungicide;
anilide;
enamide;
organosulfur heterocyclic compound;
oxacycle;
secondary carboxamide		antifungal agrochemical;
EC 1.3.5.1 [succinate dehydrogenase (quinone)] inhibitor
pifithrin[no description available]medium10aromatic ketone
alprazolam[no description available]medium156organochlorine compound;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA agonist;
muscle relaxant;
sedative;
xenobiotic
acetyl coenzyme a[no description available]medium20acyl-CoAacyl donor;
coenzyme;
effector;
fundamental metabolite
scopolamine hydrobromide[no description available]medium70
testosterone acetate[no description available]medium103-oxo-Delta(4) steroid;
androstanoid;
sterol ester		human metabolite
adamantyl isothiocyanate[no description available]medium10
potassium iodide[no description available]medium30potassium saltexpectorant;
radical scavenger
sorbitol[no description available]medium61glucitolcathartic;
Escherichia coli metabolite;
food humectant;
human metabolite;
laxative;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite;
sweetening agent
gs 4071[no description available]medium10acetate ester;
amino acid;
cyclohexenecarboxylic acid;
primary amino compound		antiviral drug;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor;
marine xenobiotic metabolite
musk[no description available]medium20macrolide
carnosol[no description available]medium10diterpenoid
salvin[no description available]medium10abietane diterpenoid;
carbotricyclic compound;
catechols;
monocarboxylic acid		angiogenesis modulating agent;
anti-inflammatory agent;
antineoplastic agent;
antioxidant;
apoptosis inducer;
food preservative;
HIV protease inhibitor;
plant metabolite
4-hydroxycoumarin[no description available]medium10hydroxycoumarin
hki 272[no description available]medium20nitrile;
quinolines		antineoplastic agent;
tyrosine kinase inhibitor
gsk 1070916[no description available]medium10pyrazoles;
ring assembly
1-(ethan-1-ol)-2-methyl-3-hydroxypyridin-4-one[no description available]medium10
artemisinin[no description available]medium30organic peroxide;
sesquiterpene lactone		antimalarial;
plant metabolite
phthalimidine[no description available]medium20gamma-lactam;
isoindoles
selenourea[no description available]medium10
phosphorylethanolamine[no description available]medium10phosphoethanolamine;
primary amino compound		algal metabolite;
human metabolite;
mouse metabolite
l 706000[no description available]medium10
rhodanine[no description available]medium20thiazolidinone
bicuculline[no description available]medium150benzylisoquinoline alkaloid;
isoquinoline alkaloid;
isoquinolines		agrochemical;
central nervous system stimulant;
GABA-gated chloride channel antagonist;
GABAA receptor antagonist;
neurotoxin
irganox 3114[no description available]medium10
uridine triphosphate[no description available]medium40pyrimidine ribonucleoside 5'-triphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
fadrozole[no description available]medium372imidazopyridine
azidopyrimidine[no description available]medium10
8-azidoadenosine 5'-triphosphate[no description available]medium10
pyridaben[no description available]medium40organochlorine acaricide;
organochlorine insecticide;
pyridazinone		mitochondrial NADH:ubiquinone reductase inhibitor
1-palmitoyl-2-oleoylphosphatidylcholine[no description available]medium10
pomalidomide[no description available]medium10aromatic amine;
dicarboximide;
isoindoles;
piperidones		angiogenesis inhibitor;
antineoplastic agent;
immunomodulator
sivelestat[no description available]medium10N-acylglycine;
pivalate ester
ulipristal acetate[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
steroid ester;
tertiary amino compound		contraceptive drug;
progesterone receptor modulator;
progestin
imiquimod[no description available]medium10imidazoquinolineantineoplastic agent;
interferon inducer
AMG-208[no description available]medium11aromatic ether;
quinolines;
triazolopyridazine		antineoplastic agent;
c-Met tyrosine kinase inhibitor
apalutamide[no description available]medium10
3beta-hydroxy-17-(1h-benzimidazole-1-yl)androsta-5,16-diene[no description available]medium203-hydroxy steroidandrogen
thiohydantoins[no description available]medium10
vrx-480773[no description available]medium30
acetanilide[no description available]medium10acetamides;
anilide		analgesic
kynurenic acid[no description available]medium10monohydroxyquinoline;
quinolinemonocarboxylic acid		G-protein-coupled receptor agonist;
human metabolite;
neuroprotective agent;
nicotinic antagonist;
NMDA receptor antagonist;
Saccharomyces cerevisiae metabolite
7-chlorokynurenic acid[no description available]medium10organochlorine compound;
quinolinemonocarboxylic acid		neuroprotective agent;
NMDA receptor antagonist
artesunic acid[no description available]medium10
cytosine[no description available]medium60aminopyrimidine;
pyrimidine nucleobase;
pyrimidone		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
topramezone[no description available]medium10
cloquintocet-mexyl[no description available]medium20aromatic ether;
carboxylic ester;
organochlorine compound;
quinolines
taprostene[no description available]medium10benzoic acids
citalopram[no description available]medium1112-benzofurans;
cyclic ether;
nitrile;
organofluorine compound;
tertiary amino compound
bms 387032[no description available]medium101,3-oxazoles;
1,3-thiazoles;
organic sulfide;
piperidinecarboxamide;
secondary carboxamide		angiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
methylguanidine[no description available]medium10guanidinesEC 1.14.13.39 (nitric oxide synthase) inhibitor;
metabolite;
uremic toxin
indican[no description available]medium10beta-D-glucoside;
exopolysaccharide;
indolyl carbohydrate
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-((phenylamino)carbonyl)-2h-tetrazolium hydroxide[no description available]medium130
cenicriviroc[no description available]medium20aromatic ether;
benzazocine;
diether;
imidazoles;
secondary carboxamide;
sulfoxide		anti-HIV agent;
anti-inflammatory agent;
antirheumatic drug;
chemokine receptor 2 antagonist;
chemokine receptor 5 antagonist
iodoacetic acid[no description available]medium10haloacetic acid;
organoiodine compound		alkylating agent
stearic acid[no description available]medium30long-chain fatty acid;
saturated fatty acid;
straight-chain saturated fatty acid		algal metabolite;
Daphnia magna metabolite;
human metabolite;
plant metabolite
lithospermic acid[no description available]medium10
fluorescein[no description available]medium922-benzofurans;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
polyphenol;
xanthene dye		fluorescent dye;
radioopaque medium
kn 93[no description available]medium20monochlorobenzenes;
monomethoxybenzene;
primary alcohol;
sulfonamide;
tertiary amino compound		EC 2.7.11.17 (Ca(2+)/calmodulin-dependent protein kinase) inhibitor;
geroprotector
3-mercapto-3,3-cyclopentamethylenepropionic acid[no description available]medium10
1,2-benzisoxazole[no description available]medium101,2-benzoxazoles;
mancude organic heterobicyclic parent
alpha-chymotrypsin[no description available]medium50
aluminum sulfate[no description available]medium10aluminium sulfate
furan[no description available]medium60furans;
mancude organic heteromonocyclic parent;
monocyclic heteroarene		carcinogenic agent;
hepatotoxic agent;
Maillard reaction product
neurotensin[no description available]medium20peptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary
neurotensin (8-13)[no description available]medium10
berberine[no description available]medium41alkaloid antibiotic;
berberine alkaloid;
botanical anti-fungal agent;
organic heteropentacyclic compound		antilipemic drug;
antineoplastic agent;
antioxidant;
EC 1.1.1.141 [15-hydroxyprostaglandin dehydrogenase (NAD(+))] inhibitor;
EC 1.1.1.21 (aldehyde reductase) inhibitor;
EC 1.13.11.52 (indoleamine 2,3-dioxygenase) inhibitor;
EC 1.21.3.3 (reticuline oxidase) inhibitor;
EC 2.1.1.116 [3'-hydroxy-N-methyl-(S)-coclaurine 4'-O-methyltransferase] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
hypoglycemic agent;
metabolite;
potassium channel blocker
peramivir[no description available]medium10
olodaterol[no description available]medium10aromatic ether;
benzoxazine;
phenols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent
edoxaban[no description available]medium20chloropyridine;
monocarboxylic acid amide;
tertiary amino compound;
thiazolopyridine		anticoagulant;
EC 3.4.21.6 (coagulation factor Xa) inhibitor;
platelet aggregation inhibitor
zearalenone[no description available]medium20macrolide;
resorcinols		fungal metabolite;
mycoestrogen
cetrorelix[no description available]medium95oligopeptideantineoplastic agent;
GnRH antagonist
4,5-diaminofluorescein[no description available]medium20
sirtinol[no description available]medium20aldimine;
benzamides;
naphthols		anti-inflammatory agent;
EC 3.5.1.98 (histone deacetylase) inhibitor;
Sir2 inhibitor
amantadine[no description available]medium30adamantanes;
primary aliphatic amine		analgesic;
antiparkinson drug;
antiviral drug;
dopaminergic agent;
NMDA receptor antagonist;
non-narcotic analgesic
sanggenone c[no description available]medium10
sifuvirtide[no description available]medium10
melanotan-ii[no description available]medium20organic molecular entity
efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination[no description available]medium10
tetrabutylammonium[no description available]medium30quaternary ammonium ion
bikinin[no description available]medium10
acrylic acid[no description available]medium30alpha,beta-unsaturated monocarboxylic acidmetabolite
apigenin[no description available]medium60trihydroxyflavoneantineoplastic agent;
metabolite
ro 32-0432[no description available]medium20
meptyldinocap[no description available]medium10C-nitro compound;
enoate ester
salmeterol xinafoate[no description available]medium20naphthoic acid
n-acetylaspartic acid[no description available]medium10N-acetyl-L-amino acid;
N-acyl-L-aspartic acid		antioxidant;
human metabolite;
mouse metabolite;
nutraceutical;
rat metabolite
creatine[no description available]medium41glycine derivative;
guanidines;
zwitterion		geroprotector;
human metabolite;
mouse metabolite;
neuroprotective agent;
nutraceutical
xl765[no description available]medium11aromatic amine;
aromatic ether;
benzamides;
quinoxaline derivative;
sulfonamide		antineoplastic agent;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
mTOR inhibitor
gdc-0973[no description available]medium10aromatic amine;
difluorobenzene;
N-acylazetidine;
organoiodine compound;
piperidines;
secondary amino compound;
tertiary alcohol		antineoplastic agent;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor
rimorphin[no description available]medium10
dynorphins[no description available]medium30
1,2-dioleoyloxy-3-(trimethylammonium)propane[no description available]medium10
6-aminophenanthridine[no description available]medium10
diacetylfluorescein[no description available]medium10
oxyma[no description available]medium40
leptomycin b[no description available]medium30
remifentanil[no description available]medium10alpha-amino acid ester;
anilide;
monocarboxylic acid amide;
piperidinecarboxylate ester		intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
sedative
7-hydroxyflavone[no description available]medium10hydroxyflavonoid
e-z cinnamic acid[no description available]medium10cinnamic acidplant metabolite
ver 155008[no description available]medium10purine nucleoside
defibrotide[no description available]medium40
procyanidin[no description available]medium10proanthocyanidin
perovskite[no description available]medium10
thiazolyl blue[no description available]medium70organic bromide saltcolorimetric reagent;
dye
guanylyl imidodiphosphate[no description available]medium20nucleoside triphosphate analogue
ranitidine[no description available]medium203C-nitro compound;
furans;
organic sulfide;
tertiary amino compound		anti-ulcer drug;
drug allergen;
environmental contaminant;
H2-receptor antagonist;
xenobiotic
dipyridamole[no description available]medium110piperidines;
pyrimidopyrimidine;
tertiary amino compound;
tetrol		adenosine phosphodiesterase inhibitor;
EC 3.5.4.4 (adenosine deaminase) inhibitor;
platelet aggregation inhibitor;
vasodilator agent
mucidin[no description available]medium10enoate ester;
enol ether		antifungal agent;
fungal metabolite
wnt-c59[no description available]medium10
lgk974[no description available]medium10bipyridines;
pyrazines;
pyridines;
secondary carboxamide		Wnt signalling inhibitor
peroxymonosulfate[no description available]medium10sulfur oxide;
sulfur oxoanion
1,2,5,8-tetrahydroxy anthraquinone[no description available]medium20tetrahydroxyanthraquinoneEC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor
isotretinoin[no description available]medium20retinoic acidantineoplastic agent;
keratolytic drug;
teratogenic agent
tenuigenin[no description available]medium1012alpha-hydroxy steroid
verdinexor[no description available]medium20
ml 7[no description available]medium10N-sulfonyldiazepane;
organoiodine compound		EC 2.7.11.18 (myosin-light-chain kinase) inhibitor
fumagillin[no description available]medium20antibiotic antifungal drug;
carboxylic ester;
dicarboxylic acid monoester;
meroterpenoid;
organooxygen heterocyclic antibiotic;
spiro-epoxide		angiogenesis inhibitor;
antibacterial drug;
antimicrobial agent;
antiprotozoal drug;
fungal metabolite;
methionine aminopeptidase 2 inhibitor
cabergoline[no description available]medium32N-acylureaantineoplastic agent;
antiparkinson drug;
dopamine agonist
ergoline[no description available]medium72diamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound
spectinomycin[no description available]medium10cyclic acetal;
cyclic hemiketal;
cyclic ketone;
pyranobenzodioxin;
secondary alcohol;
secondary amino compound		antibacterial drug;
antimicrobial agent;
bacterial metabolite
chlortoluron[no description available]medium40monochlorobenzenes;
phenylureas		agrochemical;
environmental contaminant;
herbicide;
xenobiotic
6-methyl-2-(phenylethynyl)pyridine[no description available]medium40acetylenic compound;
methylpyridines		anxiolytic drug;
metabotropic glutamate receptor antagonist
3-chloro-5-(6-(5-fluoropyridin-2-yl)pyrimidin-4-yl)benzonitrile[no description available]medium10
lycorine[no description available]medium10indolizidine alkaloidanticoronaviral agent;
antimalarial;
plant metabolite;
protein synthesis inhibitor
potassium hydroxide[no description available]medium11alkali metal hydroxide
chaetocin[no description available]medium10
cephalothin[no description available]medium20azabicycloalkene;
beta-lactam antibiotic allergen;
carboxylic acid;
cephalosporin;
semisynthetic derivative;
thiophenes		antibacterial drug;
antimicrobial agent
oxybenzone[no description available]medium20hydroxybenzophenone;
monomethoxybenzene		dermatologic drug;
environmental contaminant;
protective agent;
ultraviolet filter;
xenobiotic
4-chlorobenzoic acid[no description available]medium10monochlorobenzoic acidbacterial xenobiotic metabolite
pregnenolone[no description available]medium5020-oxo steroid;
3beta-hydroxy-Delta(5)-steroid;
C21-steroid		human metabolite;
mouse metabolite
7-ethoxycoumarin[no description available]medium30aromatic ether;
coumarins
(1,2-bis(1,2-benzisoselenazolone-3(2h)-ketone))ethane[no description available]medium10
psb603[no description available]medium20
bms-790052[no description available]medium20biphenyls;
carbamate ester;
carboxamide;
imidazoles;
valine derivative		antiviral drug;
nonstructural protein 5A inhibitor
n,n-carbonyldiimidazole[no description available]medium10
risperidone[no description available]medium401,2-benzoxazoles;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine		alpha-adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
psychotropic drug;
second generation antipsychotic;
serotonergic antagonist
bupropion[no description available]medium292aromatic ketone;
monochlorobenzenes;
secondary amino compound		antidepressant;
environmental contaminant;
xenobiotic
mianserin[no description available]medium290dibenzoazepineadrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
geroprotector;
H1-receptor antagonist;
histamine agonist;
sedative;
serotonergic antagonist
efonidipine[no description available]medium10C-nitro compound;
carboxylic ester;
dihydropyridine;
tertiary amino compound
phytosphingosine[no description available]medium10amino alcohol;
sphingoid;
triol		mouse metabolite;
Saccharomyces cerevisiae metabolite
terbufos[no description available]medium10organic thiophosphate;
organosulfur compound;
organothiophosphate insecticide		agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
2-cyano-n-((ethylamino)carbonyl)-2-(methoxyimino)acetamide[no description available]medium30
acrolein[no description available]medium20enalherbicide;
human xenobiotic metabolite;
toxin
cinnamaldehyde[no description available]medium203-phenylprop-2-enal;
cinnamaldehydes		antifungal agent;
EC 4.3.1.24 (phenylalanine ammonia-lyase) inhibitor;
flavouring agent;
hypoglycemic agent;
plant metabolite;
sensitiser;
vasodilator agent
lysophosphatidic acid[no description available]medium101-acyl-sn-glycerol 3-phosphate
promethazine[no description available]medium20phenothiazines;
tertiary amine		anti-allergic agent;
anticoronaviral agent;
antiemetic;
antipruritic drug;
H1-receptor antagonist;
local anaesthetic;
sedative
indole-2-carboxylic acid[no description available]medium10indolyl carboxylic acid
cloprostenol[no description available]medium10prostanoid
bemotrizinol[no description available]medium10methoxybenzenes
fusidic acid[no description available]medium20monoterpenoid
cetyltrimethylammonium ion[no description available]medium20quaternary ammonium ion
4-(3-isothiocyanatopyrrolidin-1-yl)-7-(n,n-dimethylaminosulfonyl)-2,1,3-benzoxadiazole[no description available]medium10
liranaftate[no description available]medium10tetralins
vu0409106[no description available]medium10
mk-0524[no description available]medium10indolyl carboxylic acid
carmustine[no description available]medium20N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
ivabradine[no description available]medium10aromatic ether;
benzazepine;
carbobicyclic compound;
tertiary amino compound		cardiotonic drug
valsartan[no description available]medium10biphenylyltetrazole;
monocarboxylic acid amide;
monocarboxylic acid		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
naloxegol[no description available]medium10aromatic ether;
organic heteropentacyclic compound;
phenols;
polyether;
tertiary alcohol		cathartic;
mu-opioid receptor antagonist
methapyrilene[no description available]medium20ethylenediamine derivativeanti-allergic agent;
carcinogenic agent;
H1-receptor antagonist;
sedative
sb674042[no description available]medium10
prolinamide[no description available]medium10amino acid amide;
L-proline derivative;
pyrrolidinecarboxamide
3-n-butylphthalide[no description available]medium10benzofurans
gma-edma[no description available]medium10
mandelic acid[no description available]medium202-hydroxy monocarboxylic acid;
benzenes		antibacterial agent;
human xenobiotic metabolite
ethylene dimethacrylate[no description available]medium30enoate esterallergen;
cross-linking reagent;
polymerisation monomer
17-dihydroexemestane[no description available]medium10
phenylglyoxal[no description available]medium10phenylacetaldehydes
gs-9669[no description available]medium21
ethyl cellulose[no description available]medium10glycoside
ethidium[no description available]medium30phenanthridinesfluorochrome;
intercalator
oleylamide[no description available]medium10primary fatty amidehuman metabolite;
plant metabolite
fenchlorazole-ethyl[no description available]medium60dichlorobenzene
dichlormid[no description available]medium10tertiary carboxamide
citrulline[no description available]medium30amino acid zwitterion;
citrulline		Daphnia magna metabolite;
EC 1.14.13.39 (nitric oxide synthase) inhibitor;
Escherichia coli metabolite;
human metabolite;
micronutrient;
mouse metabolite;
nutraceutical;
plant metabolite;
protective agent;
Saccharomyces cerevisiae metabolite
clodronic acid[no description available]medium401,1-bis(phosphonic acid);
one-carbon compound;
organochlorine compound		antineoplastic agent;
bone density conservation agent
baclofen[no description available]medium30amino acid zwitterion;
gamma-amino acid;
monocarboxylic acid;
monochlorobenzenes;
primary amino compound		central nervous system depressant;
GABA agonist;
muscle relaxant
lesogaberan[no description available]medium10
arbaclofen placarbil[no description available]medium10
bucillamine[no description available]medium10organic molecular entity
mepazine[no description available]medium10phenothiazines
ex 527[no description available]medium10carbazoles;
monocarboxylic acid amide;
organochlorine compound
pf-06687252[no description available]medium10azabicycloalkane;
enone;
phenols;
pyridines
amyloid beta-peptides[no description available]medium20
venlafaxine hydrochloride[no description available]medium444hydrochloride
sertraline[no description available]medium216dichlorobenzene;
secondary amino compound;
tetralins		antidepressant;
serotonin uptake inhibitor
safingol[no description available]medium10amino alcohol
lcl161[no description available]medium101,3-thiazoles;
aromatic ketone;
L-alanine derivative;
monofluorobenzenes;
N-acylpyrrolidine		antineoplastic agent;
apoptosis inducer
gdc-0152[no description available]medium20
dabigatran[no description available]medium10aromatic amide;
benzimidazoles;
beta-alanine derivative;
carboxamidine;
pyridines		anticoagulant;
EC 1.10.99.2 [ribosyldihydronicotinamide dehydrogenase (quinone)] inhibitor;
EC 3.4.21.5 (thrombin) inhibitor
eluxadoline[no description available]medium10amino acid amide;
benzamides;
imidazoles;
L-phenylalanine derivative;
methoxybenzoic acid		delta-opioid receptor antagonist;
gastrointestinal drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist
ethylnitrosourea[no description available]medium10N-nitrosoureasalkylating agent;
carcinogenic agent;
genotoxin;
mutagen
pateamine a[no description available]medium101,3-thiazoles;
macrodiolide;
olefinic compound;
primary amino compound;
tertiary amino compound		antineoplastic agent;
antiviral agent;
eukaryotic initiation factor 4F inhibitor;
marine metabolite
santonin[no description available]medium20botanical anti-fungal agent;
santonin		plant metabolite
fructans[no description available]medium20
phenylalanine methyl ester[no description available]medium10alpha-amino acid ester;
L-phenylalanine derivative
l-phenylalanine ethylester[no description available]medium10
dextromethorphan[no description available]medium326-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthreneantitussive;
environmental contaminant;
neurotoxin;
NMDA receptor antagonist;
oneirogen;
prodrug;
xenobiotic
flibanserin[no description available]medium20benzimidazoles;
N-alkylpiperazine;
N-arylpiperazine;
organofluorine compound		antidepressant;
serotonergic agonist;
serotonergic antagonist
brexpiprazole[no description available]medium10N-arylpiperazine
4-vinyl-1-cyclohexene dioxide[no description available]medium20epoxidecarcinogenic agent
dichlorvos[no description available]medium10alkenyl phosphate;
dialkyl phosphate;
organochlorine acaricide;
organophosphate insecticide		anthelminthic drug;
antibacterial agent;
antifungal agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
malaoxon[no description available]medium10diester;
ethyl ester;
organic thiophosphate
duloxetine hydrochloride[no description available]medium30duloxetine hydrochlorideantidepressant
nortriptyline[no description available]medium20organic tricyclic compound;
secondary amine		adrenergic uptake inhibitor;
analgesic;
antidepressant;
antineoplastic agent;
apoptosis inducer;
drug metabolite
clomipramine[no description available]medium30dibenzoazepineanticoronaviral agent;
antidepressant;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
serotonergic antagonist;
serotonergic drug;
serotonin uptake inhibitor
desipramine[no description available]medium112dibenzoazepine;
secondary amino compound		adrenergic uptake inhibitor;
alpha-adrenergic antagonist;
antidepressant;
cholinergic antagonist;
drug allergen;
EC 3.1.4.12 (sphingomyelin phosphodiesterase) inhibitor;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
serotonin uptake inhibitor
nitrofurazone[no description available]medium20
2-phenylquinoline[no description available]medium10
diphenyl[no description available]medium30aromatic fungicide;
benzenes;
biphenyls		antifungal agrochemical;
antimicrobial food preservative
sodium dodecyl sulfate[no description available]medium40organic sodium saltdetergent;
protein denaturant
8-cyclopentyl-1,3-dimethylxanthine[no description available]medium220oxopurine
quinone[no description available]medium401,4-benzoquinonescofactor;
human xenobiotic metabolite;
mouse metabolite
5,6-epoxycholesterol[no description available]medium10
GDC-0623[no description available]medium10hydroxamic acid ester;
imidazopyridine;
monofluorobenzenes;
organoiodine compound;
primary alcohol;
secondary amino compound;
substituted aniline		antineoplastic agent;
apoptosis inducer;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
4-bromoaniline[no description available]medium10
alpha-asarone[no description available]medium10asaroneanticonvulsant;
GABA modulator
opc-67683[no description available]medium10piperidines
4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol[no description available]medium10nitrosamine;
pyridines;
secondary alcohol		biomarker;
carcinogenic agent;
human urinary metabolite
jnj38877605[no description available]medium20quinolines
perylene[no description available]medium20ortho- and peri-fused polycyclic arene;
perylenes
thioinosine[no description available]medium70
4-nitrobenzylthioinosine[no description available]medium70purine nucleoside
alpha,beta-methyleneadenosine 5'-triphosphate[no description available]medium40nucleoside triphosphate analogue
adenosine 5'-o-(3-thiotriphosphate)[no description available]medium40nucleoside triphosphate analogue
gamma-valerolactone[no description available]medium10butan-4-olideflavouring agent;
human xenobiotic metabolite
1-bromopropane[no description available]medium10bromoalkane;
bromohydrocarbon		neurotoxin;
solvent
carbamylhydrazine[no description available]medium10carbohydrazide;
monocarboxylic acid amide;
one-carbon compound;
ureas
gkt137831[no description available]medium10
gossypol[no description available]medium10
benzyloxyamine[no description available]medium10
dichloroacetic acid[no description available]medium10monocarboxylic acid;
organochlorine compound		astringent;
marine metabolite
butachlor[no description available]medium40aromatic amide;
organochlorine compound;
tertiary carboxamide		environmental contaminant;
herbicide;
xenobiotic
zanamivir[no description available]medium30guanidinesantiviral agent;
EC 3.2.1.18 (exo-alpha-sialidase) inhibitor
trinitrobenzenesulfonic acid[no description available]medium50arenesulfonic acid;
C-nitro compound		epitope;
explosive;
reagent
4-methyl-1,2,4-triazoline-3,5-dione[no description available]medium60
nvp-ast487[no description available]medium10
pd 0325901[no description available]medium20difluorobenzene;
hydroxamic acid ester;
monofluorobenzenes;
organoiodine compound;
propane-1,2-diols;
secondary amino compound		antineoplastic agent;
EC 2.7.12.2 (mitogen-activated protein kinase kinase) inhibitor
thioacetic acid[no description available]medium10thioacetic acid
pronamide[no description available]medium20benzamides;
dichlorobenzene;
terminal acetylenic compound		agrochemical;
herbicide
4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acid[no description available]medium10aminopyridine;
aromatic ether;
monocarboxylic acid;
organochlorine compound;
organofluorine compound		environmental contaminant;
herbicide;
xenobiotic
florasulam[no description available]medium10sulfonamide
fluroxypyr methylheptyl ester[no description available]medium10
2-(2'-hydroxy-3',5'-di-tert-butylphenyl)benzotriazole[no description available]medium70
fluorapatite[no description available]medium10
abiraterone acetate[no description available]medium10pyridines;
sterol ester		antineoplastic agent;
EC 1.14.99.9 (steroid 17alpha-monooxygenase) inhibitor;
prodrug
tryptanthrine[no description available]medium10alkaloid antibiotic;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound
dexketoprofen trometamol[no description available]medium10
tromethamine[no description available]medium10primary amino compound;
triol		buffer
cetirizine[no description available]medium10ether;
monocarboxylic acid;
monochlorobenzenes;
piperazines		anti-allergic agent;
environmental contaminant;
H1-receptor antagonist;
xenobiotic
ginkgolide b[no description available]medium830
cyproheptadine[no description available]medium80piperidines;
tertiary amine		anti-allergic agent;
antipruritic drug;
gastrointestinal drug;
H1-receptor antagonist;
serotonergic antagonist
levocetirizine[no description available]medium10diarylmethane
cv 6209[no description available]medium200
rupatadine[no description available]medium20benzocycloheptapyridine
4-aminoquinazoline[no description available]medium10
taxane[no description available]medium51diterpene;
terpenoid fundamental parent
t-butyloxycarbonyl-methionyl-leucyl-phenylalanine[no description available]medium10
9-anthroic acid[no description available]medium10anthroic acid
boldenone[no description available]medium1017beta-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
anabolic androgenic steroid
regadenoson[no description available]medium30purine nucleoside
mobiflex[no description available]medium11heteroaryl hydroxy compound;
monocarboxylic acid amide;
pyridines;
thienothiazine		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
piroxicam[no description available]medium51benzothiazine;
monocarboxylic acid amide;
pyridines		analgesic;
antirheumatic drug;
cyclooxygenase 1 inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
5,6-dichlorobenzimidazole[no description available]medium10
eflornithine[no description available]medium20alpha-amino acid;
fluoroamino acid		trypanocidal drug
arry 520[no description available]medium10
sepharose[no description available]medium30
irganox 1010[no description available]medium10
irganox 1076[no description available]medium10
garenoxacin[no description available]medium10aromatic ether;
cyclopropanes;
isoindoles;
organofluorine compound;
quinolinemonocarboxylic acid;
quinolone antibiotic		antibacterial drug;
non-steroidal anti-inflammatory drug
enoxacin[no description available]medium101,8-naphthyridine derivative;
amino acid;
fluoroquinolone antibiotic;
monocarboxylic acid;
N-arylpiperazine;
quinolone antibiotic		antibacterial drug;
DNA synthesis inhibitor
levovirin valinate hydrochloride[no description available]medium61
formic acid[no description available]medium20monocarboxylic acidantibacterial agent;
astringent;
metabolite;
protic solvent;
solvent
givinostat[no description available]medium10carbamate ester
fenpiclonil[no description available]medium10dichlorobenzene;
nitrile;
pyrroles		antifungal agrochemical
alendronate[no description available]medium101,1-bis(phosphonic acid);
primary amino compound		bone density conservation agent;
EC 2.5.1.1 (dimethylallyltranstransferase) inhibitor
citral[no description available]medium10enal;
monoterpenoid;
polyprenal		plant metabolite;
volatile oil component
estragole[no description available]medium10alkenylbenzene;
monomethoxybenzene;
phenylpropanoid		carcinogenic agent;
flavouring agent;
genotoxin;
insect attractant;
plant metabolite
4-hydroxy-n-desmethyltamoxifen[no description available]medium10stilbenoid
afimoxifene[no description available]medium30phenols;
tertiary amino compound		antineoplastic agent;
estrogen receptor antagonist;
metabolite
aminosalicylic acid[no description available]medium10aminobenzoic acid;
phenols		antitubercular agent
iturelix[no description available]medium10
9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-[no description available]medium10
thiouracil[no description available]medium20nucleobase analogue;
thiocarbonyl compound		antithyroid drug;
metabolite
anoplin[no description available]medium10
melarsoprol[no description available]medium10triazines
n-isopropylacrylamide[no description available]medium10
pituitrin[no description available]medium30
farnesyl pyrophosphate[no description available]medium10farnesyl diphosphateEscherichia coli metabolite;
mouse metabolite
geranylgeranyl pyrophosphate[no description available]medium20geranylgeranyl diphosphatemouse metabolite
tolbutamide[no description available]medium30N-sulfonylureahuman metabolite;
hypoglycemic agent;
insulin secretagogue;
potassium channel blocker
tetrandrine[no description available]medium40bisbenzylisoquinoline alkaloid;
isoquinolines
veliparib[no description available]medium10benzimidazolesEC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
gsk1278863[no description available]medium20
n,n-diisopropylethylamine[no description available]medium50tertiary amino compound
2-(1h-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate[no description available]medium120
firefly luciferin[no description available]medium201,3-thiazolemonocarboxylic acid;
benzothiazoles;
imidothioate		luciferin
pyrithiobac sodium[no description available]medium20organic molecular entity
chlorimuron ethyl[no description available]medium20aromatic ether;
ethyl ester;
N-sulfonylurea;
organochlorine pesticide;
pyrimidines;
sulfamoylbenzoate		agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
proherbicide
bispyribac[no description available]medium10aromatic ether;
benzoic acids;
monocarboxylic acid;
pyrimidines		herbicide
imazaquin[no description available]medium30imidazolone;
monocarboxylic acid;
quinolinemonocarboxylic acid
6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid[no description available]medium10chromanol;
monocarboxylic acid;
phenols		antioxidant;
ferroptosis inhibitor;
neuroprotective agent;
radical scavenger;
Wnt signalling inhibitor
ganglioside, gd2[no description available]medium10
phosphites[no description available]medium20phosphite ion;
trivalent inorganic anion
bilirubin[no description available]medium102biladienes;
dicarboxylic acid		antioxidant;
human metabolite;
mouse metabolite
hydroxyethyl methacrylate[no description available]medium10enoate esterallergen;
polymerisation monomer
polyterephthalic acid anhydride[no description available]medium10
ferric ammonium citrate[no description available]medium10
4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione[no description available]medium10benzenes;
thiadiazolidine		anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
EC 2.7.11.26 (tau-protein kinase) inhibitor;
neuroprotective agent
ceruletide[no description available]medium40oligopeptidediagnostic agent;
gastrointestinal drug
pr-104a[no description available]medium10
tasimelteon[no description available]medium101-benzofurans;
cyclopropanes;
monocarboxylic acid amide		melatonin receptor agonist
bromodeoxyuridine[no description available]medium80pyrimidine 2'-deoxyribonucleosideantimetabolite;
antineoplastic agent
cidofovir anhydrous[no description available]medium10phosphonic acids;
pyrimidone		anti-HIV agent;
antineoplastic agent;
antiviral drug;
photosensitizing agent
brivudine[no description available]medium10
ro 31-8220[no description available]medium30imidothiocarbamic ester;
indoles;
maleimides		EC 2.7.11.13 (protein kinase C) inhibitor
debio 0932[no description available]medium10
reactive orange[no description available]medium10
buspirone[no description available]medium123azaspiro compound;
N-alkylpiperazine;
N-arylpiperazine;
organic heteropolycyclic compound;
piperidones;
pyrimidines		anxiolytic drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
sedative;
serotonergic agonist
aminophylline[no description available]medium80mixturebronchodilator agent;
cardiotonic drug
xct790[no description available]medium10cinnamamides
anabasine[no description available]medium10anabasine
tipranavir[no description available]medium40sulfonamideantiviral drug;
HIV protease inhibitor
alpha-naphthoflavone[no description available]medium70extended flavonoid;
naphtho-gamma-pyrone;
organic heterotricyclic compound		aryl hydrocarbon receptor agonist;
aryl hydrocarbon receptor antagonist;
EC 1.14.14.14 (aromatase) inhibitor
l 731988[no description available]medium30
s 1360[no description available]medium160
losartan[no description available]medium90biphenylyltetrazole;
imidazoles		angiotensin receptor antagonist;
anti-arrhythmia drug;
antihypertensive agent;
endothelin receptor antagonist
doripenem[no description available]medium10carbapenems
ixabepilone[no description available]medium201,3-thiazoles;
beta-hydroxy ketone;
epoxide;
lactam;
macrocycle		antineoplastic agent;
microtubule-destabilising agent
sapropterin[no description available]medium105,6,7,8-tetrahydrobiopterincoenzyme;
cofactor;
diagnostic agent;
human metabolite
nateglinide[no description available]medium20phenylalanine derivative
nonactin[no description available]medium20
telbivudine[no description available]medium20pyrimidine 2'-deoxyribonucleosideantiviral drug;
EC 2.7.7.49 (RNA-directed DNA polymerase) inhibitor
liarozole[no description available]medium40benzimidazoles
n(6)-cyclopentyladenosine[no description available]medium290
thionyl chloride[no description available]medium20chlorine molecular entity;
sulfinyl halide
dl 111-it[no description available]medium380
pentetic acid[no description available]medium20pentacarboxylic acidcopper chelator
1,5-benzothiazepine[no description available]medium20
simazine[no description available]medium20chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
saquinavir[no description available]medium41L-asparagine derivative;
quinolines		antiviral drug;
HIV protease inhibitor
tocopherols[no description available]medium10
tocotrienols[no description available]medium10diterpenoid
methyl tert-butyl ether[no description available]medium10etherfuel additive;
metabolite;
non-polar solvent
pyrazolo(3,4-d)pyrimidine[no description available]medium20
benzo(a)pyrene[no description available]medium30ortho- and peri-fused polycyclic arenecarcinogenic agent;
mouse metabolite
cucurbit(6)uril[no description available]medium20
ticrynafen[no description available]medium10aromatic ether;
aromatic ketone;
dichlorobenzene;
monocarboxylic acid;
thiophenes		antihypertensive agent;
hepatotoxic agent;
loop diuretic
sudoxicam[no description available]medium10
taurocholic acid[no description available]medium30amino sulfonic acid;
bile acid taurine conjugate		human metabolite
glycodeoxycholic acid[no description available]medium10bile acid glycine conjugatehuman metabolite
tcv 309[no description available]medium30
lexipafant[no description available]medium20
tibolone[no description available]medium4117beta-hydroxy steroid;
terminal acetylenic compound		bone density conservation agent;
hormone agonist
zaprinast[no description available]medium30triazolopyrimidines
18-crown-6[no description available]medium10crown ether;
saturated organic heteromonocyclic parent		phase-transfer catalyst
tinuvin 770[no description available]medium21
pramiconazole[no description available]medium146piperazines
sulfamethoxazole hydroxylamine[no description available]medium10isoxazoles;
sulfonamide		allergen;
metabolite
thromboxane b2[no description available]medium262thromboxanes Bhuman metabolite;
mouse metabolite
mk 0663[no description available]medium11bipyridines;
organochlorine compound;
sulfone		cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
6-n-propyluracil[no description available]medium10
ethyl bromoacetate[no description available]medium20
chloramphenicol[no description available]medium110C-nitro compound;
carboxamide;
diol;
organochlorine compound		antibacterial drug;
antimicrobial agent;
Escherichia coli metabolite;
geroprotector;
Mycoplasma genitalium metabolite;
protein synthesis inhibitor
minfiensine[no description available]medium10
indacrinone[no description available]medium10
flustramine b[no description available]medium10
8,11,14-eicosatrienoic acid[no description available]medium50fatty acid 20:3;
long-chain fatty acid		fungal metabolite;
human metabolite;
nutraceutical
n-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide[no description available]medium20
1,5-bis(2-methoxy-4-nitro-5-sulfophenyl)-3-((phenylamino)carbonyl)formazan[no description available]medium20
vinylphosphonic acid[no description available]medium10
ibandronic acid[no description available]medium71
phenylacetylene[no description available]medium20benzenes
acetylene[no description available]medium130alkyne;
gas molecular entity;
terminal acetylenic compound
niacin[no description available]medium50pyridine alkaloid;
pyridinemonocarboxylic acid;
vitamin B3		antidote;
antilipemic drug;
EC 3.5.1.19 (nicotinamidase) inhibitor;
Escherichia coli metabolite;
human urinary metabolite;
metabolite;
mouse metabolite;
plant metabolite;
vasodilator agent
cholic acid[no description available]medium3012alpha-hydroxy steroid;
3alpha-hydroxy steroid;
7alpha-hydroxy steroid;
bile acid;
C24-steroid;
trihydroxy-5beta-cholanic acid		human metabolite;
mouse metabolite
hexylresorcinol[no description available]medium10resorcinols
arabinose[no description available]medium40L-arabinoseEscherichia coli metabolite;
mouse metabolite
indolepropionic acid[no description available]medium10indol-3-yl carboxylic acidauxin;
human metabolite;
plant metabolite
mefenoxam[no description available]medium30acylamino acid fungicide;
anilide fungicide;
D-alanine derivative;
methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate		agrochemical
silver nitrate[no description available]medium20inorganic nitrate salt;
silver salt		astringent
digitonin[no description available]medium10
thiolactic acid[no description available]medium10mercaptopropanoic acid
2-mercaptoacetate[no description available]medium30monocarboxylic acid anion
eplerenone[no description available]medium103-oxo-Delta(4) steroid;
epoxy steroid;
gamma-lactone;
methyl ester;
organic heteropentacyclic compound;
oxaspiro compound;
steroid acid ester		aldosterone antagonist;
antihypertensive agent
benzylamine[no description available]medium10aralkylamine;
primary amine		allergen;
EC 3.5.5.1 (nitrilase) inhibitor;
plant metabolite
trovirdine[no description available]medium20
cyclam[no description available]medium30azacycloalkane;
crown amine;
saturated organic heteromonocyclic parent
fosfluconazole[no description available]medium20conazole antifungal drug;
triazole antifungal drug;
triazoles		prodrug
ly686017[no description available]medium62
benzo-1,2,3-thiadiazole[no description available]medium20
flunitrazepam[no description available]medium1701,4-benzodiazepinone;
C-nitro compound;
monofluorobenzenes		anxiolytic drug;
GABAA receptor agonist;
sedative
flumazenil[no description available]medium211ethyl ester;
imidazobenzodiazepine;
organofluorine compound		antidote to benzodiazepine poisoning;
GABA antagonist
methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate[no description available]medium70beta-carbolines
n-butyl beta-carboline-3-carboxylate[no description available]medium10beta-carbolines
ah 111585[no description available]medium10
primidone[no description available]medium30pyrimidoneanticonvulsant;
environmental contaminant;
xenobiotic
raubasine[no description available]medium10yohimban alkaloid
aceclidine[no description available]medium20quinuclidines
isobutylparaben[no description available]medium104-hydroxybenzoate ester
cv 3988[no description available]medium260
involucrin[no description available]medium10
scutellarin[no description available]medium10glucosiduronic acid;
glycosyloxyflavone;
monosaccharide derivative;
trihydroxyflavone		antineoplastic agent;
proteasome inhibitor
aplaviroc[no description available]medium80
tak 779[no description available]medium80
capsaicin[no description available]medium121capsaicinoidnon-narcotic analgesic;
TRPV1 agonist;
voltage-gated sodium channel blocker
zd 7155[no description available]medium10
diethylhexyl phthalate[no description available]medium30diester;
phthalate ester		androstane receptor agonist;
apoptosis inhibitor;
plasticiser
mono-(2-ethylhexyl)phthalate[no description available]medium30phthalic acid monoester
cimetidine[no description available]medium283aliphatic sulfide;
guanidines;
imidazoles;
nitrile		adjuvant;
analgesic;
anti-ulcer drug;
H2-receptor antagonist;
P450 inhibitor
zinc hematoporphyrin[no description available]medium30
uamc00039[no description available]medium10
ubenimex[no description available]medium10
gemfibrozil[no description available]medium31aromatic etherantilipemic drug
homocastasterone[no description available]medium10
gulonic acid[no description available]medium10gulonic acid
8-bromocyclic gmp[no description available]medium803',5'-cyclic purine nucleotide;
organobromine compound		muscle relaxant;
protein kinase G agonist
s-nitroso-n-acetylpenicillamine[no description available]medium80nitroso compound;
nitrosothio compound		nitric oxide donor;
vasodilator agent
masoprocol[no description available]medium90nordihydroguaiaretic acidantineoplastic agent;
hypoglycemic agent;
lipoxygenase inhibitor;
metabolite
cyproterone acetate[no description available]medium3020-oxo steroid;
3-oxo-Delta(4) steroid;
acetate ester;
chlorinated steroid;
steroid ester		androgen antagonist;
geroprotector;
progestin
salvinorin a[no description available]medium10organic heterotricyclic compound;
organooxygen compound		metabolite;
oneirogen
methylenecyclopropane[no description available]medium10
reserpine[no description available]medium190alkaloid ester;
methyl ester;
yohimban alkaloid		adrenergic uptake inhibitor;
antihypertensive agent;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
first generation antipsychotic;
plant metabolite;
xenobiotic
nomifensine[no description available]medium10isoquinolinesdopamine uptake inhibitor
cryptophane a[no description available]medium20
apicidin[no description available]medium10
benzyne[no description available]medium30aryne;
benzyne
fenofibrate[no description available]medium10benzochromenone;
delta-lactone;
naphtho-alpha-pyrone		platelet aggregation inhibitor;
Sir2 inhibitor
5-(5-nitrothiazol-2-ylthio)-1,3,4-thiadiazol-2-amine[no description available]medium101,3-thiazoles;
C-nitro compound;
organic sulfide;
primary amino compound;
thiadiazoles		antibacterial agent;
c-Jun N-terminal kinase inhibitor
cyclosporin o[no description available]medium10
bms201038[no description available]medium10(trifluoromethyl)benzenes;
benzamides;
fluorenes;
piperidines		anticholesteremic drug;
MTP inhibitor
threoninol[no description available]medium10
valganciclovir[no description available]medium20L-valyl ester;
purines		antiviral drug;
prodrug
methylphenidate[no description available]medium40beta-amino acid ester;
methyl ester;
piperidines
isoalloxazine[no description available]medium80benzo[g]pteridine-2,4-dione
methacholine chloride[no description available]medium61quaternary ammonium salt
2-butenal[no description available]medium10enal
argifin[no description available]medium10
n(6)-(3-iodobenzyl)-5'-n-methylcarboxamidoadenosine[no description available]medium160adenosines;
monocarboxylic acid amide;
organoiodine compound		adenosine A3 receptor agonist
mrs 1191[no description available]medium100cinnamate ester
luf 5834[no description available]medium10
atl 313[no description available]medium70
nicotinamide-beta-riboside[no description available]medium10N-glycosylnicotinamide;
pyridine nucleoside		geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
triamcinolone acetonide[no description available]medium3011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone		anti-allergic agent;
anti-inflammatory drug
2-cyanoacetamide[no description available]medium20
prohexadione-ca[no description available]medium10
diketene[no description available]medium10
benserazide[no description available]medium20carbohydrazide;
catechols;
primary alcohol;
primary amino compound		antiparkinson drug;
dopaminergic agent;
EC 4.1.1.28 (aromatic-L-amino-acid decarboxylase) inhibitor
etomidate[no description available]medium50ethyl ester;
imidazoles		intravenous anaesthetic;
sedative
rotenone[no description available]medium20organic heteropentacyclic compound;
rotenones		antineoplastic agent;
metabolite;
mitochondrial NADH:ubiquinone reductase inhibitor;
phytogenic insecticide;
piscicide;
toxin
2-methylquinoline[no description available]medium20quinolines
tak 456[no description available]medium20
propidium[no description available]medium60phenanthridines;
quaternary ammonium ion		fluorochrome;
intercalator
mtt formazan[no description available]medium10
ribose[no description available]medium100D-ribose;
ribopyranose
yohimbine[no description available]medium90methyl 17-hydroxy-20xi-yohimban-16-carboxylatealpha-adrenergic antagonist;
dopamine receptor D2 antagonist;
serotonergic antagonist
flumequine[no description available]medium103-oxo monocarboxylic acid;
organofluorine compound;
pyridoquinoline;
quinolone antibiotic
oxolinic acid[no description available]medium10aromatic carboxylic acid;
organic heterotricyclic compound;
oxacycle;
quinolinemonocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antifungal agent;
antiinfective agent;
antimicrobial agent;
enzyme inhibitor
nalidixic acid[no description available]medium301,8-naphthyridine derivative;
monocarboxylic acid;
quinolone antibiotic		antibacterial drug;
antimicrobial agent;
DNA synthesis inhibitor
cinoxacin[no description available]medium10cinnolines;
oxacycle;
oxo carboxylic acid		antibacterial drug;
antiinfective agent
r-120758[no description available]medium80
lanthanum[no description available]medium90f-block element atom;
lanthanoid atom;
scandium group element atom
thorium[no description available]medium10actinoid atom;
f-block element atom
cycloheximide[no description available]medium210antibiotic fungicide;
cyclic ketone;
dicarboximide;
piperidine antibiotic;
piperidones;
secondary alcohol		anticoronaviral agent;
bacterial metabolite;
ferroptosis inhibitor;
neuroprotective agent;
protein synthesis inhibitor
anisomycin[no description available]medium10monohydroxypyrrolidine;
organonitrogen heterocyclic antibiotic		anticoronaviral agent;
antimicrobial agent;
antineoplastic agent;
antiparasitic agent;
bacterial metabolite;
DNA synthesis inhibitor;
protein synthesis inhibitor
lathosterol[no description available]medium103beta-sterol;
C27-steroid;
cholestanoid;
Delta(7)-sterol		human metabolite;
mouse metabolite
bay 11-7085[no description available]medium10benzenes;
nitrile;
sulfone		anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
apoptosis inducer;
autophagy inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
ferroptosis inducer;
NF-kappaB inhibitor
cerulenin[no description available]medium10epoxide;
monocarboxylic acid amide		antifungal agent;
antiinfective agent;
antilipemic drug;
antimetabolite;
antimicrobial agent;
fatty acid synthesis inhibitor
2',3'-didehydro-2',3'-dideoxyuridine[no description available]medium10
3,5-dihydroxyphenylglycine[no description available]medium20alpha-amino acid
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole[no description available]medium110
acyl carrier protein (65-74)[no description available]medium10
ditiocarb[no description available]medium60dithiocarbamic acidschelator;
copper chelator
propyl gallate[no description available]medium10trihydroxybenzoic acid
grandiflorenic acid[no description available]medium10
pimozide[no description available]medium20benzimidazoles;
heteroarylpiperidine;
organofluorine compound		antidyskinesia agent;
dopaminergic antagonist;
first generation antipsychotic;
H1-receptor antagonist;
serotonergic antagonist
pyrrolidine-2,4-dicarboxylic acid[no description available]medium20
digoxigenin[no description available]medium1012beta-hydroxy steroid;
14beta-hydroxy steroid;
3beta-hydroxy steroid;
3beta-sterol		hapten;
plant metabolite
n-hydroxysuccinimidyl digoxigenin-3-o-methylcarbonyl-epsilon-aminocaproate[no description available]medium10
am 251[no description available]medium20amidopiperidine;
carbohydrazide;
dichlorobenzene;
organoiodine compound;
pyrazoles		antidepressant;
antineoplastic agent;
apoptosis inducer;
CB1 receptor antagonist
2-chloro-5-hydroxyphenylglycine[no description available]medium30
1h-(1,2,4)oxadiazolo(4,3-a)quinoxalin-1-one[no description available]medium70oxadiazoloquinoxalineEC 4.6.1.2 (guanylate cyclase) inhibitor
4,5-dihydro-1h-1,2,4-triazol-5-one[no description available]medium30
dichlofluanid[no description available]medium40organochlorine compound;
organofluorine compound;
phenylsulfamide fungicide;
sulfamides		acaricide;
antifungal agrochemical
crotamiton[no description available]medium10
recombinant soluble cd4[no description available]medium20
combivir[no description available]medium22
geraniol[no description available]medium103,7-dimethylocta-2,6-dien-1-ol;
monoterpenoid;
primary alcohol		allergen;
fragrance;
plant metabolite;
volatile oil component
myrcene[no description available]medium10monoterpeneanabolic agent;
anti-inflammatory agent;
flavouring agent;
fragrance;
plant metabolite;
volatile oil component
metyrapone[no description available]medium111aromatic ketoneantimetabolite;
diagnostic agent;
EC 1.14.15.4 (steroid 11beta-monooxygenase) inhibitor
2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline[no description available]medium20naphthalenes;
sulfonic acid derivative
bay 60-6583[no description available]medium20aminopyridine;
aromatic ether;
aryl sulfide;
cyanopyridine;
cyclopropanes;
monocarboxylic acid amide		adenosine A2B receptor agonist;
anti-inflammatory agent;
cardioprotective agent
fenoxaprop ethyl[no description available]medium10aromatic ether
11-cis-retinal[no description available]medium50retinalchromophore;
human metabolite;
mouse metabolite
galactose[no description available]medium60
monorden[no description available]medium30cyclic ketone;
enone;
epoxide;
macrolide antibiotic;
monochlorobenzenes;
phenols		antifungal agent;
metabolite;
tyrosine kinase inhibitor
bevirimat[no description available]medium10dicarboxylic acid monoester;
monocarboxylic acid;
pentacyclic triterpenoid		HIV-1 maturation inhibitor;
metabolite
selegiline[no description available]medium10selegiline;
terminal acetylenic compound		geroprotector
resorufin[no description available]medium20phenoxazine
cp-346086[no description available]medium51
nitrosobenzene[no description available]medium10benzenes;
nitroso compound		xenobiotic metabolite
modipafant[no description available]medium60
bn 50730[no description available]medium492
s 1743[no description available]medium31magnesium saltanti-ulcer drug;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor
p-dimethylaminoazobenzene[no description available]medium70azobenzenes
emodin[no description available]medium40trihydroxyanthraquinoneantineoplastic agent;
laxative;
plant metabolite;
tyrosine kinase inhibitor
5-((2-aminoethyl)amino)naphthalene-1-sulfonic acid[no description available]medium10
4-(4-dimethylaminophenylazo)benzoic acid[no description available]medium10
kavain[no description available]medium102-pyranones;
aromatic ether
v 2006[no description available]medium20
as 3201[no description available]medium10
ent-dextilidine[no description available]medium11ethyl 2-(dimethylamino)-1-phenylcyclohex-3-ene-1-carboxylate
nortilidine[no description available]medium11ethyl 2-(methylamino)-1-phenylcyclohex-3-ene-1-carboxylatedrug metabolite;
NMDA receptor antagonist
sr 16234[no description available]medium10
zibotentan[no description available]medium10phenylpyridine
thiopental[no description available]medium30barbituratesanticonvulsant;
drug allergen;
environmental contaminant;
intravenous anaesthetic;
sedative;
xenobiotic
nitroglycerin[no description available]medium62nitroglycerolexplosive;
muscle relaxant;
nitric oxide donor;
prodrug;
tocolytic agent;
vasodilator agent;
xenobiotic
galantamine[no description available]medium10benzazepine alkaloid fundamental parent;
benzazepine alkaloid;
organic heterotetracyclic compound;
tertiary amino compound		antidote to curare poisoning;
cholinergic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
plant metabolite
1-o-hexadecyl-2-n-methylcarbamylphosphatidylcholine[no description available]medium90
4-(2-chlorophenyl)-2-(2-(4-isobutylphenyl)ethyl)-6,9-dimethyl-6h-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine[no description available]medium411
ethephon[no description available]medium30phosphonic acidsplant growth regulator
gr 73632[no description available]medium11
trichostatin a[no description available]medium10antibiotic antifungal agent;
hydroxamic acid;
trichostatin		bacterial metabolite;
EC 3.5.1.98 (histone deacetylase) inhibitor;
geroprotector
diazoacetic ester[no description available]medium10
4-anisidine[no description available]medium10methoxybenzenes;
primary amino compound;
substituted aniline		genotoxin;
reagent
chlorates[no description available]medium10chlorine oxoanion;
monovalent inorganic anion
nu 1025[no description available]medium10phenols;
quinazolines		EC 2.4.2.30 (NAD(+) ADP-ribosyltransferase) inhibitor
thiocyanic acid[no description available]medium20hydracid;
one-carbon compound;
organosulfur compound		Escherichia coli metabolite
fenpropimorph[no description available]medium60alkylbenzene
fenpropidine[no description available]medium20piperidines;
tertiary amine
silodosin[no description available]medium10indolecarboxamide
tapentadol[no description available]medium10alkylbenzene
milnacipran[no description available]medium30acetamides
besifloxacin[no description available]medium10quinolines
fesoterodine[no description available]medium10diarylmethane
cgp-56697[no description available]medium10
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ilys-prolyl-alaninamide[no description available]medium10polypeptide
cadusafos[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
nematicide
phorate[no description available]medium20organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor
6-cyano-7-nitroquinoxaline-2,3-dione[no description available]medium40quinoxaline derivative
guanosine 5'-o-(2-thiodiphosphate)[no description available]medium10nucleoside diphosphate analogue
guanosine diphosphate[no description available]medium30guanosine 5'-phosphate;
purine ribonucleoside 5'-diphosphate		Escherichia coli metabolite;
mouse metabolite;
uncoupling protein inhibitor
methyl syringate[no description available]medium10benzoate ester;
dimethoxybenzene;
phenols		plant metabolite
syringaldehyde[no description available]medium20dimethoxybenzene;
hydroxybenzaldehyde		hypoglycemic agent;
plant metabolite
gallic acid[no description available]medium30trihydroxybenzoic acidantineoplastic agent;
antioxidant;
apoptosis inducer;
astringent;
cyclooxygenase 2 inhibitor;
EC 1.13.11.33 (arachidonate 15-lipoxygenase) inhibitor;
geroprotector;
human xenobiotic metabolite;
plant metabolite
2-chloropyridine[no description available]medium10monochloropyridine
thymosin[no description available]medium20
uridine diphosphate glucose[no description available]medium10UDP-D-glucosefundamental metabolite
mefenamic acid[no description available]medium50aminobenzoic acid;
secondary amino compound		analgesic;
antipyretic;
antirheumatic drug;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
environmental contaminant;
non-steroidal anti-inflammatory drug;
xenobiotic
ly 355703[no description available]medium10
cyc 202[no description available]medium202,6-diaminopurinesantiviral drug;
EC 2.7.11.22 (cyclin-dependent kinase) inhibitor
tris(2-aminoethyl)amine[no description available]medium10tetramine
6-anilino-5,8-quinolinedione[no description available]medium30aminoquinoline;
aromatic amine;
p-quinones;
quinolone		antineoplastic agent;
EC 4.6.1.2 (guanylate cyclase) inhibitor
acadesine[no description available]medium101-ribosylimidazolecarboxamide;
aminoimidazole;
nucleoside analogue		antineoplastic agent;
platelet aggregation inhibitor
thromboplastin[no description available]medium30
nickel chloride[no description available]medium10nickel coordination entitycalcium channel blocker;
hapten
sulfuric acid[no description available]medium10sulfur oxoacidcatalyst
novobiocin[no description available]medium30carbamate ester;
ether;
hexoside;
hydroxycoumarin;
monocarboxylic acid amide;
monosaccharide derivative;
phenols		antibacterial agent;
antimicrobial agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
Escherichia coli metabolite;
hepatoprotective agent
ticarcillin[no description available]medium20penicillin allergen;
penicillin		antibacterial drug
4-nitrophenylphosphate[no description available]medium10aryl phosphatemouse metabolite
croconazole[no description available]medium10aromatic ether;
conazole antifungal drug;
imidazole antifungal drug;
monochlorobenzenes
acid phosphatase[no description available]medium70
hydroxide ion[no description available]medium20oxygen hydridemouse metabolite
beta-lapachone[no description available]medium10benzochromenone;
orthoquinones		anti-inflammatory agent;
antineoplastic agent;
plant metabolite
d-glucal[no description available]medium10
kmi-420[no description available]medium10
aee 788[no description available]medium106-{4-[(4-ethylpiperazin-1-yl)methyl]phenyl}-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amineangiogenesis inhibitor;
antineoplastic agent;
apoptosis inducer;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
epidermal growth factor receptor antagonist;
trypanocidal drug
phytosterols[no description available]medium70
3-tyr-octreotide[no description available]medium10
kanamycin a[no description available]medium20kanamycinsbacterial metabolite
dihydrorhodamine 123[no description available]medium30
telmisartan[no description available]medium30benzimidazoles;
biphenyls;
carboxybiphenyl		angiotensin receptor antagonist;
antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
environmental contaminant;
xenobiotic
iminodiacetic acid[no description available]medium10amino dicarboxylic acid;
glycine derivative;
non-proteinogenic alpha-amino acid		chelator
2-picoline[no description available]medium10methylpyridine
4-methylpyridine[no description available]medium10methylpyridine
cv 1808[no description available]medium60purine nucleoside
cadmium sulfide[no description available]medium10cadmium molecular entity
allylsilane[no description available]medium10
psb 36[no description available]medium10oxopurine
avapro[no description available]medium10azaspiro compound;
biphenylyltetrazole		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
thiodigalactoside[no description available]medium10
camphor, (+-)-isomer[no description available]medium20bornane monoterpenoid;
cyclic monoterpene ketone		plant metabolite
4-phenyl-1-(1h-1,2,4-triazol-1-yl)-2-butanone[no description available]medium10
lavendustin c6[no description available]medium10
lavendustin a[no description available]medium10aromatic amine
vardenafil dihydrochloride[no description available]medium21
5-ethynyl-2'-deoxyuridine[no description available]medium10
3-azido-7-hydroxycoumarin[no description available]medium20
oxandrolone[no description available]medium1117beta-hydroxy steroid;
3-oxo steroid;
anabolic androgenic steroid;
oxa-steroid		anabolic agent;
androgen
taribavirin[no description available]medium10nucleobase-containing molecular entity
6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde o-(3,4-dichlorobenzyl)oxime[no description available]medium10
24,25-dihydrolanosterol[no description available]medium103beta-sterol;
tetracyclic triterpenoid		human metabolite;
mouse metabolite
ebericol[no description available]medium2014alpha-methyl steroid;
3beta-sterol;
tetracyclic triterpenoid		fungal metabolite
boric acid[no description available]medium20boric acidsastringent
thioperamide[no description available]medium40primary aliphatic amine
tranylcypromine[no description available]medium202-phenylcyclopropan-1-amine
(2-phenylthiazol-4-yl)-(3,4,5-trimethoxyphenyl)methanone[no description available]medium10
oxamic acid[no description available]medium10dicarboxylic acid monoamideEscherichia coli metabolite
trehalose[no description available]medium10trehaloseEscherichia coli metabolite;
geroprotector;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
vatalanib[no description available]medium10monochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound		angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
thallium chloride[no description available]medium10inorganic chloride;
thallium molecular entity
guanazole[no description available]medium151aromatic amine;
triazoles		antineoplastic agent;
DNA synthesis inhibitor;
EC 1.17.4.1 (ribonucleoside-diphosphate reductase) inhibitor
2,3-oxidosqualene[no description available]medium10epoxide;
squalene triterpenoid
bathocuproine[no description available]medium10
riboflavin[no description available]medium50flavin;
vitamin B2		anti-inflammatory agent;
antioxidant;
cofactor;
Escherichia coli metabolite;
food colouring;
fundamental metabolite;
human urinary metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite
clofarabine[no description available]medium10adenosines;
organofluorine compound		antimetabolite;
antineoplastic agent
uftoral[no description available]medium10
cmpd 167[no description available]medium30
2,4,6-triisopropylbenzenesulfonyl chloride[no description available]medium20
sansalvamide a[no description available]medium10
1,3-diphenyl-1-triazene[no description available]medium10
bromates[no description available]medium10bromine oxoanion;
monovalent inorganic anion
sorbitol[no description available]medium10hexitol
neopterin[no description available]medium21
4-(2-aminoethyl)benzenesulfonylfluoride[no description available]medium10
trichlorfon[no description available]medium10organic phosphonate;
organochlorine compound;
phosphonic ester		agrochemical;
anthelminthic drug;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
insecticide
lubiprostone[no description available]medium20
1,2-dimethylimidazole[no description available]medium10imidazoles
1-methylcyclopropene[no description available]medium10cycloalkene;
cyclopropenes		agrochemical;
plant growth regulator
1-monooleoyl-rac-glycerol[no description available]medium101-acylglycerol 18:1;
monooleoylglycerol		plant metabolite
acyloin[no description available]medium10
gliotoxin[no description available]medium10dipeptide;
organic disulfide;
organic heterotetracyclic compound;
pyrazinoindole		antifungal agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
immunosuppressive agent;
mycotoxin;
proteasome inhibitor
benzothiophene[no description available]medium401-benzothiophenes;
benzothiophene
mrk 016[no description available]medium10
8-azaadenine[no description available]medium10aromatic amine;
nucleobase analogue;
triazolopyrimidines		EC 1.17.3.2 (xanthine oxidase) inhibitor;
Mycoplasma genitalium metabolite
propargylglycine[no description available]medium20
11-hydroxyprogesterone[no description available]medium10
daminozide[no description available]medium20straight-chain fatty acid
methoxysuccinyl-alanyl-alanyl-prolyl-valine chloromethyl ketone[no description available]medium10alpha-chloroketone;
methyl ester;
tripeptide		EC 3.4.21.37 (leukocyte elastase) inhibitor
ametryne[no description available]medium10diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide
sorbic acid[no description available]medium20alpha,beta-unsaturated monocarboxylic acid;
sorbic acid
2,4,3',5'-tetramethoxystilbene[no description available]medium10
amd 070[no description available]medium10aminoquinoline
insulin detemir[no description available]medium11
vecuronium bromide[no description available]medium10organic bromide salt;
quaternary ammonium salt		muscle relaxant;
neuromuscular agent;
nicotinic antagonist
pancuronium[no description available]medium10acetate ester;
steroid ester		cholinergic antagonist;
muscle relaxant;
nicotinic antagonist
atracurium[no description available]medium10diester;
quaternary ammonium ion		muscle relaxant;
nicotinic antagonist
tubocurarine[no description available]medium10bisbenzylisoquinoline alkaloiddrug allergen;
muscle relaxant;
nicotinic antagonist
hexamethonium[no description available]medium10quaternary ammonium salt
cisatracurium[no description available]medium10diester;
quaternary ammonium ion		muscle relaxant;
nicotinic antagonist
apigetrin[no description available]medium10beta-D-glucoside;
dihydroxyflavone;
glycosyloxyflavone;
monosaccharide derivative		antibacterial agent;
metabolite;
non-steroidal anti-inflammatory drug
lissamine rhodamine b[no description available]medium10
3,3'-diaminobenzidine[no description available]medium20biphenyls;
substituted aniline		histological dye
iopromide[no description available]medium10dicarboxylic acid diamide;
organoiodine compound		environmental contaminant;
nephrotoxic agent;
radioopaque medium;
xenobiotic
bz-423[no description available]medium30
fluorodifen[no description available]medium10aromatic ether
aflatoxicol[no description available]medium10
aflatoxin b1[no description available]medium20aflatoxin;
aromatic ether;
aromatic ketone		carcinogenic agent;
human metabolite
prometryne[no description available]medium10diamino-1,3,5-triazine;
methylthio-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
fluphenacur[no description available]medium10aromatic ether;
benzoylurea insecticide;
dichlorobenzene;
N-acylurea;
organofluorine compound
pinoxaden[no description available]medium10pivalate ester;
pyrazolooxadiazepine		agrochemical;
EC 6.4.1.2 (acetyl-CoA carboxylase) inhibitor;
environmental contaminant;
proherbicide;
xenobiotic
tert-butyl alcohol[no description available]medium20tertiary alcoholhuman xenobiotic metabolite
mrk-409[no description available]medium10
potassium carbonate[no description available]medium10carbonate salt;
potassium salt		catalyst;
fertilizer;
flame retardant
aminocandin[no description available]medium20aromatic ether;
echinocandin;
homodetic cyclic peptide		antiinfective agent
kitazine[no description available]medium10
1,1-diphenylethylene[no description available]medium10
p-methoxy-n-methylphenethylamine[no description available]medium70aromatic ether;
secondary amino compound		metabolite
glutaral[no description available]medium30dialdehydecross-linking reagent;
disinfectant;
fixative
povidone-iodine[no description available]medium10
uk-432097[no description available]medium10
pyrazolo(1,5-a)pyrimidine[no description available]medium20
vx680[no description available]medium20N-arylpiperazine
bn 50739[no description available]medium560
2-amino-4-phosphonobutyric acid[no description available]medium10
fenretinide[no description available]medium10monocarboxylic acid amide;
retinoid		antineoplastic agent;
antioxidant
lasofoxifene[no description available]medium10aromatic ether;
N-alkylpyrrolidine;
naphthols;
tetralins		antineoplastic agent;
bone density conservation agent;
cardioprotective agent;
estrogen receptor agonist;
estrogen receptor antagonist
ly 353381[no description available]medium10
4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)pyrazolo(1,5-a)pyrimidine[no description available]medium10
sn003[no description available]medium30
busulfan[no description available]medium20methanesulfonate esteralkylating agent;
antineoplastic agent;
carcinogenic agent;
insect sterilant;
teratogenic agent
cyazofamid[no description available]medium10imidazole fungicide;
imidazoles;
nitrile;
organochlorine compound;
sulfamides;
sulfonamide fungicide		antifungal agrochemical;
mitochondrial cytochrome-bc1 complex inhibitor
tachyplesin peptide, tachypleus tridentatus[no description available]medium10
cyanoacetic acid[no description available]medium20monocarboxylic acid
ee 581[no description available]medium10
4-phenylenediamine[no description available]medium10phenylenediamineallergen;
dye;
hapten;
reagent
2-chloroadenosine[no description available]medium100purine nucleoside
perchlorate[no description available]medium10chlorine oxoanion;
monovalent inorganic anion
carfentanil[no description available]medium11methyl ester;
piperidines;
tertiary amino compound;
tertiary carboxamide		mu-opioid receptor agonist;
opioid analgesic;
tranquilizing drug
metazachlor[no description available]medium10aromatic amide;
organochlorine compound;
pyrazoles		environmental contaminant;
herbicide;
xenobiotic
diacetyl[no description available]medium10alpha-diketoneEscherichia coli metabolite;
Saccharomyces cerevisiae metabolite
homocysteine[no description available]medium41amino acid zwitterion;
homocysteine;
serine family amino acid		fundamental metabolite;
mouse metabolite
3,6-dioxa-1,8-octanedithiol[no description available]medium10
3-mercaptopropionic acid[no description available]medium10mercaptopropanoic acidalgal metabolite
4,5-diaminofluorescein diacetate[no description available]medium10
4-nitrophenyl acetate[no description available]medium10C-nitro compound;
phenyl acetates
proadifen[no description available]medium170diarylmethane
methylmalonic acid[no description available]medium10C4-dicarboxylic acidhuman metabolite
spliceostatin a[no description available]medium10
phlorhizin[no description available]medium10aryl beta-D-glucoside;
dihydrochalcones;
monosaccharide derivative		antioxidant;
plant metabolite
lysergic acid diethylamide[no description available]medium30ergoline alkaloid;
monocarboxylic acid amide;
organic heterotetracyclic compound		dopamine agonist;
hallucinogen;
serotonergic agonist
linoleic acid[no description available]medium40octadecadienoic acid;
omega-6 fatty acid		algal metabolite;
Daphnia galeata metabolite;
plant metabolite
suberoyl bis-hydroxamic acid[no description available]medium10hydroxamic acid
ethoxyacetic acid[no description available]medium10carboxylic acid
methoxyacetic acid[no description available]medium10ether;
monocarboxylic acid		antineoplastic agent;
apoptosis inducer;
human xenobiotic metabolite;
mutagen
phenoxyacetic acid[no description available]medium20aromatic ether;
monocarboxylic acid		allergen;
Aspergillus metabolite;
human xenobiotic metabolite;
plant growth retardant
amoxapine[no description available]medium10dibenzooxazepineadrenergic uptake inhibitor;
antidepressant;
dopaminergic antagonist;
geroprotector;
serotonin uptake inhibitor
withaferin a[no description available]medium1027-hydroxy steroid;
4-hydroxy steroid;
delta-lactone;
enone;
epoxy steroid;
ergostanoid;
primary alcohol;
secondary alcohol;
withanolide		antineoplastic agent;
apoptosis inducer
withanolides[no description available]medium10
histidinoalanine[no description available]medium10dipeptide zwitterion;
dipeptide		metabolite
cucurbit(8)uril[no description available]medium10
procainamide[no description available]medium10benzamidesanti-arrhythmia drug;
platelet aggregation inhibitor;
sodium channel blocker
tris(pyrazolyl)borate[no description available]medium10
zinc chloride[no description available]medium30inorganic chloride;
zinc molecular entity		astringent;
disinfectant;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
Lewis acid
sulfaphenazole[no description available]medium40primary amino compound;
pyrazoles;
substituted aniline;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
EC 1.14.13.181 (13-deoxydaunorubicin hydroxylase) inhibitor;
EC 1.14.13.67 (quinine 3-monooxygenase) inhibitor;
P450 inhibitor
precocene i[no description available]medium10aromatic ether;
chromenes		plant metabolite;
precocenes
strigol[no description available]medium10indenofuran;
secondary alcohol;
strigolactone
ocinaplon[no description available]medium10
sulfadoxine[no description available]medium20pyrimidines;
sulfonamide		antibacterial drug;
antimalarial
germanium[no description available]medium10carbon group element atom;
metalloid atom;
nonmetal atom
corrole[no description available]medium10
rutecarpine[no description available]medium10beta-carbolines
ceric ammonium nitrate[no description available]medium10
metamitron[no description available]medium101,2,4-triazinesenvironmental contaminant;
herbicide;
xenobiotic
ethidium homodimer[no description available]medium10
sybr green i[no description available]medium10benzothiazolium ion;
cyanine dye;
quinolines;
tertiary amine		fluorescent dye
calcium sulfate[no description available]medium10calcium salt;
inorganic calcium salt
8-(3-chlorostyryl)caffeine[no description available]medium80monochlorobenzenes;
trimethylxanthine		adenosine A2A receptor antagonist;
EC 1.4.3.4 (monoamine oxidase) inhibitor
permethrin[no description available]medium20cyclopropanecarboxylate ester;
cyclopropanes		agrochemical;
ectoparasiticide;
pyrethroid ester acaricide;
pyrethroid ester insecticide;
scabicide
raclopride[no description available]medium50salicylamides
8-hydroxyguanine[no description available]medium10oxopurine
lornoxicam[no description available]medium20heteroaryl hydroxy compound;
monocarboxylic acid amide;
organochlorine compound;
pyridines;
thienothiazine		antipyretic;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
pimonidazole[no description available]medium10
androsterone[no description available]medium1017-oxo steroid;
3alpha-hydroxy steroid;
androstanoid;
C19-steroid		androgen;
anticonvulsant;
human blood serum metabolite;
human metabolite;
human urinary metabolite;
mouse metabolite;
pheromone
8-(4-((2-aminoethyl)aminocarbonylmethyloxy)phenyl)-1,3-dipropylxanthine[no description available]medium30
bromhexine[no description available]medium10organobromine compound;
substituted aniline;
tertiary amino compound		mucolytic
furamidine[no description available]medium10
quinalphos[no description available]medium20organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
dendrodoine[no description available]medium10
1,4-benzodioxan[no description available]medium10
oxacillin[no description available]medium10penicillinantibacterial agent;
antibacterial drug
sulfalene[no description available]medium10pyrazines;
sulfonamide antibiotic;
sulfonamide
chelerythrine[no description available]medium40benzophenanthridine alkaloid;
organic cation		antibacterial agent;
antineoplastic agent;
EC 2.7.11.13 (protein kinase C) inhibitor
bisindolylmaleimide i[no description available]medium80
cariporide[no description available]medium10
emedastine[no description available]medium10benzimidazolesanti-allergic agent;
antipruritic drug;
H1-receptor antagonist
cupric acetate[no description available]medium20
formylmethionyl-leucyl-phenylalanine methyl ester[no description available]medium10peptide
ochratoxin a[no description available]medium20isochromanes;
monocarboxylic acid amide;
N-acyl-L-phenylalanine;
organochlorine compound;
phenylalanine derivative		Aspergillus metabolite;
calcium channel blocker;
carcinogenic agent;
mycotoxin;
nephrotoxin;
Penicillium metabolite;
teratogenic agent
pentaerythritol[no description available]medium30primary alcohol;
tetrol		flame retardant;
laxative
parecoxib[no description available]medium10isoxazoles;
N-sulfonylcarboxamide		cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
bromazepam[no description available]medium10organic molecular entity
fendiline[no description available]medium10diarylmethane
oxfendazole[no description available]medium10benzimidazoles;
carbamate ester;
sulfoxide		antinematodal drug
chlorprothixene[no description available]medium20chlorprothixene
pamaquine[no description available]medium10aminoquinoline
ht-2 toxin[no description available]medium10
t-2 toxin[no description available]medium10
4-nitrophenyl butyrate[no description available]medium10butyrate ester;
C-nitro compound
dimedone[no description available]medium10
strombine[no description available]medium10
cupric chloride[no description available]medium20copper molecular entity;
inorganic chloride		EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor
2-butynedioic acid[no description available]medium10acetylenic compound;
C4-dicarboxylic acid
aminoethylphosphonic acid[no description available]medium10phosphonic acids;
primary amino compound;
zwitterion		human metabolite;
metabolite;
mouse metabolite
triphenylene[no description available]medium10ortho-fused polycyclic arene
phenylacetic acid[no description available]medium20benzenes;
monocarboxylic acid;
phenylacetic acids		allergen;
Aspergillus metabolite;
auxin;
EC 6.4.1.1 (pyruvate carboxylase) inhibitor;
Escherichia coli metabolite;
human metabolite;
plant growth retardant;
plant metabolite;
Saccharomyces cerevisiae metabolite;
toxin
hypoxanthine[no description available]medium50nucleobase analogue;
oxopurine;
purine nucleobase		fundamental metabolite
4-hydroxybenzoic acid[no description available]medium10monohydroxybenzoic acidalgal metabolite;
plant metabolite
histidylproline[no description available]medium10dipeptide zwitterion;
dipeptide		metabolite
angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-[no description available]medium10organic molecular entity
n-(3-chlorophenyl)picolinamide[no description available]medium10
n,n',n''-triacetylfusarinine c[no description available]medium10iron coordination entity;
organonitrogen compound
9-(2-hydroxy-3-nonyl)adenine[no description available]medium50
uk 453,061[no description available]medium11aromatic ether
coumarin 153[no description available]medium107-aminocoumarinsfluorochrome
hydrogen cyanide[no description available]medium10hydracid;
one-carbon compound		Escherichia coli metabolite;
human metabolite;
poison
perhexiline[no description available]medium10piperidinescardiovascular drug
nsc 600032[no description available]medium20
donepezil[no description available]medium20aromatic ether;
indanones;
piperidines;
racemate		EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.1.1.8 (cholinesterase) inhibitor;
nootropic agent
limestone[no description available]medium20calcium salt;
carbonate salt;
inorganic calcium salt;
one-carbon compound		antacid;
fertilizer;
food colouring;
food firming agent
androstan-3-ol[no description available]medium103-hydroxy steroidandrogen
1-hexanol[no description available]medium10hexanol;
primary alcohol		alarm pheromone;
antibacterial agent;
fragrance;
plant metabolite
veratryl alcohol[no description available]medium20benzyl alcohols;
dimethoxybenzene;
primary alcohol		fungal metabolite
peptones[no description available]medium20
fh535[no description available]medium10sulfonamide
sodium tungstate(vi)[no description available]medium20inorganic sodium saltreagent
4,4'-dimethoxytrityl cation[no description available]medium10
acyline[no description available]medium21
xantphos[no description available]medium10
ah 23848[no description available]medium10(4Z)-7-{5-[([1,1'-biphenyl]-4-yl)methoxy]-2-(morpholin-4-yl)-3-oxocyclopentyl}hept-4-enoic acid
16,16-dimethylprostaglandin e2[no description available]medium10cyclopentanones;
monocarboxylic acid;
prostanoid;
secondary allylic alcohol		anti-ulcer drug;
gastrointestinal drug;
radiation protective agent
peptide t1249[no description available]medium10
7-amino-4-methylcoumarin[no description available]medium207-aminocoumarinsfluorochrome
h-d-phe-pip-arg-pna[no description available]medium10
bisbenzimidazole[no description available]medium10bibenzimidazole;
N-methylpiperazine		anthelminthic drug;
fluorochrome
temazepam[no description available]medium32benzodiazepine
hydroxypropyl-gamma-cyclodextrin[no description available]medium30
clavulanic acid[no description available]medium30oxapenamantibacterial drug;
anxiolytic drug;
bacterial metabolite;
EC 3.5.2.6 (beta-lactamase) inhibitor
raptors[no description available]medium10ether;
imidazolines;
imidazolone;
pyridinemonocarboxylic acid
aminolevulinic acid[no description available]medium404-oxo monocarboxylic acid;
amino acid zwitterion;
delta-amino acid		antineoplastic agent;
dermatologic drug;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
photosensitizing agent;
plant metabolite;
prodrug;
Saccharomyces cerevisiae metabolite
ambroxol[no description available]medium10aromatic amine
dihydroergotamine[no description available]medium60ergot alkaloid;
semisynthetic derivative		dopamine agonist;
non-narcotic analgesic;
serotonergic agonist;
sympatholytic agent;
vasoconstrictor agent
dicyclohexylamine[no description available]medium20primary aliphatic amine
hexanitrostilbene[no description available]medium10
n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime[no description available]medium10
l 744832[no description available]medium10benzenes;
ether;
isopropyl ester;
secondary carboxamide;
sulfone;
thiol		antineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor;
geroprotector
guanosine diphosphate mannose[no description available]medium10GDP-D-mannoseEscherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite
o-iodoxybenzoic acid[no description available]medium10benziodoxoleEC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
oxidising agent
1,4-dioxane[no description available]medium30dioxane;
volatile organic compound		carcinogenic agent;
metabolite;
NMR chemical shift reference compound;
non-polar solvent
ammonium acetate[no description available]medium10acetate salt;
ammonium salt		buffer;
food acidity regulator
o-bromobenzamide[no description available]medium10
potassium thiocyanate[no description available]medium20potassium salt
dibenzothiophene[no description available]medium10dibenzothiophenes;
mancude organic heterotricyclic parent		keratolytic drug
thiamine[no description available]medium60primary alcohol;
vitamin B1		Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
coenzyme q10[no description available]medium30ubiquinonesantioxidant;
ferroptosis inhibitor;
human metabolite
didecyldimethylammonium[no description available]medium10quaternary ammonium salt
2-iodophenol[no description available]medium102-halophenol;
iodophenol
formestane[no description available]medium38617-oxo steroid;
3-oxo-Delta(4) steroid;
enol;
hydroxy steroid		antineoplastic agent;
EC 1.14.14.14 (aromatase) inhibitor
diacetyldichlorofluorescein[no description available]medium10
tert-butylhydroperoxide[no description available]medium10alkyl hydroperoxideantibacterial agent;
oxidising agent
2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein[no description available]medium10
wortmannin[no description available]medium30acetate ester;
cyclic ketone;
delta-lactone;
organic heteropentacyclic compound		anticoronaviral agent;
antineoplastic agent;
autophagy inhibitor;
EC 2.7.1.137 (phosphatidylinositol 3-kinase) inhibitor;
geroprotector;
Penicillium metabolite;
radiosensitizing agent
1,1'-binaphthyl[no description available]medium10
ajoene[no description available]medium10sulfoxide
2-pentenenitrile[no description available]medium10
hepes[no description available]medium20HEPES;
organosulfonic acid
mancozeb[no description available]medium10
1,4-butanediol[no description available]medium10butanediol;
glycol		neurotoxin;
prodrug;
protic solvent
benzoyltyrosine ethyl ester[no description available]medium10benzamides;
ethyl ester;
L-tyrosine derivative;
phenols		chromogenic compound
ipragliflozin[no description available]medium11glycoside
cesium[no description available]medium50alkali metal atom
1-naphthol[no description available]medium10naphtholgenotoxin;
human xenobiotic metabolite
salvianolic acid B[no description available]medium101-benzofurans;
catechols;
dicarboxylic acid;
enoate ester;
polyphenol		anti-inflammatory agent;
antidepressant;
antineoplastic agent;
antioxidant;
apoptosis inducer;
autophagy inhibitor;
cardioprotective agent;
hepatoprotective agent;
hypoglycemic agent;
neuroprotective agent;
osteogenesis regulator;
plant metabolite
technetium tc 99m exametazime[no description available]medium10
ancymidol[no description available]medium40pyrimidines;
tertiary alcohol		cellulose synthesis inhibitor;
gibberellin biosynthesis inhibitor;
plant growth retardant
1,4-diazepane[no description available]medium10
bakuchiol[no description available]medium10
cesium carbonate[no description available]medium10
sr 1078[no description available]medium10
oxadixyl[no description available]medium10anilide fungicide;
aromatic amide;
carbohydrazide;
ether;
oxazolidinone		agrochemical
azathioprine[no description available]medium30aryl sulfide;
C-nitro compound;
imidazoles;
thiopurine		antimetabolite;
antineoplastic agent;
carcinogenic agent;
DNA synthesis inhibitor;
hepatotoxic agent;
immunosuppressive agent;
prodrug
diapep 277[no description available]medium10
propamidine isethionate[no description available]medium10guanidinium salt;
organosulfonate salt		antimicrobial agent;
antiseptic drug
loxtidine[no description available]medium460aromatic ether;
piperidines;
primary alcohol;
triazoles		H2-receptor antagonist
chlorophyll b[no description available]medium20chlorophyllcofactor
homoserine[no description available]medium10amino acid zwitterion;
homoserine		algal metabolite;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
gadolinium dtpa[no description available]medium20gadolinium coordination entityMRI contrast agent
tipifarnib[no description available]medium31imidazoles;
monochlorobenzenes;
primary amino compound;
quinolone		antineoplastic agent;
apoptosis inducer;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
chromated copper arsenate[no description available]medium10
diacerein[no description available]medium10anthraquinone
tolterodine tartrate[no description available]medium10tartrate salt
tamsulosin[no description available]medium105-(2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl)-2-methoxybenzenesulfonamidealpha-adrenergic antagonist;
antineoplastic agent
phenylpropanolamine[no description available]medium10amphetamines;
phenethylamine alkaloid		plant metabolite
cloxacillin[no description available]medium20penicillin allergen;
penicillin;
semisynthetic derivative		antibacterial agent;
antibacterial drug
cinacalcet[no description available]medium10(trifluoromethyl)benzenes;
naphthalenes;
secondary amino compound		calcimimetic;
P450 inhibitor
xanthosine 5'-triphosphate[no description available]medium10purine ribonucleoside 5'-monophosphate;
xanthosine 5'-phosphate		Escherichia coli metabolite;
metabolite;
mouse metabolite
xanthine[no description available]medium20xanthineSaccharomyces cerevisiae metabolite
1-naphthaleneacetic acid[no description available]medium10naphthylacetic acidsynthetic auxin
castasterone[no description available]medium1022-hydroxy steroid;
23-hydroxy steroid;
2alpha-hydroxy steroid;
3alpha-hydroxy steroid;
6-oxo steroid;
brassinosteroid		plant growth stimulator
isoproterenol[no description available]medium220catechols;
secondary alcohol;
secondary amino compound		beta-adrenergic agonist;
bronchodilator agent;
cardiotonic drug;
sympathomimetic agent
denopamine[no description available]medium10dimethoxybenzene
methanesulfonic acid[no description available]medium20alkanesulfonic acid;
one-carbon compound		Escherichia coli metabolite
neuropeptide y[no description available]medium40
bibp 3226[no description available]medium10
peptide yy[no description available]medium10
trypan blue[no description available]medium10
rimantadine[no description available]medium10alkylamine
1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole[no description available]medium10benzoic acid;
imidazolines;
organic radical		apoptosis inhibitor;
radical scavenger
2-aminoindan-2-phosphonic acid[no description available]medium10
2-phenylbenzothiazole[no description available]medium10
4-(n-methyl-n-nitrosamino)-1-(3-pyridyl)-1-butanone[no description available]medium10nitrosamine;
pyridines
isoprocarb[no description available]medium10carbamate esteragrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
hexafluoron[no description available]medium10aromatic ether;
benzoylurea insecticide;
dichlorobenzene;
N-acylurea;
organochlorine insecticide;
organofluorine insecticide
terbutylazine[no description available]medium20chloro-1,3,5-triazine;
diamino-1,3,5-triazine		environmental contaminant;
herbicide;
xenobiotic
pendimethalin[no description available]medium20C-nitro compound;
secondary amino compound;
substituted aniline		agrochemical;
environmental contaminant;
herbicide
orotic acid[no description available]medium20pyrimidinemonocarboxylic acidEscherichia coli metabolite;
metabolite;
mouse metabolite
clinafloxacin[no description available]medium10quinolines
cyclohexene[no description available]medium20cycloalkene
bretazenil[no description available]medium50
propamidine[no description available]medium20aromatic ether;
guanidines;
polyether		antimicrobial agent;
antiseptic drug
cilostazol[no description available]medium20lactam;
tetrazoles		anticoagulant;
bronchodilator agent;
EC 3.1.4.17 (3',5'-cyclic-nucleotide phosphodiesterase) inhibitor;
fibrin modulating drug;
neuroprotective agent;
platelet aggregation inhibitor;
vasodilator agent
promegestone[no description available]medium1020-oxo steroid;
3-oxo-Delta(4) steroid		antineoplastic agent;
progesterone receptor agonist;
progestin
telapristone acetate[no description available]medium10steroid ester
mangiferin[no description available]medium10C-glycosyl compound;
xanthones		anti-inflammatory agent;
antioxidant;
hypoglycemic agent;
plant metabolite
clobetasol[no description available]medium1011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(1),Delta(4)-steroid;
chlorinated steroid;
fluorinated steroid;
glucocorticoid;
tertiary alpha-hydroxy ketone		anti-inflammatory drug;
SMO receptor agonist
4,5-dicyanoimidazole[no description available]medium10
tolcapone[no description available]medium102-nitrophenols;
benzophenones;
catechols		antiparkinson drug;
EC 2.1.1.6 (catechol O-methyltransferase) inhibitor
piroximone[no description available]medium10
ns 11394[no description available]medium20
alx-0600[no description available]medium10polypeptideantioxidant;
glucagon-like peptide-2 receptor agonist;
metabolite;
protective agent
3-methyladenine[no description available]medium10
adefovir dipivoxil[no description available]medium206-aminopurines;
carbonate ester;
ether;
organic phosphonate		antiviral drug;
DNA synthesis inhibitor;
HIV-1 reverse transcriptase inhibitor;
nephrotoxic agent;
prodrug
flecainide[no description available]medium10aromatic ether;
monocarboxylic acid amide;
organofluorine compound;
piperidines		anti-arrhythmia drug
clofilium[no description available]medium10benzenes;
organic amino compound
2-chloro-n(6)-(3-iodobenzyl)adenosine-5'-n-methyluronamide[no description available]medium61
(3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid[no description available]medium10(6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
desogestrel[no description available]medium2217beta-hydroxy steroid;
terminal acetylenic compound		contraceptive drug;
progestin;
synthetic oral contraceptive
eleutherin[no description available]medium10benzoisochromanequinone;
p-quinones
isoeleutherin[no description available]medium10
antalarmin[no description available]medium20pyrrolopyrimidine;
tertiary amino compound		corticotropin-releasing factor receptor antagonist
perindopril[no description available]medium10alpha-amino acid ester;
dicarboxylic acid monoester;
ethyl ester;
organic heterobicyclic compound		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor
thioacetanilide[no description available]medium10
idph-791[no description available]medium40
fexinidazole[no description available]medium10
nickel monoxide[no description available]medium10
5-thio-d-glucose[no description available]medium10
n-acetylglucopyranosylamine[no description available]medium10
t 0070907[no description available]medium10carbonyl compound;
organohalogen compound
cyclopropane[no description available]medium10cycloalkane;
cyclopropanes		inhalation anaesthetic
alpha-cyclodextrin[no description available]medium10cyclodextrin
melamine[no description available]medium10triamino-1,3,5-triazinexenobiotic metabolite
dichlorophen[no description available]medium10bridged diphenyl fungicide;
diarylmethane
clorophene[no description available]medium10
hippuric acid[no description available]medium10N-acylglycinehuman blood serum metabolite;
uremic toxin
4-cymene[no description available]medium10monoterpene;
toluenes		human urinary metabolite;
plant metabolite;
volatile oil component
triethanolamine[no description available]medium10amino alcohol;
tertiary amino compound;
triol		buffer;
surfactant
heroin[no description available]medium10morphinane alkaloidmu-opioid receptor agonist;
opioid analgesic;
prodrug
4-chlorobiphenyl[no description available]medium10monochlorobiphenyl
17-octadecynoic acid[no description available]medium20acetylenic fatty acid;
long-chain fatty acid;
monounsaturated fatty acid;
terminal acetylenic compound		EC 1.14.14.94 (leukotriene-B4 20-monooxygenase) inhibitor;
EC 1.14.15.3 (alkane 1-monooxygenase) inhibitor;
P450 inhibitor
shogaol[no description available]medium10enone;
monomethoxybenzene;
phenols
vinyl chloride[no description available]medium10chloroethenes;
gas molecular entity;
monohaloethene		carcinogenic agent
decaprenoic acid[no description available]medium10monoterpenoid
troleandomycin[no description available]medium20acetate ester;
epoxide;
macrolide antibiotic;
monosaccharide derivative;
polyketide;
semisynthetic derivative		EC 1.14.13.97 (taurochenodeoxycholate 6alpha-hydroxylase) inhibitor;
xenobiotic
ellipticine[no description available]medium10indole alkaloid;
organic heterotetracyclic compound;
organonitrogen heterocyclic compound;
polycyclic heteroarene		antineoplastic agent;
plant metabolite
2,3,7,8-tetrabromodibenzo-4-dioxin[no description available]medium10dibenzodioxine;
organobromine compound
zinc sulfate[no description available]medium10metal sulfate;
zinc molecular entity		fertilizer
hecogenin[no description available]medium10triterpenoid
sapogenins[no description available]medium10
3-nitrotyrosine[no description available]medium212-nitrophenols;
C-nitro compound;
nitrotyrosine;
non-proteinogenic alpha-amino acid
vinyl ether[no description available]medium10ether
psn 632408[no description available]medium10
tyloxapol[no description available]medium10
cobalt phthalocyanine[no description available]medium10
ergotamine[no description available]medium93peptide ergot alkaloidalpha-adrenergic agonist;
mycotoxin;
non-narcotic analgesic;
oxytocic;
serotonergic agonist;
vasoconstrictor agent
ketotifen[no description available]medium90cyclic ketone;
olefinic compound;
organic heterotricyclic compound;
organosulfur heterocyclic compound;
piperidines;
tertiary amino compound		anti-asthmatic drug;
H1-receptor antagonist
1-methyl-3-isobutylxanthine[no description available]medium903-isobutyl-1-methylxanthine
4-chloroindole-3-acetic acid[no description available]medium10chloroindole-3-acetic acidauxin
astemizole[no description available]medium20benzimidazoles;
piperidines		anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
cisapride[no description available]medium10benzamides
r 59949[no description available]medium10diarylmethane
farnesol[no description available]medium40farnesolplant metabolite
r 59022[no description available]medium20diarylmethane
sc-10[no description available]medium10naphthalenes;
sulfonic acid derivative
contrast agent p792[no description available]medium20
zm 189154[no description available]medium20
antarelix[no description available]medium10
quinolinic acid[no description available]medium90pyridinedicarboxylic acidEscherichia coli metabolite;
human metabolite;
mouse metabolite;
NMDA receptor agonist
neticonazole[no description available]medium10aromatic ether;
benzenes;
conazole antifungal drug;
enamine;
imidazole antifungal drug;
imidazoles;
methyl sulfide		antifungal drug;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
bromocriptine[no description available]medium30indole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist
pregnanolone[no description available]medium503-hydroxy-5beta-pregnan-20-one;
3alpha-hydroxy steroid		human metabolite;
intravenous anaesthetic;
sedative
sodium sulfide[no description available]medium10
l 663536[no description available]medium100aryl sulfide;
indoles;
monocarboxylic acid;
monochlorobenzenes		antineoplastic agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
leukotriene antagonist
r-106[no description available]medium10
l 368899[no description available]medium10
2,2-dichloroacetamide[no description available]medium10
mannose-6-phosphate[no description available]medium10D-mannopyranose 6-phosphate
aa 861[no description available]medium401,4-benzoquinones;
acetylenic compound;
primary alcohol		EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor
doxazosin[no description available]medium11aromatic amine;
benzodioxine;
monocarboxylic acid amide;
N-acylpiperazine;
N-arylpiperazine;
quinazolines		alpha-adrenergic antagonist;
antihyperplasia drug;
antihypertensive agent;
antineoplastic agent;
vasodilator agent
mesotrione[no description available]medium10aromatic ketone;
beta-triketone;
C-nitro compound;
sulfone		carotenoid biosynthesis inhibitor;
EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor;
environmental contaminant;
herbicide;
xenobiotic
strontium[no description available]medium10alkaline earth metal atom
barium[no description available]medium40alkaline earth metal atom;
elemental barium
2-aminoethoxydiphenyl borate[no description available]medium40organoboron compound;
primary amino compound		calcium channel blocker;
IP3 receptor antagonist;
potassium channel opener
rmi 12330a[no description available]medium30
pirarubicin[no description available]medium10anthracycline
tak 187[no description available]medium60
2-methylthio-atp[no description available]medium10
adp beta s[no description available]medium30
sertindole[no description available]medium10heteroarylpiperidine;
imidazolidinone;
organochlorine compound;
organofluorine compound;
phenylindole		alpha-adrenergic antagonist;
H1-receptor antagonist;
second generation antipsychotic;
serotonergic antagonist
putrescine[no description available]medium20alkane-alpha,omega-diamineantioxidant;
fundamental metabolite
enprofylline[no description available]medium50oxopurineanti-arrhythmia drug;
anti-asthmatic drug;
bronchodilator agent;
non-steroidal anti-inflammatory drug
atl 146e[no description available]medium60
diethyl maleate[no description available]medium10ethyl ester;
maleate ester		glutathione depleting agent
bq 123[no description available]medium10cyclic peptide
lactacystin[no description available]medium10lactam;
S-substituted L-cysteine
bay 41-4109[no description available]medium10
phenmedipham[no description available]medium10carbamate esterenvironmental contaminant;
herbicide;
xenobiotic
1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole[no description available]medium50ether;
imidazoles;
monomethoxybenzene		TRP channel blocker
refludan[no description available]medium10
hirudin[no description available]medium20
mulundocandin[no description available]medium10
urethane[no description available]medium40carbamate esterfungal metabolite;
mutagen
desferrithiocin[no description available]medium20
nebularine[no description available]medium10purine ribonucleoside;
purines D-ribonucleoside		fungal metabolite
dihydroergocristine[no description available]medium10ergot alkaloidadrenergic antagonist;
vasodilator agent
thapsigargin[no description available]medium140butyrate ester;
organic heterotricyclic compound;
sesquiterpene lactone		calcium channel blocker;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor
mecamylamine[no description available]medium10primary aliphatic amine
etiocholanolone[no description available]medium2017-oxo steroid;
3alpha-hydroxy steroid;
androstanoid		human metabolite;
mouse metabolite
androstane-3,17-dione, (5alpha)-isomer[no description available]medium203-oxo-5alpha-steroid;
androstane-3,17-dione		mouse metabolite
furafylline[no description available]medium10oxopurine
em 800[no description available]medium10
phentin acetate[no description available]medium20acetate ester;
organotin compound		antifungal agrochemical
tetramethrin[no description available]medium10cyclopropanecarboxylate ester;
maleimides;
phthalimide insecticide		pyrethroid ester insecticide
phenylpiperazine[no description available]medium10
cgs 24012[no description available]medium50
1-chloronaphthalene[no description available]medium10
2-chloronaphthalene[no description available]medium10
phenanthrene[no description available]medium50ortho-fused polycyclic arene;
ortho-fused tricyclic hydrocarbon;
phenanthrenes		environmental contaminant;
mouse metabolite
8-epi-prostaglandin f2alpha[no description available]medium10F2-isoprostanebiomarker;
bronchoconstrictor agent;
vasoconstrictor agent
epidepride[no description available]medium10dimethoxybenzene
4-(3-butoxy-4-methoxybenzyl)-2-imidazolidinone[no description available]medium50methoxybenzenes
s-trans,trans-farnesylthiosalicylic acid[no description available]medium10sesquiterpenoid
cortodoxone[no description available]medium31deoxycortisol;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		human metabolite;
mouse metabolite
oxotremorine[no description available]medium30N-alkylpyrrolidine
n-(2,6-difluorophenyl)-5-methyl(1,2,4)-triazol(1,5-a)pyrimidine-2-sulfonamide[no description available]medium10sulfonamide
n-(1-methyl-2-phenylethyl)adenosine[no description available]medium60
n(6)-cyclohexyladenosine[no description available]medium110
megestrol[no description available]medium6317alpha-hydroxy steroid;
20-oxo steroid;
3-oxo-Delta(4) steroid;
tertiary alpha-hydroxy ketone		antineoplastic agent;
appetite enhancer;
contraceptive drug;
progestin;
synthetic oral contraceptive
anisyl alcohol[no description available]medium10benzyl alcohols
phenolsulfonphthalein[no description available]medium202,1-benzoxathiole;
arenesulfonate ester;
phenols;
sultone		acid-base indicator;
diagnostic agent;
two-colour indicator
3-hydroxyanthranilic acid[no description available]medium10aminobenzoic acid;
monohydroxybenzoic acid		human metabolite;
mouse metabolite
jjc 323[no description available]medium20
phenylthiourea[no description available]medium10thioureasEC 1.14.18.1 (tyrosinase) inhibitor
lonidamine[no description available]medium10dichlorobenzene;
indazoles;
monocarboxylic acid		antineoplastic agent;
antispermatogenic agent;
EC 2.7.1.1 (hexokinase) inhibitor;
geroprotector
mrs 1523[no description available]medium30
moclobemide[no description available]medium41benzamides;
monochlorobenzenes;
morpholines		antidepressant;
environmental contaminant;
xenobiotic
diethylstilbestrol[no description available]medium40olefinic compound;
polyphenol		antifungal agent;
antineoplastic agent;
autophagy inducer;
calcium channel blocker;
carcinogenic agent;
EC 1.1.1.146 (11beta-hydroxysteroid dehydrogenase) inhibitor;
EC 3.6.3.10 (H(+)/K(+)-exchanging ATPase) inhibitor;
endocrine disruptor;
xenoestrogen
stilbamidine[no description available]medium10
1,4-cyclohexanediol[no description available]medium10
bromoacetate[no description available]medium10carboxylic acid;
organohalogen compound
arsphenamine[no description available]medium10
fluoroacetic acid[no description available]medium10haloacetic acid;
organofluorine compound		EC 4.2.1.3 (aconitate hydratase) inhibitor
resorcinol[no description available]medium10benzenediol;
phenolic donor;
resorcinols		erythropoietin inhibitor;
sensitiser
potassium cyanide[no description available]medium20cyanide salt;
one-carbon compound;
potassium salt		EC 1.15.1.1 (superoxide dismutase) inhibitor;
EC 1.9.3.1 (cytochrome c oxidase) inhibitor;
neurotoxin
vitamin k semiquinone radical[no description available]medium70
diphenylmethane[no description available]medium10diarylmethane
methenamine[no description available]medium10polyazaalkane;
polycyclic cage;
tetramine		antibacterial drug
tert-butylbicyclophosphorothionate[no description available]medium70organic thiophosphate
tungsten[no description available]medium10chromium group element atommicronutrient
sulfamethazine[no description available]medium10pyrimidines;
sulfonamide antibiotic;
sulfonamide		antibacterial drug;
antiinfective agent;
antimicrobial agent;
carcinogenic agent;
drug allergen;
EC 2.5.1.15 (dihydropteroate synthase) inhibitor;
environmental contaminant;
ligand;
xenobiotic
salicylanilide[no description available]medium10benzanilide fungicide;
salicylamides;
salicylanilides
thiethylperazine[no description available]medium10N-methylpiperazine;
phenothiazines		antiemetic;
dopaminergic antagonist;
histamine antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
hydroxyzine[no description available]medium30hydroxyether;
monochlorobenzenes;
N-alkylpiperazine		anticoronaviral agent;
antipruritic drug;
anxiolytic drug;
dermatologic drug;
H1-receptor antagonist
perphenazine[no description available]medium10N-(2-hydroxyethyl)piperazine;
N-alkylpiperazine;
organochlorine compound;
phenothiazines		antiemetic;
dopaminergic antagonist;
phenothiazine antipsychotic drug
hydroxystilbamidine[no description available]medium10
methylthiouracil[no description available]medium40pyrimidone
ethionine[no description available]medium30S-ethylhomocysteineantimetabolite;
carcinogenic agent
furaldehyde[no description available]medium10aldehyde;
furans		Maillard reaction product;
metabolite
5-nitro-2-furaldehyde[no description available]medium10C-nitro compound;
furans
indophenol[no description available]medium40quinone iminedye
pyridoxal[no description available]medium20hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
pyridinecarbaldehyde;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
levulinic acid[no description available]medium10oxopentanoic acid;
straight-chain saturated fatty acid		plant metabolite
phenylhydrazine[no description available]medium30phenylhydrazinesxenobiotic
quinacrine[no description available]medium90acridines;
aromatic ether;
organochlorine compound;
tertiary amino compound		antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
hydrobromic acid[no description available]medium10gas molecular entity;
hydrogen halide;
mononuclear parent hydride		mouse metabolite
ethylamine[no description available]medium10primary aliphatic aminehuman metabolite
allylisopropylacetamide[no description available]medium60
apronalide[no description available]medium10N-acylurea
quinapril[no description available]medium11dicarboxylic acid monoester;
ethyl ester;
isoquinolines;
tertiary carboxamide		antihypertensive agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
prodrug
iloprost[no description available]medium50carbobicyclic compound;
monocarboxylic acid;
secondary alcohol		platelet aggregation inhibitor;
vasodilator agent
2-methyl-3-furanthiol[no description available]medium10heteroarene
furfuryl mercaptan[no description available]medium10heteroarene
chlorodiphenyl (54% chlorine)[no description available]medium10
10,10'-dimethyl-9,9'-biacridinium[no description available]medium30
ibopamine[no description available]medium22benzoate ester;
phenols
deoxyepinephrine[no description available]medium22catecholamine
vanillyl alcohol[no description available]medium20benzyl alcohols;
guaiacols		plant metabolite
indinavir sulfate[no description available]medium11dicarboxylic acid diamide;
N-(2-hydroxyethyl)piperazine;
piperazinecarboxamide		HIV protease inhibitor
dichlorfop-methyl[no description available]medium10aromatic ether;
dichlorobenzene;
diether;
methyl ester
fura-2[no description available]medium90
7-nitroindazole[no description available]medium10
ryanodine[no description available]medium20
tetracaine[no description available]medium10benzoate ester;
tertiary amino compound		local anaesthetic
cystine[no description available]medium10
isopentenyl pyrophosphate[no description available]medium10prenol phosphateantigen;
antioxidant;
epitope;
Escherichia coli metabolite;
mouse metabolite;
phosphoantigen
u 73122[no description available]medium30aromatic ether;
aza-steroid;
maleimides		EC 3.1.4.11 (phosphoinositide phospholipase C) inhibitor
1-(3-chlorophenyl)piperazine[no description available]medium185monochlorobenzenes;
N-arylpiperazine		drug metabolite;
environmental contaminant;
serotonergic agonist;
xenobiotic
4-oxothiazolidine[no description available]medium10
sch 37224[no description available]medium20
strychnine[no description available]medium70monoterpenoid indole alkaloid;
organic heteroheptacyclic compound		avicide;
cholinergic antagonist;
glycine receptor antagonist;
neurotransmitter agent;
rodenticide
bay-k-8644[no description available]medium20(trifluoromethyl)benzenes;
C-nitro compound;
dihydropyridine;
methyl ester
stigmasterol[no description available]medium203beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols;
stigmastane sterol		plant metabolite
gamma-sitosterol[no description available]medium103beta-hydroxy-Delta(5)-steroid;
3beta-sterol;
phytosterols		marine metabolite;
plant metabolite
cytellin[no description available]medium20
hematoporphyrin[no description available]medium10
testosterone propionate[no description available]medium10steroid ester
7-hydroxy-4-trifluoromethylcoumarin[no description available]medium10
trifluoperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organofluorine compound;
phenothiazines		antiemetic;
calmodulin antagonist;
dopaminergic antagonist;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor;
EC 5.3.3.5 (cholestenol Delta-isomerase) inhibitor;
phenothiazine antipsychotic drug
1-aminocyclopropane-1-carboxylic acid[no description available]medium20amino acid zwitterion;
monocarboxylic acid;
non-proteinogenic alpha-amino acid		ethylene releasers;
plant metabolite
carbonic acid[no description available]medium10carbon oxoacid;
chalcocarbonic acid		mouse metabolite
phenoxyethanol[no description available]medium10aromatic ether;
glycol ether;
primary alcohol		antiinfective agent;
central nervous system depressant
acenaphthene[no description available]medium10acenaphthenes
dodecanedioic acid[no description available]medium10alpha,omega-dicarboxylic acid;
dicarboxylic fatty acid		EC 1.1.1.1 (alcohol dehydrogenase) inhibitor;
human metabolite
meperidine[no description available]medium10ethyl ester;
piperidinecarboxylate ester;
tertiary amino compound		antispasmodic drug;
kappa-opioid receptor agonist;
mu-opioid receptor agonist;
opioid analgesic
n-benzyl-1-aminobenzotriazole[no description available]medium140
benzphetamine[no description available]medium20amphetamines;
tertiary amine		adrenergic uptake inhibitor;
appetite depressant;
dopamine uptake inhibitor;
sympathomimetic agent
7-ethoxy-4-trifluoromethylcoumarin[no description available]medium20
3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid[no description available]medium30
remoxipride[no description available]medium20dimethoxybenzene
disperse blue 1[no description available]medium10anthraquinone
dihydroxyacetone[no description available]medium10ketotriose;
primary alpha-hydroxy ketone		antifungal agent;
Escherichia coli metabolite;
human metabolite;
metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
motilin[no description available]medium10
ra vii[no description available]medium20
bucladesine[no description available]medium1203',5'-cyclic purine nucleotide
staurosporine aglycone[no description available]medium20
adenosine kinase[no description available]medium40
tricyclazole[no description available]medium10triazolobenzothiazoleantifungal agrochemical;
melanin synthesis inhibitor
vosaroxin[no description available]medium10
2,2-bis(bromomethyl)-1,3-propanediol[no description available]medium30primary alcohol
aminopyrine[no description available]medium110pyrazolone;
tertiary amino compound		antipyretic;
environmental contaminant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic
phenylmethanesulfonic acid[no description available]medium10
ns 1619[no description available]medium10(trifluoromethyl)benzenes;
benzimidazoles;
phenols		potassium channel opener
cyclothiazide[no description available]medium10benzothiadiazineantihypertensive agent;
diuretic
2-(2,3-dicarboxycyclopropyl)glycine[no description available]medium10
iodonitrotetrazolium[no description available]medium10organic chloride salthistological dye
methyl bensulfuron[no description available]medium10aromatic ether;
methyl ester;
N-sulfonylurea;
pyrimidines		agrochemical;
EC 2.2.1.6 (acetolactate synthase) inhibitor;
herbicide
schizandrin a[no description available]medium10
schizandrin b[no description available]medium20
ginkgolide a[no description available]medium20diterpene lactone
14-deoxyandrographolide[no description available]medium10
8-cyclopropyltheophylline[no description available]medium10
pamidronate[no description available]medium40phosphonoacetic acid
ketanserin[no description available]medium20aromatic ketone;
organofluorine compound;
piperidines;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
cardiovascular drug;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
5-carboxamidotryptamine[no description available]medium20tryptamines
gr 127935[no description available]medium101,2,4-oxadiazole;
benzamides;
N-alkylpiperazine;
N-arylpiperazine
l 772405[no description available]medium20
chicoric acid[no description available]medium10organooxygen compoundgeroprotector;
HIV-1 integrase inhibitor
e 6123[no description available]medium270
pd 123319[no description available]medium10imidazopyridineangiotensin receptor antagonist;
endothelin receptor antagonist;
vasoconstrictor agent
candesartan cilexetil[no description available]medium20biphenyls
ono 1078[no description available]medium50chromones
s 145[no description available]medium40monoterpenoid
2-(2-(4-chlorophenyl)ethoxy)adenosine[no description available]medium10
5-phenyl-1-pentyne[no description available]medium10
4-vinylphenol[no description available]medium10phenolshuman urinary metabolite;
human xenobiotic metabolite
tolfenamic acid[no description available]medium31aminobenzoic acid;
organochlorine compound;
secondary amino compound		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
EC 2.7.1.33 (pantothenate kinase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
rofecoxib[no description available]medium22butenolide;
sulfone		analgesic;
cyclooxygenase 2 inhibitor;
non-steroidal anti-inflammatory drug
amsacrine[no description available]medium20acridines;
aromatic ether;
sulfonamide		antineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
razoxane[no description available]medium10N-alkylpiperazine
hydroxyindoleacetic acid[no description available]medium40indole-3-acetic acidsdrug metabolite;
human metabolite;
mouse metabolite
alpha-methyltyrosine methyl ester[no description available]medium10
linsidomine[no description available]medium220morpholines
molsidomine[no description available]medium230ethyl ester;
morpholines;
oxadiazole;
zwitterion		antioxidant;
apoptosis inhibitor;
cardioprotective agent;
nitric oxide donor;
vasodilator agent
yessotoxin[no description available]medium10ciguatoxin
norvaline[no description available]medium102-aminopentanoic acid;
L-alpha-amino acid zwitterion		bacterial metabolite;
hypoglycemic agent;
neuroprotective agent
norleucine[no description available]medium202-aminohexanoic acid;
L-alpha-amino acid zwitterion;
non-proteinogenic L-alpha-amino acid
steviolbioside[no description available]medium10monocarboxylic acid anion
steviol[no description available]medium10bridged compound;
ent-kaurane diterpenoid;
monocarboxylic acid;
tertiary allylic alcohol;
tetracyclic diterpenoid		antineoplastic agent
stevioside[no description available]medium10beta-D-glucoside;
bridged compound;
diterpene glycoside;
ent-kaurane diterpenoid;
tetracyclic diterpenoid		anti-inflammatory agent;
antineoplastic agent;
antioxidant;
hypoglycemic agent;
plant metabolite;
sweetening agent
pyridinoline[no description available]medium20organonitrogen compound;
organooxygen compound
pefloxacin[no description available]medium10fluoroquinolone antibiotic;
monocarboxylic acid;
N-alkylpiperazine;
N-arylpiperazine;
quinolone antibiotic;
quinolone		antibacterial drug;
antiinfective agent;
DNA synthesis inhibitor
dicloran[no description available]medium20aromatic fungicide;
dichlorobenzene;
nitroaniline		antifungal agrochemical
cefazolin[no description available]medium40beta-lactam antibiotic allergen;
cephalosporin;
tetrazoles;
thiadiazoles		antibacterial drug
2-phenylphenol[no description available]medium10hydroxybiphenylsantifungal agrochemical;
environmental food contaminant
copper[no description available]medium10copper cation;
monoatomic monocation		cofactor
pindolol[no description available]medium41indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent
abecarnil[no description available]medium10
acrylamide[no description available]medium30acrylamides;
N-acylammonia;
primary carboxamide		alkylating agent;
carcinogenic agent;
Maillard reaction product;
mutagen;
neurotoxin
pyridine-2-carbothioamide[no description available]medium10
cp 96345[no description available]medium20
doxifluridine[no description available]medium20organofluorine compound;
pyrimidine 5'-deoxyribonucleoside		antimetabolite;
antineoplastic agent;
prodrug
nikkomycin[no description available]medium30
5-chloromethylfluorescein diacetate[no description available]medium10acetate esterfluorochrome
clonidine[no description available]medium101clonidine;
imidazoline
tizanidine[no description available]medium10benzothiadiazole;
imidazoles		alpha-adrenergic agonist;
muscle relaxant
candesartan[no description available]medium10benzimidazolecarboxylic acid;
biphenylyltetrazole		angiotensin receptor antagonist;
antihypertensive agent;
environmental contaminant;
xenobiotic
ezetimibe[no description available]medium10azetidines;
beta-lactam;
organofluorine compound		anticholesteremic drug;
antilipemic drug;
antimetabolite
valdecoxib[no description available]medium10isoxazoles;
sulfonamide		antipyretic;
antirheumatic drug;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
tak 603[no description available]medium151
osteoprotegerin[no description available]medium21long-chain fatty acid
zirconium[no description available]medium20titanium group element atom
fluo-3[no description available]medium20xanthene dyefluorochrome
u 0126[no description available]medium10aryl sulfide;
dinitrile;
enamine;
substituted aniline		antineoplastic agent;
antioxidant;
apoptosis inducer;
EC 2.7.11.24 (mitogen-activated protein kinase) inhibitor;
osteogenesis regulator;
vasoconstrictor agent
testosterone enanthate[no description available]medium11heptanoate ester;
sterol ester		androgen
r 121919[no description available]medium10
cp 154526[no description available]medium10
anisole[no description available]medium10monomethoxybenzeneplant metabolite
pyridoxal isonicotinoyl hydrazone[no description available]medium10
abarelix[no description available]medium10polypeptideantineoplastic agent;
hormone antagonist
fludarabine phosphate[no description available]medium10nucleoside analogue;
organofluorine compound;
purine arabinonucleoside monophosphate		antimetabolite;
antineoplastic agent;
antiviral agent;
DNA synthesis inhibitor;
immunosuppressive agent;
prodrug
vidarabine phosphate[no description available]medium10
oblimersen[no description available]medium10
methoxuron[no description available]medium103-(3,4-substituted-phenyl)-1,1-dimethylurea;
monochlorobenzenes;
monomethoxybenzene		agrochemical;
environmental contaminant;
herbicide;
photosystem-II inhibitor;
plant growth regulator;
xenobiotic
3-(2-hydroxy-4-(1,1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol[no description available]medium40alkylbenzene;
ring assembly
fluorescein glucuronide[no description available]medium10
grifolin[no description available]medium10sesquiterpenoid
reboxetine[no description available]medium40aromatic ether
gepirone[no description available]medium32N-arylpiperazine
methiocarb[no description available]medium40aryl sulfide;
carbamate ester;
methyl sulfide		acaricide;
agrochemical;
avicide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
molluscicide;
xenobiotic
pirimicarb[no description available]medium20aminopyrimidine;
carbamate ester;
tertiary amino compound		agrochemical;
carbamate insecticide;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide;
xenobiotic
phenyl-n-tert-butylnitrone[no description available]medium10
iberiotoxin[no description available]medium70
triadimenol a[no description available]medium50
propane[no description available]medium50alkane;
gas molecular entity		food propellant
deamino arginine vasopressin[no description available]medium10heterodetic cyclic peptidediagnostic agent;
renal agent;
vasopressin receptor agonist
yf 476[no description available]medium10
foscarnet[no description available]medium10carboxylic acid;
one-carbon compound;
phosphonic acids		antiviral drug;
geroprotector;
HIV-1 reverse transcriptase inhibitor;
sodium-dependent Pi-transporter inhibitor
prolinedithiocarbamate[no description available]medium10
rwj 67657[no description available]medium10
palmarumycin cp(1)[no description available]medium10
2',3'-o-(2,4,6-trinitrophenyl)adenosine 5'-triphosphate[no description available]medium10C-nitro compound;
spiroketal		antagonist
hafnium[no description available]medium10titanium group element atom
chloroacetaldehyde[no description available]medium10organochlorine compound
bay 11-7082[no description available]medium10nitrile;
sulfone		apoptosis inducer;
EC 2.7.11.10 (IkappaB kinase) inhibitor;
EC 3.1.3.48 (protein-tyrosine-phosphatase) inhibitor;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor
s-nitrosoglutathione[no description available]medium30glutathione derivative;
nitrosothio compound		bronchodilator agent;
nitric oxide donor;
platelet aggregation inhibitor;
signalling molecule
8-((4-chlorophenyl)thio)cyclic-3',5'-amp[no description available]medium103',5'-cyclic purine nucleotide;
adenyl ribonucleotide;
aryl sulfide;
organochlorine compound		protein kinase agonist
butenafine[no description available]medium20naphthalenes;
tertiary amine		antifungal drug;
EC 1.14.13.132 (squalene monooxygenase) inhibitor
fluoroboric acid[no description available]medium10boron fluoride
cyclopentenone[no description available]medium10alicyclic ketone;
enone		Hsp70 inducer
acetic anhydride[no description available]medium30acyclic carboxylic anhydridemetabolite;
reagent
(prolyl-hydroxylprolyl-glycine)10[no description available]medium10
1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide methiodide[no description available]medium10
pimagedine[no description available]medium40guanidines;
one-carbon compound		EC 1.14.13.39 (nitric oxide synthase) inhibitor;
EC 1.4.3.4 (monoamine oxidase) inhibitor
fg 7142[no description available]medium20beta-carbolines
rubidium[no description available]medium20alkali metal atom
ethosuximide[no description available]medium10dicarboximide;
pyrrolidinone		anticonvulsant;
geroprotector;
T-type calcium channel blocker
2,5-norbornadiene[no description available]medium10
fg 9041[no description available]medium10quinoxaline derivative
dephostatin[no description available]medium10
s-nitro-n-acetylpenicillamine[no description available]medium60
2-adamantanol[no description available]medium10
1-adamantanol[no description available]medium10
purvalanol a[no description available]medium10purvalanol
sk&f 95282[no description available]medium20piperidines
arachidonyltrifluoromethane[no description available]medium10fatty acid derivative;
ketone;
olefinic compound;
organofluorine compound		EC 3.1.1.4 (phospholipase A2) inhibitor
vanoxerine[no description available]medium10ether;
N-alkylpiperazine;
organofluorine compound;
tertiary amino compound		dopamine uptake inhibitor
trimethylsilyl cyanide[no description available]medium10
5-ethynyl-1-ribofuranosylimidazole-4-carboxamide[no description available]medium10
nuarimol, (+-)-isomer[no description available]medium20
sch 51048[no description available]medium70
sibutramine[no description available]medium10organochlorine compound;
tertiary amino compound		anti-obesity agent;
serotonin uptake inhibitor
hp 228[no description available]medium10
chlorzoxazone[no description available]medium201,3-benzoxazoles;
heteroaryl hydroxy compound;
organochlorine compound		muscle relaxant;
sedative
deferitrin[no description available]medium20
eglumetad[no description available]medium10L-alpha-amino acid
alphaxalone[no description available]medium40corticosteroid hormone
lomustine[no description available]medium10N-nitrosoureas;
organochlorine compound		alkylating agent;
antineoplastic agent
l-826266[no description available]medium10
2,6-diaminopurine[no description available]medium102,6-diaminopurines;
primary amino compound		antineoplastic agent
2-aminopurine[no description available]medium102-aminopurines;
nucleobase analogue		antimetabolite
thromboxane a2[no description available]medium280epoxy monocarboxylic acid;
thromboxanes A		mouse metabolite
ku 2285[no description available]medium10
nimorazole[no description available]medium20C-nitro compound;
imidazoles
puromycin aminonucleoside[no description available]medium303'-deoxyribonucleoside;
adenosines
nsc 401077[no description available]medium20
nelfinavir[no description available]medium11aryl sulfide;
benzamides;
organic heterobicyclic compound;
phenols;
secondary alcohol;
tertiary amino compound		antineoplastic agent;
HIV protease inhibitor
steganacin[no description available]medium20
triazulenone[no description available]medium10imidazobenzodiazepine
propizepine[no description available]medium10organonitrogen heterocyclic compound
neurokinin a[no description available]medium10
vasoactive intestinal peptide[no description available]medium70
europium cryptate[no description available]medium10
1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane[no description available]medium10
fibrin[no description available]medium20peptide
nepafenac[no description available]medium20monocarboxylic acid amidecyclooxygenase 1 inhibitor;
cyclooxygenase 2 inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug
prochlorperazine[no description available]medium10N-alkylpiperazine;
N-methylpiperazine;
organochlorine compound;
phenothiazines		alpha-adrenergic antagonist;
antiemetic;
cholinergic antagonist;
dopamine receptor D2 antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
first generation antipsychotic
mercaptoethanol[no description available]medium30alkanethiol;
primary alcohol		geroprotector
muraglitazar[no description available]medium101,3-oxazoles
bumetanide[no description available]medium10amino acid;
benzoic acids;
sulfonamide		diuretic;
EC 3.6.3.49 (channel-conductance-controlling ATPase) inhibitor
nitroarginine[no description available]medium70guanidines;
L-arginine derivative;
N-nitro compound;
non-proteinogenic L-alpha-amino acid
n-succinimidyl 3-(2-pyridyldithio)propionate[no description available]medium10
dextrorphan[no description available]medium20morphinane alkaloid
mre 3008-f20[no description available]medium80
n-desmethyltamoxifen[no description available]medium10stilbenoid
tyramine[no description available]medium21monoamine molecular messenger;
primary amino compound;
tyramines		EC 3.1.1.8 (cholinesterase) inhibitor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
neurotransmitter
bentazone[no description available]medium40benzothiadiazineenvironmental contaminant;
herbicide;
xenobiotic
9-(3-hydroxy-2-phosphonomethoxypropyl)-2,6-diaminopurine[no description available]medium10
besonprodil[no description available]medium10
trimebutine[no description available]medium21trihydroxybenzoic acid
benomyl[no description available]medium40aromatic amide;
benzimidazole fungicide;
benzimidazoles;
benzimidazolylcarbamate fungicide;
carbamate ester		acaricide;
anthelminthic drug;
antifungal agrochemical;
microtubule-destabilising agent;
tubulin modulator
fenclorim[no description available]medium10organohalogen compound;
pyrimidines
dinitrochlorobenzene[no description available]medium10C-nitro compound;
monochlorobenzenes		allergen;
epitope;
sensitiser
fluxofenim[no description available]medium10organochlorine compound
benoxacor[no description available]medium10benzoxazine
2-amino-1,3,4-thiadiazole[no description available]medium10
etilefrine[no description available]medium10phenols
senicapoc[no description available]medium10
carnitine[no description available]medium20amino-acid betainehuman metabolite;
mouse metabolite
polygalacturonic acid[no description available]medium10D-galacturonic acid
ramipril[no description available]medium10azabicycloalkane;
cyclopentapyrrole;
dicarboxylic acid monoester;
dipeptide;
ethyl ester		bradykinin receptor B2 agonist;
cardioprotective agent;
EC 3.4.15.1 (peptidyl-dipeptidase A) inhibitor;
matrix metalloproteinase inhibitor;
prodrug
eicosapentaenoic acid[no description available]medium20icosapentaenoic acid;
omega-3 fatty acid		anticholesteremic drug;
antidepressant;
antineoplastic agent;
Daphnia galeata metabolite;
fungal metabolite;
micronutrient;
mouse metabolite;
nutraceutical
omacor[no description available]medium10
iron tetraphenylporphyrin[no description available]medium10
granisetron[no description available]medium10aromatic amide;
indazoles
arginine[no description available]medium10
nirtetralin[no description available]medium10
niranthin[no description available]medium10
n-hydroxy-n'-aminoguanidine[no description available]medium10
sulpiride[no description available]medium10benzamides;
N-alkylpyrrolidine;
sulfonamide		antidepressant;
antiemetic;
antipsychotic agent;
dopaminergic antagonist
4-(3-(benzotriazol-1-yl)propyl)-1-(2-methoxyphenyl)piperazine[no description available]medium80
nan 190[no description available]medium30N-alkylpiperazine;
N-arylpiperazine;
phthalimides		serotonergic antagonist
phosphoric acid[no description available]medium10phosphoric acidsalgal metabolite;
fertilizer;
human metabolite;
NMR chemical shift reference compound;
solvent
naringenin[no description available]medium10(2S)-flavan-4-one;
naringenin		expectorant;
plant metabolite
apocarotenal[no description available]medium10apo carotenoid triterpenoid;
enal
3-methylcholanthrene[no description available]medium80ortho- and peri-fused polycyclic arenearyl hydrocarbon receptor agonist;
carcinogenic agent
mephenytoin[no description available]medium10imidazolidine-2,4-dioneanticonvulsant
sulprostone[no description available]medium10prostanoid
17-phenyltrinorprostaglandin e2[no description available]medium10alicyclic ketone;
beta-hydroxy ketone;
hydroxy monocarboxylic acid;
olefinic compound;
oxo monocarboxylic acid;
prostanoid;
secondary alcohol		human metabolite;
prostaglandin receptor agonist
cefotaxime[no description available]medium201,3-thiazoles;
cephalosporin;
oxime O-ether		antibacterial drug;
drug allergen
guanylin[no description available]medium10
1-(5-isoquinolinesulfonyl)-2-methylpiperazine[no description available]medium40isoquinolines;
N-sulfonylpiperazine		EC 2.7.11.13 (protein kinase C) inhibitor
kn 62[no description available]medium10piperazines
nimodipine[no description available]medium102-methoxyethyl ester;
C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
isopropyl ester		antihypertensive agent;
calcium channel blocker;
cardiovascular drug;
vasodilator agent
1-((2-hydroxyethoxy)methyl)-6-(phenylthio)thymine[no description available]medium10aryl sulfide;
primary alcohol;
pyrimidone		antiviral drug;
HIV-1 reverse transcriptase inhibitor
atamestane[no description available]medium42
glycerol 1-stearate[no description available]medium101-acylglycerol 18:0;
rac-1-monoacylglycerol		algal metabolite;
Caenorhabditis elegans metabolite
tramadol[no description available]medium102-[(dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanoladrenergic uptake inhibitor;
antitussive;
capsaicin receptor antagonist;
delta-opioid receptor agonist;
kappa-opioid receptor agonist;
metabolite;
mu-opioid receptor agonist;
muscarinic antagonist;
nicotinic antagonist;
NMDA receptor antagonist;
opioid analgesic;
serotonergic antagonist;
serotonin uptake inhibitor
levorphanol[no description available]medium10morphinane alkaloid
cercosporin[no description available]medium10
alfentanil[no description available]medium11monocarboxylic acid amide;
piperidines		central nervous system depressant;
intravenous anaesthetic;
mu-opioid receptor agonist;
opioid analgesic;
peripheral nervous system drug
lawsone[no description available]medium10
hexachlorocyclohexane[no description available]medium10chlorocyclohexane
2,5-dimethylpyrazine[no description available]medium10pyrazines
lithium hydroxide[no description available]medium10alkali metal hydroxide
ytterbium(iii) triflate[no description available]medium10
2-aminobenzimidazole[no description available]medium10benzimidazolesmarine xenobiotic metabolite
4-fluorobenzaldehyde[no description available]medium10
phenyl isocyanate[no description available]medium10benzenes;
isocyanates		allergen;
hapten
oxybutynin[no description available]medium20acetylenic compound;
carboxylic ester;
racemate;
tertiary alcohol;
tertiary amino compound		antispasmodic drug;
calcium channel blocker;
local anaesthetic;
muscarinic antagonist;
muscle relaxant;
parasympatholytic
virginiamycin[no description available]medium10
dalfopristin[no description available]medium10
quinupristin[no description available]medium10cyclodepsipeptide
hydroxynefazodone[no description available]medium156piperazines
benzotriazol-1-yloxy-tris(dimethylamino)phosphonium[no description available]medium10
diethyl malonate[no description available]medium10dicarboxylic acid
sulfur dioxide[no description available]medium10sulfur oxideEscherichia coli metabolite;
food bleaching agent;
refrigerant
methylinositol[no description available]medium10
pak 104p[no description available]medium10
ezogabine[no description available]medium20carbamate ester;
organofluorine compound;
secondary amino compound;
substituted aniline		anticonvulsant;
potassium channel modulator
ganaxolone[no description available]medium10corticosteroid hormone
ly 300164[no description available]medium10benzodioxoles
nandrolone[no description available]medium1017beta-hydroxy steroid;
3-oxo-Delta(4) steroid;
anabolic androgenic steroid		human metabolite
ly 73497[no description available]medium20
xylitol[no description available]medium10
quisqualic acid[no description available]medium20non-proteinogenic alpha-amino acid
paxilline[no description available]medium20diterpene alkaloid;
enone;
organic heterohexacyclic compound;
terpenoid indole alkaloid;
tertiary alcohol		anticonvulsant;
Aspergillus metabolite;
EC 3.6.3.8 (Ca(2+)-transporting ATPase) inhibitor;
genotoxin;
geroprotector;
mycotoxin;
Penicillium metabolite;
potassium channel blocker
2-fluoroethylazide[no description available]medium10
1,4-diethynylbenzene[no description available]medium10
dicofol[no description available]medium10monochlorobenzenes;
organochlorine acaricide;
tertiary alcohol
oxepins[no description available]medium20
1-ethyl-2-benzimidazolinone[no description available]medium10imidazoles
6-hydroxydopa[no description available]medium10non-proteinogenic alpha-amino acid
dihydroxyphenylalanine[no description available]medium30hydroxyphenylalanine;
non-proteinogenic alpha-amino acid;
tyrosine derivative		human metabolite
tryptoquivaline[no description available]medium10
1,2-dioxetane[no description available]medium10
bretylium tosylate[no description available]medium10organosulfonate salt;
quaternary ammonium salt		adrenergic antagonist;
anti-arrhythmia drug;
antihypertensive agent
terazosin[no description available]medium10furans;
piperazines;
primary amino compound;
quinazolines		alpha-adrenergic antagonist;
antihypertensive agent;
antineoplastic agent
pheophorbide a[no description available]medium10
trans-4-coumaric acid[no description available]medium104-coumaric acidfood component;
mouse metabolite;
plant metabolite
promazine[no description available]medium20phenothiazines;
tertiary amine		antiemetic;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
H1-receptor antagonist;
muscarinic antagonist;
phenothiazine antipsychotic drug;
serotonergic antagonist
fuberidazole[no description available]medium20benzimidazole fungicide;
benzimidazoles;
furans		antifungal agrochemical
sodium ethoxide[no description available]medium10organic sodium saltnucleophilic reagent
benzoxazolone[no description available]medium10benzoxazoleallelochemical;
phytoalexin
2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone[no description available]medium10
lonafarnib[no description available]medium104-{2-[4-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperidin-1-yl]-2-oxoethyl}piperidine-1-carboxamideantineoplastic agent;
EC 2.5.1.58 (protein farnesyltransferase) inhibitor
nordazepam[no description available]medium111,4-benzodiazepinone;
organochlorine compound		anticonvulsant;
anxiolytic drug;
GABA modulator;
human metabolite;
sedative
desvenlafaxine succinate[no description available]medium11
trichloroethylene[no description available]medium20chloroethenesinhalation anaesthetic;
mouse metabolite
ethylene chlorohydrin[no description available]medium10chloroethanolxenobiotic metabolite
2,2,2-trichloroethanol[no description available]medium10chloroethanolmouse metabolite
17-alpha-hydroxyprogesterone[no description available]medium2117alpha-hydroxy-C21-steroid;
17alpha-hydroxy steroid;
tertiary alpha-hydroxy ketone		human metabolite;
metabolite;
mouse metabolite;
progestin
jasplakinolide[no description available]medium10cyclodepsipeptide;
phenols		actin polymerisation inducer;
animal metabolite;
antifungal agent;
antineoplastic agent;
apoptosis inducer;
marine metabolite;
neuroprotective agent
alachlor[no description available]medium30aromatic amide;
monocarboxylic acid amide;
organochlorine compound		environmental contaminant;
herbicide;
xenobiotic
didodecyldimethylammonium[no description available]medium10
ancriviroc[no description available]medium20aromatic carboxylic acid;
pyridinemonocarboxylic acid
thioflavin t[no description available]medium10organic chloride saltfluorochrome;
geroprotector;
histological dye
caseins[no description available]medium30
1-methylimidazole[no description available]medium20imidazoles
hexacyanoferrate iii[no description available]medium10
4-amino-3-(2-furyl)-5-mercapto-1,2,4-triazole[no description available]medium10triazoles
2-phenylbenzotriazole[no description available]medium10
1,2,4-triazine[no description available]medium101,2,4-triazines;
triazine
phoxim[no description available]medium10
tin[no description available]medium10carbon group element atom;
elemental tin;
metal atom		micronutrient
norfentanyl[no description available]medium11anilide;
monocarboxylic acid amide;
piperidines		drug metabolite;
opioid analgesic
2-furoic acid[no description available]medium20furoic acidbacterial xenobiotic metabolite;
human xenobiotic metabolite;
inhibitor;
plant metabolite;
Saccharomyces cerevisiae metabolite
1,1-cyclopropanedicarboxylate[no description available]medium10
diphenylacetic acid[no description available]medium10monocarboxylic acidxenobiotic metabolite
novaluron[no description available]medium10aromatic ether;
benzoylurea insecticide;
monochlorobenzenes;
organofluorine compound
2,4,6-trichlorophenol[no description available]medium20trichlorophenolcarcinogenic agent
flavanone[no description available]medium10flavanones
tak-220[no description available]medium10
pentachlorophenol[no description available]medium10aromatic fungicide;
chlorophenol;
organochlorine pesticide;
pentachlorobenzenes		human xenobiotic metabolite
picryl chloride[no description available]medium10C-nitro compound;
monochlorobenzenes		allergen;
epitope;
explosive;
hapten
3-(3-(dimethylamino)propyl)-4-hydroxy-n-(4-(4-pyridinyl)phenyl)benzamide[no description available]medium10
fk 866[no description available]medium10benzamides;
N-acylpiperidine
n,n-dimethyl-4-anisidine[no description available]medium10
sk&f-38393[no description available]medium30benzazepine;
catechols;
secondary amino compound
6-methyl-2-ethyl-3-hydroxypyridine[no description available]medium10
icatibant[no description available]medium40
benzene oxide[no description available]medium10
methyl benzoate[no description available]medium10benzoate ester;
methyl ester		insect attractant;
metabolite
diphenyldiselenide[no description available]medium10
efaroxan[no description available]medium101-benzofurans
dihexadecyldimethylammonium chloride[no description available]medium10
hydrofluoric acid[no description available]medium10hydrogen halide;
mononuclear parent hydride		NMR chemical shift reference compound
kaempferol[no description available]medium107-hydroxyflavonol;
flavonols;
tetrahydroxyflavone		antibacterial agent;
geroprotector;
human blood serum metabolite;
human urinary metabolite;
human xenobiotic metabolite;
plant metabolite
n-oleoylethanolamine[no description available]medium10endocannabinoid;
N-(long-chain-acyl)ethanolamine;
N-acylethanolamine 18:1		EC 3.5.1.23 (ceramidase) inhibitor;
geroprotector;
PPARalpha agonist
n 0437, (-)-isomer[no description available]medium10tetralins
paliperidone palmitate[no description available]medium101,2-benzoxazoles;
fatty acid ester;
heteroarylpiperidine;
organofluorine compound;
pyridopyrimidine
2-aminothiazole[no description available]medium101,3-thiazoles;
primary amino compound
oxiconazole[no description available]medium50conazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
oxime O-ether		antiinfective agent
intrinsic factor[no description available]medium10
allopurinol riboside[no description available]medium10nucleoside analoguemetabolite
bay n 7133[no description available]medium371
2,3-dihydro-1h-imidazo(1,2-b)pyrazole[no description available]medium20
2-amino-3-methylimidazo(4,5-f)quinoline[no description available]medium10imidazoquinolinecarcinogenic agent
4-methyl-5-amino-1-formylisoquinoline thiosemicarbazone[no description available]medium20
isoconazole[no description available]medium40dichlorobenzene;
ether;
imidazoles
butoconazole[no description available]medium30aryl sulfide;
conazole antifungal drug;
dichlorobenzene;
imidazole antifungal drug;
imidazoles;
monochlorobenzenes
sulconazole[no description available]medium20dichlorobenzene;
imidazoles;
monochlorobenzenes;
organic sulfide
bay-i 9139[no description available]medium120
ici 153066[no description available]medium190
rhc 3164[no description available]medium40
hydralazine pyruvic acid hydrazone[no description available]medium10
3-methyl-s-triazolo(3,4-a)phthalazine[no description available]medium40triazolophthalazine
mizoribine[no description available]medium10imidazolesanticoronaviral agent
pyrazofurin[no description available]medium10C-glycosyl compound;
pyrazoles		antimetabolite;
antimicrobial agent;
antineoplastic agent;
EC 4.1.1.23 (orotidine-5'-phosphate decarboxylase) inhibitor
fla-136[no description available]medium60
methohexital[no description available]medium10acetylenic compound;
barbiturates		drug allergen;
intravenous anaesthetic
sk&f 93479[no description available]medium20
lamtidine[no description available]medium80aromatic amine
burimamide[no description available]medium10imidazoles
metergoline[no description available]medium10carbamate ester;
ergoline alkaloid		dopamine agonist;
geroprotector;
serotonergic antagonist
physostigmine salicylate[no description available]medium10azaheterocycle salicylate salt;
salicylates
timolol[no description available]medium72timololanti-arrhythmia drug;
antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist
physostigmine[no description available]medium40carbamate ester;
indole alkaloid		antidote to curare poisoning;
EC 3.1.1.8 (cholinesterase) inhibitor;
miotic
metaproterenol[no description available]medium10aralkylamino compound;
phenylethanolamines;
resorcinols;
secondary alcohol;
secondary amino compound
pentifylline[no description available]medium10oxopurine
ici 63197[no description available]medium30triazolopyrimidines
cromolyn sodium[no description available]medium80organic sodium saltanti-asthmatic drug;
drug allergen
osmium tetroxide[no description available]medium20osmium coordination entityfixative;
histological dye;
oxidising agent;
poison
oxatomide[no description available]medium10benzimidazoles;
diarylmethane;
N-alkylpiperazine		anti-allergic agent;
anti-inflammatory agent;
geroprotector;
H1-receptor antagonist;
serotonergic antagonist
muscimol[no description available]medium40alkaloid;
isoxazoles;
primary amino compound		fungal metabolite;
GABA agonist;
oneirogen;
psychotropic drug
beta-carboline-3-carboxylic acid ethyl ester[no description available]medium20beta-carbolines
cilofungin[no description available]medium30antibiotic antifungal drug;
echinocandin		antiinfective agent
phenylbutazone[no description available]medium60pyrazolidinesantirheumatic drug;
EC 1.1.1.184 [carbonyl reductase (NADPH)] inhibitor;
metabolite;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
peripheral nervous system drug
anaxirone[no description available]medium221
furagin[no description available]medium10
furazolidone[no description available]medium20nitrofuran antibiotic;
oxazolidines		antibacterial drug;
antiinfective agent;
antitrichomonal drug;
EC 1.4.3.4 (monoamine oxidase) inhibitor
pentazocine[no description available]medium10benzazocine
1-hydroxy-6-nitrobenzotriazole[no description available]medium10
heptenophos[no description available]medium10organochlorine compound;
organophosphate insecticide;
trialkyl phosphate		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
formycins[no description available]medium30
7-azatryptophan[no description available]medium10
3-fluorophenylalanine[no description available]medium10
2-fluorophenylalanine[no description available]medium10monofluorobenzenes;
non-proteinogenic alpha-amino acid;
phenylalanine derivative
triazolealanine[no description available]medium10non-proteinogenic alpha-amino acid;
triazoles
p-fluorophenylalanine[no description available]medium10fluoroamino acid;
monofluorobenzenes;
non-proteinogenic alpha-amino acid;
phenylalanine derivative
flurazepam[no description available]medium961,4-benzodiazepinone;
monofluorobenzenes;
organochlorine compound;
tertiary amino compound		anticonvulsant;
anxiolytic drug;
GABAA receptor agonist;
sedative
ureidosuccinic acid[no description available]medium10aspartic acid derivative;
C4-dicarboxylic acid;
N-carbamoyl-amino acid		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
orotidine[no description available]medium10nucleoside;
pyrimidinemonocarboxylic acid;
uridines		bacterial metabolite;
fungal metabolite;
plant metabolite
dimercaprol[no description available]medium10dithiol;
primary alcohol		chelator
lucanthone hydrochloride[no description available]medium30
oxamniquine[no description available]medium10aromatic primary alcohol;
C-nitro compound;
quinolines;
secondary amino compound
diisopropanolnitrosamine[no description available]medium10diol;
nitrosamine;
secondary alcohol		carcinogenic agent
clofibrate[no description available]medium80aromatic ether;
ethyl ester;
monochlorobenzenes		anticholesteremic drug;
antilipemic drug;
geroprotector;
PPARalpha agonist
3-(n-salicyloyl)amino-1,2,4-triazole[no description available]medium10
phenyl salicylate[no description available]medium10benzoate ester;
phenols;
salicylates		ultraviolet filter
thymidine monophosphate[no description available]medium10thymidine 5'-monophosphatefundamental metabolite
protoporphyrin ix[no description available]medium30
stearyl alcohol[no description available]medium10long-chain primary fatty alcohol;
octadecanol		algal metabolite;
human metabolite;
plant metabolite
4-amino-5-hydrazino-1,2,4-triazole-3-thiol[no description available]medium20
suritozole[no description available]medium71triazoles
microcystin[no description available]medium20peptide
p-chloroamphetamine[no description available]medium20
ici 195739[no description available]medium514
bisacodyl[no description available]medium10diarylmethane
cp 66713[no description available]medium30
1-propanol[no description available]medium30propan-1-ols;
short-chain primary fatty alcohol		metabolite;
protic solvent
nitroaniline[no description available]medium10
edifenphos[no description available]medium10organic thiophosphateantifungal agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
neurotoxin;
phospholipid biosynthesis inhibitor
ly 171883[no description available]medium50acetophenones;
aromatic ether;
phenols;
tetrazoles		anti-asthmatic drug;
leukotriene antagonist
ds 4574[no description available]medium132
n-formylmethionylphenylalanine[no description available]medium10peptide
tsao-t[no description available]medium10
arginyl-glycyl-aspartyl-phenylalanine[no description available]medium10
evans blue[no description available]medium120organic sodium saltfluorochrome;
histological dye;
sodium channel blocker;
teratogenic agent
veratridine[no description available]medium10
bis(1,3-diethylthiobarbiturate)trimethineoxonol[no description available]medium10
sodium bicarbonate[no description available]medium10one-carbon compound;
organic sodium salt		antacid;
food anticaking agent
sri 63-441[no description available]medium160
r-82913[no description available]medium10
sm 8668[no description available]medium585
setipafant[no description available]medium181
sc 51316[no description available]medium70
foropafant[no description available]medium90
cytidine diphosphate choline[no description available]medium10nucleotide-(amino alcohol)s;
phosphocholines		human metabolite;
mouse metabolite;
neuroprotective agent;
psychotropic drug;
Saccharomyces cerevisiae metabolite
1-palmityl-2-acetylglycerol[no description available]medium10
pyrilamine[no description available]medium270aromatic ether;
ethylenediamine derivative		H1-receptor antagonist
methysergide[no description available]medium110ergoline alkaloid
n-(3-chlorophenyl)-3-(3-pyridinyl)-1h,3h-pyrrolo(1,2-c)thiazole-7-carboxamide[no description available]medium50
2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid[no description available]medium10
leukotriene e4[no description available]medium30amino dicarboxylic acid;
L-cysteine thioether;
leukotriene;
non-proteinogenic L-alpha-amino acid;
secondary alcohol
phalloidine[no description available]medium20homodetic cyclic peptide
pobilukast[no description available]medium30
meclofenamic acid[no description available]medium20aminobenzoic acid;
organochlorine compound;
secondary amino compound		analgesic;
anticonvulsant;
antineoplastic agent;
antipyretic;
antirheumatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug
sta 2[no description available]medium20
lipoxin b4[no description available]medium10hydroxy fatty acid anion;
lipoxin anion
bis(4-nitrophenyl)phosphate[no description available]medium10aryl phosphate
bn 52063[no description available]medium20
1,25-dihydroxy-16-ene-vitamin d3[no description available]medium10
epiyangambin[no description available]medium40
a25822b[no description available]medium10
bm 13505[no description available]medium30
thromboxanes[no description available]medium60
obtusifoliol[no description available]medium1014alpha-methyl steroid;
3beta-sterol		mouse metabolite;
plant metabolite
methylaniline[no description available]medium10methylaniline;
phenylalkylamine;
secondary amine
1-hexadecyl-2-methoxyglycero-3-phosphocholine[no description available]medium10
p-aminohippuric acid[no description available]medium20N-acylglycineDaphnia magna metabolite
gallopamil[no description available]medium10benzenes;
organic amino compound
nitrendipine[no description available]medium20C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
ethyl ester;
methyl ester		antihypertensive agent;
calcium channel blocker;
geroprotector;
vasodilator agent
17-n,n-diethylcarbamoyl-4-methyl-4-azaandrostane-3-one[no description available]medium10
technetium tc 99m pentetate[no description available]medium20
1,3-dipropyl-8-(2-amino-4-chlorophenyl)xanthine[no description available]medium20
butyric acid[no description available]medium10fatty acid 4:0;
straight-chain saturated fatty acid		human urinary metabolite;
Mycoplasma genitalium metabolite
n-((1s,trans)-2-hydroxycyclopentyl)adenosine[no description available]medium10purine nucleoside
metrifudil[no description available]medium10
3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one[no description available]medium50
rp 48740[no description available]medium40
n-hydroxyamphetamine[no description available]medium11
azelastine[no description available]medium40monochlorobenzenes;
phthalazines;
tertiary amino compound		anti-allergic agent;
anti-asthmatic drug;
bronchodilator agent;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
H1-receptor antagonist;
platelet aggregation inhibitor
fpl 55712[no description available]medium50aromatic ketone
e 6080[no description available]medium10
2-phenylpyrazolo(4,3-c)quinolin-3(5h)-one[no description available]medium30
dpi 201-106[no description available]medium10diarylmethane
ym 264[no description available]medium20
isradipine[no description available]medium20benzoxadiazole;
dihydropyridine;
isopropyl ester;
methyl ester
we 201[no description available]medium10
bay x 1005[no description available]medium10
arecoline[no description available]medium10enoate ester;
methyl ester;
pyridine alkaloid;
tetrahydropyridine		metabolite;
muscarinic agonist
chloroneb[no description available]medium10aromatic fungicide;
dichlorobenzene;
dimethoxybenzene		antifungal agrochemical
2,5-bis(3,4,5-trimethoxyphenyl)tetrahydrofuran[no description available]medium150
pentagastrin[no description available]medium30organic molecular entity
pca 4248[no description available]medium40dihydropyridine
quipazine[no description available]medium30piperazines;
pyridines
ro 31-7549[no description available]medium10
trimethadione[no description available]medium10oxazolidinoneanticonvulsant;
geroprotector
sodium metasilicate[no description available]medium10inorganic sodium salt
sodium borate[no description available]medium10
8-hydroxy-2-(di-n-propylamino)tetralin[no description available]medium40phenols;
tertiary amino compound;
tetralins		serotonergic antagonist
kf 17837s[no description available]medium30
tetragastrin[no description available]medium10peptidyl amide;
tetrapeptide		anxiogenic;
human metabolite
5-hydroxy-6,8,11,14-eicosatetraenoic acid[no description available]medium20HETEhuman metabolite;
mouse metabolite
d 888[no description available]medium10aromatic ether;
nitrile;
tertiary amino compound		anti-arrhythmia drug;
calcium channel blocker;
vasodilator agent
dequalinium[no description available]medium10quinolinium ionantifungal agent;
antineoplastic agent;
antiseptic drug;
mitochondrial NADH:ubiquinone reductase inhibitor
(9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one[no description available]medium1121-hydroxy steroid
dihydroxyfumarate[no description available]medium102-hydroxydicarboxylic acid;
C4-dicarboxylic acid
nisoldipine[no description available]medium10C-nitro compound;
dicarboxylic acids and O-substituted derivatives;
diester;
dihydropyridine;
methyl ester
methionine sulfoximine[no description available]medium10methionine derivative;
non-proteinogenic alpha-amino acid;
sulfoximide
precocene ii[no description available]medium20chromenesprecocenes
dauricine[no description available]medium10aromatic ether;
bisbenzylisoquinoline alkaloid;
isoquinolines;
phenols;
tertiary amino compound		plant metabolite
4-methyl-3-methylsulfonyl-5-phenyl-4h-1,2,4-triazole[no description available]medium40
ifetroban[no description available]medium20benzenes;
monocarboxylic acid
phenylalanyl-prolyl-arginine-chloromethyl ketone[no description available]medium10
15-crown-5[no description available]medium10crown ether;
saturated organic heteromonocyclic parent
prolylleucine[no description available]medium10
1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine[no description available]medium20
sri 63-675[no description available]medium30
ono 3708[no description available]medium10
alpha-methylhistamine[no description available]medium10aralkylamino compound;
imidazoles		animal metabolite;
H3-receptor agonist
gr 117289[no description available]medium101-benzofurans;
biaryl;
imidazolyl carboxylic acid;
monocarboxylic acid;
organobromine compound;
organochlorine compound;
tetrazoles		angiotensin receptor antagonist;
antihypertensive agent
bw-755c[no description available]medium80
vesamicol[no description available]medium10piperidines
hemicholinium 3[no description available]medium20
ibotenic acid[no description available]medium10non-proteinogenic alpha-amino acidneurotoxin
procaterol[no description available]medium10quinolines
sc 41930[no description available]medium20
afdx 116[no description available]medium10benzodiazepine
n-methylscopolamine[no description available]medium10
phosphoramidon[no description available]medium10deoxyaldohexose phosphate;
dipeptide		bacterial metabolite;
EC 3.4.24.11 (neprilysin) inhibitor;
EC 3.4.24.71 (endothelin-converting enzyme 1) inhibitor
propionyl-coenzyme a[no description available]medium10acyl-CoAEscherichia coli metabolite;
metabolite;
mouse metabolite
methyl 2-((3,4-dihydro-3,4-dioxo-1-naphthalenyl)amino)benzoate[no description available]medium20
as 35[no description available]medium10
clonixin[no description available]medium20aminopyridine;
organochlorine compound;
pyridinemonocarboxylic acid		antipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
lipoxygenase inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
platelet aggregation inhibitor;
vasodilator agent
flunixin meglumine[no description available]medium20organoammonium saltantipyretic;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug
c 1303[no description available]medium10
vapiprost[no description available]medium20
cgp 47645[no description available]medium50
9,10-dimethyl-1,2-benzanthracene[no description available]medium80ortho-fused polycyclic arene;
tetraphenes		carcinogenic agent
cosyntropin[no description available]medium11
ci 986[no description available]medium10
methylmethacrylate[no description available]medium10enoate ester;
methyl ester		allergen;
polymerisation monomer
apraclonidine[no description available]medium10dichlorobenzene;
guanidines;
imidazolines		alpha-adrenergic agonist;
antiglaucoma drug;
beta-adrenergic agonist;
diagnostic agent;
ophthalmology drug
succinylcholine[no description available]medium30quaternary ammonium ion;
succinate ester		drug allergen;
muscle relaxant;
neuromuscular agent
ozagrel[no description available]medium50cinnamic acids
ici 192605[no description available]medium10
prostaglandin d2[no description available]medium30prostaglandins Dhuman metabolite;
mouse metabolite
prostaglandin a1[no description available]medium10prostaglandins A
ro 5-4864[no description available]medium40
1-naphthylisothiocyanate[no description available]medium10isothiocyanateinsecticide
zileuton[no description available]medium201-benzothiophenes;
ureas		anti-asthmatic drug;
EC 1.13.11.34 (arachidonate 5-lipoxygenase) inhibitor;
ferroptosis inhibitor;
leukotriene antagonist;
non-steroidal anti-inflammatory drug
phenylhydroquinone[no description available]medium10
nedocromil[no description available]medium50dicarboxylic acid;
organic heterotricyclic compound		anti-allergic agent;
anti-asthmatic drug;
non-steroidal anti-inflammatory drug
galactosamine[no description available]medium30D-galactosamine;
primary amino compound		toxin
nitrosomethylurethane[no description available]medium10carboxylic ester
1-nitrosoindole-3-acetonitrile[no description available]medium10
propyl-n'-nitro-n-nitrosoguanidine[no description available]medium10
methylnitronitrosoguanidine[no description available]medium40nitroso compoundalkylating agent
enng[no description available]medium10
sodium fluoride[no description available]medium20fluoride saltmutagen
lipoteichoic acid[no description available]medium10
carprofen[no description available]medium10carbazoles;
organochlorine compound		EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-steroidal anti-inflammatory drug;
photosensitizing agent
sarpogrelate[no description available]medium10hemisuccinate;
stilbenoid
sulotroban[no description available]medium50
gr 144053[no description available]medium10piperazines
edelfosine[no description available]medium40glycerophosphocholine
zm 230487[no description available]medium10
n(6)-2-(4-amino-3-iodophenyl)ethyladenosine[no description available]medium10
tris-(2,4-di-tert-butylphenyl) phosphite[no description available]medium10alkylbenzene
mazindol[no description available]medium10organic molecular entity
amanitins[no description available]medium10
bw a1433[no description available]medium20
n-(2-(dimethylamino)ethyl)-n-methyl-4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1h-purin-8-yl)benzenesulfonamide[no description available]medium10
dehydroascorbic acid[no description available]medium10dehydroascorbic acid;
vitamin C		coenzyme;
mouse metabolite
monodehydroascorbate[no description available]medium10organic radicalmouse metabolite
desflurane[no description available]medium10organofluorine compoundinhalation anaesthetic
cme-carbodiimide[no description available]medium10
vasotocin[no description available]medium20
ethoxyresorufin[no description available]medium40phenoxazine
pentoxyresorufin[no description available]medium20
carbidopa[no description available]medium10
carbidopa, levodopa drug combination[no description available]medium10
9,10-anthraquinone[no description available]medium10anthraquinone
1,3-dichloro-1-propene[no description available]medium10
methidathion[no description available]medium10organic thiophosphate;
organothiophosphate insecticide		acaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor
aldicarb[no description available]medium10
ralitoline[no description available]medium10
remacemide[no description available]medium10stilbenoid
tiagabine[no description available]medium20beta-amino acid;
piperidinemonocarboxylic acid;
tertiary amino compound;
thiophenes		anticonvulsant;
GABA reuptake inhibitor
4-chloromercuribenzenesulfonate[no description available]medium10arenesulfonic acid;
arylmercury compound
barium chloride[no description available]medium10barium salt;
inorganic chloride		potassium channel blocker
ornithine[no description available]medium10non-proteinogenic L-alpha-amino acid;
ornithine		algal metabolite;
hepatoprotective agent;
mouse metabolite
n(g)-iminoethylornithine[no description available]medium10L-alpha-amino acid
3-(2-carboxypiperazine-4-yl)-1-propenyl-1-phosphonic acid[no description available]medium10
picrotoxinin[no description available]medium20
chlormethiazole[no description available]medium20thiazoles
uridine diphosphate[no description available]medium20pyrimidine ribonucleoside 5'-diphosphate;
uridine 5'-phosphate		Escherichia coli metabolite;
mouse metabolite
phosphorus radioisotopes[no description available]medium20
10-undecynoic acid[no description available]medium20medium-chain fatty acid
octanoylcarnitine[no description available]medium10O-octanoylcarnitine;
saturated fatty acyl-L-carnitine		human metabolite
acetoacetic acid[no description available]medium103-oxo fatty acid;
ketone body		metabolite
web 2347[no description available]medium50
marimastat[no description available]medium10hydroxamic acid;
secondary carboxamide		antineoplastic agent;
matrix metalloproteinase inhibitor
batimastat[no description available]medium20hydroxamic acid;
L-phenylalanine derivative;
organic sulfide;
secondary carboxamide;
thiophenes;
triamide		angiogenesis inhibitor;
antineoplastic agent;
matrix metalloproteinase inhibitor
o-(chloroacetylcarbamoyl)fumagillol[no description available]medium30carbamate ester;
organochlorine compound;
semisynthetic derivative;
sesquiterpenoid;
spiro-epoxide		angiogenesis inhibitor;
antineoplastic agent;
EC 1.5.1.3 (dihydrofolate reductase) inhibitor;
methionine aminopeptidase 2 inhibitor;
retinoic acid receptor alpha antagonist
irsogladine[no description available]medium10dichlorobenzene
seratrodast[no description available]medium20organic molecular entity
4,4-dimethyloxazoline[no description available]medium10
adenosine-3',5'-cyclic phosphorothioate[no description available]medium20nucleoside 3',5'-cyclic phosphorothioate
peroxynitric acid[no description available]medium30nitrogen oxoacid
1,1-diethyl-2-hydroxy-2-nitrosohydrazine[no description available]medium20organic anion
way 100135[no description available]medium10piperazines
ipsapirone[no description available]medium10N-arylpiperazine
cp 99994[no description available]medium10
resiniferatoxin[no description available]medium10carboxylic ester;
diterpenoid;
enone;
monomethoxybenzene;
organic heteropentacyclic compound;
ortho ester;
phenols;
tertiary alpha-hydroxy ketone		analgesic;
neurotoxin;
plant metabolite;
TRPV1 agonist
ahc 52[no description available]medium10
tryptophol[no description available]medium10indolyl alcoholauxin;
plant metabolite;
Saccharomyces cerevisiae metabolite
nitric acid[no description available]medium10nitrogen oxoacidprotic solvent;
reagent
sodium lactate[no description available]medium10lactate salt;
organic sodium salt		food acidity regulator;
food preservative
iodosobenzene[no description available]medium10
sodium tetradecyl sulfate[no description available]medium10
cl 184005[no description available]medium10
nitrous acid[no description available]medium10nitrogen oxoacid
s-nitrosocysteine[no description available]medium10L-cysteine derivative;
nitrosothio compound		hematologic agent;
platelet aggregation inhibitor;
vasodilator agent
bw a522[no description available]medium10
ha 1004[no description available]medium20isoquinolines
2,4-dimethylpyridine[no description available]medium10methylpyridines
2-hexynyladenosine-5'-n-ethylcarboxamide[no description available]medium30
1,3-diisopropylcarbodiimide[no description available]medium20carbodiimidepeptide coupling reagent
cromakalim[no description available]medium20
folpet[no description available]medium20organochlorine compound;
organosulfur compound;
phthalimide fungicide		antifungal agrochemical
4-aminophenol[no description available]medium10aminophenolallergen;
metabolite
dibutyryl cyclic gmp[no description available]medium10
sodium borohydride[no description available]medium10inorganic sodium salt;
metal tetrahydridoborate
rogletimide[no description available]medium20
ono 4057[no description available]medium10
tri-o-cresyl phosphate[no description available]medium10
onapristone[no description available]medium10
bromouracil[no description available]medium10nucleobase analogue;
pyrimidines		mutagen
bromacil[no description available]medium10organobromine compound;
pyrimidone
terbacil[no description available]medium10organohalogen compound;
pyrimidines
hexazinone[no description available]medium101,3,5-triazines
cytidylyl-3',5'-adenosine[no description available]medium30nucleoside analogue;
purines
mechlorethamine[no description available]medium30nitrogen mustard;
organochlorine compound		alkylating agent
ici 198615[no description available]medium30
mk 458[no description available]medium10hydrochlorideanticonvulsant;
antiparkinson drug;
dopamine agonist
roxatidine acetate[no description available]medium10piperidines
pibutidine hydrochloride[no description available]medium10hydrochlorideanti-ulcer drug;
H2-receptor antagonist
sufotidine[no description available]medium85piperidines
6-(4-nitrobenzylthio)guanosine[no description available]medium10
phenyldiazene[no description available]medium20
fura-2-am[no description available]medium10
5-iodotubercidin[no description available]medium10organoiodine compound
tubercidin[no description available]medium10antibiotic antifungal agent;
N-glycosylpyrrolopyrimidine;
ribonucleoside		antimetabolite;
antineoplastic agent;
bacterial metabolite
draflazine[no description available]medium10
microcystin rr[no description available]medium10microcystin;
organic molecular entity		bacterial metabolite;
environmental contaminant;
xenobiotic
diphenic acid[no description available]medium10dicarboxylic acid
cyclobenzaprine[no description available]medium10carbotricyclic compoundantidepressant;
muscle relaxant;
tranquilizing drug
charybdotoxin[no description available]medium20
phentolamine[no description available]medium10imidazoles;
phenols;
substituted aniline;
tertiary amino compound		alpha-adrenergic antagonist;
vasodilator agent
flag peptide[no description available]medium10peptide
1-o-hexadecyl-2-arachidonyl-sn-glycero-3-phosphocholine[no description available]medium10
rink amide resin[no description available]medium10
betamethasone sodium phosphate[no description available]medium10organic sodium salt;
tertiary alpha-hydroxy ketone
betamethasone[no description available]medium2011beta-hydroxy steroid;
17alpha-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
fluorinated steroid;
glucocorticoid;
primary alpha-hydroxy ketone;
tertiary alpha-hydroxy ketone		anti-asthmatic agent;
anti-inflammatory drug;
immunosuppressive agent
pergolide[no description available]medium10diamine;
methyl sulfide;
organic heterotetracyclic compound		antiparkinson drug;
dopamine agonist
lactoferricin b[no description available]medium10
2-methyl-5-nitroimidazole[no description available]medium10C-nitro compound;
imidazoles
avitriptan[no description available]medium10tryptamines
4-ethyl-5-(4-fluorophenyl)-2,4-dihydro-3h-1,2,4-triazole-3-thione[no description available]medium10
mezlocillin[no description available]medium10penicillin allergen;
penicillin		antibacterial drug
acriflavine[no description available]medium20
penicillin v[no description available]medium10penicillin allergen;
penicillin
4-carboxyfluorescein[no description available]medium10monocarboxylic acidfluorochrome
sch 37370[no description available]medium10
1,2-diaminoanthraquinone[no description available]medium10
alpha-conotoxin pnia[no description available]medium10
aminopotentidine[no description available]medium10aromatic ether;
benzamides;
guanidines;
nitrile;
piperidines;
substituted aniline		H2-receptor antagonist
amthamine[no description available]medium10thiazoles
iodoaminopotentidine[no description available]medium10
p-hydroxyamphetamine[no description available]medium11amphetamines
1-butanol[no description available]medium30alkyl alcohol;
primary alcohol;
short-chain primary fatty alcohol		human metabolite;
mouse metabolite;
protic solvent
quinelorane[no description available]medium10quinazolines
2-(2,4-difluorophenyl)-3-(4-(4-(2-(4-trifluoromethoxybenzyl)-2h-1,2,4-triazol-3-one-4-yl)phenyl)piperazin-1-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol[no description available]medium80
coomassie brilliant blue[no description available]medium10
ethylmaleimide[no description available]medium70maleimidesanticoronaviral agent;
EC 1.3.1.8 [acyl-CoA dehydrogenase (NADP(+))] inhibitor;
EC 2.1.1.122 [(S)-tetrahydroprotoberberine N-methyltransferase] inhibitor;
EC 2.7.1.1 (hexokinase) inhibitor
tabersonine[no description available]medium10alkaloid ester;
methyl ester;
monoterpenoid indole alkaloid;
organic heteropentacyclic compound		antineoplastic agent;
metabolite
2,5-pyridinedicarboxylic acid[no description available]medium10pyridinedicarboxylic acid
sch 23982[no description available]medium10
camonagrel[no description available]medium20
setoperone[no description available]medium10
spiperone[no description available]medium20aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound		alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
7-hydroxy-2-n,n-dipropylaminotetralin[no description available]medium10tetralins
cefdinir[no description available]medium10
3-(2-(2,4,6-trimethylphenyl)thioethyl)-4-methylsydnone[no description available]medium10
ornidazole[no description available]medium10C-nitro compound;
imidazoles;
organochlorine compound;
secondary alcohol		antiamoebic agent;
antibacterial drug;
antiinfective agent;
antiprotozoal drug;
antitrichomonal drug;
epitope
tinidazole[no description available]medium10imidazolesantiamoebic agent;
antibacterial drug;
antiparasitic agent;
antiprotozoal drug
doranidazole[no description available]medium10
a 85783.0[no description available]medium10
triphenyl phosphate[no description available]medium10aryl phosphateflame retardant;
plasticiser
meclizine[no description available]medium30diarylmethane
benztropine[no description available]medium10diarylmethane
cy 208-243[no description available]medium10phenanthridines
ethyl 4-dimethylaminobenzoate[no description available]medium10benzoate ester;
ethyl ester;
tertiary amino compound
triethylene glycol dimethacrylate[no description available]medium10
camphoroquinone[no description available]medium10bornane monoterpenoid;
carbobicyclic compound
binodenoson[no description available]medium20
8-((4-chlorophenyl)thio)cyclic-3',5'-gmp[no description available]medium103',5'-cyclic purine nucleotide;
aryl sulfide;
organochlorine compound;
ribonucleotide		protein kinase agonist
ethyl chloride[no description available]medium10chloroethanesantipruritic drug;
inhalation anaesthetic;
local anaesthetic
bromoethane[no description available]medium10bromoalkane;
bromohydrocarbon;
volatile organic compound		alkylating agent;
carcinogenic agent;
local anaesthetic;
refrigerant;
solvent
direct blue 15[no description available]medium10
pentane[no description available]medium10alkane;
volatile organic compound		non-polar solvent;
refrigerant
phenylalanylglycine[no description available]medium10dipeptidemetabolite
ethofumesate[no description available]medium101-benzofurans;
ether;
methanesulfonate ester
rottlerin[no description available]medium10aromatic ketone;
benzenetriol;
chromenol;
enone;
methyl ketone		anti-allergic agent;
antihypertensive agent;
antineoplastic agent;
apoptosis inducer;
K-ATP channel agonist;
metabolite
go 6976[no description available]medium10indolocarbazole;
organic heterohexacyclic compound		EC 2.7.11.13 (protein kinase C) inhibitor
7,12-dimethylbenz(a)anthracene-dihydrodiol[no description available]medium10
nicorandil[no description available]medium10nitrate ester;
pyridinecarboxamide		potassium channel opener;
vasodilator agent
pinacidil[no description available]medium10pyridines
2-(1-octynyl)adenosine[no description available]medium20
mrs 1067[no description available]medium10
bufotenin[no description available]medium10tertiary amine;
tryptamine alkaloid		coral metabolite;
hallucinogen
ym 022[no description available]medium10
8-bromoguanosino-3',5'-cyclic monophosphorothioate[no description available]medium10
eticlopride[no description available]medium10salicylamides
deoxyguanosine triphosphate[no description available]medium10deoxyguanosine phosphate;
guanyl deoxyribonucleotide;
purine 2'-deoxyribonucleoside 5'-triphosphate		Arabidopsis thaliana metabolite;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
plant metabolite;
Saccharomyces cerevisiae metabolite
4-(dimethylamino)benzaldehyde[no description available]medium10benzaldehydes;
substituted aniline;
tertiary amino compound		chromogenic compound
cerium sulfate[no description available]medium10
mestranol[no description available]medium1117beta-hydroxy steroid;
aromatic ether;
terminal acetylenic compound		prodrug;
xenoestrogen
glycidamide[no description available]medium10
calcein am[no description available]medium102-benzofurans;
acetate ester;
gamma-lactone;
organic heteropentacyclic compound;
oxaspiro compound;
xanthene dye		fluorochrome
ro 15-4513[no description available]medium20organic heterotricyclic compound;
organonitrogen heterocyclic compound
aspartimide[no description available]medium10dicarboximide;
primary amino compound;
pyrrolidinone		Maillard reaction product
1,2-dichloroethylene[no description available]medium10chloroethenes
phosphoryl chloride[no description available]medium10phosphorus coordination entity
pseudouridine[no description available]medium20pseudouridinesfundamental metabolite
bwa 4c[no description available]medium10
alloxan[no description available]medium10pyrimidonehyperglycemic agent;
metabolite
hydantocidin[no description available]medium10
cgp 35348[no description available]medium10
1-oleoyl-2-acetylglycerol[no description available]medium101,2-diglyceride
2,2'-azobis(2-amidinopropane)[no description available]medium10monoazo compound
nitroblue tetrazolium[no description available]medium30organic cation
allyl sulfide[no description available]medium10organic sulfide
2-keto-4-methylvalerate[no description available]medium112-oxo monocarboxylic acid;
branched-chain keto acid		algal metabolite;
human metabolite
herbimycin[no description available]medium101,4-benzoquinones;
lactam;
macrocycle		antimicrobial agent;
apoptosis inducer;
herbicide;
Hsp90 inhibitor;
tyrosine kinase inhibitor
daidzein[no description available]medium107-hydroxyisoflavonesantineoplastic agent;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
phytoestrogen;
plant metabolite
tosylphenylalanyl chloromethyl ketone[no description available]medium20alpha-chloroketone;
sulfonamide		alkylating agent;
serine proteinase inhibitor
pyrrolidine dithiocarbamate[no description available]medium20dithiocarbamic acids;
pyrrolidines		anticonvulsant;
antineoplastic agent;
geroprotector;
neuroprotective agent;
NF-kappaB inhibitor;
radical scavenger
2-(4-(2-(2-((4-aminophenyl)methylcarbonylamino)ethylaminocarbonyl)ethyl)phenyl)ethylamino-5'-n-ethylcarboxamidoadenosine[no description available]medium10
5-(n,n-hexamethylene)amiloride[no description available]medium10aromatic amine;
azepanes;
guanidines;
monocarboxylic acid amide;
organochlorine compound;
pyrazines		antineoplastic agent;
apoptosis inducer;
odorant receptor antagonist;
sodium channel blocker
4-chloroaniline[no description available]medium10chloroaniline;
monochlorobenzenes
retinol acetate[no description available]medium10acetate ester
anhydrovitamin a[no description available]medium10sesquiterpenoid
5,8,11,14-eicosatetraynoic acid[no description available]medium20long-chain fatty acid
dodine[no description available]medium10acetate salt;
aliphatic nitrogen antifungal agent		antibacterial agent;
antifungal agrochemical
dimethyldithiocarbamate[no description available]medium10dithiocarbamate anions
quintozene[no description available]medium10aromatic fungicide;
C-nitro compound;
pentachlorobenzenes		antifungal agrochemical
ferbam[no description available]medium10
triforine[no description available]medium10amide fungicide;
formamides;
N-alkylpiperazine;
organochlorine compound		allergen;
antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
fluocinolone acetonide[no description available]medium1011beta-hydroxy steroid;
20-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(1),Delta(4)-steroid;
cyclic ketal;
fluorinated steroid;
glucocorticoid;
organic heteropentacyclic compound;
primary alpha-hydroxy ketone		anti-inflammatory drug;
antipruritic drug
norfluoxetine[no description available]medium10(trifluoromethyl)benzenes
desmethylsertraline[no description available]medium10
p(1),p(5)-di(adenosine-5'-)pentaphosphate[no description available]medium10organophosphate oxoanion
ly 367265[no description available]medium10dihydropyridine;
fluoroindole;
tertiary amino compound;
thiadiazoloquinoline		antidepressant;
geroprotector;
serotonergic antagonist;
serotonin uptake inhibitor
trimethylsilyl iodide[no description available]medium10
sodium iodide[no description available]medium10inorganic sodium salt;
iodide salt
manoalide[no description available]medium10butenolide;
lactol;
sesterterpenoid		EC 3.1.1.4 (phospholipase A2) inhibitor;
EC 5.99.1.2 (DNA topoisomerase) inhibitor;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
metabolite
12-hydroxy-5,8,10,14-eicosatetraenoic acid[no description available]medium10
mepivacaine[no description available]medium10piperidinecarboxamidedrug allergen;
local anaesthetic
himbacine[no description available]medium10gamma-lactone;
organic heterotricyclic compound;
piperidine alkaloid		muscarinic antagonist
5'-n-methylcarboxamideadenosine[no description available]medium10
suplatast tosilate[no description available]medium10
ebastine[no description available]medium10organic molecular entity
seocalcitol[no description available]medium10
desoxycorticosterone[no description available]medium1020-oxo steroid;
21-hydroxy steroid;
3-oxo-Delta(4) steroid;
mineralocorticoid;
primary alpha-hydroxy ketone		human metabolite;
mouse metabolite
tetrahydrodeoxycorticosterone[no description available]medium1021-hydroxy steroid
1,4-cyclohexadiene[no description available]medium10cyclohexadiene
calvatic acid[no description available]medium10
methyl sulfate[no description available]medium10alkyl sulfate;
one-carbon compound
diazipine[no description available]medium10
angiotensin i[no description available]medium10angiotensin;
peptide zwitterion		human metabolite;
neurotransmitter agent
terics[no description available]medium10
n-(2-(hydroxyethoxy)methyl)-5-methyluracil[no description available]medium10
methylacetylene[no description available]medium10alkyne;
gas molecular entity;
terminal acetylenic compound
ethion[no description available]medium10organic thiophosphateacaricide;
agrochemical;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
environmental contaminant;
insecticide
sulindac sulfide[no description available]medium10aryl sulfide;
monocarboxylic acid;
organofluorine compound		antineoplastic agent;
apoptosis inducer;
non-steroidal anti-inflammatory drug
sulindac[no description available]medium10monocarboxylic acid;
organofluorine compound;
sulfoxide		analgesic;
antineoplastic agent;
antipyretic;
apoptosis inducer;
EC 1.14.99.1 (prostaglandin-endoperoxide synthase) inhibitor;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
prodrug;
tocolytic agent
diazoxon[no description available]medium10organic phosphate;
pyrimidines		marine xenobiotic metabolite
14,15-epoxy-5,8,11-eicosatrienoic acid[no description available]medium10long-chain fatty acid
nitazoxanide[no description available]medium10benzamides;
carboxylic ester
canavanine[no description available]medium20amino acid zwitterion;
non-proteinogenic L-alpha-amino acid		phytogenic insecticide;
plant metabolite
dichlorprop[no description available]medium10aromatic ether;
dichlorobenzene;
monocarboxylic acid
norclozapine[no description available]medium10dibenzodiazepine;
organochlorine compound;
piperazines		delta-opioid receptor agonist;
metabolite;
serotonergic antagonist
vigabatrin[no description available]medium10gamma-amino acidanticonvulsant;
EC 2.6.1.19 (4-aminobutyrate--2-oxoglutarate transaminase) inhibitor
castanospermine[no description available]medium10indolizidine alkaloidanti-HIV-1 agent;
anti-inflammatory agent;
EC 3.2.1.* (glycosidase) inhibitor;
metabolite
1-azafagomine[no description available]medium10
7-hydroxystaurosporine[no description available]medium10
sq-11725[no description available]medium11
pnu 142633f[no description available]medium10
ly 334370[no description available]medium10
s-nitroso-n-acetylcysteine[no description available]medium10
2-amino-5-(3,4-dimethoxyphenyl)-1,3,4-thiadiazole[no description available]medium10
methyl octanoate[no description available]medium10fatty acid methyl ester;
octanoate ester		metabolite
elarofiban[no description available]medium10
5'-adenylyl (beta,gamma-methylene)diphosphonate[no description available]medium10nucleoside triphosphate analogue
thiotepa[no description available]medium10aziridines
4,4'-diisothiocyanostilbene-2,2'-disulfonic acid[no description available]medium10
aspartame[no description available]medium10carboxylic acid;
dipeptide zwitterion;
dipeptide;
methyl ester		apoptosis inhibitor;
EC 3.1.3.1 (alkaline phosphatase) inhibitor;
environmental contaminant;
micronutrient;
nutraceutical;
sweetening agent;
xenobiotic
gibberellin a1[no description available]medium10C19-gibberellin;
gibberellin monocarboxylic acid;
lactone		plant metabolite
3-((3-cholamidopropyl)dimethylammonium)-1-propanesulfonate[no description available]medium101,1-diunsubstituted alkanesulfonate
idoxifene[no description available]medium20stilbenoid
ecdysone[no description available]medium1014alpha-hydroxy steroid;
22-hydroxy steroid;
25-hydroxy steroid;
2beta-hydroxy steroid;
3beta-sterol;
6-oxo steroid;
ecdysteroid		prohormone
cyhexatin[no description available]medium10
vendex[no description available]medium10organotin acaricide
nitisinone[no description available]medium10(trifluoromethyl)benzenes;
C-nitro compound;
cyclohexanones;
mesotrione		EC 1.13.11.27 (4-hydroxyphenylpyruvate dioxygenase) inhibitor
9-ethylguanine[no description available]medium10
potassium bromide[no description available]medium10potassium salt
pkh 26[no description available]medium10
rolofylline[no description available]medium10oxopurine
adenosine amine congener[no description available]medium10
2,3-dihydroxybenzoic acid[no description available]medium10dihydroxybenzoic acidhuman xenobiotic metabolite;
plant metabolite
sulfasalazine[no description available]medium10
chlorfenapyr[no description available]medium10hemiaminal ether;
monochlorobenzenes;
nitrile;
organochlorine acaricide;
organochlorine insecticide;
organofluorine acaricide;
organofluorine insecticide;
pyrroles		proacaricide;
proinsecticide
dimethomorph[no description available]medium10aromatic ether;
enamide;
monochlorobenzenes;
morpholine fungicide;
tertiary carboxamide
droloxifene[no description available]medium10stilbenoid
zindoxifene[no description available]medium10phenylindole
tat 59[no description available]medium10aryl phosphate
e 5880[no description available]medium10
ddms[no description available]medium10chlorophenylethane;
monochlorobenzenes
cephalexin[no description available]medium60beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative		antibacterial drug
phenoxybenzamine[no description available]medium20aromatic amine
nafenopin[no description available]medium10aromatic ether;
monocarboxylic acid
nialamide[no description available]medium10organonitrogen compound;
organooxygen compound
methyldopa[no description available]medium10L-tyrosine derivative;
non-proteinogenic L-alpha-amino acid		alpha-adrenergic agonist;
antihypertensive agent;
hapten;
peripheral nervous system drug;
sympatholytic agent
normetanephrine[no description available]medium10catecholamine
etazolate[no description available]medium10ethyl ester;
hydrazone;
pyrazolopyridine		alpha-secretase activator;
antidepressant;
antipsychotic agent;
anxiolytic drug;
GABA agent;
neuroprotective agent;
phosphodiesterase IV inhibitor
fenclonine[no description available]medium10phenylalanine derivative
dimethylnitrosamine[no description available]medium30nitrosaminegeroprotector;
mutagen
ribavirin 5'-diphosphate[no description available]medium101-ribosyltriazole;
aromatic amide;
monocarboxylic acid amide;
primary carboxamide;
ribose monophosphate		antiviral agent;
drug metabolite;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
human blood serum metabolite
hexobarbital[no description available]medium70barbiturates
dianisidine[no description available]medium10biphenyls
benzydamine[no description available]medium10aromatic ether;
indazoles;
tertiary amino compound		analgesic;
central nervous system stimulant;
hallucinogen;
local anaesthetic;
non-steroidal anti-inflammatory drug
azaserine[no description available]medium30carboxylic ester;
diazo compound;
L-serine derivative;
non-proteinogenic L-alpha-amino acid		antifungal agent;
antimetabolite;
antimicrobial agent;
antineoplastic agent;
glutamine antagonist;
immunosuppressive agent;
metabolite
l 11204[no description available]medium20
carbon disulfide[no description available]medium10one-carbon compound;
organosulfur compound
3-chloroperbenzoic acid[no description available]medium10monochlorobenzenes;
peroxy acid
papaverine[no description available]medium60benzylisoquinoline alkaloid;
dimethoxybenzene;
isoquinolines		antispasmodic drug;
vasodilator agent
showdomycin[no description available]medium10
allantoin[no description available]medium10imidazolidine-2,4-dione;
ureas		Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite;
vulnerary
cephaloridine[no description available]medium10beta-lactam antibiotic allergen;
cephalosporin;
semisynthetic derivative		antibacterial drug
ethylenebis(isothiocyanate)[no description available]medium10
methimazole[no description available]medium201,3-dihydroimidazole-2-thionesantithyroid drug
thiamylal[no description available]medium10barbiturates;
organosulfur compound		sedative
l 10503[no description available]medium30
secobarbital[no description available]medium11barbituratesanaesthesia adjuvant;
GABA modulator;
sedative
nitrazepam[no description available]medium911,4-benzodiazepinone;
C-nitro compound		anticonvulsant;
antispasmodic drug;
drug metabolite;
GABA modulator;
sedative
histidinol[no description available]medium10amino alcohol;
imidazoles		EC 2.3.1.97 (glycylpeptide N-tetradecanoyltransferase) inhibitor;
Escherichia coli metabolite;
human metabolite;
Saccharomyces cerevisiae metabolite
puromycin[no description available]medium20puromycinsantiinfective agent;
antimicrobial agent;
antineoplastic agent;
EC 3.4.11.14 (cytosol alanyl aminopeptidase) inhibitor;
EC 3.4.14.2 (dipeptidyl-peptidase II) inhibitor;
nucleoside antibiotic;
protein synthesis inhibitor
acetoin[no description available]medium10methyl ketone;
secondary alpha-hydroxy ketone		metabolite
betazole[no description available]medium10primary amino compound;
pyrazoles		diagnostic agent;
gastrointestinal drug;
histamine agonist
trapidil[no description available]medium10triazolopyrimidines
phenylmethylsulfonyl fluoride[no description available]medium10acyl fluorideserine proteinase inhibitor
rp 59227[no description available]medium30
ly 255283[no description available]medium10aromatic ketone
prostaglandin f1[no description available]medium20prostaglandins Falphahuman metabolite
moxisylyte[no description available]medium10monoterpenoid
ritanserin[no description available]medium10organofluorine compound;
piperidines;
thiazolopyrimidine		antidepressant;
antipsychotic agent;
anxiolytic drug;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
serotonergic antagonist
4-bromophenacyl bromide[no description available]medium10
progabide[no description available]medium10diarylmethane
2-(4-chlorophenyl)-2,5-dihydropyrazolo(4,3-c)quinoline-3(3h)-one[no description available]medium10
dermorphin[no description available]medium10oligopeptide
enkephalinamide-leu[no description available]medium10
mephenesin[no description available]medium20aromatic ether;
glycerol ether
dichlorodiphenyldichloroethane[no description available]medium10chlorophenylethane;
monochlorobenzenes;
organochlorine insecticide		xenobiotic metabolite
3-nitro-2-pyridinesulfenyl[no description available]medium10
bn 50726[no description available]medium40
bendazac[no description available]medium10indazoles;
monocarboxylic acid		non-steroidal anti-inflammatory drug;
radical scavenger
sri 62-834[no description available]medium30
saperconazole[no description available]medium30
rs 5186[no description available]medium10
methylprednisolone hemisuccinate[no description available]medium10corticosteroid hormone;
hemisuccinate
mdl 19660[no description available]medium40
phosphocreatine[no description available]medium20phosphagen;
phosphoamino acid		human metabolite;
mouse metabolite
esculetin[no description available]medium20hydroxycoumarinantioxidant;
plant metabolite;
ultraviolet filter
l 659989[no description available]medium20
ro 19-3704[no description available]medium20
beta-endorphin[no description available]medium10
phosphatidylethanol[no description available]medium10
ro 24-4736[no description available]medium10
netropsin[no description available]medium10
lexitropsin[no description available]medium10
ws 7739 b[no description available]medium10
ym 461[no description available]medium10
quinone methide[no description available]medium10quinomethane
tiotidine[no description available]medium10thiazoles
thymopentin[no description available]medium10oligopeptide
thymalfasin[no description available]medium10polypeptide
septide[no description available]medium10
senktide[no description available]medium10
n-formylnorleucyl-leucyl-4-phenylalanine[no description available]medium10
l 670596[no description available]medium10carbazoles
arachidonic acid 5-hydroperoxide[no description available]medium10HPETEhuman xenobiotic metabolite
captafol[no description available]medium10isoindoles;
organochlorine compound;
organosulfur compound;
phthalimide fungicide		antifungal agrochemical
ro 24-0238[no description available]medium10
lemax[no description available]medium10
ginkgolide j[no description available]medium10
ginkgolide c[no description available]medium30
selfotel[no description available]medium20non-proteinogenic alpha-amino acid
8-(n,n-diethylamino)octyl-3,4,5-trimethoxybenzoate[no description available]medium20trihydroxybenzoic acid
impromidine[no description available]medium10
quinomethionate[no description available]medium10dithioloquinoxaline;
quinoxaline acaricide;
quinoxaline antifungal agent		agrochemical
1-dodecylimidazole[no description available]medium10
ono 6240[no description available]medium10
2-(2-hydroxy-4-methylphenyl)aminothiazole[no description available]medium10organic molecular entity
etizolam[no description available]medium10organic molecular entity
temelastine[no description available]medium10pyrimidone
diphenylhexatriene[no description available]medium10alkatrienefluorochrome
aphidicolin[no description available]medium10tetracyclic diterpenoidantimicrobial agent;
antimitotic;
antineoplastic agent;
antiviral drug;
apoptosis inducer;
Aspergillus metabolite;
DNA synthesis inhibitor;
EC 2.7.7.7 (DNA-directed DNA polymerase) inhibitor;
fungal metabolite
phenidone[no description available]medium10
6-(5-methylimidazol-1-yl)methyl-2-naphthoic acid hydrochloride[no description available]medium10
dazmegrel[no description available]medium10
u 44069[no description available]medium10prostanoid
ici 204,219[no description available]medium10carbamate ester;
indoles;
N-sulfonylcarboxamide		anti-asthmatic agent;
leukotriene antagonist
cumene hydroperoxide[no description available]medium10peroxolenvironmental contaminant;
Mycoplasma genitalium metabolite;
oxidising agent
dicarbethoxydihydrocollidine[no description available]medium10dihydropyridine;
ethyl ester		hepatic steatosis inducing agent
3,5-dicarbethoxy-2,6-dimethyl-4-ethyl-1,4-dihydropyridine[no description available]medium10
sdz 64-412[no description available]medium10
methylbenzoprim[no description available]medium10
cathepsin g[no description available]medium10
1,2-distearoyllecithin[no description available]medium10
7,8-dichloro-1,2,3,4-tetrahydroisoquinoline[no description available]medium10isoquinolines;
organochlorine compound
mafosfamide[no description available]medium20
sarcosine[no description available]medium20N-alkylglycine zwitterion;
N-alkylglycine;
N-methyl-amino acid;
N-methylglycines		Escherichia coli metabolite;
glycine receptor agonist;
glycine transporter 1 inhibitor;
human metabolite;
mouse metabolite
sarcosine dithiocarbamate[no description available]medium20
racemetirosine[no description available]medium10
kadsurenone[no description available]medium10benzofurans
doxantrazole[no description available]medium10
cgs 15696[no description available]medium10
octylonium[no description available]medium10benzamides
octylmethoxycinnamate[no description available]medium10cinnamate ester
idazoxan[no description available]medium10benzodioxine;
imidazolines		alpha-adrenergic antagonist
tridemorph[no description available]medium10morpholines;
tertiary amino compound		antifungal agrochemical
halofantrine[no description available]medium10phenanthrenes
l 643441[no description available]medium10
inosine dialdehyde[no description available]medium10
dihydroalprenolol[no description available]medium10
hyaluronoglucosaminidase[no description available]medium10
fomepizole[no description available]medium10pyrazolesantidote;
EC 1.1.1.1 (alcohol dehydrogenase) inhibitor;
protective agent
cadaverine[no description available]medium10alkane-alpha,omega-diamineDaphnia magna metabolite;
Escherichia coli metabolite;
mouse metabolite;
plant metabolite
rb 6110[no description available]medium10
monomethylarsonic acid[no description available]medium10arsonic acids;
one-carbon compound;
organoarsonic acid
methylphosphonic acid[no description available]medium10one-carbon compound;
phosphonic acids
dazoxiben[no description available]medium10
salicylhydroxamic acid[no description available]medium10hydroxamic acid;
phenols		antibacterial drug;
EC 1.11.2.2 (myeloperoxidase) inhibitor;
EC 3.5.1.5 (urease) inhibitor;
trypanocidal drug
tiazofurin[no description available]medium101,3-thiazoles;
C-glycosyl compound;
monocarboxylic acid amide		antineoplastic agent;
EC 1.1.1.205 (IMP dehydrogenase) inhibitor;
prodrug
estazolam[no description available]medium10triazoles;
triazolobenzodiazepine		anticonvulsant;
anxiolytic drug;
GABA modulator
n-nitrosobutylurea[no description available]medium10
propiolactone[no description available]medium10propan-3-olide
methyl methanesulfonate[no description available]medium10methanesulfonate esteralkylating agent;
apoptosis inducer;
carcinogenic agent;
genotoxin;
mutagen
11-dodecynoic acid[no description available]medium10medium-chain fatty acid
azaconazole[no description available]medium10conazole fungicide;
cyclic ketal;
dichlorobenzene;
dioxolane;
triazole fungicide;
triazoles		antifungal agrochemical;
EC 1.14.13.70 (sterol 14alpha-demethylase) inhibitor
ornithylamphotericin methyl ester[no description available]medium20
2-nitrophenol[no description available]medium102-nitrophenols
chloral hydrate[no description available]medium10aldehyde hydrate;
ethanediol;
organochlorine compound		general anaesthetic;
mouse metabolite;
sedative;
xenobiotic
triiodothyronine, reverse[no description available]medium103,3',5'-triiodothyronine;
amino acid zwitterion
sulbenicillin[no description available]medium10penicillin
carbenicillin[no description available]medium10penicillin allergen;
penicillin		antibacterial drug
cyclacillin[no description available]medium10penicillinantibacterial drug
delphinidin[no description available]medium10anthocyanidin chloride
dicumarol[no description available]medium10hydroxycoumarinanticoagulant;
EC 1.6.5.2 [NAD(P)H dehydrogenase (quinone)] inhibitor;
Hsp90 inhibitor;
vitamin K antagonist
thioguanine anhydrous[no description available]medium202-aminopurinesanticoronaviral agent;
antimetabolite;
antineoplastic agent
gentian violet[no description available]medium10organic chloride saltanthelminthic drug;
antibacterial agent;
antifungal agent;
antiseptic drug;
histological dye
halothane[no description available]medium20haloalkane;
organobromine compound;
organochlorine compound;
organofluorine compound		inhalation anaesthetic
prenylamine[no description available]medium20diarylmethane
lidoflazine[no description available]medium10diarylmethane
khellin[no description available]medium10furanochromone;
organic heterotricyclic compound;
oxacycle		anti-asthmatic agent;
bronchodilator agent;
cardiovascular drug;
vasodilator agent
nitrosoguanidines[no description available]medium10
phosphoenolpyruvate[no description available]medium30carboxyalkyl phosphate;
monocarboxylic acid		fundamental metabolite
glyceraldehyde[no description available]medium10aldotriosefundamental metabolite
tripelennamine[no description available]medium10aromatic amine
1-aminoadenosine[no description available]medium10
methallibure[no description available]medium10
chlormezanone[no description available]medium101,3-thiazine;
lactam;
monochlorobenzenes;
sulfone		antipsychotic agent;
anxiolytic drug;
muscle relaxant
methocarbamol[no description available]medium10aromatic ether;
carbamate ester;
secondary alcohol
cyclamic acid[no description available]medium20sulfamic acidsenvironmental contaminant;
human xenobiotic metabolite
vanilmandelic acid[no description available]medium102-hydroxy monocarboxylic acid;
aromatic ether;
phenols		human metabolite
zoxazolamine[no description available]medium30benzoxazole
trichloroacetic acid[no description available]medium10monocarboxylic acid;
organochlorine compound		carcinogenic agent;
metabolite;
mouse metabolite
dicamba[no description available]medium10dichlorobenzene;
methoxybenzoic acid		agrochemical;
environmental contaminant;
herbicide;
synthetic auxin;
xenobiotic
oxalates[no description available]medium10
mescaline[no description available]medium10methoxybenzenes;
phenethylamine alkaloid;
primary amino compound		hallucinogen
tetrabenazine[no description available]medium10benzoquinolizine;
cyclic ketone;
tertiary amino compound
8-azahypoxanthine[no description available]medium10nucleobase analogue;
triazolopyrimidines		antimalarial;
EC 2.4.2.8 (hypoxanthine phosphoribosyltransferase) inhibitor
sulfaguanidine[no description available]medium10sulfonamide antibioticantiinfective agent
pyridoxine[no description available]medium10hydroxymethylpyridine;
methylpyridines;
monohydroxypyridine;
vitamin B6		cofactor;
Escherichia coli metabolite;
human metabolite;
mouse metabolite;
Saccharomyces cerevisiae metabolite
oxyphenbutazone[no description available]medium10phenols;
pyrazolidines		antimicrobial agent;
antineoplastic agent;
antipyretic;
drug metabolite;
gout suppressant;
non-narcotic analgesic;
non-steroidal anti-inflammatory drug;
xenobiotic metabolite
trazodone hydrochloride[no description available]medium1280hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
fusarium[no description available]medium2303
octachloronaphthalene[no description available]medium30
isomethyleugenol[no description available]medium421isomethyleugenol
glyphosate[no description available]medium190glycine derivative;
phosphonic acid		agrochemical;
EC 2.5.1.19 (3-phosphoshikimate 1-carboxyvinyltransferase) inhibitor;
herbicide
diospyros[no description available]medium10
foxes[no description available]medium11
sabinene[no description available]medium80thujeneplant metabolite
s,n,n'-tripropylthiocarbamate[no description available]medium212tertiary amine
exudates[no description available]medium41
ursolic acid[no description available]medium40hydroxy monocarboxylic acid;
pentacyclic triterpenoid		geroprotector;
plant metabolite
humulene[no description available]medium30alpha-humulene
ppi-0903[no description available]medium101,3-thiazoles;
cephalosporin;
iminium betaine;
organic phosphoramidate;
oxime O-ether;
thiadiazoles		antibacterial drug;
antimicrobial agent;
prodrug
eye[no description available]medium201
cucurbitaceae[no description available]medium20
methyl salicylate[no description available]medium20benzoate ester;
methyl ester;
salicylates		flavouring agent;
insect attractant;
metabolite
torpedo[no description available]medium30
trolamine salicylate[no description available]medium100
rebaudioside a[no description available]medium10beta-D-glucoside;
rebaudioside;
tetracyclic diterpenoid		sweetening agent
apnea[no description available]medium10purine nucleoside
jaw[no description available]medium60indolecarboxamide
rosmarinic acid[no description available]medium10rosmarinic acidgeroprotector;
plant metabolite
phenylephrine hydrochloride[no description available]medium30hydrochloride
cinidon-ethyl[no description available]medium10ethyl ester;
isoindoles;
monochlorobenzenes		herbicide
cetylpyridinium chloride anhydrous[no description available]medium22chloride salt;
organic chloride salt		antiseptic drug;
surfactant
4-methoxyamphetamine[no description available]medium40
guaifenesin[no description available]medium10methoxybenzenes
hypericum[no description available]medium11penicillanic acids
inositol 3-phosphate[no description available]medium20
fenpyroximate[no description available]medium10pyrazole acaricide;
tert-butyl ester		mitochondrial NADH:ubiquinone reductase inhibitor
ConditionIndicatedRelationship StrengthStudiesTrials
(pPNET) Peripheral Primitive Neuroectodermal Tumors0low10
2019 Novel Coronavirus Disease0medium262
2019 Novel Coronavirus Infection0medium262
2019-nCoV Disease0medium262
2019-nCoV Infection0medium262
22q11.2 Deletion Syndrome0low10
22q11.2DS0low10
4 Hydroxyphenylpyruvate Dioxygenase Deficiency Disease0low10
4-Hydroxyphenol Pyruvic Acid Oxidase Deficiency Disease0low10
4-Hydroxyphenylpyruvate Dioxygenase Deficiency0low10
4-Hydroxyphenylpyruvic Acid Oxidase Deficiency0low10
46,XX Gonadal Dysgenesis, Complete, Sry-Positive0low10
46,XX True Hermaphroditism, Sry-Positive0low10
47,XX,+210low10
47,XY,+210low10
48,XXYY Syndrome0medium61
49,XXXXY Syndrome0medium61
6th Nerve Palsy0low10
7-Dehydrocholesterol Reductase Deficiency0low10
A-V Dissociation0medium21
Abdominal Abscess0low20
Abdominal Aortic Aneurysm0low40
Abdominal Cryptorchidism0low10
Abdominal Epilepsy0medium125
Abdominal Migraine0medium23878
Abdominal Neoplasms0low10
Abdominal Pain0medium61
Abducens Nerve Diseases0low10
Abducens Nerve Palsy0low10
Abducens Palsy0low10
Abducens Palsy, Childhood, Benign Recurrent0low10
Aberrant Crypt Foci0low10
Aberrant Tissue0low30
Abnormal Movements0low20
Abnormalities, Autosome0low230
Abnormalities, Cardiovascular0low10
Abnormalities, Chromosomal0low230
Abnormalities, Chromosome0low230
Abnormalities, Congenital0low50
Abnormalities, Congenital, Nervous System0low10
Abnormalities, Drug-Induced0low320
Abnormalities, Multiple0low10
Abnormalities, Nervous System0low10
Abnormality, Heart0low50
Abnormality, Torsion0low10
Abortion, Spontaneous0medium135
Abortion, Tubal0medium135
Abortion, Veterinary0low20
Abscess0low190
Abscess, Abdominal0low20
Abscess, Amebic0low100
Abscess, Epidural0low40
Abscess, Extradural0low40
Abscess, Hepatic0low20
Abscess, Intra-Abdominal0low20
Abscess, Intracranial, Subdural0low10
Abscess, Pulmonary0low40
Abscesses, Pulmonary0low40
Absence Seizure0medium1153
Absence Seizure Disorder0medium81
Absence Seizures0medium1153
Absence Status0low50
Academic Disorder, Developmental0low10
Acalculous Cholecystitis0low10
Acalculous Gallbladder Inflammation0low10
Acanthamebiasis0low100
Acanthamoeba Infection0low100
Acanthamoeba Keratitis0low120
Acanthamoeba Meningoencephalitis0low20
Acantholysis0low10
Acatalasemia0low20
Acatalasemia Japanese Type0low20
Acatalasemia Swiss Type0low20
Acatalasia0low20
Acathisia, Drug-Induced0low40
Acetonemia0low10
Acetonuria0low10
Ache0medium8117
Achlorhydria0low30
Achromatopsia0medium11
Achylia Gastrica0low30
Acid Aspiration Syndrome0low30
Acid beta-Glucosidase Deficiency0low40
Acid beta-Glucosidase Deficiency Disease0low40
Acidosis0low60
Acidosis, Diabetic0low50
Acidosis, Renal Tubular0low20
Acidosis, Renal Tubular, Type I0low20
Acidosis, Renal Tubular, Type II0low20
Acidosis, Respiratory0low10
Acinar Carcinoma0low10
Acinar Cell Adenocarcinoma0low10
Acinetobacter Infections0low10
Acinic Cell Adenocarcinoma0low10
Acinic Cell Carcinoma0low10
Acinic Cell Tumor0low10
ACL Injuries0low10
ACL Tears0low10
Acne0medium51
Acne Vulgaris0medium51
Acquired Autoimmune Hemolytic Anemia0low10
Acquired Communication Disorders0medium11
Acquired Immune Deficiency Syndrome0medium432
Acquired Immuno-Deficiency Syndrome0medium432
Acquired Immunodeficiency Syndrome0medium432
Acquired Metabolic Diseases, Brain0low10
Acquired Metabolic Diseases, Nervous System0low10
Acquired Metabolic Encephalopathies0low10
Acquired Nephrogenic Diabetes Insipidus0low10
Acquired Storage Pool Disease0low10
Acquired-Immune Deficiency Syndrome Dementia Complex0medium21
Acrania0low10
Acromegaly0low20
ACTH-Producing Pituitary Adenoma0low10
ACTH-Secreting Pituitary Adenoma0low10
Actinic Reticuloid Syndrome0low170
Actinomycetales Infections0low10
Actinomycete Infections0low10
Actinomycetoma0low800
Action Tremor0low50
Active Hyperemia0medium153
Acute Biphenotypic Leukemia0low10
Acute Brain Injuries0medium131
Acute Chest Syndrome0medium11
Acute Confusional Migraine0medium23878
Acute Confusional Senile Dementia0medium815
Acute Coronary Syndrome0medium21
Acute Disease0medium12424
Acute Edematous Pancreatitis0low420
Acute Hemolytic Transfusion Reaction0medium11130
Acute Hepatic Failure0low120
Acute Hypercapnic Respiratory Failure0low50
Acute Hypoxemic Respiratory Failure0low50
Acute Ischemic Stroke0low20
Acute Kidney Failure0medium393
Acute Kidney Injury0medium393
Acute Kidney Insufficiency0medium393
Acute Liver Failure0low120
Acute Liver Injury, Drug-Induced0medium1134
Acute Lung Injury0medium71
Acute Lymphoid Leukemia0medium791
Acute Mesenteric Arterial Embolus0low10
Acute Mesenteric Arterial Thrombosis0low10
Acute Myelogenous Leukemia0medium23830
Acute Myeloid Leukemia0medium23830
Acute Myeloid Leukemia with Maturation0medium23830
Acute Myeloid Leukemia without Maturation0medium23830
Acute Necrotizing Pancreatitis0low20
Acute Neuronopathic Gaucher Disease0low40
Acute Onset Aura Migraine0low30
Acute Pancreatitis0low420
Acute Porphyria0low30
Acute Post-operative Pain0low30
Acute Post-Traumatic Stress Disorder0medium178
Acute Postoperative Pain0low30
Acute Promyelocytic Leukemia0low110
Acute Relapsing Multiple Sclerosis0low10
Acute Renal Failure0medium393
Acute Renal Injury0medium393
Acute Renal Insufficiency0medium393
Acute Respiratory Distress Syndrome0low110
Acute Rheumatic Fever0low10
Acute Stress Disorders0low10
Acute Symptom Flare0medium21
Acute-Phase Reaction0low10
Acute-Phase State0low10
ADDH0low20
Addiction, Opioid0medium63
Adenitis0low10
Adenocarcinoma0medium625
Adenocarcinoma Of Kidney0medium142
Adenocarcinoma of Lung0low100
Adenocarcinoma, Basal Cell0medium625
Adenocarcinoma, Clear Cell0low10
Adenocarcinoma, Endometrioid0medium41
Adenocarcinoma, Granular Cell0medium625
Adenocarcinoma, Mucinous0low40
Adenocarcinoma, Oxyphilic0medium625
Adenocarcinoma, Renal0medium142
Adenocarcinoma, Renal Cell0medium142
Adenocarcinoma, Scirrhous0low20
Adenocarcinoma, Tubular0medium625
Adenocystic Carcinoma0low30
Adenohypophyseal Diseases0low10
Adenoma0low50
Adenoma Sebaceum0low10
Adenoma, Basal Cell0low50
Adenoma, Follicular0low50
Adenoma, Hepatocellular0low10
Adenoma, Liver Cell0low10
Adenoma, Malignant0medium625
Adenoma, Microcystic0low50
Adenoma, Monomorphic0low50
Adenoma, Papillary0low50
Adenoma, Prolactin-Secreting, Pituitary0low10
Adenoma, Prostatic0medium61
Adenoma, Trabecular0low50
Adenosis of Breast0low10
Adenoviridae Infections0low10
Adenovirus Infections0low10
Adenovirus Infections, Human0low10
ADH-Resistant Diabetes Insipidus0low10
Adhesions, Tissue0low60
Adhesive Capsulitis0low10
Adhesive Capsulitis of the Shoulder0low10
Adiadochokinesis0low10
Adipocere0low10
Adjustment Disorder0medium31
Adjustment Disorders0medium31
Adjuvant Arthritis0low240
Adolescent Gynecomastia0medium175
Adolescent Myoclonic Epilepsy0low10
ADPKD0low60
Adrenal Cancer0low50
Adrenal Cortex Cancer0low10
Adrenal Cortex Neoplasms0low10
Adrenal Gland Cancer0low50
Adrenal Gland Hypofunction0low30
Adrenal Gland Neoplasms0low50
Adrenal Hyperplasia, Congenital0low20
Adrenal Insufficiency0low30
Adrenal Neoplasm0low50
Adrenocortical Cancer0low10
Adrenocorticotropic Hormone, Inappropriate Secretion0low20
Adult Fanconi Syndrome0medium161
Adult Learning Disabilities0low10
Adult Learning Disorders0low10
Adult Polycystic Kidney Disease0low60
Adult Polycystic Kidney Disease Type 10low60
Adult Polycystic Kidney Disease Type 20low60
Adult Premature Aging Syndrome0low20
Adult Progeria0low20
Adult Respiratory Distress Syndrome0low110
Adult Rickets0low10
Adult-Onset Dystonias0low10
Adult-Onset Idiopathic Focal Dystonias0low10
Adult-Onset Idiopathic Torsion Dystonias0low10
Advanced Sleep Phase Syndrome0medium41
Adverse Drug Event0medium7517
Adverse Drug Reaction0medium7517
Adverse Effects, Long Term0low10
Affective Disorders0medium31
Affective Psychosis, Bipolar0medium184
African Lymphoma0medium91
African Sleeping Sickness0low80
African Trypanosomiasis0low80
Agammaglobulinemia0low20
Age-Related Macular Degeneration0low40
Age-Related Maculopathies0low40
Age-Related Maculopathy0low40
Age-Related Memory Disorders0medium243
Age-Related Osteoporosis0medium337
Aggression0medium121
Aggressive Systemic Mastocytosis0low10
Aging0medium6512
Agitation, Psychomotor0low10
Agnogenic Myeloid Metaplasia0low80
Agnosia0low10
Agnosia for Pain0low10
Agnosia for Smell0low10
Agnosia for Taste0low10
Agnosia for Temperature0low10
Agoraphobia0low10
Agranulocytosis0low60
Agricultural Worker Disease0low40
Agricultural Worker's Disease0low40
Agricultural Workers' Diseases0low40
AIDS0medium432
AIDS Dementia Complex0medium21
AIDS Encephalopathy0medium21
AIDS Seroconversion0medium113
AIDS Seropositivity0medium113
AIDS-Associated Lymphoma0low10
AIDS-Related Complex0medium22
AIDS-Related Dementia Complex0medium21
AIDS-Related Lymphoma0low10
AIDS-Related Opportunistic Infections0medium565
AIDS, Simian0low130
Air Sickness0medium33
Airflow Obstruction, Chronic0medium234
Airsickness0medium33
Airway Hyper-Responsiveness0medium151
Airway Obstruction0low20
Airway Remodeling0low20
Airway Remodelling0low20
Airway Wall Remodelling0low20
Akathisia0low10
Akathisia, Drug-Induced0low40
Akathisia, Tardive0low40
Akinetic Petit Mal0medium81
Akinetic-Rigid Variant of Huntington Disease0low130
AL Amyloidosis0low10
Alactasia0medium11
Albright Syndrome0medium101
Albright-Mccune-Sternberg Syndrome0medium101
Albright-Sternberg Syndrome0medium101
Albright's Disease0medium101
Albright's Disease of Bone0medium101
Albright's Syndrome0medium101
Albright's Syndrome with Precocious Puberty0medium101
Albuminuria0medium83
Alcohol Abuse0medium217
Alcohol Addiction0medium217
Alcohol Dependence0medium217
Alcohol Drinking0medium222
Alcohol Problem0low10
Alcohol Use Disorder0medium217
Alcohol Withdrawal Seizures0low10
Alcohol Withdrawal-Induced Major Motor Seizure0low10
Alcohol Withdrawal-Induced Seizure0low10
Alcohol Withdrawal-Induced Status Epilepticus0low10
Alcohol-Induced Peripheral Neuropathy0low10
Alcohol-Induced Polyneuropathy0low10
Alcohol-Related Autonomic Polyneuropathy0low10
Alcohol-Related Disorders0low10
Alcohol-Related Polyneuropathy0low10
Alcohol-Related Seizures0low10
Alcoholic Axonal Neuropathy0low10
Alcoholic Cirrhosis0low30
Alcoholic Intoxication, Chronic0medium217
Alcoholic Liver Diseases0low10
Alcoholic Neuropathy0low10
Alcoholism0medium217
Aldosteronism0low30
Algodystrophic Syndrome0low20
Algodystrophy0low20
Algor Mortis0low10
Alkalosis0low20
ALL, Childhood0medium791
Allergic Alveolitis, Extrinsic0low40
Allergic Bronchopulmonary Aspergilloses0medium402
Allergic Bronchopulmonary Aspergillosis0medium402
Allergic Bronchopulmonary Mycosis0medium1207
Allergic Conjunctivitis0low20
Allergic Contact Dermatitis0low160
Allergic Cutaneous Angiitis0low10
Allergic Cutaneous Vasculitis0low10
Allergic Encephalomyelitis0low30
Allergic Encephalomyelitis, Experimental0low30
Allergic Reaction0medium221
Allergy0medium221
Allergy, Drug0low80
Allergy, Food0low20
Allergy, Latex0low10
Allodynia0medium361
Allodynia, Mechanical0medium361
Allodynia, Tactile0medium361
Allodynia, Thermal0medium361
Alloxan Diabetes0low740
Alopecia0medium51
Alopecia Areata0low10
Alopecia Cicatrisata0medium51
Alopecia Circumscripta0low10
Alopecia, Androgenetic0medium51
Alopecia, Male Pattern0medium51
alpha-L-Iduronidase Deficiency0low20
ALS - Amyotrophic Lateral Sclerosis0medium41
Alternariosis0low60
Altidudinal Hemianopia0low10
Altitudinal Hemianopsia0low10
Alveolar Bone Atrophy0low10
Alveolar Bone Loss0low10
Alveolar Process Atrophy0low10
Alveolar Proteinoses, Pulmonary0low10
Alveolar Proteinosis, Pulmonary0low10
Alveolar Resorption0low10
Alveolitis, Extrinsic Allergic0low40
Alveolitis, Fibrosing0low100
Alzheimer Dementia0medium815
Alzheimer Disease0medium815
Alzheimer Disease, Early Onset0medium815
Alzheimer Disease, Late Onset0medium815
Alzheimer Sclerosis0medium815
Alzheimer Syndrome0medium815
Alzheimer Type Senile Dementia0medium815
Alzheimer-Type Dementia (ATD)0medium815
Alzheimer's Disease0medium815
Alzheimer's Disease, Focal Onset0medium815
Alzheimer's Diseases0medium815
Amaurosis0low60
Amaurosis Fugax0low10
Ambiguous Genitalia0low20
Amblyopia0low10
Amblyopia, Developmental0low10
Amblyopia, Stimulus Deprivation-Induced0low10
Amblyopia, Suppression0low10
Ambulation Disorders, Neurologic0low30
Amebiasis0low100
Amebic Meningoencephalitis0low20
Ameboma0low100
Amenorrhea0medium52
Amentia0medium42
American Trypanosomiasis0medium965
Amino Acid Metabolism Disorders, Inborn0low10
Amino Acid Metabolism, Inborn Error0low10
Amino Acid Metabolism, Inborn Errors0low10
Amino Acid Metabolism, Inherited Disorders0low10
Amino Acidopathies, Congenital0low10
Amino Acidopathies, Inborn0low10
AML M30low110
Amnesia0low30
Amnesia-Memory Loss0low30
Amnesia, Dissociative0low30
Amnesia, Global0low30
Amnesia, Hysterical0low30
Amnesia, Pre-Ictal0low20
Amnesia, Retrograde0low20
Amnesia, Tactile0low30
Amnesia, Temporary0low30
Amnestic State0low30
Amoebiasis0low100
Amygdalo-Hippocampal Epilepsy0medium125
Amyloid Deposits0low50
Amyloid Plaques0low50
Amyloidosis0low10
Amyloidosis, Immunoglobulin Light-chain0low10
Amyloidosis, Primary0low10
Amyotonia Congenita0low20
Amyotrophic Lateral Sclerosis0medium41
Amyotrophic Lateral Sclerosis With Dementia0medium41
Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Complex 10medium41
Amyotrophic Lateral Sclerosis, Guam Form0medium41
Amyotrophic Lateral Sclerosis, Parkinsonism-Dementia Complex of Guam0medium41
Amyotrophy, Thenar, Of Carpal Origin0medium32
Anal Cancer0low10
Anal Neoplasms0low10
Analgesic Overuse Headache0low20
Analgesic Rebound Headache0low20
Anankastic Personality0medium62
Anaphylactic Reaction0low390
Anaphylactoid Reaction0low390
Anaphylactoid Shock0low390
Anaphylaxis0low390
Anaplastic Astrocytoma0low30
Anaplastic Ependymoma0low20
Anaplastic Large-Cell Lymphoma0low20
Anasarca0medium1151
Androgen-Independent Prostatic Cancer0medium233
Androgen-Independent Prostatic Neoplasms0medium233
Androgen-Insensitive Prostatic Cancer0medium233
Androgen-Insensitive Prostatic Neoplasms0medium233
Androgen-Resistant Prostatic Cancer0medium233
Androgen-Resistant Prostatic Neoplasms0medium233
Androgenetic Alopecia0medium51
Androgenic Alopecia0medium51
Androgenization0low10
Anemia0medium4516
Anemia With Multinucleated Erythroblasts0medium21
Anemia, Aplastic0medium386
Anemia, Congenital Dyserythropoietic0medium21
Anemia, Congenital Dyserythropoietic, Type II0medium21
Anemia, Congenital Hypoplastic, Of Blackfan And Diamond0low40
Anemia, Congenital Nonspherocytic Hemolytic0low10
Anemia, Cooley's0medium15749
Anemia, Diamond-Blackfan0low40
Anemia, Diamond-Blackfan Type0low40
Anemia, Dyserythropoietic Congenital, Type I0medium21
Anemia, Dyserythropoietic Congenital, Type II0medium21
Anemia, Dyserythropoietic Congenital, Type III0medium21
Anemia, Dyserythropoietic, Congenital0medium21
Anemia, Dyserythropoietic, Congenital Type 10medium21
Anemia, Dyserythropoietic, Congenital Type 20medium21
Anemia, Dyserythropoietic, Congenital, Type I0medium21
Anemia, Dyserythropoietic, Congenital, Type II0medium21
Anemia, Dyserythropoietic, Congenital, Type III0medium21
Anemia, Erythroblastic0medium15749
Anemia, Fanconi0medium31
Anemia, Hemolytic0low10
Anemia, Hemolytic Congenital, Nonspherocytic0low10
Anemia, Hemolytic, Acquired0low10
Anemia, Hemolytic, Autoimmune0low10
Anemia, Hemolytic, Cold Antibody0low10
Anemia, Hemolytic, Congenital Nonspherocytic0low10
Anemia, Hemolytic, Idiopathic Acquired0low10
Anemia, Hypoplastic0medium386
Anemia, Iron-Deficiency0medium31
Anemia, Macrocytic0low10
Anemia, Mediterranean0medium15749
Anemia, Microangiopathic0low10
Anemia, Refractory0low10
Anemia, Refractory, with Excess of Blasts0low10
Anemia, Sickle Cell0medium389
Anemia, Sideroblastic0low10
Anemias, Iron-Deficiency0medium31
Anesthesia0low140
Aneuploid0low20
Aneuploid Cell0low20
Aneuploidy0low20
Aneurysm0low10
Aneurysm, Abdominal Aortic0low40
Aneurysm, Anterior Cerebral Artery0low20
Aneurysm, Anterior Communicating Artery0low20
Aneurysm, Aortic0low10
Aneurysm, Bacterial0low50
Aneurysm, Basilar Artery0low20
Aneurysm, Cerebral0low20
Aneurysm, False0low10
Aneurysm, Infected0low50
Aneurysm, Intracranial0low20
Aneurysm, Middle Cerebral Artery0low20
Aneurysm, Mycotic0low50
Aneurysm, Posterior Cerebral Artery0low20
Aneurysm, Posterior Communicating Artery0low20
Aneurysm, Ruptured0low10
Aneurysm, Thoracic Aortic0low20
Angiitis0low50
Angiitis, Allergic Cutaneous0low10
Angiitis, Hypersensitivity0low10
Angina at Rest0medium11
Angina Pectoris0low40
Angina Pectoris, Unstable0medium11
Angina, Preinfarction0medium11
Angina, Unstable0medium11
Angioblastic Meningioma0low10
Angioedema0low60
Angiogenesis, Pathologic0medium472
Angiogenesis, Pathological0medium472
Angiomatous Meningioma0low10
Angioneurotic Edema0low60
Angiosarcoma0low10
Angiospasm, Intracranial0low10
Angiostrongylus Infections0low10
Angor Pectoris0low40
Animal Diseases0low10
Animal Mammary Carcinoma0low130
Anisometropic Amblyopia0low10
Ankle Injuries0low10
Ankle Sprains0low10
Ankylosing Spondylarthritis0medium102
Ankylosing Spondylitis0medium102
Ankylosing Spondyloarthritis0medium102
ANLL0medium23830
Anniversary Reaction0medium31
Anochlesia0low210
Anomalies, Nervous System0low10
Anorectal Diseases0medium52
Anorectal Disorders0medium52
Anorexia0medium71
Anosmic Hypogonadism0medium11
Anosmic Idiopathic Hypogonadotropic Hypogonadism0medium11
Anosognosia0low10
Anovulation0medium205
Anoxemia0medium681
Anoxia0medium681
Anoxia-Ischemia, Brain0low50
Anoxia-Ischemia, Cerebral0low50
Anoxia, Brain0low40
Anoxia, Cerebral0low40
Anoxia, Fetal0low20
Anoxic Brain Damage0low40
Anoxic Encephalopathy0low40
Anoxic-Ischemic Encephalopathy0low50
ANS (Autonomic Nervous System) Diseases0medium42
ANS Diseases0medium42
Anterior Cerebral Artery Aneurysm0low20
Anterior Cerebral Circulation Infarction0low30
Anterior Choroidal Artery Infarction0low70
Anterior Circulation Brain Infarction0low30
Anterior Circulation Infarction, Brain0low30
Anterior Circulation Transient Ischemic Attack0low110
Anterior Communicating Artery Aneurysm0low20
Anterior Cruciate Ligament Injuries0low10
Anterior Cruciate Ligament Injury0low10
Anterior Cruciate Ligament Tear0low10
Anterior Cruciate Ligament Tears0low10
Anterior Horn Cell Disease0low10
Anterior Pituitary Diseases0low10
Anti-HIV Positivity0medium113
Anti-MuSK Myasthenia Gravis0low30
Anti-Phospholipid Antibody Syndrome0low20
Anti-Phospholipid Syndrome0low20
Antibiotic-Associated Colitis0low40
Antibody Deficiency Syndrome0low30
Antidiuretic Hormone, Inappropriate Secretion0low10
Antiphospholipid Antibody Syndrome0low20
Antiphospholipid Syndrome0low20
Anus Neoplasms0low10
Anxiety0medium399
Anxiety Disorders0medium2411
Anxiety Neuroses0medium2411
Anxiety States, Neurotic0medium2411
Aortic Aneurysm0low10
Aortic Aneurysm, Abdominal0low40
Aortic Aneurysm, Thoracic0low20
Aortic Aneurysm, Thoracoabdominal0low20
Aortic Diseases0low20
Aortic Dissection0low10
Aortic Stenosis0low20
Aortic Valve Stenosis0low20
Ape Diseases0low20
Aplasia Pure Red Cell0low20
Aplastic Anaemia0medium386
Aplastic Anemia0medium386
Apnea0low10
Apnea, Obstructive Sleep0medium52
Apnea, Sleep0medium11
Apoplexy0medium145
Apparent Mineralocorticoid Excess Syndrome0low60
Appetite Disorders0low10
Apraxia0low10
Apraxia of Phonation0low10
Apraxia, Articulatory0low10
Apraxia, Developmental Verbal0low10
Apraxia, Facial-Oral0low10
Apraxia, Gestural0low10
Apraxia, Motor0low10
Apraxia, Oral0low10
Apraxia, Verbal0low10
Apraxias0low10
Aqueductal Stenosis0low10
Arachnoidal Cerebellar Sarcoma, Circumscribed0low100
ARC0medium22
ARDS, Human0low110
Argentaffinoma0low90
Armstrong Syndrome0low10
Armstrong's Syndrome0low10
Arrhythmia0medium202
Arrhythmias, Cardiac0medium202
Arrythmia0medium202
Arterial Diseases, Carotid0medium41
Arterial Diseases, Common Carotid0medium41
Arterial Diseases, External Carotid0medium41
Arterial Diseases, Internal Carotid0medium41
Arterial Hyperemia0medium153
Arterial Obstructive Diseases0low70
Arterial Occlusive Diseases0low70
Arteriosclerosis0low100
Arteriosclerosis, Coronary0medium102
Arthralgia0medium299
Arthritides, Bacterial0low110
Arthritis0low90
Arthritis, Acute Rheumatic0low10
Arthritis, Adjuvant0low240
Arthritis, Adjuvant-Induced0low240
Arthritis, Bacterial0low110
Arthritis, Collagen-Induced0low240
Arthritis, Degenerative0low80
Arthritis, Experimental0low240
Arthritis, Gouty0low20
Arthritis, Infectious0low110
Arthritis, Juvenile0low20
Arthritis, Juvenile Chronic0low20
Arthritis, Juvenile Idiopathic0low20
Arthritis, Juvenile Rheumatoid0low20
Arthritis, Psoriatic0medium112
Arthritis, Rheumatic, Acute0low10
Arthritis, Rheumatoid0medium7220
Arthritis, Septic0low110
Arthritis, Spinal0medium21
Arthritis, Suppurative0low110
Arthritis, Viral0low110
Arthropathies0medium93
Arthroses0low80
Arthrosis0low80
Arthus Phenomenon0low50
Arthus Reaction0low50
As If Personality0medium32
Asbestosis0low10
Ascites0medium61
Ascites, Chylous0low10
Ascorbic Acid Deficiency0low10
Aseptic Necrosis of Bone0low10
Asialia0low30
Aspergilloses, Allergic Bronchopulmonary0medium402
Aspergilloses, Bronchopulmonary0medium973
Aspergillosis0medium77238
Aspergillosis, Allergic Bronchopulmonary0medium402
Aspergillosis, Bronchopulmonary0medium973
Aspergillosis, Bronchopulmonary Allergic0medium402
Aspergillosis, Nervous System Invasive0low410
Aspergillus Infection0medium77238
Asphyxia0low20
Aspiration Pneumonia0low30
Astasia-Abasia0medium21
Asterixis0low20
Asthenia0low20
Asthma0medium558
Asthma, Bronchial0medium558
Asthma, Exercise-Induced0medium11
Asthmatic Airway Remodeling0low20
Asthmatic Airway Remodelling0low20
Asthmatic Airway Wall Remodeling0low20
Asthmatic Airway Wall Remodelling0low20
Astigmatism0low10
Astrocytoma0low30
Astrocytoma, Grade I0low30
Astrocytoma, Grade II0low30
Astrocytoma, Grade III0low30
Astrocytoma, Grade IV0medium341
Astrocytoma, Protoplasmic0low30
Astrocytoma, Subependymal Giant Cell0low30
Astrocytosis0medium41
Astroglioma0low30
Astrogliosis0medium41
Asymmetric Diabetic Proximal Motor Neuropathy0low30
Asystole0low30
Ataxia0low30
Ataxia Telangiectasia0low20
Ataxia Telangiectasia Syndrome0low20
Ataxia-Telangiectasia0low20
Ataxia, Appendicular0low30
Ataxia, Cerebellar0low10
Ataxia, Limb0low30
Ataxia, Motor0low30
Ataxia, Sensory0low30
Ataxia, Truncal0low30
Ataxy0low30
Atelectasis0low10
Atelectasis, Congestive0low10
Atherogenesis0medium154
Atheroma0low30
Atheromatous Plaque0low30
Atheromatous Plaques0low30
Atherosclerosis0medium154
Atherosclerosis, Coronary0medium102
Atherosclerotic Disease, Carotid0medium41
Atherosclerotic Parkinsonism0low70
Atherosclerotic Plaque0low30
Atherosclerotic Plaques0low30
Athlete's Foot0medium122
ATLL0low50
Atonic Absence Seizure0medium1153
Atonic Absence Seizures0medium1153
Atonic Seizure0medium1153
Atonic Seizures0medium1153
Atopic Hypersensitivity0low40
Atrial Fibrillation0low100
Atrioventricular Block0low10
Atrioventricular Conduction Block0low10
Atrioventricular Dissociation0medium21
Atrioventricular Nodal Re-Entrant Tachycardia0low50
Atrioventricular Reentrant Tachycardia0low50
Atrophy0medium91
Atrophy, Muscle0low20
Atrophy, Muscular, Peroneal0low10
Attention Deficit and Disruptive Behavior Disorders0low10
Attention Deficit and Disruptive Behavioral Disorders0low10
Attention Deficit Disorder0low20
Attention Deficit Disorder with Hyperactivity0low20
Attention Deficit Disorders with Hyperactivity0low20
Attention Deficit Hyperactivity Disorder0low20
Attention Deficit Hyperactivity Disorders0low20
Attention Deficit-Hyperactivity Disorder0low20
Atypical Cluster Headache0low30
Atypical Ductal Hyperplasia0medium123
Atypical Endometrial Hyperplasia0medium104
Atypical Lipomatous Tumor0medium52
Atypical Mycobacterial Infection, Disseminated0low30
Atypical Mycobacterial Infection, Familial Disseminated0low30
Atypical Mycobacteriosis, Familial0low30
Atypical Mycobacteriosis, Familial Disseminated0low30
Atypical Mycobacterium Infections0low30
Auditory Agnosia0low10
Auditory Agnosia, Congenital0low10
Aura0medium826
Auricular Fibrillation0low100
Auriculo-Ventricular Dissociation0medium21
Autism0low30
Autism Spectrum Disorder0medium63
Autism Spectrum Disorders0medium63
Autism-Dementia-Ataxia-Loss of Purposeful Hand Use Syndrome0low10
Autism, Dementia, Ataxia, and Loss of Purposeful Hand Use0low10
Autism, Early Infantile0low30
Autism, Infantile0low30
Autistic Disorder0low30
Autistic Spectrum Disorder0medium63
Autoimmune Chronic Hepatitis0low30
Autoimmune Diabetes0medium235
Autoimmune Disease0low90
Autoimmune Diseases0low90
Autoimmune Encephalomyelitis, Experimental0low30
Autoimmune Experimental Encephalomyelitis0low30
Autoimmune Haemolytic Anaemia0low10
Autoimmune Hemolytic Anemia0low10
Autoimmune Hepatitis0low30
Autoimmune Thrombocytopenia0low30
Autoimmune Thrombocytopenic Purpura0low30
Autoimmune Thyroiditis0low10
Autolysis0low20
Autonomic Central Nervous System Diseases0medium42
Autonomic Diseases0medium42
Autonomic Nervous System Diseases0medium42
Autonomic Nervous System Disorders0medium42
Autonomic Peripheral Nervous System Diseases0medium42
Autosomal Chromosome Disorders0low20
Autosomal Dominant Cerebellar Ataxia, Type II0low10
Autosomal Dominant Distal Renal Tubular Acidosis0low20
Autosomal Dominant Familial Dystonia0low10
Autosomal Dominant Form of Kallmann Syndrome0medium11
Autosomal Dominant Juvenile Parkinson Disease0low240
Autosomal Dominant Juvenile Parkinsonism0low240
Autosomal Dominant Opitz G-Bbb Syndrome0low10
Autosomal Dominant Parkinsonism0low240
Autosomal Dominant Polycystic Kidney0low60
Autosomal Hemophilia A0low40
Autosomal Recessive Chronic Granulomatous Disease0medium353
Autosomal Recessive Familial Dystonia0low10
Autosomal Recessive Form of Kallmann Syndrome0medium11
Autosomal Recessive Juvenile Parkinson Disease0low240
Autosomal Recessive Juvenile Parkinsonism0low240
Autosomal Recessive Parkinsonism0low240
Autosome Abnormalities0low230
AV Block0low10
Avascular Necrosis of Bone0low10
Avian Diseases0low90
Avoidant Personality Disorder0medium32
Awakening Epilepsy0medium826
Azoospermia0medium52
B and T Cell Acute Lymphoblastic Leukemia0low10
B and T Cell Leukemia, Acute0low10
B Virus Infection0low10
B- and T-Cell Acute Lymphoblastic Leukemia0low10
B- and T-Cell Leukemia, Acute0low10
B-Cell Chronic Lymphocytic Leukemia0medium182
B-Cell Leukemia0low20
B-Cell Leukemia, Chronic0medium182
B-Cell Lymphoma0low80
B-Cell Malignancy, Low-Grade0medium182
B-Lymphocytic Leukemia0low20
B-Lymphocytic Leukemia, Chronic0medium182
B16 Melanoma0low210
Back Ache0medium21
Back Pain0medium21
Back Pain with Radiation0medium21
Back Pain without Radiation0medium21
Backache0medium21
Bacteremia0low100
Bacterial Aneurysm0low50
Bacterial Aneurysms0low50
Bacterial Arthritides0low110
Bacterial Arthritis0low110
Bacterial Disease0medium352
Bacterial Eye Infections0low40
Bacterial Infection0medium352
Bacterial Infections0medium352
Bacterial Infections, Central Nervous System0low10
Bacterial Infections, Gram-Negative0low50
Bacterial Meningitides0low10
Bacterial Meningitis0low10
Bacterial Ocular Infections0low40
Bacterial Pneumonia0medium174
Bacterial Vaginitides0low10
Bacterial Vaginitis0low10
Bacterial Vaginoses0low10
Bacterial Vaginosis0low10
Bacteriuria0medium11
Balamuthia Infection0low100
Balamuthia mandrillaris CNS Infection0low20
Balamuthia mandrillaris Meningoencephalitis0low20
Baldness0medium51
Baldness, Male Pattern0medium51
Ballismus0low20
Bare Lymphocyte Syndrome0low10
Barrett Epithelium0low10
Barrett Esophagus0low10
Barrett Metaplasia0low10
Barrett Syndrome0low10
Barrett's Esophagus0low10
Barrett's Syndrome0low10
Basal Cell Cancer0low10
Basal Cell Neoplasms0low10
Basal Ganglia Diseases0medium31
Basal Ganglia Disorders0medium31
Basilar Artery Aneurysm0low20
Basilar Artery Migraine0low30
Basilar Migraine0low30
Basilar-Type Migraine0low30
Bechterew Disease0medium102
Bechterew Syndrome0low30
Bechterew's Disease0medium102
Becker Muscular Dystrophy0low20
Becker's Muscular Dystrophy0low20
Bed Sores0low20
Bedsore0low20
Bedwetting0low10
Behavior Disorder, Rapid Eye Movement Sleep0low10
Behavior Disorder, REM0low10
Behavior Disorders0medium154
Benign Cerebellar Neoplasms0low80
Benign Essential Tremor0medium11
Benign Focal Epilepsy, Childhood0medium125
Benign Infantile Myoclonic Epilepsy0low50
Benign Intracranial Hypertension0low10
Benign Mastocytoma0low20
Benign Meningeal Neoplasms0low20
Benign Meningioma0low10
Benign Neonatal Sleep Myoclonus0low10
Benign Neoplasms0medium31633
Benign Neoplasms, Brain0medium484
Benign Occipital Epilepsy0medium125
Benign Occipital Epilepsy, Childhood0medium125
Benign Optic Nerve Neoplasm0low10
Benign Optic Nerve Sheath Neoplasms0low10
Benign Optic Nerve Sheath Tumors0low10
Benign Optic Nerve Tumor0low10
Benign Prostatic Hyperplasia0medium61
Benign Psychomotor Epilepsy, Childhood0low30
Benign Recurrent Abducens Palsy of Childhood0low10
Benign Recurrent Abducens Palsy, Children0low10
Berry Aneurysm0low20
Besnier-Boeck Disease0low50
Besnier-Boeck-Schaumann Syndrome0low50
Besnoitiasis0low10
Besnoitiosis0low10
beta Thalassemia0medium15749
beta-Thalassemia0medium15749
Beuren Syndrome0low10
Bezoars0low10
BH4 Deficiency0low10
Bilateral Blindness0low60
Bilateral Cryptorchidism0low10
Bilateral Deafness0low10
Bilateral Headache0medium3719
Bile Duct Cancer0medium61
Bile Duct Neoplasms0medium61
Bile Duct Obstruction0low40
Bilharziasis0low40
Biliary Cirrhosis0low20
Biliary Cirrhosis, Primary0low20
Biliary Cirrhosis, Primary, 10low20
Biliary Cirrhosis, Secondary0low20
Biliary Fistula0low10
Biliary Stasis0low40
Biliary Tract Cancer0low20
Biliary Tract Diseases0medium22
Biliary Tract Neoplasms0low20
Binasal Hemianopia0low10
Binge Alcohol Consumption0low10
Binge Drinking0low10
Binge Eating0medium42
Binge-Eating Disorder0medium42
Biological Clock Disturbances0low10
Biphenotypic Acute Leukemia0low10
Bipolar Disorder0medium184
Bipolar Mood Disorder0medium184
Bird Diseases0low90
Birth Defects0low50
Birth Weight0low50
Bisphosphonate Osteonecrosis0low10
Bisphosphonate-Associated Osteonecrosis0low10
Bisphosphonate-Associated Osteonecrosis of the Jaw0low10
Bisphosphonate-Associated Osteonecrosis of the Jaws0low10
Bisphosphonate-Induced Osteonecrosis of the Jaw0low10
Bisphosphonate-Induced Osteonecrosis of the Jaws0low10
Bisphosphonate-Related Osteonecrosis of the Jaw0low10
Bitemporal Hemianopia0low10
Bites0low10
Bites and Stings0low10
Black Fever0low60
Blackfan Diamond Anemia0low40
Blackfan-Diamond Disease0low40
Blackfan-Diamond Syndrome0low40
Bladder Cancer0low100
Bladder Diseases0medium41
Bladder Disorder, Neurogenic0low10
Bladder Exstrophy0low10
Bladder Extrophy0low10
Bladder Neoplasms0low100
Bladder Neurogenesis0low10
Bladder Tumors0low100
Bladder, Neurogenic0low10
Bladder, Overactive0low30
Blast Crisis0medium41
Blast Phase0medium41
Blastocyst Disintegration0low10
Blastomyces brasiliensis Infection0medium73
Blastomyces brasiliensis Infections0medium73
Blastomycosis0medium271
Blastomycosis, North American0medium271
Blastomycosis, South American0medium73
Bleb0medium31
Bleeding0medium111
Bleeding Between Periods0low10
Blepharitis0low10
Blepharoptosis0low50
Blindness0low60
Blindness, Acquired0low60
Blindness, Bilateral0low60
Blindness, Complete0low60
Blindness, Hysterical0low60
Blindness, Legal0low60
Blindness, Monocular0low60
Blindness, Monocular, Transient0low10
Blindness, Transient0low60
Blindness, Unilateral0low60
Blister0medium31
Blood Clot0medium141
Blood Coagulation Disorders0low20
Blood Diseases0medium434
Blood Loss, Surgical0medium11
Blood Poisoning0medium273
Blood Pressure, High0medium617
Blood Pressure, Low0low240
Blood Transfusion-Associated Adverse Reactions0medium11130
Blood Vessel Dissection0low10
Bloodstream Infection0medium273
Blow Out Fracture0low20
Blow-Out Fractures0low20
Body Weight0medium21334
Body Weight, Fetal0low40
Body-Image Agnosia0low10
Boeck Disease0low50
Boeck's Disease0low50
Boeck's Sarcoid0low50
Bone Cancer0medium483
Bone Diseases0medium61
Bone Diseases, Infectious0low20
Bone Diseases, Metabolic0medium103
Bone Fractures0medium2711
Bone Hypertrophy0low10
Bone Inflammation0medium21
Bone Loss, Age-Related0medium337
Bone Loss, Alveolar0low10
Bone Loss, Osteoclastic0medium2511
Bone Loss, Perimenopausal0medium3219
Bone Loss, Periodontal0low10
Bone Loss, Postmenopausal0medium3219
Bone Marrow Diseases0low30
Bone Marrow Fibrosis0low80
Bone Necrosis0low10
Bone Neoplasms0medium483
Bone Resorption0medium2511
Bonnevie-Ullrich Syndrome0low10
Bouillaud Disease0low10
Bouillaud's Disease0low10
Bourneville Disease0low10
Bourneville Phakomatosis0low10
Bourneville Syndrome0low10
Bourneville-Pringle Disease0low10
Bourneville-Pringle's Disease0low10
Bourneville's Disease0low10
Bourneville's Syndrome0low10
Bovine Diseases0low10
Bowel Diseases, Inflammatory0medium132
Brachial Paresis0low10
Brachial Plexopathy0low10
Brachial Plexus Diseases0low10
Brachial Plexus Disorders0low10
Brachial Plexus Neuropathies0low10
Bradyarrhythmia0low30
Bradyarrhythmias0low30
Bradycardia0low30
Bradykinesia0low10
Brain Abscess0low400
Brain Abscess, Child0low400
Brain Abscess, Multiple0low400
Brain Abscess, Pyogenic0low400
Brain Abscess, Sterile0low400
Brain Aneurysm0low20
Brain Anoxia0low40
Brain Anoxia-Ischemia0low50
Brain Cancer0medium484
Brain Dead0low20
Brain Death0low20
Brain Diseases0medium351
Brain Diseases, Metabolic0low10
Brain Diseases, Metabolic, Acquired0low10
Brain Disorders0medium351
Brain Disorders, Metabolic0low10
Brain Disorders, Metabolic, Acquired0low10
Brain Dysfunction, Minimal0low20
Brain Edema0low50
Brain Emboli0low10
Brain Embolism0low10
Brain Embolism and Thrombosis0low10
Brain Hemorrhage, Cerebral0low40
Brain Hypoxia0low40
Brain Hypoxia-Ischemia0low50
Brain Infarct0low30
Brain Infarction0low30
Brain Infarction, Anterior Circulation0low30
Brain Infarction, Posterior Circulation0low30
Brain Infarction, Venous0low30
Brain Inflammation0low100
Brain Injuries0medium131
Brain Injuries, Acute0medium131
Brain Injuries, Focal0medium131
Brain Injuries, Traumatic0medium51
Brain Ischemia0low300
Brain Ischemia-Anoxia0low50
Brain Ischemia-Hypoxia0low50
Brain Lacerations0medium131
Brain Metastases0medium484
Brain Neoplasm, Primary0medium484
Brain Neoplasms0medium484
Brain Neoplasms, Benign0medium484
Brain Neoplasms, Malignant0medium484
Brain Neoplasms, Malignant, Primary0medium484
Brain Neoplasms, Primary Malignant0medium484
Brain Stem Ischemia, Transient0low110
Brain Stem Neoplasms0low40
Brain Stem Neoplasms, Primary0low40
Brain Stem Transient Ischemic Attack0low110
Brain Stem Tumors0low40
Brain Swelling0low50
Brain Syndrome, Metabolic0low10
Brain Syndrome, Metabolic, Acquired0low10
Brain TIA0low110
Brain Tumor, Primary0medium484
Brain Tumor, Recurrent0medium484
Brain Tumors0medium484
Brain Vascular Disorders0low40
Brain Ventricular Neoplasms0low10
Brainstem Ischemia, Transient0low110
Brainstem Neoplasms0low40
Brainstem Neoplasms, Primary0low40
Brainstem Transient Ischemic Attack0low110
Brainstem Tumors0low40
Branch Retinal Artery Occlusion0low10
Branch Vein Occlusion0low10
Break-Bone Fever0low30
Breakbone Fever0low30
Breakthrough Bleeding0low10
Breast Cancer0medium1,790464
Breast Cancer, Male0medium142
Breast Carcinoma0medium1,790464
Breast Carcinoma In Situ0low10
Breast Carcinoma, Male0medium142
Breast Diseases0medium43
Breast Dysplasia0low10
Breast Neoplasms0medium1,790464
Breast Neoplasms, Male0medium142
Breast Tumors0medium1,790464
Breast Tumors, Male0medium142
Breathing Sounds0medium21
Breathlessness0medium11
Bright Disease0low80
Brill-Symmers Disease0low30
Briquet Syndrome0medium21
Broken Bones0medium2711
Bronchial Asthma0medium558
Bronchial Diseases0low30
Bronchial Hyperreactivity0medium181
Bronchial Neoplasms0low20
Bronchial Spasm0low70
Bronchiectasis0low20
Bronchiolitis0low10
Bronchiolitis Obliterans0low40
Bronchiolitis, Exudative0low40
Bronchiolitis, Proliferative0low40
Bronchitis0low100
Bronchopulmonary Aspergilloses0medium973
Bronchopulmonary Aspergilloses, Allergic0medium402
Bronchopulmonary Aspergillosis0medium973
Bronchopulmonary Aspergillosis, Allergic0medium402
Bronchopulmonary Sequestration0low20
Bronchopulmonary Sequestrations0low20
Bronchospasm0low70
Bronchospasm, Exercise-Induced0medium11
Bronze Diabetes0medium241
Bronzed Cirrhosis0medium241
Brown Tendon Sheath Syndrome0low20
Brown's Tendon Sheath Syndrome0low20
Buckley Syndrome0low10
Buerger Disease0low10
Buerger's Disease0low10
Bulbar Polio0low10
Bulbar Poliomyelitis0low10
Bulimia0medium42
Bulla0medium31
Bullae0medium31
Bullous Dermatoses0low20
Bullous Lesion0medium31
Bullous Skin Diseases0low20
Burkitt Cell Leukemia0medium91
Burkitt Leukemia0medium91
Burkitt Lymphoma0medium91
Burkitt Tumor0medium91
Burkitt's Leukemia0medium91
Burkitt's Lymphoma0medium91
Burkitt's Tumor0medium91
Burns0low90
Burns, Inhalation0low10
Bursitis0low10
C gattii Infection0medium894
C neoformans Infection0medium894
C. gattii Infection0medium894
C. neoformans Infection0medium894
CACH Syndrome0low10
CACH VWM Syndrome0low10
Cachexia0low40
Cadaver0low10
Cadmium Poisoning0low20
Cafe-au-Lait Spots0low20
Calcification, Pathologic0low40
Calcinosis0low40
Calcinosis, Tumoral0low40
Calculosis0low10
Campylobacter Infection0medium22
Campylobacter Infections0medium22
Campylobacteriosis0medium22
Cancer0medium31633
Cancer of Adrenal Cortex0low10
Cancer of Anus0low10
Cancer of Bile Duct0medium61
Cancer of Biliary Tract0low20
Cancer of Bladder0low100
Cancer of Bone0medium483
Cancer of Brain0medium484
Cancer of Breast0medium1,790464
Cancer of Cervix0medium123
Cancer of Colon0medium382
Cancer of Endocrine Gland0low10
Cancer of Endometrium0medium556
Cancer of Esophagus0medium152
Cancer of Gallbladder0low10
Cancer of Gastrointestinal Tract0medium51
Cancer of Granulosa Cells0low70
Cancer of Head0medium251
Cancer of Head and Neck0medium251
Cancer of Kidney0medium182
Cancer of Larynx0low10
Cancer of Liver0medium815
Cancer of Lung0medium17213
Cancer of Maxillary Sinus0low10
Cancer of Mediastinum0low20
Cancer of Mouth0low90
Cancer of Muscle0low20
Cancer of Nasopharynx0low50
Cancer of Neck0medium251
Cancer of Nose0low10
Cancer of Oropharnyx0medium21
Cancer of Ovary0medium8112
Cancer of Pancreas0medium495
Cancer of Parotid0low20
Cancer of Pelvis0low30
Cancer of Pituitary0low60
Cancer of Prostate0medium726
Cancer of Rectum0medium73
Cancer of Salivary Gland0low40
Cancer of Skin0medium562
Cancer of Spleen0low10
Cancer of Stomach0medium492
Cancer of Testis0low60
Cancer of the Adrenal Cortex0low10
Cancer of the Adrenal Gland0low50
Cancer of the Anus0low10
Cancer of the Bile Duct0medium61
Cancer of the Biliary Tract0low20
Cancer of the Bladder0low100
Cancer of the Bone0medium483
Cancer of the Brain0medium484
Cancer of the Breast0medium1,790464
Cancer of the Cervix0medium123
Cancer of the Colon0medium382
Cancer of the Endocrine Gland0low10
Cancer of the Endometrium0medium556
Cancer of the Esophagus0medium152
Cancer of the Fallopian Tube0medium11
Cancer of the Gallbladder0low10
Cancer of the Gastrointestinal Tract0medium51
Cancer of the Head0medium251
Cancer of the Head and Neck0medium251
Cancer of the Kidney0medium182
Cancer of the Larynx0low10
Cancer of the Liver0medium815
Cancer of the Lung0medium17213
Cancer of the Mediastinum0low20
Cancer of the Mouth0low90
Cancer of the Muscle0low20
Cancer of the Nasopharynx0low50
Cancer of the Neck0medium251
Cancer of the Nose0low10
Cancer of the Oropharynx0medium21
Cancer of the Ovary0medium8112
Cancer of the Pancreas0medium495
Cancer of the Parotid0low20
Cancer of the Pelvis0low30
Cancer of the Pituitary0low60
Cancer of the Prostate0medium726
Cancer of the Rectum0medium73
Cancer of the Retina0low30
Cancer of the Salivary Gland0low40
Cancer of the Skin0medium562
Cancer of the Spleen0low10
Cancer of the Stomach0medium492
Cancer of the Testes0low60
Cancer of the Testis0low60
Cancer of the Thymus0low20
Cancer of the Thyroid0medium261
Cancer of the Tongue0low10
Cancer of the Uterine Cervix0medium123
Cancer of the Uterus0medium367
Cancer of the Vulva0low20
Cancer of Thymus0low20
Cancer of Thyroid0medium261
Cancer of Tongue0low10
Cancer of Uterus0medium367
Cancer of Vulva0low20
Cancer Pain0medium42
Cancer-Associated Pain0medium42
Cancer-Related Pain0medium42
Cancer, Embryonal0low30
Cancer, Embryonal and Mixed0low30
Cancer, Hepatocellular0medium815
Cancer, Radiation-Induced0low60
Cancer, Retinal0low30
Cancer, Second Primary0medium125
Candida Infection0medium41915
Candidemia0medium313
Candidiasis0medium41915
Candidiasis, Chronic Mucocutaneous0medium71
Candidiasis, Cutaneous0low40
Candidiasis, Genital0medium7421
Candidiasis, Invasive0medium335
Candidiasis, Oral0medium516
Candidiasis, Vulvovaginal0medium7421
Canine Diseases0medium222
Cannabis Abuse0medium52
Cannabis Dependence0medium52
Cannabis-Related Disorder0medium52
Capsulitis0low10
Capsulitis, Adhesive0low10
Car Sickness0medium33
Carbon Tetrachloride Poisoning0low60
Carcinogenesis0medium171
Carcinoid0low90
Carcinoid Tumor0low90
Carcinoid, Goblet Cell0low90
Carcinoma0medium517
Carcinoma 256, Walker0low40
Carcinoma in Situ0medium62
Carcinoma of Endocrine Gland0low10
Carcinoma of Endometrium0medium556
Carcinoma, Acinar Cell0low10
Carcinoma, Adenoid Cystic0low30
Carcinoma, Anaplastic0medium517
Carcinoma, Basal Cell0low90
Carcinoma, Basal Cell, Pigmented0low90
Carcinoma, Bronchial0low10
Carcinoma, Bronchogenic0low10
Carcinoma, Colloid0low40
Carcinoma, Cribriform0medium625
Carcinoma, Ductal0medium61
Carcinoma, Ductal, Breast0medium8619
Carcinoma, Ductal, Pancreatic0medium142
Carcinoma, Ehrlich Tumor0low170
Carcinoma, Embryonal0low20
Carcinoma, Endometrioid0medium41
Carcinoma, Epidermoid0medium472
Carcinoma, Granular Cell0medium625
Carcinoma, Hepatocellular0medium543
Carcinoma, Hypernephroid0medium142
Carcinoma, Infiltrating Duct0medium8619
Carcinoma, Intraductal0medium123
Carcinoma, Intraductal, Noninfiltrating0medium123
Carcinoma, Intraepithelial0medium62
Carcinoma, Invasive Ductal, Breast0medium8619
Carcinoma, Krebs 20low10
Carcinoma, Lewis Lung0low70
Carcinoma, Lobular0medium369
Carcinoma, Mammary Ductal0medium8619
Carcinoma, Medullary0low20
Carcinoma, Merkel Cell0low60
Carcinoma, Mucinous0low40
Carcinoma, Mucoepidermoid0low10
Carcinoma, Neuroendocrine0low40
Carcinoma, Non-Small Cell Lung0medium687
Carcinoma, Non-Small-Cell Lung0medium687
Carcinoma, Oat Cell0low50
Carcinoma, Ovarian Epithelial0medium81
Carcinoma, Pancreatic Ductal0medium142
Carcinoma, Papillary0medium41
Carcinoma, Planocellular0medium472
Carcinoma, Preinvasive0medium62
Carcinoma, Renal Cell0medium142
Carcinoma, Scirrhous0low20
Carcinoma, Signet Ring Cell0low10
Carcinoma, Small Cell0low50
Carcinoma, Small Cell Lung0low120
Carcinoma, Spindle-Cell0medium517
Carcinoma, Squamous0medium472
Carcinoma, Squamous Cell0medium472
Carcinoma, Squamous Cell of Head and Neck0low130
Carcinoma, Thymic0low10
Carcinoma, Transitional Cell0low10
Carcinoma, Tubular0medium625
Carcinoma, Undifferentiated0medium517
Carcinoma, Verrucous0low10
Carcinomatosis0medium517
Carcinomatous Meningitis0low30
Carcinosarcoma0low30
Carcinosarcoma 256, Walker0low40
Cardiac Arrest0low30
Cardiac Arrest, Sudden0low20
Cardiac Arrhythmia0medium202
Cardiac Arrhythmias0medium202
Cardiac Cancer0low10
Cardiac Carcinoma0low10
Cardiac Death0low40
Cardiac Diseases0medium122
Cardiac Disorders0medium122
Cardiac Dysrhythmia0medium202
Cardiac Failure0medium255
Cardiac Hypertrophy0low50
Cardiac Neoplasms0low10
Cardiac Remodeling, Ventricular0low90
Cardiac Rupture, Traumatic0low20
Cardiac Sudden Death0low20
Cardiac Tamponade0low10
Cardiac Toxicity0low90
Cardiac Tumor0low10
Cardiac Tumors0low10
Cardiomegaly0low50
Cardiometabolic Syndrome0medium195
Cardiomyopathies0medium185
Cardiomyopathies, Primary0medium185
Cardiomyopathies, Secondary0medium185
Cardiomyopathy, Chagas0low40
Cardiomyopathy, Congestive0low90
Cardiomyopathy, Dilated0low90
Cardiomyopathy, Dilated, 1a0low90
Cardiomyopathy, Dilated, 3B0low20
Cardiomyopathy, Dilated, Autosomal Recessive0low90
Cardiomyopathy, Dilated, CMD1A0low90
Cardiomyopathy, Dilated, LMNA0low90
Cardiomyopathy, Dilated, With Conduction Defect 10low90
Cardiomyopathy, Dilated, with Conduction Deffect10low90
Cardiomyopathy, Dilated, X-Linked0low20
Cardiomyopathy, Familial Idiopathic0low90
Cardiomyopathy, Hypertrophic0low10
Cardiomyopathy, Hypertrophic Obstructive0low10
Cardiomyopathy, Idiopathic Dilated0low90
Cardiopulmonary Arrest0low30
Cardiotoxicity0low90
Cardiovascular Abnormalities0low10
Cardiovascular Diseases0medium5813
Cardiovascular Stroke0medium292
Cardiovirus Infections0low10
Carditis0medium51
Caries, Dental0low20
Carious Dentin0low20
Carious Lesions0low20
Carney Complex0low10
Carney Complex, Type 10low10
Carney Complex, Type 20low10
Carney Complex, Type I0low10
Carney Complex, Type II0low10
Carney Myxoma-Endocrine Complex0low10
Carney Myxoma-Endocrine Complex, Type II0low10
Carney Syndrome0low10
Carotid Arteriopathies, Traumatic0low50
Carotid Artery Diseases0medium41
Carotid Artery Disorders0medium41
Carotid Artery Injuries0low50
Carotid Artery Narrowing0low40
Carotid Artery Plaque0low40
Carotid Artery Stenosis0low40
Carotid Artery Thrombosis0low60
Carotid Artery Ulcerating Plaque0low40
Carotid Atherosclerosis0medium41
Carotid Atherosclerotic Disease0medium41
Carotid Circulation Transient Ischemic Attack0low110
Carotid False Aneurysm0low50
Carotid Pseudoaneurysm0low50
Carotid Stenosis0low40
Carotid Thrombosis0low60
Carotid Ulcer0low40
Carpal Tunnel Syndrome0medium32
Carsickness0medium33
Castration-Resistant Prostatic Cancer0medium233
Castration-Resistant Prostatic Neoplasms0medium233
Cat Diseases0low70
Catalase Deficiency0low20
Catalepsy0low210
Cataleptic Attacks0low10
Cataplexy0low10
Cataract0medium51
Cataract, Membranous0medium51
Catarrh0medium11
Catatonic Rigidity0low10
Catch220low10
Catheter-Associated Infections0low100
Catheter-Related Infections0low100
Cattle Diseases0low10
Cavernous Sinus Thrombophlebitis0low20
Cavernous Sinus Thrombosis0low20
Cavernous Sinus, Phlebitis, Septic0low20
Caverous Sinus Septic Phlebitis0low20
CCl4 Poisoning0low60
CD30-Positive Anaplastic Large-Cell Lymphoma0low20
CD30+ Anaplastic Large-Cell Lymphoma0low20
CD4-Positive T-Lymphocytopenia, Idiopathic0low10
CD4+ T-Lymphocytopenia0low10
CD4+ T-Lymphocytopenia, Idiopathic0low10
Cell Transformation, Neoplastic0low320
Cells, Neoplasm Circulating0low20
Cellular Ependymoma0low20
Cellulitis0medium41
Cellulitis, Orbital0low20
Central Autonomic Nervous System Diseases0medium42
Central European Encephalitis0low30
Central Hypothyroidism0medium61
Central Nervous System Bacterial Infections0low10
Central Nervous System Cysts0low10
Central Nervous System Disease0low120
Central Nervous System Diseases0low120
Central Nervous System Disorder0low120
Central Nervous System Disorders0low120
Central Nervous System Disorders, Intracranial0medium351
Central Nervous System Fungal Infections0medium531
Central Nervous System Infection0medium61
Central Nervous System Infections0medium61
Central Nervous System Intracranial Disorders0medium351
Central Nervous System Metabolic Disorders0low10
Central Nervous System Mycoses0medium531
Central Nervous System Neoplasm0low20
Central Nervous System Neoplasms0low20
Central Nervous System Neoplasms, Primary0low20
Central Nervous System Origin Vertigo0low10
Central Nervous System Phaeohyphomycosis0low50
Central Nervous System Phaeohyphomycosis, Primary0low50
Central Nervous System Protozoal Infections0low20
Central Nervous System Syphilis0low20
Central Nervous System Toxoplasmosis0low10
Central Nervous System Tumor0low20
Central Nervous System Tumors0low20
Central Retinal Artery Occlusion0low10
Central Retinal Edema, Cystoid0low30
Central Retinal Vein Occlusion0low10
Centrala nervsystemets sjukdomar@sv0low120
Cephalalgia0medium3719
Cephalgia0medium3719
Cephalgia Syndromes0low10
Cephalodynia0medium3719
Cerea Flexibilitas0low210
Cerebellar Ataxia0low10
Cerebellar Cancer0low80
Cerebellar Degeneration with Slow Eye Movements0low10
Cerebellar Diseases0low10
Cerebellar Disorders0low10
Cerebellar Dysfunction0low10
Cerebellar Dysmetria0low10
Cerebellar Hemiataxia0low10
Cerebellar Incoordination0low10
Cerebellar Neoplasms0low80
Cerebellar Neoplasms, Benign0low80
Cerebellar Neoplasms, Malignant0low80
Cerebellar Neoplasms, Primary0low80
Cerebellar Syndromes0low10
Cerebellar Tumors0low80
Cerebelloparenchymal Disorder I0low10
Cerebellum Diseases0low10
Cerebral Abscess0low400
Cerebral Aneurysm0low20
Cerebral Angiospasm0low10
Cerebral Anoxia0low40
Cerebral Anoxia-Ischemia0low50
Cerebral Artery Spasm0low10
Cerebral Astrocytoma0low30
Cerebral Convexity Meningioma0low10
Cerebral Cryptococcosis0low320
Cerebral Edema0low50
Cerebral Edema, Cytotoxic0low50
Cerebral Edema, Vasogenic0low50
Cerebral Emboli0low10
Cerebral Embolism0low10
Cerebral Embolism and Thrombosis0low10
Cerebral Hemorrhage0low40
Cerebral Hypoxia0low40
Cerebral Hypoxia-Ischemia0low50
Cerebral Infarct0low70
Cerebral Infarction0low70
Cerebral Infarction, Left Hemisphere0low70
Cerebral Infarction, Middle Cerebral Artery0low40
Cerebral Infarction, Right Hemisphere0low70
Cerebral Ischemia0low300
Cerebral Ischemia-Anoxia0low50
Cerebral Ischemia-Hypoxia0low50
Cerebral Ischemia, Transient0low110
Cerebral Nocardiosis0low10
Cerebral Parenchymal Hemorrhage0low40
Cerebral Phaeohyphomycosis0low50
Cerebral Protozoal Infections0low20
Cerebral Sclerosis0low10
Cerebral Stroke0medium145
Cerebral Toxoplasmosis0low10
Cerebral Vasospasm0low10
Cerebral Ventricle Neoplasms0low10
Cerebral Ventricle Tumors0low10
Cerebral Ventriculomegaly0low10
Cerebral, Left Hemisphere, Infarction0low70
Cerebral, Right Hemisphere, Infarction0low70
Cerebroatrophic Hyperammonemia0low10
Cerebromeningitis0low30
Cerebroside Lipidosis Syndrome0low40
Cerebrovascular Accident0medium145
Cerebrovascular Accident, Acute0medium145
Cerebrovascular Apoplexy0medium145
Cerebrovascular Diseases0low40
Cerebrovascular Disorders0low40
Cerebrovascular Insufficiency0low40
Cerebrovascular Occlusion0low40
Cerebrovascular Spasm0low10
Cerebrovascular Stroke0medium145
Cerebroventricular Neoplasms0low10
Cervical Cancer0medium123
Cervical Migraine Syndrome0medium23878
Cervical Neoplasms0medium123
Cervical Sympathetic Dystrophy0low20
Cervix Cancer0medium123
Cervix Neoplasms0medium123
Chagas Cardiomyopathy0low40
Chagas Disease0medium965
Chagas' Cardiomyopathy0low40
Chagas' Disease0medium965
Charcot Disease0medium41
Charcot Gait0low30
Charcot-Marie Disease0low10
Charcot-Marie-Tooth Disease0low10
Charcot-Marie-Tooth Disease, Autosomal Dominant, With Focally Folded Myelin Sheaths, Type 1A0low10
Charcot-Marie-Tooth Disease, Autosomal Dominant, with Focally Folded Myelin Sheaths, Type 1B0low10
Charcot-Marie-Tooth Disease, Demyelinating, Type 1A0low10
Charcot-Marie-Tooth Disease, Demyelinating, Type 1B0low10
Charcot-Marie-Tooth Disease, Slow Nerve Conduction Type, Linked To Duffy0low10
Charcot-Marie-Tooth Disease, Type 1A0low10
Charcot-Marie-Tooth Disease, Type 1B0low10
Charcot-Marie-Tooth Disease, Type I0low10
Charcot-Marie-Tooth Disease, Type IA0low10
Charcot-Marie-Tooth Disease, Type IB0low10
Charcot-Marie-Tooth Disease, Type II0low10
Charcot-Marie-Tooth Hereditary Neuropathy0low10
Charcot-Marie-Tooth Neuropathy, Type 1A0low10
Charcot-Marie-Tooth Neuropathy, Type 1B0low10
Charcot-Marie-Tooth Syndrome0low10
Charcot's Gait0low30
Cheilitis0low60
Chemical and Drug Induced Liver Injury0medium1134
Chemical and Drug Induced Liver Injury, Chronic0medium11
Chemical Dependence0medium153
Chemical Sensitivities, Multiple0low10
Chemical Sensitivity, Multiple0low10
Chemical-Induced Liver Injury, Chronic0medium11
Chemically-Induced Liver Injury, Chronic0medium11
Chemically-Induced Liver Toxicity0medium1134
Chemotherapy-Induced Acral Erythema0low20
Chemotherapy-Induced Febrile Neutropenia0low20
Chemotherapy-Induced Palmoplantar Erythrodysesthesia0low20
Chest Injuries0low10
Chest Pain0low10
Chicken Pox0low10
Chickenpox0low10
Child Development Disorders, Pervasive0low10
Childhood Absence Epilepsy0medium81
Childhood Ataxia with Central Nervous System Hypomyelination0low10
Childhood Ataxia with Central Nervous System Hypomyelinization0low10
Childhood Ataxia with Diffuse Central Nervous System Hypomyelination0low10
Childhood Benign Focal Epilepsy0medium125
Childhood Benign Occipital Epilepsy0medium125
Childhood Benign Psychomotor Epilepsy0low30
Childhood Cerebral Astrocytoma0low30
Childhood Communication Disorders0medium11
Childhood Muscular Dystrophy, Pseudohypertrophic0low20
Childhood Onset Dystonias0low10
Childhood Pseudohypertrophic Muscular Dystrophy0low20
Chills0low20
Chlamydia Infections0low10
Chlamydia pneumoniae Infections0low20
Chlamydophila Infections0low20
Chloasma0low20
Chloracne0low10
Chlorine Acne0low10
Chloroma0low10
Choked Disk0low10
Choking0low20
Cholangiitis, Sclerosing0low10
Cholangiocarcinoma0medium71
Cholangiocellular Carcinoma0medium71
Cholangitis0medium11
Cholangitis, Chronic Nonsuppurative Destructive0low20
Cholangitis, Primary Sclerosing0low10
Cholangitis, Sclerosing0low10
Cholecystitis0low10
Cholecystitis, Acalculous0low10
Cholelithiasis0low10
Cholera0medium11
Cholera Infantum0medium3210
Cholestasis0low40
Choline Deficiency0low20
Chondrosarcoma0low20
Chorea0low10
Chorea Disorders0low10
Chorea Syndromes0low10
Chorea, Benign Hereditary0low10
Chorea, Chronic Progressive0low10
Chorea, Chronic Progressive Hereditary (Huntington)0low130
Chorea, Rheumatic0low10
Chorea, Senile0low10
Chorea, Sydenham0low10
Choreatic Disorders0low10
Choreatic Syndromes0low10
Choreic Movement0low10
Choreiform Movement0low10
Choriocarcinoma0low90
Chorioretinitis0low50
Choristoma0low30
Choroby OUN@pl0low120
Choroid Diseases0low10
Choroid Neoplasms0low70
Choroid Neovascularization0low30
Choroidal Diseases0low10
Choroidal Neoplasms0low70
Choroidal Neovascularization0low30
Choroiditis0low10
Chromoblastomycosis0low160
Chromomycosis0low160
Chromophil Renal Cell Carcinoma0medium142
Chromophobe Renal Cell Carcinoma0medium142
Chromosomal Aberrations0low230
Chromosomal Disorders0low20
Chromosomal Translocation0medium41
Chromosomal Triplication0low10
Chromosome 6-Linked Autosomal Recessive Parkinsonism0low240
Chromosome 7q11.23 Deletion Syndrome0low10
Chromosome Aberrations0low230
Chromosome Abnormalities0low230
Chromosome Abnormality Disorders0low20
Chromosome Deletion0low30
Chromosome Disorders0low20
Chromosome Inversion0low10
Chromosome-Defective Micronuclei0low90
Chronic Actinic Dermatitis0low170
Chronic Airflow Obstruction0medium234
Chronic Cluster Headache0low30
Chronic Congenital Agenerative Anemia0low40
Chronic Cystic Mastitis0low10
Chronic Daily Headache0low10
Chronic Disease0medium13238
Chronic Drug-Induced Liver Injury0medium11
Chronic Fatigue and Immune Dysfunction Syndrome0medium21
Chronic Fatigue Disorder0medium21
Chronic Fatigue Syndrome0medium21
Chronic Fatigue-Fibromyalgia Syndrome0medium21
Chronic Gaucher Disease0low40
Chronic Granulomatous Disease0medium353
Chronic Granulomatous Disease, Atypical0medium353
Chronic Granulomatous Disease, X-Linked0medium353
Chronic Headache0low10
Chronic Hepatitis0low10
Chronic Hepatitis B0low30
Chronic Hepatitis B Virus Infection0low30
Chronic Hepatitis C0medium171
Chronic Idiopathic Intestinal Pseudo-Obstruction0low10
Chronic Idiopathic Myelofibrosis0low80
Chronic Illness0medium13238
Chronic Insomnia0medium12341
Chronic Kidney Diseases0medium3514
Chronic Kidney Failure0medium328
Chronic Kidney Insufficiency0medium3514
Chronic Liver Failure0low20
Chronic Lung Injury0low60
Chronic Lymphocytic Leukemia0medium182
Chronic Motor and Vocal Tic Disorder0low10
Chronic Necrotizing Pulmonary Aspergillosis0medium1207
Chronic Obstructive Airway Disease0medium234
Chronic Obstructive Lung Disease0medium234
Chronic Obstructive Pulmonary Disease0medium234
Chronic Obstructive Pulmonary Diseases0medium234
Chronic Pain0low80
Chronic Post-operative Pain0low30
Chronic Post-surgical Pain0low30
Chronic Post-Traumatic Stress Disorder0medium178
Chronic Postoperative Pain0low30
Chronic Postsurgical Pain0low30
Chronic Primary Open Angle Glaucoma0medium43
Chronic Progressive Hereditary Chorea (Huntington)0low130
Chronic Renal Diseases0medium3514
Chronic Renal Insufficiency0medium3514
Chronic Wasting Disease0low10
Chronically Ill0medium13238
Chronobiology Disorders0low10
Chyloperitoneum0low10
Chylous Ascites0low10
Chylous Peritonitis0low10
Cicatrix0medium32
Cicatrization0medium32
Ciliary Neuralgia0low30
Circadian Dysregulation0low10
Circadian Rhythm Disorders0low10
Circadian Rhythm Sleep Disorder0medium41
Circadian Rhythm Sleep Disorders0medium41
Circulating Cells, Neoplasm0low20
Circulating Neoplastic Cells0low20
Circulating Tumor Cells0low20
Circulatory Collapse0low50
Circulatory Failure0low50
Cirrhoses, Experimental Liver0medium51
Cirrhosis0medium351
Cirrhosis, Experimental Liver0medium51
Cirrhosis, Liver0medium363
Clasp-Knife Spasticity0low20
Classic Distal Renal Tubular Acidosis0low20
Classic Hemophilia0low40
Classic Migraine0low30
Classical Dengue0low30
Classical Dengue Fever0low30
Classical Migraine0low30
Claustrophobia0medium83
Clear Cell Ependymoma0low20
Clear Cell Meningioma0low10
Clear Cell Renal Carcinoma0medium142
Clear Cell Renal Cell Carcinoma0medium142
Cleft Palate0low10
Cleft Palate, Isolated0low10
Clerambault Syndrome0medium32
Clinically Isolated CNS Demyelinating Syndrome0low10
Clinically Isolated Syndrome, CNS Demyelinating0low10
Clonic Seizure0medium1153
Clonic Seizures0medium1153
Clostridioides difficile Infection0low20
Clostridioides Infections0low20
Clostridioides perfringens Food Poisoning0low20
Clostridioides perfringens Infections0low20
Clostridioides sordellii Infection0low20
Clostridium difficile Infection0low20
Clostridium difficile Infections0low20
Clostridium Enterocolitis0low40
Clostridium Infections0low20
Clostridium perfringens Food Poisoning0low20
Clostridium perfringens Infections0low20
Clostridium sordellii Infection0low20
Clostridium sordellii Infections0low20
Clubfeet0low10
Clubfeet, Congenital0low10
Clubfoot0low10
Clubfoot, Congenital0low10
Cluster Headache0low30
Cluster Headache Syndrome0low30
CNS Cysts0low10
CNS Disease0low120
CNS Diseases0low120
CNS Disorders, Intracranial0medium351
CNS Fungal Infections0medium531
CNS Infections0medium61
CNS Metabolic Disorders0low10
CNS Metabolic Disorders, Acquired0low10
CNS Neoplasm0low20
CNS Neoplasms0low20
CNS Origin Vertigo0low10
CNS Protozoal Infections0low20
Co-infection0medium112
COAD0medium234
Coagulation Disorders, Blood0low20
Coagulation, Disseminated Intravascular0low20
Coarse Tremor0low50
Cocaine Abuse0medium63
Cocaine Addiction0medium63
Cocaine Dependence0medium63
Cocaine-Related Disorders0medium63
Cocarcinogenesis0low10
Coccidioides immitis Infection0medium594
Coccidioidomycosis0medium594
Coccidiosis0low10
Cochlear Hearing Loss0low20
Cognition Disorders0medium273
Cognitive Decline0medium143
Cognitive Dysfunction0medium143
Cognitive Impairments0medium143
Cogwheel Rigidity0low10
Coin Lesion, Pulmonary0low20
Coin Lesions, Pulmonary0low20
Coinfection0medium112
Cold Agglutinin Disease0low10
Cold Antibody Disease0low10
Cold Antibody Hemolytic Anemia0low10
Cold Fingers, Hereditary0low10
Cold, Common0medium11
Colicky Pain0medium61
Colitis0medium262
Colitis Gravis0medium183
Colitis, Collagenous0low10
Colitis, Granulomatous0medium171
Colitis, Ischemic0low20
Colitis, Lymphocytic0low10
Colitis, Pseudomembranous0low40
Colitis, Ulcerative0medium183
Collagen Arthritis0low240
Collagenous Colitis0low10
Collecting Duct Carcinoma0medium142
Collecting Duct Carcinoma (Kidney)0medium142
Collecting Duct Carcinoma of the Kidney0medium142
Colles' Fracture0low10
Colon Cancer0medium382
Colon Neoplasms0medium382
Colonic Cancer0medium382
Colonic Diseases0low30
Colonic Inertia0medium31
Colonic Neoplasms0medium382
Color Blindness0medium11
Color Blindness, Acquired0medium11
Color Blindness, Blue0medium11
Color Blindness, Green0medium11
Color Blindness, Inherited0medium11
Color Blindness, Red0medium11
Color Blindness, Red-Green0medium11
Color Vision Defects0medium11
Color Vision Deficiency0medium11
Colorectal Cancer0medium495
Colorectal Carcinoma0medium495
Colorectal Neoplasms0medium495
Colorectal Tumors0medium495
Coma0low10
Coma Depasse0low20
Comatose0low10
Combat Disorders0medium108
Combat Neuroses0medium108
Combat Neurosis0medium108
Combat Stress Disorders0medium108
Combined Multiple Motor and Vocal Tic Disorder0low10
Combined Vocal and Multiple Motor Tic Disorder0low10
Common Carotid Artery Diseases0medium41
Common Carotid Artery Stenosis0low40
Common Carotid Artery Thrombosis0low60
Common Cold0medium11
Common Migraine0medium42
Common Variable Hypogammaglobulinemia0low10
Common Variable Immune Deficiency0low10
Common Variable Immunodeficiency0low10
Communicable Diseases0low30
Communicable Diseases, Emerging0low80
Communicable Diseases, Re-Emerging0low80
Communicable Diseases, Reemerging0low80
Communicating Hydrocephalus0low10
Communication Disabilities0medium11
Communication Disorders0medium11
Communication Disorders, Childhood0medium11
Communication Disorders, Developmental0medium11
Communication Disorders, Neurogenic0medium11
Communicative Disorders0medium11
Communicative Dysfunction0medium11
Community Acquired Infection0medium184
Community-Acquired Infection0medium184
Community-Acquired Infections0medium184
Compensatory Hyperinsulinemia0low60
Complex Endometrial Hyperplasia0medium104
Complex Partial Epilepsy0low10
Complex Partial Seizure0medium1153
Complex Partial Seizure Disorder0low10
Complex Partial Seizures0medium1153
Complex Partial Status Epilepticus0low50
Complex Regional Pain Syndrome, Type I0low20
Complicated Migraine0low30
Complication, Intraoperative0low10
Complication, Peroperative0low10
Complication, Postoperative0medium972
Complications of Diabetes Mellitus0medium362
Complications, Hematologic Pregnancy0low40
Complications, Infectious Pregnancy0medium134
Complications, Pregnancy0medium41
Compression Atelectasis0low10
Compression Fractures0low10
Compression Neuropathy, Carpal Tunnel0medium32
Compression Pulmonary Atelectasis0low10
Condition, Preneoplastic0medium71
Conditions, Preneoplastic0medium71
Congenital Abnormalities0low50
Congenital Abnormalities, Nervous System0low10
Congenital Adrenal Hyperplasia0low20
Congenital Amino Acidopathies0low10
Congenital Anomalies, Nervous System0low10
Congenital Auditory Agnosia0low10
Congenital Defects0low50
Congenital Dyserythropoietic Anemia0medium21
Congenital Dyserythropoietic Anemia Type 10medium21
Congenital Dyserythropoietic Anemia Type II0medium21
Congenital Dyserythropoietic Anemia, Type I0medium21
Congenital Dyserythropoietic Anemia, Type III0medium21
Congenital Erythroid Hypoplastic Anemia0low40
Congenital Erythropoietic Porphyria0low30
Congenital Familial Lymphedema0low10
Congenital Heart Defect0low50
Congenital Heart Defects0low50
Congenital Heart Disease0low50
Congenital Hereditary Lymphedema0low10
Congenital Hydrocephalus0low10
Congenital Hypoplastic Anemia of Blackfan and Diamond0low40
Congenital Malformations, Nervous System0low10
Congenital Myotonic Dystrophy0low10
Congenital Nephrogenic Diabetes Insipidus0low10
Congenital Nonspherocytic Hemolytic Anemia0low10
Congenital Pure Red Cell Anemia0low40
Congenital Pure Red Cell Aplasia0low40
Congenital Short Bowel Syndrome0low10
Congenital Talipes Equinovarus0low10
Congenital Zika Syndrome0low10
Congenital Zika Virus Infection0low10
Congestive Atelectasis0low10
Congestive Cardiomyopathy0low90
Congestive Heart Failure0medium255
Congestive Pulmonary Atelectasis0low10
Conjugate Nystagmus0low10
Conjunctival Diseases0medium21
Conjunctivitis0low10
Conjunctivitis, Allergic0low20
Conjunctivitis, Atopic0low20
Conjunctivitis, Giant Papillary0low20
Conjunctivitis, Vernal0low20
Conn Syndrome0low30
Conn's Syndrome0low30
Conotruncal Anomaly Face Syndrome0low10
Conotruncal Anomaly Face Syndrome (CTAF)0low10
Constipation0medium31
Constricted Pupil0medium22
Constriction, Pathologic0low20
Constriction, Pathological0low20
Constrictive Bronchiolitis0low40
Consumption Coagulopathy0low20
Contact Dermatitis0low150
Contiguous Gene Syndrome, Williams0low10
Continuous Tremor0low50
Contraction Pulmonary Atelectasis0low10
Conus Medullaris Syndrome0low30
Convergence Excess0low20
Convergence Insufficiency0low20
Convergence Nystagmus0low10
Conversion Disorder0medium21
Conversion Neurosis0medium21
Conversion Reaction0medium21
Convulsion0medium1153
Convulsion, Non-Epileptic0medium1153
Convulsions0medium1153
Convulsions, Febrile0low20
Convulsions, Grand Mal0medium31
Convulsive Generalized Seizure Disorder0medium71
Convulsive Seizure0medium1153
Convulsive Seizure Disorder, Generalized0medium71
Convulsive Seizures0medium1153
Coordination Impairment0low30
COPD0medium234
Coracohumeral Impingement0low10
Coracohumeral Impingement Syndrome0low10
Coracoid Impingement Syndrome0low10
Cornea Injuries0low40
Corneal Abrasions0low40
Corneal Angiogenesis0low10
Corneal Damage0low40
Corneal Diseases0low40
Corneal Edema0low10
Corneal Endothelial Cell Damage0low10
Corneal Endothelial Cell Loss0low10
Corneal Injuries0low40
Corneal Neovascularization0low10
Corneal Opacity0low20
Corneal Perforation0medium32
Corneal Scar0low40
Corneal Trauma0low40
Corneal Ulcer0medium5910
Coronary Arteriosclerosis0medium102
Coronary Artery Disease0medium102
Coronary Artery Stenosis0low10
Coronary Artery Vasospasm0low10
Coronary Atherosclerosis0medium102
Coronary Disease0medium101
Coronary Heart Disease0medium101
Coronary Restenosis0low20
Coronary Stenoses0low10
Coronary Stenosis0low10
Coronary Thrombosis0low30
Coronary Vasospasm0low10
Coronavirus Disease 20190medium262
Coronavirus Disease-190medium262
Coronavirus Infections0low40
Corpse0low10
Corpus Luteum Cyst0medium52
Cortical Lewy Body Disease0low10
Cortical Malformations, Group II0low10
Corticotroph Adenoma0low10
Coryza, Acute0medium11
Cough0low10
COVID-190medium262
COVID-19 Pandemic0medium262
COVID-19 Pandemics0medium262
COVID-19 Virus Disease0medium262
COVID-19 Virus Infection0medium262
COVID190medium262
Crackles0medium21
Cramp-Fasciculation Syndrome0low20
Cranial Epidural Abscess0low40
Cranial Extradural Abscess0low40
Cranial Nerve Diseases0low20
Cranial Nerve Disorders0low20
Cranial Nerve II Diseases0low10
Cranial Nerve II Disorder0low10
Cranial Nerve Palsies0low20
Cranial Nerve VI Diseases0low10
Cranial Nerve VI Palsy0low10
Cranial Neuropathies0low20
Cranial Neuropathies, Multiple0low20
Cranial Pain0medium3719
Cranial Sinus Thrombosis0low10
Craniocerebral Injuries0low10
Craniocerebral Trauma0low10
Craniofacial Abnormalities0low80
Craniorachischisis0low10
Cranioschisis0low10
Cree Leukoencephalopathy0low10
Crescendo Transient Ischemic Attacks0low110
Critical Illness0medium448
Critically Ill0medium448
Crohn Disease0medium171
Crohn's Disease0medium171
Crohn's Enteritis0medium171
Cronobacter Infections0low30
Cross Infection0medium361
CRPS Type I0low20
Cruor0low10
Crural Paresis0low10
Crushing Skull Injury0low10
Cryoglobulinemia0low10
Cryptococcal Meningitis0low320
Cryptococcosis0medium894
Cryptococcus gattii Infection0medium894
Cryptococcus Infection0medium894
Cryptococcus Infections0medium894
Cryptococcus neoformans Infection0medium894
Cryptogenic Chronic Hepatitis0low10
Cryptogenic Embolism Stroke0low20
Cryptogenic Fibrosing Alveolitis0low40
Cryptogenic Infantile Spasms0medium144
Cryptogenic Ischemic Stroke0low20
Cryptogenic Myoclonic Epilepsy0low50
Cryptogenic Partial Complex Epilepsy0low10
Cryptogenic Stroke0low20
Cryptogenic Tonic-Clonic Epilepsy0medium31
Cryptogenic West Syndrome0medium144
Cryptorchidism0low10
Cryptorchidism, Unilateral Or Bilateral0low10
Cryptorchism0low10
Cryptosporidiosis0low30
Cryptosporidium Infection0low30
Curling Ulcer0medium31
Curling's Ulcer0medium31
Cushing Disease0low20
Cushing Disease, Pituitary0low20
Cushing Syndrome0low10
Cushing's Disease0low20
Cushing's Syndrome0low10
Cutaneous Allergic Vasculitis0low10
Cutaneous Alternariosis0low60
Cutaneous Hyalohyphomycosis0low20
Cutaneous Leukocytoclastic Angiitis0low10
Cutaneous Leukocytoclastic Vasculitis0low10
Cutaneous Phaeohyphomycosis0low160
Cutaneous T-Cell Lymphoma0low30
CVA (Cerebrovascular Accident)0medium145
Cyanosis0low10
Cyclophoria0low20
Cylindroma0low30
Cyst0low70
Cystadenocarcinoma, Papillary0low10
Cystadenocarcinoma, Serous0medium31
Cystadenoma0low10
Cystic Breast Disease0low10
Cystic Disease of Breast0low10
Cystic Fibrosis0medium552
Cystic Fibrosis of Pancreas0medium552
Cystitis0low20
Cystoid Macular Dystrophy0low30
Cystoid Macular Edema0low30
Cystoid Macular Edema, Postoperative0low30
Cysts0low70
Cysts, Central Nervous System0low10
Cytochrome B-Negative Granulomatous Disease, Chronic, X-Linked0medium353
Cytochrome B-Positive Granulomatous Disease, Chronic, X-Linked0medium353
Cytogenetic Aberrations0low230
Cytogenetic Abnormalities0low230
Cytomegalic Inclusion Disease0low140
Cytomegalovirus0low120
Cytomegalovirus Infections0low140
Cytotoxic Brain Edema0low50
Cytotoxic Cerebral Edema0low50
Dairy Product Intolerance0medium11
Darkness Tremor0low50
Day Blindness0low200
Daytime Sleepiness0medium72
Daytime Somnolence0medium72
DCIS0medium123
DDPAC0medium11
De Toni-Debre-Fanconi Syndrome0medium161
Deafness Bilateral0low10
Deafness Neurosensory0low20
Deafness, Transitory0low30
Death0low40
Death, Sudden0medium21
Death, Sudden, Cardiac0low20
Debility0low10
Decay, Dental0low20
Decerebrate Posturing0low50
Decerebrate State0low50
Decorticate Rigidity0low50
Decorticate State0low50
Decreased Intraocular Pressure-Associated Papilledema0low10
Decreased Muscle Tone0low10
Decubitus Ulcer0low20
Deep Vein Thrombosis0low80
Deep Venous Thrombosis0low80
Deep-Vein Thrombosis0low80
Deep-Venous Thrombosis0low80
Defects, Congenital0low50
Defects, Congenital Heart0low50
Deficiency Disease, 4-Hydroxyphenol Pyruvic Acid Oxidase0low10
Deficiency Disease, Dihydropteridine Reductase0low10
Deficiency Disease, Fumarylacetoacetase0low10
Deficiency Disease, Phenylalanine Hydroxylase0low10
Deficiency Disease, Phenylalanine Hydroxylase, Severe0low10
Deficiency Disease, Tyrosine Transaminase0low10
Deficiency Diseases0low10
Deficiency of Glucose-6-Phosphate Dehydrogenase0low50
Deficiency of Uroporphyrinogen III Synthase0low30
Deficiency Syndrome, Immunologic0low30
Deficiency Syndromes, Antibody0low30
Deficiency Syndromes, Immunologic0low30
Deficiency, Ascorbic Acid0low10
Deficiency, Choline0low20
Deficiency, Factor VIII0low40
Deficiency, Glucosephosphate Dehydrogenase0low50
Deficiency, GPD0low50
Deficiency, Magnesium0low20
Deficiency, Mental0medium154
Deficiency, Oxygen0medium681
Deficiency, Platelet Storage Pool0low10
Deficiency, Protein0low10
Deficiency, Smooth Pursuit0low20
Deficiency, Storage Pool0low10
Deficiency, Vitamin C0low10
Deficiency, Vitamin D0medium41
Deficiency, Vitamin E0low30
Deformities0low50
Degenerative Disc Disease0low10
Degenerative Diseases, Central Nervous System0medium231
Degenerative Diseases, Nervous System0medium231
Degenerative Diseases, Neurologic0medium231
Degenerative Diseases, Spinal Cord0medium231
Degenerative Intervertebral Discs0low10
Degenerative Intervertebral Disks0low10
Degenerative Neurologic Diseases0medium231
Degenerative Neurologic Disorders0medium231
Deglutition Disorders0low10
Dehydration0low30
Dejerine-Klumpke Palsy0low10
Delayed Awakening from Anesthesia0low10
Delayed Awakening, Post-Anesthesia0low10
Delayed Awakening, Post-Procedural0low10
Delayed Effects, Prenatal Exposure0medium242
Delayed Emergence from Anesthesia0low10
Delayed Graft Function0low20
Delayed Hemolytic Transfusion Reaction0medium11130
Delayed Hypersensitivity0low70
Delayed Onset Post-Traumatic Stress Disorder0medium178
Delayed Puberty0medium1411
Delayed Recovery from Anesthesia0low10
Delayed Regaining of Consciousness0low10
Delayed Return of Consciousness0low10
Delayed Serologic Transfusion Reaction0medium11130
Delayed Sleep Phase Syndrome0medium41
Delayed Sleep-Phase Syndrome0medium41
Deletion 22q11.2 Syndrome0low10
Delirium0medium153
Delirium of Mixed Origin0medium153
Delirium, Dementia, Amnestic, Cognitive Disorders0medium32
Delusional Disorder0low10
Dementia0medium42
Dementia Complex, Acquired Immune Deficiency Syndrome0medium21
Dementia Complex, AIDS-Related0medium21
Dementia Praecox0medium276
Dementia With Amyotrophic Lateral Sclerosis0medium41
Dementia, Alzheimer Type0medium815
Dementia, Frontotemporal0medium11
Dementia, Frontotemporal, with Parkinsonism0medium11
Dementia, Hereditary Dysphasic Disinhibition0medium11
Dementia, Lewy Body0low10
Dementia, Presenile0medium815
Dementia, Primary Senile Degenerative0medium815
Dementia, Senile0medium815
Demyelinating Diseases0low10
Demyelinating Disorders0low10
Demyelination0low10
Dengue0low30
Dengue Fever0low30
Dent Disease0medium11
Dent's Disease0medium11
Dental Caries0low20
Dental Decay0low20
Dental Plaque0low30
Dental White Spot0low20
Dental White Spots0low20
Dents Disease0medium11
Dependence, Opioid0medium63
Depression0medium4612
Depression, Bipolar0medium184
Depression, Endogenous0medium15846
Depression, Involutional0medium5134
Depression, Neurotic0medium15846
Depression, Postpartum0low30
Depression, Reactive0medium31
Depression, Unipolar0medium15846
Depressive Disorder0medium15846
Depressive Disorder, Major0medium5134
Depressive Syndrome0medium15846
Dermal Alternariosis0low60
Dermatitis0medium81
Dermatitis Medicamentosa0medium294
Dermatitis Seborrheica0medium32
Dermatitis Venenata0low150
Dermatitis Verrucosa0low160
Dermatitis, Actinic0low170
Dermatitis, Adverse Drug Reaction0medium294
Dermatitis, Allergic Contact0low160
Dermatitis, Allergic Eczematous0low160
Dermatitis, Atopic0low10
Dermatitis, Contact0low150
Dermatitis, Contact, Allergic0low160
Dermatitis, Contact, Photoallergic0low20
Dermatitis, Contact, Photosensitive0low20
Dermatitis, Contact, Phototoxic0low120
Dermatitis, Irritant0medium21
Dermatitis, Occupational0low90
Dermatitis, Photoallergic0low20
Dermatitis, Photocontact0low20
Dermatitis, Phototoxic0low120
Dermatitis, Primary Irritant0medium21
Dermatitis, Radiation-Induced0low50
Dermatitis, Seborrheic0medium32
Dermatomycoses0medium1063
Dermatomycosis0medium1063
Dermatomyositis0low10
Dermatomyositis, Adult Type0low10
Dermatomyositis, Childhood Type0low10
Dermatophyte Infection0medium1063
Dermatophytoses0low320
Dermatophytosis0low320
Dermatopolymyositis0low10
Dermatosclerosis0low20
Dermatoses0low150
Dermatosis0low150
Dermatosis, Industrial0low90
Determination of Death0low40
Deutan Defect0medium11
Developmental Academic Disability0low10
Developmental Academic Disorder0low10
Developmental Agnosia0low10
Developmental Communication Disorders0medium11
Developmental Defects, Neural Tube0low10
Developmental Disabilities of Scholastic Skills0low10
Developmental Disorders of Scholastic Skills0low10
Developmental Neural Tube Defects0low10
Developmental Psychomotor Disorders0medium31
Developmental Verbal Dyspraxia0low10
Devic Disease0low10
Devic Neuromyelitis Optica0low10
Devic Syndrome0low10
Devic's Disease0low10
Devic's Neuromyelitis Optica0low10
Devic's Syndrome0low10
DHPR Deficiency0low10
Di Guglielmo Disease0low40
Di Guglielmo's Disease0low40
Diabetes Complications0medium362
Diabetes Insipidus0low20
Diabetes Insipidus Renalis0low10
Diabetes Insipidus, Nephrogenic0low10
Diabetes Insipidus, Nephrogenic, Autosomal0low10
Diabetes Insipidus, Nephrogenic, Type 10low10
Diabetes Insipidus, Nephrogenic, Type I0low10
Diabetes Insipidus, Nephrogenic, Type II0low10
Diabetes Insipidus, Nephrogenic, X-Linked0low10
Diabetes Mellitus0medium555
Diabetes Mellitus, Adult-Onset0medium560179
Diabetes Mellitus, Brittle0medium235
Diabetes Mellitus, Experimental0low740
Diabetes Mellitus, Gestational0low30
Diabetes Mellitus, Insulin-Dependent0medium235
Diabetes Mellitus, Insulin-Dependent, 10medium235
Diabetes Mellitus, Juvenile-Onset0medium235
Diabetes Mellitus, Ketosis-Prone0medium235
Diabetes Mellitus, Ketosis-Resistant0medium560179
Diabetes Mellitus, Maturity-Onset0medium560179
Diabetes Mellitus, Non Insulin Dependent0medium560179
Diabetes Mellitus, Non-Insulin-Dependent0medium560179
Diabetes Mellitus, Noninsulin Dependent0medium560179
Diabetes Mellitus, Noninsulin-Dependent0medium560179
Diabetes Mellitus, Slow-Onset0medium560179
Diabetes Mellitus, Stable0medium560179
Diabetes Mellitus, Sudden-Onset0medium235
Diabetes Mellitus, Type 10medium235
Diabetes Mellitus, Type 20medium560179
Diabetes Mellitus, Type I0medium235
Diabetes Mellitus, Type II0medium560179
Diabetes-Related Complications0medium362
Diabetes, Autoimmune0medium235
Diabetes, Bronze0medium241
Diabetes, Gestational0low30
Diabetes, Pregnancy-Induced0low30
Diabetic Acidosis0low50
Diabetic Amyotrophy0low30
Diabetic Angiopathies0medium101
Diabetic Asymmetric Polyneuropathy0low30
Diabetic Autonomic Neuropathy0low30
Diabetic Cardiomyopathies0low40
Diabetic Complications0medium362
Diabetic Glomerulosclerosis0medium235
Diabetic Ketoacidosis0low50
Diabetic Ketosis0low50
Diabetic Kidney Disease0medium235
Diabetic Mononeuropathy0low30
Diabetic Mononeuropathy Simplex0low30
Diabetic Nephropathies0medium235
Diabetic Nephropathy0medium235
Diabetic Neuralgia0low30
Diabetic Neuropathies0low30
Diabetic Neuropathy, Painful0low30
Diabetic Polyneuropathy0low30
Diabetic Retinopathy0low60
Diabetic Vascular Complications0medium101
Diabetic Vascular Diseases0medium101
Diagnosis, Psychiatric0medium154
Diamond-Blackfan Anemia0low40
Diaphragmatic Paralysis0low10
Diarrhea0medium196
Diastematomyelia0low10
Diathesis0medium181
Diffuse Cutaneous Systemic Sclerosis0low10
Diffuse Intrinsic Pontine Glioma0low20
Diffuse Large B-Cell Lymphoma0medium314
Diffuse Large-Cell Lymphoma0medium314
Diffuse Lewy Body Disease0low10
Diffuse Lymphocytic Lymphoma, Poorly-Differentiated0low110
Diffuse Mixed Small and Large Cell Lymphoma0medium205
Diffuse Mixed-Cell Lymphoma0medium205
Diffuse Myofascial Pain Syndrome0medium21
Diffuse Parenchymal Lung Disease0low20
Diffuse Parenchymal Lung Diseases0low20
Diffuse Scleroderma0low10
Diffuse Small Cleaved-Cell Lymphoma0medium205
Diffuse Systemic Sclerosis0low10
Diffuse Undifferentiated Lymphoma0medium205
Diffuse Well-Differentiated Lymphocytic Lymphoma0medium182
Diffuse, Large B-Cell, Lymphoma0medium314
DiGeorge Anomaly0low10
DiGeorge Sequence0low10
DiGeorge Syndrome0low10
Digestive Epilepsy0medium125
Dihydropteridine Reductase Deficiency0low10
Dihydropteridine Reductase Deficiency Disease0low10
Dilated Cardiomyopathy0low90
DIMS (Disorders of Initiating and Maintaining Sleep)0medium12341
DIPG Brain Tumors0low20
DIPG, Diffuse Intrinsic Pontine Glioma0low20
Diplopia0low10
Diplopia, Cortical0low10
Diplopia, Horizontal0low10
Diplopia, Intermittent0low10
Diplopia, Monocular0low10
Diplopia, Refractive0low10
Diplopia, Unilateral0low10
Diplopia, Vertical0low10
Disability, Intellectual0medium154
Disc Degeneration0low10
Disc Degradation0low10
Disc, Herniated0low10
Discitis0low70
Disease0low10
Disease Exacerbation0medium15031
Disease Models, Animal0medium7109
Disease Progression0medium15031
Disease Resistance0medium51
Disease Susceptibility0medium181
Disease, Pulmonary0medium222
Diseases in Twins0low30
Diseases of Endocrine System0low20
Diseases of Immune System0low20
Diseases of Nasopharynx0low10
Diseases of Pharynx0medium72
Diseases, Animal0low10
Diseases, Metabolic0low40
Diseases, Occupational0medium61
Diseases, Peripheral Vascular0low20
Diseases, Pulmonary0medium222
Disinhibition-Dementia-Parkinsonism-Amyotrophy Complex0medium11
Disinhibition-Dementia-Parkinsonism-Amytrophy Complex0medium11
Disintegration of Blastocyst0low10
Disintegration of Embryo0low10
Disk Degeneration0low10
Disk Degradation0low10
Disk Prolapse0low10
Disk, Herniated0low10
Diskitis0low70
Disorder, Complex Partial Seizures0low10
Disorders of Excessive Somnolence0medium72
Disorders of Initiating and Maintaining Sleep0medium12341
Disorders of Sex Development0low20
Disorders of Sexual Development0low20
Disorders of the Autonomic Nervous System0medium42
Disorders, Blood Coagulation0low20
Disrupted In B-Cell Malignancy0medium182
Disruptive Behavior Disorder0low10
Disruptive Behavioral Disorder0low10
Disruptive, Impulse Control, and Conduct Disorders0medium32
Dissecting Aneurysm0low10
Dissection, Blood Vessel0low10
Disseminated Coagulation, Intravascular0low20
Disseminated Fungal Infection0medium15415
Disseminated Fusariosis0medium391
Disseminated Hyalohyphomycosis0low20
Disseminated Intravascular Coagulation0low20
Disseminated Trichosporonosis0low170
Dissociated Nystagmus0low10
Distal Renal Tubular Acidosis0low20
Distorted Hearing0low10
Disturbed Nyctohemeral Rhythm0medium41
Diverticular Bleeding0low10
Diverticular Diseases0low10
Dizziness0medium124
Dizzyness0medium124
Doenu00E7as do Sistema Nervoso Central@pt0low120
DOES (Disorders of Excessive Somnolence)0medium72
Dog Diseases0medium222
Dominantly-Inherited Spinocerebellar Ataxias0low10
Doose Syndrome0low50
Double Vision0low10
Down Syndrome0low10
Down Syndrome, Partial Trisomy 210low10
Down's Syndrome0low10
Dravet Syndrome0low50
DRESS Syndrome0medium21
Dressing Apraxia0low10
Drop Attack0low10
Dropsy0medium1151
Drug Abuse0medium153
Drug Abuse, Intravenous0low40
Drug Abuse, Parenteral0low40
Drug Addiction0medium153
Drug Allergy0low80
Drug Dependence0medium153
Drug Eruptions0medium294
Drug Habituation0medium153
Drug Hypersensitivity0low80
Drug Hypersensitivity Syndrome0medium21
Drug Overdose0low100
Drug Reaction With Eosinophilia And Systemic Symptom0medium21
Drug Reaction with Eosinophilia and Systemic Symptoms0medium21
Drug Reaction with Eosinophilia and Systemic Symptoms Syndrome0medium21
Drug Refractory Epilepsy0low70
Drug Resistant Epilepsy0low70
Drug Side Effects0medium7517
Drug Toxicity0medium7517
Drug Use Disorders0medium153
Drug Withdrawal Symptoms0medium325
Drug-Induced Abnormalities0low320
Drug-Induced Acute Liver Injury0medium1134
Drug-Induced Akathisia0low40
Drug-Induced Febrile Neutropenia0low20
Drug-Induced Liver Disease0medium1134
Drug-Induced Liver Injury0medium1134
Drug-Induced Liver Injury, Chronic0medium11
Drug-Induced Stevens Johnson Syndrome0low40
Drug-Induced Stevens-Johnson Syndrome0low40
Drug-Related Side Effects and Adverse Reactions0medium7517
Dry Eye0low20
Dry Eye Disease0low20
Dry Eye Syndromes0low20
Duchenne and Becker Muscular Dystrophy0low20
Duchenne Muscular Dystrophy0low20
Duchenne-Becker Muscular Dystrophy0low20
Duchenne-Type Progressive Muscular Dystrophy0low20
Duck Gait0low30
Duct-Cell Carcinoma of the Pancreas0medium142
Duct-Cell Carcinoma, Pancreas0medium142
Ductal Carcinoma0medium61
Ductal Carcinoma In Situ0medium123
Ductal Carcinoma of the Pancreas0medium142
Duncan Disease0low30
Duncan's Syndrome0low30
Duodenal Ulcer0medium31
Dwarfism0medium42
Dysacusis0low10
Dyschezia0medium31
Dyscoordination0low30
Dysembryoma0low20
Dyserythropoietic Anemia, Congenital0medium21
Dyserythropoietic Anemia, Congenital Type 10medium21
Dyserythropoietic Anemia, Congenital Type 20medium21
Dyserythropoietic Anemia, Congenital, Type I0medium21
Dyserythropoietic Anemia, Congenital, Type II0medium21
Dyserythropoietic Anemia, Congenital, Type III0medium21
Dyserythropoietic Anemia, HEMPAS Type0medium21
Dysesthesia0low30
Dysfunctional Uterine Bleeding0low10
Dyskeratosis Congenita0low10
Dyskeratosis Congenita, X-Linked0low10
Dyskinesia Syndromes0low40
Dyskinesia, Drug-Induced0low110
Dyskinesia, Medication-Induced0low110
Dyskinesias0low20
Dyskinesias, Paroxysmal0low10
Dyslipidemia0medium125
Dyslipidemias0medium125
Dyslipoproteinemias0medium125
Dysmenorrhea0medium31
Dysmetabolic Syndrome X0medium195
Dysmetria0low10
Dysmyelopoietic Syndromes0medium13528
Dyspareunia0medium73
Dyspepsia0medium11
Dysphagia0low10
Dysphonia0low10
Dysplasia Olfactogenitalis of De Morsier0medium11
Dyspnea0medium11
Dyspraxia0low10
Dyspraxia, Articulatory0low10
Dyspraxia, Oral0low10
Dyspraxia, Verbal0low10
Dyssynergia0low30
Dysthymia0medium74
Dysthymia and Chronic Depression0medium74
Dysthymic Disorder0medium74
Dystonia0medium31
Dystonia Disorders0low10
Dystonia, Diurnal0medium31
Dystonia, Hereditary0low10
Dystonia, Limb0medium31
Dystonia, Paroxysmal0medium31
Dystonia, Primary0low10
Dystonia, Psychogenic0low10
Dystonia, Secondary0low10
Dystonias, Sporadic0low10
Dystonic Disorders0low10
Dystrophia Myotonica0low10
Dystrophia Myotonica 10low10
Dystrophia Myotonica 20low10
E coli Infections0low130
E. coli Infection0low130
Ear Diseases0low20
Ear Infection0low10
Ear Inflammation0low10
Earache0low10
Eardrum Perforation0low10
Early Awakening0medium12341
Early Childhood Epilepsy, Myoclonic0low50
Early Childhood, Myoclonic Epilepsy0low50
Early Onset Alzheimer Disease0medium815
Early Onset Lymphedema0low10
Early Pregnancy Loss0medium135
Eating and Feeding Disorders0low10
Eating Disorders0low10
Ebola Hemorrhagic Fever0low20
Ebola Infection0low20
Ebola Virus Disease0low20
Ebola Virus Infection0low20
Ebolavirus Infection0low20
EBV Infections0low40
Ectopic Ossification0low10
Ectopic Pregnancy0medium11
Ectopic Tissue0low30
Eczema, Atopic0low10
Eczema, Contact0low150
Eczema, Infantile0low10
Edema0medium1151
Edema of the Optic Disc0low10
Edema of the Optic Disk0low10
Edema-Proteinuria-Hypertension Gestosis0low40
Edema, Pulmonary0low100
Edemas, Pulmonary0low100
Ehrlich Ascites Tumor0low170
EHS Tumor0low60
Ejaculatio Praecox0medium74
Electrocardiogram QT Prolonged0medium214
Electrolytes0low170
Electron Transport Chain Deficiencies, Mitochondrial0low10
Elevated Cholesterol0medium63
Elevated ICP (Intracranial Pressure)0low10
Elevated Intracranial Pressure0low10
Embolic Infarction, Middle Cerebral Artery0low40
Embolic Tumor Cells0low20
Embolism0medium21
Embolism and Thrombosis, Brain0low10
Embolism, Brain0low10
Embolism, Intracranial0low10
Embolism, Pulmonary0medium71
Embolism, Tumor0low20
Embolisms, Pulmonary0medium71
Embolus0medium21
Embolus, Middle Cerebral Artery0low40
Embryo Death0low10
Embryo Disintegration0low10
Embryo Loss0low10
Embryo Resorption0low10
Embryonal Neoplasms0low30
Embryopathies0low10
Emergencies0low20
Emesis0medium184
Emphysema0low10
Empyema0low40
Empyema, Gall Bladder0low10
Empyema, Gallbladder0low10
Empyema, Pleural0low30
Empyema, Subdural0low10
Empyema, Thoracic0low30
Encephalitis0low100
Encephalitis Infection0low10
Encephalitis, Central European0low30
Encephalitis, Equine0low10
Encephalitis, European Tick-Borne0low30
Encephalitis, Far Eastern Russian0low30
Encephalitis, Infectious0low10
Encephalitis, Japanese0low10
Encephalitis, Japanese B0low10
Encephalitis, JC Polyomavirus0low80
Encephalitis, Louping Ill0low30
Encephalitis, Polio0low10
Encephalitis, Rasmussen0low100
Encephalitis, Russian Spring-Summer0low30
Encephalitis, Tick-Borne0low30
Encephalitis, West Nile Fever0low20
Encephalomeningitis0low30
Encephalomyelitis, Allergic0low30
Encephalomyelitis, Autoimmune, Experimental0low30
Encephalomyelitis, Equine0low10
Encephalomyelitis, Experimental Autoimmune0low30
Encephalomyelitis, Lymphocytic Choriomeningitis Virus0low10
Encephalomyelitis, Myalgic0medium21
Encephalon Diseases0medium351
Encephalopathies, Metabolic0low10
Encephalopathy0medium351
Encephalopathy, AIDS0medium21
Encephalopathy, Anoxic-Ischemic0low50
Encephalopathy, Hepatic0low20
Encephalopathy, Hepatocerebral0low20
Encephalopathy, HIV0medium21
Encephalopathy, Hypoxic0low40
Encephalopathy, Hypoxic-Ischemic0low50
Encephalopathy, Ischemic0low300
Encephalopathy, Metabolic, Acquired0low10
Encephalopathy, Myoclonic0low50
Encephalopathy, Portal-Systemic0low20
Encephalopathy, Portosystemic0low20
Encephalopathy, Toxic0low130
Encephalopathy, Traumatic0medium51
End Of Life0low40
End Stage Liver Disease0low20
End-Of-Life0low40
End-Stage Kidney Disease0medium328
End-Stage Renal Disease0medium328
Endocarditis0low250
Endocarditis, Loeffler0low10
Endocarditis, Loeffler's0low10
Endocrine Breast Diseases0medium43
Endocrine Cancer0low10
Endocrine Diseases0low20
Endocrine Gland Cancer0low10
Endocrine Gland Carcinoma0low10
Endocrine Gland Neoplasms0low10
Endocrine System Diseases0low20
Endogenous Hyperinsulinism0low60
Endolymphatic Stromal Myosis0low30
Endometrial Cancer0medium556
Endometrial Carcinoma0medium556
Endometrial Diseases0medium72
Endometrial Hyperplasia0medium104
Endometrial Neoplasms0medium556
Endometrial Stromal Sarcoma0low140
Endometrial Stromal Tumors0low30
Endometrioid Adenocarcinoma0medium41
Endometrioma0medium6018
Endometriosis0medium6018
Endometrium Cancer0medium556
Endomyocardial Fibrosis0low10
Endophthalmitis0medium671
Endothelial Cell Loss, Corneal0low10
Endotoxemia0low90
Endotoxin Shock0medium281
Enfermedades del Sistema Nervioso Central@es0low120
Enlarged Heart0low50
Enlarged Liver0low20
Enophthalmos0low10
Entamoeba histolytica Infection0low10
Entamoeba Infections0low10
Entamoebiasis0low10
Enteric Neuropathy0low10
Enteritis0low20
Enteritis, Granulomatous0medium171
Enteritis, Pseudomembranous0low40
Enteritis, Regional0medium171
Enterobacteriaceae Infections0low30
Enterobacterial Infections0low30
Enterocolitis0low20
Enterocolitis, Necrotizing0low30
Enterocolitis, Pseudomembranous0low40
Enterovirus Infections0low10
Enthesitis-Related Arthritis, Juvenile0low20
Entomophthoramycosis0medium701
Entrapment Neuropathy, Carpal Tunnel0medium32
Envenomation, Snakebite0low10
Eosinophilia0low100
Eosinophilia, Pulmonary0low70
Eosinophilia, Tropical0low100
Eosinophilias, Pulmonary0low70
Eosinophilic Pneumonia0low70
Ependymoma0low20
Ependymoma, Myxopapillary0low20
Ependymoma, Papillary0low20
Eperythrozoonosis0low10
EPH Complex0low40
EPH Gestosis0low40
EPH Toxemias0low40
Epidemic Acute Poliomyelitis0low10
Epidermal Necrolysis, Toxic0low40
Epidermophytosis0low320
Epidural Abscess0low40
Epidural Abscess, Intracranial0low40
Epidural Abscess, Spinal0low40
Epilepsies, Myoclonic0low50
Epilepsies, Partial0medium125
Epilepsy0medium826
Epilepsy Juvenile Absence0medium81
Epilepsy, Absence0medium81
Epilepsy, Absence, Atypical0medium81
Epilepsy, Akinetic0medium71
Epilepsy, Atonic0medium71
Epilepsy, Benign Occipital0medium125
Epilepsy, Benign Psychomotor, Childhood0low30
Epilepsy, Complex Partial0low10
Epilepsy, Cryptogenic0medium826
Epilepsy, Cryptogenic, Partial Complex0low10
Epilepsy, Drug Refractory0low70
Epilepsy, Drug Resistant0low70
Epilepsy, Early Childhood, Myoclonic0low50
Epilepsy, Focal0medium125
Epilepsy, Generalized0medium71
Epilepsy, Grand Mal0medium31
Epilepsy, Intractable0low70
Epilepsy, Lateral Temporal0low30
Epilepsy, Localization-Related0medium125
Epilepsy, Major0medium31
Epilepsy, Minor0medium81
Epilepsy, Myoclonic Juvenile0low10
Epilepsy, Myoclonic, Early Childhood0low50
Epilepsy, Myoclonic, Infantile0low50
Epilepsy, Myoclonic, Infantile, Benign0low50
Epilepsy, Myoclonic, Infantile, Severe0low50
Epilepsy, Myoclonic, Juvenile0low10
Epilepsy, Myoclonus0low50
Epilepsy, Partial0medium125
Epilepsy, Petit Mal0medium81
Epilepsy, Psychic Equivalent0low10
Epilepsy, Psychomotor0low10
Epilepsy, Simple Partial0medium125
Epilepsy, Symptomatic, Partial Complex0low10
Epilepsy, Temporal Lobe0low30
Epilepsy, Tonic0medium71
Epilepsy, Tonic-Clonic0medium31
Epilepsy, Tonic-Clonic, Cryptogenic0medium31
Epilepsy, Tonic-Clonic, Familial0medium31
Epilepsy, Tonic-Clonic, Symptomatic0medium31
Epilepsy, Uncinate0low30
Epileptic Seizure0medium1153
Epileptic Seizures0medium1153
Epileptiform Neuralgia0low20
Epiloia0low10
Episcleritis0low60
Episodic Cluster Headache0low30
Epithelial Neoplasms0medium92
Epithelial Neoplasms, Malignant0medium517
Epithelial Ovarian Cancer0medium81
Epithelial Ovarian Carcinoma0medium81
Epithelial Tumors, Malignant0medium517
Epithelioma0medium517
Epithelioma, Basal Cell0low90
Epstein-Barr Virus Infection0low40
Epstein-Barr Virus Infection, Familial Fatal0low30
Epstein-Barr Virus Infections0low40
Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males0low30
Equine Diseases0low100
Equine Encephalitis0low10
Equine Encephalomyelitis Viral Infections0low10
Equine Encephalomyelitis Virus Infections0low10
Equinovarus0low10
ER-Negative PR-Negative HER2-Negative Breast Cancer0medium442
ER-Negative PR-Negative HER2-Negative Breast Neoplasms0medium442
Erb Paralysis0low10
Erb-Duchenne Paralysis0low10
Erb's Palsy0low10
Erectile Dysfunction0medium52
Erysipelas0low10
Erythema0medium91
Erythema Multiforme0low10
Erythema Nodosum0low10
Erythremic Myelosis0low40
Erythroblastic Anemia0medium15749
Erythroblastic Leukemia, Acute0low40
Erythrocyte Aplasia0low20
Erythrocytosis0low20
Erythrogenesis Imperfecta0low40
Erythrohepatic Protoporphyria0low10
Erythroleukemia0low40
Erythrophagocytic Lymphohistiocytosis, Familial0low10
Erythropoietic Porphyria0low30
Erythropoietic Protoporphyria0low10
Escherichia coli Infections0low130
Esophageal and Gastric Varices0medium11
Esophageal Cancer0medium152
Esophageal Diseases0medium84
Esophageal Dysphagia0low10
Esophageal Neoplasms0medium152
Esophageal Reflux0medium31
Esophageal Varices0medium11
Esophageal Varix0medium11
Esophagitis0medium51
Esophagitis, Peptic0medium11
Esophagitis, Reflux0medium11
Esophagus Cancer0medium152
Esophagus Neoplasm0medium152
Esophagus, Barrett0low10
ESRD0medium328
Essential Tremor0medium11
Etat Marbre0low40
Ethanol Abuse0medium217
Ethmoid Sinusitis0medium41
Ethmoidal Sinusitis0medium41
Eumycetoma0low800
European Tick-Borne Encephalitis0low30
Evaporative Dry Eye0low20
Evaporative Dry Eye Disease0low20
Evaporative Dry Eye Syndrome0low20
Ewing Sarcoma0low80
Ewing Tumor0low80
Ewing's Sarcoma0low80
Ewing's Tumor0low80
Exanthem0medium111
Exanthema0medium111
Excessive Daytime Sleepiness0medium72
Excessive Somnolence Disorders0medium72
Excitement, Psychomotor0low10
Exencephaly0low10
Exercise-Induced Asthma0medium11
Exercise-Induced Bronchospasm0medium11
Exogenous Hyperinsulinism0low60
Exophthalmos0low10
Exostoses0low20
Exostosis0low20
Experimental Allergic Encephalomyelitis0low30
Experimental Autoimmune Encephalomyelitis0low30
Experimental Diabetes Mellitus0low740
Experimental Hepatoma0medium211
Experimental Hepatomas0medium211
Experimental Leukemia0low100
Experimental Leukemias0low100
Experimental Liver Cirrhoses0medium51
Experimental Liver Cirrhosis0medium51
Experimental Liver Neoplasms0medium211
Experimental Lung Inflammation0medium322
Experimental Mammary Neoplasms0low480
Experimental Melanoma0low210
Experimental Melanomas0low210
Experimental Neoplasms0low690
Experimental Parkinson Disease0low240
Experimental Parkinsonism0low240
Experimental Parkinsonism, MPTP-Induced0low240
Experimental Radiation Injuries0low50
Experimental Sarcoma0low60
Experimental Sarcomas0low60
Experimental Spinal Cord Ischemia0low10
Exstrophy Of Bladder0low10
Exstrophy of the Bladder0low10
Extensively Drug-Resistant Tuberculosis0low10
Extensor Rigidity0low10
External Carotid Artery Diseases0medium41
External Carotid Artery Stenosis0low40
External Carotid Artery Thrombosis0low60
External Ear Inflammation0low20
External Ophthalmoplegia0low50
External Otitis0low20
Extracranial Primitive Neuroectodermal Tumor0low10
Extracutaneous Mastocytoma0low20
Extrahepatic Cholangiocarcinoma0medium71
Extramedullary Myeloid Cell Tumor0low10
Extramedullary Spinal Cord Compression0low30
Extramembranous Glomerulopathy0medium21
Extranodal NK-T-Cell Lymphoma0low10
Extranodal NK-T-Cell Lymphoma, Nasal0low10
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type0low10
Extranodal NK-T-Cell Lymphoma, Nasal Type0low10
Extrapyramidal Disorders0medium31
Extrapyramidal Rigidity0low10
Extravasation of Contrast Media0low30
Extravasation of Diagnostic and Therapeutic Materials0low30
Extravasation of Diagnostic, Therapeutic Materials0low30
Extravascular Hemolysis0low350
Extremely Drug-Resistant Tuberculosis0low10
Exudative Bronchiolitis0low40
Eye Cancer, Retinoblastoma0low20
Eye Diseases0medium51
Eye Disorders0medium51
Eye Foreign Bodies0low40
Eye Foreign Object0low40
Eye Infections, Bacterial0low40
Eye Infections, Fungal0medium14812
Eye Infections, Parasitic0low20
Eye Infections, Viral0low10
Eye Injuries0low70
Eye Injuries, Penetrating0low40
Eye Motility Disorders0low20
Eye Movement Disorders0low20
Eyelid Diseases0low10
Facial Dermatoses0low40
Facial Dermatosis0low40
Facial Injuries0low10
Facial Neoplasms0low10
Factor 8 Deficiency, Congenital0low40
Factor VIII Deficiency0low40
Factor VIII Deficiency, Congenital0low40
Fainting0low10
Fallopian Tube Cancer0medium11
Fallopian Tube Neoplasms0medium11
False Aneurysm0low10
False Aneurysm, Carotid0low50
Familial Alzheimer Disease (FAD)0medium815
Familial Atrial Fibrillation0low100
Familial Dementia0medium42
Familial Dystonia0low10
Familial Dystonia, Autosomal Dominant0low10
Familial Dystonia, Autosomal Recessive0low10
Familial Dystonia, Idiopathic0low10
Familial Erythrophagocytic Lymphohistiocytosis0low10
Familial Fatal Epstein-Barr Infection0low30
Familial Hemiplegic Migraine0low30
Familial Hemochromatosis0medium241
Familial Hemophagocytic Histiocytosis0low10
Familial Hemophagocytic Lymphocytosis0low10
Familial Hemophagocytic Lymphohistiocytosis0low10
Familial Hemophagocytic Reticulosis0low10
Familial Histiocytic Reticulosis0low10
Familial Idiopathic Pulmonary Fibrosis0low40
Familial Juvenile Parkinsonism0low240
Familial Motor Neuron Disease0low10
Familial Nonmedullary Thyroid Cancer0low10
Familial Parkinson Disease, Autosomal Recessive0low240
Familial Pick's Disease0medium11
Familial Platelet Storage Pool Disease0low10
Familial Precocious Puberty0medium245
Familial Primary Pulmonary Hypertension0low10
Familial Retinoblastoma0low20
Familial Third and Fourth Pharyngeal Pouch Syndrome0low10
Familial Tonic-Clonic Epilepsy0medium31
Familial Tremor0medium11
Familial True Hermaphroditism0low10
Familial Waldenstrom's Macroglobulinaemia0low50
Familial XX True Hermaphroditism0low10
Fanconi Anemia0medium31
Fanconi Bickel Syndrome0medium161
Fanconi Hypoplastic Anemia0medium31
Fanconi Pancytopenia0medium31
Fanconi Panmyelopathy0medium31
Fanconi Renotubular Syndrome0medium161
Fanconi Syndrome0medium161
Fanconi Syndrome with Intestinal Malabsorption and Galactose Intolerance0medium161
Fanconi Syndrome without Cystinosis0medium161
Fanconi-Bickel Syndrome0medium161
Fanconi's Anemia0medium31
Far Eastern Russian Encephalitis0low30
Fasciculation-Cramp Syndrome, Benign0low20
Fasciitis, Necrotizing0low40
Fascitis, Necrotizing0low40
Fasting Hypoglycemia0medium4820
Fatigable Positional Nystagmus0low10
Fatigue0medium135
Fatigue Syndrome, Chronic0medium21
Fatigue Syndrome, Postviral0medium21
Fatty Liver0medium291
Fatty Liver, Nonalcoholic0medium152
Fatty Streak, Arterial0low30
Favre-Racouchot Syndrome0low40
Febrile Convulsion Seizure0low20
Febrile Fit0low20
Febrile Neutropenia0medium71
Febrile Non-Hemolytic Transfusion Reaction0medium11130
Febrile Seizures0low20
Feeding and Eating Disorders0low10
Feeding Disorders0low10
Feline Diseases0low70
Female Genital Diseases0medium52
Female Genital Neoplasms0medium32
Female Pattern Baldness0medium51
Femoral Fractures0low10
Femoral Neoplasms0low10
Ferrochelatase Deficiency0low10
Fetal Anomalies0low50
Fetal Anoxia0low20
Fetal Cerebral Ventriculomegaly0low10
Fetal Death0low40
Fetal Demise0low40
Fetal Diseases0low10
Fetal Growth Restriction0low10
Fetal Growth Retardation0low10
Fetal Hypoxia0low20
Fetal Malformations0low50
Fetal Mummification0low40
Fetal Resorption0low30
Fetal Weight0low40
Fever0medium577
Fever Convulsion0low20
Fever of Unknown Origin0low40
Fever Seizure0low20
Fever, Zika0low10
Fibrillary Astrocytoma0low30
Fibroatheroma0low30
Fibroatheromatous Plaques0low30
Fibrocystic Breast Disease0low10
Fibrocystic Changes of Breast0low10
Fibrocystic Disease of Breast0low10
Fibrocystic Disease of Pancreas0medium552
Fibrocystic Mastopathy0low10
Fibrocystic Pulmonary Dysplasia0low40
Fibrodysplasia Ossificans Progressiva0low10
Fibroid0medium176
Fibroid Tumor0medium176
Fibroid Uterus0medium176
Fibroids, Uterine0medium176
Fibroma0low20
Fibroma, Shope0low20
Fibroma, Uterine0medium176
Fibromatosis0low20
Fibromatosis, Abdominal0low10
Fibromyalgia0medium21
Fibromyalgia-Fibromyositis Syndrome0medium21
Fibromyalgia, Primary0medium21
Fibromyalgia, Secondary0medium21
Fibromyoma0medium176
Fibromyositis-Fibromyalgia Syndrome0medium21
Fibromyxoma0low20
Fibrosarcoma0low120
Fibroses, Pulmonary0low100
Fibrosing Alveolitis, Cryptogenic0low40
Fibrosis0medium351
Fibrosis, Bone Marrow0low80
Fibrosis, Liver0medium363
Fibrosis, Pulmonary0low100
Fibrositis0medium21
Fibrous Dysplasia with Pigmentary Skin Changes and Precocious Puberty0medium101
Fibrous Dysplasia, Polyostotic0medium101
Fibrous Meningioma0low10
Fine Tremor0low50
Finger Agnosia0low10
Fish Diseases0low20
Fistula0low10
Flaccid Muscle Tone0low10
Flaccid Quadriplegia0low10
Flaccid Tetraplegia0low10
Flexibility, Waxy0low210
Floppy Muscles0low10
Fluoride Poisoning0low20
FMR1-Related Primary Ovarian Insufficiency0medium31
Focal Brain Injuries0medium131
Focal Dystonia0low10
Focal Onset Alzheimer's Disease0medium815
Focal Segmental Glomerulosclerosis0low10
Focal Seizure Disorder0medium125
Foley-Denny-Brown Syndrome0low20
Follicular Large-Cell Lymphoma0low30
Follicular Lymphoma0low30
Follicular Lymphoma, Giant0low30
Follicular Lymphoma, Grade 10low30
Follicular Lymphoma, Grade 20low30
Follicular Lymphoma, Grade 30low30
Follicular Mixed-Cell Lymphoma0low30
Folliculitis0low10
Folling Disease0low10
Folling's Disease0low10
Food Allergy0low20
Food Hypersensitivity0low20
Food Poisoning0low30
Food-borne Disease0low30
Food-borne Diseases0low30
Food-borne Illness0low30
Food-borne Illnesses0low30
Foodborne Disease0low30
Foodborne Diseases0low30
Foodborne Illness0low30
Foodborne Illnesses0low30
Foot Dermatoses0medium5621
Foot Dermatosis0medium5621
Foot Diseases0low20
Foot Injuries0low10
Forehead Trauma0low10
Foreign Bodies0low10
Foreign Objects0low10
Foreign-Body Migration0low10
Foreign-Body Reaction0low30
Formication0low30
Foster-Kennedy Syndrome0low10
Fothergill Disease0low20
Fowl Paralysis0low10
Fra(X) Syndrome0low20
Fracture, Pathologic0low10
Fracture, Pathological0low10
Fractures, Blow-Out0low20
Fractures, Bone0medium2711
Fractures, Compound0low20
Fractures, Compression0low10
Fractures, Open0low20
Fractures, Pathologic0low10
Fractures, Pathological0low10
Fractures, Spontaneous0low10
Fragile X Mental Retardation Syndrome0low20
Fragile X Premature Ovarian Failure0medium31
Fragile X Syndrome0low20
Fragile X-Associated Primary Ovarian Insufficiency0medium31
Fragile X-F Mental Retardation Syndrome0low20
Frailness0low10
Frailty0low10
Frailty Syndrome0low10
FRAXA Syndrome0low20
FRAXE Syndrome0low20
Freckles0low20
Friedreich Ataxia0low20
Friedreich Disease0low20
Friedreich Familial Ataxia0low20
Friedreich Hereditary Ataxia0low20
Friedreich Hereditary Spinal Ataxia0low20
Friedreich Spinocerebellar Ataxia0low20
Friedreich's Ataxia0low20
Friedreich's Disease0low20
Friedreich's Familial Ataxia0low20
Friedreich's Hereditary Ataxia0low20
Friedreich's Hereditary Spinal Ataxia0low20
Frigidity0medium133
Frontal Linear Scleroderma en Coup de Sabre0low20
Frontal Region Trauma0low10
Frontotemporal Dementia0medium11
Frontotemporal Dementia with Parkinsonism0medium11
Frontotemporal Dementia with Parkinsonism-170medium11
Frontotemporal Dementia, Ubiquitin-Positive0medium11
Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions0medium11
Frontotemporal Lobe Dementia0medium11
Frontotemporal Lobe Dementia (FLDEM)0medium11
Frozen Shoulder0low10
FTD-GRN0medium11
FTD-PGRN0medium11
FTDP-170medium11
FTLD with TDP-43 Pathology0medium11
FTLD-17 GRN0medium11
FTLD-TDP0medium11
Fulminant Hepatic Failure0low120
Fulminant Hepatic Failure with Cerebral Edema0low20
Fulminating Hepatic Failure0low120
Fulminating Liver Failure0low120
Fumarylacetoacetase Deficiency0low10
Fumarylacetoacetase Deficiency Disease0low10
Functional Gastrointestinal Disorders0medium3210
Fungal Aneurysm0low50
Fungal Diseases0medium90367
Fungal Eye Infections0medium14812
Fungal Infections0medium90367
Fungal Infections, Central Nervous System0medium531
Fungal Lung Diseases0medium2107
Fungal Meningitis0medium291
Fungal Skin Diseases0medium1063
Fungemia0medium1164
Fungus Diseases0medium90367
Fungus Infections0medium90367
Furrow Keratitis0low10
Fusariosis0medium391
Fusarium Infection0medium391
Fusiform Aneurysm0low10
G6PD Deficiency0low50
Gait Disorder, Sensorimotor0low30
Gait Disorders, Neurologic0low30
Gait Dysfunction, Neurologic0low30
Gait, Athetotic0low30
Gait, Broadened0low30
Gait, Drop Foot0low30
Gait, Festinating0low30
Gait, Frontal0low30
Gait, Hemiplegic0low30
Gait, Hysterical0low30
Gait, Reeling0low30
Gait, Rigid0low30
Gait, Scissors0low30
Gait, Shuffling0low30
Gait, Spastic0low30
Gait, Stumbling0low30
Gait, Unsteady0low30
Gait, Widebased0low30
Gall Bladder Cancer0low10
Gallbladder Cancer0low10
Gallbladder Inflammation0low10
Gallbladder Inflammation, Acalculous0low10
Gallbladder Neoplasms0low10
Gallstone Disease0low10
Gambling0medium42
Gambling, Pathologic0medium42
Gambling, Pathological0medium42
Gammapathy, Monoclonal0low10
Gammopathy, Monoclonal0low10
Gangrene0low10
Gargoylism0low20
Gargoylism, Hurler Syndrome0low20
Gastric Acid Aspiration Syndrome0low30
Gastric Acid Reflux0medium31
Gastric Acid Reflux Disease0medium31
Gastric Cancer0medium492
Gastric Cancer, Familial Diffuse0medium492
Gastric Diseases0low20
Gastric Neoplasms0medium492
Gastric Stasis0medium11
Gastric Ulcer0low390
Gastric Varices0medium11
Gastric Varix0medium11
Gastritis0medium21
Gastro-Esophageal Reflux0medium31
Gastro-Esophageal Reflux Disease0medium31
Gastro-oesophageal Reflux0medium31
Gastroduodenal Ulcer0low30
Gastroenteritis0medium21
Gastroesophageal Reflux0medium31
Gastroesophageal Reflux Disease0medium31
Gastrointestinal Cancer0medium51
Gastrointestinal Diseases0medium3210
Gastrointestinal Disorders0medium3210
Gastrointestinal Disorders, Functional0medium3210
Gastrointestinal Hemorrhage0medium31
Gastrointestinal Neoplasms0medium51
Gastrointestinal Stromal Neoplasm0low60
Gastrointestinal Stromal Neoplasms0low60
Gastrointestinal Stromal Sarcoma0low60
Gastrointestinal Stromal Tumor0low60
Gastrointestinal Stromal Tumors0low60
Gastroparesis0medium11
Gaucher Disease0low40
Gaucher Disease Type 10low40
Gaucher Disease Type 20low40
Gaucher Disease Type 30low40
Gaucher Disease, Acute Neuronopathic0low40
Gaucher Disease, Acute Neuronopathic Type0low40
Gaucher Disease, Chronic0low40
Gaucher Disease, Chronic Neuronopathic Type0low40
Gaucher Disease, Infantile0low40
Gaucher Disease, Infantile Cerebral0low40
Gaucher Disease, Juvenile0low40
Gaucher Disease, Juvenile and Adult, Cerebral0low40
Gaucher Disease, Neuronopathic0low40
Gaucher Disease, Non-Neuronopathic Form0low40
Gaucher Disease, Noncerebral Juvenile0low40
Gaucher Disease, Subacute Neuronopathic Form0low40
Gaucher Disease, Subacute Neuronopathic Type0low40
Gaucher Disease, Type 10low40
Gaucher Disease, Type 20low40
Gaucher Disease, Type 30low40
Gaucher Disease, Type I0low40
Gaucher Disease, Type II0low40
Gaucher Disease, Type III0low40
Gaucher Splenomegaly0low40
Gaucher Syndrome0low40
Gaucher's Disease0low40
Gauchers Disease0low40
GBA Deficiency0low40
Gegenhalten0low10
Gehrig's Disease0medium41
Gelastic Epilepsy0medium125
Gelineau Syndrome0low20
Gelineau's Syndrome0low20
Gemistocytic Astrocytoma0low30
General Paralysis0low20
General Paralysis of the Insane0low20
General Paresis0low20
General Paresis of the Insane0low20
Generalized Absence Seizure0medium1153
Generalized Absence Seizures0medium1153
Generalized Convulsive Epilepsy0medium71
Generalized Convulsive Status Epilepticus0low50
Generalized Headache0medium3719
Generalized Nonconvulsive Epilepsy0medium71
Generalized Nonconvulsive Seizure Disorder0medium71
Generalized Onset Seizure Disorder0medium71
Generalized Seizure Disorder, Convulsive0medium71
Generalized Seizure Disorder, Nonconvulsive0medium71
Generalized Tonic-Clonic Seizures0medium1153
Genetic Diseases, X-Chromosome Linked0low20
Genetic Diseases, X-Linked0low20
Genetic Hemochromatosis0medium241
Genetic Non-Disjunction0low10
Genetic Nondisjunction0low10
Genetic Predisposition0medium162
Genetic Predisposition to Disease0medium162
Genetic Susceptibility0medium162
Genital Ambiguity0low20
Genital Diseases, Female0medium52
Genital Diseases, Male0medium32
Genital Neoplasms, Female0medium32
Genital Vulvovaginal Candidiasis0medium7421
Genome Instability0low20
Genome Stability0low20
Genomic Instability0low20
Genomic Stability0low20
Genotoxicant-Induced Micronuclei0low90
Geotrichosis0low110
GERD0medium31
Germ Cell and Embryonal Neoplasms0low30
Germ Cell and Embryonic Neoplasms0low30
Germ Cell Cancer0low30
Germ Cell Neoplasms0low30
Germ Cell Tumor0low30
Germinoblastoma0medium191
Gestational Diabetes0low30
Gestosis, EPH0low40
Giant Cell Glioblastoma0medium341
Giant Follicular Lymphoma0low30
Giant Intracranial Aneurysm0low20
Gilchrist Disease0medium271
Gilchrist's Disease0medium271
Gilles de la Tourette Disorder0low10
Gilles de la Tourette Syndrome0low10
Gilles de la Tourette's Disease0low10
Gilles De La Tourette's Syndrome0low10
Gingival Hemorrhage0medium21
Gingival Hyperplasia0low10
Gingival Overgrowth0low10
Gingivitis0medium31
Glandular and Epithelial Neoplasms0medium92
Glandular Neoplasms0medium92
Glaucoma0low40
Glaucoma Simplex0medium43
Glaucoma, Angle Closure0low10
Glaucoma, Angle-Closure0low10
Glaucoma, Closed-Angle0low10
Glaucoma, Compensated0medium43
Glaucoma, Compensative0medium43
Glaucoma, Narrow-Angle0low10
Glaucoma, Open Angle0medium43
Glaucoma, Open-Angle0medium43
Glaucoma, Pigmentary0medium43
Glaucoma, Primary Open Angle0medium43
Glaucoma, Secondary Open Angle0medium43
Glaucoma, Simple0medium43
Glaucoma, Suspect0medium21
Glaucoma, Uncompensated0low10
Glaucoma, Uncompensative0low10
Glial Cell Tumors0low290
Glial Scar0medium41
Glioblastoma0medium341
Glioblastoma Multiforme0medium341
Glioblastoma with Sarcomatous Component0low10
Glioblastoma, Retinal0low20
Glioma0low290
Glioma, Astrocytic0low30
Glioma, Retinal0low20
Gliosarcoma0low10
Gliosis0medium41
Glomerulonephritis0low80
Glomerulonephritis, Focal Sclerosing0low10
Glomerulonephritis, Lupus0low60
Glomerulonephritis, Membranous0medium21
Glomerulosclerosis, Diabetic0medium235
Glomerulosclerosis, Focal0low10
Glomerulosclerosis, Focal Segmental0low10
Glossitis0low20
Glucocerebrosidase Deficiency0low40
Glucocerebrosidase Deficiency Disease0low40
Glucocerebrosidosis0low40
Glucose 6 Phosphate Dehydrogenase Deficiency0low50
Glucose Intolerance0medium114
Glucose-6-Phosphate Dehydrogenase Deficiency0low50
Glucosephosphate Dehydrogenase Deficiencies0low50
Glucosephosphate Dehydrogenase Deficiency0low50
Glucosyl Cerebroside Lipidosis0low40
Glucosylceramidase Deficiency0low40
Glucosylceramide Beta-Glucosidase Deficiency0low40
Glucosylceramide Beta-Glucosidase Deficiency Disease0low40
Glucosylceramide Lipidosis0low40
Glycogen Storage Disease XI0medium161
Glycogenosis, Fanconi Type0medium161
Glycosuria0medium11
Goiter0low70
Goiter, Nodular0medium11
Goldblatt Syndrome0low10
Gonadal Agenesis0low10
Gonadal Dysgenesis0low10
Gonadal Dysgenesis, 45,X0low10
Gonadal Dysgenesis, XO0low10
Gonadotropin-Resistant Ovary Syndrome0medium31
Gonorrhea0medium103
Gossypiboma0low10
Gout0medium4912
Gouty Arthritis0low20
GPD Deficiency0low50
Gradenigo Syndrome0low10
Gradenigo-Lannois Syndrome0low10
Gradenigo's Syndrome0low10
Graft vs Host Disease0medium7610
Graft-Versus-Host Disease0medium7610
Graft-vs-Host Disease0medium7610
Gram-Negative Bacterial Infections0low50
Grand Mal Seizure Disorder0medium31
Grand Mal Status Epilepticus0low50
Granulocytic Leukemia0medium381
Granulocytic Leukemia, Chronic0low200
Granulocytopenia0low60
Granuloma0low110
Granuloma, Hodgkin0medium61
Granuloma, Hodgkin's0medium61
Granuloma, Hodgkins0medium61
Granuloma, Malignant0medium61
Granulomas0low110
Granulomatosis with Polyangiitis0low40
Granulomatosis, Wegener's0low40
Granulomatous Disease, Chronic0medium353
Granulomatous Disease, Chronic, X-Linked0medium353
Granulomatous Disease, Chronic, X-Linked, Variant0medium353
Granulomatous Slack Skin0low30
Granulomous Cerebral Cryptococcosis0low320
Granulosa Cell Cancer0low70
Granulosa Cell Tumor0low70
Grawitz Tumor0medium142
Great Pox0low20
Grippe0medium131
GRN-Related Frontotemporal Dementia0medium11
Group A Strep Infection0low70
Group A Streptococcal Infection0low70
Group A Streptococcal Infections0low70
Group B Strep Infection0low70
Group B Streptococcal Infection0low70
Group B Streptococcal Infections0low70
Growth Disorders0medium2211
Growth Retardation, Intrauterine0low10
Guam Disease0medium41
Guam Form of Amyotrophic Lateral Sclerosis0medium41
Gunther Disease0low30
Gunther's Disease0low30
Gustatory Agnosia0low10
Gynecologic Diseases0medium52
Gynecologic Neoplasms0medium32
Gynecomastia0medium175
Habit Chorea0low10
Habit Spasm0low10
Habituation Spasm0low10
Haemochromatosis0medium241
Haemolysis0low350
Haemolytic Anaemia0low10
Haemophilia0low40
Haemophilus Infections0low20
Haemophilus influenzae Infection0low20
Haemophilus influenzae Meningitis Type B0low10
Haemophilus influenzae Type b Infection0low20
Hair Balls0low10
Hair Loss0medium51
Hairy Cell Leukemia0low10
Hallucination of Body Sensation0medium121
Hallucinations0medium121
Hallucinations, Auditory0medium121
Hallucinations, Dissociative0medium121
Hallucinations, Elementary0medium121
Hallucinations, Formed, of People0medium121
Hallucinations, Gustatory0medium121
Hallucinations, Hypnagogic0medium121
Hallucinations, Hypnapompic0medium121
Hallucinations, Internal Body Sensation0medium121
Hallucinations, Kinesthetic0medium121
Hallucinations, Mood Congruent0medium121
Hallucinations, Mood Incongruent0medium121
Hallucinations, Olfactory0medium121
Hallucinations, Organic0medium121
Hallucinations, Reflex0medium121
Hallucinations, Sensory0medium121
Hallucinations, Somatic0medium121
Hallucinations, Tactile0medium121
Hallucinations, Verbal Auditory0medium121
Hallucinations, Visual0medium121
Hallucinations, Visual, Formed0medium121
Hallucinations, Visual, Unformed0medium121
Hand Dermatoses0low100
Hand Dermatosis0low100
Hand-Foot Syndrome0low20
Hantavirus Infections0low10
Hantavirus Pulmonary Syndrome0low10
Hantavirus-Associated Respiratory Distress Syndrome0low10
Harding Passey Melanoma0low210
HARDS0low10
Hashish Abuse0medium52
Hay Fever0medium11
Hayfever0medium11
HbS Disease0medium389
HDDD10medium11
HDDD20medium11
Head and Neck Cancer0medium251
Head and Neck Neoplasm0medium251
Head and Neck Neoplasms0medium251
Head and Neck Squamous Cell Carcinoma0low130
Head And Neck Squamous Cell Carcinomas0low130
Head Cancer0medium251
Head Injuries0low10
Head Injuries, Multiple0low10
Head Injury, Minor0low10
Head Injury, Open0low10
Head Injury, Superficial0low10
Head Neoplasm0medium251
Head Neoplasms0medium251
Head Pain0medium3719
Head Trauma0low10
Head, Neck Neoplasms0medium251
Headache0medium3719
Headache Disorders0low10
Headache Disorders, Secondary0low20
Headache Syndromes0low10
Headache, Cluster0low30
Headache, Intractable0low10
Headache, Migraine0medium23878
Headache, Tension0medium21
Health Care Associated Infection0medium361
Health Care Associated Infections0medium361
Healthcare Associated Infections0medium361
Hearing Disorders0low10
Hearing Impairment0low30
Hearing Loss0low30
Hearing Loss, Bilateral0low10
Hearing Loss, Cochlear0low20
Hearing Loss, Sensorineural0low20
Hearing Loss, Transitory0low30
Heart Abnormalities0low50
Heart Arrest0low30
Heart Attack0medium292
Heart Block0medium21
Heart Cancer0low10
Heart Decompensation0medium255
Heart Defect, Congenital0low50
Heart Defects, Congenital0low50
Heart Disease, Ischemic0medium231
Heart Diseases0medium122
Heart Disorders0medium122
Heart Enlargement0low50
Heart Failure0medium255
Heart Failure, Congestive0medium255
Heart Failure, Left-Sided0medium255
Heart Failure, Right-Sided0medium255
Heart Hypertrophy0low50
Heart Injuries0low20
Heart Neoplasms0low10
Heart Rupture, Traumatic0low20
Heart Tumor0low10
Heart Valve Diseases0low30
Heart Valvular Disease0low30
Heart, Malformation Of0low50
Heavy Menstrual Bleeding0low10
Heavy Metal Poisoning0low40
Heavy Periods0low10
Helicobacter Infections0low40
Hemangioblastic Meningioma0low10
Hemangiopericytic Meningioma0low10
Hemangiosarcoma0low10
Hemarthrosis0low10
Hematochezia0medium31
Hematologic Diseases0medium434
Hematologic Malignancies0medium14617
Hematologic Malignancy0medium14617
Hematologic Neoplasms0medium14617
Hematologic Pregnancy Complications0low40
Hematological Diseases0medium434
Hematological Malignancies0medium14617
Hematological Neoplasms0medium14617
Hematoma0low10
Hematoma, Subdural, Cranial0low10
Hematoma, Subdural, Intracranial0low10
Hematopoetic Myelodysplasia0medium13528
Hematopoietic Malignancies0medium14617
Hematopoietic Neoplasms0medium14617
Hematuria0low10
Heme Synthetase Deficiency0low10
Hemeralopia0low200
Hemianopia0low10
Hemianopsia0low10
Hemianopsia, Binasal0low10
Hemianopsia, Bitemporal0low10
Hemianopsia, Homonymous0low10
Hemiballism0low20
Hemiballismus0low20
Hemicrania0medium3719
Hemicrania Migraine0medium23878
Hemiparesis0low10
Hemiplegic Migraine, Familial0low30
Hemiplegic-Ophthalmoplegic Migraine0low30
Hemisensory Neglect0low40
Hemispatial Neglect0low40
Hemochromatoses0medium241
Hemochromatosis0medium241
Hemoglobin F Disease0medium15749
Hemoglobin S Disease0medium389
Hemoglobinopathies0medium41
Hemoglobinuria0low10
Hemolysis0low350
Hemolytic Anemia0low10
Hemolytic Anemia Due to G6PD Deficiency0low50
Hemolytic Anemia, Acquired0low10
Hemolytic Anemia, Autoimmune0low10
Hemolytic Anemia, Congenital Nonspherocytic0low10
Hemolytic Transfusion Reaction0medium11130
Hemophagocytic Lymphohistiocytosis Familial -10low10
Hemophagocytic Lymphohistiocytosis, Familial0low10
Hemophagocytic Lymphohistiocytosis, Familial, 10low10
Hemophagocytic Reticulosis, Familial0low10
Hemophagocytic Syndrome0low10
Hemophagocytic Syndrome, Infection-Associated0low10
Hemophagocytic Syndrome, Reactive0low10
Hemophagocytic Syndromes0low10
Hemophilia0low40
Hemophilia A0low40
Hemophilia A, Congenital0low40
Hemophilia, Classic0low40
Hemophilus Infections0low20
Hemophilus influenzae Meningitis Type B0low10
Hemoptysis0low70
Hemorrhage0medium111
Hemorrhage, Cerebral0low40
Hemorrhage, Cerebrum0low40
Hemorrhage, Gastrointestinal0medium31
Hemorrhage, Gingival0medium21
Hemorrhage, Retinal0low10
Hemorrhage, Retrobulbar0low10
Hemorrhage, Subarachnoid0low20
Hemorrhage, Surgical0medium11
Hemorrhage, Uterine0medium103
Hemorrhagic Fever with Renal Syndrome0low20
Hemorrhagic Fever, Ebola0low20
Hemorrhagic Fever, Epidemic0low20
Hemorrhagic Fever, Korean0low20
Hemorrhagic Necrotic Pancreatitis0low20
Hemorrhagic Nephroso-Nephritis0low20
Hemorrhagic Shock0low60
Hemosiderosis0medium136
HEMPAS0medium21
HEMPAS Anemia0medium21
Henneberg Syndrome0low10
Hepatic Cancer0medium815
Hepatic Cirrhosis0medium363
Hepatic Cirrhosis, Alcoholic0low30
Hepatic Cirrhosis, Experimental0medium51
Hepatic Coma0low20
Hepatic Encephalopathy0low20
Hepatic Failure0low100
Hepatic Failure, Acute0low120
Hepatic Failure, Fulminant0low120
Hepatic Glycogenosis with Amino Aciduria and Glucosuria0medium161
Hepatic Glycogenosis with Fanconi Nephropathy0medium161
Hepatic Insufficiency0medium21
Hepatic Neoplasms0medium815
Hepatic Stupor0low20
Hepatic Veno Occlusive Disease0medium21
Hepatic Veno-Occlusive Disease0medium21
Hepatitis0low60
Hepatitis A0medium11
Hepatitis B0medium71
Hepatitis B Virus Infection0medium71
Hepatitis B Virus Infection, Chronic0low30
Hepatitis B, Chronic0low30
Hepatitis C0medium204
Hepatitis C, Chronic0medium171
Hepatitis, Animal0low10
Hepatitis, Autoimmune0low30
Hepatitis, Chronic0low10
Hepatitis, Chronic Active0low10
Hepatitis, Chronic Persistent0low10
Hepatitis, Chronic, Cryptogenic0low10
Hepatitis, Chronic, Drug-Induced0medium11
Hepatitis, Chronic, Drug-Related0medium11
Hepatitis, Drug-Induced0medium1134
Hepatitis, Infectious0medium11
Hepatitis, Toxic0medium1134
Hepatitis, Viral, Human0low20
Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted0medium204
Hepatoblastoma0low30
Hepatocellular Cancer0medium815
Hepatocellular Carcinoma0medium543
Hepatocerebral Encephalopathy0low20
Hepatoma0medium543
Hepatoma, Benign0low10
Hepatoma, Experimental0medium211
Hepatoma, Morris0medium211
Hepatoma, Novikoff0medium211
Hepatomas, Experimental0medium211
Hepatomegaly0low20
Hepatorenal Glycogenosis with Renal Fanconi Syndrome0medium161
Hepatorenal Tyrosinemia0low10
Hereditary Areflexic Dystasia0low10
Hereditary Chorea0low10
Hereditary Dysphasic Disinhibition Dementia0medium11
Hereditary Erythroblast Multinuclearity with Positive Acidified Serum0medium21
Hereditary Erythroblastic Multinuclearity with Positive Acidified-Serum Test0medium21
Hereditary Essential Tremor0medium11
Hereditary Lymphedema0low10
Hereditary Lymphedema 10low10
Hereditary Lymphedema Type I0low10
Hereditary Motor and Sensory Neuropathy 1A0low10
Hereditary Motor and Sensory Neuropathy 1B0low10
Hereditary Motor and Sensory Neuropathy IA0low10
Hereditary Motor And Sensory Neuropathy IB0low10
Hereditary Motor and Sensory-Neuropathy Type II0low10
Hereditary Motor, and Sensory Neuropathy Type I0low10
Hereditary Progressive Chorea Without Dementia0low10
Hereditary Retinoblastoma0low20
Hereditary Spinal Ataxia, Friedreich0low20
Hereditary Spinal Ataxia, Friedreich's0low20
Hereditary Spinal Sclerosis0low20
Hereditary Type I Motor and Sensory Neuropathy0low10
Hereditary Tyrosinemia, Type I0low10
Hereditary Tyrosinemia, Type II0low10
Hereditary Tyrosinemia, Type III0low10
Hereditary Tyrosinemias0low10
Heritable Pulmonary Arterial Hypertension0low10
Hermaphroditism0low20
Hermaphroditism, True0low10
Herniated Disc0low10
Herniated Disk0low10
Heroin Abuse0low20
Heroin Addiction0low20
Heroin Dependence0low20
Heroin Smoking0low20
Herpes Simplex0low60
Herpes Simplex Keratitis0low20
Herpes Simplex Virus Infection0low60
Herpes Simplex, Ocular0low20
Herpes Zoster0low20
Herpesviridae Infections0low10
Herpesvirus 4 Infections, Human0low40
Herpesvirus Infections0low10
Heterotopic Ossification0low10
Heterotopic Tissue0low30
Heymann Nephritis0medium21
HFRS0low20
Hib Infection0low20
Hibernation, Myocardial0low10
HIE Syndrome0low10
HIES, Autosomal Dominant0low10
HIES, Autosomal Recessive0low10
High Cholesterol Levels0medium63
Hip Fractures0medium21
Hirsutism0medium31
Histamine Cephalgia0low30
Histiocytic Lymphoma0medium314
Histiocytic Lymphoma, Diffuse0medium314
Histiocytic Lymphoma, Nodular0low30
Histomoniasis0low10
Histoplasma capsulatum Infection0medium302
Histoplasma Infection0medium302
Histoplasmosis0medium302
HIV0medium372
HIV Antibody Positivity0medium113
HIV Coinfection0medium547104
HIV Dementia0medium21
HIV Encephalopathy0medium21
HIV Infections0medium547104
HIV Lipodystrophy Syndrome0low10
HIV Seroconversion0medium113
HIV Seropositivity0medium113
HIV-1 Cognitive and Motor Complex0medium21
HIV-1-Associated Cognitive Motor Complex0medium21
HIV-Associated Cognitive Motor Complex0medium21
HIV-Associated Lipodystrophy0low10
HIV-Associated Lipodystrophy Syndrome0low10
HIV-Related Lymphoma0low10
HIV-Related Opportunistic Infections0medium565
Hives0low50
HMN Distal Type I0low10
HMSN 1A0low10
HMSN 1B0low10
HMSN I0low10
HMSN IA0low10
HMSN IB0low10
HMSN II0low10
HMSN Type I0low10
HMSN Type II0low10
HMSN1A0low10
HMSN1B0low10
HNSCC0low130
Hoarseness0medium11
Hoarseness of Voice0medium11
Hodgkin Disease0medium61
Hodgkin Lymphoma0medium61
Hodgkin Lymphoma, Adult0medium61
Hodgkin's Disease0medium61
Hodgkin's Lymphoma0medium61
Hodgkins Disease0medium61
Homologous Wasting Disease0medium7610
Homonymous Hemianopia0low10
Horizontal Nystagmus0low10
Hormone Refractory Prostatic Cancer0medium233
Hormone Refractory Prostatic Neoplasms0medium233
Hormone-Dependent Neoplasms0medium19447
Horse Diseases0low100
Horton Syndrome0low30
Horton's Syndrome0low30
Hospital Infections0medium361
Hospital-Acquired Condition0medium61
Hot Flashes0medium189
HPABH4C0low10
HTLV I Associated T Cell Leukemia Lymphoma0low50
HTLV-Associated Leukemia-Lymphoma0low50
HTLV-I Infections0low10
HTLV-I-Associated T-Cell Leukemia-Lymphoma0low50
HTLV-III Infections0medium547104
HTLV-III Seroconversion0medium113
HTLV-III Seropositivity0medium113
HTLV-III-LAV Infections0medium547104
Hughes Syndrome0low20
Human Adenovirus Infections0low10
Human Flu0medium131
Human Herpes Virus 4 Infections0low40
Human Herpesvirus 4 Infections0low40
Human Influenza0medium131
Human Mammary Carcinoma0medium1,790464
Human T Lymphotropic Virus Associated Leukemia Lymphoma0low50
Human T Lymphotropic Virus-Associated Leukemia-Lymphoma0low50
Human T-Cell Leukemia-Lymphoma0low50
Human T-lymphotropic Virus 1 Infection0low10
Human T-lymphotropic Virus 1 Infections0low10
Human Trichinellosis0low10
Huntington Chorea0low130
Huntington Chronic Progressive Hereditary Chorea0low130
Huntington Disease0low130
Huntington Disease, Akinetic-Rigid Variant0low130
Huntington Disease, Juvenile0low130
Huntington Disease, Juvenile-Onset0low130
Huntington Disease, Late Onset0low130
Huntington's Chorea0low130
Huntington's Disease0low130
Hurler Disease0low20
Hurler Syndrome0low20
Hurler-Scheie Syndrome0low20
Hurler's Disease0low20
Hurler's Syndrome0low20
Hyalinosis, Segmental0low10
Hyalinosis, Segmental Glomerular0low10
Hyalohyphomycosis0low20
Hybrid Acute Leukemias0low10
Hydrocephalus0low10
Hydrocephalus Ex-Vacuo0low10
Hydrocephaly0low10
Hydronephrosis0low10
Hydrops0medium1151
Hydroxymethylbilane Synthase Deficiency0low30
Hymenolepiasis0low10
Hymenolepis Infection0low10
Hyper-IgE Recurrent Infection Syndrome, Autosomal Recessive0low10
Hyper-IgE Syndrome0low10
Hyper-IgE Syndrome, Autosomal Dominant0low10
Hyper-IgE Syndrome, Autosomal Recessive0low10
Hyper-Immunoglobulin E Syndrome, Autosomal Dominant0low10
Hyper-Immunoglobulin E Syndrome, Autosomal Recessive0low10
Hyperactivity, Motor0low20
Hyperaldosteronism0low30
Hyperalgesia0medium361
Hyperalgesia, Mechanical0medium361
Hyperalgesia, Primary0medium361
Hyperalgesia, Secondary0medium361
Hyperalgesia, Tactile0medium361
Hyperalgesia, Thermal0medium361
Hyperalgesic Sensations0medium361
Hyperalgia0medium361
Hyperalgia, Mechanical0medium361
Hyperalgia, Primary0medium361
Hyperalgia, Secondary0medium361
Hyperammonemia0low20
Hyperandrogenism0medium93
Hypercalcemia0low60
Hypercalcemia-Supravalvar Aortic Stenosis0low10
Hypercalciuria0low30
Hypercapnia0low40
Hypercapnic Acute Respiratory Failure0low50
Hypercapnic Respiratory Failure0low50
Hypercholesteremia0medium63
Hypercholesterolemia0medium63
Hypercoagulability0low10
Hypercortisolism0low10
Hyperemia0medium153
Hypereosinophilic Syndrome0low10
Hypereosinophilic Syndrome, Idiopathic0low10
Hyperglycemia0medium3814
Hyperglycemia, Postprandial0medium3814
Hypergonadotropic Hypogonadism0medium2812
Hypergonadotropic Ovarian Failure, X-Linked0medium31
Hyperimmunoglobulin E-Recurrent Infection Syndrome0low10
Hyperimmunoglobulin E, Recurrent Infection Syndrome0low10
Hyperimmunoglobulinemia E Syndrome0low10
Hyperinsulinemia0low60
Hyperinsulinism0low60
Hyperkalemia0low10
Hyperkinesia0low20
Hyperkinesia, Generalized0low20
Hyperkinesis0low20
Hyperkinetic Dysphonia0low10
Hyperkinetic Movements0low20
Hyperkinetic Syndrome0low20
Hyperlipemia0low110
Hyperlipidemia0low110
Hyperlipidemias0low110
Hypermelanosis0low20
Hypermenorrhea0low10
Hypermetria0low10
Hypernephroma0medium142
Hyperostosis0low10
Hyperotosis Corticalis Generalisata Familiaris0low10
Hyperoxaluria, Primary0low10
Hyperoxia0low30
Hyperparathyroidism0low10
Hyperparathyroidism, Primary0low10
Hyperphagia0low10
Hyperphenylalaninaemia0low10
Hyperphenylalaninemia Caused by a Defect in Biopterin Metabolism0low10
Hyperphenylalaninemia, BH4-Deficient, C0low10
Hyperphenylalaninemia, Non-Phenylketonuric0low10
Hyperphenylalaninemia, Tetrahydrobiopterin-Deficient, Due To DHPR Deficiency0low10
Hyperphosphatemia0low10
Hyperpigmentation0low20
Hyperplasia0low280
Hyperplasia, Congenital Adrenal0low20
Hyperpotassemia0low10
Hypersensitivity0medium221
Hypersensitivity Angiitis0low10
Hypersensitivity Pneumonitis0low40
Hypersensitivity Vasculitis0low10
Hypersensitivity, Atopic0low40
Hypersensitivity, Contact0low150
Hypersensitivity, Delayed0low70
Hypersensitivity, Drug0low80
Hypersensitivity, Food0low20
Hypersensitivity, Immediate0low40
Hypersensitivity, Latex0low10
Hypersensitivity, Respiratory0medium151
Hypersensitivity, Tuberculin-Type0low70
Hypersensitivity, Type I0low40
Hypersensitivity, Type III0low30
Hypersensitivity, Type IV0low70
Hypersomnia0medium72
Hypersomnia with Periodic Respiration0medium11
Hypersomnia, Post-Traumatic0low10
Hypersomnia, Posttraumatic0low10
Hypersomnia, Recurrent0medium72
Hypersomnolence0medium72
Hypersomnolence Disorders0medium72
Hypersomnolence Disorders, Primary0medium72
Hypersomnolence Disorders, Secondary0medium72
Hypertension0medium617
Hypertension-Edema-Proteinuria Gestosis0low40
Hypertension, Goldblatt0low10
Hypertension, Ocular0medium21
Hypertension, Pulmonary0medium181
Hypertension, Renal0low80
Hypertension, Renovascular0low10
Hypertriglyceridemia0low20
Hypertrophy0low40
Hypertrophy, Left Ventricular0low30
Hypertrophy, Right Ventricular0low10
Hypertyrosinemia0low10
Hypertyrosinemia, Type I0low10
Hyperuricemia0medium293
Hypesthesia0low20
Hypesthesia, Tactile0low20
Hypesthesia, Thermal0low20
Hypoactive Sexual Desire Disorder0medium133
Hypoacusis0low30
Hypoadrenalism0low30
Hypoalbuminemia0low20
Hypocalcemia0low20
Hypocatalasemia0low20
Hypocatalasia0low20
Hypochlorhydria0low30
Hypodynamia0low10
Hypoesthesia0low20
Hypogammaglobulinemia0low20
Hypogammaglobulinemia, Acquired0low10
Hypoglycemia0medium4820
Hypogonadism0medium2812
Hypogonadism, Isolated Hypogonadotropic0medium2812
Hypogonadotropic Hypogonadism0medium2812
Hypogonadotropic Hypogonadism and Anosmia0medium11
Hypogonadotropic Hypogonadism-Anosmia Syndrome0medium11
Hypogonadotropic Hypogonadism, Anosmia, and Midline Cranial Anomalies (Cleft Lip, Cleft Palate and Imperfect Fusion)0medium11
Hypokalemia0low90
Hypokinesia0low10
Hypokinesia, Antiorthostatic0low10
Hypolactasia0medium11
Hypomenorrhea0medium95
Hypomyotonia0low10
Hyponatremia0low60
Hypoparathyroidism0medium11
Hypopharyngeal Squamous Cell Carcinoma0low130
Hypophosphatemia0low20
Hypophyseal Disorders0low10
Hypoplasia of Thymus and Parathyroids0low10
Hypoplastic Congenital Anemia0low40
Hypopotassemia0low90
Hyposalivation0low30
Hypospermatogenesis0low20
Hypotension0low240
Hypotension, Orthostatic0low10
Hypotension, Postural0low10
Hypotension, Vascular0low240
Hypotensive Transfusion Reaction0medium11130
Hypothermia0medium91
Hypothermia, Accidental0medium91
Hypothyroidism0medium61
Hypotonia0low10
Hypotony, Muscle0low10
Hypotrichosis0low10
Hypovolemic Shock0low50
Hypoxemia0medium681
Hypoxemic Acute Respiratory Failure0low50
Hypoxemic Respiratory Failure0low50
Hypoxia0medium681
Hypoxia-Ischemia, Brain0low50
Hypoxia-Ischemia, Cerebral0low50
Hypoxia, Brain0low40
Hypoxia, Cerebral0low40
Hypoxic Brain Damage0low40
Hypoxic Encephalopathy0low40
Hypoxic-Ischemic Encephalopathy0low50
Hypsarrhythmia0medium144
Hysteria0low10
Hysteria, Conversion0medium21
Hysterical Neuroses0low10
Iatrogenic Disease0medium61
Ichthyosis0low10
ICP (Intracranial Pressure) Elevation0low10
ICP (Intracranial Pressure) Increase0low10
Icterus0low40
IDDM0medium235
Ideational Agnosia0low10
Ideational Apraxia0low10
Idiocy0medium154
Idiopathic Autoimmune Hemolytic Anemia0low10
Idiopathic CD4 Positive T-Lymphocytopenia0low10
Idiopathic CD4-Positive T-Lymphocytopenia0low10
Idiopathic CD4+ T-Lymphocytopenia0low10
Idiopathic De Toni-Debre-Fanconi Syndrome0medium161
Idiopathic Diffuse Interstitial Pulmonary Fibrosis0low100
Idiopathic Environmental Intolerance0low10
Idiopathic Environmental Intolerances0low10
Idiopathic Fibrosing Alveolitis, Chronic Form0low40
Idiopathic Headache0medium21
Idiopathic Hypereosinophilic Syndrome0low10
Idiopathic Hypoparathyroidism0medium11
Idiopathic Inflammatory Myopathies0low20
Idiopathic Inflammatory Myopathy0low20
Idiopathic Inflammatory Myositis0low20
Idiopathic Interstitial Pneumonitis - from Asbestos Exposure0low10
Idiopathic Intracranial Hypertension0low10
Idiopathic Membranous Glomerulonephritis0medium21
Idiopathic Membranous Nephropathy0medium21
Idiopathic Myelofibrosis0low80
Idiopathic Myoclonic Epilepsy0low50
Idiopathic Parkinson Disease0medium438
Idiopathic Parkinson's Disease0medium438
Idiopathic Proctocolitis0medium183
Idiopathic Pulmonary Arterial Hypertension0low10
Idiopathic Pulmonary Fibrosis0low40
Idiopathic Pulmonary Fibrosis, Familial0low40
Idiopathic Pulmonary Hypertension0low10
Idiopathic Sexual Precocity0medium245
Idiopathic Thrombocytopenic Purpura0low30
Idiopathic Ventricular Tachycardia0low50
IgA Vasculitis0low10
IgE-Mediated Hypersensitivity0low40
Ileal Diseases0low10
Ileitis, Regional0medium171
Ileitis, Terminal0medium171
Ileocolitis0medium171
Ileus0low20
Immune Complex Diseases0low30
Immune Diseases0low20
Immune Disorders0low20
Immune Reconstitution Disease0low90
Immune Reconstitution Inflammatory Syndrome0low90
Immune Reconstitution Syndrome0low90
Immune Restoration Disease0low90
Immune Restoration Syndrome0low90
Immune System Diseases0low20
Immune System Disorders0low20
Immune Thrombocytopenia0low30
Immune Thrombocytopenic Purpura0low30
Immunodeficiency 50low30
Immunodeficiency Syndrome, Acquired0medium432
Immunodeficiency Syndrome, Severe Combined0low10
Immunodeficiency, Common Variable0low10
Immunodeficiency, Severe Combined0low10
Immunodeficiency, X-Linked Progressive Combined Variable0low30
Immunoglobulin Deficiency, Late-Onset0low10
Immunoglobulin Light-chain Amyloidosis0low10
Immunologic Deficiency Syndrome0low30
Immunologic Deficiency Syndrome, Acquired0medium432
Immunologic Deficiency Syndromes0low30
Immunologic Deficiency, Severe Combined0low10
Immunologic Diseases0low20
Immunological Deficiency Syndromes0low30
Immunological Diseases0low20
Impaired Glucose Tolerance0medium114
Impaired Sensation0low20
Impotence0medium52
Impulse Control Disorders0medium32
Impulse-Control Disorders0medium32
Impulse-Ridden Personality0medium32
Impulsive Petit Mal Epilepsy0low10
Impulsive Petit Mal, Janz0low10
Inadequate Personality0medium32
Inadequate Sleep0medium71
Inappropriate ACTH Secretion Syndrome0low20
Inappropriate ADH Syndrome0low10
Inappropriate Adrenocorticotropic Hormone Secretion0low20
Inappropriate GH Secretion Syndrome (Acromegaly)0low20
Inappropriate Growth Hormone Secretion Syndrome (Acromegaly)0low20
Inappropriate Vasopressin Secretion Syndrome0low10
Inborn Errors of Metabolism0low30
Inborn Errors, Amino Acid Metabolism0low10
Inclusion Disease0low140
Incoordination0low30
Increased Intracranial Pressure-Associated Papilledema0low10
Indigestion0medium11
Indolent Systemic Mastocytosis0low10
Industrial Dermatosis0low90
Infant Gynecomastia0medium175
Infant, Newborn, Diseases0low10
Infant, Premature, Diseases0low40
Infant, Small for Gestational Age0medium11
Infantile Gaucher Disease0low40
Infantile Paralysis0low10
Infantile Severe Myoclonic Epilepsy0low50
Infantile Spasms0medium144
Infarct0low30
Infarction0low30
Infarction, Anterior Cerebral Circulation0low30
Infarction, Anterior Circulation, Brain0low30
Infarction, Brain, Anterior Circulation0low30
Infarction, Brain, Posterior Circulation0low30
Infarction, Cerebral0low70
Infarction, Cerebral, Left Hemisphere0low70
Infarction, Cerebral, Right Hemisphere0low70
Infarction, Left Hemisphere, Cerebral0low70
Infarction, Middle Cerebral Artery0low40
Infarction, Posterior Circulation, Brain0low30
Infarction, Right Hemisphere, Cerebral0low70
Infected Aneurysm0low50
Infection0medium133
Infection and Infestation0medium133
Infection, Bacterial0medium352
Infection, Central Nervous System, Protozoal0low20
Infection, Cross0medium361
Infection, Postoperative Wound0low190
Infection, Puerperal0low10
Infection, Surgical Wound0low190
Infection, Toxoplasma gondii0low20
Infection, Wound0low30
Infections0medium133
Infections and Infestations0medium133
Infections, Acinetobacter0low10
Infections, Actinomycetales0low10
Infections, Actinomycete0low10
Infections, Adenoviridae0low10
Infections, Adenovirus0low10
Infections, Atypical Mycobacterium0low30
Infections, Bacterial0medium352
Infections, Bacterial Eye0low40
Infections, Bacterial Ocular0low40
Infections, Bacterial, Central Nervous System0low10
Infections, Campylobacter0medium22
Infections, Cardiovirus0low10
Infections, Central Nervous System0medium61
Infections, Chlamydia0low10
Infections, Clostridium0low20
Infections, Community-Acquired0medium184
Infections, Coronavirus0low40
Infections, Cytomegalovirus0low140
Infections, E coli0low130
Infections, EBV0low40
Infections, Enterobacteriaceae0low30
Infections, Enterobacterial0low30
Infections, Enterovirus0low10
Infections, Epstein-Barr Virus0low40
Infections, Equine Encephalomyelitis Virus0low10
Infections, Escherichia coli0low130
Infections, Fungal, Central Nervous System0medium531
Infections, Gram-Negative Bacterial0low50
Infections, Haemophilus0low20
Infections, Hantavirus0low10
Infections, Helicobacter0low40
Infections, Hemophilus0low20
Infections, Herpesviridae0low10
Infections, Herpesvirus0low10
Infections, Hospital0medium361
Infections, HTLV-I0low10
Infections, Human Adenovirus0low10
Infections, Klebsiella0low30
Infections, Legionella pneumophila0low10
Infections, Listeria0low10
Infections, Microspora0low10
Infections, Mimae0low10
Infections, Mycobacterium0low10
Infections, Mycoplasma0low10
Infections, Neisseriaceae0low10
Infections, Nocardia0low10
Infections, Nosocomial0medium361
Infections, Orthomyxoviridae0low80
Infections, Orthomyxovirus0low80
Infections, Paramyxoviridae0low20
Infections, Picornaviridae0low10
Infections, Picornavirus0low10
Infections, Plasmodium0low180
Infections, Pneumococcal0low60
Infections, Prosthesis-Related0low140
Infections, Proteus0low10
Infections, Protozoal, Central Nervous System0low20
Infections, Protozoan0low10
Infections, Pseudomonas0low60
Infections, Respiratory0medium131
Infections, Respiratory Syncytial Virus0low30
Infections, Respiratory Tract0medium131
Infections, Respirovirus0low10
Infections, Retroviridae0low10
Infections, Retrovirus0low10
Infections, Serratia0low30
Infections, Soft Tissue0low120
Infections, Staphylococcal0low240
Infections, Staphylococcal Skin0low10
Infections, Stephanurus dentatus0low10
Infections, Streptococcal0low70
Infections, Streptococcus pneumoniae0low60
Infections, Strongylida0low10
Infections, Tumor Virus0low20
Infections, Upper Respiratory0medium131
Infections, Upper Respiratory Tract0medium131
Infections, Ureaplasma0low20
Infections, Vibrio0low30
Infectious Arthritis0low110
Infectious Diseases0low30
Infectious Diseases, Emerging0low80
Infectious Diseases, Re-Emerging0low80
Infectious Diseases, Reemerging0low80
Infectious Encephalitis0low10
Infectious Endophthalmitis0medium671
Infectious Hepatitis0medium11
Infectious Mononucleosis-Like Syndrome, Chronic0medium21
Infectious Myositis0low20
Infectious Pregnancy Complications0medium134
Infective Endocarditis0low250
Infertility0medium138
Infertility, Female0medium15359
Infertility, Male0medium206
Inflammation0medium18010
Inflammation, Brain0low100
Inflammatory Bowel Disease 10medium171
Inflammatory Bowel Disease, Ulcerative Colitis Type0medium183
Inflammatory Bowel Diseases0medium132
Inflammatory Breast Cancer0low10
Inflammatory Breast Cancer (IBC)0low10
Inflammatory Breast Carcinoma0low10
Inflammatory Breast Neoplasms0low10
Inflammatory Muscle Diseases0low20
Inflammatory Myopathies, Idiopathic0low20
Inflammatory Myopathy0low20
Inflammatory Myopathy, Idiopathic0low20
Inflammatory Response Syndrome, Systemic0low30
Inflammatory Rheumatism0low10
Influenza0medium131
Influenza in Humans0medium131
Influenza, Human0medium131
Infusion Site Adverse Event0low10
Infusion Site Adverse Reaction0low10
Infusion Site Reaction0low10
Inguinal Cryptorchidism0low10
Inhalation Burns0low10
Inherited Errors of Amino Acid Metabolism0low10
Inherited Erythroblastopenia0low40
Iniencephaly0low10
Injection Site Adverse Event0low10
Injection Site Event0low10
Injection Site Reaction0low10
Injuries0low130
Injuries and Wounds0low130
Injuries, Acute Brain0medium131
Injuries, Ankle0low10
Injuries, Brain0medium131
Injuries, Carotid Artery0low50
Injuries, Chest0low10
Injuries, Craniocerebral0low10
Injuries, Experimental Radiation0low50
Injuries, Eye0low70
Injuries, Facial0low10
Injuries, Foot0low10
Injuries, Head0low10
Injuries, Heart0low20
Injuries, Knee0low10
Injuries, Leg0low20
Injuries, Mandibular0low10
Injuries, Multiple0low10
Injuries, Needlestick0low10
Injuries, Penetrating Eye0low40
Injuries, Radiation0low80
Injuries, Soft Tissue0low10
Injuries, Spinal Cord0low90
Injuries, Surgical0low10
Injuries, Thoracic0low10
Injuries, Wounds0low130
Injuries, Wrist0low10
Injury, Brain, Traumatic0medium51
Injury, Ischemia-Reperfusion0medium481
Injury, Myocardial Reperfusion0low230
Injury, Reperfusion0medium481
Innate Inflammatory Response0medium18010
Insect Bites0low10
Insect Bites and Stings0low10
Insect Stings0low10
Insomnia0medium12341
Insomnia Disorder0medium12341
Insufficient Sleep0medium71
Insufficient Sleep Syndrome0medium71
Insulin Coma0low10
Insulin Resistance0medium6719
Insulin Resistance Syndrome X0medium195
Insulin Sensitivity0medium6719
Insulin Shock0low10
Insulin-Dependent Diabetes Mellitus 10medium235
Intellectual Development Disorder0medium154
Intellectual Disability0medium154
Intention Tremor0low50
Intermenstrual Bleeding0low10
Intermittent Explosive Disorder0medium32
Intermittent Tremor0low50
Internal Carotid Artery Diseases0medium41
Internal Carotid Artery Stenosis0low40
Internal Carotid Artery Thrombosis0low60
Internal Impingement Syndrome0low10
Internal Ophthalmoplegia0low50
Internuclear Ophthalmoplegia0low20
Intersex Conditions0low20
Intersexuality0low20
Interstitial Lung Disease0low20
Interstitial Lung Diseases0low20
Interstitial Nephritis0low40
Interstitial Pneumonitis, Usual0low40
Intertrigo0low10
Intertrochanteric Fractures0medium21
Intervertebral Disc Degeneration0low10
Intervertebral Disc Displacement0low10
Intervertebral Disk Degeneration0low10
Intervertebral Disk Displacement0low10
Intestinal Diseases0low70
Intestinal Obstruction0low20
Intestinal Perforation0low60
Intestinal Pseudo-Obstruction0low10
Intestinal Pseudo-Obstruction, Idiopathic0low10
Intestinal Pseudoobstruction0low10
Intra-Abdominal Infections0low10
Intraabdominal Infections0low10
Intracapillary Glomerulosclerosis0medium235
Intracavitary Tumors of the Heart0low10
Intracerebral Hemorrhage0low40
Intracranial Aneurysm0low20
Intracranial Angiospasm0low10
Intracranial Astrocytoma0low30
Intracranial Central Nervous System Disorders0medium351
Intracranial CNS Disorders0medium351
Intracranial Edema0low50
Intracranial Embolism0low10
Intracranial Embolism and Thrombosis0low10
Intracranial Extradural Abscess0low40
Intracranial Hypertension0low10
Intracranial Hypertension, Benign0low10
Intracranial Hypertension, Idiopathic0low10
Intracranial Meningeal Neoplasms0low20
Intracranial Meningioma0low10
Intracranial Neoplasms0medium484
Intracranial Pressure Increase0low10
Intracranial Sinus Thrombophlebitis0low10
Intracranial Subdural Hematoma0low10
Intracranial Subdural Hematoma, Traumatic0low10
Intracranial Toxoplasmosis0low10
Intracranial Vascular Disorders0low40
Intracranial Vascular Spasm0low10
Intracranial Vasospasm0low10
Intractable Epilepsy0low70
Intraductal Carcinoma, Noninfiltrating0medium123
Intradural-Extramedullary Spinal Cord Neoplasms0low20
Intraepithelial Neoplasms0medium62
Intrahepatic Cholangiocarcinoma0medium71
Intramedullary Spinal Cord Neoplasms0low20
Intramedullary Spinal Cord Neoplasms, Primary0low20
Intraocular Pressure0medium169
Intraoperative Complications0low10
Intraorbital Meningioma0low10
Intrauterine Growth Restriction0low10
Intrauterine Growth Retardation0low10
Intravascular Coagulation, Disseminated0low20
Intravascular Disseminated Coagulation0low20
Intravascular Hemolysis0low350
Intravenous Drug Abuse0low40
Intraventricular Meningioma0low10
Intraventricular Neoplasms0low10
Intrinsic Sleep Disorders0low10
Invasive Ductal Carcinoma, Breast0medium8619
Invasive Fungal Infections0medium15415
Invasive Fusariosis0medium391
Invasive Hyalohyphomycosis0low20
Invasive Mycoses0medium15415
Invasive Pulmonary Aspergillosis0medium1207
Invasive Pulmonary Fusariosis0medium391
Invasive Trichosporonosis0low170
Invasiveness, Neoplasm0medium615
Inversion of Circadian Rhythm, Psychogenic0low10
Inversion, Chromosomal0low10
Inversion, Chromosome0low10
Involuntary Movements0low20
Involuntary Quiver0low50
Iodamoebiasis0low100
Iris Diseases0low10
Iron Metabolism Disorders0medium71
Iron Overload0medium32376
Iron Storage Disorder0medium241
Iron-Deficiency Anemia0medium31
Iron-Deficiency Anemias0medium31
Irregular Menses0medium95
Irregular Menstruation0medium95
Irreversible Coma0low20
Irritant Dermatitis0medium21
Irvine-Gass Syndrome0low30
Ischaemic Stroke0low20
Ischemia0low280
Ischemia-Anoxia, Brain0low50
Ischemia-Anoxia, Cerebral0low50
Ischemia-Hypoxia, Brain0low50
Ischemia-Hypoxia, Cerebral0low50
Ischemia-Reperfusion Injury0medium481
Ischemia, Cerebral0low300
Ischemia, Myocardial0medium231
Ischemic Attack, Transient0low110
Ischemic Colitis0low20
Ischemic Encephalopathy0low300
Ischemic Heart Disease0medium231
Ischemic Myelopathy0low10
Ischemic Stroke0low20
Ischemic-Hypoxic Encephalopathy0low50
Isochromosomes0low10
Itai-Itai0low20
Itching0medium81
Jackknife Seizures0medium144
Jacksonian Seizure0medium1153
Janz Impulsive Petit Mal0low10
Janz Juvenile Myoclonic Epilepsy0low10
Janz Syndrome0low10
Japanese B Encephalitis0low10
Japanese B Viral Encephalitis0low10
Japanese Encephalitis0low10
Japanese Summer-Type Hypersensitivity Pneumonitis0low170
Jaundice0low40
Jaundice, Cholestatic0low10
Jaundice, Hemolytic0low40
Jaundice, Mechanical0low10
Jaundice, Obstructive0low10
Jaundice, Spirochetal0low10
Jaw Fractures0low10
JC Polyomavirus Encephalopathy0low80
Jejunal Diseases0low10
Jerk Nystagmus0low10
JME (Juvenile Myoclonic Epilepsy)0low10
Job Syndrome0low10
Job-Buckley Syndrome0low10
Job's Syndrome0low10
Joint Diseases0medium93
Joint Pain0medium299
Jorge Lobo Disease0low10
Jorge Lobo's Disease0low10
Juvenile Absence Epilepsy0medium81
Juvenile Chronic Arthritis0low20
Juvenile Dermatomyositis0low10
Juvenile Huntington Disease0low130
Juvenile Idiopathic Arthritis0low20
Juvenile Myoclonic Epilepsy0low10
Juvenile Myoclonic Epilepsy of Janz0low10
Juvenile Myositis0low10
Juvenile Paresis0low20
Juvenile Parkinson Disease0low240
Juvenile Parkinson Disease, Autosomal Dominant0low240
Juvenile Parkinson Disease, Autosomal Recessive0low240
Juvenile Parkinsonism, Autosomal Dominant0low240
Juvenile Parkinsonism, Autosomal Recessive0low240
Juvenile Pilocytic Astrocytoma0low30
Juvenile Rheumatoid Arthritis0low20
Juvenile-Onset Diabetes0medium235
Juvenile-Onset Huntington Disease0low130
Juvenile-Onset Still Disease0low20
Juvenile-Onset Stills Disease0low20
Kahler Disease0medium8213
Kala-Azar0low60
Kallmann Syndrome0medium11
Kallmann Syndrome 10medium11
Kallmann Syndrome 20medium11
Kallmann Syndrome 30medium11
Kallmann Syndrome, Type 1, X-linked0medium11
Kallmann Syndrome, Type 3, Recessive0medium11
Kallmann's Syndrome0medium11
Kandinsky Syndrome0medium32
Kanner's Syndrome0low30
Kaposi Sarcoma0low50
Kaposi's Sarcoma0low50
Katayama Fever0low40
Keloidal Blastomycosis0low10
Kerasin Histiocytosis0low40
Kerasin Lipoidosis0low40
Kerasin thesaurismosis0low40
Keratitis0medium552
Keratitis, Acanthamoeba0low120
Keratitis, Dendritic0low10
Keratitis, Furrow0low10
Keratitis, Herpetic0low20
Keratitis, Ulcerative0medium5910
Keratoconjunctivitis, Vernal0low20
Keratoconus0low20
Keratoderma Blennorrhagicum0low20
Keratoma0low20
Keratosis0low20
Keratosis Blennorrhagica0low20
Keratosis Palmoplantaris with Corneal Dystrophy0low10
Kerion Celsi0low30
Keskushermoston sairaudet@fi0low120
Ketoacidemia0low10
Ketoacidosis0low10
Ketoacidosis, Diabetic0low50
Ketoaciduria0low10
Ketonemia0low10
Ketonuria0low10
Ketosis0low10
Ketosis, Diabetic0low50
Ki-1 Lymphoma0low20
Kidney Cancer0medium182
Kidney Diseases0medium533
Kidney Failure0medium316
Kidney Failure, Acute0medium393
Kidney Failure, Chronic0medium328
Kidney Insufficiency0medium316
Kidney Insufficiency, Acute0medium393
Kidney Insufficiency, Chronic0medium3514
Kidney Neoplasms0medium182
Kidney Scarring0low80
Kidney, Polycystic0low10
Kidney, Polycystic, Autosomal Dominant0low60
Kienbock Disease0low10
Kienbock's Disease0low10
Kienboeck Disease0low10
Kienboeck's Disease0low10
Kimmelstiel-Wilson Disease0medium235
Kimmelstiel-Wilson Syndrome0medium235
Klebsiella Infections0low30
Kleptomania0medium32
Klinefelter Syndrome0medium61
Klinefelter Syndrome, Variants0medium61
Klinefelter's Syndrome0medium61
Klumpke Paralysis0low10
Klumpke's Palsy0low10
Knee Injuries0low10
Koch's Disease0medium231
Kochs Disease0medium231
Kraurosis Vulvae0low30
Labor, Premature0low20
Lacazia loboi Infection0low10
Lacaziosis0low10
Lacaziosis-like Disease0low10
Lacerations0low10
Lack of Coordination0low30
Lactose Intolerance0medium11
Lactose Malabsorption0medium11
Lactotroph Adenoma0low10
LAMB - Lentigines, Atrial Myxoma, Mucocutaneous Myoma, Blue Nevus Syndrome0low10
LAMB Syndrome0low10
Large Lymphoid Lymphoma, Diffuse0medium314
Large Lymphoid Lymphoma, Nodular0low30
Large-Cell Lymphoma, Diffuse0medium314
Large-Cell Lymphoma, Follicular0low30
Laryngeal Cancer0low10
Laryngeal Diseases0low10
Laryngeal Neoplasms0low10
Laryngeal Perichondritis0low10
Laryngeal Squamous Cell Carcinoma0low130
Laryngitis0low10
Larynx Cancer0low10
Larynx Diseases0low10
Larynx Neoplasms0low10
Lassa Fever0low20
Lassa Virus Infection0low20
Lassitude0medium135
Late Effects, Prenatal Exposure0medium242
Late Onset Alzheimer Disease0medium815
Late-Onset Huntington Disease0low130
Latent Infection0low10
Lateral Rectus Palsy0low10
Lateral Sclerosis0low10
Latex Allergy0low10
Latex Hypersensitivity0low10
Lazy Eye0low10
LCIS, Lobular Carcinoma In Situ0low10
Lead Poisoning0low20
Learning Disabilities0low10
Learning Disorders0low10
Learning Disorders, Adult0low10
Learning Disturbance0low10
Left Hemisphere, Cerebral Infarction0low70
Left Hemisphere, Infarction, Cerebral0low70
Left Main Coronary Artery Disease0medium102
Left Main Coronary Disease0medium102
Left Main Disease0medium102
Left Middle Cerebral Artery Infarction0low40
Left Ventricle Remodeling0low90
Left Ventricular Dysfunction0medium61
Left Ventricular Hypertrophy0low30
Left Ventricular Outflow Obstruction0low10
Left Ventricular Remodeling0low90
Left-Sided Heart Failure0medium255
Leg Dermatoses0low20
Leg Dermatosis0low20
Leg Injuries0low20
Leg Ulcer0low50
Legionella pneumophila Infections0low10
Legionnaire Disease0low10
Legionnaires' Disease0low10
Leiomyoma0medium176
Leiomyoma, Uterine0medium176
Leiomyomatosis0medium41
Leiomyosarcoma0medium41
Leiomyosarcoma, Epithelioid0medium41
Leiomyosarcoma, Myxoid0medium41
Leishmania Infection0low190
Leishmaniasis0low190
Leishmaniasis, American0low60
Leishmaniasis, Cutaneous0low60
Leishmaniasis, Diffuse Cutaneous0low10
Leishmaniasis, New World0low60
Leishmaniasis, Old World0low60
Leishmaniasis, Visceral0low60
Lennox Gastaut Syndrome0medium369
Lennox-Gastaut Syndrome0medium369
Lens Opacities0medium51
Lenticulostriate Disorders0medium31
Lentigines0low20
Lentiginosis0low20
Lentiginosis, Perioral0low60
Lentigo0low20
Leptomeningeal Carcinomatosis0low30
Leptomeningeal Neoplasms0low20
Leptospirosis, Icterohemorrhagic0low10
Lethal Acrodysgenital Syndrome0low10
Leucocythaemia0medium777
Leucocythemia0medium777
Leukemia0medium777
Leukemia L 12100low160
Leukemia L12100low160
Leukemia Lymphoma, Adult T Cell0low50
Leukemia Lymphoma, T Cell, Acute, HTLV I Associated0low50
Leukemia Model, Animal0low100
Leukemia P3880low60
Leukemia-Lymphoma, Adult T-Cell0low50
Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated0low50
Leukemia, Acute Lymphoblastic0medium791
Leukemia, Acute Monocytic0low40
Leukemia, Acute Myelogenous0medium23830
Leukemia, Acute Myeloid0medium23830
Leukemia, Acute Promyelocytic0low110
Leukemia, Adult T-Cell0low50
Leukemia, B Cell, Chronic0medium182
Leukemia, B-Cell0low20
Leukemia, B-Cell, Chronic0medium182
Leukemia, Biphenotypic, Acute0low10
Leukemia, Chronic Lymphatic0medium182
Leukemia, Chronic Lymphocytic0medium182
Leukemia, Chronic Lymphocytic, B-Cell0medium182
Leukemia, Chronic Myelogenous0low200
Leukemia, Chronic Myeloid0low200
Leukemia, Eosinophilic0low10
Leukemia, Erythroblastic, Acute0low40
Leukemia, Experimental0low100
Leukemia, Granulocytic0medium381
Leukemia, Granulocytic, Chronic0low200
Leukemia, Hairy Cell0low10
Leukemia, Lymphoblastic0medium791
Leukemia, Lymphoblastic, Acute0medium791
Leukemia, Lymphoblastic, Acute, L10medium791
Leukemia, Lymphoblastic, Acute, L20medium791
Leukemia, Lymphoblastic, Acute, Philadelphia-Positive0medium791
Leukemia, Lymphoblastic, Acute, T Cell0low130
Leukemia, Lymphoblastic, Acute, T-Cell0low130
Leukemia, Lymphoblastic, Burkitt-Type0medium91
Leukemia, Lymphoblastic, Chronic0medium182
Leukemia, Lymphocytic0low20
Leukemia, Lymphocytic, Acute0medium791
Leukemia, Lymphocytic, Acute T Cell0low130
Leukemia, Lymphocytic, Acute, L10medium791
Leukemia, Lymphocytic, Acute, L20medium791
Leukemia, Lymphocytic, Acute, Mixed Cell0low10
Leukemia, Lymphocytic, Acute, Mixed-Cell0low10
Leukemia, Lymphocytic, Acute, T-Cell0low130
Leukemia, Lymphocytic, B Cell0low20
Leukemia, Lymphocytic, B-Cell0low20
Leukemia, Lymphocytic, Chronic0medium182
Leukemia, Lymphocytic, Chronic, B Cell0medium182
Leukemia, Lymphocytic, Chronic, B-Cell0medium182
Leukemia, Lymphocytic, L30medium91
Leukemia, Lymphocytic, T Cell0low20
Leukemia, Lymphocytic, T-Cell0low20
Leukemia, Lymphoid0low20
Leukemia, Lymphoid, Acute0medium791
Leukemia, Mast-Cell0medium31
Leukemia, Megakaryoblastic, Acute0low20
Leukemia, Megakaryocytic0low20
Leukemia, Megakaryocytic, Acute0low20
Leukemia, Mixed-Cell0low10
Leukemia, Mixed, B and T Cell0low10
Leukemia, Mixed, B- and T-Cell0low10
Leukemia, Monoblastic, Acute0low40
Leukemia, Monocytic, Acute0low40
Leukemia, Monocytic, Chronic0medium381
Leukemia, Myeloblastic, Acute0medium23830
Leukemia, Myelocytic0medium381
Leukemia, Myelocytic, Acute0medium23830
Leukemia, Myelocytic, Chronic0low200
Leukemia, Myelogenous0medium381
Leukemia, Myelogenous, Acute0medium23830
Leukemia, Myelogenous, Chronic0low200
Leukemia, Myelogenous, Chronic, BCR-ABL Positive0low200
Leukemia, Myelogenous, Ph1 Positive0low200
Leukemia, Myelogenous, Ph1-Positive0low200
Leukemia, Myeloid0medium381
Leukemia, Myeloid, Acute0medium23830
Leukemia, Myeloid, Acute, M10medium23830
Leukemia, Myeloid, Acute, M20medium23830
Leukemia, Myeloid, Acute, M30low110
Leukemia, Myeloid, Acute, M40low60
Leukemia, Myeloid, Acute, M50low40
Leukemia, Myeloid, Acute, M60low40
Leukemia, Myeloid, Acute, M70low20
Leukemia, Myeloid, Chronic0low200
Leukemia, Myeloid, Naegeli-Type0low60
Leukemia, Myeloid, Ph1 Positive0low200
Leukemia, Myeloid, Ph1-Positive0low200
Leukemia, Myeloid, Philadelphia Positive0low200
Leukemia, Myeloid, Philadelphia-Positive0low200
Leukemia, Myeloid, Schilling Type0low40
Leukemia, Myeloid, Schilling-Type0low40
Leukemia, Myelomonocytic, Acute0low60
Leukemia, Myelomonocytic, Chronic0low10
Leukemia, Nonlymphoblastic, Acute0medium23830
Leukemia, Nonlymphocytic, Acute0medium23830
Leukemia, Plasma Cell0low10
Leukemia, Plasmacytic0low10
Leukemia, Pre-B-Cell0low50
Leukemia, Progranulocytic0low110
Leukemia, Promyelocytic, Acute0low110
Leukemia, Smoldering0low10
Leukemia, Smouldering0low10
Leukemia, T-Cell0low20
Leukemia, T-Cell, Acute0low130
Leukemias, Experimental0low100
Leukemic Reticuloendotheliosis0low10
Leukocytopenia0medium193
Leukocytosis0low40
Leukoencephalopathies0low10
Leukoencephalopathy0low10
Leukoencephalopathy Syndrome, Posterior0low10
Leukoencephalopathy with Vanishing White Matter0low10
Leukoencephalopathy, Progressive Multifocal0low80
Leukoma0low20
Leukopenia0medium193
Leukorrhea0low20
Lewy Body Dementia0low10
Lewy Body Disease0low10
Lewy Body Disease, Cortical0low10
Lewy Body Disease, Diffuse0low10
Lewy Body Parkinson Disease0medium438
Lewy Body Parkinson's Disease0medium438
Lewy Body Type Senile Dementia0low10
Libman-Sacks Disease0medium133
Lichen Planus0low10
Lichen Ruber Planus0low10
Lichen Rubra Planus0low10
Lichen Sclerosus of Vulva0low30
Light Sensitivity0medium41
Light-Headedness0medium124
Lightheadedness0medium124
Lightning Attacks0medium144
Lignac-Fanconi Syndrome0medium161
Linear Scleroderma0low20
Lingual-Facial-Buccal Dyskinesia0low20
Linguofacial Dyskinesia0low20
Lipemia0low110
Lipid Metabolism Disorders0medium11
Lipidemia0low110
Lipidoses0low30
Lipidosis0low30
Lipochondrodystrophy0low20
Lipodystrophy0medium21
Lipodystrophy Syndrome, HIV0low10
Lipoid Histiocytosis (Kerasin Type)0low40
Lipoidosis0low30
Liposarcoma0medium52
Liposarcoma, Dedifferentiated0medium52
Liposarcoma, Myxoid0low10
Liposarcoma, Pleomorphic0medium52
Liposarcoma, Well Differentiated0medium52
Listeria Infections0low10
Listeriosis0low10
Lithiasis0low10
Liver Abscess0low20
Liver Cancer0medium815
Liver Cancer, Adult0medium543
Liver Cell Carcinoma0medium543
Liver Cell Carcinoma, Adult0medium543
Liver Cirrhoses, Experimental0medium51
Liver Cirrhosis0medium363
Liver Cirrhosis, Alcoholic0low30
Liver Cirrhosis, Biliary0low20
Liver Cirrhosis, Experimental0medium51
Liver Cirrhosis, Obstructive0low20
Liver Diseases0medium479
Liver Diseases, Alcoholic0low10
Liver Dysfunction0medium479
Liver Failure0low100
Liver Failure, Acute0low120
Liver Failure, Chronic0low20
Liver Failure, Fulminant0low120
Liver Fibrosis0medium363
Liver Injury, Drug-Induced0medium1134
Liver Injury, Drug-Induced, Acute0medium1134
Liver Injury, Drug-Induced, Chronic0medium11
Liver Insufficiency0medium21
Liver Neoplasms0medium815
Liver Neoplasms, Experimental0medium211
Liver Steatosis0medium291
Livor Mortis0low10
Lobar Pneumonia0medium322
Lobomycosis0low10
Lobomycosis-like Disease0low10
Lobular Carcinoma In Situ0low10
Local Neoplasm Recurrence0medium21158
Local Neoplasm Recurrences0medium21158
Locomotion Disorders, Neurologic0low30
Locoregional Neoplasm Recurrence0medium21158
Loeffler Endocarditis0low10
Loeffler Syndrome0low70
Loeffler's Endocarditis0low10
Long QT Syndrome0medium214
Long Sleeper Syndrome0medium217
Long Term Adverse Effects0low10
Lou Gehrig Disease0medium41
Lou Gehrig's Disease0medium41
Lou-Gehrigs Disease0medium41
Louis-Bar Syndrome0low20
Louping Ill Encephalitis0low30
Low Back Ache0low10
Low Back Pain0low10
Low Back Pain, Mechanical0low10
Low Back Pain, Posterior Compartment0low10
Low Back Pain, Postural0low10
Low Back Pain, Recurrent0low10
Low Backache0low10
Low Blood Pressure0low240
Low Bone Density0medium103
Low Bone Mineral Density0medium103
Low Sperm Count0low20
Lower Back Pain0low10
Lower Brachial Plexus Neuropathy0low10
Lower Brachial Plexus Palsy0low10
Lower Extremity Paresis0low10
Lower Motor Neuron Disease0low10
Lower Urinary Tract Symptom0low10
Lower Urinary Tract Symptoms0low10
Luder-Sheldon Syndrome0medium161
Lumbago0low10
Lung Abscess0low40
Lung Adenocarcinoma0low100
Lung Aspergillosis0medium973
Lung Cancer0medium17213
Lung Collapse0low10
Lung Diseases0medium222
Lung Diseases, Fungal0medium2107
Lung Diseases, Interstitial0low20
Lung Diseases, Obstructive0medium41
Lung Inflammation0medium322
Lung Injuries0low60
Lung Injury0low60
Lung Injury, Acute0medium71
Lung Neoplasms0medium17213
Lung Sounds0medium21
Lupus Erythematosus Disseminatus0medium133
Lupus Erythematosus, Chronic Cutaneous0low40
Lupus Erythematosus, Cutaneous0medium41
Lupus Erythematosus, Cutaneous, Chronic0low40
Lupus Erythematosus, Cutaneous, Subacute0medium41
Lupus Erythematosus, Discoid0low40
Lupus Erythematosus, Subacute Cutaneous0medium41
Lupus Erythematosus, Systemic0medium133
Lupus Glomerulonephritis0low60
Lupus Nephritis0low60
Lyell's Syndrome0low40
Lymph Node Metastasis0medium5714
Lymphadenitis0low10
Lymphadenopathy Syndrome0medium22
Lymphangioleiomyomatosis0low10
Lymphangiomyomatosis0low10
Lymphangitis0low10
Lymphatic Diseases0low10
Lymphatic Metastasis0medium5714
Lymphatic Sarcoma0medium205
Lymphatism0low10
Lymphedema0low10
Lymphedema, Early-Onset0low10
Lymphedema, Hereditary, Ia0low10
Lymphoblastic Leukemia0medium791
Lymphoblastic Leukemia, Acute0medium791
Lymphoblastic Leukemia, Acute, Adult0medium791
Lymphoblastic Leukemia, Acute, Childhood0medium791
Lymphoblastic Leukemia, Acute, L10medium791
Lymphoblastic Leukemia, Acute, L20medium791
Lymphoblastic Leukemia, Acute, T Cell0low130
Lymphoblastic Leukemia, Acute, T-Cell0low130
Lymphoblastic Leukemia, Chronic0medium182
Lymphoblastic Lymphoma0medium791
Lymphocyte Depletion Hodgkin's Lymphoma0medium61
Lymphocyte-Rich Classical Hodgkin's Lymphoma0medium61
Lymphocytic Choriomeningitis0low10
Lymphocytic Choriomeningitis Virus Encephalomyelitis0low10
Lymphocytic Colitis0low10
Lymphocytic Leukemia0low20
Lymphocytic Leukemia, Acute0medium791
Lymphocytic Leukemia, Acute, B and T Cell0low10
Lymphocytic Leukemia, Acute, B- and T-Cell0low10
Lymphocytic Leukemia, B-Cell0low20
Lymphocytic Leukemia, Chronic0medium182
Lymphocytic Leukemia, Chronic, B Cell0medium182
Lymphocytic Leukemia, Chronic, B-Cell0medium182
Lymphocytic Leukemia, L10medium791
Lymphocytic Leukemia, L20medium791
Lymphocytic Leukemia, L30medium91
Lymphocytic Leukemia, T Cell, Acute0low130
Lymphocytic Leukemia, T-Cell0low20
Lymphocytic Leukemia, T-Cell, Acute0low130
Lymphocytic Lymphoma0medium182
Lymphocytic Lymphoma, Diffuse, Poorly Differentiated0low110
Lymphocytic Lymphoma, Diffuse, Poorly-Differentiated0low110
Lymphocytic Lymphoma, Diffuse, Well Differentiated0medium182
Lymphocytic Lymphoma, Diffuse, Well-Differentiated0medium182
Lymphocytic Lymphoma, Nodular, Poorly Differentiated0low30
Lymphocytic Lymphoma, Nodular, Poorly-Differentiated0low30
Lymphocytic Lymphoma, Well Differentiated0medium182
Lymphocytic Lymphoma, Well-Differentiated0medium182
Lymphocytopenia0low30
Lymphogranuloma, Malignant0medium61
Lymphohistiocytosis, Hemophagocytic0low10
Lymphoid Leukemia0low20
Lymphoma0medium191
Lymphoma, AIDS-Associated0low10
Lymphoma, AIDS-Related0low10
Lymphoma, Atypical Diffuse Small Lymphoid0medium205
Lymphoma, B-Cell0low80
Lymphoma, Burkitt0medium91
Lymphoma, Centrocytic Small-Cell0low110
Lymphoma, Diffuse0medium205
Lymphoma, Diffuse Large-Cell0medium314
Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic0medium205
Lymphoma, Extranodal NK-T-Cell0low10
Lymphoma, Follicular0low30
Lymphoma, Follicular Large-Cell0low30
Lymphoma, Follicular, Grade 10low30
Lymphoma, Follicular, Grade 20low30
Lymphoma, Follicular, Grade 30low30
Lymphoma, Follicular, Mixed Cell0low30
Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic0low30
Lymphoma, Follicular, Mixed Small and Large Lymphoid0low30
Lymphoma, Follicular, Small and Large Cleaved Cell0low30
Lymphoma, Follicular, Small and Large Cleaved-Cell0low30
Lymphoma, Giant Follicular0low30
Lymphoma, High-Grade0medium205
Lymphoma, Histiocytic0medium314
Lymphoma, Histiocytic, Diffuse0medium314
Lymphoma, Histiocytic, Nodular0low30
Lymphoma, HIV-Related0low10
Lymphoma, Intermediate-Grade0medium205
Lymphoma, Large B-Cell, Diffuse0medium314
Lymphoma, Large Cell, Diffuse0medium314
Lymphoma, Large Cell, Follicular0low30
Lymphoma, Large Lymphoid, Diffuse0medium314
Lymphoma, Large Lymphoid, Nodular0low30
Lymphoma, Large-Cell, Anaplastic0low20
Lymphoma, Large-Cell, Diffuse0medium314
Lymphoma, Large-Cell, Follicular0low30
Lymphoma, Large-Cell, Ki-10low20
Lymphoma, Low-Grade0medium205
Lymphoma, Lymphoblastic0medium791
Lymphoma, Lymphocytic0medium182
Lymphoma, Lymphocytic, Diffuse, Intermediate Differentiated0low110
Lymphoma, Lymphocytic, Diffuse, Poorly-Differentiated0low110
Lymphoma, Lymphocytic, Diffuse, Well Differentiated0medium182
Lymphoma, Lymphocytic, Diffuse, Well-Differentiated0medium182
Lymphoma, Lymphocytic, Intermediate0low110
Lymphoma, Lymphocytic, Nodular, Poorly Differentiated0low30
Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated0low30
Lymphoma, Lymphocytic, Plasmacytoid0low50
Lymphoma, Lymphocytic, Well Differentiated0medium182
Lymphoma, Lymphocytic, Well-Differentiated0medium182
Lymphoma, Lymphoplasmacytoid0low50
Lymphoma, Lymphoplasmacytoid, CLL0medium182
Lymphoma, Malignant0medium191
Lymphoma, Mantle-Cell0low110
Lymphoma, Mixed0medium205
Lymphoma, Mixed Cell, Diffuse0medium205
Lymphoma, Mixed Lymphocytic-Histiocytic0medium205
Lymphoma, Mixed Small and Large Cell, Diffuse0medium205
Lymphoma, Mixed-Cell0medium205
Lymphoma, Mixed-Cell, Diffuse0medium205
Lymphoma, Mixed-Cell, Follicular0low30
Lymphoma, Nodular0low30
Lymphoma, Nodular, Large Follicular Center Cell0low30
Lymphoma, Nodular, Large Follicular Center-Cell0low30
Lymphoma, Nodular, Mixed Lymphocytic Histiocytic0low30
Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic0low30
Lymphoma, Nodular, Mixed Small and Large Cell0low30
Lymphoma, Non-Hodgkin0medium205
Lymphoma, Non-Hodgkin, Familial0medium205
Lymphoma, Non-Hodgkin's0medium205
Lymphoma, Non-Hodgkins0medium205
Lymphoma, Nonhodgkin's0medium205
Lymphoma, Nonhodgkins0medium205
Lymphoma, Pleomorphic0medium205
Lymphoma, Primary Effusion0low30
Lymphoma, Small and Large Cleaved-Cell, Diffuse0medium205
Lymphoma, Small Cleaved Cell, Diffuse0medium205
Lymphoma, Small Cleaved Cell, Follicular0low30
Lymphoma, Small Cleaved-Cell, Diffuse0medium205
Lymphoma, Small Cleaved-Cell, Follicular0low30
Lymphoma, Small Follicular Center-Cell0low30
Lymphoma, Small Lymphocytic0medium182
Lymphoma, Small Lymphocytic, Plasmacytoid0medium182
Lymphoma, Small Lymphoid, Follicular0low30
Lymphoma, Small Non-Cleaved-Cell0medium205
Lymphoma, Small Noncleaved-Cell0medium205
Lymphoma, Small-Cell0medium182
Lymphoma, Small-Cell, Centrocytic0low110
Lymphoma, T Cell, Cutaneous0low30
Lymphoma, T Cell, Peripheral0low10
Lymphoma, T-Cell0medium21
Lymphoma, T-Cell, Cutaneous0low30
Lymphoma, T-Cell, Peripheral0low10
Lymphoma, Undifferentiated0medium205
Lymphoma, Undifferentiated, Diffuse0medium205
Lymphopenia0low30
Lymphoplasmacytoid Lymphoma, CLL0medium182
Lymphoproliferative Disease, X-Linked0low30
Lymphoproliferative Disorders0low30
Lymphoproliferative Syndrome, X-Linked, 10low30
Lymphosarcoma0medium205
M3 ANLL0low110
Macroglobulinemia0low50
Macrophage Activation Syndrome0low10
Macroprolactinoma0low10
Macropsia0low200
Macular Degeneration0low40
Macular Degeneration, Age-Related0low40
Macular Dystrophy0low40
Macular Dystrophy, Dominant Cystoid0low30
Macular Edema0low30
Macular Edema, Cystoid0low30
Maculopapular Drug Eruption0medium294
Maculopapular Exanthem0medium294
Maculopathies, Age-Related0low40
Maculopathy0low40
Maculopathy, Age-Related0low40
Madura Foot0low800
Maduromycosis0low800
Magnesium Deficiency0low20
Major Depressive Disorder0medium5134
Major Motor Seizure Disorder0medium31
Major Motor Seizure, Alcohol Withdrawal-Induced0low10
Maladie du systu00E8me nerveux central@fr0low120
Malaria0low180
Malaria, Falciparum0medium264
Malaria, Vivax0medium21
Malassezia furfur Infection0medium52
Malattie del sistema nervoso centrale@it0low120
Male Breast Cancer0medium142
Male Breast Enlargement0medium175
Male Breast Neoplasms0medium142
Male Genital Diseases0medium32
Male Impotence0medium52
Male Pattern Baldness0medium51
Male Sexual Impotence0medium52
Malformations Due to Abnormal Neuronal Migration0low10
Malformations of Cortical Development, Group II0low10
Malformations Secondary to Abnormal Neuronal Migration0low10
Malformations, Nervous System, Congenital0low10
Malignancies, Hematologic0medium14617
Malignancy0medium31633
Malignancy, Hematologic0medium14617
Malignant Cerebellar Neoplasms0low80
Malignant Epithelial Neoplasms0medium517
Malignant Glioma0low290
Malignant Melanoma0medium411
Malignant Meningeal Neoplasms0low20
Malignant Meningioma0low10
Malignant Mesothelioma0low40
Malignant Neoplasm of Breast0medium1,790464
Malignant Neoplasms0medium31633
Malignant Neoplasms, Brain0medium484
Malignant Neurilemmoma0low10
Malignant Neurilemoma0low10
Malignant Optic Nerve Neoplasm0low10
Malignant Optic Nerve Sheath Neoplasms0low10
Malignant Optic Nerve Sheath Tumors0low10
Malignant Optic Nerve Tumor0low10
Malignant Peripheral Nerve Sheath Tumor0low10
Malignant Peripheral Nerve Sheath Tumors0low10
Malignant Pleural Mesothelioma0low40
Malignant Primary Brain Neoplasms0medium484
Malignant Primary Brain Tumors0medium484
Malignant Tumor of Breast0medium1,790464
Malignant Tumor of Urinary Bladder0low100
Malnourishment0medium11
Malnutrition0medium11
Mammary Cancer0medium1,790464
Mammary Carcinoma, Animal0low130
Mammary Carcinoma, Human0medium1,790464
Mammary Ductal Carcinoma0medium8619
Mammary Dysplasia0low10
Mammary Neoplasm, Human0medium1,790464
Mammary Neoplasms0low130
Mammary Neoplasms, Animal0low130
Mammary Neoplasms, Experimental0low480
Mammary Neoplasms, Human0medium1,790464
Mandibular Injuries0low10
Mange, Sarcoptic0low10
Manic Depression0medium184
Manic Disorder0medium184
Manic-Depressive Psychosis0medium184
Mantle-Cell Lymphoma0low110
Mantle-Zone Lymphoma0low110
Mar (X) Syndrome0low20
Marche a Petit Pas0low30
Marek Disease0low10
Marek's Disease0low10
Marginal Ulcer0low30
Marie-Struempell Disease0medium102
Marie-Strumpell Spondylitis0low30
Marihuana Abuse0medium52
Marijuana Abuse0medium52
Marijuana Dependence0medium52
Marker X Syndrome0low20
Marsh Fever0low180
Martin-Bell Syndrome0low20
Massive Tremor0low50
Mast-Cell Leukemia0medium31
Mast-Cell Sarcoma0low20
Mastitis, Bovine0low10
Mastocytoma0low20
Mastocytoma, Benign0low20
Mastocytoma, Extracutaneous0low20
Mastocytoma, Malignant0low20
Mastocytosis, Systemic0low10
Mastoiditis0low10
Maternal Sepsis0medium134
Maturity-Onset Diabetes0medium560179
Maturity-Onset Diabetes Mellitus0medium560179
Maxillary Diseases0low20
Maxillary Sinus Cancer0low10
Maxillary Sinus Neoplasms0low10
Maxillary Sinusitis0medium81
MCA Infarct0low40
MCA Infarction0low40
McCune-Albright Syndrome0medium101
Measles0low10
Mechanical Allodynia0medium361
Mechanical Hyperalgesia0medium361
Mechanical Low Back Pain0low10
Median Neuropathy, Carpal Tunnel0medium32
Mediastinal Cancer0low20
Mediastinal Diseases0low30
Mediastinal Neoplasms0low20
Mediastinitis0low60
Mediastinum Cancer0low20
Mediastinum Inflammation0low60
Mediastinum Neoplasms0low20
Medically Unexplained Syndrome0medium21
Medically Unexplained Syndromes0medium21
Medication Overuse Headache0low20
Medication Resistant Epilepsy0low70
Medication-Induced Dyskinesia0low110
Mediterranean Anemia0medium15749
Medullary Neoplasms0low40
Medullary Tumors0low40
Medulloblastoma0low100
Medulloblastoma, Adult0low100
Medulloblastoma, Childhood0low100
Medulloblastoma, Desmoplastic0low100
Medullomyoblastoma0low100
Megacolon, Toxic0low10
Megakaryoblastic Leukemia, Acute0low20
Megakaryocytic Leukemia0low20
Megakaryocytic Leukemia, Acute0low20
Meigs Syndrome0low10
Meigs' Syndrome0low10
Melancholia0medium15846
Melancholia, Involutional0medium5134
Melanism0low20
Melanocytic Medulloblastoma0low100
Melanoma0medium411
Melanoma, B160low210
Melanoma, Cloudman S910low210
Melanoma, Experimental0low210
Melanoma, Harding-Passey0low210
Melanomas, Experimental0low210
Melanosis0low20
Melasma0low20
Membranous Glomerulonephropathy0medium21
Membranous Glomerulopathy0medium21
Membranous Nephropathy0medium21
Memory Deficits0medium243
Memory Disorder, Semantic0medium243
Memory Disorder, Spatial0medium243
Memory Disorders0medium243
Memory Disorders, Age-Related0medium243
Memory Loss0medium243
Memory Loss, Retrograde0low20
Mendelson Syndrome0low30
Mendelson's Syndrome0low30
Meningeal Cancer0low20
Meningeal Carcinomatosis0low30
Meningeal Neoplasms0low20
Meningeal Neoplasms, Benign0low20
Meningeal Neoplasms, Intracranial0low20
Meningeal Neoplasms, Malignant0low20
Meningeal Tumors0low20
Meningioma0low10
Meningiomas, Multiple0low10
Meningiomatosis0low10
Meningitides, Bacterial0low10
Meningitis0low220
Meningitis, Bacterial0low10
Meningitis, Cryptococcal0low320
Meningitis, Fungal0medium291
Meningitis, Haemophilus0low10
Meningitis, Haemophilus influenzae Type F0low10
Meningitis, Haemophilus parainfluenzae0low10
Meningitis, Hemophilus0low10
Meningitis, Hemophilus influenzae Type F0low10
Meningitis, Hemophilus influenzae, Type B0low10
Meningoencephalitis0low30
Meningoencephalitis, Protozoal0low20
Meningotheliomatous Meningioma0low10
Meninigitis, HiB0low10
Menopause0medium248
Menorrhagia0low10
Menstrual Irregularities0medium95
Menstrual Irregularity0medium95
Menstruation Disorders0medium95
Menstruation Disturbances0medium95
Menstruation, Painful0medium31
Menstruation, Retrograde0medium95
Mental Deficiency0medium154
Mental Deterioration0medium143
Mental Disorders0medium154
Mental Disorders, Organic0medium32
Mental Disorders, Severe0medium154
Mental Illness0medium154
Mental Retardation0medium154
Mental Retardation, Psychosocial0medium154
Mental Retardation, X-Linked, Associated With Fragile Site Fraxe0low20
Mental Retardation, X-Linked, Associated With Marxq280low20
Menzel Type OPCA0low10
Merkel Cell Cancer0low60
Merkel Cell Carcinoma0low60
Merkel Cell Tumor0low60
Merkle Tumors0low60
MERS (Middle East Respiratory Syndrome)0low40
Mesencephalic Neoplasms0low40
Mesenteric Ischemia0low10
Mesenteric Vascular Insufficiency0low10
Mesenteric Vascular Occlusion0low10
Mesenteric Venous Thrombosis0low10
Mesothelioma0low50
Mesothelioma, Malignant0low40
Mesothelioma, Malignant Pleural0low40
Metabolic Acidosis0low60
Metabolic Bone Diseases0medium103
Metabolic Brain Diseases0low10
Metabolic Brain Diseases, Acquired0low10
Metabolic Brain Syndrome0low10
Metabolic Brain Syndrome, Acquired0low10
Metabolic Brain Syndromes0low10
Metabolic Brain Syndromes, Acquired0low10
Metabolic Cardiovascular Syndrome0medium195
Metabolic Diseases0low40
Metabolic Diseases, Acquired, Nervous System0low10
Metabolic Disorder, Central Nervous System, Acquired0low10
Metabolic Disorders, Brain0low10
Metabolic Disorders, Central Nervous System0low10
Metabolic Disorders, CNS0low10
Metabolic Disorders, CNS, Acquired0low10
Metabolic Encephalopathies0low10
Metabolic Ketoacidosis0low10
Metabolic Ketosis0low10
Metabolic Syndrome0medium195
Metabolic Syndrome X0medium195
Metabolic X Syndrome0medium195
Metabolism Errors, Inborn0low30
Metabolism, Inborn Errors0low30
Metachronous Neoplasms0medium125
Metachronous Second Primary Neoplasms0medium125
Metamorphopsia0low200
Metaplasia0medium42
Metastase0medium14029
Metastases, Neoplasm0medium14029
Metastasis0medium14029
Metastasis, Neoplasm0medium14029
Methemoglobinemia0low10
Metrorrhagia0low10
Microangiopathic Hemolytic Anemia0low10
Microangiopathy, Diabetic0medium101
Microbial Superinvasion0low30
Microcalcification0low40
Microcalcinosis0low40
Microcystic Meningioma0low10
Microcytemia, beta Type0medium15749
Microglandular Adenosis0low10
Micrometastases, Neoplasm0low10
Micrometastasis0low10
Micrometastasis, Neoplasm0low10
Micronuclei, Chromosome-Defective0low90
Micronuclei, Genotoxicant-Induced0low90
Micronucleus, Chromosome-Defective0low90
Microprolactinoma0low10
Micropsia0low200
Microspora Infections0low10
Microsporidia Infection0low10
Microsporidiosis0low10
Midbrain Neoplasms0low40
Midbrain Tumors0low40
Middle Brachial Plexus Neuropathy0low10
Middle Cerebral Artery Aneurysm0low20
Middle Cerebral Artery Circulation Infarction0low40
Middle Cerebral Artery Embolic Infarction0low40
Middle Cerebral Artery Embolus0low40
Middle Cerebral Artery Infarction0low40
Middle Cerebral Artery Occlusion0low40
Middle Cerebral Artery Stroke0low40
Middle Cerebral Artery Syndrome0low40
Middle Cerebral Artery Thrombosis0low40
Middle Cerebral Artery Thrombotic Infarction0low40
Middle Ear Effusion0low30
Middle Ear Inflammation0low40
Middle East Respiratory Syndrome0low40
Migraine0medium23878
Migraine Aura without Headache0low30
Migraine Disorders0medium23878
Migraine Headache0medium23878
Migraine Variant0medium23878
Migraine with Acute Onset Aura0low30
Migraine with Aura0low30
Migraine with Prolonged Aura0low30
Migraine with Typical Aura0low30
Migraine without Aura0medium42
Migraine, Classic0low30
Migraine, Common0medium42
Migraine, Prolonged Aura0low30
Mild Cognitive Impairment0medium143
Mild Neurocognitive Disorder0medium143
Milk Sugar Intolerance0medium11
Milk-Alkali Syndrome0low60
Milroy Disease0low10
Milroy's Disease0low10
Mimae Infections0low10
Mineralocorticoid Excess Syndrome, Apparent0low60
Minimal Brain Dysfunction0low20
Minimal Disease, Residual0low50
Minimal Residual Disease0low50
Miosis0medium22
Miosis, Persistent0medium22
Miscarriage0medium135
Mitochondrial Diseases0low10
Mitochondrial Disorders0low10
Mitochondrial Electron Transport Chain Deficiencies0low10
Mitochondrial Respiratory Chain Deficiencies0low10
Mitral Incompetence0low10
Mitral Insufficiency0low10
Mitral Regurgitation0low10
Mitral Valve Incompetence0low10
Mitral Valve Insufficiency0low10
Mitral Valve Regurgitation0low10
Mixed Cellularity Hodgkin's Lymphoma0medium61
Mixed Central and Obstructive Sleep Apnea0medium11
Mixed Glioma0low290
Mixed Infection0medium112
Mixed Small and Large Cell Lymphoma, Diffuse0medium205
Mixed Tumor, Malignant0low10
Mixed Tumor, Mullerian0medium21
Mixed-Cell Lymphoma0medium205
Mixed-Cell Lymphoma, Diffuse0medium205
Mixed-Cell Lymphoma, Follicular0low30
Mixed-Lineage Acute Leukemias0low10
MODS0low60
MODY0medium560179
Mongolism0low10
Moniliasis0medium41915
Moniliasis, Cutaneous0low40
Moniliasis, Oral0medium516
Moniliasis, Vulvovaginal0medium7421
Monkey Diseases0low10
Monoblastic Leukemia, Acute0low40
Monochromatopsia0medium11
Monoclonal Gammapathies0low10
Monoclonal Gammopathies0low10
Monoclonal Gammopathy0low10
Monocular Blindness, Transient0low10
Monocytic Leukemia, Acute0low40
Monocytic Leukemia, Chronic0medium381
Mononeuropathy, Diabetic0low30
Monoparesis0low10
Monosomy X0low10
Monosomy, Partial0low30
Mood Disorders0medium31
Moral Injury0medium178
Morbid Obesity0medium53
Morbilliform Drug Reaction0medium294
Morbilliform Exanthem0medium294
Morphea0low20
Morphine Abuse0low40
Morphine Addiction0low40
Morphine Dependence0low40
Motion Sickness0medium33
Motor Neuron Disease0low10
Motor Neuron Disease, Amyotrophic Lateral Sclerosis0medium41
Motor Neuron Disease, Familial0low10
Motor Neuron Disease, Lower0low10
Motor Neuron Disease, Secondary0low10
Motor Neuron Disease, Upper0low10
Motor System Disease0low10
Mouth Cancer0low90
Mouth Diseases0medium71
Mouth Dryness0low30
Mouth Neoplasms0low90
Movement Disorder Syndromes0low40
Movement Disorders0low40
MPNST0low10
MPTP Neurotoxicity Syndrome0low40
MPTP Poisoning0low40
MPTP-Induced Degeneration of the Striatum0low40
MPTP-Induced Experimental Parkinsonism0low240
MPTP-Induced Parkinsonism0low40
MS (Multiple Sclerosis)0medium91
Mucopolysaccharidosis 10low20
Mucopolysaccharidosis 50low20
Mucopolysaccharidosis I0low20
Mucopolysaccharidosis I-S0low20
Mucopolysaccharidosis Type I0low20
Mucopolysaccharidosis Type Ih0low20
Mucopolysaccharidosis Type Ih S0low20
Mucopolysaccharidosis Type Is0low20
Mucopolysaccharidosis V0low20
Mucorales Infection0medium2678
Mucorales Infections0medium2678
Mucormycoses0medium2678
Mucormycosis0medium2678
Mucositis0medium82
Mucositis, Oral0medium21
Mucoviscidosis0medium552
Multidirectional Nystagmus0low10
Multiple Abnormalities0low10
Multiple Chemical Sensitivities0low10
Multiple Chemical Sensitivity0low10
Multiple Chemical Sensitivity Syndrome0low10
Multiple Head Injuries0low10
Multiple Idiopathic Pigmented Hemangiosarcoma0low50
Multiple Injuries0low10
Multiple Motor and Vocal Tic Disorder, Combined0low10
Multiple Myeloma0medium8213
Multiple Organ Dysfunction Syndrome0low60
Multiple Organ Failure0low60
Multiple Primary Neoplasms0low70
Multiple Primary Neoplasms, Synchronous0low70
Multiple Pulmonary Nodules0low10
Multiple Sclerosis0medium91
Multiple Sclerosis, Acute Fulminating0medium91
Multiple Sclerosis, Acute Relapsing0low10
Multiple Sclerosis, Relapsing-Remitting0low10
Multiple System Tauopathy with Presenile Dementia0medium11
Multiple Trauma0low10
Muscle Cancer0low20
Muscle Contraction0low620
Muscle Diseases, Inflammatory0low20
Muscle Disorders0medium41
Muscle Dystonia0medium31
Muscle Flaccidity0low10
Muscle Hypotonia0low10
Muscle Neoplasms0low20
Muscle Pain0medium11
Muscle Paresis0low10
Muscle Relaxation0low260
Muscle Rigidity0low10
Muscle Soreness0medium11
Muscle Spasticity0low20
Muscle Tenderness0medium11
Muscle Tone Atonic0low10
Muscle Tone Poor0low10
Muscle Weakness0low30
Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis0low30
Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis0low30
Muscular Atrophy0low20
Muscular Atrophy, Peroneal0low10
Muscular Diseases0medium41
Muscular Dystrophy Pseudohypertrophic Progressive, Becker Type0low20
Muscular Dystrophy, Becker0low20
Muscular Dystrophy, Becker Type0low20
Muscular Dystrophy, Childhood, Pseudohypertrophic0low20
Muscular Dystrophy, Duchenne0low20
Muscular Dystrophy, Duchenne and Becker Types0low20
Muscular Dystrophy, Duchenne Type0low20
Muscular Dystrophy, Pseudohypertrophic0low20
Muscular Dystrophy, Pseudohypertrophic Progressive, Becker Type0low20
Muscular Dystrophy, Pseudohypertrophic Progressive, Duchenne Type0low20
Muscular Dystrophy, Pseudohypertrophic, Childhood0low20
Muscular Flaccidity0low10
Muscular Hypotonia0low10
Muscular Paresis0low10
Muscular Weakness0low30
Musculoskeletal Diseases0medium106
Musculoskeletal Pain0medium53
MuSK MG0low30
MuSK Myasthenia Gravis0low30
Myalgia0medium11
Myalgic Encephalomyelitis0medium21
Myasthenia Gravis0low30
Myasthenia Gravis, Generalized0low30
Myasthenia Gravis, Ocular0low30
Mycetoma0low800
Mycobacterium abscessus Infection0low30
Mycobacterium Infections0low10
Mycobacterium Infections, Atypical0low30
Mycobacterium Infections, Nontuberculous0low30
Mycobacterium tuberculosis Infection0medium231
Mycoplasma Infections0low10
Mycoplasma-Induced Stevens Johnson Syndrome0low40
Mycoplasma-Induced Stevens-Johnson Syndrome0low40
Mycoses0medium90367
Mycoses, Central Nervous System0medium531
Mycosis, Ocular0medium14812
Mycotic Aneurysm0low50
Mycotic Aneurysm, Intracranial0low20
Mycotic Infections, Ocular0medium14812
Mydriasis0medium42
Myelinosis Centralis Diffusa0low10
Myeloblastic Leukemia, Acute0medium23830
Myelocytic Leukemia0medium381
Myelocytic Leukemia, Acute0medium23830
Myelocytic Leukemia, Chronic0low200
Myelodysplastic Syndromes0medium13528
Myelodysplastic-Myeloproliferative Diseases0low10
Myelofibrosis0low80
Myelofibrosis With Myeloid Metaplasia0low80
Myelogenous Leukemia0medium381
Myelogenous Leukemia, Acute0medium23830
Myelogenous Leukemia, Chronic0low200
Myelogenous Leukemia, Ph1-Positive0low200
Myeloid Cell Tumor, Extramedullary0low10
Myeloid Leukemia0medium381
Myeloid Leukemia, Acute0medium23830
Myeloid Leukemia, Acute, M10medium23830
Myeloid Leukemia, Acute, M20medium23830
Myeloid Leukemia, Acute, M30low110
Myeloid Leukemia, Acute, M40low60
Myeloid Leukemia, Acute, M50low40
Myeloid Leukemia, Acute, M60low40
Myeloid Leukemia, Acute, M70low20
Myeloid Leukemia, Chronic0low200
Myeloid Leukemia, Naegeli-Type0low60
Myeloid Leukemia, Ph1-Positive0low200
Myeloid Leukemia, Philadelphia-Positive0low200
Myeloid Leukemia, Schilling-Type0low40
Myeloid Metaplasia0low80
Myeloid Sarcoma0low10
Myelolipoma0low10
Myeloma-Multiple0medium8213
Myeloma, Multiple0medium8213
Myeloma, Plasma-Cell0medium8213
Myelomatosis0medium8213
Myelomonocytic Leukemia, Acute0low60
Myelomonocytic Leukemia, Chronic0low10
Myelopathy, Compressive0low30
Myelopathy, Traumatic0low90
Myeloproliferative Disorders0low10
Myeloproliferative-Myelodisplastic Diseases0low10
Myelosclerosis0low80
Myelosis, Nonleukemic0low80
Myocardial Diseases0medium185
Myocardial Diseases, Primary0medium185
Myocardial Diseases, Secondary0medium185
Myocardial Failure0medium255
Myocardial Hibernation0low10
Myocardial Infarct0medium292
Myocardial Infarction0medium292
Myocardial Ischemia0medium231
Myocardial Ischemic Reperfusion Injury0low230
Myocardial Preinfarction Syndrome0medium11
Myocardial Remodeling, Ventricular0low90
Myocardial Reperfusion Injury0low230
Myocardial Stunning0low10
Myocardial Tumors (Rhabdomyomas and Fibromas)0low10
Myocardiopathies0medium185
Myocarditis0medium51
Myocarditis, Chagas0low40
Myoclonic Absence Epilepsy0low50
Myoclonic Astatic Epilepsy0low50
Myoclonic Encephalopathy0low50
Myoclonic Epilepsy0low50
Myoclonic Epilepsy, Adolescent0low10
Myoclonic Epilepsy, Benign Infantile0low50
Myoclonic Epilepsy, Early Childhood0low50
Myoclonic Epilepsy, Infantile0low50
Myoclonic Epilepsy, Infantile, Benign0low50
Myoclonic Epilepsy, Infantile, Severe0low50
Myoclonic Epilepsy, Juvenile0low10
Myoclonic Epilepsy, Juvenile, 10low10
Myoclonic Epilepsy, Severe Infantile0low50
Myoclonic Epilepsy, Severe, Of Infancy0low50
Myoclonic Jerk0low10
Myoclonic Jerking0low10
Myoclonic Seizure0medium1153
Myoclonic Seizure Disorder0low50
Myoclonic Seizures0medium1153
Myoclonus0low10
Myoclonus Simplex0low10
Myoclonus, Action0low10
Myoclonus, Benign Neonatal Sleep0low10
Myoclonus, Eyelid0low10
Myoclonus, Intention0low10
Myoclonus, Lower Extremity0low10
Myoclonus, Nocturnal0low10
Myoclonus, Oculopalatal0low10
Myoclonus, Palatal0low10
Myoclonus, Segmental0low10
Myoclonus, Sleep0low10
Myoclonus, Upper Extremity0low10
Myofascial Pain Syndrome, Diffuse0medium21
Myopathic Conditions0medium41
Myopathies0medium41
Myopathies, Idiopathic Inflammatory0low20
Myopathy, Inflammatory0low20
Myopia0low10
Myopia, Degenerative0low10
Myopia, Pathological0low10
Myopia, Progressive0low10
Myositis0low20
Myositis Ossificans0low10
Myositis Ossificans Progressiva0low10
Myositis, Focal0low20
Myositis, Infectious0low20
Myositis, Proliferative0low20
Myotonia0low10
Myotonia Atrophica0low10
Myotonia Dystrophica0low10
Myotonic Dystrophy0low10
Myotonic Dystrophy 10low10
Myotonic Dystrophy 20low10
Myotonic Dystrophy, Congenital0low10
Myotonic Myopathy, Proximal0low10
Myotonic Phenomenon0low10
Myxofibroma0low20
Myxoid Liposarcoma0low10
Myxoma, Spotty Pigmentation, and Endocrine Overactivity0low10
Naegleria fowleri Infection0low20
Naegleria fowleri Meningoencephalitis0low20
NAFLD0medium152
Nagana0low80
Nail Diseases0medium61
Nail Fungus0medium12631
NAME Syndrome0low10
Nanism0medium42
Narcissistic Personality Disorder0medium32
Narcolepsy0low20
Narcolepsy-Cataplexy Syndrome0low20
Narcoleptic Syndrome0low20
Narcosis0low10
Nasal Cancer0low10
Nasal Catarrh0low100
Nasal Diseases0low120
Nasal Disorders0low120
Nasal Neoplasms0low10
Nasal Polyps0low10
Nasopharyngeal Cancer0low50
Nasopharyngeal Carcinoma0low40
Nasopharyngeal Diseases0low10
Nasopharyngeal Neoplasms0low50
Nasopharyngitis0medium22
Nasopharynx Cancer0low50
Nasopharynx Neoplasms0low50
Natural Rubber Latex Allergy0low10
Nausea0medium3315
Near Drowning0low60
Near-Death Experience0low40
Near-Drowning0low60
Nearsightedness0low10
Neck Cancer0medium251
Neck Neoplasm0medium251
Neck Neoplasms0medium251
Necrosis0low540
Necrosis, Aseptic, of Bone0low10
Necrosis, Avascular, of Bone0low10
Necrotizing Enterocolitis0low30
Necrotizing Pancreatitis, Acute0low20
Necrotizing Pneumonia0low10
Necrotizing Pyelonephritis0low40
Necrotizing Scleritis0low60
Needle Stick0low10
Needle-Stick0low10
Needle-Stick Injuries0low10
Needle-Sticks0low10
Needlestick0low10
Needlestick Injuries0low10
Needlesticks0low10
Neglected Diseases0low50
Neisseria gonorrhoeae Infection0medium103
Neisseriaceae Infections0low10
Nelson Syndrome0low10
nemoci centru00E1lnu00EDho nervovu00E9ho systu00E9mu@cs0low120
Neointima0low30
Neointima Formation0low30
Neonatal De Toni-Debre-Fanconi Syndrome0medium161
Neonatal Diseases0low10
Neonatal Hypotonia0low10
Neonatal Sleep Myoclonus, Benign0low10
Neoplasia0medium31633
Neoplasm0medium31633
Neoplasm Circulating Cells0low20
Neoplasm Invasion0medium615
Neoplasm Invasiveness0medium615
Neoplasm Metastases0medium14029
Neoplasm Metastasis0medium14029
Neoplasm Micrometastases0low10
Neoplasm Micrometastasis0low10
Neoplasm Recurrence, Local0medium21158
Neoplasm Recurrence, Locoregional0medium21158
Neoplasm Recurrences, Local0medium21158
Neoplasm-Associated Pain0medium42
Neoplasm-Related Pain0medium42
Neoplasm, Benign, Optic Nerve0low10
Neoplasm, Optic Nerve, Benign0low10
Neoplasm, Residual0low50
Neoplasms0medium31633
Neoplasms of Pelvis0low30
Neoplasms, Adrenal Cortex0low10
Neoplasms, Adrenal Gland0low50
Neoplasms, Anal0low10
Neoplasms, Anus0low10
Neoplasms, Basal Cell0low10
Neoplasms, Benign0medium31633
Neoplasms, Bile Duct0medium61
Neoplasms, Biliary Tract0low20
Neoplasms, Bladder0low100
Neoplasms, Bone0medium483
Neoplasms, Brain0medium484
Neoplasms, Brain Stem0low40
Neoplasms, Brain, Benign0medium484
Neoplasms, Brain, Malignant0medium484
Neoplasms, Brain, Primary0medium484
Neoplasms, Brainstem0low40
Neoplasms, Brainstem, Primary0low40
Neoplasms, Breast0medium1,790464
Neoplasms, Breast, Male0medium142
Neoplasms, Bronchial0low20
Neoplasms, Cardiac0low10
Neoplasms, Central Nervous System0low20
Neoplasms, Cerebellar0low80
Neoplasms, Cerebellar, Benign0low80
Neoplasms, Cerebellar, Malignant0low80
Neoplasms, Cerebellar, Primary0low80
Neoplasms, Cerebral Ventricle0low10
Neoplasms, Cerebroventricular0low10
Neoplasms, Cervical0medium123
Neoplasms, Cervix0medium123
Neoplasms, Colonic0medium382
Neoplasms, Colorectal0medium495
Neoplasms, Cystic, Mucinous, and Serous0low20
Neoplasms, Embryonal0low30
Neoplasms, Embryonal and Mixed0low30
Neoplasms, Endocrine Gland0low10
Neoplasms, Endometrial0medium556
Neoplasms, Epithelial0medium92
Neoplasms, Esophageal0medium152
Neoplasms, Experimental0low690
Neoplasms, Experimental Liver0medium211
Neoplasms, Experimental Mammary0low480
Neoplasms, Female Genital0medium32
Neoplasms, Gallbladder0low10
Neoplasms, Gastric0medium492
Neoplasms, Gastrointestinal0medium51
Neoplasms, Germ Cell0low30
Neoplasms, Germ Cell and Embryonal0low30
Neoplasms, Germ Cell and Embryonic0low30
Neoplasms, Glandular0medium92
Neoplasms, Glandular and Epithelial0medium92
Neoplasms, Glandular Epithelial0medium92
Neoplasms, Gynecologic0medium32
Neoplasms, Head0medium251
Neoplasms, Head and Neck0medium251
Neoplasms, Heart0low10
Neoplasms, Hematologic0medium14617
Neoplasms, Hematopoietic0medium14617
Neoplasms, Hepatic0medium815
Neoplasms, Hormone-Dependent0medium19447
Neoplasms, Intracranial0medium484
Neoplasms, Intraepithelial0medium62
Neoplasms, Intraventricular0low10
Neoplasms, Kidney0medium182
Neoplasms, Laryngeal0low10
Neoplasms, Leptomeningeal0low20
Neoplasms, Liver0medium815
Neoplasms, Lung0medium17213
Neoplasms, Male Breast0medium142
Neoplasms, Malignant Epithelial0medium517
Neoplasms, Mammary0low130
Neoplasms, Maxillary Sinus0low10
Neoplasms, Mediastinal0low20
Neoplasms, Medullary0low40
Neoplasms, Meningeal0low20
Neoplasms, Mesencephalic0low40
Neoplasms, Metachronous0medium125
Neoplasms, Metachronous Second Primary0medium125
Neoplasms, Midbrain0low40
Neoplasms, Mouth0low90
Neoplasms, Multiple Primary0low70
Neoplasms, Muscle0low20
Neoplasms, Nasopharyngeal0low50
Neoplasms, Neck0medium251
Neoplasms, Nerve Sheath0low20
Neoplasms, Nose0low10
Neoplasms, Optic Nerve0low10
Neoplasms, Oral0low90
Neoplasms, Oropharyngeal0medium21
Neoplasms, Ovarian0medium8112
Neoplasms, Pancreatic0medium495
Neoplasms, Parotid0low20
Neoplasms, Pleural0low50
Neoplasms, Pontine0low40
Neoplasms, Prostate0medium726
Neoplasms, Prostatic0medium726
Neoplasms, Pulmonary0medium17213
Neoplasms, Radiation-Induced0low60
Neoplasms, Rectal0medium73
Neoplasms, Retinal0low30
Neoplasms, Salivary Gland0low40
Neoplasms, Second Primary0medium125
Neoplasms, Skin0medium562
Neoplasms, Spinal Cord0low20
Neoplasms, Splenic0low10
Neoplasms, Squamous Cell0low10
Neoplasms, Stomach0medium492
Neoplasms, Synchronous0low70
Neoplasms, Synchronous Multiple Primary0low70
Neoplasms, Testicular0low60
Neoplasms, Testis0low60
Neoplasms, Therapy-Associated0medium125
Neoplasms, Therapy-Related0medium125
Neoplasms, Thymic0low20
Neoplasms, Thymus0low20
Neoplasms, Thyroid0medium261
Neoplasms, Tongue0low10
Neoplasms, Treatment-Associated0medium125
Neoplasms, Treatment-Related0medium125
Neoplasms, Upper Aerodigestive Tract0medium251
Neoplasms, Uterine0medium367
Neoplasms, Uterus0medium367
Neoplasms, Ventricular, Brain0low10
Neoplasms, Vulvar0low20
Neoplastic Cell Transformation0low320
Neoplastic Cells, Circulating0low20
Neoplastic Transformation, Cell0low320
Neovascularization, Choroid0low30
Neovascularization, Choroidal0low30
Neovascularization, Optic Disc0low40
Neovascularization, Pathologic0medium472
Neovascularization, Pathological0medium472
Neovascularization, Retinal0low40
Nephritis0low40
Nephritis, Interstitial0low40
Nephritis, Lupus0low60
Nephritis, Tubulointerstitial0low40
Nephrogenic Diabetes Insipidus0low10
Nephrogenic Diabetes Insipidus, Type I0low10
Nephrogenic Diabetes Insipidus, Type II0low10
Nephroid Carcinoma0medium142
Nephrolithiasis0low30
Nephropathia Epidemica0low20
Nephropathy, Membranous0medium21
Nephrosis0low30
Nephrotic Syndrome0low20
Nerve Degeneration0low80
Nerve Pain0low180
Nerve Sheath Neoplasm0low20
Nerve Sheath Neoplasms0low20
Nerve Sheath Tumor0low20
Nerve Sheath Tumors0low20
Nerve Sheath Tumors, Peripheral0low20
Nervous System Abnormalities0low10
Nervous System Acquired Metabolic Diseases0low10
Nervous System Anomalies0low10
Nervous System Congenital Abnormalities0low10
Nervous System Congenital Malformations0low10
Nervous System Degenerative Diseases0medium231
Nervous System Diseases0medium82
Nervous System Diseases, Autonomic0medium42
Nervous System Diseases, Parasympathetic0medium42
Nervous System Diseases, Sympathetic0medium42
Nervous System Disorders0medium82
Nervous System Invasive Aspergillosis0low410
Nervous System Malformations0low10
Nervous System Malformations, Congenital0low10
Nervous System Poisoning0low130
Nervus Cranialis Disorders0low20
Neural Tube Defects0low10
Neural Tube Developmental Defects0low10
Neural-Optical Lesion0low10
Neuralgia0low180
Neuralgia, Atypical0low180
Neuralgia, Diabetic0low30
Neuralgia, Iliohypogastric Nerve0low180
Neuralgia, Ilioinguinal0low180
Neuralgia, Perineal0low180
Neuralgia, Sciatic0low10
Neuralgia, Stump0low180
Neuralgia, Supraorbital0low180
Neuralgia, Vidian0low180
Neuralgic Migraine0low30
Neurally Mediated Faint0low10
Neurenteric Cyst0low10
Neurilemmosarcoma0low10
Neuritic Plaques0low50
Neuroaspergillosis0low410
Neuroblastoma0medium361
Neuroblastoma, Retinal0low20
Neurocognitive Disorders0medium32
Neurodegenerative Diseases0medium231
Neurodegenerative Disorders0medium231
Neurodermatitis, Atopic0low10
Neurodermatitis, Disseminated0low10
Neurodynia0low180
Neuroectodermal Neoplasm, Peripheral Primitive0low10
Neuroectodermal Tumor, Peripheral0low10
Neuroectodermal Tumor, Peripheral Primitive0low10
Neuroectodermal Tumors, Primitive, Peripheral0low10
Neuroendocrine Tumors0low50
Neuroenteric Cyst0low10
Neuroepithelioma, Peripheral0low10
Neurofibrosarcoma0low10
Neurogenic Bladder0low10
Neurogenic Bladder Disorder0low10
Neurogenic Bladder, Atonic0low10
Neurogenic Bladder, Spastic0low10
Neurogenic Bladder, Uninhibited0low10
Neurogenic Communication Disorders0medium11
Neurogenic Dysfunction of the Urinary Bladder0low10
Neurogenic Hoarseness0medium11
Neurogenic Inflammation0low10
Neurogenic Muscular Atrophy0low20
Neurogenic Urinary Bladder Disorder0low10
Neurogenic Urinary Bladder, Atonic0low10
Neurogenic Urinary Bladder, Spastic0low10
Neurogenic Urinary Bladder, Uninhibited0low10
Neurohypophyseal Diseases0low10
Neuroleptic Malignant Syndrome0low10
Neuroleptic-Induced Neuroleptic Malignant Syndrome0low10
Neuroleptic-Malignant Syndrome, Neuroleptic Induced0low10
Neurologic Adducter Spastic Dysphonia0low10
Neurologic Ambulation Disorders0low30
Neurologic Degenerative Conditions0medium231
Neurologic Degenerative Diseases0medium231
Neurologic Diseases, Degenerative0medium231
Neurologic Disorders0medium82
Neurologic Locomotion Disorders0low30
Neurological Disorders0medium82
Neuromuscular Diseases0low20
Neuromyelitis Optica0low10
Neuromyelitis Optica (NMO) Spectrum Disorder0low10
Neuromyelitis Optica (NMO) Spectrum Disorders0low10
Neuromyelitis Optica Spectrum Disorder0low10
Neuromyelitis Optica Spectrum Disorders0low10
Neuron Degeneration0low80
Neuronal Migration Disorders0low10
Neuronopathic Gaucher Disease0low40
Neuropathic Bladder0low10
Neuropathic Pain0low180
Neuropathies, Cranial0low20
Neuropathy, Alcoholic0low10
Neuropathy, Type I Hereditary Motor and Sensory0low10
Neuropathy, Type II Hereditary Motor and Sensory0low10
Neuroses0medium11
Neuroses, Anxiety0medium2411
Neuroses, Phobic0medium83
Neuroses, Post-Traumatic0medium178
Neuroses, Posttraumatic0medium178
Neuroses, War0medium108
Neurosis, Depressive0medium15846
Neurosis, Obsessive-Compulsive0medium62
Neurosyphilis0low20
Neurosyphilis, Asymptomatic0low20
Neurosyphilis, Gummatous0low20
Neurosyphilis, Juvenile0low20
Neurosyphilis, Secondary0low20
Neurosyphilis, Symptomatic0low20
Neurotic Depression, Persistent Depressive Disorder0medium74
Neurotic Disorders0medium11
Neurotoxic Disorders0low130
Neurotoxicity Syndrome, MPTP0low40
Neurotoxicity Syndromes0low130
Neurotoxin Diseases0low130
Neurotoxin Disorders0low130
Neurotoxoplasmosis0low10
Neurotrophic Muscular Atrophy0low20
Neurovisceral Storage Disease with Vertical Supranuclear Ophthalmoplegia0low20
Neutropenia0medium16523
Nevi, Atrial Myxoma, Skin Myxoma, Ephelides Syndrome0low10
Newborn Gynecomastia0medium175
Nicotine Addiction0low20
Nicotine Dependence0low20
Nicotine Use Disorder0low20
NIDDM0medium560179
Niemann-Pick Disease Type C0low20
Niemann-Pick Disease Type D0low20
Niemann-Pick Disease with Cholesterol Esterification Block0low20
Niemann-Pick Disease without Sphingomyelinase Deficiency0low20
Niemann-Pick Disease, Chronic Neuronopathic Form0low20
Niemann-Pick Disease, Nova Scotian0low20
Niemann-Pick disease, Subacute Juvenile Form0low20
Niemann-Pick Disease, Type C0low20
Niemann-Pick Disease, Type C10low20
Niemann-Pick Disease, Type D0low20
Niemann-Pick Type C Disease0low20
Niemann-Pick Type D Disease0low20
Niemann-Pick's Disease Type C0low20
Niemann-Pick's Disease Type D0low20
Nighttime Urinary Incontinence0low10
NMO Spectrum Disorder0low10
NMS (Neuroleptic Malignant Syndrome)0low10
Nocardia asteroides Infection0low10
Nocardia Infections0low10
Nocardiosis0low10
Nociceptive Pain0low40
Nocturnal Enuresis0low10
Nocturnal Wandering0low10
Nodding Spasm0medium144
Nodular Elastoidosis0low40
Nodular Elastosis0low40
Nodular Glomerulosclerosis0medium235
Nodular Goiter0medium11
Nodular Large Follicular Center-Cell Lymphoma0low30
Nodular Lymphocyte-Predominant Hodgkin's Lymphoma0medium61
Nodular Sclerosing Hodgkin's Lymphoma0medium61
Nodule, Solitary Pulmonary0low20
Nodules, Solitary Pulmonary0low20
Non-24 Hour Sleep-Wake Disorder0medium41
Non-alcoholic Fatty Liver Disease0medium152
Non-Convulsive Status Epilepticus0low50
Non-Disjunction, Genetic0low10
Non-Epileptic Seizure0medium1153
Non-Epileptic Seizures0medium1153
Non-Fatigable Positional Nystagmus0low10
Non-Hodgkin Lymphoma0medium205
Non-Hodgkin's Lymphoma0medium205
Non-Neuronopathic Gaucher Disease0low40
Non-Phenylketonuric Hyperphenylalaninemia0low10
Non-Small Cell Lung Cancer0medium687
Non-Small Cell Lung Carcinoma0medium687
Non-Small-Cell Lung Carcinoma0medium687
Nonalcoholic Fatty Liver Disease0medium152
Nonalcoholic Steatohepatitis0medium152
Nonconvulsive Generalized Seizure Disorder0medium71
Nonconvulsive Seizure Disorder, Generalized0medium71
Nondisjunction, Genetic0low10
Nonepileptic Seizure0medium1153
Nonepileptic Seizures0medium1153
Noninsulin-Dependent Diabetes Mellitus0medium560179
Nonlymphoblastic Leukemia, Acute0medium23830
Nonlymphocytic Leukemia, Acute0medium23830
Nonmedullary Thyroid Carcinoma0low10
Nonne-Milroy Disease0low10
Nonne-Milroy Lymphedema0low10
Nonne-Milroy-Meige Disease0low10
Nonocclusive Mesenteric Ischemia0low10
Nonorganic Insomnia0medium12341
Nonorganic Sleep Wake Cycle Disorder0medium41
Nonorganic Sleep Wake Cycle Disorders0medium41
Nonpsychotic Organic Brain Syndrome0medium32
Nonsmall Cell Lung Cancer0medium687
Nonstaphylococcal Scalded Skin Syndrome0low40
Nonsustained Ventricular Tachycardia0low50
Nose Cancer0low10
Nose Diseases0low120
Nose Neoplasms0low10
Nosocomial Infections0medium361
Nova Scotia (Type D) Form of Niemann-Pick Disease0low20
Nova Scotia Niemann-Pick Disease (Type D)0low20
Nuchal Rigidity0low10
Numbness0low20
Nutritional Deficiency0medium11
Nystagmus, Pathologic0low10
Oat Cell Carcinoma0low50
Oat Cell Carcinoma of Lung0low120
Oat Cell Lung Cancer0low120
Obesity0medium9617
Obesity, Morbid0medium53
Obesity, Severe0medium53
Obsessive-Compulsive Disorder0medium62
Obstetric Labor, Premature0low20
Obstructive Hydrocephalus0low10
Obstructive Lung Diseases0medium41
Obstructive Pulmonary Diseases0medium41
Obstructive Sleep Apnea0medium52
Obstructive Sleep Apnea Syndrome0medium52
Occipital Lobe Epilepsy0medium125
Occipital Region Trauma0low10
Occipital Trauma0low10
Occlusion, Middle Cerebral Artery0low40
Occlusive Mesenteric Arterial Ischemia0low10
Occult Spinal Dysraphism0low10
Occult Spinal Dysraphism Sequence0low10
Occupational Dermatitis0low90
Occupational Diseases0medium61
Occupational Illnesses0medium61
Ocular Headache0medium3719
Ocular Herpes Simplex0low20
Ocular Hypertension0medium21
Ocular Infections, Bacterial0low40
Ocular Infections, Fungal0medium14812
Ocular Infections, Parasitic0low20
Ocular Infections, Viral0low10
Ocular Motility Disorders0low20
Ocular Torticollis0low20
Oculomotor Paralysis0low50
Oculomycosis0medium14812
Oesophageal Squamous Cell Carcinoma0low130
Olfactory Agnosia0low10
Olfactory Groove Meningioma0low10
Oligoarthritis, Juvenile0low20
Oligoasthenoteratozoospermia0low20
Oligoastrocytoma, Mixed0low30
Oligomenorrhea0low10
Oligophrenia Phenylpyruvica0low10
Oligospermia0low20
Oligozoospermia0low20
Olivopontocerebellar Atrophy 20low10
Olivopontocerebellar Atrophy I0low10
Olivopontocerebellar Atrophy II0low10
Olivopontocerebellar Atrophy III0low10
Olivopontocerebellar Atrophy IV0low10
Olivopontocerebellar Atrophy, Holguin Type0low10
Omenn Syndrome0low10
Omenn's Syndrome0low10
Oncogenesis0medium171
Oncological Pain0medium42
Oncology Pain0medium42
Onychomycosis0medium12631
OPCA with Macular Degeneration and External Ophthalmoplegia0low10
OPCA with Retinal Degeneration0low10
Open Head Injury0low10
Open-Angle Glaucoma0medium43
Ophthalmia0medium671
Ophthalmoparesis0low50
Ophthalmoplegia0low50
Opiate Abuse0medium63
Opiate Addiction0medium63
Opiate Dependence0medium63
Opioid Abuse0medium63
Opioid Addiction0medium63
Opioid Dependence0medium63
Opioid Misuse0medium63
Opioid Use Disorder0medium63
Opioid-Related Disorders0medium63
Oppenheim Disease0low20
Oppenheim's Disease0low20
Opportunistic Infections0medium1377
Opportunistic Infections, AIDS-Related0medium565
Opportunistic Infections, HIV-Related0medium565
Oppositional Defiant Disorder0low10
Opsoclonus0low20
Optic Disc Disorders0low10
Optic Disc Edema0low10
Optic Disc Neovascularization0low40
Optic Disk Disorders0low10
Optic Disk Edema0low10
Optic Disk Neovascularization0low40
Optic Nerve Diseases0low10
Optic Nerve Neoplasm, Benign0low10
Optic Nerve Neoplasms0low10
Optic Nerve Papillitis0low10
Optic Nerve Sheath Neoplasm0low10
Optic Nerve Sheath Neoplasms, Malignant0low10
Optic Nerve Sheath Tumors0low10
Optic Nerve Sheath Tumors, Benign0low10
Optic Nerve Sheath Tumors, Malignant0low10
Optic Nerve Tumor, Malignant0low10
Optic Neuropathy0low10
Optic Papilla Edema0low10
Oral Cancer0low90
Oral Cavity Squamous Cell Carcinoma0low130
Oral Dyskinesia0low20
Oral Mucositis0medium21
Oral Neoplasms0low90
Oral Squamous Cell Carcinoma0low130
Oral Squamous Cell Carcinomas0low130
Oral Tongue Squamous Cell Carcinoma0low130
Oral-Facial Dyskinesia0low20
Orbital Cellulitis0low20
Orbital Diseases0low220
Orbital Fracture0low20
Orbital Fractures0low20
Orbital Neoplasms0low10
Oregon Type Tyrosinemia0low10
Organ Dysfunction Syndrome, Multiple0low60
Organ Failure, Multiple0low60
Organic Brain Syndrome, Nonpsychotic0medium32
Organic Mental Disorders0medium32
Organic Mental Disorders, Psychotic0medium32
Organic Mental Disorders, Substance-Induced0medium153
Organic Tremor Dysphonia0low10
Organophosphate Poisoning0low40
Organophosphorus Poisoning0low40
Organothiophosphate Poisoning0low40
Organothiophosphonate Poisoning0low40
Orgasmic Disorder0medium133
Oriental Sore0low60
Orofacial Dyskinesia0low20
Oromucositis0medium21
Oropharyngeal Cancer0medium21
Oropharyngeal Dysphagia0low10
Oropharyngeal Neoplasms0medium21
Oropharyngeal Squamous Cell Carcinoma0low130
Oropharynx Cancer0medium21
Oropharynx Neoplasms0medium21
Orphan Diseases0low60
Orthomyxoviridae Infections0low80
Orthomyxovirus Infections0low80
Orthopedic Disorders0medium106
Orthostasis0medium124
Orthostatic Headache0medium3719
Orthostatic Hypotension0low10
OSAHS0medium52
Ossification, Ectopic0low10
Ossification, Heterotopic0low10
Ossification, Pathologic0low10
Ossification, Pathological0low10
Osteitis0medium21
Osteoarthritis0low80
Osteoarthritis of Knee0low10
Osteoarthritis of the Knee0low10
Osteoarthritis, Knee0low10
Osteoarthrosis0low80
Osteoarthrosis Deformans0low80
Osteoclastic Bone Loss0medium2511
Osteogenic Sarcoma0medium181
Osteolysis0low30
Osteomalacia0low10
Osteomyelitis0medium341
Osteonecrosis0low10
Osteonecrosis of the Jaw, Bisphosphonate-Associated0low10
Osteonecrosis of the Jaw, Bisphosphonate-Induced0low10
Osteonecrosis of the Jaw, Bisphosphonate-Related0low10
Osteonecrosis of the Jaws, Bisphosphonate-Associated0low10
Osteonecrosis of the Jaws, Bisphosphonate-Induced0low10
Osteonecrosis of the Jaws, Bisphosphonate-Related0low10
Osteopenia0medium103
Osteoporosis0medium337
Osteoporosis, Age-Related0medium337
Osteoporosis, Involutional0medium337
Osteoporosis, Post-Menopausal0medium3219
Osteoporosis, Post-Traumatic0medium337
Osteoporosis, Postmenopausal0medium3219
Osteoporosis, Senile0medium337
Osteoporotic Fractures0medium21
Osteosarcoma0medium181
Osteosarcoma Tumor0medium181
Otalgia0low10
Otitis0low10
Otitis Externa0low20
Otitis Media0low40
Otitis Media with Effusion0low30
Otitis Media, Purulent0low20
Otitis Media, Secretory0low30
Otitis Media, Serous0low30
Otitis Media, Suppurative0low20
Otologic Diseases0low20
Otological Diseases0low20
Outflow Obstruction, Left Ventricular0low10
Outflow Obstruction, Right Ventricular0low10
Outlet Impingement0low10
Outlet Impingement Syndrome0low10
Ovarian Cancer0medium8112
Ovarian Cancer, Epithelial0medium81
Ovarian Cysts0medium52
Ovarian Diseases0low30
Ovarian Epithelial Cancer0medium81
Ovarian Epithelial Carcinoma0medium81
Ovarian Failure, Premature0medium31
Ovarian Hyperstimulation Syndrome0medium228
Ovarian Hyperstimulation Syndrome, Familial Gestational Spontaneous0medium228
Ovarian Neoplasms0medium8112
Ovary Cancer0medium8112
Ovary Neoplasms0medium8112
Overactive Bladder0low30
Overactive Detrusor0low30
Overactive Detrusor Function0low30
Overactive Urinary Bladder0low30
Overeating0low10
Overinclusion0medium273
Overweight0medium83
Ovine Diseases0low20
Ovotesticular Disorder Of Sex Development0low10
Ovotesticular Disorders of Sex Development0low10
Ovotesticular DSD0low10
Oxaluria, Primary0low10
Oxidative Phosphorylation Deficiencies0low10
Oxygen Deficiency0medium681
P carinii Pneumonia0low10
P. carinii Pneumonia0low10
P. jirovecii Pneumonia0low10
P388D(1) Leukemia0low60
Pachymeningitis0low220
Pachymeningitis, Fungal0medium291
PAH Deficiency0low10
Pain0medium8117
Pain Disorder0medium21
Pain Syndrome Type I, Complex Regional0low20
Pain Syndrome Type I, Regional, Complex0low20
Pain, Burning0medium8117
Pain, Chronic0low80
Pain, Crushing0medium8117
Pain, Menstrual0medium31
Pain, Migratory0medium8117
Pain, Post-operative0low30
Pain, Postoperative0low30
Pain, Radiating0medium8117
Pain, Splitting0medium8117
Palmoplantaris Pustulosis0medium156
Palsy0low30
Paludism0low180
Panayiotopoulos Syndrome0medium125
Pancreas Cancer0medium495
Pancreas Neoplasms0medium495
Pancreatic Cancer0medium495
Pancreatic Cystic Fibrosis0medium552
Pancreatic Diseases0low10
Pancreatic Duct Cell Carcinoma0medium142
Pancreatic Ductal Carcinoma0medium142
Pancreatic Necrosis0low20
Pancreatic Neoplasms0medium495
Pancreatic Parenchyma with Edema0low420
Pancreatic Parenchymal Edema0low420
Pancreatitis0low420
Pancreatitis Necrotising0low20
Pancreatitis Necrotizing0low20
Pancreatitis, Acute0low420
Pancreatitis, Acute Edematous0low420
Pancreatitis, Acute Necrotizing0low20
Pancytopenia0low40
Panic Attacks0medium104
Panic Disorder0medium104
Panophthalmitis0low10
Papillary Carcinoma Of Thyroid0low10
Papillary Ependymoma0low20
Papillary Meningioma0low10
Papillary Renal Cell Carcinoma0medium142
Papillary Thyroid Carcinoma0low10
Papilledema0low10
Papilledema Associated with Decreased Intraocular Pressure0low10
Papilledema Associated with Increased Intracranial Pressure0low10
Papillitis0low10
Papillitis, Optic0low10
Papilloma0low10
Papilloma, Shope0low20
Papilloma, Squamous Cell0low10
Papillomatosis0low10
Papulosquamous Disorders0low10
Papulosquamous Skin Diseases0low10
Paracoccidioidal Granuloma0medium73
Paracoccidioides brasiliensis Infection0medium73
Paracoccidioides Infection0medium73
Paracoccidioides Infections0medium73
Paracoccidioidomycoses0medium73
Paracoccidioidomycosis0medium73
Paracousis0low10
Paracusis0low10
Paraimmunoglobulinemias0low10
Parainfluenza0low20
Parainfluenza Virus Infections0low20
Paralysis0low30
Paralysis Agitans0medium438
Paralysis of the Lower Brachial Plexus0low10
Paralysis, General0low20
Paralysis, Legs0low10
Paralysis, Lower Extremities0low10
Paralysis, Lower Limbs0low10
Paralysis, Respiratory Muscle0low10
Paralysis, Spinal, Quadriplegic0low10
Paralytic Ileus0low10
Paramyxoviridae Infections0low20
Paranasal Sinus Diseases0low150
Paraneoplastic Syndromes0low30
Paranoid Schizophrenia0low10
Paraphilias0medium11
Paraphilic Disorders0medium11
Paraphrenia, Involutional0medium5134
Paraplegia0low10
Paraplegia, Ataxic0low10
Paraplegia, Cerebral0low10
Paraplegia, Flaccid0low10
Paraplegia, Spastic0low10
Paraplegia, Spinal0low10
Paraproteinemias0low10
Parasagittal Meningioma0low10
Parasite Infections0low30
Parasitemia0medium133
Parasitic Diseases0low30
Parasitic Eye Infections0low20
Parasitic Infections0low30
Parasitic Skin Diseases0low20
Parasomnias0low10
Parasympathetic Nervous System Diseases0medium42
Parenterally-Transmitted Non-A, Non-B Hepatitis0medium204
Paresis0low10
Paresthesia0low30
Paresthesia, Distal0low30
Paresthesia, Painful0low30
Paretic Neurosyphilis0low20
Parietal Region Trauma0low10
Parinaud Syndrome0low20
Parinaud's Syndrome0low20
Parkinson Disease0medium438
Parkinson Disease 20low240
Parkinson Disease 2, Autosomal Recessive Juvenile0low240
Parkinson Disease Autosomal Recessive, Early Onset0low240
Parkinson Disease, Autosomal Dominant. Juvenile0low240
Parkinson Disease, Experimental0low240
Parkinson Disease, Familial, Autosomal Recessive0low240
Parkinson Disease, Idiopathic0medium438
Parkinson Disease, Juvenile0low240
Parkinson Disease, Juvenile, Autosomal Dominant0low240
Parkinson Disease, Juvenile, Autosomal Recessive0low240
Parkinson Disease, Secondary0low70
Parkinson Disease, Secondary Vascular0low70
Parkinson Disease, Symptomatic0low70
Parkinson's Disease0medium438
Parkinson's Disease, Idiopathic0medium438
Parkinson's Disease, Lewy Body0medium438
Parkinsonian Diseases0low240
Parkinsonian Disorders0low240
Parkinsonian Syndrome0low240
Parkinsonian Syndromes0low240
Parkinsonism0low240
Parkinsonism, Early Onset, with Diurnal Fluctuation0low240
Parkinsonism, Early-Onset, With Diurnal Fluctuation0low240
Parkinsonism, Experimental0low240
Parkinsonism, Juvenile0low240
Parkinsonism, Juvenile, Autosomal Dominant0low240
Parkinsonism, Juvenile, Autosomal Recessive0low240
Parkinsonism, Secondary0low70
Parkinsonism, Symptomatic0low70
Parotid Cancer0low20
Parotid Neoplasms0low20
Paroxysmal Atrial Fibrillation0low100
Paroxysmal Dyskinesias0low10
Paroxysmal Nerve Pain0low180
Paroxysmal Ocular Dyskinesia0low20
Paroxysmal Sleep0low20
Paroxysmal Supraventricular Tachycardia0low50
Partial Complex Epilepsy, Cryptogenic0low10
Partial Complex Epilepsy, Symptomatic0low10
Partial Epilepsy0medium125
Partial Monosomy0low30
Partial Seizure0medium1153
Partial Seizure Disorder0medium125
Partial Seizures0medium1153
Partial Seizures, Simple, Consciousness Preserved0medium125
Partial Trisomy0low10
Partial Trisomy 21 Down Syndrome0low10
Passive Hyperemia0medium153
Passive Tremor0low50
Pasteurellosis, Pneumonic0low10
Pathologic Angiogenesis0medium472
Pathologic Calcification0low40
Pathologic Constriction0low20
Pathologic Neovascularization0medium472
Pathologic Ossification0low10
Pathological Fracture0low10
Pathological Fractures0low10
Pathological Gambling0medium42
Pattern Baldness0medium51
PBGD Deficiency0low30
PCP Infection0low10
PCP Pneumonia0low10
Pediatric Respiratory Distress Syndrome0low110
Pelvic Cancer0low30
Pelvic Neoplasms0low30
Pelvic Pain0medium126
Pelvis Cancer0low30
Pelvis Neoplasms0low30
Pemphigoid0low10
Pemphigoid, Bullous0low10
Pemphigus0low10
Pemphigus Foliaceus0low10
Pemphigus Vulgaris0low10
Pendular Nystagmus0low10
Penetrating Eye Injuries0low40
Peptic Ulcer0low30
Perceptual Disorders0low40
Percussion Myotonia0low10
Pericardial Tamponade0low10
Pericarditis0low20
Pericementitis0low30
Perimenopausal Bone Loss0medium3219
Perinatal Subarachnoid Hemorrhage0low20
Perineurioma0low20
Periodic Alternating Nystagmus0low10
Periodontal Bone Loss0low10
Periodontal Pocket0low10
Periodontal Resorption0low10
Periodontitis0low30
Periorbital Headache0medium3719
Periorificial Lentiginosis Syndrome0low60
Periostitis0low170
Peripancreatic Fat Necrosis0low420
Peripheral Angiopathies0low20
Peripheral Arterial Disease0low20
Peripheral Arterial Diseases0low20
Peripheral Artery Disease0low20
Peripheral Autonomic Nervous System Diseases0medium42
Peripheral Nerve Diseases0medium121
Peripheral Nerve Injuries0low40
Peripheral Nerve Injury0low40
Peripheral Nerve Sheath Tumor0low20
Peripheral Nerve Sheath Tumors0low20
Peripheral Nerve Sheath Tumors, Malignant0low10
Peripheral Nervous System Disease0medium121
Peripheral Nervous System Diseases0medium121
Peripheral Nervous System Disorders0medium121
Peripheral Neuropathies0medium121
Peripheral Neuropathy, Alcohol-Induced0low10
Peripheral Primitive Neuroectodermal Neoplasm0low10
Peripheral Primitive Neuroectodermal Tumor0low10
Peripheral Primitive Neuroectodermal Tumors0low10
Peripheral T-Cell Lymphoma0low10
Peripheral Vascular Diseases0low20
Periphlebitis0low10
Peritoneal Carcinomatosis0medium122
Peritoneal Diseases0low60
Peritoneal Neoplasms0medium122
Peritoneal Surface Malignancy0medium122
Peritonitis0low230
Peritonitis, Chylous0low10
Permanent Nystagmus0low10
Peroneal Muscular Atrophy0low10
Peroperative Complications0low10
Persistent Atrial Fibrillation0low100
Persistent Depressive Disorder, Dysthymia0medium74
Persistent Postsurgical Pain0low30
Persistent Tremor0low50
Personality Disorders0medium32
Pervasive Child Development Disorders0low10
Pervasive Development Disorders0low10
Pes Anserine Bursitis0low10
Petit Mal Convulsion0medium1153
Petit Mal Epilepsy0medium81
Petit Mal Status0low50
Petit Mal, Impulsive0low10
Petit Mal, Impulsive, Janz0low10
Petrositis0low10
Petrous Apicitis0low10
Petrous Sinus Thrombophlebitis0low10
Petrous Sinus Thrombosis0low10
Peutz-Jegher's Syndrome0low60
Peutz-Jeghers Polyposis0low60
Peutz-Jeghers Syndrome0low60
Pfaundler-Hurler Syndrome0low20
Phacomatosis, Bourneville0low10
Phaeohyphomycosis0low160
Phaeohyphomycosis, Central Nervous System0low50
Phaeohyphomycosis, Central Nervous System, Primary0low50
Phakomatosis, Bourneville0low10
Pharyngeal Diseases0medium72
Pharyngeal Pouch Syndrome0low10
Pharyngitis0low20
Pharyngo-Conjunctival Fever0low10
Pharynx Diseases0medium72
Phenylalanine Hydroxylase Deficiency0low10
Phenylalanine Hydroxylase Deficiency Disease0low10
Phenylalanine Hydroxylase Deficiency Disease, Severe0low10
Phenylketonuria0low10
Phenylketonuria I0low10
Phenylketonuria II0low10
Phenylketonuria Type 20low10
Phenylketonuria, Atypical0low10
Phenylketonuria, Classical0low10
Phenylketonurias0low10
Pheochromocytoma0low30
Pheochromocytoma, Extra-Adrenal0low30
Phlebitis0low10
Phlebitis, Cavernous Sinus, Septic0low20
Phlebothrombosis0low80
Phlegmasia Alba Dolens0low20
Phlegmon0medium41
Phobia, School0medium83
Phobias0medium83
Phobic Disorders0medium83
Phobic Neuroses0medium83
Phonation Disorders0low10
Photoallergic Contact Dermatitis0low20
Photoallergy0low20
Photodermatitis0low170
Photophobia0medium41
Photosensitive Contact Dermatitis0low20
Photosensitivity Disorders0low170
Photosensitization0low170
Phototoxic Contact Dermatitis0low120
Phototoxic Dermatitis0low120
Phototoxicity0low120
Phycomycosis0medium701
Picornaviridae Infections0low10
Picornavirus Infections0low10
Pie Torcido0low10
Pigmentary Cirrhosis0medium241
Pill Rolling Tremor0low50
Pilocytic Astrocytoma0low30
Pink Eye0low10
Pituitary ACTH Hypersecretion0low20
Pituitary Adenoma0low60
Pituitary Adenoma, ACTH-Secreting0low10
Pituitary Adenoma, Prolactin-Secreting0low10
Pituitary Cancer0low60
Pituitary Carcinoma0low60
Pituitary Corticotropin-Secreting Adenoma0low10
Pituitary Cushing Syndrome0low20
Pituitary Diseases0low10
Pituitary Disorders0low10
Pituitary Gland Diseases0low10
Pituitary Neoplasms0low60
Pituitary Tumors0low60
Pituitary-Dependant Cushing Syndrome0low20
Pituitary-Dependant Hypercortisolism0low20
Pituitary-Dependant Hypercortisolism Disorder0low20
Pityriasis Folliculitis0medium52
Pityriasis Versicolor0medium52
Pityrosporum orbiculare Infection0medium52
PKU, Atypical0low10
Plaque, Amyloid0low50
Plaque, Atherosclerotic0low30
Plaque, Dental0low30
Plaque, Ulcerating, Carotid Artery0low40
Plaques, Amyloid0low50
Plasma Cell Dyscrasias0low10
Plasma Cell Leukemia0low10
Plasma Cell Myeloma0medium8213
Plasma Cell Tumor0low20
Plasmacytic Leukemia0low10
Plasmacytoma0low20
Plasmocytoma0low20
Plasmodium falciparum Malaria0medium264
Plasmodium Infections0low180
Plasmodium vivax Malaria0medium21
Platelet Storage Pool Deficiencies0low10
Platelet Storage Pool Deficiency0low10
Platelet Storage Pool Disease0low10
Plegia0low30
Pleocytosis0low40
Pleural Effusion0low50
Pleural Effusion, Malignant0low30
Pleural Neoplasms0low50
Pleural Rub0medium21
Pleurisy0low110
Pleuritis0low110
Pleuropericarditis0low20
Plica Syndrome0low20
Pneumococcal Diseases0low60
Pneumococcal Infections0low60
Pneumocystis carinii Pneumonia0low10
Pneumocystis jirovecii Pneumonia0low10
Pneumocystis Pneumonia0low10
Pneumocystosis0low10
Pneumonia0medium322
Pneumonia, Aspiration0low30
Pneumonia, Bacterial0medium174
Pneumonia, Eosinophilic0low70
Pneumonia, Interstitial0low20
Pneumonia, Interstitial Plasma Cell0low10
Pneumonia, Lobar0medium322
Pneumonia, Necrotizing0low10
Pneumonia, Pneumococcal0low10
Pneumonia, Pneumocystis0low10
Pneumonia, Pneumocystis carinii0low10
Pneumonia, Viral0low40
Pneumonitis0medium322
Pneumonitis, Hypersensitivity0low40
Pneumonitis, Interstitial0low20
Pneumothorax0low20
Pneumothorax, Primary Spontaneous0low20
PNS (Peripheral Nervous System) Diseases0medium121
PNS Diseases0medium121
Pocket, Periodontal0low10
Poisoning0low60
Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine0low40
Poisoning, Blood0medium273
Poisoning, Cadmium0low20
Poisoning, Carbon Tetrachloride0low60
Poisoning, CCl40low60
Poisoning, Fluoride0low20
Poisoning, Food0low30
Poisoning, Lead0low20
Poisoning, Nervous System0low130
Polio0low10
Polio Encephalitis0low10
Poliomyelitis0low10
Poliomyelitis Infection0low10
Poliomyelitis, Acute0low10
Poliomyelitis, Bulbar0low10
Poliomyelitis, Medullary Involvement0low10
Poliomyelitis, Nonpoliovirus0low10
Poliomyelitis, Preparalytic0low10
Pollen Allergy0medium11
Pollinosis0medium11
Polyarthralgia0medium299
Polyarthritis0low90
Polyarthritis Rheumatica0low10
Polyarthritis, Juvenile, Rheumatoid Factor Negative0low20
Polyarthritis, Juvenile, Rheumatoid Factor Positive0low20
Polycystic Kidney0low10
Polycystic Kidney Disease0low10
Polycystic Kidney Disease 20low60
Polycystic Kidney Disease, Adult0low60
Polycystic Kidney Disease, Adult Type 20low60
Polycystic Kidney Disease, Adult, Type II0low60
Polycystic Kidney Disease, Autosomal Dominant0low60
Polycystic Kidney Disease, Type 20low60
Polycystic Kidney Diseases0low10
Polycystic Kidney, Autosomal Dominant0low60
Polycystic Kidney, Type 1 Autosomal Dominant Disease0low60
Polycystic Kidney, Type 2 Autosomal Dominant Disease0low60
Polycystic Kidneys0low10
Polycystic Ovarian Syndrome0medium12434
Polycystic Ovary Syndrome0medium12434
Polycystic Ovary Syndrome 10medium12434
Polycystic Renal Disease0low10
Polycythemia0low20
Polydactyly, Sex Reversal, Renal Hypoplasia, And Unilobar Lung0low10
Polymenorrhea0medium95
Polymicrobial Infection0medium112
Polymyoclonus0low10
Polymyositis-Dermatomyositis0low10
Polyneuritis, Alcoholic0low10
Polyneuropathy, Alcoholic0low10
Polyomavirus Infections0low10
Polyopsia0low10
Polyostotic Fibrous Dysplasia0medium101
Polyphagia0low10
Polyploid0low70
Polyploid Cell0low70
Polyploidy0low70
Polyposis, Hamartomatous Intestinal0low60
Polyps0medium11
Polyps-and-Spots Syndrome0low60
Polytrauma0low10
Pongidae Diseases0low20
Pontiac Fever0low10
Pontine Neoplasms0low40
Pontine Tumors0low40
Porphobilinogen Deaminase Deficiency0low30
Porphyria0low50
Porphyria Cutanea Tarda0medium41
Porphyria Variegata0low10
Porphyria Variegate0low10
Porphyria, Acute Intermittent0low30
Porphyria, Congenital Erythropoietic0low30
Porphyria, Erythropoietic0low30
Porphyria, Erythropoietic, Congenital0low30
Porphyria, South African Type0low10
Porphyria, Swedish Type0low30
Porphyria, Variegate0low10
Porphyrias0low50
Porphyrin Disorder0low50
Portal-Systemic Encephalopathy0low20
Portosystemic Encephalopathy0low20
Position Agnosia0low10
Positional Vertigo0low10
Post Traumatic Stress Disorder0medium178
Post-Natal Depression0low30
Post-operative Pain0low30
Post-operative Pain, Acute0low30
Post-operative Pain, Chronic0low30
Post-Partum Depression0low30
Post-surgical Pain0low30
Post-Transfusion Purpura0medium11130
Post-Traumatic Hydrocephalus0low10
Post-Traumatic Myelopathy0low90
Post-Traumatic Stress Disorders0medium178
Postabsorptive Hypoglycemia0medium4820
Posterior Cerebral Artery Aneurysm0low20
Posterior Choroidal Artery Infarction0low70
Posterior Circulation Brain Infarction0low30
Posterior Circulation Infarction, Brain0low30
Posterior Circulation Transient Ischemic Attack0low110
Posterior Communicating Artery Aneurysm0low20
Posterior Fossa Meningioma0low10
Posterior Leukoencephalopathy Syndrome0low10
Posterior Pituitary Diseases0low10
Posterior Reversible Encephalopathy Syndrome0low10
Posterosuperior Glenoid Impingement0low10
Postmenopausal Bone Loss0medium3219
Postmenopausal Osteoporosis0medium3219
Postmortem Changes0low10
Postnatal Depression0low30
Postoperative Complications0medium972
Postoperative Pain0low30
Postoperative Pain, Acute0low30
Postoperative Pain, Chronic0low30
Postoperative Pulmonary Atelectasis0low10
Postoperative Residual Curarisation0low10
Postoperative Residual Curarization0low10
Postoperative Residual Weakness0low10
Postoperative Wound Infection0low190
Postpartum Amenorrhea0medium52
Postpartum Depression0low30
Postpartum Sepsis0low10
Postprandial Hyperglycemia0medium3814
Postprandial Hypoglycemia0medium4820
Postsurgical Pain0low30
Posttransfusion Purpura0medium11130
Posttraumatic Stress Disorders0medium178
Postural Low Back Pain0low10
Postviral Fatigue Syndrome0medium21
Poultry Diseases0low20
Powassan Encephalitis0low30
Powassan Virus Disease0low30
Pph1 With Hht0low10
Ppox Deficiency0low10
Pre B-ALL0low50
Pre-B ALL0low50
Pre-B-Cell Leukemia0low50
Pre-Eclampsia0low40
Pre-Ictal Memory Loss0low20
Precancerous Conditions0medium71
Precocious Puberty0medium245
Precocious Puberty, Central0medium245
Precocious Puberty, Male Limited0medium245
Precocious Puberty, Male-Limited0medium245
Precordial Catch0low10
Precordial Catch Syndrome0low10
Precursor B-Cell Lymphoblastic Leukemia0low50
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma0low50
Precursor B-Cell Lymphoblastic Lymphoma0low50
Precursor Cell Lymphoblastic Leukemia-Lymphoma0medium791
Precursor T-Cell Lymphoblastic Leukemia0low130
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma0low130
Precursor T-Cell Lymphoblastic Lymphoma0low130
Prediabetes0low30
Prediabetic State0low30
Predisposition, Genetic0medium162
Preeclampsia0low40
Preeclampsia Eclampsia 10low40
Pregnancy0medium429104
Pregnancy Complications0medium41
Pregnancy Complications, Hematologic0low40
Pregnancy Complications, Hematological0low40
Pregnancy Complications, Infectious0medium134
Pregnancy Toxemias0low40
Pregnancy, Ectopic0medium11
Pregnancy, Extrauterine0medium11
Pregnancy, Hematologic Complications0low40
Pregnancy, Infectious Complications0medium134
Pregnancy, Prolonged0low10
Premature Birth0low20
Premature Ejaculation0medium74
Premature Labor0low20
Premature Obstetric Labor0low20
Premature Ovarian Failure0medium31
Premature Ovarian Failure 10medium31
Premature Ovarian Failure, X-Linked0medium31
Premenstrual Syndrome0medium82
Premenstrual Tension0medium82
Prenatal Exposure Delayed Effects0medium242
Preneoplastic Condition0medium71
Preneoplastic Conditions0medium71
Prescription Drug Abuse0medium153
Prescription Opioid Abuse0medium63
Prescription Opioid Misuse0medium63
Presenile Alzheimer Dementia0medium815
Pressure Pneumothorax0low20
Pressure Sore0low20
Pressure Ulcer0low20
Presyncope0low10
Preterm Birth0low20
Preterm Labor0low20
Priapism0low40
Primary Amebic Meningoencephalitis0low20
Primary Amyloidosis0low10
Primary Biliary Cholangitis0low20
Primary Biliary Cirrhosis0low20
Primary Brain Neoplasms0medium484
Primary Brain Stem Neoplasms0low40
Primary Brainstem Neoplasms0low40
Primary Cardiac Tumors, Childhood0low10
Primary Central Nervous System Neoplasm0low20
Primary Central Nervous System Neoplasms0low20
Primary Central Nervous System Phaeohyphomycosis0low50
Primary Congenital Lymphedema0low10
Primary Cutaneous Nocardiosis0low10
Primary Effusion Lymphoma0low30
Primary Graft Dysfunction0low10
Primary Hemochromatosis0medium241
Primary Hemophagocytic Hymphohistiocytosis0low10
Primary Hemophagocytic Lymphohistiocytosis0low10
Primary Hyperaldosteronism0low30
Primary Hyperoxaluria0low10
Primary Hyperparathyroidism0low10
Primary Hypersomnia Disorders0medium72
Primary Hypersomnolence Disorders0medium72
Primary Hypothyroidism0medium61
Primary Insomnia0medium12341
Primary Intramedullary Spinal Cord Neoplasms0low20
Primary Lateral Sclerosis0low10
Primary Macroglobulinemia0low50
Primary Malignant Brain Neoplasms0medium484
Primary Malignant Brain Tumors0medium484
Primary Myelofibrosis0low80
Primary Myocardial Diseases0medium185
Primary Neoplasms, Cerebellum0low80
Primary Open Angle Glaucoma0medium43
Primary Ovarian Insufficiency0medium31
Primary Ovarian Insufficiency, Fragile X-Associated0medium31
Primary Oxalosis0low10
Primary Oxaluria0low10
Primary Parkinsonism0medium438
Primary Peritonitis0low230
Primary Pulmonary Hypertension0low10
Primary Sclerosing Cholangitis0low10
Primary Senile Degenerative Dementia0medium815
Primary Spinal Cord Neoplasms, Intramedullary0low20
Primary Spontaneous Pneumothorax0low20
Primary Systemic Amyloidosis0low10
Primary Toni-Debre-Fanconi Syndrome0medium161
Primitive Neuroectodermal Tumor, Extracranial0low10
PRL-Secreting Pituitary Adenoma0low10
Progeria, Adult0low20
Progranulocytic Leukemia0low110
Progressive Chorea, Chronic Hereditary (Huntington)0low130
Progressive Chorea, Hereditary, Chronic (Huntington)0low130
Progressive Multifocal Leukoencephalopathy0low80
Progressive Muscular Dystrophy, Duchenne Type0low20
Progressive Myositis Ossificans0low10
Progressive Ossifying Myositis0low10
Prolactin-Producing Pituitary Adenoma0low10
Prolactin-Secreting Pituitary Adenoma0low10
Prolactinoma0low10
Prolactinoma, Familial0low10
Prolapsed Disc0low10
Prolapsed Disk0low10
Proliferative Bronchiolitis0low40
Proliferative Vitreoretinopathy0low20
Prolonged Pregnancy0low10
PROMM (Proximal Myotonic Myopathy)0low10
Promyelocytic Leukemia, Acute0low110
Proptosis0low10
Prostate Cancer0medium726
Prostate Neoplasms0medium726
Prostatic Adenoma0medium61
Prostatic Cancer0medium726
Prostatic Cancer, Androgen-Independent0medium233
Prostatic Cancer, Androgen-Insensitive0medium233
Prostatic Cancer, Androgen-Resistant0medium233
Prostatic Cancer, Castration-Resistant0medium233
Prostatic Cancer, Hormone Refractory0medium233
Prostatic Diseases0low20
Prostatic Hyperplasia0medium61
Prostatic Hyperplasia, Benign0medium61
Prostatic Hypertrophy0medium61
Prostatic Hypertrophy, Benign0medium61
Prostatic Neoplasms0medium726
Prostatic Neoplasms, Androgen-Independent0medium233
Prostatic Neoplasms, Androgen-Insensitive0medium233
Prostatic Neoplasms, Androgen-Resistant0medium233
Prostatic Neoplasms, Castration-Resistant0medium233
Prostatic Neoplasms, Hormone Refractory0medium233
Prosthesis Related Infection0low140
Prosthesis-Related Infection0low140
Prosthesis-Related Infections0low140
Protan Defect0medium11
Protein Aggregation, Pathological0low20
Protein Deficiency0low10
Proteinoses, Pulmonary Alveolar0low10
Proteinosis, Pulmonary Alveolar0low10
Proteinuria0low200
Proteinuria-Edema-Hypertension Gestosis0low40
Proteus Infections0low10
Protoporphyria, Erythropoietic0low10
Protoporphyrinogen Oxidase Deficiency0low10
Protozoal Infections, Central Nervous System0low20
Protozoal Infections, Cerebral0low20
Protozoal Meningoencephalitis0low20
Protozoan Infections0low10
Proximal Myotonic Myopathy0low10
Proximal Renal Tubular Acidosis0low20
Proximal Renal Tubular Dysfunction0medium161
Pruritis0medium81
Pruritus0medium81
Psammomatous Meningioma0low10
Pseudarthrosis0low10
Pseudo-Obstruction, Intestinal0low10
Pseudo-Phlorizin Diabetes0medium161
Pseudoakathisia0low40
Pseudoaneurysm0low10
Pseudoaphakia0medium51
Pseudoarthrosis0low10
Pseudocoma0low10
Pseudodystonia0low10
Pseudohermaphroditism0low20
Pseudohypertrophic Childhood Muscular Dystrophy0low20
Pseudohypertrophic Muscular Dystrophy, Childhood0low20
Pseudointestinal Obstruction Syndrome0low10
Pseudomembranous Colitis0low40
Pseudomembranous Enteritis0low40
Pseudomembranous Enterocolitis0low40
Pseudomonas aeruginosa Infection0low60
Pseudomonas Infections0low60
Pseudoobstructive Syndrome0low10
Pseudoophthalmoplegia0low20
Pseudopelade0medium51
Pseudophakia0low10
Pseudotumor Cerebri0low10
Psoriasis0medium156
Psoriasis Arthropathica0medium112
Psoriasis, Arthritic0medium112
Psoriatic Arthritis0medium112
Psoriatic Arthritis, Juvenile0low20
Psoriatic Arthropathy0medium112
Psychiatric Diagnosis0medium154
Psychiatric Diseases0medium154
Psychiatric Disorders0medium154
Psychiatric Illness0medium154
Psychogenic Headache0medium21
Psychogenic Inversion of Circadian Rhythm0low10
Psychomotor Agitation0low10
Psychomotor Disorders0medium31
Psychomotor Disorders, Developmental0medium31
Psychomotor Hyperactivity0low10
Psychomotor Impairment0medium31
Psychomotor Restlessness0low10
Psychoneuroses0medium11
Psychophysiologic Disorders0medium33
Psychophysiological Disorders0medium33
Psychophysiological Insomnia0medium12341
Psychoses0low30
Psychoses, Drug0low10
Psychoses, Manic-Depressive0medium184
Psychoses, Substance-Induced0low10
Psychoses, Toxic0low10
Psychoses, Traumatic0medium32
Psychosexual Disorders0medium133
Psychosexual Dysfunctions0medium133
Psychosis0low30
Psychosis, Brief Reactive0low30
Psychosis, Involutional0medium5134
Psychosis, Manic-Depressive0medium184
Psychosomatic Disorders0medium33
Psychotic Disorders0low30
PT-NANBH0medium204
Pterygium0low20
Ptosis, Eyelid0low50
PTSD0medium178
Pubertas Praecox0medium245
Puberty, Delayed0medium1411
Puberty, Precocious0medium245
Puerperal Disorders0low10
Puerperal Infection0low10
Pulmonary Abscess0low40
Pulmonary Abscesses0low40
Pulmonary Alveolar Proteinoses0low10
Pulmonary Alveolar Proteinosis0low10
Pulmonary Arterial Remodeling0low20
Pulmonary Aspergillosis0medium973
Pulmonary Aspergillosis - Invasive0medium1207
Pulmonary Atelectasis0low10
Pulmonary Cancer0medium17213
Pulmonary Coin Lesion0low20
Pulmonary Coin Lesions0low20
Pulmonary Consumption0low60
Pulmonary Cystic Fibrosis0medium552
Pulmonary Disease0medium222
Pulmonary Disease, Chronic Obstructive0medium234
Pulmonary Diseases0medium222
Pulmonary Edema0low100
Pulmonary Edemas0low100
Pulmonary Embolism0medium71
Pulmonary Embolisms0medium71
Pulmonary Eosinophilia0low70
Pulmonary Eosinophilias0low70
Pulmonary Fibroses0low100
Pulmonary Fibrosis0low100
Pulmonary Fibrosis - from Asbestos Exposure0low10
Pulmonary Fibrosis, Idiopathic0low40
Pulmonary Fungal Diseases0medium2107
Pulmonary Fungal Infections0medium2107
Pulmonary Fusariosis0medium391
Pulmonary Hyalohyphomycosis0low20
Pulmonary Hypertension0medium181
Pulmonary Hypertension, Primary, 10low10
Pulmonary Hypertension, Primary, 1, With Hereditary Hemorrhagic Telangiectasia0low10
Pulmonary Hypertension, Primary, Dexfenfluramine-Associated0low10
Pulmonary Hypertension, Primary, Fenfluramine-Associated0low10
Pulmonary Inflammation0medium322
Pulmonary Injury0low60
Pulmonary Neoplasms0medium17213
Pulmonary Nocardiosis0low10
Pulmonary Nodule, Solitary0low20
Pulmonary Nodules, Solitary0low20
Pulmonary Phthisis0low60
Pulmonary Sarcoidosis0low20
Pulmonary Sequestration0low20
Pulmonary Sequestrations0low20
Pulmonary Thromboembolism0medium71
Pulmonary Thromboembolisms0medium71
Pulmonary Tuberculoses0low60
Pulmonary Tuberculosis0low60
Pupillary Miosis0medium22
Pure Hereditary Red Cell Aplasia0low40
Pure Red-Cell Aplasia0low20
Purpura, Thrombocytopenic0low10
Purpura, Thrombocytopenic, Autoimmune0low30
Purpura, Thrombocytopenic, Idiopathic0low30
Purpura, Thrombopenic0low10
Purtilo Syndrome0low30
Pus0low10
Pustular Dermatosis, Subcorneal0low20
Pustular Psoriasis of Palms and Soles0medium156
Pustulosis of Palms and Soles0medium156
Pustulosis Palmaris et Plantaris0medium156
Pyaemia0medium273
Pyelonephritis0low40
Pyelonephritis, Acute Necrotizing0low40
Pyemia0medium273
Pykno-Epilepsy0medium81
Pyknolepsy0medium81
Pyohemia0medium273
Pyothorax0low30
Pyrexia0medium577
Pyrexial Convulsion0low20
Pyrexial Seizure0low20
Pythiosis0low40
Pythiosis Insidiosi0low40
Pythium insidiosum Infection0low40
QDPR Deficiency0low10
Quadrantanopia0low10
Quadrantanopsia0low10
Quadriparesis0low10
Quadriplegia0low10
Quincke's Edema0low60
Quinoid Dihydropteridine Reductase Deficiency0low10
Radiation Injuries0low80
Radiation Injuries, Experimental0low50
Radiation Recall Dermatitis0low50
Radiation Recall Reaction0low50
Radiation Sickness0low80
Radiation Syndrome0low80
Radiation-Induced Cancer0low60
Radiation-Induced Dermatitis0low50
Radiation-Induced Neoplasms0low60
Radiodermatitis0low50
RAEB0low10
RAEM0low10
Rales0medium21
Ramsay Hunt Paralysis Syndrome0low240
Rapid Eye Movement Sleep Behavior Disorder0low10
Rapid Fatigue of Gait0low30
Rare Diseases0low60
Rash0medium111
Rasmussen Encephalitis0low100
Rasmussen Syndrome0low100
Rasmussen's Syndrome0low100
Rathke Cleft Cyst0low10
Rathke Cleft Cysts0low10
Rathke's Cleft Cyst0low10
Rathke's Cleft Cysts0low10
Raynaud Disease0low10
Raynaud Phenomenon0low10
Raynaud's Disease0low10
Reaction, Acute-Phase0low10
Reactivation Infection0low10
Reactive Disorders0medium31
Reactive Hemophagocytic Syndrome0low10
Reactive Hyperemia0medium153
Reactive Hypoglycemia0medium4820
Reaven Syndrome X0medium195
Rebound Insomnia0medium12341
Rebound Nystagmus0low10
Recrudescence0medium13636
Rectal Cancer0medium73
Rectal Diseases0medium52
Rectal Disorders0medium52
Rectal Neoplasms0medium73
Rectal Tumors0medium73
Rectum Cancer0medium73
Rectum Neoplasms0medium73
Recurrence0medium13636
Recurrence, Local Neoplasm0medium21158
Recurrence, Locoregional Neoplasm0medium21158
Recurrences, Local Neoplasm0medium21158
Recurrent Low Back Pain0low10
Red Cell Aplasia, Pure, Hereditary0low40
Red-Cell Aplasia, Pure0low20
Reduced Sensation0low20
Reflex Sympathetic Dystrophy0low20
Reflex Sympathetic Dystrophy Syndrome0low20
Reflux, Gastroesophageal0medium31
Refractory Anemia0low10
Refractory Anemia with Excess of Blasts0low10
Refractory Epilepsy0low70
Regional Enteritis0medium171
Relapse0medium13636
Relapsing-Remitting Multiple Sclerosis0low10
REM Behavior Disorder0low10
REM Sleep Behavior Disorder0low10
REM Sleep Deprivation0medium71
Remission, Spontaneous0medium42
Remittent Fever0low180
Remitting-Relapsing Multiple Sclerosis0low10
Renal Cancer0medium182
Renal Carcinoma0medium142
Renal Cell Cancer0medium142
Renal Cell Carcinoma0medium142
Renal Cell Carcinoma, Papillary0medium142
Renal Collecting Duct Carcinoma0medium142
Renal Disease, End-Stage0medium328
Renal Failure0medium316
Renal Failure, Acute0medium393
Renal Failure, Chronic0medium328
Renal Failure, End-Stage0medium328
Renal Fanconi Syndrome0medium161
Renal Insufficiency0medium316
Renal Insufficiency, Acute0medium393
Renal Insufficiency, Chronic0medium3514
Renal Neoplasms0medium182
Renal Tubular Acidosis0low20
Renal Tubular Acidosis 10low20
Renal Tubular Acidosis I0low20
Renal Tubular Acidosis II0low20
Renal Tubular Acidosis, Distal, Autosomal Dominant0low20
Renal Tubular Acidosis, Proximal0low20
Renal Tubular Acidosis, Proximal, with Ocular Abnormalities0low20
Renal Tubular Acidosis, Type I0low20
Renal Tubular Acidosis, Type II0low20
Reperfusion Damage0medium481
Reperfusion Injury0medium481
Reperfusion Injury, Myocardial0low230
Reproductive Sterility0medium138
Research-Related Injuries0low130
Residual Block0low10
Residual Cancer0low50
Residual Disease, Minimal0low50
Residual Neoplasm0low50
Residual Neuromuscular Block0low10
Residual Neuromuscular Blockade0low10
Residual Paralysis, Post-Anesthesia0low10
Residual Tumor0low50
Residual Tumour0low50
Resistance, Disease0medium51
Resistant Ovary Syndrome0medium31
Resorption Atelectasis0low10
Resorption Pulmonary Atelectasis0low10
Respiration Disorders0low10
Respiratory Acidosis0low10
Respiratory Chain Deficiencies, Mitochondrial0low10
Respiratory Depression0low50
Respiratory Distress Syndrome0low110
Respiratory Distress Syndrome, Acute0low110
Respiratory Distress Syndrome, Adult0low110
Respiratory Distress Syndrome, Pediatric0low110
Respiratory Failure0low50
Respiratory Hypersensitivity0medium151
Respiratory Infections0medium131
Respiratory Insufficiency0low50
Respiratory Paralysis0low10
Respiratory Sounds0medium21
Respiratory Syncytial Virus Infection0low30
Respiratory Syncytial Virus Infections0low30
Respiratory Syndrome, Acute, Severe0low40
Respiratory Syndrome, Severe Acute0low40
Respiratory Tract Diseases0medium31
Respiratory Tract Infections0medium131
Respirovirus Infections0low10
Response Evaluation Criteria in Solid Tumors0medium21
Response, Acute-Phase0low10
Rest Tremor0low50
Resting Tremor0low50
Restless Leg Syndrome0low20
Restless Legs0low20
Restless Legs Syndrome0low20
Restlessness0low10
Retained Surgical Instruments0low10
Retained Surgical Items0low10
Retained Surgical Needle0low10
Retained Surgical Sponge0low10
Retained Surgical Tools0low10
Retardation, Mental0medium154
Retention Disorders, Cognitive0medium243
Reticuloendotheliosis, Familial0low10
Reticuloendotheliosis, Leukemic0low10
Reticulolymphosarcoma0medium191
Reticulosarcoma0medium205
Reticulosis, Familial Histiocytic0low10
Reticulum Cell Sarcoma0medium205
Reticulum-Cell Sarcoma0medium205
Retinal Artery Occlusion0low10
Retinal Branch Vein Occlusion0low10
Retinal Cancer0low30
Retinal Degeneration0low10
Retinal Detachment0low30
Retinal Diseases0low100
Retinal Edema0low10
Retinal Hemorrhage0low10
Retinal Neoplasms0low30
Retinal Neovascularization0low40
Retinal Pigment Epithelial Detachment0low30
Retinal Tumors0low30
Retinal Vein Occlusion0low10
Retinal Vein Thrombosis0low10
Retinoblastoma0low20
Retraction Nystagmus0low10
Retro-Ocular Headache0medium3719
Retrobulbar Hemorrhage0low10
Retrograde Amnesia0low20
Retroperitoneal Neoplasms0low10
Retroviridae Infections0low10
Retrovirus Infections0low10
Rett Disorder0low10
Rett Syndrome0low10
Rett's Disorder0low10
Rett's Syndrome0low10
Reversible Posterior Leukoencephalopathy Syndrome0low10
Rhabdoid Tumor0low10
Rhabdomyolysis0medium71
Rhabdomyosarcoma0low30
Rhabdomyosarcoma, Embryonal0low10
Rheumatic Arthritis0low10
Rheumatic Chorea0low10
Rheumatic Fever0low10
Rheumatic Heart Disease0low10
Rheumatism, Acute Articular0low10
Rheumatism, Articular, Acute0low10
Rheumatism, Muscular0medium21
Rheumatoid Arthritis0medium7220
Rheumatoid Nodule0low10
Rheumatoid Nodulosis0low10
Rheumatoid Spondylitis0medium102
Rhinencephalic Epilepsy0medium125
Rhinitis0low100
Rhinitis, Allergic, Nonseasonal0low30
Rhinitis, Allergic, Perennial0low30
Rhinitis, Allergic, Seasonal0medium11
Rhonchi0medium21
Richner-Hanhart Syndrome0low10
Richner-Hanhart Syndrome, Tyrosinosis, Oculocutaneous Type0low10
Ricker Syndrome0low10
Right Hemisphere, Cerebral Infarction0low70
Right Hemisphere, Infarction, Cerebral0low70
Right Middle Cerebral Artery Infarction0low40
Right Ventricular Hypertrophy0low10
Right Ventricular Outflow Obstruction0low10
Right-Sided Heart Failure0medium255
Rigidity, Decerebrate0low50
Rigidity, Decorticate0low50
Rigidity, Muscular0low10
Ringworm0low320
Rodent Diseases0low30
Rodent Ulcer0low90
Rotary Nystagmus0low10
Rotational Nystagmus0low10
Rotator Cuff Impingement0low10
Rotator Cuff Impingement Syndrome0low10
Round Cell Liposarcoma0low10
Roussy Levy Hereditary Areflexic Dystasia0low10
Roussy-Levy Disease0low10
Roussy-Levy Hereditary Areflexic Dystasia0low10
Roussy-Levy Syndrome0low10
Royal Free Disease0medium21
RSD (Reflex Sympathetic Dystrophy)0low20
RSH Syndrome0low10
RSH-SLO Syndrome0low10
RTA, Classic Type0low20
RTA, Distal Type, Autosomal Dominant0low20
RTA, Gradient Type0low20
RTA, Proximal Type0low20
Rubber Allergy0low10
Rubber Latex Allergy0low10
Rubeola0low10
Runt Disease0medium7610
Ruptured Aneurysm0low10
Russian Spring-Summer Encephalitis0low30
Rutledge Friedman Harrod Syndrome0low10
Rutledge Lethal Multiple Congenital Anomaly Syndrome0low10
Saccular Aneurysm0low10
SAH (Subarachnoid Hemorrhage)0low20
SAIDS0low130
Salaam Attacks0medium144
Salaam Seizures0medium144
Salivary Gland Cancer0low40
Salivary Gland Neoplasms0low40
Salivary Gland Virus Disease0low140
San Joaquin Valley Fever0medium594
Sappinia diploidea Meningoencephalitis0low20
Sarcoidosis0low50
Sarcoidosis, Pulmonary0low20
Sarcoma0medium123
Sarcoma 1800low20
Sarcoma 180, Crocker0low20
Sarcoma, Cerebellar, Circumscribed Arachnoidal0low100
Sarcoma, Endometrial Stromal0low140
Sarcoma, Endometrial Stromal, Low-Grade0low30
Sarcoma, Engelbreth-Holm-Swarm0low60
Sarcoma, Epithelioid0medium123
Sarcoma, Ewing0low80
Sarcoma, Ewing's0low80
Sarcoma, Experimental0low60
Sarcoma, Germinoblastic0medium191
Sarcoma, Granulocytic0low10
Sarcoma, Jensen0low60
Sarcoma, Kaposi0low50
Sarcoma, Lymphatic0medium205
Sarcoma, Mast-Cell0low20
Sarcoma, Myeloid0low10
Sarcoma, Neurogenic0low10
Sarcoma, Osteogenic0medium181
Sarcoma, Reticulum-Cell0medium205
Sarcoma, Soft Tissue0medium123
Sarcoma, Spindle Cell0medium123
Sarcoma, Synovial0low10
Sarcomas, Experimental0low60
Sarcomatoid Renal Cell Carcinoma0medium142
Sarcomatous Glioma0low10
Sarcopenia0medium11
SARS (Severe Acute Respiratory Syndrome)0low40
SARS Coronavirus 2 Infection0medium262
SARS-CoV-2 Infection0medium262
Saturnine Tremor0low50
SCA10low10
Scabies0low10
Scalded Skin Syndrome, Nonstaphylococcal0low40
Scar0medium32
Scarlet Fever0low10
Scarring0medium32
Scars0medium32
Schaumann Disease0low50
Schaumann Syndrome0low50
Schaumann's Syndrome0low50
Scheie Syndrome0low20
Scheie's Syndrome0low20
Schistoma Infection0low40
Schistosoma mansoni Infection0low20
Schistosomiasis0low40
Schistosomiasis mansoni0low20
Schistosomiasis, Intestinal0low20
Schizencephalic Cleft0low10
Schizencephalic Cyst0low10
Schizencephaly0low10
Schizoaffective Disorder0low30
Schizophrenia0medium276
Schizophrenia, Paranoid0low10
Schizophrenic Disorders0medium276
Schizophreniform Disorders0low30
Scholastic Skills Development Disorders0low10
Schut-Haymaker Type OPCA0low10
Schwannoma, Malignant0low10
Schwartz-Bartter Syndrome0low10
Sciatic Neuralgia0low10
Sciatica0low10
Sciatica, Bilateral0low10
Scleritis0low60
Sclerocystic Ovarian Degeneration0medium12434
Sclerocystic Ovaries0medium12434
Sclerocystic Ovary Syndrome0medium12434
Scleroderma, Circumscribed0low20
Scleroderma, Diffuse0low10
Scleroderma, Linear0low20
Scleroderma, Localized0low20
Scleroderma, Progressive0low10
Scleroderma, Systemic0low50
Sclerosing Cholangitis0low10
Sclerosis Tuberosa0low10
Sclerosis, Disseminated0medium91
Sclerosis, Hereditary Spinal0low20
Sclerosis, Progressive Systemic0low10
Sclerosis, Systemic0low50
Sea Fan Neovascularization0low40
Sea Sickness0medium33
Seasickness0medium33
Seasonal Affective Disorder0medium11
Seasonal Affective Disorders0medium11
Seasonal Allergic Rhinitis0medium11
Seasonal Mood Disorder0medium11
Seborrhea0medium32
Seborrheic Dermatitis0medium32
Second Cancer0medium125
Second Cranial Nerve Diseases0low10
Second Malignancy0medium125
Second Neoplasm0medium125
Second Primary Neoplasms0medium125
Second Primary Neoplasms, Metachronous0medium125
Secondary Biliary Cholangitis0low20
Secondary Biliary Cirrhosis0low20
Secondary Dystonia0low10
Secondary Headache Disorders0low20
Secondary Hypersomnia Disorders0medium72
Secondary Hypersomnolence Disorders0medium72
Secondary Hypothyroidism0medium61
Secondary Infection0medium112
Secondary Infections0medium112
Secondary Insomnia0medium12341
Secondary Motor Neuron Disease0low10
Secondary Myocardial Diseases0medium185
Secondary Neurosyphilis0low20
Secondary Open Angle Glaucoma0medium43
Secondary Parkinsonism0low70
Secondary Peritonitis0low230
Secondary Trigeminal Neuralgia0low20
Secondary Vascular Parkinson Disease0low70
Secretory Meningioma0low10
Sedlackova Syndrome0low10
See-Saw Nystagmus0low10
Segmental Autonomic Dysfunction0medium42
Segmental Glomerular Hyalinosis0low10
Segond Fracture0low20
Seizure0medium1153
Seizure Disorder0medium826
Seizure Disorder, Absence0medium81
Seizure Disorder, Complex Partial0low10
Seizure Disorder, Convulsive, Generalized0medium71
Seizure Disorder, Focal0medium125
Seizure Disorder, Generalized0medium71
Seizure Disorder, Generalized Nonconvulsive0medium71
Seizure Disorder, Generalized Onset0medium71
Seizure Disorder, Generalized, Convulsive0medium71
Seizure Disorder, Grand Mal0medium31
Seizure Disorder, Major Motor0medium31
Seizure Disorder, Nonconvulsive Generalized0medium71
Seizure Disorder, Partial0medium125
Seizure Disorder, Tonic Clonic0medium31
Seizure, Febrile, Complex0low20
Seizure, Febrile, Simple0low20
Seizures0medium1153
Seizures, Alcoholic0low10
Seizures, Auditory0medium1153
Seizures, Clonic0medium1153
Seizures, Convulsive0medium1153
Seizures, Epileptic0medium1153
Seizures, Febrile0low20
Seizures, Focal0medium1153
Seizures, Generalized0medium1153
Seizures, Gustatory0medium1153
Seizures, Motor0medium1153
Seizures, Olfactory0medium1153
Seizures, Sensory0medium1153
Seizures, Somatosensory0medium1153
Seizures, Tonic0medium1153
Seizures, Tonic-Clonic0medium1153
Seizures, Vertiginous0medium1153
Seizures, Vestibular0medium1153
Seizures, Visual0medium1153
Semantic Dementia0medium11
Semantic Memory Disorder0medium243
Senile Chorea0low10
Senile Dementia, Acute Confusional0medium815
Senile Dementia, Alzheimer Type0medium815
Senile Osteoporosis0medium337
Senile Paranoid Dementia0medium42
Senile Plaques0low50
Senile Tremor0low50
Sensation Disorders0low10
Sensitivities, Multiple Chemical0low10
Sensitivity and Specificity0medium20816
Sensitivity, Contact0low150
Sensitivity, Multiple Chemical0low10
Sensorimotor Gait Disorder0low30
Sensorineural Hearing Loss0low20
Sensory Agnosia0low10
Sensory Disorders0low10
Sensory Neglect0low40
Sensory Paroxysms, Sleep0low10
Sepsis0medium273
Sepsis Associated Delirium0low10
Sepsis Associated Encephalopathy0low10
Sepsis during Pregnancy0medium134
Sepsis in Pregnancy0medium134
Sepsis Syndrome0low30
Sepsis-Associated Delirium0low10
Sepsis-Associated Encephalopathy0low10
Septic Phlebitis, Cavernous Sinus0low20
Septic Shock0medium281
Septicemia0medium273
Sequestration, Bronchopulmonary0low20
Sequestration, Pulmonary0low20
Sequestrations, Bronchopulmonary0low20
Sequestrations, Pulmonary0low20
Serotonin Syndrome0low30
Serous Acinar Adenoma0low10
Serratia Infections0low30
Sertoli Cell Tumor0low30
Severe Acute Respiratory Syndrome0low40
Severe Combined Immune Deficiency0low10
Severe Combined Immunodeficiency0low10
Severe Combined Immunodeficiency Syndrome0low10
Severe Combined Immunologic Deficiency0low10
Severe Infantile Myoclonic Epilepsy0low50
Severe Myoclonic Epilepsy Of Infancy0low50
Severe Myoclonic Epilepsy, Infantile0low50
Severe Sepsis0medium273
Sex Development Disorders0low20
Sex Deviations0medium11
Sex Differentiation Disorders0low20
Sex Disorders0medium82
Sexual Arousal Disorder0medium133
Sexual Aversion Disorder0medium133
Sexual Development Disorders0low20
Sexual Differentiation Disorders0low20
Sexual Disorders, Physiological0medium82
Sexual Dysfunction, Physiological0medium82
Sexual Dysfunctions, Physiological0medium82
Sexual Dysfunctions, Psychological0medium133
Sexual Precocity0medium245
Sexually Transmitted Disease, Viral0medium11
Sexually Transmitted Diseases0medium21
Sexually Transmitted Diseases, Viral0medium11
Sexually Transmitted Infections0medium21
Sharp Headache0medium3719
Sharps Injuries0low10
Sheep Diseases0low20
Shell Shock0medium108
Shift-Work Sleep Disorder0medium41
Shingles0low20
Shipping Fever0low10
Shock0low50
Shock Lung0low110
Shock, Anaphylactic0low390
Shock, Cardiogenic0low20
Shock, Endotoxic0medium281
Shock, Hemorrhagic0low60
Shock, Septic0medium281
Shock, Toxic0medium281
Shock, Traumatic0low30
Short Bowel Syndrome0low10
Short Sleep Phenotype0medium217
Short Sleeper Syndrome0medium217
Shortness of Breath0medium11
Shoulder Adhesive Capsulitis0low10
Shoulder Impingement0low10
Shoulder Impingement Syndrome0low10
Shoulder Injuries0low10
Shoulder-Hand Syndrome0low20
Shprintzen Syndrome0low10
Shprintzen VCF Syndrome0low10
SIADH0low10
Sicca Syndrome0low20
Sick Headache0medium23878
Sickle Cell Anemia0medium389
Sickle Cell Disease0medium389
Sickle Cell Disorders0medium389
Sickling Disorder Due to Hemoglobin S0medium389
Side Effects of Drugs0medium7517
Siderosis0medium31
Signet Ring Cell Carcinoma0low10
Silicosis0low10
Simian Acquired Immune Deficiency Syndrome0low130
Simian Acquired Immuno-Deficiency Syndrome0low130
Simian Acquired Immunodeficiency Syndrome0low130
Simian AIDS0low130
Simple Endometrial Hyperplasia0medium104
Simple Partial Seizures0medium125
Simple Partial Status Epilepticus0low50
Simple Pulmonary Eosinophilia0low70
Single Seizure0medium1153
Sinus Infections0medium291
Sinus Tachycardia0low10
Sinus Thrombosis0low10
Sinus Thrombosis, Intracranial0low10
Sinusitis0medium291
Sinusitis, Ethmoid0medium41
Sinusitis, Maxillary0medium81
Sinusitis, Sphenoid0low60
Sinusoidal Obstruction Syndrome0medium21
Sister Joseph's Nodule0low10
Sister Mary Joseph's Nodule0low10
Sixth Cranial Nerve Diseases0low10
Sixth Cranial Nerve Disorders0low10
Sixth Cranial Nerve Palsy0low10
Sixth Nerve Palsy0low10
Sjogren Syndrome0low20
Sjogren's Syndrome0low20
Skew Deviation0low20
Skin Aging0low40
Skin and Subcutaneous Tissue Disorders0low150
Skin Cancer0medium562
Skin Diseases0low150
Skin Diseases, Bullous0low20
Skin Diseases, Fungal0medium1063
Skin Diseases, Papulosquamous0low10
Skin Diseases, Parasitic0low20
Skin Diseases, Staphylococcal0low10
Skin Diseases, Vascular0low10
Skin Diseases, Vesicular0low20
Skin Diseases, Vesiculobullous0low20
Skin Infections, Staphylococcal0low10
Skin Neoplasms0medium562
Skin Rash0medium111
Skin Ulcer0low60
SLAP Tears0low10
Sleep Apnea Hypopnea Syndrome0medium52
Sleep Apnea Syndrome, Obstructive0medium52
Sleep Apnea Syndromes0medium11
Sleep Apnea, Mixed0medium11
Sleep Apnea, Mixed Central and Obstructive0medium11
Sleep Apnea, Obstructive0medium52
Sleep Debt0medium71
Sleep Deprivation0medium71
Sleep Disorder, Shift-Work0medium41
Sleep Disorders0medium217
Sleep Disorders, Circadian Rhythm0medium41
Sleep Disorders, Intrinsic0low10
Sleep Drunkenness0low10
Sleep Fragmentation0medium71
Sleep Hypopnea0medium11
Sleep Initiation and Maintenance Disorders0medium12341
Sleep Initiation Dysfunction0medium12341
Sleep Insufficiency0medium71
Sleep State Misperception0low10
Sleep Wake Disorders0medium217
Sleep Walking0low10
Sleep Walking Disorder0low10
Sleep-Disordered Breathing0medium11
Sleep-Related Abnormal Swallowing Syndrome0low10
Sleep-Related Neurogenic Tachypnea0medium217
Sleep-Wake Cycle Disorder0medium41
Sleep-Wake Cycle Disorders0medium41
Sleep-Wake Disorder, Non-24 Hour0medium41
Sleep-Wake Schedule Disorder0medium41
Sleep-Wake Schedule Disorders0medium41
Sleepiness0medium22
Sleeplessness0medium12341
Sleepwalking0low10
Slipped Disc0low10
Slipped Disk0low10
SLO Syndrome0low10
Small Airway Remodeling0low20
Small Airway Remodelling0low20
Small Cell Cancer Of The Lung0low120
Small Cell Carcinoma0low50
Small Cell Lung Cancer0low120
Small Cell Lung Carcinoma0low120
Small Cleaved-Cell Lymphoma, Diffuse0medium205
Small Cleaved-Cell Lymphoma, Follicular0low30
Small Follicular Center-Cell Lymphoma0low30
Small Non-Cleaved-Cell Lymphoma0medium205
Small Noncleaved-Cell Lymphoma0medium205
Small Pupil0medium22
Small-Cell Lymphoma0medium182
Smith Lemli Opitz syndrome, type 10low10
Smith-Lemli-Opitz Syndrome0low10
Smith-Lemli-Opitz Syndrome, Type 10low10
Smith-Lemli-Opitz Syndrome, Type 20low10
Smith-Lemli-Opitz Syndrome, Type I0low10
Smith-Lemli-Opitz Syndrome, Type II0low10
Smoking Cessation0low20
Smooth Pursuit Deficiency0low20
Snake Bites0low10
Snake Envenoming0low10
Snakebites0low10
Sneddon-Wilkinson Disease0low20
Sneezing0low10
Soft Tissue Infections0low120
Soft Tissue Injuries0low10
Soft Tissue Neoplasms0medium41
Solitary Pulmonary Nodule0low20
Solitary Pulmonary Nodules0low20
Somatic Pain0low40
Somatization Disorder0medium21
Somatoform Disorders0medium21
Somatosensory Agnosia0low10
Somatosensory Discrimination Disorder0low40
Somatotropin Hypersecretion Syndrome (Acromegaly)0low20
Somnambulism0low10
Somnolence0medium22
Sore Throat0low20
Spasm of Conjugate Gaze0low20
Spasms, Infantile0medium144
Spasmus Nutans0medium144
Spastic0low20
Spastic Dysphonia0low10
Spastic Dysphonia, Neurologic Adducter0low10
Spastic Paraplegia0low10
Spastic Quadriplegia0low10
Spastic Tetraplegia0low10
Spatial Memory Disorder0medium243
Special Senses Disorders0low10
Speech And Language Disorder With Orofacial Dyspraxia0low10
Speech-Language Disorder 10low10
Sphenoid Sinusitis0low60
Sphenoid Wing Meningioma0low10
Sphenoidal Sinusitis0low60
Spherocytosis, Hereditary0low10
Spinal Arthritis0medium21
Spinal Cord Compression0low30
Spinal Cord Compression, Extramedullary0low30
Spinal Cord Contusion0low90
Spinal Cord Injuries0low90
Spinal Cord Ischemia0low10
Spinal Cord Ischemia, Experimental0low10
Spinal Cord Laceration0low90
Spinal Cord Myelodysplasia0low10
Spinal Cord Neoplasms0low20
Spinal Cord Neoplasms, Benign0low20
Spinal Cord Neoplasms, Intradural-Extramedullary0low20
Spinal Cord Neoplasms, Intramedullary0low20
Spinal Cord Neoplasms, Malignant0low20
Spinal Cord Neoplasms, Primary Intramedullary0low20
Spinal Cord Transection0low90
Spinal Cord Trauma0low90
Spinal Diseases0low20
Spinal Extradural Abscess0low40
Spinal Meningeal Neoplasms0low20
Spinal Meningioma0low10
Spinal Neoplasms0low40
Spinning Sensation0low10
Spinocerebellar Ataxia 10low10
Spinocerebellar Ataxia 20low10
Spinocerebellar Ataxia 40low10
Spinocerebellar Ataxia 50low10
Spinocerebellar Ataxia 60low10
Spinocerebellar Ataxia 70low10
Spinocerebellar Ataxia Type 10low10
Spinocerebellar Ataxia Type 20low10
Spinocerebellar Ataxia Type 40low10
Spinocerebellar Ataxia Type 50low10
Spinocerebellar Ataxia Type 60low10
Spinocerebellar Ataxia Type 70low10
Spinocerebellar Ataxia with Slow Eye Movements0low10
Spinocerebellar Ataxia-10low10
Spinocerebellar Ataxia-20low10
Spinocerebellar Ataxia-40low10
Spinocerebellar Ataxia-50low10
Spinocerebellar Ataxia-60low10
Spinocerebellar Ataxia-70low10
Spinocerebellar Ataxia, Autosomal Dominant, with Sensory Axonal Neuropathy0low10
Spinocerebellar Ataxia, Cuban Type0low10
Spinocerebellar Ataxias0low10
Spinocerebellar Ataxias, Dominantly-Inherited0low10
Spinocerebellar Atrophies0low10
Spinocerebellar Atrophy 20low10
Spinocerebellar Atrophy I0low10
Spinocerebellar Atrophy II0low10
Spinocerebellar Degeneration with Slow Eye Movements0low10
Spiral Fractures0medium2711
Spleen Cancer0low10
Spleen Neoplasms0low10
Splenic Cancer0low10
Splenic Diseases0low60
Splenic Hyalohyphomycosis0low20
Splenic Neoplasms0low10
Spondylarthritis0medium21
Spondylarthritis Ankylopoietica0medium102
Spondylarthropathies0low30
Spondylarthropathy0low30
Spondylitis0medium81
Spondylitis Ankylopoietica0medium102
Spondylitis, Ankylosing0medium102
Spondyloarthritis Ankylopoietica0medium102
Spondyloarthropathy0low30
Spondylodiscitis0low70
Spondylodiskitis0low70
Spontaneous Abortion0medium135
Spontaneous Ocular Nystagmus0low10
Spontaneous Pneumothorax0low20
Sporadic Retinoblastoma0low20
Sporothrix brasiliensis Infection0low150
Sporothrix Infection0low150
Sporothrix schenckii Infection0low150
Sporotrichosis0low150
Spotting0low10
Squamous Cell Cancer0low10
Squamous Cell Carcinoma0medium472
Squamous Cell Carcinoma of Head and Neck0low130
Squamous Cell Carcinoma of Larynx0low130
Squamous Cell Carcinoma of the Head and Neck0low130
Squamous Cell Carcinoma of the Larynx0low130
Squamous Cell Carcinoma of the Mouth0low130
Squamous Cell Carcinoma of the Nasal Cavity0low130
Squamous Cell Carcinoma, Head And Neck0low130
Squamous Cell Neoplasms0low10
SREDIu0160NJI u017DIVu010CANI SUSTAV, BOLESTI@hr0low120
St. Vitus's Dance0low10
Staphylococcal Diseases, Skin0low10
Staphylococcal Infections0low240
Staphylococcal Infections, Skin0low10
Staphylococcal Skin Diseases0low10
Staphylococcal Skin Infections0low10
Staphylococcus aureus Infection0low240
Starvation0low30
Static Tremor0low50
Status Bonnevie-Ullrich0low10
Status Cataplexicus0low10
Status Epilepticus0low50
Status Epilepticus, Alcohol Withdrawal-Induced0low10
Status Epilepticus, Complex Partial0low50
Status Epilepticus, Electrographic0low50
Status Epilepticus, Generalized0low50
Status Epilepticus, Generalized Convulsive0low50
Status Epilepticus, Grand Mal0low50
Status Epilepticus, Non-Convulsive0low50
Status Epilepticus, Simple Partial0low50
Status Epilepticus, Subclinical0low50
Status Lymphaticus0low10
Status Marmoratus0low40
Status Migrainosus0medium23878
STDs0medium21
Steatohepatitis0medium291
Steatosis of Liver0medium291
Stein-Leventhal Syndrome0medium12434
Steinert Disease0low10
Steinert Myotonic Dystrophy0low10
Steinert's Disease0low10
Stenocardia0low40
Stenosis0low20
Stenosis, Common Carotid Artery0low40
Stenosis, External Carotid Artery0low40
Stephanurus dentatus Infections0low10
Sterility0medium138
Sterility, Female0medium15359
Sterility, Male0medium206
Sterility, Postpartum0medium15359
Sterility, Reproductive0medium138
Stevens Johnson Syndrome Toxic Epidermal Necrolysis0low40
Stevens Johnson Syndrome Toxic Epidermal Necrolysis Spectrum0low40
Stevens-Johnson Syndrome0low40
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis0low40
Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum0low40
Still Disease, Juvenile-Onset0low20
Still's Disease, Juvenile-Onset0low20
Stillbirth0low10
Stimulus Deprivation-Induced Amblyopia0low10
Stings0low10
Stings and Bites0low10
STIs0medium21
Stomach Cancer0medium492
Stomach Diseases0low20
Stomach Neoplasms0medium492
Stomach Ulcer0low390
Stomatitis0medium21
Stomatitis, Denture0medium31
Storage Pool Deficiency0low10
Storage Pool Deficiency, Platelet0low10
Storage Pool Platelet Disease0low10
Streptococcal Infections0low70
Streptococcus pneumoniae Infections0low60
Streptozocin Diabetes0low740
Streptozotocin Diabetes0low740
Stress Disorder, Post Traumatic0medium178
Stress Disorders, Acute0low10
Stress Disorders, Post-Traumatic0medium178
Stress Disorders, Posttraumatic0medium178
Stress Disorders, Traumatic, Acute0low10
Stress Headache0medium21
Stricture0low20
Stridor0medium21
Stroke0medium145
Stroke, Acute0medium145
Stroke, Middle Cerebral Artery0low40
Strongylida Infections0low10
Stunned Myocardium0low10
Stunted Growth0medium2211
Stunting0medium2211
Stupor0low10
Sub-Fertility0medium138
Sub-Fertility, Female0medium15359
Sub-Fertility, Male0medium206
Subacromial Impingement Syndrome0low10
Subacute Delirium0medium153
Subacute Neuronopathic Gaucher Disease0low40
Subarachnoid Hemorrhage0low20
Subarachnoid Hemorrhage, Aneurysmal0low20
Subarachnoid Hemorrhage, Intracranial0low20
Subarachnoid Hemorrhage, Spontaneous0low20
Subclinical Seizure0medium125
Subcorneal Pustular Dermatosis0low20
Subcortical Infarction0low70
Subcutaneous Alternariosis0low60
Subcutaneous Hyalohyphomycosis0low20
Subcutaneous Phaeohyphomycosis0low160
Subdural Empyema0low10
Subdural Hematoma, Traumatic, Intracranial0low10
Subependymal Giant Cell Astrocytoma0low30
Subfertility0medium138
Subfertility, Female0medium15359
Subfertility, Male0medium206
Substance Abuse0medium153
Substance Abuse, Intravenous0low40
Substance Addiction0medium153
Substance Dependence0medium153
Substance Use0medium153
Substance Use Disorders0medium153
Substance Withdrawal Syndrome0medium325
Substance-Induced Psychoses0low10
Substance-Related Disorders0medium153
Subtrochanteric Fractures0medium21
Subwakefullness Syndrome0medium217
Sudden Cardiac Arrest0low20
Sudden Cardiac Death0low20
Sudden Death0medium21
Sudden Onset Scleroderma0low10
Sudden Visual Loss0low60
Sudek Atrophy0low20
Sudek's Atrophy0low20
Suffering, Physical0medium8117
Suffocation0low20
Suicidal Ideation0low20
Summer-Type Hypersensitivity Pneumonitis0low170
Sunburn0low10
Superficial Head Injury0low10
Superinfection0low30
Superinvasion, Microbial0low30
Superior Labrum from Anterior to Posterior Injuries0low10
Suppuration0low10
Suppurative Arthritis0low110
Suprasellar Cyst0low10
Supravalvar Aortic Stenosis Syndrome0low10
Surgery-Induced Tissue Adhesions0low60
Surgical Adhesions0low60
Surgical Blood Loss0medium11
Surgical Hemorrhage0medium11
Surgical Injuries0low10
Surgical Site Infection0low190
Surgical Wound Infection0low190
Susceptibility, Disease0medium181
Susceptibility, Genetic0medium162
Swallowing Disorders0low10
Swine Influenza0low80
Sycosis0low10
Sydenham Chorea0low10
Sydenham's Chorea0low10
Sykdommer i sentralnervesystemet@no0low120
Symmetric Diabetic Proximal Motor Neuropathy0low30
Sympathetic Nervous System Diseases0medium42
Sympathetic Reflex Dystrophia0low20
Symptom Cluster0medium232
Symptom Exacerbation0medium21
Symptom Exaggeration0medium21
Symptom Flare Up0medium21
Symptom Flare-up0medium21
Symptom Flareup0medium21
Symptom Flaring Up0medium21
Symptom Increase0medium21
Symptom Magnification0medium21
Symptom Worsening0medium21
Symptomatic Generalized Epilepsy0medium71
Symptomatic Infantile Spasms0medium144
Symptomatic Myoclonic Epilepsy0low50
Symptomatic Nystagmus0low10
Symptomatic Parkinson Disease0low70
Symptomatic Partial Complex Epilepsy0low10
Symptomatic Tonic-Clonic Epilepsy0medium31
Symptomatic West Syndrome0medium144
Synchronous Multiple Primary Neoplasms0low70
Synchronous Neoplasms0low70
Syncopal Episode0low10
Syncopal Vertigo0low10
Syncope0low10
Syncope, Cardiogenic0low10
Syncope, Carotid Sinus0low10
Syncope, Cerebral0low10
Syncope, Convulsive0low10
Syncope, Deglutitional0low10
Syncope, Effort0low10
Syncope, Hyperventilation0low10
Syncope, Malignant Neurocardiogenic0low10
Syncope, Micturition0low10
Syncope, Neurocardiogenic0low10
Syncope, Neurogenic0low10
Syncope, Postural0low10
Syncope, Situational0low10
Syncope, Stokes-Adams0low10
Syncope, Supine0low10
Syncope, Tussive0low10
Syncope, Vasodepressor0low10
Syncope, Vasovagal0low10
Syncope, Vasovagal, Neurally-Mediated0low10
Syndesmotic Injuries0low10
Syndrome0medium232
Syndrome of Inappropriate ADH (SIADH) Secretion0low10
Syndrome X, Insulin Resistance0medium195
Syndrome X, Metabolic0medium195
Syndrome, Brown's Tendon Sheath0low20
Syndrome, Obstructive Sleep Apnea0medium52
Syndrome, Reflex Sympathetic Dystrophy0low20
Syndrome, Sleep Apnea, Obstructive0medium52
Syndrome, Upper Airway Resistance, Sleep Apnea0medium52
Syngamiasis0low10
Synovial Hypertrophy0low20
Synovial Plica Syndrome0low20
Synovial Thickening0low20
Synovioma0low10
Synovitis0low20
Syphilis0low20
Syphilis, Central Nervous System0low20
Syphilis, CNS0low20
Systemic Anaplastic Large-Cell Lymphoma0low20
Systemic Arthritis, Juvenile0low20
Systemic Exertion Intolerance Disease0medium21
Systemic Inflammatory Response Syndrome0low30
Systemic Lupus Erythematosus0medium133
Systemic Mast-Cell Disease0low10
Systemic Scleroderma0low50
Systemic Sclerosis0low50
T Cell Leukemia Lymphoma, HTLV I Associated0low50
T Cell Leukemia, Adult0low50
T Lymphocytic Leukemia0low20
T-ALL0low130
T-Cell Acute Lymphocytic Leukemia0low130
T-Cell Leukemia0low20
T-Cell Leukemia-Lymphoma, Adult0low50
T-Cell Leukemia-Lymphoma, HTLV-I-Associated0low50
T-Cell Leukemia, Acute0low130
T-Cell Leukemia, Adult0low50
T-Cell Lymphoma0medium21
T-Cell Lymphoma, Cutaneous0low30
T-Cell Lymphoma, Peripheral0low10
T-Lymphocytic Leukemia0low20
T-Lymphocytic Leukemia, Acute0low130
T-Lymphocytopenia, Idiopathic CD4-Positive0low10
T-Lymphocytopenia, Idiopathic CD4+0low10
T-Lymphotropic Virus Type III Infections, Human0medium547104
Tachyarrhythmia0medium41
Tachycardia0medium41
Tachycardia, Sinus0low10
Tachycardia, Ventricular0low50
Tachypnea0low10
Tactile Agnosia0low10
Tactile Allodynia0medium361
TAGHD0medium11130
Takahara Disease0low20
Takahara's Disease0low20
Talipes Equinovarus0low10
Tardive Oral Dyskinesia0low20
Taste Disorder, Anterior Tongue0low10
Taste Disorder, Posterior Tongue0low10
Taste Disorder, Primary0low10
Taste Disorder, Primary, Bitter0low10
Taste Disorder, Primary, Salt0low10
Taste Disorder, Primary, Sweet0low10
Taste Disorder, Secondary0low10
Taste Disorder, Secondary, Bitter0low10
Taste Disorder, Secondary, Salt0low10
Taste Disorder, Secondary, Sweet0low10
Taste Disorders0low10
Taste Dysfunction0low10
Taste, Metallic0low10
Tat Deficiency0low10
Tauopathies0low50
Tauopathy0low50
TBI (Traumatic Brain Injury)0medium51
TBIs (Traumatic Brain Injuries)0medium51
Telangiectasia, Cerebello-Oculocutaneous0low20
Temporal Region Trauma0low10
Temporary Nystagmus0low10
Tendinitis0low20
Tendinopathy0low20
Tendinosis0low20
Tendon Sheath Syndrome of Brown0low20
Tendonitis0low20
Tendonopathy0low20
Tendonosis0low20
Tenosynovitis0low10
Tension Headache0medium21
Tension Pneumothorax0low20
Tension-Type Headache0medium21
Tension-Vascular Headache0medium21
Teratocarcinoma0low20
Teratogenesis0low20
Teratoid Tumor0low20
Teratoma0low20
Teratoma, Benign0low20
Teratoma, Cystic0low20
Teratoma, Immature0low20
Teratoma, Malignant0low20
Teratoma, Mature0low20
Testes, Undescended0low10
Testicular Cancer0low60
Testicular Diseases0low10
Testicular Neoplasm0low60
Testicular Neoplasms0low60
Testicular Tumor0low60
Testicular Tumors0low60
Testis Cancer0low60
Testis Neoplasms0low60
Testis, Undescended0low10
Testotoxicosis0medium245
Tethered Cord Syndrome0low10
Tethered Spinal Cord Syndrome0low10
Tetrahydrobiopterin Deficiency0low10
Tetraplegia0low10
Texidor's Twinge0low10
Textiloma0low10
Thalassemia0medium7515
Thalassemia Intermedia0medium15749
Thalassemia Major0medium15749
Thalassemia Major (beta-Thalassemia Major)0medium15749
Thalassemia Minor0medium15749
Thalassemia Minor (beta-Thalassemia Minor)0medium15749
Thalassemia, beta Type0medium15749
Thalassemias0medium7515
Therapy-Associated Cancer0medium125
Therapy-Associated Neoplasms0medium125
Therapy-Related Cancer0medium125
Therapy-Related Neoplasms0medium125
Thermal Allodynia0medium361
Thesaurismosis0low40
Third and Fourth Pharyngeal Pouch Syndrome0low10
Thoracic Diseases0low10
Thoracic Injuries0low10
Thoracoabdominal Aortic Aneurysm0low20
Throbbing Headache0medium3719
Thromboangiitis Obliterans0low10
Thromboangitis Obliterans0low10
Thrombocytopenia0medium234
Thrombocytopenic Purpura, Autoimmune0low30
Thromboembolism0medium41
Thromboembolism, Pulmonary0medium71
Thromboembolism, Venous0medium21
Thromboembolisms, Pulmonary0medium71
Thrombopenia0medium234
Thrombophilia0low10
Thrombophlebitis0low20
Thrombosis0medium141
Thrombosis, Carotid0low60
Thrombosis, Carotid Artery0low60
Thrombosis, Cavernous Sinus0low20
Thrombosis, Common Carotid Artery0low60
Thrombosis, Coronary0low30
Thrombosis, Deep Vein0low80
Thrombosis, External Carotid Artery0low60
Thrombosis, Internal Carotid Artery0low60
Thrombosis, Middle Cerebral Artery0low40
Thrombosis, Retinal Vein0low10
Thrombosis, Venous0low80
Thrombotic Infarction, Middle Cerebral Artery0low40
Thrombus0medium141
Thrush0medium516
Thymic Aplasia Syndrome0low10
Thymic Cancer0low20
Thymic Neoplasms0low20
Thymic Tumors0low20
Thymoma0low10
Thymus Cancer0low20
Thymus Neoplasms0low20
Thymus Tumors0low20
Thyroid Adenoma0medium261
Thyroid Cancer0medium261
Thyroid Cancer, Anaplastic0low40
Thyroid Cancer, Papillary0low10
Thyroid Carcinoma0medium261
Thyroid Carcinoma, Anaplastic0low40
Thyroid Carcinoma, Papillary0low10
Thyroid Diseases0low30
Thyroid Neoplasms0medium261
Thyroid-Stimulating Hormone Deficiency0medium61
Thyroiditis0low30
Thyroiditis, Autoimmune0low10
Thyroiditis, Lymphocytic0low10
Thyroiditis, Lymphomatous0low10
TIA (Transient Ischemic Attack)0low110
Tibial Fractures0low20
Tic0low10
Tic Disorder, Combined Vocal and Multiple Motor0low10
Tic Doloureux0low20
Tic Douloureux0low20
Tic, Gestural0low10
Tic, Motor0low10
Tic, Transient0low10
Tic, Vocal0low10
Tick-Borne Encephalitis0low30
Tics0low10
Tillaux Fracture0low20
Time Agnosia0low10
Tinea0low320
Tinea Capitis0low30
Tinea Capitis Profunda0low30
Tinea Corporis0low320
Tinea Pedis0medium122
Tinea Unguium0medium12631
Tinea Versicolor0medium52
Tissue Adhesions0low60
Tissue Pain0low40
Tobacco Dependence0low20
Tobacco Use Disorder0low20
Tobacco-Use Disorder0low20
Todd Paralysis0low30
Todd's Paralysis0low30
Toddler's Fracture0low20
Tonelessness Syndrome0low10
Tongue Cancer0low10
Tongue Neoplasms0low10
Toni-Debre-Fanconi Syndrome0medium161
Tonic Clonic Convulsions0medium31
Tonic Clonic Seizure0medium1153
Tonic Seizure0medium1153
Tonic Seizures0medium1153
Tonic-Clonic Convulsion Disorder0medium31
Tonic-Clonic Convulsion Syndrome0medium31
Tonic-Clonic Seizure0medium1153
Tonic-Clonic Seizure Disorder0medium31
Tonic-Clonic Seizure Syndrome0medium31
Tonic-Clonic Seizures0medium1153
Tonsillitis0low10
Topographical Agnosia0low10
Torsade de Pointes0low150
Torsades de Pointes0low150
Torsion Abnormality0low10
Torsion Fractures0medium2711
Toruloma0low320
Torulosis0medium894
Tourette Disease0low10
Tourette Disorder0low10
Tourette Syndrome0low10
Tourette's Disease0low10
Tourette's Disorder0low10
Tourette's Syndrome0low10
Toxemia Of Pregnancy0low40
Toxemias, Pregnancy0low40
Toxic Encephalitis0low130
Toxic Epidermal Necrolysis0low40
Toxic Epidermal Necrolysis Stevens Johnson Syndrome0low40
Toxic Epidermal Necrolysis Stevens Johnson Syndrome Spectrum0low40
Toxic Epidermal Necrolysis Stevens-Johnson Syndrome0low40
Toxic Epidermal Necrolysis Stevens-Johnson Syndrome Spectrum0low40
Toxic Hepatitis0medium1134
Toxic Megacolon0low10
Toxic Psychoses0low10
Toxic Shock0medium281
Toxic Shock Syndrome0medium281
Toxicity, Drug0medium7517
Toxocariasis0low10
Toxoplasma gondii Infection0low20
Toxoplasmosis0low20
Toxoplasmosis, Animal0low10
Toxoplasmosis, Central Nervous System0low10
Toxoplasmosis, Cerebral0low10
Tracheal Diseases0low10
Tracheitis0low40
Transformation, Neoplastic Cell0low320
Transfusion Reaction0medium11130
Transfusion-Associated Allergic Reaction0medium11130
Transfusion-Associated Circulatory Overload0medium11130
Transfusion-Associated Dyspnea0medium11130
Transfusion-Associated Graft Vs. Host Disease0medium11130
Transfusion-Transmitted Infection0medium11130
Transient Insomnia0medium12341
Transient Ischemic Attack0low110
Transient Ischemic Attack, Anterior Circulation0low110
Transient Ischemic Attack, Brain Stem0low110
Transient Ischemic Attack, Brainstem0low110
Transient Ischemic Attack, Carotid Circulation0low110
Transient Ischemic Attack, Posterior Circulation0low110
Transient Ischemic Attack, Vertebrobasilar Circulation0low110
Transient Ischemic Attacks, Crescendo0low110
Transient Situational Disturbance0medium31
Transitional Meningioma0low10
Transitory Hearing Loss0low30
Translocation, Chromosomal0medium41
Translocation, Genetic0medium41
Trauma0low130
Trauma, Brain0medium51
Trauma, Carotid Artery0low50
Trauma, Head0low10
Trauma, Multiple0low10
Traumatic Brain Injury0medium51
Traumatic Encephalopathy0medium51
Traumatic Intracranial Subdural Hematoma0low10
Treatment-Associated Cancer0medium125
Treatment-Associated Neoplasms0medium125
Treatment-Related Cancer0medium125
Treatment-Related Neoplasms0medium125
Tremor0low50
Tremor, Limb0low50
Tremor, Muscle0low50
Tremor, Neonatal0low50
Tremor, Nerve0low50
Tremor, Perioral0low50
Tremor, Rubral0low30
Tremor, Semirhythmic0low50
Trichinelliasis0low10
Trichinellosis0low10
Trichinosis0low10
Trichobezoars0low10
Trichomonas Vaginitis0low10
Trichomoniasis, Human0low10
Trichophytia Profunda Barbae0low30
Trichophytia Profunda Capitis0low30
Trichophyton mentagrophytes Infection0low320
Trichophytosis0low320
Trichosporon Infection0low170
Trichosporonosis0low170
Trichostrongyloidiasis0low10
Trichostrongylosis0low10
Trifacial Neuralgia0low20
Trigeminal Neuralgia0low20
Trigeminal Neuralgia, Idiopathic0low20
Trigeminal Neuralgia, Secondary0low20
Triple Negative Breast Cancer0medium442
Triple Negative Breast Neoplasms0medium442
Triple-Negative Breast Cancer0medium442
Triple-Negative Breast Neoplasm0medium442
Trisomy0low10
Trisomy 210low10
Trisomy 21, Meiotic Nondisjunction0low10
Trisomy 21, Mitotic Nondisjunction0low10
Trisomy G0low10
Tritan Defect0medium11
Trochanteric Fractures0medium21
Troisier-Hanot-Chauffard Syndrome0medium241
Tropical Eosinophilia0low100
Tropical Eosinophilic Pneumonia0low70
True Hermaphroditism0low10
Trypanosoma cruzi Infection0medium965
Trypanosomiasis0low10
Trypanosomiasis, African0low80
Trypanosomiasis, Cardiovascular0low40
Trypanosomiasis, South American0medium965
TSH Deficiency0medium61
Tuberculin-Type Hypersensitivity0low70
Tuberculoses, Pulmonary0low60
Tuberculosis0medium231
Tuberculosis, Drug-Resistant0low20
Tuberculosis, Extensively Drug-Resistant0low10
Tuberculosis, Extremely Drug-Resistant0low10
Tuberculosis, MDR0low20
Tuberculosis, Multi-Drug Resistant0low20
Tuberculosis, Multidrug-Resistant0low20
Tuberculosis, Pulmonary0low60
Tuberose Sclerosis0low10
Tuberous Sclerosis0low10
Tuberous Sclerosis Complex0low10
Tubulointerstitial Nephritis0low40
Tumor Cells, Embolic0low20
Tumor Lysis Syndrome0low30
Tumor of Rete Testis0low60
Tumor Virus Infections0low20
Tumor-Associated Pain0medium42
Tumor-Related Pain0medium42
Tumor, Benign, Optic Nerve0low10
Tumor, Malignant, Optic Nerve0low10
Tumor, Optic Nerve, Benign0low10
Tumor, Optic Nerve, Malignant0low10
Tumorigenesis0medium171
Tumorigenic Transformation0low320
Tumors0medium31633
Tumors of the Nerve Sheath0low20
Tumors, Breast0medium1,790464
Tumors, Breast, Male0medium142
Tumors, Central Nervous System0low20
Tumors, Retinal0low30
Tumors, Spinal Cord0low20
Tumour Lysis Syndrome0low30
Turf Toe0low10
Turner Syndrome0low10
Turner's Syndrome0low10
Tympanic Membrane Perforation0low10
Tympanic Membrane Rupture0low10
Type 1 Diabetes0medium235
Type 1 Diabetes Mellitus0medium235
Type 1 Gaucher Disease0low40
Type 1 Spinocerebellar Ataxia0low10
Type 2 Diabetes0medium560179
Type 2 Diabetes Mellitus0medium560179
Type 2 Gaucher Disease0low40
Type 2 Spinocerebellar Ataxia0low10
Type 3 Gaucher Disease0low40
Type 4 Spinocerebellar Ataxia0low10
Type 5 Spinocerebellar Ataxia0low10
Type 6 Spinocerebellar Ataxia0low10
Type 7 Spinocerebellar Ataxia0low10
Type B Haemophilus influenzae Meningitis0low10
Type B Hemophilus influenzae Meningitis0low10
Type I Complex Regional Pain Syndrome0low20
Type I Congenital Dyserythropoietic Anemia0medium21
Type I Hypersensitivity0low40
Type I Renal Tubular Acidosis0low20
Type II Renal Tubular Acidosis0low20
Type III Hypersensitivity0low30
Type IV Hypersensitivity0low70
Typical Aura without Headache0low30
Tyrosine Aminotransferase Deficiency0low10
Tyrosine Transaminase Deficiency0low10
Tyrosine Transaminase Deficiency Disease0low10
Tyrosinemia0low10
Tyrosinemia Type 10low10
Tyrosinemia, Type 20low10
Tyrosinemia, Type I0low10
Tyrosinemia, Type II0low10
Tyrosinemia, Type III0low10
Tyrosinemias0low10
Tyrosinemias, Hereditary0low10
Tyrosinosis, Oculocutaneous Type0low10
u041Du0415u0420u0412u041Du041Eu0419 u0421u0418u0421u0422u0415u041Cu042B u0426u0415u041Du0422u0420u0410u041Bu042Cu041Du041Eu0419 u0411u041Eu041Bu0415u0417u041Du0418@ru0low120
u4E2Du67A2u795Eu7D4Cu7CFBu75BEu60A3@ja0low120
UADT Neoplasm0medium251
UADT Neoplasms0medium251
Ulcer0low90
Ulcer, Rodent0low90
Ulcerating Plaque, Carotid Artery0low40
Ulcerative Colitis0medium183
Ullrich-Turner Syndrome0low10
Uncinate Seizures0medium125
Undernutrition0medium11
Undescended Testis0low10
Undifferentiated Lymphoma0medium205
Unidirectional Nystagmus0low10
Unilateral Blindness0low60
Unilateral Cryptorchidism0low10
Unilateral Headache0medium3719
Unilateral Hypotonia0low10
Unipolar Depression0medium15846
Unstable Angina0medium11
Upper Aerodigestive Tract Neoplasm0medium251
Upper Aerodigestive Tract Neoplasms0medium251
Upper Airway Resistance Sleep Apnea Syndrome0medium52
Upper Brachial Plexus Neuropathy0low10
Upper Extremity Paresis0low10
Upper Motor Neuron Disease0low10
Upper Respiratory Infections0medium131
Upper Respiratory Tract Infection0medium131
Upper Respiratory Tract Infections0medium131
UPS Deficiency0low30
Ureaplasma Infections0low20
Uremia0low10
Ureteral Diseases0low10
Ureteral Obstruction0low100
Urethral Obstruction0low10
Urinary Bladder Cancer0low100
Urinary Bladder Diseases0medium41
Urinary Bladder Disorder, Neurogenic0low10
Urinary Bladder Exstrophy0low10
Urinary Bladder Neoplasms0low100
Urinary Bladder Neurogenesis0low10
Urinary Bladder Neurogenic Dysfunction0low10
Urinary Bladder, Neurogenic0low10
Urinary Bladder, Overactive0low30
Urinary Incontinence0low10
Urinary Incontinence, Stress0low10
Urinary Stress Incontinence0low10
Urinary Tract Diseases0medium22
Urinary Tract Infections0medium122
Urination Disorders0medium21
Urologic Diseases0medium22
Urological Diseases0medium22
Uroporphyrinogen III Synthase, Deficiency of0low30
Uroporphyrinogen Synthase Deficiency0low30
UROS Deficiency0low30
Urticaria0low50
Urticaria, Giant0low60
Usual Interstitial Pneumonia0low40
Uterine Bleeding0medium103
Uterine Cancer0medium367
Uterine Cervical Cancer0medium123
Uterine Cervical Neoplasms0medium123
Uterine Diseases0medium72
Uterine Hemorrhage0medium103
Uterine Neoplasms0medium367
Uterus Cancer0medium367
Uterus Neoplasms0medium367
Uveal Neoplasms0medium31
Uveitis0low20
Uveitis, Anterior0low10
Vaccinia0low20
Vaginal Bleeding0medium103
Vaginal Diseases0medium94
Vaginal Yeast Infection0medium7421
Vaginal Yeast Infections0medium7421
Vaginitides, Bacterial0low10
Vaginitis0medium81
Vaginitis, Bacterial0low10
Vaginitis, Monilial0medium7421
Vaginitis, Nonspecific0low10
Vaginoses, Bacterial0low10
Vaginosis, Bacterial0low10
Valley Fever0medium594
Valvular Heart Diseases0low30
Vanishing White Matter Disease0low10
Vanishing White Matter Leukodystrophy0low10
Varicella0low10
Varices0low20
Varicose Veins0low20
Variegate Porphyria0low10
Varix0low20
Vascular Accident, Brain0medium145
Vascular Diseases0low20
Vascular Diseases, Intracranial0low40
Vascular Diseases, Peripheral0low20
Vascular Hypotension0low240
Vascular Injuries0low10
Vascular Remodeling0low20
Vascular Skin Diseases0low10
Vascular System Injuries0low10
Vasculitis0low50
Vasculitis, Allergic Cutaneous0low10
Vasculitis, Hypersensitivity0low10
Vasculitis, Leukocytoclastic, Cutaneous0low10
Vasogenic Brain Edema0low50
Vasogenic Cerebral Edema0low50
Vasopressin-Resistant Diabetes Insipidus0low10
Vasospasm, Intracranial0low10
VCF Syndrome0low10
Velo-Cardio-Facial Syndrome0low10
Velocardiofacial Syndrome0low10
Venereal Diseases0medium21
Venereal Diseases, Viral0medium11
Veno-Occlusive Disease, Hepatic0medium21
Venous Congestion0medium153
Venous Engorgement0medium153
Venous Infarction, Brain0low30
Venous Sinus Thrombosis, Cranial0low10
Venous Thromboembolism0medium21
Venous Thrombosis0low80
Ventilatory Depression0low50
Ventricle Remodeling0low90
Ventricular Dysfunction0low20
Ventricular Dysfunction, Left0medium61
Ventricular Fibrillation0low100
Ventricular Hypertrophy, Left0low30
Ventricular Hypertrophy, Right0low10
Ventricular Neoplasms, Brain0low10
Ventricular Outflow Obstruction0low10
Ventricular Outflow Obstruction, Left0low10
Ventricular Outflow Obstruction, Right0low10
Ventricular Remodeling0low90
Ventricular Tachyarrhythmias0low50
Ventricular Tachycardia0low50
Ventricular Tumors, Brain0low10
Vertebrobasilar Circulation Transient Ischemic Attack0low110
Vertebrogenic Pain Syndrome0medium21
Vertex Headache0medium3719
Vertical Nystagmus0low10
Vertigo0low10
Vertigo, Brain Stem0low10
Vertigo, Brainstem0low10
Vertigo, Central Nervous System Origin0low10
Vertigo, Central Origin0low10
Vertigo, Constant0low10
Vertigo, Essential0low10
Vertigo, Intermittant0low10
Vertigo, Paroxysmal0low10
Vertigo, Peripheral0low10
Vertigo, Subjective0low10
Vesication0medium31
Vesicular Skin Diseases0low20
Vesiculobullous Dermatoses0low20
Vesiculobullous Skin Diseases0low20
Vestibular Diseases0medium31
Veterinary Abortion0low20
VI Nerve Palsy0low10
Vibrio cholerae Infection0medium11
Vibrio Illness0low30
Vibrio Infections0low30
Vibriosis0low30
Viral Diseases0low20
Viral Encephalitis, Japanese B0low10
Viral Eye Infections0low10
Viral Hepatitis, Human0low20
Viral Infections0low20
Viral Sexually Transmitted Disease0medium11
Viral Sexually Transmitted Diseases0medium11
Viral Venereal Diseases0medium11
Viremia0medium93
Virilism0low10
Virilization0low10
Virus Diseases0low20
Virus Infections0low20
Visceral Myopathy0low10
Visceral Steatosis0medium291
Vision Disability0low200
Vision Disorders0low200
Visual Agnosia0low10
Visual Agnosia for Objects0low10
Visual Disorders0low200
Visual Disorientation Syndrome0low10
Visual Impairment0low200
Visuospatial Agnosia0low10
Vitamin C Deficiency0low10
Vitamin D Deficiency0medium41
Vitamin E Deficiency0low30
VIth Cranial Nerve Diseases0low10
Vitreoretinopathy Neovascular Inflammatory0low20
Vitreoretinopathy, Proliferative0low20
Voice Hoarseness0medium11
Vomiting0medium184
Von Recklenhausen-Applebaum Disease0medium241
Vulva Cancer0low20
Vulva Neoplasms0low20
Vulvar Cancer0low20
Vulvar Diseases0low10
Vulvar Lichen Sclerosus0low30
Vulvar Neoplasms0low20
Vulvovaginitis0medium32
Wadia Swami Syndrome0low10
Wadia-Swami Syndrome0low10
Wake-up Stroke0low20
Waldenstrom Macroglobulinemia0low50
Waldenstrom's Macroglobulinaemia0low50
Waldenstrom's Macroglobulinemia0low50
War Neuroses0medium108
War Neurosis0medium108
Wasting Disease, Chronic0low10
Water Stress0low30
Water-Electrolyte Imbalance0low20
Wegener Granulomatosis0low40
Wegener's Granulomatosis0low40
Weight Gain0medium293
Weight Loss0medium3111
Weight Reduction0medium3111
Weil Disease0low10
Weil's Disease0low10
Well Differentiated Liposarcoma0medium52
Werlhof Disease0low30
Werlhof's Disease0low30
Werner Syndrome0low20
Werner's Syndrome0low20
Werners Syndrome0low20
West Nile Fever0low20
West Nile Fever Encephalitis0low20
West Nile Fever Meningitis0low20
West Nile Fever Meningoencephalitis0low20
West Nile Fever Myelitis0low20
West Nile Virus Infection0low20
West Syndrome0medium144
Wet Lung0low100
Wheezing0medium21
White Matter Diseases0low10
White Spot, Dental0low20
White Spots, Dental0low20
Widespread Chronic Pain0low80
Wilhelmsen-Lynch Disease0medium11
Williams Contiguous Gene Syndrome0low10
Williams Syndrome0low10
Williams-Beuren Syndrome0low10
Willis Ekbom Disease0low20
Willis Ekbom Syndrome0low20
Willis-Ekbom Disease0low20
Willis-Ekbom Syndrome0low20
Winter Depression0medium11
Withdrawal Symptoms0medium325
Wittmaack Ekbom Syndrome0low20
Wittmaack-Ekbom Syndrome0low20
WNV Infection0low20
Wound Infection0low30
Wound Infection, Postoperative0low190
Wound Infection, Surgical0low190
Wounds0low130
Wounds and Injuries0low130
Wounds and Injury0low130
Wounds, Injury0low130
Wounds, Multiple0low10
Wrist Injuries0low10
Writer's Cramp0low10
X-Linked Chronic Granulomatous Disease0medium353
X-Linked Genetic Diseases0low20
X-Linked Hypergonadotropic Ovarian Failure0medium31
X-Linked Lymphoproliferative Disease0low30
X-Linked Lymphoproliferative Disorder0low30
X-Linked Lymphoproliferative Syndrome0low30
X-Linked Mental Retardation and Macroorchidism0low20
Xanthomatous Meningioma0low10
XDR-TB0low10
Xenotropic MuLV-related Virus Infection0low10
Xenotropic Murine Leukemia Virus-related Virus Infection0low10
Xeroderma0low10
Xerostomia0low30
XMRV Infection0low10
XX Male Syndrome, Sry-Positive0low10
XXXY Males0medium61
XXY Syndrome0medium61
XXY Trisomy0medium61
Xxyy Syndrome0medium61
Zentralnervensystemkrankheiten@de0low120
Ziekte, centraalzenuwstelsel-@nl0low120
Zika Fever0low10
Zika Virus Disease0low10
Zika Virus Infection0low10
ZikV Infection0low10
Zinsser-Cole-Engman Syndrome0low10
Zona0low20
Zoster0low20
Zygomycosis0medium701

Research Highlights

Safety/Toxicity (825)

ArticleYear
Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures.
Bioorganic chemistry, Volume: 141		2023
Integrated safety analysis of filgotinib for ulcerative colitis: Results from SELECTION and SELECTIONLTE.
Alimentary pharmacology & therapeutics, Volume: 58, Issue: 9		2023
Comprehensive evaluation of chiral sedaxane with four stereoisomers for risk reduction: Bioactivity, toxicity, and stereoselective dissipation in crop planting systems.
Food chemistry, Feb-15, Volume: 434		2024
Rational understanding of chiral fungicide penthiopyrad stereoselectivity: Bioactivity, aquatic toxicity and cytotoxicity.
The Science of the total environment, Dec-20, Volume: 905		2023
Comparing efficacy and safety of stair step protocols for clomiphene citrate and letrozole in ovulation induction for women with polycystic ovary syndrome (PCOS): a randomized controlled clinical trial.
Journal of medicine and life, Volume: 16, Issue: 5		2023
New insights into triazole fungicide-caused hematopoietic abnormality in zebrafish based on GRα screening developmental toxicity.
Environmental pollution (Barking, Essex : 1987), Oct-01, Volume: 334		2023
A systematic review and meta-analysis of efficacy and safety of isavuconazole for the treatment and prophylaxis of invasive fungal infections.
Mycoses, Volume: 66, Issue: 9		2023
Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
Medical mycology, Jun-05, Volume: 61, Issue: 6		2023
Modifications of geldanamycin via CuAAC altering affinity to chaperone protein Hsp90 and cytotoxicity.
European journal of medicinal chemistry, Aug-05, Volume: 256		2023
Design, Synthesis and Cytotoxicity of New Coumarin-1,2,3-triazole Derivatives: Evaluation of Anticancer Activity and Molecular Docking Studies.
Chemistry & biodiversity, Volume: 20, Issue: 7		2023
Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies.
Scientific reports, 04-25, Volume: 13, Issue: 1		2023
Resveratrol ameliorates penconazole-induced cardiotoxicity by inhibition of oxidative stress and apoptosis in zebrafish larvae.
Ecotoxicology and environmental safety, Volume: 256		2023
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses.
Journal of clinical pharmacology, Volume: 63, Issue: 6		2023
Triadimenol promotes the production of reactive oxygen species and apoptosis with cardiotoxicity and developmental abnormalities in zebrafish.
The Science of the total environment, Mar-01, Volume: 862		2023
Joint toxic effects of thiamethoxam and flusilazole on the adult worker honey bees (Apis mellifera L.).
Environmental pollution (Barking, Essex : 1987), Jan-15, Volume: 317		2023
Isavuconazole for the Treatment of Invasive Mold Disease in Solid Organ Transplant Recipients: A Multicenter Study on Efficacy and Safety in Real-life Clinical Practice.
Transplantation, 03-01, Volume: 107, Issue: 3		2023
Efficacy and safety of isavuconazole against deep-seated mycoses: A phase 3, randomized, open-label study in Japan.
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, Volume: 29, Issue: 2		2023
Glycoconjugation of Quinoline Derivatives Using the C-6 Position in Sugars as a Strategy for Improving the Selectivity and Cytotoxicity of Functionalized Compounds.
Molecules (Basel, Switzerland), Oct-15, Volume: 27, Issue: 20		2022
Letrozole: Pharmacology, toxicity and potential therapeutic effects.
Life sciences, Dec-01, Volume: 310		2022
Difenoconazole disrupts the blood-brain barrier and results in neurotoxicity in carp by inhibiting the Nrf2 pathway mediated ROS accumulation.
Ecotoxicology and environmental safety, Oct-01, Volume: 244		2022
Voriconazole-induced severe skin allergy and neurological adverse event in a liver failure patient: A case report.
Journal of clinical pharmacy and therapeutics, Volume: 47, Issue: 10		2022
Bromuconazole exposure induces cardiotoxicity and lipid transport disorder in larval zebrafish.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 262		2022
Evaluation of titanium and silicon role in mitigation of fungicides toxicity in wheat expressed at the level of biochemical and antioxidant profile.
Chemosphere, Volume: 308, Issue: Pt 1		2022
Brief Report: Efficacy and Safety of Oral Islatravir Once Daily in Combination With Doravirine Through 96 Weeks for Treatment-Naive Adults With HIV-1 Infection Receiving Initial Treatment With Islatravir, Doravirine, and Lamivudine.
Journal of acquired immune deficiency syndromes (1999), 09-01, Volume: 91, Issue: 1		2022
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.
Cancer chemotherapy and pharmacology, Volume: 90, Issue: 3		2022
Synthesis of ribavirin 1,2,3- and 1,2,4-triazolyl analogs with changes at the amide and cytotoxicity in breast cancer cell lines.
Nucleosides, nucleotides & nucleic acids, Volume: 42, Issue: 1		2023
Sub-structure-based category formation for the prioritisation of genotoxicity hazard assessment for pesticide residues (part 2): Triazoles.
Regulatory toxicology and pharmacology : RTP, Volume: 134		2022
Mechanisms, toxicity and optimal conditions - research on the removal of benzotriazoles from water using Wolffia arrhiza.
The Science of the total environment, Nov-15, Volume: 847		2022
Toxicity prediction of 1,2,4-triazoles compounds by QSTR and interspecies QSTTR models.
Ecotoxicology and environmental safety, Sep-01, Volume: 242		2022
Difenoconazole causes cardiotoxicity in common carp (Cyprinus carpio): Involvement of oxidative stress, inflammation, apoptosis and autophagy.
Chemosphere, Volume: 306		2022
Torsade de Pointes/QT Prolongation Associated with Antifungal Triazoles: A Pharmacovigilance Study Based on the U.S. FDA Adverse Event Reporting System（FAERS）.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, Volume: 25		2022
Enantioselective neurotoxicity and oxidative stress effects of paclobutrazol in zebrafish (Danio rerio).
Pesticide biochemistry and physiology, Volume: 185		2022
Stereoselective bioactivity, toxicity and degradation of novel fungicide sedaxane with four enantiomers under rice-wheat rotation mode.
Ecotoxicology and environmental safety, Volume: 241		2022
Low trifloxystrobin-tebuconazole concentrations induce cardiac and developmental toxicity in zebrafish by regulating notch mediated-oxidative stress generation.
Ecotoxicology and environmental safety, Volume: 241		2022
Effectiveness and safety of isavuconazole prophylaxis for invasive fungal infections in the haematologic setting.
Hematology (Amsterdam, Netherlands), Volume: 27, Issue: 1		2022
Acute toxicity and antitumor potential of 1,3,4-trisubstituted-1,2,3-triazole dhmtAc-loaded liposomes on a triple-negative breast cancer model.
Archiv der Pharmazie, Volume: 355, Issue: 9		2022
Selinexor Combined with Ibrutinib Demonstrates Tolerability and Safety in Advanced B-Cell Malignancies: A Phase I Study.
Clinical cancer research : an official journal of the American Association for Cancer Research, 08-02, Volume: 28, Issue: 15		2022
Exposure to difenoconazole induces reproductive toxicity in zebrafish by interfering with gamete maturation and reproductive behavior.
The Science of the total environment, Sep-10, Volume: 838, Issue: Pt 1		2022
New Triazolyl N^N Bidentate Rh(III), Ir(III), Ru(II) and Os(II) Complexes: Synthesis and Characterization, Probing Possible Relations between Cytotoxicity with Transfer Hydrogenation Efficacy and Interaction with Model Biomolecules.
Molecules (Basel, Switzerland), Mar-23, Volume: 27, Issue: 7		2022
Network Pharmacology Combined with Metabolomics Approach to Investigate the Toxicity Mechanism of Paclobutrazol.
Chemical research in toxicology, 04-18, Volume: 35, Issue: 4		2022
Toxicity, bioactivity of triazole fungicide metconazole and its effect on mycotoxin production by Fusarium verticillioides: New perspective from an enantiomeric level.
The Science of the total environment, Jul-01, Volume: 828		2022
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database.
Expert opinion on drug safety, Volume: 21, Issue: 8		2022
Developmental toxicity of fenbuconazole in zebrafish: Effects on mitochondrial respiration and locomotor behavior.
Toxicology, 03-30, Volume: 470		2022
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects.
Clinical pharmacology in drug development, Volume: 11, Issue: 6		2022
Safety and Effectiveness of Isavuconazole Treatment for Fungal Infections in Solid Organ Transplant Recipients (ISASOT Study).
Microbiology spectrum, 02-23, Volume: 10, Issue: 1		2022
Synthesis, in vitro cytotoxicity, molecular docking and ADME study of some indolin-2-one linked 1,2,3-triazole derivatives.
Computational biology and chemistry, Volume: 97		2022
Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial.
The lancet. Psychiatry, Volume: 9, Issue: 3		2022
Risk Assessment of the Chiral Fungicide Triticonazole: Enantioselective Effects, Toxicity, and Fate.
Journal of agricultural and food chemistry, Mar-02, Volume: 70, Issue: 8		2022
Enantioselective acute toxicity, oxidative stress effects, neurotoxicity, and thyroid disruption of uniconazole in zebrafish (Danio rerio).
Environmental science and pollution research international, Volume: 29, Issue: 26		2022
Efficacy and safety of Isavuconazole for the treatment of invasive
Expert opinion on pharmacotherapy, Volume: 23, Issue: 5		2022
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study.
Clinical lymphoma, myeloma & leukemia, Volume: 22, Issue: 7		2022
Exposure-response relationships for the efficacy and safety of filgotinib and its metabolite GS-829845 in subjects with rheumatoid arthritis based on phase 2 and phase 3 studies.
British journal of clinical pharmacology, Volume: 88, Issue: 7		2022
Novel Coumarin Derivatives Containing a Triazole Moiety: A Study on Synthesis, Cytotoxicity, Membrane Dysfunction, Apoptosis, Cell Cycle, and Antiangiogenic Effects.
Anti-cancer agents in medicinal chemistry, Volume: 22, Issue: 13		2022
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)
Modern rheumatology, Feb-28, Volume: 32, Issue: 2		2022
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Modern rheumatology, Feb-28, Volume: 32, Issue: 2		2022
Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis.
Medicine, Dec-10, Volume: 100, Issue: 49		2021
Chiral fungicide penconazole: Absolute configuration, bioactivity, toxicity, and stereoselective degradation in apples.
The Science of the total environment, Feb-20, Volume: 808		2022
Ecotoxicity of herbicide carfentrazone-ethyl towards earthworm Eisenia fetida in soil.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 253		2022
Design, Synthesis, biological investigations and molecular interactions of triazole linked tacrine glycoconjugates as Acetylcholinesterase inhibitors with reduced hepatotoxicity.
Bioorganic chemistry, Volume: 118		2022
Selective Orexin Receptor Antagonists as Novel Augmentation Treatments for Major Depressive Disorder: Evidence for Safety and Efficacy From a Phase 2B Study of Seltorexant.
The international journal of neuropsychopharmacology, 01-12, Volume: 25, Issue: 1		2022
Evaluating posaconazole, its pharmacology, efficacy and safety for the prophylaxis and treatment of fungal infections.
Expert opinion on pharmacotherapy, Volume: 23, Issue: 2		2022
Permeabilized Cryopreserved Human Hepatocytes as an Exogenous Metabolic System in a Novel Metabolism-Dependent Cytotoxicity Assay for the Evaluation of Metabolic Activation and Detoxification of Drugs Associated with Drug-Induced Liver Injuries: Results w
Drug metabolism and disposition: the biological fate of chemicals, Volume: 50, Issue: 2		2022
Integrated safety analysis of filgotinib in patients with moderately to severely active rheumatoid arthritis receiving treatment over a median of 1.6 years.
Annals of the rheumatic diseases, Volume: 81, Issue: 2		2022
A comprehensive review of 1,2,4-triazole fungicide toxicity in zebrafish (Danio rerio): A mitochondrial and metabolic perspective.
The Science of the total environment, Feb-25, Volume: 809		2022
1,2,3-Triazole derivatives: synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity.
Chemico-biological interactions, Dec-01, Volume: 350		2021
The discovery of combined toxicity effects and mechanisms of hexaconazole and arsenic to mice based on untargeted metabolomics.
Ecotoxicology and environmental safety, Dec-15, Volume: 226		2021
Potential neurotoxicity, immunotoxicity, and carcinogenicity induced by metribuzin and tebuconazole exposure in earthworms (Eisenia fetida) revealed by transcriptome analysis.
The Science of the total environment, Feb-10, Volume: 807, Issue: Pt 1		2022
Bromuconazole caused genotoxicity and hepatic and renal damage via oxidative stress process in Wistar rats.
Environmental science and pollution research international, Volume: 29, Issue: 10		2022
Efficacy and safety of antiseizure medication for Lennox-Gastaut syndrome: a systematic review and network meta-analysis.
Developmental medicine and child neurology, Volume: 64, Issue: 3		2022
Efficacy and Safety of Molidustat for Anemia in ESA-Naive Nondialysis Patients: A Randomized, Phase 3 Trial.
American journal of nephrology, Volume: 52, Issue: 10-11		2021
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes.
Clinical lymphoma, myeloma & leukemia, Volume: 22, Issue: 1		2022
Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3.
RMD open, Volume: 7, Issue: 2		2021
Acute toxicity of the insecticide abamectin and the fungicide difenoconazole (individually and in mixture) to the tropical stingless bee Melipona scutellaris.
Ecotoxicology (London, England), Volume: 30, Issue: 9		2021
Degradation of difenoconazole in water and soil: Kinetics, degradation pathways, transformation products identification and ecotoxicity assessment.
Journal of hazardous materials, 09-15, Volume: 418		2021
Efficacy and Safety of Seltorexant as Adjunctive Therapy in Major Depressive Disorder: A Phase 2b, Randomized, Placebo-Controlled, Adaptive Dose-Finding Study.
The international journal of neuropsychopharmacology, 12-08, Volume: 24, Issue: 12		2021
Efficacy and safety of rufinamide as adjunctive therapy in patients with Lennox Gastaut syndrome: A systematic review and Meta-analysis.
Seizure, Volume: 91		2021
Histology and multi-omic profiling reveal the mixture toxicity of tebuconazole and difenoconazole in adult zebrafish.
The Science of the total environment, Nov-15, Volume: 795		2021
In silico modelling of acute toxicity of 1, 2, 4-triazole antifungal agents towards zebrafish (Danio rerio) embryos: Application of the Small Dataset Modeller tool.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 75		2021
Transcriptomic changes upon epoxiconazole exposure in a human stem cell-based model of developmental toxicity.
Chemosphere, Volume: 284		2021
QSCR Analysis of Cytotoxicity of 6-Fluoro-3-(4H-1,2,4-triazol-3- yl)quinolin-4(1H)-ones on Chinese Hamster Ovary Cell Line: Design of REPUBLIC1986.
Current medicinal chemistry, Volume: 29, Issue: 2		2022
Cytotoxic 1,2,3-Triazoles as Potential Leads Targeting the S100A2-p53 Complex: Synthesis and Cytotoxicity.
ChemMedChem, 09-16, Volume: 16, Issue: 18		2021
Efficacy and safety of isavuconazole compared with voriconazole as primary antifungal prophylaxis in allogeneic hematopoietic cell transplant recipients.
Medical mycology, Oct-04, Volume: 59, Issue: 10		2021
The safety of JAK-1 inhibitors.
Rheumatology (Oxford, England), 05-05, Volume: 60, Issue: Suppl 2		2021
A toxicogenomics approach reveals characteristics supporting the honey bee (Apis mellifera L.) safety profile of the butenolide insecticide flupyradifurone.
Ecotoxicology and environmental safety, Jul-01, Volume: 217		2021
Tebuconazole induced cytotoxic and genotoxic effects in HCT116 cells through ROS generation.
Pesticide biochemistry and physiology, Volume: 174		2021
Synthesis of sorafenib analogues incorporating a 1,2,3-triazole ring and cytotoxicity towards hepatocellular carcinoma cell lines.
Bioorganic chemistry, Volume: 112		2021
Three widely used pesticides and their mixtures induced cytotoxicity and apoptosis through the ROS-related caspase pathway in HepG2 cells.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, Volume: 152		2021
Design of molecular hybrids of phthalimide-triazole agents with potent selective MCF-7/HepG2 cytotoxicity: Synthesis, EGFR inhibitory effect, and metabolic stability.
Bioorganic chemistry, Volume: 111		2021
Fungicide bromuconazole has the potential to induce hepatotoxicity at the physiological, metabolomic and transcriptomic levels in rats.
Environmental pollution (Barking, Essex : 1987), Jul-01, Volume: 280		2021
Early Toxic Effects in a Central American Native Fish (Parachromis dovii) Exposed to Chlorpyrifos and Difenoconazole.
Environmental toxicology and chemistry, Volume: 40, Issue: 7		2021
Overview of Ocular Side Effects of Selinexor.
The oncologist, Volume: 26, Issue: 7		2021
Evaluation of triazophos induced immunotoxicity of spleen and head kidney in fresh water teleost, Channa punctata.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, Volume: 245		2021
Tebuconazole-induced toxicity and the protective effect of Ficus carica extract in Neotropical fruit-eating bats.
Chemosphere, Volume: 275		2021
TNFα enhances trovafloxacin-induced in vitro hepatotoxicity by inhibiting protective autophagy.
Toxicology letters, May-15, Volume: 342		2021
Efficacy, safety and central nervous system effects after switch from efavirenz/tenofovir/emtricitabine to doravirine/tenofovir/lamivudine.
AIDS (London, England), 04-01, Volume: 35, Issue: 5		2021
Long-term Efficacy and Safety of Once-daily Efinaconazole 10% Topical Solution (Jublia) for Dermatophyte Toenail Onychomycosis: An Interim Analysis.
Skin therapy letter, Volume: 26, Issue: 1		2021
Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs.
The Journal of rheumatology, Volume: 48, Issue: 8		2021
Neuroprotective effects of Myricetin on Epoxiconazole-induced toxicity in F98 cells.
Free radical biology & medicine, 02-20, Volume: 164		2021
Phase II, randomised, double-blind, multicentre study evaluating the safety and efficacy of filgotinib and lanraplenib in patients with lupus membranous nephropathy.
RMD open, Volume: 6, Issue: 3		2020
Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity.
Regulatory toxicology and pharmacology : RTP, Volume: 120		2021
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Long-term Use (83)

ArticleYear
Voriconazole-induced periostitis.
Reumatismo, Apr-19, Volume: 73, Issue: 1		2021
Effect of Chronic Administration of 5-(3-chlorophenyl)-4-Hexyl-2,4 -Dihydro-3
International journal of molecular sciences, Mar-25, Volume: 22, Issue: 7		2021
Rufinamide add-on therapy for drug-resistant epilepsy.
The Cochrane database of systematic reviews, 11-08, Volume: 11		2020
Dementia-Like Symptoms Associated With Posaconazole.
Journal of pharmacy practice, Volume: 35, Issue: 1		2022
1,2,3-Triazole hybrids with anti-HIV-1 activity.
Archiv der Pharmazie, Volume: 354, Issue: 1		2021
Induced expression of CYP51 associated with difenoconazole resistance in the pathogenic Alternaria sect. on potato in China.
Pest management science, Volume: 76, Issue: 5		2020
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
The Journal of dermatology, Volume: 46, Issue: 8		2019
Ghrelin signalling within the rat nucleus accumbens and skilled reach foraging.
Psychoneuroendocrinology, Volume: 106		2019
Lack of Toxicity With Long-term Isavuconazole Use in Patients With Hematologic Malignancy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 10-15, Volume: 69, Issue: 9		2019
Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis.
Neuropharmacology, Volume: 141		2018
Rufinamide add-on therapy for refractory epilepsy.
The Cochrane database of systematic reviews, 04-25, Volume: 4		2018
The Y137H mutation in the cytochrome P450 FgCYP51B protein confers reduced sensitivity to tebuconazole in Fusarium graminearum.
Pest management science, Volume: 74, Issue: 6		2018
Long-term efficacy and safety of aromatase inhibitor use for leiomyomatosis peritonealis disseminata.
The journal of obstetrics and gynaecology research, Volume: 43, Issue: 9		2017
Residue and intake risk assessment of prothioconazole and its metabolite prothioconazole-desthio in wheat field.
Environmental monitoring and assessment, Volume: 189, Issue: 5		2017
The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, Volume: 46, Issue: 10		2017
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.
American journal of kidney diseases : the official journal of the National Kidney Foundation, Volume: 69, Issue: 6		2017
Effect of imatinib on growth of experimental endometriosis in rats.
European journal of obstetrics, gynecology, and reproductive biology, Volume: 197		2016
Beneficial properties of maraviroc on neuropathic pain development and opioid effectiveness in rats.
Progress in neuro-psychopharmacology & biological psychiatry, Jan-04, Volume: 64		2016
Structure-function-behavior relationship in estrogen-induced synaptic plasticity.
Hormones and behavior, Volume: 74		2015
Unprecedented therapeutic potential with a combination of A2A/NR2B receptor antagonists as observed in the 6-OHDA lesioned rat model of Parkinson's disease.
PloS one, Volume: 9, Issue: 12		2014
Renoprotective effect of sitagliptin against hypertensive nephropathy induced by chronic administration of L-NAME in rats: role of GLP-1 and GLP-1 receptor.
European journal of pharmacology, Nov-15, Volume: 720, Issue: 1-3		2013
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study.
International journal of clinical pharmacology and therapeutics, Volume: 51, Issue: 9		2013
Multifocal periostitis as a complication of chronic use of voriconazole in a lung transplant recipient.
Transplant infectious disease : an official journal of the Transplantation Society, Volume: 15, Issue: 4		2013
Long-term treatment with Sitagliptin, a dipeptidyl peptidase-4 inhibitor, reduces colon carcinogenesis and reactive oxygen species in 1,2-dimethylhydrazine-induced rats.
International journal of cancer, Nov-15, Volume: 133, Issue: 10		2013
Alleviating anastrozole induced bone toxicity by selenium nanoparticles in SD rats.
Toxicology and applied pharmacology, Apr-15, Volume: 268, Issue: 2		2013
Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.
Cell cycle (Georgetown, Tex.), Jan-01, Volume: 12, Issue: 1		2013
Increased incidence of cutaneous squamous cell carcinoma in lung transplant recipients taking long-term voriconazole.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Volume: 31, Issue: 11		2012
A case of aromatase inhibitor (anastrozole)-induced side-effects successfully treated with Kampo medicines.
Journal of alternative and complementary medicine (New York, N.Y.), Volume: 17, Issue: 11		2011
Periostitis secondary to prolonged voriconazole therapy in a lung transplant recipient.
Orthopedics, Nov-09, Volume: 34, Issue: 11		2011
Modulatory effects of the CCR5 antagonist maraviroc on microglial pro-inflammatory activation elicited by gp120.
Journal of neurochemistry, Volume: 120, Issue: 1		2012
Successful long-term use of sitagliptin for the treatment of new-onset diabetes mellitus after solid organ transplantation: a case report.
Transplantation proceedings, Volume: 43, Issue: 5		2011
Use of aromatase inhibitors to treat endometriosis-related pain symptoms: a systematic review.
Reproductive biology and endocrinology : RB&E, Jun-21, Volume: 9		2011
Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects.
Journal of neuroinflammation, Apr-12, Volume: 8		2011
Prophylactic neuroprotection against stroke: low-dose, prolonged treatment with deferoxamine or deferasirox establishes prolonged neuroprotection independent of HIF-1 function.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, Volume: 31, Issue: 6		2011
Periostitis secondary to prolonged voriconazole therapy in lung transplant recipients.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, Volume: 9, Issue: 12		2009
Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
Expert review of anti-infective therapy, Volume: 7, Issue: 2		2009
Caffeine and a selective adenosine A2A receptor antagonist induce reward and sensitization behavior associated with increased phospho-Thr75-DARPP-32 in mice.
Psychopharmacology, Volume: 204, Issue: 2		2009
Voriconazole-induced photosensitivity.
Clinical medicine & research, Volume: 6, Issue: 2		2008
A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in Japan.
International journal of hematology, Volume: 88, Issue: 1		2008
Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
Journal of neuroendocrinology, Volume: 20 Suppl 1		2008
Complexity of interactions between voriconazole and antiretroviral agents.
The Annals of pharmacotherapy, Volume: 42, Issue: 5		2008
Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study.
European journal of haematology, Volume: 80, Issue: 2		2008
Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.
European journal of pharmacology, Jul-02, Volume: 566, Issue: 1-3		2007
Continuing with letrozole offers greater benefits.
Journal of cancer research and clinical oncology, Volume: 133, Issue: 7		2007
Antiobesity effects of the novel in vivo neutral cannabinoid receptor antagonist 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-3-hexyl-1H-1,2,4-triazole--LH 21.
Neuropharmacology, Volume: 51, Issue: 2		2006
Safety considerations of adjuvant therapy in early breast cancer in postmenopausal women.
Oncology, Volume: 69, Issue: 1		2005
Refractory coccidioidomycosis treated with posaconazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Jun-15, Volume: 40, Issue: 12		2005
Effects of adenosine and adenosine A2A receptor agonist on motor nerve conduction velocity and nerve blood flow in experimental diabetic neuropathy.
Neurological research, Volume: 27, Issue: 1		2005
Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Headache, Volume: 44, Issue: 9		2004
Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections.
International journal of clinical practice, Volume: 58, Issue: 6		2004
The effects of hormone therapy on cognition in breast cancer.
The Journal of steroid biochemistry and molecular biology, Volume: 86, Issue: 3-5		2003
High-risk AML complicated by pulmonary aspergillosis: successful treatment with nonmyeloablative stem cell transplantation and long-term administration of voriconazole.
Annals of hematology, Volume: 83, Issue: 2		2004
Pharmacokinetics of third-generation aromatase inhibitors.
Seminars in oncology, Volume: 30, Issue: 4 Suppl 14		2003
Aromatase inhibition for the treatment of idiopathic hypogonadotropic hypogonadism in men with premature ejaculation.
Southern medical journal, Volume: 96, Issue: 6		2003
Involvement of adenosine A1 and A2A receptors in the motor effects of caffeine after its acute and chronic administration.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 28, Issue: 7		2003
Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, Volume: 14, Issue: 3		2002
Mechanisms for the induction of oxidative stress in Syrian hamster embryo cells by acrylonitrile.
Toxicological sciences : an official journal of the Society of Toxicology, Volume: 67, Issue: 2		2002
Interaction between dopamine and adenosine A2A receptors as a basis for the treatment of Parkinson's disease.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, Volume: 22, Issue: 1		2001
Protein binding alters the activity of suramin, carboxyamidotriazole, and UCN-01 in an ex vivo rat aortic ring angiogenesis assay.
Clinical cancer research : an official journal of the American Association for Cancer Research, Volume: 7, Issue: 7		2001
Regulation of ionotropic glutamate receptor subunits in different rat brain areas by a preferential sigma(1) receptor ligand and potential atypical antipsychotic.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Volume: 23, Issue: 5		2000
Nefazodone and the treatment of nonparaphilic compulsive sexual behavior: a retrospective study.
The Journal of clinical psychiatry, Volume: 61, Issue: 4		2000
The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A(2A) adenosine receptor antagonists.
Psychopharmacology, Volume: 148, Issue: 2		2000
Effect of chronic administration of an aromatase inhibitor to adult male rats on pituitary and testicular function and fertility.
The Journal of endocrinology, Volume: 164, Issue: 2		2000
Electrophysiological effects of E-5842, a sigma1 receptor ligand and potential atypical antipsychotic, on A9 and A10 dopamine neurons.
European journal of pharmacology, Jul-28, Volume: 378, Issue: 1		1999
Captopril and platelet-activating factor (PAF) antagonist prevent cardiac allograft vasculopathy in rats: role of endogenous PAF and PAF-like compounds.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation, Volume: 18, Issue: 5		1999
[Biochemical and immunohistological changes in the gastric mucosa of rats with long-term administration of histamine H2-receptor antagonist].
Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, Volume: 95, Issue: 12		1998
Letrozole. A review of its use in postmenopausal women with advanced breast cancer.
Drugs, Volume: 56, Issue: 6		1998
Novel serotonergic mechanisms and clinical experience with nefazodone.
Clinical neuropharmacology, Volume: 16 Suppl 3		1993
Vorozole, a specific non-steroidal aromatase inhibitor.
Breast cancer research and treatment, Volume: 30, Issue: 1		1994
The serotonergic antidepressant nefazodone inhibits the serotonin transporter: in vivo and ex vivo studies.
Life sciences, Volume: 57, Issue: 24		1995
Amitrole: strain differences in morphological response of the liver following subchronic administration to mice.
Toxicology letters, Volume: 29, Issue: 2-3		1985
Down-regulation of serotonin2, but not of beta-adrenergic receptors during chronic treatment with amitriptyline is independent of stimulation of serotonin2 and beta-adrenergic receptors.
Neuropharmacology, Volume: 25, Issue: 12		1986
Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome.
The American journal of medicine, Volume: 85, Issue: 4		1988
The effects of a potential antidepressant, 2,4-dimethyl-5-(3-fluorophenyl)-3H-1,2,4-triazole-3-thione, in an electrophysiological model responsive to desipramine.
Neuropharmacology, Volume: 29, Issue: 6		1990
Nefazodone: preclinical pharmacology of a new antidepressant.
Psychopharmacology bulletin, Volume: 26, Issue: 3		1990
Endocrine and antitumoral effects of R76713 in rats.
Journal of enzyme inhibition, Volume: 4, Issue: 2		1990
Chronic administration of H2-antagonists does not alter gastric secretory responses to histamine, or the antisecretory activity of sufotidine.
Alimentary pharmacology & therapeutics, Volume: 4 Suppl 1		1990
Potential hazards of long-term acid suppression.
Scandinavian journal of gastroenterology. Supplement, Volume: 178		1990
Evidence for platelet-activating factor as a late-phase mediator of chronic pancreatitis in the rat.
The American journal of pathology, Volume: 137, Issue: 6		1990
Anticonvulsant profile of MDL 27,266: an orally active, broad-spectrum anticonvulsant agent.
Epilepsy research, Volume: 12, Issue: 3		1992
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pharmacokinetics (600)

ArticleYear
High Variability in Isavuconazole Unbound Fraction in Clinical Practice: A Call to Reconsider Pharmacokinetic/Pharmacodynamic Targets and Breakpoints.
Clinical pharmacokinetics, Volume: 62, Issue: 12		2023
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.
Clinical pharmacokinetics, Volume: 62, Issue: 12		2023
Pharmacokinetic and Exposure Response Analysis of the Double-Blind Randomized Study of Posaconazole and Voriconazole for Treatment of Invasive Aspergillosis.
Clinical drug investigation, Volume: 43, Issue: 9		2023
[Comparative clinical study of pharmacokinetics and bioequivalence of Relonova and Maxalt].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, Volume: 123, Issue: 8		2023
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease.
Clinical pharmacokinetics, Volume: 62, Issue: 7		2023
New Targeted Drugs for Acute Myeloid Leukemia and Antifungals: Pharmacokinetic Challenges and Opportunities.
Chemotherapy, Volume: 68, Issue: 3		2023
A Hybrid Algorithm Combining Population Pharmacokinetic and Machine Learning for Isavuconazole Exposure Prediction.
Pharmaceutical research, Volume: 40, Issue: 4		2023
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses.
Journal of clinical pharmacology, Volume: 63, Issue: 6		2023
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
Drugs, Volume: 83, Issue: 1		2023
A Review of Population Pharmacokinetic Models of Posaconazole.
Drug design, development and therapy, Volume: 16		2022
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-01, Volume: 178		2022
Safe administration and pharmacokinetic monitoring of crushed venetoclax tablets with posaconazole and clarithromycin via percutaneous endoscopic gastrostomy tube in a patient with acute myeloid leukemia.
Cancer chemotherapy and pharmacology, Volume: 90, Issue: 3		2022
External evaluation of population pharmacokinetic models for voriconazole in Chinese adult patients with hematological malignancy.
European journal of clinical pharmacology, Volume: 78, Issue: 9		2022
Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration.
Journal of veterinary internal medicine, Volume: 36, Issue: 4		2022
Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments.
Clinical pharmacokinetics, Volume: 61, Issue: 8		2022
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study.
Mycoses, Volume: 65, Issue: 6		2022
Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation.
Radiation oncology (London, England), Apr-11, Volume: 17, Issue: 1		2022
Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Isavuconazonium Sulfate in Healthy Adult Japanese Subjects.
Clinical pharmacology in drug development, Volume: 11, Issue: 6		2022
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Clinical pharmacology in drug development, Volume: 11, Issue: 6		2022
Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling.
The AAPS journal, 01-05, Volume: 24, Issue: 1		2022
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Jan-01, Volume: 168		2022
Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants.
Clinical pharmacology in drug development, Volume: 11, Issue: 2		2022
Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis.
The Journal of antimicrobial chemotherapy, 11-12, Volume: 76, Issue: 12		2021
Pharmacokinetics and Bioequivalence of Isavuconazole Administered as Isavuconazonium Sulfate Intravenous Solution via Nasogastric Tube or Orally in Healthy Subjects.
Antimicrobial agents and chemotherapy, 08-17, Volume: 65, Issue: 9		2021
Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 49, Issue: 9		2021
A Target-Mediated Drug Disposition Model to Explain Nonlinear Pharmacokinetics of the 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor SPI-62 in Healthy Adults.
Journal of clinical pharmacology, Volume: 61, Issue: 11		2021
Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats.
Drug design, development and therapy, Volume: 15		2021
Intestinal Excretion, Intestinal Recirculation, and Renal Tubule Reabsorption Are Underappreciated Mechanisms That Drive the Distribution and Pharmacokinetic Behavior of Small Molecule Drugs.
Journal of medicinal chemistry, 06-10, Volume: 64, Issue: 11		2021
Clinical Pharmacokinetics of Triazoles in Pediatric Patients.
Clinical pharmacokinetics, Volume: 60, Issue: 9		2021
Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug-Drug Interactions of Selinexor with Posaconazole in Rats.
Drug design, development and therapy, Volume: 15		2021
Hemodialysis Clearance of Enarodustat (JTZ-951), an Oral Erythropoiesis Stimulating Agent, in Patients with End-Stage Renal Disease.
Clinical pharmacology in drug development, Volume: 10, Issue: 5		2021
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.
Cancer chemotherapy and pharmacology, Volume: 88, Issue: 1		2021
JAK selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib.
Annals of the rheumatic diseases, Volume: 80, Issue: 7		2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
Therapeutic drug monitoring, 08-01, Volume: 43, Issue: 4		2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
The Journal of antimicrobial chemotherapy, 04-13, Volume: 76, Issue: 5		2021
Pharmacokinetics and tolerability of intravenous posaconazole in healthy Chinese volunteers: a randomized, open-label and single-dose study.
Die Pharmazie, 10-01, Volume: 75, Issue: 10		2020
Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects.
European journal of drug metabolism and pharmacokinetics, Volume: 46, Issue: 1		2021
Discovery of IPN60090, a Clinical Stage Selective Glutaminase-1 (GLS-1) Inhibitor with Excellent Pharmacokinetic and Physicochemical Properties.
Journal of medicinal chemistry, 11-12, Volume: 63, Issue: 21		2020
Differential Impacts of Azole Antifungal Drugs on the Pharmacokinetic Profiles of Dasatinib in Rats by LC-MS-MS.
Current drug metabolism, Volume: 21, Issue: 13		2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
Journal of drugs in dermatology : JDD, Sep-01, Volume: 19, Issue: 9		2020
Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin.
Journal of clinical pharmacology, Volume: 61, Issue: 3		2021
Navafenterol (AZD8871) in patients with mild asthma: a randomised placebo-controlled phase I study evaluating the safety, tolerability, pharmacokinetics, and pharmacodynamics of single ascending doses of this novel inhaled long-acting dual-pharmacology br
Respiratory research, Sep-09, Volume: 21, Issue: Suppl 1		2020
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.
Respiratory research, Sep-09, Volume: 21, Issue: Suppl 1		2020
Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator.
Respiratory research, Sep-09, Volume: 21, Issue: Suppl 1		2020
Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1.
Antimicrobial agents and chemotherapy, 10-20, Volume: 64, Issue: 11		2020
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions.
Clinical drug investigation, Volume: 40, Issue: 10		2020
Antifungal drugs: An updated review of central nervous system pharmacokinetics.
Mycoses, Volume: 63, Issue: 10		2020
Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
International journal of antimicrobial agents, Volume: 56, Issue: 4		2020
Application of Azamulin to Determine the Contribution of CYP3A4/5 to Drug Metabolic Clearance Using Human Hepatocytes.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 48, Issue: 9		2020
Pharmacokinetics, safety and tolerability of long-acting parenteral intramuscular injection formulations of doravirine.
Journal of clinical pharmacy and therapeutics, Volume: 45, Issue: 5		2020
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluation.
Expert opinion on drug metabolism & toxicology, Volume: 16, Issue: 7		2020
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Mycoses, Volume: 63, Issue: 8		2020
Pharmacokinetics and Pharmacodynamics of Posaconazole.
Drugs, Volume: 80, Issue: 7		2020
Characterisation of the pharmacodynamic effects of the P2X7 receptor antagonist JNJ-54175446 using an oral dexamphetamine challenge model in healthy males in a randomised, double-blind, placebo-controlled, multiple ascending dose trial.
Journal of psychopharmacology (Oxford, England), Volume: 34, Issue: 9		2020
The Pharmacokinetic-Pharmacodynamic (PKPD) Relationships of AZD3229, a Novel and Selective Inhibitor of KIT, in a Range of Mouse Xenograft Models of GIST.
Clinical cancer research : an official journal of the American Association for Cancer Research, 07-15, Volume: 26, Issue: 14		2020
Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.
Bioorganic chemistry, Volume: 96		2020
Development of an oral bentonite-based modified-release freeze-dried powder of vactosertib: Pharmacokinetics and anti-colitis activity in rodent models of ulcerative colitis.
International journal of pharmaceutics, Mar-30, Volume: 578		2020
Effects of oral iron and calcium supplement on the pharmacokinetics and pharmacodynamics of molidustat: an oral HIF-PH inhibitor for the treatment of renal anaemia.
European journal of clinical pharmacology, Volume: 76, Issue: 2		2020
The Effects of Special Patient Population Plasma on Pharmacokinetic Quantifications Using LC-MS/MS.
Drug metabolism letters, Volume: 13, Issue: 2		2019
Comparative in vitro pharmacodynamic analysis of isavuconazole, voriconazole, and posaconazole against clinical isolates of aspergillosis, mucormycosis, fusariosis, and phaeohyphomycosis.
Diagnostic microbiology and infectious disease, Volume: 95, Issue: 3		2019
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine.
Clinical pharmacokinetics, Volume: 58, Issue: 12		2019
A population pharmacokinetic analysis of the oral CYP17 lyase and androgen receptor inhibitor seviteronel in patients with advanced/metastatic castration-resistant prostate cancer or breast cancer.
Cancer chemotherapy and pharmacology, Volume: 84, Issue: 4		2019
Population pharmacokinetics of cyclosporine in Chinese children receiving hematopoietic stem cell transplantation.
Acta pharmacologica Sinica, Volume: 40, Issue: 12		2019
Population pharmacokinetics of total and unbound concentrations of intravenous posaconazole in adult critically ill patients.
Critical care (London, England), Jun-06, Volume: 23, Issue: 1		2019
Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone.
Clinical pharmacology in drug development, Volume: 9, Issue: 2		2020
Evaluation of the Pharmacokinetics of Metformin Following Coadministration With Doravirine in Healthy Volunteers.
Clinical pharmacology in drug development, Volume: 9, Issue: 1		2020
A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.
PloS one, Volume: 14, Issue: 3		2019
Ultra-performance hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry for simultaneous determination of allopurinol, oxypurinol and lesinurad in rat plasma: Application to pharmacokinetic study in rats.
PloS one, Volume: 14, Issue: 3		2019
The impact of initiating posaconazole on tacrolimus pharmacokinetics in allogeneic stem cell transplantation.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, Volume: 26, Issue: 1		2020
Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects.
Clinical drug investigation, Volume: 39, Issue: 5		2019
Pharmacokinetic stability of macrocyclic peptide triazole HIV-1 inactivators alone and in liposomes.
Journal of peptide science : an official publication of the European Peptide Society, Volume: 25, Issue: 4		2019
Lesinurad: Evaluation of Pharmacokinetic and Pharmacodynamic Interactions With Warfarin in Healthy Volunteers.
Clinical pharmacology in drug development, Volume: 8, Issue: 5		2019
Population Pharmacokinetics of Doravirine and Exposure-Response Analysis in Individuals with HIV-1.
Antimicrobial agents and chemotherapy, Volume: 63, Issue: 4		2019
Safety, Pharmacokinetics, and Pharmacodynamics of ASP3662, a Novel 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Healthy Young and Elderly Subjects.
Clinical and translational science, Volume: 12, Issue: 3		2019
Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects.
The journal of sexual medicine, Volume: 16, Issue: 2		2019
Predicting the Effects of Different Triazole Antifungal Agents on the Pharmacokinetics of Tamoxifen.
AAPS PharmSciTech, Jan-02, Volume: 20, Issue: 1		2019
Isavuconazole: Case Report and Pharmacokinetic Considerations.
Chemotherapy, Volume: 63, Issue: 5		2018
Characterization of Stereoselective Metabolism, Inhibitory Effect on Uric Acid Uptake Transporters, and Pharmacokinetics of Lesinurad Atropisomers.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 47, Issue: 2		2019
Inhibitory effect of isavuconazole, ketoconazole, and voriconazole on the pharmacokinetics of methadone in vivo and in vitro.
Drug testing and analysis, Volume: 11, Issue: 4		2019
Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
The journal of sexual medicine, Volume: 15, Issue: 11		2018
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
European journal of drug metabolism and pharmacokinetics, Volume: 44, Issue: 2		2019
Influence of age and renal impairment on the steady state pharmacokinetics of filgotinib, a selective JAK1 inhibitor.
British journal of clinical pharmacology, Volume: 84, Issue: 12		2018
Clinical Pharmacokinetics and Drug Interactions of Doravirine.
European journal of drug metabolism and pharmacokinetics, Volume: 43, Issue: 6		2018
A pharmacokinetic case study of intravenous posaconazole in a critically ill patient with hypoalbuminaemia receiving continuous venovenous haemodiafiltration.
International journal of antimicrobial agents, Volume: 52, Issue: 4		2018
[Determination of anaprazole in human plasma by LC-MS/MS in pharmacokinetic study].
Yao xue xue bao = Acta pharmaceutica Sinica, Volume: 51, Issue: 12		2016
Pharmacokinetic/Pharmacodynamic Analysis of Isavuconazole Against Aspergillus spp. and Candida spp. in Healthy Subjects and Patients With Hepatic or Renal Impairment by Monte Carlo Simulation.
Journal of clinical pharmacology, Volume: 58, Issue: 10		2018
Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
Clinical pharmacokinetics, Volume: 57, Issue: 12		2018
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
Antimicrobial agents and chemotherapy, Volume: 62, Issue: 7		2018
Safety, Tolerability, and Pharmacokinetics of Suvorexant: A Randomized Rising-Dose Trial in Healthy Men.
Clinical drug investigation, Volume: 38, Issue: 7		2018
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.
Clinical pharmacokinetics, Volume: 58, Issue: 1		2019
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Journal of clinical pharmacology, Volume: 58, Issue: 7		2018
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Journal de mycologie medicale, Volume: 28, Issue: 1		2018
Isavuconazole pharmacokinetics in a patient with cystic fibrosis following bilateral orthotopic lung transplantation.
Transplant infectious disease : an official journal of the Transplantation Society, Volume: 20, Issue: 3		2018
Physiologically-based pharmacokinetic modelling of a CYP2C19 substrate, BMS-823778, utilizing pharmacogenetic data.
British journal of clinical pharmacology, Volume: 84, Issue: 6		2018
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology, Volume: 81, Issue: 3		2018
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus.
Journal of medicinal chemistry, 02-08, Volume: 61, Issue: 3		2018
Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects.
Drug metabolism and pharmacokinetics, Volume: 32, Issue: 6		2017
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
European journal of drug metabolism and pharmacokinetics, Volume: 43, Issue: 3		2018
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children.
Pharmacogenetics and genomics, Volume: 28, Issue: 1		2018
Development of an Adult Physiologically Based Pharmacokinetic Model of Solithromycin in Plasma and Epithelial Lining Fluid.
CPT: pharmacometrics & systems pharmacology, Volume: 6, Issue: 12		2017
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Onset of Action (2)

ArticleYear
Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists.
The Journal of pharmacology and experimental therapeutics, Volume: 298, Issue: 1		2001
Comparison of antisecretory potency and duration of action of the H2-receptor antagonists AH 22216, cimetidine, ranitidine and SK & F 93479 in the dog.
Agents and actions, Volume: 13, Issue: 2-3		1983
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioavailability (375)

ArticleYear
Triazole hybrid compounds: A new frontier in malaria treatment.
European journal of medicinal chemistry, Nov-05, Volume: 259		2023
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease.
Clinical pharmacokinetics, Volume: 62, Issue: 7		2023
Permeability of New Antifungal Fluconazole Derivatives through a Lipophilic Membrane: Experiment and Modeling.
Molecules (Basel, Switzerland), Jan-02, Volume: 28, Issue: 1		2023
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
Drugs, Volume: 83, Issue: 1		2023
Clinical research advances of isavuconazole in the treatment of invasive fungal diseases.
Frontiers in cellular and infection microbiology, Volume: 12		2022
Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability.
Journal of medicinal chemistry, 12-22, Volume: 65, Issue: 24		2022
In silico identification of 1,2,4-triazoles as potential Candida Albicans inhibitors using 3D-QSAR, molecular docking, molecular dynamics simulations, and ADMET profiling.
Molecular diversity, Volume: 27, Issue: 5		2023
Semisynthetic Derivatives of Pentacyclic Triterpenes Bearing Heterocyclic Moieties with Therapeutic Potential.
Molecules (Basel, Switzerland), Oct-03, Volume: 27, Issue: 19		2022
Radiotherapy-induced oxidative stress and fibrosis in breast cancer are suppressed by vactosertib, a novel, orally bioavailable TGF-β/ALK5 inhibitor.
Scientific reports, 09-27, Volume: 12, Issue: 1		2022
Discovery and Optimization of the First Highly Effective and Orally Available Galectin-3 Inhibitors for Treatment of Fibrotic Disease.
Journal of medicinal chemistry, 10-13, Volume: 65, Issue: 19		2022
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-01, Volume: 178		2022
Single oral or intravenous administration of voriconazole achieved recommended therapeutic minimum inhibitory concentrations against Aspergillus in the common raven (Corvus corax).
American journal of veterinary research, Aug-31, Volume: 83, Issue: 10		2022
Incorporating Tenax into the in vitro method to improve the predictive capability of bioaccessibility of triazole fungicides in grape.
Food chemistry, Dec-01, Volume: 396		2022
Biopredictive capability assessment of two dissolution/permeation assays, µFLUX™ and PermeaLoop™, using supersaturating formulations of Posaconazole.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Sep-01, Volume: 176		2022
Pharmacokinetics of isavuconazole in healthy cats after oral and intravenous administration.
Journal of veterinary internal medicine, Volume: 36, Issue: 4		2022
Contributions of intestine and liver to the absorption and disposition of FZJ-003, a selective JAK1 inhibitor with structure modification of filgotinib.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Aug-01, Volume: 175		2022
Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Radiology and oncology, 04-07, Volume: 56, Issue: 2		2022
Posaconazole bioavailability of the solid oral tablet is reduced during severe intestinal mucositis.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, Volume: 28, Issue: 7		2022
Proof of Concept in Assignment of Within-Subject Variability During Virtual Bioequivalence Studies: Propagation of Intra-Subject Variation in Gastrointestinal Physiology Using Physiologically Based Pharmacokinetic Modeling.
The AAPS journal, 01-05, Volume: 24, Issue: 1		2022
Persistence Pays Off: Milvexian Emerges from the Industry's Longstanding Search for Orally Bioavailable Factor XIa Inhibitors.
Journal of medicinal chemistry, 02-10, Volume: 65, Issue: 3		2022
Accumulation of epoxiconazole from soil via oleic acid-embedded cellulose acetate membranes and bioavailability evaluation in earthworms (Eisenia fetida).
Environmental pollution (Barking, Essex : 1987), Jan-01, Volume: 292, Issue: Pt A		2022
Discovery of Milvexian, a High-Affinity, Orally Bioavailable Inhibitor of Factor XIa in Clinical Studies for Antithrombotic Therapy.
Journal of medicinal chemistry, 02-10, Volume: 65, Issue: 3		2022
Suboptimal plasma concentrations with posaconazole suspension as prophylaxis in critically ill COVID-19 patients at risk of Covid-associated pulmonary aspergillosis.
Journal of clinical pharmacy and therapeutics, Volume: 47, Issue: 3		2022
Cu(I)-Catalyzed Click Chemistry in Glycoscience and Their Diverse Applications.
Chemical reviews, 07-14, Volume: 121, Issue: 13		2021
1,2,3-Triazoles as Biomimetics in Peptide Science.
Molecules (Basel, Switzerland), May-14, Volume: 26, Issue: 10		2021
A highly sensitive and selective UPLC-MS/MS assay for the determination of enarodustat (JTZ-951) in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, Jun-30, Volume: 1176		2021
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Medical mycology, Sep-03, Volume: 59, Issue: 9		2021
JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat.
European journal of pharmacology, May-05, Volume: 898		2021
Triazole fungicides in soil affect the yield of fruit, green biomass, and phenolics production of Solanum lycopersicum L.
Food chemistry, Jul-30, Volume: 351		2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
Therapeutic drug monitoring, 08-01, Volume: 43, Issue: 4		2021
Conazole fungicides epoxiconazole and tebuconazole in biochar amended soils: Degradation and bioaccumulation in earthworms.
Chemosphere, Volume: 274		2021
Selinexor, a First in Class, Nuclear Export Inhibitor for the Treatment of Advanced Malignant Peripheral Nerve Sheath Tumor.
The oncologist, Volume: 26, Issue: 4		2021
Residual analysis of chitosan-based agronanofungicides as a sustainable alternative in oil palm disease management.
Scientific reports, 12-18, Volume: 10, Issue: 1		2020
A copper(II)-binding triazole derivative with ionophore properties is active against Candida spp.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, Volume: 25, Issue: 8		2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole;
Molecular pharmaceutics, 12-07, Volume: 17, Issue: 12		2020
Ageing effect on conazole fungicide bioaccumulation in arable soils.
Chemosphere, Volume: 262		2021
PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery.
Journal of pharmacokinetics and pharmacodynamics, Volume: 47, Issue: 5		2020
Comparative assessment of in vitro/in vivo performances of orodispersible electrospun and casting films containing rizatriptan benzoate.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Volume: 154		2020
Pentabromobenzyl-RP versus triazole-HILIC columns for separation of the polar basic analytes famotidine and famotidone: LC method development combined with in silico tools to follow the potential consequences of famotidine gastric instability.
Journal of pharmaceutical and biomedical analysis, Jul-15, Volume: 186		2020
Absorption, distribution, metabolism and excretion of molidustat in healthy participants.
Basic & clinical pharmacology & toxicology, Volume: 127, Issue: 3		2020
Composition and Orientation of the Core Region of Novel HIV-1 Entry Inhibitors Influences Metabolic Stability.
Molecules (Basel, Switzerland), Mar-21, Volume: 25, Issue: 6		2020
Synthesis of biocompatible triazole based non-ionic surfactant and its vesicular drug delivery investigation.
Chemistry and physics of lipids, Volume: 228		2020
Comparative Bioavailability of Oral Granule Formulations of the HIV Antiretroviral Drugs Doravirine, Lamivudine, and Tenofovir Disoproxil Fumarate.
AAPS PharmSciTech, Feb-13, Volume: 21, Issue: 3		2020
Integrated nanovesicular/self-nanoemulsifying system (INV/SNES) for enhanced dual ocular drug delivery: statistical optimization, in vitro and in vivo evaluation.
Drug delivery and translational research, Volume: 10, Issue: 3		2020
The influence of crushing amorphous solid dispersion dosage forms on the in-vitro dissolution kinetics.
International journal of pharmaceutics, Jan-05, Volume: 573		2020
Evaluation of posaconazole plasma concentrations achieved with the delayed-release tablets in Korean high-risk patients with haematologic malignancy.
Mycoses, Volume: 63, Issue: 2		2020
Interplay of Supersaturation and Solubilization: Lack of Correlation between Concentration-Based Supersaturation Measurements and Membrane Transport Rates in Simulated and Aspirated Human Fluids.
Molecular pharmaceutics, 12-02, Volume: 16, Issue: 12		2019
High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers.
Molecular cancer therapeutics, Volume: 18, Issue: 10		2019
Adsorption behavior of three triazole fungicides on polystyrene microplastics.
The Science of the total environment, Nov-15, Volume: 691		2019
Microbiological and biochemical properties of soil polluted with a mixture of spiroxamine, tebuconazole, and triadimenol under the cultivation of Triticum aestivum L.
Environmental monitoring and assessment, Jun-06, Volume: 191, Issue: 7		2019
XPO1 inhibitor KPT-330 synergizes with Bcl-xL inhibitor to induce cancer cell apoptosis by perturbing rRNA processing and Mcl-1 protein synthesis.
Cell death & disease, 05-21, Volume: 10, Issue: 6		2019
Fate and bioavailability of four conazole fungicides in twelve different arable soils - Effects of soil and pesticide properties.
Chemosphere, Volume: 230		2019
Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations.
Scientific reports, 04-10, Volume: 9, Issue: 1		2019
Molecular hybridization approach for phenothiazine incorporated 1,2,3-triazole hybrids as promising antimicrobial agents: Design, synthesis, molecular docking and in silico ADME studies.
European journal of medicinal chemistry, Apr-15, Volume: 168		2019
The Relative Bioavailability and Effects of Food and Acid-Reducing Agents on Filgotinib Tablets in Healthy Subjects.
Clinical pharmacology in drug development, Volume: 8, Issue: 5		2019
Therapeutic drug monitoring and adverse events of delayed-release posaconazole tablets in patients with chronic pulmonary aspergillosis.
The Journal of antimicrobial chemotherapy, 04-01, Volume: 74, Issue: 4		2019
A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Molecular neurodegeneration, 11-07, Volume: 13, Issue: 1		2018
Clinical Pharmacokinetics of Second-Generation Triazoles for the Treatment of Invasive Aspergillosis and Candidiasis.
European journal of drug metabolism and pharmacokinetics, Volume: 44, Issue: 2		2019
5-Benzoyl triazole as new structural dimension in glycoconjugates.
Carbohydrate research, Volume: 469		2018
Metabolism and disposition of lesinurad, a uric acid reabsorption inhibitor, in humans.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 49, Issue: 7		2019
Impact of patient education on plasma concentrations and effectiveness of posaconazole oral suspension under clinical conditions.
Basic & clinical pharmacology & toxicology, Volume: 124, Issue: 1		2019
In vitro antileishmanial activity of ravuconazole, a triazole antifungal drug, as a potential treatment for leishmaniasis.
The Journal of antimicrobial chemotherapy, 09-01, Volume: 73, Issue: 9		2018
A Population Pharmacokinetic Model for a Solid Oral Tablet Formulation of Posaconazole.
Antimicrobial agents and chemotherapy, Volume: 62, Issue: 7		2018
Enhanced delivery of fixed-dose combination of synergistic antichagasic agents posaconazole-benznidazole based on amorphous solid dispersions.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Jul-01, Volume: 119		2018
Clinical Pharmacokinetics and Dose Recommendations for Posaconazole in Infants and Children.
Clinical pharmacokinetics, Volume: 58, Issue: 1		2019
Clinical Implications of Targeting XPO1-mediated Nuclear Export in Multiple Myeloma.
Clinical lymphoma, myeloma & leukemia, Volume: 18, Issue: 5		2018
Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity.
Journal de mycologie medicale, Volume: 28, Issue: 1		2018
Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia.
ChemMedChem, 05-23, Volume: 13, Issue: 10		2018
ANTIBACTERIAL AND CENTRAL NERVOUS SYSTEM ACTIVITY OF (4,5-DIARYL-4H-1,2,4-TRIAZOL-3-YL)METHACRYLIC ACID DERIVATIVES.
Acta poloniae pharmaceutica, Volume: 74, Issue: 1		2017
Development of MK-8353, an orally administered ERK1/2 inhibitor, in patients with advanced solid tumors.
JCI insight, 02-22, Volume: 3, Issue: 4		2018
Evaluation and optimized selection of supersaturating drug delivery systems of posaconazole (BCS class 2b) in the gastrointestinal simulator (GIS): An in vitro-in silico-in vivo approach.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Mar-30, Volume: 115		2018
Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies.
Scientific reports, 01-26, Volume: 8, Issue: 1		2018
Effects of posaconazole (a strong CYP3A4 inhibitor), two new tablet formulations, and food on the pharmacokinetics of idasanutlin, an MDM2 antagonist, in patients with advanced solid tumors.
Cancer chemotherapy and pharmacology, Volume: 81, Issue: 3		2018
Discovery of LY3104607: A Potent and Selective G Protein-Coupled Receptor 40 (GPR40) Agonist with Optimized Pharmacokinetic Properties to Support Once Daily Oral Treatment in Patients with Type 2 Diabetes Mellitus.
Journal of medicinal chemistry, 02-08, Volume: 61, Issue: 3		2018
Bioavailability of Metsulfuron and Sulfentrazone Herbicides in Soil as Affected by Amendment with Two Contrasting Willow Biochars.
Bulletin of environmental contamination and toxicology, Volume: 100, Issue: 2		2018
Comparison of pharmacokinetics of newly discovered aromatase inhibitors by a cassette microdosing approach in healthy Japanese subjects.
Drug metabolism and pharmacokinetics, Volume: 32, Issue: 6		2017
A Review of the Clinical Pharmacokinetics and Pharmacodynamics of Isavuconazole.
European journal of drug metabolism and pharmacokinetics, Volume: 43, Issue: 3		2018
Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
European journal of medicinal chemistry, Oct-20, Volume: 139		2017
Expanding the Therapeutic Potential of the Iron Chelator Deferasirox in the Development of Aqueous Stable Ti(IV) Anticancer Complexes.
Inorganic chemistry, Jul-17, Volume: 56, Issue: 14		2017
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
The European journal of health economics : HEPAC : health economics in prevention and care, Volume: 19, Issue: 4		2018
Enhancement of dissolution rate through eutectic mixture and solid solution of posaconazole and benznidazole.
International journal of pharmaceutics, Jun-15, Volume: 525, Issue: 1		2017
Therapeutic drug monitoring for invasive mould infections and disease: pharmacokinetic and pharmacodynamic considerations.
The Journal of antimicrobial chemotherapy, 03-01, Volume: 72, Issue: suppl_1		2017
The Effect of Food on Doravirine Bioavailability: Results from Two Pharmacokinetic Studies in Healthy Subjects.
Clinical drug investigation, Volume: 37, Issue: 6		2017
Impact of Mucositis on Absorption and Systemic Drug Exposure of Isavuconazole.
Antimicrobial agents and chemotherapy, Volume: 61, Issue: 6		2017
Cognition in female rats after blocking conversion of androgens to estrogens.
Hormones and behavior, Volume: 90		2017
Effect of gender and age on the relative bioavailability of doravirine: results of a Phase I trial in healthy subjects.
Antiviral therapy, Volume: 22, Issue: 4		2017
[A Case of Interstitial Pneumonitis Induced by Lapatinib plus Letrozole].
Gan to kagaku ryoho. Cancer & chemotherapy, Volume: 43, Issue: 12		2016
Discovery of First-in-Class, Potent, and Orally Bioavailable Embryonic Ectoderm Development (EED) Inhibitor with Robust Anticancer Efficacy.
Journal of medicinal chemistry, 03-23, Volume: 60, Issue: 6		2017
Novel amphiphilic chitosan nanocarriers for sustained oral delivery of hydrophobic drugs.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Mar-01, Volume: 99		2017
Preparation and evaluation of posaconazole-loaded enteric microparticles in rats.
Drug development and industrial pharmacy, Volume: 43, Issue: 4		2017
Prediction of Plasma Concentration-time Profiles of Drugs in Humans from Animals Following Oral Administration: An Allometric Approach.
Current drug metabolism, Volume: 17, Issue: 10		2016
Toxicity, pharmacokinetics and metabolism of a novel inhibitor of IL-6-induced STAT3 activation.
Cancer chemotherapy and pharmacology, Volume: 78, Issue: 6		2016
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer.
Breast cancer research and treatment, Volume: 160, Issue: 1		2016
Discovery of 8-Trifluoromethyl-3-cyclopropylmethyl-7-[(4-(2,4-difluorophenyl)-1-piperazinyl)methyl]-1,2,4-triazolo[4,3-a]pyridine (JNJ-46356479), a Selective and Orally Bioavailable mGlu2 Receptor Positive Allosteric Modulator (PAM).
Journal of medicinal chemistry, 09-22, Volume: 59, Issue: 18		2016
Increased inhibition of cytochrome P450 3A4 with the tablet formulation of posaconazole.
Drug metabolism and pharmacokinetics, Volume: 31, Issue: 5		2016
Synthesis and biological evaluation of some novel triazole hybrids of curcumin mimics and their selective anticancer activity against breast and prostate cancer cell lines.
Bioorganic & medicinal chemistry letters, 09-01, Volume: 26, Issue: 17		2016
Isavuconazole absorption following oral administration in healthy subjects is comparable to intravenous dosing, and is not affected by food, or drugs that alter stomach pH.
International journal of clinical pharmacology and therapeutics, Volume: 54, Issue: 8		2016
Sodium Lauryl Sulfate Competitively Interacts with HPMC-AS and Consequently Reduces Oral Bioavailability of Posaconazole/HPMC-AS Amorphous Solid Dispersion.
Molecular pharmaceutics, 08-01, Volume: 13, Issue: 8		2016
Synthesis, Anticlotting and Antiplatelet Effects of 1,2,3-Triazoles Derivatives.
Medicinal chemistry (Shariqah (United Arab Emirates)), Volume: 12, Issue: 8		2016
Characterization of Brain-Penetrant Pyrimidine-Containing Molecules with Differential Microtubule-Stabilizing Activities Developed as Potential Therapeutic Agents for Alzheimer's Disease and Related Tauopathies.
The Journal of pharmacology and experimental therapeutics, Volume: 357, Issue: 2		2016
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Dosage (1115)

ArticleYear
Triazole Antifungal Quantification for Therapeutic Drug Monitoring in Serum by Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS): Posaconazole, Voriconazole, Itraconazole, and Hydroxyitraconazole.
Methods in molecular biology (Clifton, N.J.), Volume: 2737		2024
Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies.
Clinical pharmacokinetics, Volume: 62, Issue: 12		2023
Effect of Processing on Reduction in Chiral Pesticide Hexaconazole for Kiwifruit Juice.
Molecules (Basel, Switzerland), Aug-17, Volume: 28, Issue: 16		2023
Combination chelation therapy.
Annals of the New York Academy of Sciences, Volume: 1529, Issue: 1		2023
Ferrozoles: Ferrocenyl derivatives of letrozole with dual effects as potent aromatase inhibitors and cytostatic agents.
Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, Volume: 28, Issue: 6		2023
Population Pharmacokinetics of Posaconazole in Immune-Compromised Children and Assessment of Target Attainment in Invasive Fungal Disease.
Clinical pharmacokinetics, Volume: 62, Issue: 7		2023
Population Pharmacokinetics, Exposure-Safety, and Probability of Target Attainment Analyses for Isavuconazole in Japanese Patients With Deep-Seated Mycoses.
Journal of clinical pharmacology, Volume: 63, Issue: 6		2023
An Integrated Population Pharmacokinetic Analysis for Posaconazole Oral Suspension, Delayed-Release Tablet, and Intravenous Infusion in Healthy Volunteers.
Drugs, Volume: 83, Issue: 1		2023
1,2,3-Triazole Derivatives as Novel Antifibrinolytic Drugs.
International journal of molecular sciences, Nov-29, Volume: 23, Issue: 23		2022
Progress of triazole antifungal agent posaconazole in individualized therapy.
Journal of clinical pharmacy and therapeutics, Volume: 47, Issue: 12		2022
Model-Informed Dose Justifications of Posaconazole in Japanese Patients for Prophylaxis and Treatment Against Fungal Infection.
Journal of clinical pharmacology, Volume: 63, Issue: 4		2023
A Review of Population Pharmacokinetic Models of Posaconazole.
Drug design, development and therapy, Volume: 16		2022
Different spectrophotometric methods for simultaneous determination of lesinurad and allopurinol in the new FDA approved pharmaceutical preparation; additional greenness evaluation.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Jan-15, Volume: 285		2023
Effect of posaconazole on the concentration of intravenous and oral cyclosporine in patients undergoing hematopoietic stem cell transplantation.
European journal of clinical pharmacology, Volume: 78, Issue: 10		2022
Population pharmacokinetics of posaconazole in Chinese pediatric patients with acute leukaemia: Effect of food on bioavailability and dose optimization.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Nov-01, Volume: 178		2022
Dose of deferasirox correlates with its effects, which differ between low-risk myelodysplastic syndrome and aplastic anaemia.
Journal of clinical pharmacy and therapeutics, Volume: 47, Issue: 10		2022
Inhibition of Mtorc1/2 and DNA-PK via CC-115 Synergizes with Carboplatin and Paclitaxel in Lung Squamous Cell Carcinoma.
Molecular cancer therapeutics, 09-06, Volume: 21, Issue: 9		2022
Contributions of intestine and liver to the absorption and disposition of FZJ-003, a selective JAK1 inhibitor with structure modification of filgotinib.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Aug-01, Volume: 175		2022
Efficacy and Tolerability of Twice-Daily Dosing Schedule of Deferasirox in Transfusion-Dependent Paediatric Beta-Thalassaemia Patients: A Randomized Controlled Study.
Journal of pharmacy practice, Volume: 36, Issue: 4		2023
Exposure to intravenous posaconazole in critically ill patients with influenza: A pharmacokinetic analysis of the POSA-FLU study.
Mycoses, Volume: 65, Issue: 6		2022
Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease.
The Journal of antimicrobial chemotherapy, 06-29, Volume: 77, Issue: 7		2022
Ganetespib selectively sensitizes cancer cells for proximal and distal spread-out Bragg peak proton irradiation.
Radiation oncology (London, England), Apr-11, Volume: 17, Issue: 1		2022
Decreased isavuconazole trough concentrations in the treatment of invasive aspergillosis in an adult patient receiving extracorporeal membrane oxygenation support.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 07-22, Volume: 79, Issue: 15		2022
Guidance for Use and dosing of Selinexor in Multiple Myeloma in 2021: Consensus From International Myeloma Foundation Expert Roundtable.
Clinical lymphoma, myeloma & leukemia, Volume: 22, Issue: 7		2022
Longitudinal multimodal imaging-compatible mouse model of triazole-sensitive and -resistant invasive pulmonary aspergillosis.
Disease models & mechanisms, 03-01, Volume: 15, Issue: 3		2022
Real-World Comparison of Isavuconazole and Voriconazole in Terms of the Need for Dosage Adjustments Guided by Clinical Pharmacological Advice During Primary Prophylaxis of Invasive Fungal Infections in Pediatric Patients with Hemato-Oncological Malignanci
Therapeutic drug monitoring, 10-01, Volume: 44, Issue: 5		2022
A novel validated simple derivatization liquid chromatographic method with diode array detection for the simultaneous determination of mancozeb, azoxystrobin and difenoconazole in pesticide dosage form.
Analytical methods : advancing methods and applications, 03-03, Volume: 14, Issue: 9		2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.
Molecular cancer therapeutics, 04-01, Volume: 21, Issue: 4		2022
Use of Modeling and Simulation to Predict the Influence of Triazole Antifungal Agents on the Pharmacokinetics of Crizotinib.
Clinical pharmacology in drug development, Volume: 11, Issue: 6		2022
Development of a Once-Daily Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772 using DiffCORE Technology.
Pharmaceutical research, Volume: 39, Issue: 1		2022
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies.
Arthritis research & therapy, 01-03, Volume: 24, Issue: 1		2022
Therapeutic drug monitoring of posaconazole delayed release tablet while managing COVID-19-associated mucormycosis in a real-life setting.
Mycoses, Volume: 65, Issue: 3		2022
Integrating in vitro chemical transplacental passage into a generic PBK model: A QIVIVE approach.
Toxicology, 01-15, Volume: 465		2022
Milvexian for the Prevention of Venous Thromboembolism.
The New England journal of medicine, 12-02, Volume: 385, Issue: 23		2021
Population pharmacokinetics of a posaconazole tablet formulation in transplant adult allogeneic stem cell recipients.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, Jan-01, Volume: 168		2022
Evaluation of Voriconazole and Posaconazole Dosing in Patients With Thermal Burn Injuries.
Journal of burn care & research : official publication of the American Burn Association, 07-01, Volume: 43, Issue: 4		2022
Posaconazole treatment of refractory coccidioidomycosis in dogs.
Journal of veterinary internal medicine, Volume: 35, Issue: 6		2021
First-in-human study of milvexian, an oral, direct, small molecule factor XIa inhibitor.
Clinical and translational science, Volume: 15, Issue: 2		2022
The 'comeback' of Selinexor: From toxic to tolerable.
Current problems in cancer, Volume: 46, Issue: 1		2022
Pharmacological management of antifungal agents in pulmonary aspergillosis: an updated review.
Expert review of anti-infective therapy, Volume: 20, Issue: 2		2022
Comparative effects of fluconazole, posaconazole, and isavuconazole upon tacrolimus and cyclosporine serum concentrations.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, Volume: 28, Issue: 6		2022
Human metabolism and kinetics of the UV absorber 2-(2H-benzotriazol-2-yl)-4,6-di-tert-pentylphenol (UV 328) after oral administration.
Archives of toxicology, Volume: 95, Issue: 8		2021
Seeking an optimal dosing regimen for OZ439/DSM265 combination therapy for treating uncomplicated falciparum malaria.
The Journal of antimicrobial chemotherapy, 08-12, Volume: 76, Issue: 9		2021
Thorough QT/QTc Evaluation of the Cardiac Safety of Enarodustat (JTZ-951), an Oral Erythropoiesis-Stimulating Agent, in Healthy Adults.
Clinical pharmacology in drug development, Volume: 10, Issue: 8		2021
Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 49, Issue: 9		2021
Development of a Prototype, Once-Daily, Modified-Release Formulation for the Short Half-Life RIPK1 Inhibitor GSK2982772.
Pharmaceutical research, Volume: 38, Issue: 7		2021
FDA Approval Summary: Selinexor for Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
The oncologist, Volume: 26, Issue: 10		2021
Heat Shock Protein 90 Inhibitor Effects on Pancreatic Cancer Cell Cultures.
Pancreas, 04-01, Volume: 50, Issue: 4		2021
Regioselective synthesis of triazolo[3,4-
Folia medica, Apr-30, Volume: 63, Issue: 2		2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients.
Annals of hematology, Volume: 100, Issue: 6		2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Investigational new drugs, Volume: 39, Issue: 5		2021
Disposition of posaconazole after single oral administration in large falcons (Falco spp): Effect of meal and dosage and a non-compartmental model to predict effective dosage.
Medical mycology, Sep-03, Volume: 59, Issue: 9		2021
Subtherapeutic posaconazole prophylaxis in a gastric bypass patient following hematopoietic stem cell transplantation.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 07-09, Volume: 78, Issue: 14		2021
Posaconazole micelles for ocular delivery: in vitro permeation, ocular irritation and antifungal activity studies.
Drug delivery and translational research, Volume: 12, Issue: 3		2022
Levels of residues and dietary risk assessment of the fungicides myclobutanil, penconazole, tebuconazole, and triadimenol in squash.
Biomedical chromatography : BMC, Volume: 35, Issue: 8		2021
A simple alternative and improved HPLC method for the estimation of doravirine, lamivudine, and tenofovir disoproxil fumarate in solid oral dosage form.
Biomedical chromatography : BMC, Volume: 35, Issue: 8		2021
In vivo evaluation of combination therapy targeting the isoprenoid biosynthetic pathway.
Pharmacological research, Volume: 167		2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short Communication.
Therapeutic drug monitoring, 08-01, Volume: 43, Issue: 4		2021
Is Posaconazole Really Effective in Adolescent patients as a Prophylactic Agent: Experience of a Tertiary Care Center.
Journal of pediatric hematology/oncology, 07-01, Volume: 43, Issue: 5		2021
Pharmacokinetics and target attainment of intravenous posaconazole in critically ill patients during extracorporeal membrane oxygenation.
The Journal of antimicrobial chemotherapy, 04-13, Volume: 76, Issue: 5		2021
Different chemometric assisted approaches for spectrophotometric quantitative analysis of lesinurad and allopurinol.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Apr-15, Volume: 251		2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.
Cancer chemotherapy and pharmacology, Volume: 87, Issue: 4		2021
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipients.
Medical mycology, Jul-06, Volume: 59, Issue: 7		2021
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa.
The Journal of antimicrobial chemotherapy, 02-11, Volume: 76, Issue: 3		2021
Effects of exposure to prothioconazole and its metabolite prothioconazole-desthio on oxidative stress and metabolic profiles of liver and kidney tissues in male mice.
Environmental pollution (Barking, Essex : 1987), Jan-15, Volume: 269		2021
Determination of Rufinamide in the Presence of 1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4 Carboxylic Acid Using RP-HPLC and Derivative Ratio Methods as Stability Indicating Assays to Be Applied on Dosage Form.
Journal of AOAC International, Sep-01, Volume: 103, Issue: 5		2020
Efficacy and Tolerability of Rufinamide in Epileptic Children Younger Than 4 Years.
Journal of child neurology, Volume: 36, Issue: 4		2021
Spectrophotometric determination of lesinurad and allopurinol in recently approved FDA pharmaceutical preparation.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Feb-15, Volume: 247		2021
Potency and timing of antiviral therapy as determinants of duration of SARS-CoV-2 shedding and intensity of inflammatory response.
Science advances, Volume: 6, Issue: 47		2020
Safety, Pharmacokinetics, and Efficacy of Efinaconazole 10% Topical Solution for Onychomycosis Treatment in Pediatric Patients.
Journal of drugs in dermatology : JDD, Sep-01, Volume: 19, Issue: 9		2020
Midostaurin in acute myeloid leukemia: current evidence and practical considerations in routine clinical use.
Minerva medica, Volume: 111, Issue: 5		2020
Experience using intravenous posaconazole in paediatric and young adult oncology patients.
The Journal of antimicrobial chemotherapy, 12-01, Volume: 75, Issue: 12		2020
Navafenterol (AZD8871) in healthy volunteers: safety, tolerability and pharmacokinetics of multiple ascending doses of this novel inhaled, long-acting, dual-pharmacology bronchodilator, in two phase I, randomised, single-blind, placebo-controlled studies.
Respiratory research, Sep-09, Volume: 21, Issue: Suppl 1		2020
New pharmacologic agents for insomnia and hypersomnia.
Current opinion in pulmonary medicine, Volume: 26, Issue: 6		2020
Application of different spectrofluorimetric methods for determination of lesinurad and allopurinol in pharmaceutical preparation and human plasma.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, Jan-05, Volume: 244		2021
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0.
HIV medicine, Volume: 21, Issue: 10		2020
Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole;
Molecular pharmaceutics, 12-07, Volume: 17, Issue: 12		2020
Management of posaconazole-induced pseudohyperaldosteronism.
The Journal of antimicrobial chemotherapy, 12-01, Volume: 75, Issue: 12		2020
Evaluating posaconazole dosing regimens of the different formulations against Aspergillus spp. in adults: a pharmacokinetic/pharmacodynamic analysis using Monte Carlo simulation.
International journal of antimicrobial agents, Volume: 56, Issue: 4		2020
Non-invasive monitoring of drug action: A new live in vitro assay design for Chagas' disease drug discovery.
PLoS neglected tropical diseases, Volume: 14, Issue: 7		2020
Initial posaconazole dosing to achieve therapeutic serum posaconazole concentrations among children, adolescents, and young adults receiving delayed-release tablet and intravenous posaconazole.
Pediatric transplantation, Volume: 24, Issue: 6		2020
Comparative assessment of in vitro/in vivo performances of orodispersible electrospun and casting films containing rizatriptan benzoate.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, Volume: 154		2020
Novel methodology to perform incurred sample reanalysis on dried blood spot cards: Experimental data using darolutamide and filgotinib.
Biomedical chromatography : BMC, Volume: 34, Issue: 11		2020
Selinexor (KPT-330), an Oral Selective Inhibitor of Nuclear Export (SINE) Compound, in Combination with FOLFOX in Patients with Metastatic Colorectal Cancer (mCRC) - Final Results of the Phase I Trial SENTINEL.
Current cancer drug targets, Volume: 20, Issue: 10		2020
Optimal oral cyclosporin dosing with concomitant posaconazole post allogeneic stem cell transplantation.
Leukemia & lymphoma, Volume: 61, Issue: 10		2020
A systematic evaluation of zoxamide at enantiomeric level.
The Science of the total environment, Sep-01, Volume: 733		2020
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center.
Medical mycology, Oct-01, Volume: 58, Issue: 7		2020
Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder.
Neurology, 05-26, Volume: 94, Issue: 21		2020
Rufinamide as add-on therapy in children with epileptic encephalopathies other than Lennox-Gastaut syndrome: A study of 34 patients.
Epilepsy & behavior : E&B, Volume: 108		2020
Phase 2 Study of Seviteronel (INO-464) in Patients With Metastatic Castration-Resistant Prostate Cancer After Enzalutamide Treatment.
Clinical genitourinary cancer, Volume: 18, Issue: 4		2020
Isavuconazole as Primary Antifungal Prophylaxis in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-label, Prospective, Phase 2 Study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 05-18, Volume: 72, Issue: 10		2021
The Pharmacokinetic-Pharmacodynamic (PKPD) Relationships of AZD3229, a Novel and Selective Inhibitor of KIT, in a Range of Mouse Xenograft Models of GIST.
Clinical cancer research : an official journal of the American Association for Cancer Research, 07-15, Volume: 26, Issue: 14		2020
Impact of temperature on the toxicity of Kraft 36 EC® (a.s. abamectin) and Score 250 EC® (a.s. difenoconazole) to soil organisms under realistic environmental exposure scenarios.
Ecotoxicology and environmental safety, Volume: 194		2020
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HI
Journal of mass spectrometry : JMS, Volume: 55, Issue: 6		2020
Discovery of LY3325656: A GPR142 agonist suitable for clinical testing in human.
Bioorganic & medicinal chemistry letters, 03-01, Volume: 30, Issue: 5		2020
Implications for IV posaconazole dosing in the era of obesity.
The Journal of antimicrobial chemotherapy, 04-01, Volume: 75, Issue: 4		2020
Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder.
Annals of neurology, Volume: 87, Issue: 3		2020
Probing in Vitro Release Kinetics of Long-Acting Injectable Nanosuspensions via Flow-NMR Spectroscopy.
Molecular pharmaceutics, 02-03, Volume: 17, Issue: 2		2020
Evaluation of target attainment of oral posaconazole suspension in immunocompromised children.
The Journal of antimicrobial chemotherapy, 03-01, Volume: 75, Issue: 3		2020
Alginate Oligosaccharides Affect Mechanical Properties and Antifungal Activity of Alginate Buccal Films with Posaconazole.
Marine drugs, Dec-09, Volume: 17, Issue: 12		2019
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Interactions (206)

ArticleYear
Isavuconazole-tacrolimus drug-drug interactions in HSCT patients.
The Journal of antimicrobial chemotherapy, 10-03, Volume: 78, Issue: 10		2023
Evaluation of the Drug-Drug Interaction Potential of Ensitrelvir Fumaric Acid with Cytochrome P450 3A Substrates in Healthy Japanese Adults.
Clinical drug investigation, Volume: 43, Issue: 5		2023
Ribosome biogenesis-based predictive biomarkers in endocrine therapy (Anastrozole) combined with mTOR inhibitor (Vistusertib) in endometrial cancer: translational study from the VICTORIA trial in collaboration with the GINECO group.
Molecular oncology, Volume: 17, Issue: 1		2023
Study of the metabolic stability profiles of perampanel, rufinamide and stiripentol and prediction of drug interactions using HepaRG cells as an in vitro human model.
Toxicology in vitro : an international journal published in association with BIBRA, Volume: 82		2022
Network Pharmacology Combined with Metabolomics Approach to Investigate the Toxicity Mechanism of Paclobutrazol.
Chemical research in toxicology, 04-18, Volume: 35, Issue: 4		2022
Therapeutic Drug Monitoring for Rufinamide in Japanese Patients With Epilepsy: Focus on Drug Interactions, Tolerability, and Clinical Effectiveness.
Therapeutic drug monitoring, 08-01, Volume: 44, Issue: 4		2022
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Modern rheumatology, Feb-28, Volume: 32, Issue: 2		2022
Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs.
The Lancet. Haematology, Volume: 9, Issue: 1		2022
Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma.
International journal of hematology, Volume: 115, Issue: 2		2022
The Novel PKC Activator 10-Methyl-Aplog-1 Combined with JQ1 Induced Strong and Synergistic HIV Reactivation with Tolerable Global T Cell Activation.
Viruses, 10-09, Volume: 13, Issue: 10		2021
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Investigational new drugs, Volume: 40, Issue: 2		2022
[Clinical observation on horizontal penetration needling combined with rizatriptan monobenzoate tablets for migraine without aura in acute stage].
Zhongguo zhen jiu = Chinese acupuncture & moxibustion, Sep-12, Volume: 41, Issue: 9		2021
Perioperative anidulafungin combined with triazole prophylaxis for the prevention of early invasive candidiasis in lung transplant recipients.
Transplant infectious disease : an official journal of the Transplantation Society, Volume: 23, Issue: 4		2021
Kinase Inhibitors of DNA-PK, ATM and ATR in Combination with Ionizing Radiation Can Increase Tumor Cell Death in HNSCC Cells While Sparing Normal Tissue Cells.
Genes, 06-17, Volume: 12, Issue: 6		2021
Leveraging Physiologically Based Pharmacokinetic Modeling and Experimental Data to Guide Dosing Modification of CYP3A-Mediated Drug-Drug Interactions in the Pediatric Population.
Drug metabolism and disposition: the biological fate of chemicals, Volume: 49, Issue: 9		2021
Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan.
Clinical and translational science, Volume: 14, Issue: 6		2021
Islatravir in combination with doravirine for treatment-naive adults with HIV-1 infection receiving initial treatment with islatravir, doravirine, and lamivudine: a phase 2b, randomised, double-blind, dose-ranging trial.
The lancet. HIV, Volume: 8, Issue: 6		2021
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Investigational new drugs, Volume: 39, Issue: 5		2021
Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug-Drug Interactions of Selinexor with Posaconazole in Rats.
Drug design, development and therapy, Volume: 15		2021
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
The Lancet. Infectious diseases, Volume: 21, Issue: 8		2021
Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study.
Clinical cancer research : an official journal of the American Association for Cancer Research, 06-15, Volume: 27, Issue: 12		2021
BET inhibitors combined with chemotherapy synergistically inhibit the growth of NSCLC cells.
Oncology reports, Volume: 45, Issue: 5		2021
HMG-CoA Reductase Inhibitors (Statins) and their Drug Interactions Involving CYP Enzymes, P-glycoprotein and OATP Transporters-An Overview.
Current drug metabolism, Volume: 22, Issue: 5		2021
A phase 1b trial of selinexor, a first-in-class selective inhibitor of nuclear export (SINE), in combination with doxorubicin in patients with advanced soft tissue sarcomas (STS).
European journal of cancer (Oxford, England : 1990), Volume: 144		2021
Dose adjustment of venetoclax when co-administered with posaconazole: clinical drug-drug interaction predictions using a PBPK approach.
Cancer chemotherapy and pharmacology, Volume: 87, Issue: 4		2021
In vitro synergy of isavuconazole in combination with colistin against Candida auris.
Scientific reports, 12-08, Volume: 10, Issue: 1		2020
Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
Haematologica, 12-01, Volume: 106, Issue: 12		2021
Lack of Drug-Drug Interaction Between Filgotinib, a Selective JAK1 Inhibitor, and Oral Hormonal Contraceptives Levonorgestrel/Ethinyl Estradiol in Healthy Volunteers.
Clinical pharmacology in drug development, Volume: 10, Issue: 4		2021
Clinical Pharmacokinetics of the Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitor Doravirine: An Assessment of the Effect of Patient Characteristics and Drug-Drug Interactions.
Clinical drug investigation, Volume: 40, Issue: 10		2020
PBPK modeling of CYP3A and P-gp substrates to predict drug-drug interactions in patients undergoing Roux-en-Y gastric bypass surgery.
Journal of pharmacokinetics and pharmacodynamics, Volume: 47, Issue: 5		2020
Pentabromobenzyl-RP versus triazole-HILIC columns for separation of the polar basic analytes famotidine and famotidone: LC method development combined with in silico tools to follow the potential consequences of famotidine gastric instability.
Journal of pharmaceutical and biomedical analysis, Jul-15, Volume: 186		2020
Inhibition of TGF-β signalling in combination with nal-IRI plus 5-Fluorouracil/Leucovorin suppresses invasion and prolongs survival in pancreatic tumour mouse models.
Scientific reports, 02-19, Volume: 10, Issue: 1		2020
JQ1 inhibits tumour growth in combination with cisplatin and suppresses JAK/STAT signalling pathway in ovarian cancer.
European journal of cancer (Oxford, England : 1990), Volume: 126		2020
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research, 01-01, Volume: 26, Issue: 1		2020
Clinical Pharmacodynamics, Pharmacokinetics, and Drug Interaction Profile of Doravirine.
Clinical pharmacokinetics, Volume: 58, Issue: 12		2019
Comparative efficacy and safety of lesinurad 200 mg and 400 mg combined with a xanthine oxidase inhibitor in hyperuricemic patients with gout: A Bayesian network meta-analysis of randomized controlled trials
.
International journal of clinical pharmacology and therapeutics, Volume: 57, Issue: 7		2019
Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations.
Scientific reports, 04-10, Volume: 9, Issue: 1		2019
Posaconazole-digoxin drug-drug interaction mediated by inhibition of P-glycoprotein.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, Volume: 25, Issue: 7		2019
Drug-Drug Interaction Between Isavuconazole and Tacrolimus: Is Empiric Dose Adjustment Necessary?
Journal of pharmacy practice, Volume: 33, Issue: 2		2020
Clinical Pharmacokinetics and Drug Interactions of Doravirine.
European journal of drug metabolism and pharmacokinetics, Volume: 43, Issue: 6		2018
Verinurad combined with febuxostat in Japanese adults with gout or asymptomatic hyperuricaemia: a phase 2a, open-label study.
Rheumatology (Oxford, England), 09-01, Volume: 57, Issue: 9		2018
Clinical Drug-Drug Interaction Potential of BFE1224, Prodrug of Antifungal Ravuconazole, Using Two Types of Cocktails in Healthy Subjects.
Clinical and translational science, Volume: 11, Issue: 5		2018
The Effect of Lesinurad in Combination With Allopurinol on Serum Uric Acid Levels in Patients With Gout.
Journal of clinical pharmacology, Volume: 58, Issue: 9		2018
Anti-candidal activity of selected analgesic drugs used alone and in combination with fluconazole, itraconazole, voriconazole, posaconazole and isavuconazole.
Journal de mycologie medicale, Volume: 28, Issue: 2		2018
Pharmacokinetics and Tolerability of Letermovir Coadministered With Azole Antifungals (Posaconazole or Voriconazole) in Healthy Subjects.
Journal of clinical pharmacology, Volume: 58, Issue: 7		2018
Palbociclib in combination with letrozole as first-line treatment for advanced breast cancer: A Japanese phase II study.
Cancer science, Volume: 109, Issue: 3		2018
Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling.
PloS one, Volume: 13, Issue: 1		2018
Lethal effects of Cr(III) alone and in combination with propiconazole and clothianidin in honey bees.
Chemosphere, Volume: 191		2018
Comparative pharmacokinetics study of anastrozole after single administration and combination with celecoxib.
Xenobiotica; the fate of foreign compounds in biological systems, Volume: 48, Issue: 3		2018
Comparison of micellar extraction combined with ionic liquid based vortex-assisted liquid-liquid microextraction and modified quick, easy, cheap, effective, rugged, and safe method for the determination of difenoconazole in cowpea.
Journal of chromatography. A, Oct-06, Volume: 1518		2017
Evaluation of selected Indian medicinal plants for antagonistic potential against Malassezia spp. and the synergistic effect of embelin in combination with ketoconazole.
Microbial pathogenesis, Volume: 110		2017
Trace determination of five triazole fungicide residues in traditional Chinese medicine samples by dispersive solid-phase extraction combined with ultrasound-assisted dispersive liquid-liquid microextraction and UHPLC-MS/MS.
Journal of separation science, Volume: 40, Issue: 16		2017
Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial.
Arthritis & rheumatology (Hoboken, N.J.), Volume: 69, Issue: 9		2017
Gonadotropin-Releasing Hormone Agonist Combined With a Levonorgestrel-Releasing Intrauterine System or Letrozole for Fertility-Preserving Treatment of Endometrial Carcinoma and Complex Atypical Hyperplasia in Young Women.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, Volume: 27, Issue: 6		2017
Comparison of palbociclib in combination with letrozole or fulvestrant with endocrine therapies for advanced/metastatic breast cancer: network meta-analysis.
Current medical research and opinion, Volume: 33, Issue: 8		2017
Evaluation of Active Hexose Correlated Compound (AHCC) in Combination With Anticancer Hormones in Orthotopic Breast Cancer Models.
Integrative cancer therapies, Volume: 16, Issue: 3		2017
Letrozole combined with low dose highly purified HMG for ovulation induction in clomiphene citrate-resistant infertile Chinese women with polycystic ovary syndrome: a prospective study.
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Volume: 33, Issue: 6		2017
Synergistic drug combination effectively blocks Ebola virus infection.
Antiviral research, Volume: 137		2017
Quantitative analysis of pharmacokinetic profiles of verapamil and drug-drug interactions induced by a CYP inhibitor using a stable isotope-labeled compound.
Drug metabolism and pharmacokinetics, Volume: 31, Issue: 6		2016
Results of a Doravirine-Atorvastatin Drug-Drug Interaction Study.
Antimicrobial agents and chemotherapy, Volume: 61, Issue: 2		2017
Anti-tumor activity of selective inhibitor of nuclear export (SINE) compounds, is enhanced in non-Hodgkin lymphoma through combination with mTOR inhibitor and dexamethasone.
Cancer letters, 12-28, Volume: 383, Issue: 2		2016
Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer.
Breast cancer research and treatment, Volume: 160, Issue: 1		2016
Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.
Oncotarget, Dec-06, Volume: 7, Issue: 49		2016
Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study).
Arthritis & rheumatology (Hoboken, N.J.), Volume: 69, Issue: 1		2017
Clinical Drug-Drug Interactions Through Cytochrome P450 3A (CYP3A) for the Selective ALK Inhibitor Alectinib.
Clinical pharmacology in drug development, Volume: 6, Issue: 3		2017
A comparison among different methods of letrozole combined with gonadotropin in an antagonist protocol and high-dose gonadotropin ovarian stimulation antagonist protocol in poor ovarian responders undergoing in vitro fertilization.
Archives of gynecology and obstetrics, Volume: 294, Issue: 5		2016
CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Inflammation research : official journal of the European Histamine Research Society ... [et al.], Volume: 65, Issue: 11		2016
Efficacy and safety of palbociclib in combination with letrozole as first-line treatment of ER-positive, HER2-negative, advanced breast cancer: expanded analyses of subgroups from the randomized pivotal trial PALOMA-1/TRIO-18.
Breast cancer research : BCR, 06-28, Volume: 18, Issue: 1		2016
Pharmacokinetic and Pharmacodynamic Evaluation of the Drug-Drug Interaction Between Isavuconazole and Warfarin in Healthy Subjects.
Clinical pharmacology in drug development, Volume: 6, Issue: 1		2017
Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.
Clinical pharmacology in drug development, Volume: 6, Issue: 1		2017
Drug-Drug Interaction Associated with Mold-Active Triazoles among Hospitalized Patients.
Antimicrobial agents and chemotherapy, Volume: 60, Issue: 6		2016
A Phase I Study of the AKT Inhibitor MK-2206 in Combination with Hormonal Therapy in Postmenopausal Women with Estrogen Receptor-Positive Metastatic Breast Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research, 06-01, Volume: 22, Issue: 11		2016
Lesinurad in combination with allopurinol: results of a phase 2, randomised, double-blind study in patients with gout with an inadequate response to allopurinol.
Annals of the rheumatic diseases, Volume: 75, Issue: 6		2016
Clinical Confirmation that the Selective JAK1 Inhibitor Filgotinib (GLPG0634) has a Low Liability for Drug-drug Interactions.
Drug metabolism letters, Volume: 10, Issue: 1		2016
Use of letrozole and clomiphene citrate combined with gonadotropins in clomiphene-resistant infertile women with polycystic ovary syndrome: a prospective study.
Drug design, development and therapy, Volume: 9		2015
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth.
Drug design, development and therapy, Volume: 9		2015
Phase I/II dose-escalation study of PI3K inhibitors pilaralisib or voxtalisib in combination with letrozole in patients with hormone-receptor-positive and HER2-negative metastatic breast cancer refractory to a non-steroidal aromatase inhibitor.
Breast cancer research and treatment, Volume: 154, Issue: 2		2015
Extended evaluation on the ES-D3 cell differentiation assay combined with the BeWo transport model, to predict relative developmental toxicity of triazole compounds.
Archives of toxicology, Volume: 90, Issue: 5		2016
A randomized phase II study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel in second-line therapy of advanced non-small cell lung cancer (GALAXY-1).
Annals of oncology : official journal of the European Society for Medical Oncology, Volume: 26, Issue: 8		2015
Absence of Drug-Drug Interactions Between Luseogliflozin, a Sodium-Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males.
Advances in therapy, Volume: 32, Issue: 5		2015
The HSP90 inhibitor ganetespib: A potential effective agent for Acute Myeloid Leukemia in combination with cytarabine.
Leukemia research, Volume: 39, Issue: 6		2015
Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.
The Journal of clinical investigation, Volume: 125, Issue: 5		2015
TH-302 in Combination with Radiotherapy Enhances the Therapeutic Outcome and Is Associated with Pretreatment [18F]HX4 Hypoxia PET Imaging.
Clinical cancer research : an official journal of the American Association for Cancer Research, Jul-01, Volume: 21, Issue: 13		2015
Minimal stimulation using gonadotropin combined with clomiphene citrate or letrozole for intrauterine insemination.
Yonsei medical journal, Volume: 56, Issue: 2		2015
A computational modelling approach combined with cellular electrophysiology data provides insights into the therapeutic benefit of targeting the late Na+ current.
The Journal of physiology, Mar-15, Volume: 593, Issue: 6		2015
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.
The Lancet. Oncology, Volume: 16, Issue: 1		2015
Using improved serial blood sampling method of mice to study pharmacokinetics and drug-drug interaction.
Journal of pharmaceutical sciences, Volume: 104, Issue: 3		2015
Effects of modified Shu-Gan-Liang-Xue decoction combined with anastrozole on osteoblastic proliferation and differentiation of MC3T3-E1 cells.
Molecular medicine reports, Volume: 11, Issue: 3		2015
P-glycoprotein inhibition by the agricultural pesticide propiconazole and its hydroxylated metabolites: Implications for pesticide-drug interactions.
Toxicology letters, Jan-05, Volume: 232, Issue: 1		2015
[Effect of genistein combined with anastrozole on mammary tumors in ovariectomized rats].
Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine, Volume: 34, Issue: 4		2014
Fast ultrasound-assisted extraction followed by capillary gas chromatography combined with nitrogen-phosphorous selective detector for the trace determination of tebuconazole in garlic, soil and water samples.
Journal of separation science, Volume: 37, Issue: 11		2014
Safety and efficacy of sitagliptin in combination with transient continuous subcutaneous insulin infusion (CSII) therapy in patients with newly diagnosed type 2 diabetes.
Endocrine journal, Volume: 61, Issue: 5		2014
Clinically relevant drug-drug interactions between antiretrovirals and antifungals.
Expert opinion on drug metabolism & toxicology, Volume: 10, Issue: 4		2014
Norethisterone acetate versus norethisterone acetate combined with letrozole for the treatment of ovarian endometriotic cysts: a patient preference study.
European journal of obstetrics, gynecology, and reproductive biology, Volume: 174		2014
Everolimus in combination with letrozole inhibit human breast cancer MCF-7/Aro stem cells via PI3K/mTOR pathway: an experimental study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, Volume: 35, Issue: 2		2014
Letrozole combined with gonadotropin-releasing hormone analog for metastatic male breast cancer.
Breast cancer research and treatment, Volume: 141, Issue: 1		2013
The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
Human fertility (Cambridge, England), Volume: 16, Issue: 4		2013
In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens.
The Journal of antimicrobial chemotherapy, Volume: 68, Issue: 12		2013
Smac mimetics in combination with TRAIL selectively target cancer stem cells in nasopharyngeal carcinoma.
Molecular cancer therapeutics, Volume: 12, Issue: 9		2013
Synergistic activity of carbosilane dendrimers in combination with maraviroc against HIV in vitro.
AIDS (London, England), Aug-24, Volume: 27, Issue: 13		2013
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Natural Sources (4)

ArticleYear
Direct Keap1-Nrf2 disruption as a potential therapeutic target for Alzheimer's disease.
PLoS genetics, Volume: 13, Issue: 3		2017
The hunt for a selective 17,20 lyase inhibitor; learning lessons from nature.
The Journal of steroid biochemistry and molecular biology, Volume: 163		2016
Synthesis of 3-O-propargylated betulinic acid and its 1,2,3-triazoles as potential apoptotic agents.
European journal of medicinal chemistry, Volume: 63		2013
Essramycin: a first triazolopyrimidine antibiotic isolated from nature.
The Journal of antibiotics, Volume: 61, Issue: 3		2008
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]